1	-	:	O	-	_	0	SENT_1	[p1l57t96r144b130],
2	ORIGINAL	NNP	O	ORIGINAL	nn	7	SENT_1	[p1l158t96r360b130],
3	CONTRIBUTION	NNP	O	CONTRIBUTION	nn	7	SENT_1	[p1l373t96r693b130],
4	ONLINE	NNP	O	ONLINE	nn	7	SENT_1	[p1l59t224r208b255],
5	FIRST	NNP	ORDINAL	FIRST	nn	7	SENT_1	[p1l227t224r335b255],
6	Dosing	NNP	O	Dosing	nn	7	SENT_1	[p1l65t305r352b407],
7	Clopidogrel	NNP	O	Clopidogrel	nsubj	8	SENT_1	[p1l370t299r830b407],
8	Based	VBD	O	base	_	0	SENT_1	[p1l857t299r1097b382],
9	on	IN	O	on	_	0	SENT_1	[p1l1117t324r1218b382],
10	CYPZC19	NN	O	cypzc19	nn	11	SENT_1	[p1l1241t304r1683b382],
11	Genotype	NN	O	genotype	prep_on	8	SENT_1	[p1l1704t304r2101b407],
12	and	CC	O	and	_	0	SENT_1	[p1l60t411r217b494],
13	the	DT	O	the	det	14	SENT_1	[p1l250t411r388b494],
14	Effect	NN	O	effect	conj_and	11	SENT_1	[p1l422t410r669b494],
15	on	IN	O	on	_	0	SENT_1	[p1l696t436r800b494],
16	Platelet	NN	O	platelet	nn	17	SENT_1	[p1l839t411r1157b494],
17	Reactivity	NN	O	reactivity	prep_on	8	SENT_1	[p1l1188t417r1610b519],
18	in	IN	O	in	_	0	SENT_1	[p1l65t529r134b605],
19	Patients	NNS	O	patient	prep_in	17	SENT_1	[p1l173t529r511b606],
20	With	IN	O	with	_	0	SENT_1	[p1l541t523r753b606],
21	Stable	JJ	O	stable	amod	23	SENT_1	[p1l787t523r1048b606],
22	Cardiovascular	NNP	O	Cardiovascular	nn	23	SENT_1	[p1l1083t523r1718b606],
23	Disease	NNP	O	Disease	prep_with	19	SENT_1	[p1l1748t529r2076b606],

1	Jessica	NNP	PERSON	Jessica	nn	2	SENT_2	[p1l11t916r364b1019],
2	L.	NNP	PERSON	L.	_	0	SENT_2	[p1l405t916r504b1009],
3	Mega	JJ	PERSON	mega	dep	2	SENT_2	[p1l549t916r857b1046],
4	,	,	O	,	_	0	SENT_2	[p1l549t916r857b1046],
5	MD	NN	O	md	appos	3	SENT_2	[p1l907t916r1127b1029],
6	,	,	O	,	_	0	SENT_2	[p1l907t916r1127b1029],
7	MPH	NNP	O	MPH	nn	9	SENT_2	[p1l1171t916r1446b1009],
8	Willihald	NNP	PERSON	Willihald	nn	9	SENT_2	[p1l11t1107r496b1203],
9	Hochholzer	NNP	PERSON	Hochholzer	appos	3	SENT_2	[p1l537t1107r1189b1222],
10	,	,	O	,	_	0	SENT_2	[p1l537t1107r1189b1222],
11	MD	NNP	O	MD	nn	15	SENT_2	[p1l1239t1107r1429b1201],
12	Andrew	NNP	PERSON	Andrew	nn	15	SENT_2	[p1l6t1300r422b1394],
13	L.	NNP	PERSON	L.	nn	15	SENT_2	[p1l463t1300r562b1394],
14	Frelinger	NNP	PERSON	Frelinger	nn	15	SENT_2	[p1l607t1300r1094b1430],
15	HI	NNP	O	HI	appos	3	SENT_2	[p1l1135t1300r1300b1413],
16	,	,	O	,	_	0	SENT_2	[p1l1135t1300r1300b1413],
17	PhD	NNP	O	PhD	nn	20	SENT_2	[p1l1350t1300r1586b1393],
18	Michael	NNP	PERSON	Michael	nn	20	SENT_2	[p1l14t1491r436b1587],
19	J.	NNP	PERSON	J.	nn	20	SENT_2	[p1l474t1491r548b1595],
20	Kluk	NNP	PERSON	Kluk	appos	3	SENT_2	[p1l593t1491r879b1606],
21	,	,	O	,	_	0	SENT_2	[p1l593t1491r879b1606],
22	MD	NNP	O	MD	appos	3	SENT_2	[p1l929t1491r1149b1606],
23	,	,	O	,	_	0	SENT_2	[p1l929t1491r1149b1606],
24	PhD	NNP	O	PhD	nn	27	SENT_2	[p1l1193t1491r1429b1585],
25	Dominick	NNP	PERSON	Dominick	nn	27	SENT_2	[p1l14t1680r538b1774],
26	J.	NNP	PERSON	J.	nn	27	SENT_2	[p1l574t1680r648b1784],
27	Angiolillo	NNP	PERSON	Angiolillo	appos	3	SENT_2	[p1l686t1680r1233b1810],
28	,	,	O	,	_	0	SENT_2	[p1l686t1680r1233b1810],
29	MD	NNP	O	MD	nn	32	SENT_2	[p1l1282t1680r1473b1773],
30	Dean	NNP	O	Dean	nn	32	SENT_2	[p1l14t1872r290b1966],
31	J.	NNP	PERSON	J.	nn	32	SENT_2	[p1l329t1872r403b1975],
32	Kereiakes	NNP	PERSON	Kereiakes	appos	3	SENT_2	[p1l449t1872r998b1985],
33	,	,	O	,	_	0	SENT_2	[p1l449t1872r998b1985],
34	MD	NNP	O	MD	nn	36	SENT_2	[p1l1048t1872r1239b1965],
35	Steven	NNP	PERSON	Steven	nn	36	SENT_2	[p1l17t2061r364b2157],
36	Isserman	NNP	PERSON	Isserman	appos	3	SENT_2	[p1l406t2063r909b2176],
37	,	,	O	,	_	0	SENT_2	[p1l406t2063r909b2176],
38	MD	NNP	O	MD	nn	41	SENT_2	[p1l959t2063r1149b2156],
39	William	NNP	PERSON	William	nn	41	SENT_2	[p1l11t2256r427b2350],
40	J.	NNP	PERSON	J.	nn	41	SENT_2	[p1l466t2256r540b2359],
41	Rogers	NNP	PERSON	Rogers	appos	3	SENT_2	[p1l585t2256r972b2386],
42	,	,	O	,	_	0	SENT_2	[p1l585t2256r972b2386],
43	MD	NNP	PERSON	MD	nn	46	SENT_2	[p1l1022t2256r1212b2349],
44	Christian	NNP	PERSON	Christian	nn	46	SENT_2	[p1l15t2447r495b2543],
45	T.	NNP	PERSON	T.	nn	46	SENT_2	[p1l534t2447r637b2542],
46	Ruff	NNP	PERSON	Ruff	appos	3	SENT_2	[p1l683t2447r936b2562],
47	,	,	O	,	_	0	SENT_2	[p1l683t2447r936b2562],
48	MD	NNP	O	MD	appos	3	SENT_2	[p1l986t2447r1206b2562],
49	,	,	O	,	_	0	SENT_2	[p1l986t2447r1206b2562],
50	MPH	NNP	O	MPH	nn	52	SENT_2	[p1l1250t2447r1525b2541],
51	Charles	NNP	PERSON	Charles	nn	52	SENT_2	[p1l15t2639r409b2735],
52	Contant	NNP	PERSON	Contant	appos	3	SENT_2	[p1l452t2639r895b2754],
53	,	,	O	,	_	0	SENT_2	[p1l452t2639r895b2754],
54	PhD	NNP	O	PhD	nn	57	SENT_2	[p1l945t2640r1181b2734],
55	Michael	NNP	PERSON	Michael	nn	57	SENT_2	[p1l14t2833r436b2928],
56	J.	NNP	PERSON	J.	nn	57	SENT_2	[p1l474t2833r548b2937],
57	Pencina	NNP	PERSON	Pencina	appos	3	SENT_2	[p1l593t2833r1047b2946],
58	,	,	O	,	_	0	SENT_2	[p1l593t2833r1047b2946],
59	PhD	NNP	O	PhD	nn	62	SENT_2	[p1l1097t2833r1333b2927],
60	Benjamin	NNP	PERSON	Benjamin	nn	62	SENT_2	[p1l14t3021r522b3152],
61	M.	NNP	PERSON	M.	nn	62	SENT_2	[p1l563t3021r689b3116],
62	Scirica	NNP	PERSON	Scirica	appos	3	SENT_2	[p1l738t3020r1118b3135],
63	,	,	O	,	_	0	SENT_2	[p1l738t3020r1118b3135],
64	MD	NNP	O	MD	appos	3	SENT_2	[p1l1168t3021r1388b3135],
65	,	,	O	,	_	0	SENT_2	[p1l1168t3021r1388b3135],
66	MPH	NNP	O	MPH	nn	69	SENT_2	[p1l1432t3021r1707b3115],
67	Janina	NNP	PERSON	Janina	nn	69	SENT_2	[p1l11t3214r356b3317],
68	A.	NNP	PERSON	A.	nn	69	SENT_2	[p1l389t3214r496b3307],
69	Longtine	NNP	PERSON	Longtine	appos	3	SENT_2	[p1l541t3214r1042b3344],
70	,	,	O	,	_	0	SENT_2	[p1l541t3214r1042b3344],
71	MD	NNP	O	MD	appos	3	SENT_2	[p1l1092t3214r1312b3327],
72	,	,	O	,	_	0	SENT_2	[p1l1092t3214r1312b3327],
73	PhD	NNP	O	PhD	nn	76	SENT_2	[p1l1356t3214r1592b3307],
74	Alan	NNP	PERSON	Alan	nn	76	SENT_2	[p1l6t3405r253b3499],
75	D.	NNP	PERSON	D.	nn	76	SENT_2	[p1l295t3405r406b3499],
76	Michelson	NNP	PERSON	Michelson	appos	3	SENT_2	[p1l452t3405r1023b3518],
77	,	,	O	,	_	0	SENT_2	[p1l452t3405r1023b3518],
78	MD	NNP	O	MD	nn	81	SENT_2	[p1l1072t3405r1262b3498],
79	Marc	NNP	PERSON	Marc	nn	81	SENT_2	[p1l14t3597r279b3692],
80	S.	NNP	PERSON	S.	nn	81	SENT_2	[p1l324t3596r408b3692],
81	Sabatine	NNP	PERSON	Sabatine	appos	3	SENT_2	[p1l457t3596r936b3711],
82	,	,	O	,	_	0	SENT_2	[p1l457t3596r936b3711],
83	MD	NNP	O	MD	appos	3	SENT_2	[p1l986t3597r1206b3711],
84	,	,	O	,	_	0	SENT_2	[p1l986t3597r1206b3711],
85	MPH	NNP	O	MPH	appos	3	SENT_2	[p1l1249t3597r1524b3691],

1	LOPIDOGREL	NNP	O	LOPIDOGREL	nsubj	2	SENT_3	[p2l544t183r1265b254],
2	BLOCKS	VBZ	O	block	_	0	SENT_3	[p2l1326t183r1754b254],
3	THE	DT	O	the	dobj	2	SENT_3	[p2l1821t185r2035b253],

1	platelet	NN	O	platelet	nn	8	SENT_4	[p2l535t310r989b435],
2	P2Y12	NN	O	p2y12	nn	8	SENT_4	[p2l1053t317r1375b422],
3	adenosine	NN	O	adenosine	nn	8	SENT_4	[p2l1441t310r2044b405],
4	diphosphate	NN	O	diphosphate	nn	8	SENT_4	[p2l537t460r1231b585],
5	(	CD	NUMBER	(	num	8	SENT_4	[p2l1293t460r1634b570],
6	ADP	NN	ORGANIZATION	adp	nn	8	SENT_4	[p2l1293t460r1634b570],
7	)	NN	O	)	nn	8	SENT_4	[p2l1293t460r1634b570],
8	receptor	NN	O	receptor	_	0	SENT_4	[p2l1697t494r2043b585, p2l538t633r717b724],
9	,	,	O	,	_	0	SENT_4	[p2l1697t494r2043b585, p2l538t633r717b724],
10	inhibition	NN	O	inhibition	appos	8	SENT_4	[p2l767t611r1303b705],
11	of	IN	O	of	_	0	SENT_4	[p2l1350t609r1458b705],
12	which	WDT	O	which	dep	15	SENT_4	[p2l1492t611r1824b705],
13	has	VBZ	O	have	aux	15	SENT_4	[p2l1869t611r2044b705],
14	been	VBN	O	be	auxpass	15	SENT_4	[p2l11t760r265b856],
15	shown	VBN	O	show	prepc_of	10	SENT_4	[p2l312t760r664b856],
16	to	TO	O	to	aux	17	SENT_4	[p2l714t784r811b856],
17	reduce	VB	O	reduce	xcomp	15	SENT_4	[p2l860t760r1220b856],
18	cardiovascular	JJ	O	cardiovascular	amod	19	SENT_4	[p2l1270t760r2046b856],
19	events	NNS	O	event	dobj	17	SENT_4	[p2l15t934r350b1005],
20	in	IN	O	in	_	0	SENT_4	[p2l391t920r496b1004],
21	patients	NNS	O	patient	prep_in	17	SENT_4	[p2l534t920r956b1035],
22	with	IN	O	with	_	0	SENT_4	[p2l995t911r1237b1005],
23	an	DT	O	a	det	26	SENT_4	[p2l1278t945r1404b1005],
24	acute	JJ	O	acute	amod	26	SENT_4	[p2l1444t934r1724b1005],
25	coronary	JJ	O	coronary	amod	26	SENT_4	[p2l1768t945r2043b1005, p2l13t1096r262b1186],
26	syndrome	NN	O	syndrome	prep_with	21	SENT_4	[p2l315t1061r870b1186],
27	(	CD	NUMBER	(	num	29	SENT_4	[p2l934t1060r1264b1170],
28	ACS	NN	ORGANIZATION	ac	nn	29	SENT_4	[p2l934t1060r1264b1170],
29	)	NN	O	)	nsubjpass	15	SENT_4	[p2l934t1060r1264b1170],
30	and	CC	O	and	_	0	SENT_4	[p2l1328t1061r1531b1156],
31	in	IN	O	in	mark	33	SENT_4	[p2l1584t1071r1691b1154],
32	those	DT	O	those	nsubj	33	SENT_4	[p2l1748t1061r2044b1156],
33	undergoing	VBG	O	undergo	conj_and	15	SENT_4	[p2l12t1213r667b1339],
34	percutaneous	JJ	O	percutaneous	amod	38	SENT_4	[p2l720t1236r1484b1339],
35	coronary	JJ	O	coronary	amod	38	SENT_4	[p2l1543t1248r2047b1339],
36	intervention	NN	O	intervention	nn	38	SENT_4	[p2l13t1372r713b1457],
37	(	NN	O	(	nn	38	SENT_4	[p2l774t1358r1236b1471],
38	PC1	NN	O	pc1	dobj	33	SENT_4	[p2l774t1358r1236b1471],
39	)	CD	NUMBER	)	number	40	SENT_4	[p2l774t1358r1236b1471],
40	.1	CD	NUMBER	.1	num	41	SENT_4	[p2l774t1358r1236b1471],
41	“	NN	O	“	dep	38	SENT_4	[p2l774t1358r1236b1471],
42	*	CD	NUMBER	*	dep	38	SENT_4	[p2l774t1358r1236b1471],
43	Although	IN	O	although	mark	53	SENT_4	[p2l1287t1362r1818b1488],
44	the	DT	O	the	det	49	SENT_4	[p2l1874t1363r2044b1457],
45	standard	JJ	O	standard	amod	49	SENT_4	[p2l14t1514r509b1610],
46	75-mg	JJ	O	75-mg	amod	49	SENT_4	[p2l570t1522r926b1640],
47	daily	JJ	SET	daily	amod	49	SENT_4	[p2l984t1514r1260b1640],
48	maintenance	NN	O	maintenance	nn	49	SENT_4	[p2l1314t1525r2044b1610],
49	dose	NN	O	dose	nsubj	53	SENT_4	[p2l15t1666r256b1760],
50	of	IN	O	of	_	0	SENT_4	[p2l308t1664r417b1760],
51	clopidogrel	NN	O	clopidogrel	prep_of	49	SENT_4	[p2l458t1665r1069b1791],
52	has	VBZ	O	have	aux	53	SENT_4	[p2l1118t1665r1294b1760],
53	proven	VBN	O	prove	advcl	71	SENT_4	[p2l1343t1700r1722b1790],
54	to	TO	O	to	aux	57	SENT_4	[p2l1774t1689r1872b1760],
55	be	VB	O	be	cop	57	SENT_4	[p2l1921t1665r2044b1760],
56	clinically	RB	O	clinically	advmod	57	SENT_4	[p2l15t1816r501b1941],
57	efficacious	JJ	O	efficacious	xcomp	53	SENT_4	[p2l541t1815r1105b1911],
58	in	IN	O	in	_	0	SENT_4	[p2l1146t1826r1250b1909],
59	these	DT	O	these	det	60	SENT_4	[p2l1292t1816r1564b1911],
60	settings	NNS	O	setting	prep_in	57	SENT_4	[p2l1604t1826r2041b1941],
61	,	,	O	,	_	0	SENT_4	[p2l1604t1826r2041b1941],
62	variability	NN	O	variability	nsubjpass	71	SENT_4	[p2l11t1968r579b2094],
63	in	IN	O	in	_	0	SENT_4	[p2l629t1979r736b2061],
64	the	DT	O	the	det	66	SENT_4	[p2l791t1968r959b2064],
65	pharmacodynamic	JJ	O	pharmacodynamic	amod	66	SENT_4	[p2l1011t1968r2044b2094],
66	response	NN	O	response	prep_in	62	SENT_4	[p2l13t2153r484b2244],
67	to	TO	O	to	_	0	SENT_4	[p2l530t2142r628b2214],
68	clopidogrel	NN	O	clopidogrel	prep_to	66	SENT_4	[p2l677t2119r1281b2245],
69	is	VBZ	O	be	auxpass	71	SENT_4	[p2l1324t2128r1405b2214],
70	well	RB	O	well	advmod	71	SENT_4	[p2l1446t2119r1669b2214],
71	recognized	VBN	O	recognize	rcmod	42	SENT_4	[p2l1712t2152r2043b2245, p2l13t2269r333b2384],
72	,	,	O	,	_	0	SENT_4	[p2l1712t2152r2043b2245, p2l13t2269r333b2384],
73	and	CC	O	and	_	0	SENT_4	[p2l378t2269r574b2365],
74	patients	NNS	O	patient	dobj	33	SENT_4	[p2l612t2280r1036b2395],
75	with	IN	O	with	_	0	SENT_4	[p2l1075t2269r1317b2365],
76	higher	JJR	O	higher	amod	78	SENT_4	[p2l1357t2269r1704b2395],
77	platelet	NN	O	platelet	nn	78	SENT_4	[p2l1742t2269r2044b2395, p2l13t2420r146b2516],
78	reactivity	NN	O	reactivity	prep_with	74	SENT_4	[p2l188t2431r688b2546],
79	While	IN	O	while	mark	82	SENT_4	[p2l728t2420r1022b2516],
80	receiving	VBG	O	receive	csubj	82	SENT_4	[p2l1067t2431r1557b2546],
81	clopidogrel	NN	O	clopidogrel	dobj	80	SENT_4	[p2l1603t2420r2044b2546, p2l14t2570r221b2696],
82	are	VBP	O	be	dep	15	SENT_4	[p2l274t2605r436b2665],
83	at	IN	O	at	_	0	SENT_4	[p2l490t2594r587b2665],
84	increased	VBN	O	increase	amod	85	SENT_4	[p2l637t2570r1162b2665],
85	risk	NN	O	risk	prep_at	82	SENT_4	[p2l1213t2570r1424b2665],
86	of	IN	O	of	_	0	SENT_4	[p2l1476t2569r1587b2665],
87	adverse	JJ	O	adverse	amod	89	SENT_4	[p2l1631t2570r2044b2665],
88	cardiovascular	JJ	O	cardiovascular	amod	89	SENT_4	[p2l15t2720r793b2816],
89	events	NNS	O	event	prep_of	85	SENT_4	[p2l833t2717r1240b2816],
90	?	.	O	?	_	0	SENT_4	[p2l833t2717r1240b2816],

1	Clopidogrel	NNP	O	Clopidogrel	nsubj	6	SENT_5	[p2l1287t2720r1949b2846],
2	,	,	O	,	_	0	SENT_5	[p2l1287t2720r1949b2846],
3	a	DT	O	a	det	4	SENT_5	[p2l1994t2755r2044b2816],
4	prodrug	NN	O	prodrug	appos	1	SENT_5	[p2l12t2871r485b2997],
5	,	,	O	,	_	0	SENT_5	[p2l12t2871r485b2997],
6	needs	VBZ	O	need	_	0	SENT_5	[p2l539t2871r846b2966],
7	to	TO	O	to	aux	8	SENT_5	[p2l901t2894r999b2966],
8	undergo	VB	O	undergo	xcomp	6	SENT_5	[p2l1051t2871r1502b2997],
9	biotransContext	NN	O	biotranscontext	dobj	8	SENT_5	[p2l1553t2871r2043b2966, p2l35t3204r257b3248],

1	Variants	NNS	O	variant	_	0	SENT_6	[p2l297t3205r491b3248],
2	in	IN	O	in	_	0	SENT_6	[p2l503t3206r540b3247],
3	the	DT	O	the	det	5	SENT_6	[p2l552t3202r628b3248],
4	C	NN	O	c	nn	5	SENT_6	[p2l641t3205r676b3248],
5	YP2C	NN	O	yp2c	nn	9	SENT_6	[p2l681t3205r811b3248],
6	7	CD	NUMBER	7	number	7	SENT_6	[p2l815t3206r836b3247],
7	9	CD	NUMBER	9	amod	9	SENT_6	[p2l842t3206r871b3247],
8	gene	NN	O	gene	nn	9	SENT_6	[p2l883t3216r999b3261],
9	influence	NN	O	influence	prep_in	1	SENT_6	[p2l1012t3202r1223b3248],
10	the	DT	O	the	det	14	SENT_6	[p2l1233t3202r1309b3248],
11	pharmacologic	JJ	O	pharmacologic	amod	14	SENT_6	[p2l1323t3202r1670b3262],
12	and	CC	O	and	_	0	SENT_6	[p2l1680t3202r1765b3248],
13	clinical	JJ	O	clinical	conj_and	11	SENT_6	[p2l1779t3202r1929b3248],
14	response	NN	O	response	dep	1	SENT_6	[p2l1944t3216r2150b3262],
15	to	TO	O	to	_	0	SENT_6	[p2l34t3273r82b3314],
16	the	DT	O	the	det	21	SENT_6	[p2l98t3269r175b3314],
17	standard	JJ	O	standard	amod	21	SENT_6	[p2l192t3269r399b3314],
18	75-mg	JJ	O	75-mg	amod	21	SENT_6	[p2l418t3273r583b3327],
19	daily	JJ	SET	daily	amod	21	SENT_6	[p2l598t3269r709b3327],
20	maintenance	NN	O	maintenance	nn	21	SENT_6	[p2l727t3272r1036b3314],
21	dose	NN	O	dose	prep_to	14	SENT_6	[p2l1054t3269r1164b3314],
22	of	IN	O	of	_	0	SENT_6	[p2l1182t3268r1231b3314],
23	the	DT	O	the	det	26	SENT_6	[p2l1245t3269r1322b3314],
24	antiplatelet	JJ	O	antiplatelet	amod	26	SENT_6	[p2l1339t3269r1609b3328],
25	drug	NN	O	drug	nn	26	SENT_6	[p2l1624t3269r1736b3327],
26	clopidogrel	NN	O	clopidogrel	prep_of	21	SENT_6	[p2l1752t3269r2029b3328],
27	.	.	O	.	_	0	SENT_6	[p2l1752t3269r2029b3328],

1	Objective	NN	O	objective	nsubj	14	SENT_7	[p3l35t17r310b76],
2	To	TO	O	to	aux	3	SENT_7	[p3l352t20r414b62],
3	test	VB	O	test	infmod	1	SENT_7	[p3l432t21r522b62],
4	whether	IN	O	whether	complm	7	SENT_7	[p3l538t17r746b62],
5	higher	JJR	O	higher	amod	6	SENT_7	[p3l764t17r921b75],
6	doses	NNS	O	dose	nsubj	7	SENT_7	[p3l936t17r1073b62],
7	(	VBP	O	(	ccomp	3	SENT_7	[p3l1092t19r1172b76],
8	up	RP	O	up	prt	7	SENT_7	[p3l1092t19r1172b76],
9	to	TO	O	to	_	0	SENT_7	[p3l1189t21r1238b62],
10	300	CD	NUMBER	300	num	11	SENT_7	[p3l1256t20r1351b62],
11	mg	NN	O	mg	prep_to	7	SENT_7	[p3l1370t31r1448b75],
12	daily	JJ	SET	daily	amod	13	SENT_7	[p3l1465t17r1596b75],
13	)	NN	O	)	dep	11	SENT_7	[p3l1465t17r1596b75],
14	improve	VB	O	improve	_	0	SENT_7	[p3l1617t20r1818b76],
15	the	DT	O	the	det	16	SENT_7	[p3l1835t17r1914b62],
16	response	NN	O	response	dobj	14	SENT_7	[p3l1934t31r2150b76],
17	to	TO	O	to	_	0	SENT_7	[p3l34t87r83b129],
18	clopidogrel	NN	O	clopidogrel	prep_to	14	SENT_7	[p3l104t83r376b143],
19	in	IN	O	in	_	0	SENT_7	[p3l400t87r437b128],
20	the	DT	O	the	det	21	SENT_7	[p3l459t83r538b129],
21	setting	NN	O	setting	prep_in	18	SENT_7	[p3l558t87r726b142],
22	of	IN	O	of	_	0	SENT_7	[p3l745t83r795b129],
23	loss-of-function	JJ	O	loss-of-function	amod	27	SENT_7	[p3l815t83r1206b129],
24	CYP2C	NN	O	cyp2c	nn	27	SENT_7	[p3l1230t86r1469b129],
25	’	CD	NUMBER	’	num	27	SENT_7	[p3l1230t86r1469b129],
26	I9	NN	O	i9	nn	27	SENT_7	[p3l1230t86r1469b129],
27	genotypes	NNS	O	genotype	prep_of	21	SENT_7	[p3l1490t87r1761b143],
28	.	.	O	.	_	0	SENT_7	[p3l1490t87r1761b143],

1	Design	NN	O	design	nsubj	11	SENT_8	[p3l37t165r247b223],
2	,	,	O	,	_	0	SENT_8	[p3l37t165r247b223],
3	Setting	VBG	O	set	appos	1	SENT_8	[p3l268t165r487b223],
4	,	,	O	,	_	0	SENT_8	[p3l268t165r487b223],
5	and	CC	O	and	_	0	SENT_8	[p3l506t163r610b209],
6	Patients	NNS	O	patient	conj_and	1	SENT_8	[p3l631t164r863b209],
7	ELEVATE-TIMI	NN	O	elevate-timus	dep	6	SENT_8	[p3l908t166r1271b209],
8	56	CD	NUMBER	56	num	7	SENT_8	[p3l1292t167r1354b209],
9	was	VBD	O	be	cop	11	SENT_8	[p3l1371t177r1465b209],
10	a	DT	O	a	det	11	SENT_8	[p3l1483t177r1510b209],
11	multicenter	NN	O	multicenter	_	0	SENT_8	[p3l1528t163r1820b217],
12	,	,	O	,	_	0	SENT_8	[p3l1528t163r1820b217],
13	randomized	VBN	O	randomize	partmod	11	SENT_8	[p3l1842t163r2148b217],
14	,	,	O	,	_	0	SENT_8	[p3l1842t163r2148b217],
15	double-blind	JJ	O	double-blind	amod	16	SENT_8	[p3l35t230r349b275],
16	trial	NN	O	trial	appos	11	SENT_8	[p3l372t230r462b275],
17	that	WDT	O	that	nsubj	20	SENT_8	[p3l485t230r585b275],
18	enrolled	VBD	O	enrol	rcmod	16	SENT_8	[p3l605t230r801b275],
19	and	CC	O	and	_	0	SENT_8	[p3l825t230r914b275],
20	genotyped	VBD	O	genotype	rcmod	16	SENT_8	[p3l938t230r1203b289],
21	333	CD	NUMBER	333	num	22	SENT_8	[p3l1226t233r1318b275],
22	patients	NNS	O	patient	dobj	20	SENT_8	[p3l1345t233r1538b289],
23	with	IN	O	with	_	0	SENT_8	[p3l1559t230r1665b275],
24	cardiovascular	JJ	O	cardiovascular	amod	25	SENT_8	[p3l1689t230r2044b275],
25	disease	NN	O	disease	prep_with	20	SENT_8	[p3l2063t230r2148b275, p3l35t312r142b343],
26	across	IN	O	across	_	0	SENT_8	[p3l163t312r312b343],
27	32	CD	NUMBER	32	num	28	SENT_8	[p3l332t301r391b343],
28	sites	NNS	O	site	prep_across	25	SENT_8	[p3l414t301r518b343],
29	from	IN	O	from	_	0	SENT_8	[p3l537t297r653b343],
30	October	NNP	DATE	October	prep_from	28	SENT_8	[p3l677t298r884b343],
31	2010	CD	DATE	2010	num	30	SENT_8	[p3l901t301r1029b343],
32	until	IN	O	until	_	0	SENT_8	[p3l1051t298r1154b343],
33	September	NNP	DATE	September	prep_until	20	SENT_8	[p3l1177t298r1446b357],
34	2011	CD	DATE	2011	num	33	SENT_8	[p3l1464t301r1604b343],
35	.	.	O	.	_	0	SENT_8	[p3l1464t301r1604b343],

1	Interventions	NNS	O	intervention	nn	3	SENT_9	[p3l37t379r420b423],
2	Maintenance	NN	O	maintenance	nn	3	SENT_9	[p3l464t381r789b423],
3	doses	NNS	O	dose	nsubj	17	SENT_9	[p3l806t378r943b423],
4	of	IN	O	of	_	0	SENT_9	[p3l959t377r1009b423],
5	clopidogrel	NN	O	clopidogrel	prep_of	3	SENT_9	[p3l1024t377r1296b437],
6	for	IN	O	for	_	0	SENT_9	[p3l1313t377r1385b423],
7	4	CD	NUMBER	4	num	9	SENT_9	[p3l1397t382r1427b422],
8	treatment	NN	O	treatment	nn	9	SENT_9	[p3l1442t382r1690b423],
9	periods	NNS	O	period	prep_for	5	SENT_9	[p3l1706t378r1898b437],
10	,	,	O	,	_	0	SENT_9	[p3l1706t378r1898b437],
11	each	DT	O	each	appos	3	SENT_9	[p3l1917t377r2028b423],
12	lasting	VBG	O	last	partmod	11	SENT_9	[p3l2048t377r2148b423, p3l37t448r109b503],
13	approximately	RB	O	approximately	quantmod	14	SENT_9	[p3l122t444r466b504],
14	14	CD	DURATION	14	num	15	SENT_9	[p3l482t448r540b489],
15	days	NNS	NUMBER	day	tmod	12	SENT_9	[p3l554t444r674b503],
16	,	,	O	,	_	0	SENT_9	[p3l554t444r674b503],
17	based	VBN	O	base	_	0	SENT_9	[p3l693t444r828b490],
18	on	IN	O	on	_	0	SENT_9	[p3l844t458r902b490],
19	genotype	NN	O	genotype	prep_on	17	SENT_9	[p3l919t448r1158b504],
20	.	.	O	.	_	0	SENT_9	[p3l919t448r1158b504],

1	In	IN	O	in	_	0	SENT_10	[p3l1179t448r1218b489],
2	total	NN	O	total	prep_in	39	SENT_10	[p3l1233t444r1354b497],
3	,	,	O	,	_	0	SENT_10	[p3l1233t444r1354b497],
4	247	CD	NUMBER	247	num	5	SENT_10	[p3l1370t448r1462b489],
5	noncarriers	NNS	O	noncarrier	nsubj	39	SENT_10	[p3l1479t448r1740b490],
6	of	IN	O	of	_	0	SENT_10	[p3l1755t444r1804b490],
7	a	DT	O	a	det	9	SENT_10	[p3l1816t458r1843b490],
8	CYP2C19	NN	O	cyp2c19	nn	9	SENT_10	[p3l1857t445r2149b490],
9	*	NN	O	*	prep_of	5	SENT_10	[p3l1857t445r2149b490],
10	2	CD	NUMBER	2	num	12	SENT_10	[p3l1857t445r2149b490],
11	loss-of-function	JJ	O	loss-of-function	amod	12	SENT_10	[p3l37t511r427b556],
12	allele	NN	O	allele	nsubj	13	SENT_10	[p3l451t511r574b556],
13	were	VBD	O	be	rcmod	9	SENT_10	[p3l594t525r715b556],
14	to	TO	O	to	aux	15	SENT_10	[p3l735t515r784b556],
15	receive	VB	O	receive	xcomp	13	SENT_10	[p3l807t514r977b556],
16	75	CD	NUMBER	75	num	20	SENT_10	[p3l997t515r1058b556],
17	and	CC	O	and	_	0	SENT_10	[p3l1080t511r1168b556],
18	150	CD	NUMBER	150	conj_and	16	SENT_10	[p3l1193t514r1286b556],
19	mg	NN	O	mg	nn	20	SENT_10	[p3l1308t525r1385b569],
20	daily	NN	SET	daily	iobj	15	SENT_10	[p3l1404t511r1519b569],
21	of	IN	O	of	_	0	SENT_10	[p3l1539t511r1589b556],
22	clopidogrel	NN	O	clopidogrel	nn	23	SENT_10	[p3l1608t511r1880b570],
23	(	NN	O	(	prep_of	20	SENT_10	[p3l1904t513r1948b562],
24	2	CD	NUMBER	2	num	25	SENT_10	[p3l1904t513r1948b562],
25	periods	NNS	O	period	tmod	20	SENT_10	[p3l1973t511r2150b570],
26	each	DT	O	each	dobj	15	SENT_10	[p3l35t578r180b631],
27	)	NN	O	)	tmod	15	SENT_10	[p3l35t578r180b631],
28	,	,	O	,	_	0	SENT_10	[p3l35t578r180b631],
29	whereas	IN	O	whereas	mark	32	SENT_10	[p3l197t578r401b623],
30	86	CD	NUMBER	86	num	31	SENT_10	[p3l417t581r478b623],
31	carriers	NNS	O	carrier	nsubj	32	SENT_10	[p3l493t581r666b623],
32	(	VBP	O	(	dep	27	SENT_10	[p3l683t579r762b629],
33	80	CD	NUMBER	80	num	34	SENT_10	[p3l683t579r762b629],
34	heterozygotes	NNS	O	heterozygote	dobj	32	SENT_10	[p3l779t578r1138b636],
35	,	,	O	,	_	0	SENT_10	[p3l779t578r1138b636],
36	6	CD	NUMBER	6	num	37	SENT_10	[p3l1156t581r1185b623],
37	homozygotes	NNS	O	homozygote	appos	34	SENT_10	[p3l1202t578r1549b636],
38	)	CD	NUMBER	)	dep	37	SENT_10	[p3l1202t578r1549b636],
39	were	VBD	O	be	_	0	SENT_10	[p3l1566t592r1685b623],
40	to	TO	O	to	aux	41	SENT_10	[p3l1700t582r1749b623],
41	receive	VB	O	receive	xcomp	39	SENT_10	[p3l1766t581r1934b623],
42	75	CD	NUMBER	75	dobj	41	SENT_10	[p3l1950t582r2024b631],
43	,	,	O	,	_	0	SENT_10	[p3l1950t582r2024b631],
44	150	CD	NUMBER	150	dobj	41	SENT_10	[p3l2045t581r2149b631],
45	,	,	O	,	_	0	SENT_10	[p3l2045t581r2149b631],
46	225	CD	NUMBER	225	dobj	41	SENT_10	[p3l34t647r143b696],
47	,	,	O	,	_	0	SENT_10	[p3l34t647r143b696],
48	and	CC	NUMBER	and	_	0	SENT_10	[p3l166t643r254b688],
49	300	CD	NUMBER	300	num	50	SENT_10	[p3l277t647r372b688],
50	mg	NN	O	mg	dobj	41	SENT_10	[p3l393t657r471b701],
51	daily	RB	SET	daily	advmod	41	SENT_10	[p3l490t643r617b701],
52	.	.	O	.	_	0	SENT_10	[p3l490t643r617b701],

1	Main	NNP	O	Main	nn	4	SENT_11	[p3l34t724r176b769],
2	Outcome	NNP	O	Outcome	nn	4	SENT_11	[p3l192t725r452b769],
3	Measures	NNS	O	measure	nn	4	SENT_11	[p3l467t727r739b769],
4	Platelet	NN	O	platelet	nsubj	7	SENT_11	[p3l783t723r958b769],
5	function	NN	O	function	nn	6	SENT_11	[p3l970t723r1167b769],
6	test	NN	O	test	dep	4	SENT_11	[p3l1183t727r1270b769],
7	results	VBZ	O	result	_	0	SENT_11	[p3l1285t723r1433b769],
8	(	CD	NUMBER	(	num	10	SENT_11	[p3l1450t723r1998b775],
9	vasodilator-stimulated	JJ	O	vasodilator-stimulated	amod	10	SENT_11	[p3l1450t723r1998b775],
10	phosphoprotein	NN	O	phosphoprotein	dep	14	SENT_11	[p3l2017t723r2149b783, p3l37t791r306b850],
11	[	CD	NUMBER	[	num	14	SENT_11	[p3l327t793r496b841],
12	VASP	NN	O	vasp	nn	14	SENT_11	[p3l327t793r496b841],
13	]	NN	O	]	nn	14	SENT_11	[p3l327t793r496b841],
14	phosphorylation	NN	O	phosphorylation	dep	7	SENT_11	[p3l517t791r916b850],
15	and	CC	O	and	_	0	SENT_11	[p3l935t791r1023b836],
16	VerifyNow	NNP	O	VerifyNow	nn	18	SENT_11	[p3l1040t790r1308b849],
17	P2Y12	NN	O	p2y12	nn	18	SENT_11	[p3l1327t794r1459b844],
18	assays	NNS	O	assay	dep	19	SENT_11	[p3l1476t792r1646b849],
19	)	CD	NUMBER	)	dep	7	SENT_11	[p3l1476t792r1646b849],
20	and	CC	O	and	_	0	SENT_11	[p3l1664t791r1752b836],
21	adverse	JJ	O	adverse	amod	22	SENT_11	[p3l1771t791r1959b836],
22	events	NNS	O	event	conj_and	14	SENT_11	[p3l1975t795r2147b836],
23	.	.	O	.	_	0	SENT_11	[p3l1975t795r2147b836],

1	Results	NNS	O	result	nsubj	18	SENT_12	[p3l37t870r234b915],
2	With	IN	O	with	_	0	SENT_12	[p3l274t870r386b915],
3	75	CD	NUMBER	75	num	4	SENT_12	[p3l399t874r457b915],
4	mg	NN	O	mg	prep_with	18	SENT_12	[p3l470t884r545b928],
5	daily	RB	SET	daily	advmod	18	SENT_12	[p3l553t870r670b928],
6	,	,	O	,	_	0	SENT_12	[p3l553t870r670b928],
7	CYP2C19	NN	O	cyp2c19	nn	8	SENT_12	[p3l683t870r966b915],
8	*	NN	O	*	nsubj	18	SENT_12	[p3l683t870r966b915],
9	2	CD	NUMBER	2	num	10	SENT_12	[p3l683t870r966b915],
10	heterozygotes	NNS	O	heterozygote	nsubj	11	SENT_12	[p3l980t870r1304b928],
11	had	VBD	O	have	rcmod	8	SENT_12	[p3l1316t870r1398b915],
12	significantly	RB	O	significantly	advmod	13	SENT_12	[p3l1410t869r1677b928],
13	higher	JJR	O	higher	amod	16	SENT_12	[p3l1689t870r1835b928],
14	on-treatment	JJ	O	on-treatment	amod	16	SENT_12	[p3l1842t874r2152b915],
15	platelet	NN	O	platelet	nn	16	SENT_12	[p3l37t936r213b996],
16	reactivity	NN	O	reactivity	dobj	11	SENT_12	[p3l226t940r441b995],
17	than	IN	O	than	prep	11	SENT_12	[p3l452t936r559b982],
18	did	VBD	O	do	_	0	SENT_12	[p3l573t936r644b982],
19	noncarriers	JJ	O	noncarriers	amod	21	SENT_12	[p3l661t940r924b982],
20	(	CD	NUMBER	(	tmod	19	SENT_12	[p3l938t938r1089b988],
21	VASP	NN	ORGANIZATION	vasp	iobj	18	SENT_12	[p3l938t938r1089b988],
22	platelet	NN	O	platelet	nn	24	SENT_12	[p3l1103t936r1280b996],
23	reactivity	NN	O	reactivity	nn	24	SENT_12	[p3l1292t940r1508b995],
24	index	NN	O	index	dobj	18	SENT_12	[p3l1521t936r1649b982],
25	[	CD	NUMBER	[	num	26	SENT_12	[p3l1665t939r1791b987],
26	PRI	NNP	O	PRI	dep	24	SENT_12	[p3l1665t939r1791b987],
27	]	CD	NUMBER	]	num	26	SENT_12	[p3l1665t939r1791b987],
28	:	:	O	:	_	0	SENT_12	[p3l1665t939r1791b987],
29	mean	VB	O	mean	dep	24	SENT_12	[p3l1809t950r1954b990],
30	,	,	O	,	_	0	SENT_12	[p3l1809t950r1954b990],
31	70.0	CD	PERCENT	70.0	num	32	SENT_12	[p3l1969t938r2148b990],
32	%	NN	PERCENT	%	nsubj	61	SENT_12	[p3l1969t938r2148b990],
33	;	:	O	;	_	0	SENT_12	[p3l1969t938r2148b990],
34	95	CD	PERCENT	95	number	35	SENT_12	[p3l34t1005r148b1049],
35	%	NN	PERCENT	%	amod	36	SENT_12	[p3l34t1005r148b1049],
36	Cl	NN	O	cl	dep	32	SENT_12	[p3l169t1005r233b1056],
37	,	,	O	,	_	0	SENT_12	[p3l169t1005r233b1056],
38	66.0	CD	PERCENT	66.0	num	39	SENT_12	[p3l251t1005r620b1056],
39	%	NN	PERCENT	%	nsubj	61	SENT_12	[p3l251t1005r620b1056],
40	-74.0	CD	PERCENT	-74.0	num	41	SENT_12	[p3l251t1005r620b1056],
41	%	NN	PERCENT	%	dep	39	SENT_12	[p3l251t1005r620b1056],
42	,	,	O	,	_	0	SENT_12	[p3l251t1005r620b1056],
43	vs	CC	O	vs	_	0	SENT_12	[p3l637t1017r686b1048],
44	57.5	CD	PERCENT	57.5	num	45	SENT_12	[p3l701t1005r880b1056],
45	%	NN	PERCENT	%	conj_vs	39	SENT_12	[p3l701t1005r880b1056],
46	;	:	O	;	_	0	SENT_12	[p3l701t1005r880b1056],
47	95	CD	PERCENT	95	number	48	SENT_12	[p3l897t1005r1011b1049],
48	%	NN	PERCENT	%	amod	49	SENT_12	[p3l897t1005r1011b1049],
49	CI	NN	O	ci	dep	45	SENT_12	[p3l1032t1005r1095b1056],
50	,	,	O	,	_	0	SENT_12	[p3l1032t1005r1095b1056],
51	55.1	CD	PERCENT	55.1	num	52	SENT_12	[p3l1113t1007r1212b1048],
52	%	NN	PERCENT	%	conj_and	32	SENT_12	[p3l1229t1005r1483b1056],
53	-59.9	CD	PERCENT	-59.9	num	54	SENT_12	[p3l1229t1005r1483b1056],
54	%	NN	PERCENT	%	dep	52	SENT_12	[p3l1229t1005r1483b1056],
55	,	,	O	,	_	0	SENT_12	[p3l1229t1005r1483b1056],
56	and	CC	O	and	_	0	SENT_12	[p3l1501t1003r1587b1048],
57	VerifyNow	NNP	O	VerifyNow	nn	60	SENT_12	[p3l1604t1002r1866b1061],
58	P2Y12	NN	O	p2y12	nn	60	SENT_12	[p3l1883t1006r2014b1056],
59	reaction	NN	O	reaction	nn	60	SENT_12	[p3l2032t1017r2148b1048, p3l34t1072r120b1114],
60	units	NNS	O	unit	conj_and	32	SENT_12	[p3l134t1072r239b1114],
61	[	VBP	O	[	ccomp	29	SENT_12	[p3l252t1072r397b1120],
62	PRU	NNP	O	PRU	dobj	61	SENT_12	[p3l252t1072r397b1120],
63	]	CD	NUMBER	]	num	62	SENT_12	[p3l252t1072r397b1120],
64	:	:	O	:	_	0	SENT_12	[p3l252t1072r397b1120],
65	mean	VB	O	mean	parataxis	29	SENT_12	[p3l412t1083r551b1122],
66	,	,	O	,	_	0	SENT_12	[p3l412t1083r551b1122],
67	225.6	CD	NUMBER	225.6	dobj	18	SENT_12	[p3l562t1072r709b1122],
68	;	:	O	;	_	0	SENT_12	[p3l562t1072r709b1122],
69	95	CD	PERCENT	95	num	70	SENT_12	[p3l720t1071r831b1115],
70	%	NN	PERCENT	%	dep	67	SENT_12	[p3l720t1071r831b1115],
71	C	NN	O	c	num	70	SENT_12	[p3l846t1071r1557b1122],
72	|	CD	NUMBER	|	number	71	SENT_12	[p3l846t1071r1557b1122],
73	,207.7	CD	NUMBER	,207.7	number	71	SENT_12	[p3l846t1071r1557b1122],
74	-243.4	CD	NUMBER	-243.4	number	71	SENT_12	[p3l846t1071r1557b1122],
75	,	,	O	,	_	0	SENT_12	[p3l846t1071r1557b1122],
76	vs163	CD	NUMBER	vs163	num	77	SENT_12	[p3l846t1071r1557b1122],
77	.6	CD	NUMBER	.6	appos	70	SENT_12	[p3l846t1071r1557b1122],
78	;	:	O	;	_	0	SENT_12	[p3l846t1071r1557b1122],
79	95	CD	PERCENT	95	number	80	SENT_12	[p3l846t1071r1557b1122],
80	%	NN	PERCENT	%	amod	81	SENT_12	[p3l846t1071r1557b1122],
81	Cl	NN	O	cl	dep	70	SENT_12	[p3l1572t1072r1632b1122],
82	,	,	O	,	_	0	SENT_12	[p3l1572t1072r1632b1122],
83	154.4-173	CD	NUMBER	154.4-173	num	84	SENT_12	[p3l1646t1072r1946b1122],
84	.9	NN	NUMBER	.9	appos	81	SENT_12	[p3l1646t1072r1946b1122],
85	;	:	O	;	_	0	SENT_12	[p3l1646t1072r1946b1122],
86	P	NN	O	p	dep	70	SENT_12	[p3l1958t1072r2037b1114],
87	<	JJR	O	<	amod	86	SENT_12	[p3l1958t1072r2037b1114],
88	.001	CD	NUMBER	.001	dep	87	SENT_12	[p3l2050t1072r2141b1114],
89	for	IN	O	for	dep	88	SENT_12	[p3l34t1136r104b1182],
90	both	CC	O	both	dep	67	SENT_12	[p3l117t1136r224b1182],
91	comparisons	NNS	O	comparison	conj	67	SENT_12	[p3l240t1138r572b1196],
92	)	CD	NUMBER	)	dep	91	SENT_12	[p3l240t1138r572b1196],
93	.	.	O	.	_	0	SENT_12	[p3l240t1138r572b1196],

1	Among	IN	O	among	_	0	SENT_13	[p3l587t1140r769b1195],
2	CYP2C19	NN	O	cyp2c19	nn	3	SENT_13	[p3l783t1137r1076b1182],
3	*	NN	O	*	prep_among	14	SENT_13	[p3l783t1137r1076b1182],
4	2	CD	NUMBER	2	num	5	SENT_13	[p3l783t1137r1076b1182],
5	heterozygotes	NNS	O	heterozygote	dep	3	SENT_13	[p3l1094t1136r1447b1195],
6	,	,	O	,	_	0	SENT_13	[p3l1094t1136r1447b1195],
7	doses	NNS	O	dose	nsubj	14	SENT_13	[p3l1463t1136r1596b1182],
8	up	RB	O	up	advmod	14	SENT_13	[p3l1612t1150r1670b1196],
9	to	TO	O	to	_	0	SENT_13	[p3l1682t1140r1731b1182],
10	300	CD	NUMBER	300	num	11	SENT_13	[p3l1744t1140r1838b1182],
11	mg	NN	O	mg	prep_to	8	SENT_13	[p3l1853t1150r1929b1195],
12	daily	JJ	SET	daily	advmod	13	SENT_13	[p3l1941t1136r2052b1195],
13	significantly	RB	O	significantly	advmod	14	SENT_13	[p3l2065t1140r2148b1195, p3l37t1202r249b1261],
14	reduced	VBN	O	reduce	_	0	SENT_13	[p3l263t1203r449b1248],
15	platelet	NN	O	platelet	nn	16	SENT_13	[p3l465t1203r639b1262],
16	reactivity	NN	O	reactivity	nn	41	SENT_13	[p3l651t1206r875b1261],
17	,	,	O	,	_	0	SENT_13	[p3l651t1206r875b1261],
18	with	IN	O	with	_	0	SENT_13	[p3l889t1203r990b1248],
19	VASP	NN	ORGANIZATION	vasp	nn	21	SENT_13	[p3l1003t1205r1138b1248],
20	PRI	NNP	O	PRI	nn	21	SENT_13	[p3l1152t1206r1225b1249],
21	decreasingto	NN	O	decreasingto	prep_with	16	SENT_13	[p3l1240t1203r1551b1261],
22	48.9	CD	PERCENT	48.9	num	23	SENT_13	[p3l1562t1205r1723b1250],
23	%	NN	PERCENT	%	dep	21	SENT_13	[p3l1562t1205r1723b1250],
24	(	CD	PERCENT	(	num	27	SENT_13	[p3l1741t1204r1870b1254],
25	95	CD	PERCENT	95	number	26	SENT_13	[p3l1741t1204r1870b1254],
26	%	NN	PERCENT	%	amod	27	SENT_13	[p3l1741t1204r1870b1254],
27	CI	NN	O	ci	dep	23	SENT_13	[p3l1888t1205r1950b1256],
28	,	,	O	,	_	0	SENT_13	[p3l1888t1205r1950b1256],
29	44.6	CD	PERCENT	44.6	num	30	SENT_13	[p3l1963t1205r2124b1250],
30	%	NN	PERCENT	%	prep_with	16	SENT_13	[p3l1963t1205r2124b1250],
31	53.2	CD	PERCENT	53.2	number	32	SENT_13	[p3l2134t1229r2148b1234, p3l35t1273r138b1314],
32	%	NN	PERCENT	%	amod	30	SENT_13	[p3l149t1271r215b1321],
33	)	CD	NUMBER	)	dep	30	SENT_13	[p3l149t1271r215b1321],
34	and	CC	O	and	_	0	SENT_13	[p3l228t1269r313b1314],
35	PRU	NNP	ORGANIZATION	PRU	conj_and	21	SENT_13	[p3l329t1273r428b1315],
36	to	TO	O	to	_	0	SENT_13	[p3l441t1273r489b1314],
37	127.5	CD	PERCENT	127.5	number	38	SENT_13	[p3l503t1273r637b1314],
38	(	CD	PERCENT	(	prep_to	35	SENT_13	[p3l651t1271r779b1321],
39	95	CD	PERCENT	95	number	40	SENT_13	[p3l651t1271r779b1321],
40	%	NN	PERCENT	%	amod	41	SENT_13	[p3l651t1271r779b1321],
41	C	NN	O	c	dobj	14	SENT_13	[p3l796t1271r1406b1322],
42	|	CD	NUMBER	|	num	43	SENT_13	[p3l796t1271r1406b1322],
43	,109.9	CD	NUMBER	,109.9	dep	48	SENT_13	[p3l796t1271r1406b1322],
44	-145.2	CD	NUMBER	-145.2	num	45	SENT_13	[p3l796t1271r1406b1322],
45	)	NN	O	)	dep	43	SENT_13	[p3l796t1271r1406b1322],
46	(	CD	NUMBER	(	num	47	SENT_13	[p3l796t1271r1406b1322],
47	P	NN	O	p	dep	48	SENT_13	[p3l796t1271r1406b1322],
48	<	JJR	O	<	dep	14	SENT_13	[p3l796t1271r1406b1322],
49	.001	CD	NUMBER	.001	num	50	SENT_13	[p3l796t1271r1406b1322],
50	fortrend	NN	O	fortrend	dep	48	SENT_13	[p3l1425t1269r1624b1314],
51	across	IN	O	across	_	0	SENT_13	[p3l1638t1283r1780b1314],
52	doses	NNS	O	dose	prep_across	14	SENT_13	[p3l1791t1269r1922b1314],
53	for	IN	O	for	_	0	SENT_13	[p3l1932t1269r2001b1314],
54	both	DT	O	both	det	55	SENT_13	[p3l2011t1269r2148b1321],
55	)	NN	O	)	prep_for	52	SENT_13	[p3l2011t1269r2148b1321],
56	.	.	O	.	_	0	SENT_13	[p3l2011t1269r2148b1321],

1	Whereas	IN	O	whereas	mark	11	SENT_14	[p3l34t1336r248b1382],
2	52	CD	PERCENT	52	num	3	SENT_14	[p3l266t1338r379b1383],
3	%	NN	PERCENT	%	nsubj	11	SENT_14	[p3l266t1338r379b1383],
4	of	IN	O	of	_	0	SENT_14	[p3l401t1336r451b1382],
5	C	NN	O	c	nn	7	SENT_14	[p3l467t1339r503b1382],
6	YP2C19	NN	O	yp2c19	nn	7	SENT_14	[p3l508t1337r761b1382],
7	*	NN	O	*	prep_of	3	SENT_14	[p3l508t1337r761b1382],
8	2	CD	NUMBER	2	num	9	SENT_14	[p3l508t1337r761b1382],
9	heterozygotes	NNS	O	heterozygote	dep	7	SENT_14	[p3l782t1336r1122b1395],
10	were	VBD	O	be	cop	11	SENT_14	[p3l1138t1350r1256b1382],
11	nonresponders	NNS	O	nonresponder	advcl	26	SENT_14	[p3l1276t1336r1632b1396],
12	(	CD	NUMBER	(	number	13	SENT_14	[p3l1651t1338r1809b1388],
13	2230	CD	DATE	2230	num	14	SENT_14	[p3l1651t1338r1809b1388],
14	PRU	NNP	O	PRU	dep	11	SENT_14	[p3l1829t1338r1949b1388],
15	)	CD	NUMBER	)	num	14	SENT_14	[p3l1829t1338r1949b1388],
16	with	IN	O	with	_	0	SENT_14	[p3l1967t1336r2070b1382],
17	75	CD	NUMBER	75	num	19	SENT_14	[p3l2089t1340r2149b1382],
18	mg	NN	O	mg	nn	19	SENT_14	[p3l37t1417r113b1461],
19	ofclopidogrel	NN	O	ofclopidogrel	prep_with	14	SENT_14	[p3l124t1402r462b1462],
20	,	,	O	,	_	0	SENT_14	[p3l124t1402r462b1462],
21	only	RB	O	only	quantmod	22	SENT_14	[p3l477t1403r579b1461],
22	10	CD	PERCENT	10	num	23	SENT_14	[p3l593t1405r704b1449],
23	%	NN	PERCENT	%	nsubj	26	SENT_14	[p3l593t1405r704b1449],
24	were	VBD	O	be	cop	26	SENT_14	[p3l721t1417r839b1448],
25	non	JJ	O	non	amod	26	SENT_14	[p3l853t1417r941b1448],
26	responders	NNS	O	responder	_	0	SENT_14	[p3l949t1403r1210b1462],
27	with	IN	O	with	_	0	SENT_14	[p3l1221t1403r1324b1448],
28	225	CD	NUMBER	225	prep_with	26	SENT_14	[p3l1338t1406r1430b1448],
29	or	CC	O	or	_	0	SENT_14	[p3l1443t1417r1493b1448],
30	300	CD	NUMBER	300	num	33	SENT_14	[p3l1503t1406r1596b1448],
31	mg	NN	O	mg	nn	33	SENT_14	[p3l1610t1417r1686b1461],
32	(	NN	O	(	nn	33	SENT_14	[p3l1699t1404r1746b1455],
33	P	NN	O	p	conj_or	26	SENT_14	[p3l1699t1404r1746b1455],
34	<	VBG	O	<	dep	33	SENT_14	[p3l1756t1411r1796b1445],
35	.001	CD	NUMBER	.001	dobj	34	SENT_14	[p3l1811t1406r1907b1448],
36	for	IN	O	for	prep	34	SENT_14	[p3l1927t1402r1997b1448],
37	both	CC	O	both	dep	34	SENT_14	[p3l2009t1403r2148b1454],
38	)	RB	O	)	conj	34	SENT_14	[p3l2009t1403r2148b1454],
39	.	.	O	.	_	0	SENT_14	[p3l2009t1403r2148b1454],

1	Clopidogrel	NNP	O	Clopidogrel	nsubj	7	SENT_15	[p3l36t1471r325b1530],
2	,	,	O	,	_	0	SENT_15	[p3l36t1471r325b1530],
3	225	CD	NUMBER	225	num	4	SENT_15	[p3l339t1474r430b1516],
4	mg	NN	O	mg	appos	1	SENT_15	[p3l446t1485r522b1529],
5	daily	RB	SET	daily	advmod	4	SENT_15	[p3l533t1471r655b1529],
6	,	,	O	,	_	0	SENT_15	[p3l533t1471r655b1529],
7	reduced	VBD	O	reduce	_	0	SENT_15	[p3l672t1471r860b1516],
8	platelet	NN	O	platelet	nn	9	SENT_15	[p3l877t1471r1052b1530],
9	reactivity	NN	O	reactivity	iobj	7	SENT_15	[p3l1064t1474r1278b1529],
10	in	IN	O	in	_	0	SENT_15	[p3l1292t1474r1329b1515],
11	C	NN	O	c	nn	13	SENT_15	[p3l1344t1473r1380b1516],
12	YP2C19	NN	O	yp2c19	nn	13	SENT_15	[p3l1385t1471r1637b1516],
13	*	NN	O	*	prep_in	9	SENT_15	[p3l1385t1471r1637b1516],
14	2	CD	NUMBER	2	num	15	SENT_15	[p3l1385t1471r1637b1516],
15	heterozygotes	NNS	O	heterozygote	dobj	7	SENT_15	[p3l1653t1471r1991b1529],
16	to	TO	O	to	_	0	SENT_15	[p3l2002t1475r2050b1516],
17	levels	NNS	O	level	prep_to	15	SENT_15	[p3l2064t1471r2148b1516, p3l35t1537r95b1583],
18	achieved	VBN	O	achieve	partmod	17	SENT_15	[p3l112t1537r321b1583],
19	with	IN	O	with	_	0	SENT_15	[p3l340t1537r443b1583],
20	standard	JJ	O	standard	amod	21	SENT_15	[p3l462t1537r668b1583],
21	clopidogrel	NN	O	clopidogrel	prep_with	18	SENT_15	[p3l688t1537r966b1597],
22	,	,	O	,	_	0	SENT_15	[p3l688t1537r966b1597],
23	75	CD	NUMBER	75	num	24	SENT_15	[p3l985t1541r1044b1582],
24	mg	NN	O	mg	appos	21	SENT_15	[p3l1064t1551r1153b1596],
25	,	,	O	,	_	0	SENT_15	[p3l1064t1551r1153b1596],
26	in	IN	O	in	_	0	SENT_15	[p3l1173t1541r1210b1582],
27	noncarriers	NNS	O	noncarrier	prep_in	18	SENT_15	[p3l1232t1541r1494b1583],
28	(	CD	NUMBER	(	num	30	SENT_15	[p3l1513t1539r1662b1589],
29	mean	JJ	O	mean	amod	30	SENT_15	[p3l1513t1539r1662b1589],
30	ratios	NNS	O	ratio	dep	27	SENT_15	[p3l1683t1541r1810b1583],
31	of	IN	O	of	_	0	SENT_15	[p3l1827t1537r1876b1583],
32	platelet	NN	O	platelet	nn	33	SENT_15	[p3l1893t1537r2069b1597],
33	reactivity	NN	O	reactivity	prep_of	30	SENT_15	[p3l2086t1551r2148b1583, p3l35t1606r218b1661],
34	,	,	O	,	_	0	SENT_15	[p3l2086t1551r2148b1583, p3l35t1606r218b1661],
35	VASP	NN	ORGANIZATION	vasp	nn	36	SENT_15	[p3l242t1606r377b1648],
36	PRI	NNP	ORGANIZATION	PRI	appos	33	SENT_15	[p3l403t1606r493b1656],
37	,	,	O	,	_	0	SENT_15	[p3l403t1606r493b1656],
38	0.92	CD	NUMBER	0.92	amod	33	SENT_15	[p3l517t1606r639b1656],
39	;	:	O	;	_	0	SENT_15	[p3l517t1606r639b1656],
40	90	CD	PERCENT	90	number	41	SENT_15	[p3l664t1605r778b1649],
41	%	NN	PERCENT	%	amod	42	SENT_15	[p3l664t1605r778b1649],
42	CI	NN	O	ci	dep	30	SENT_15	[p3l807t1606r870b1656],
43	,	,	O	,	_	0	SENT_15	[p3l807t1606r870b1656],
44	0.85-0	CD	NUMBER	0.85-0	number	45	SENT_15	[p3l894t1606r1149b1656],
45	.99	CD	NUMBER	.99	appos	42	SENT_15	[p3l894t1606r1149b1656],
46	,	,	O	,	_	0	SENT_15	[p3l894t1606r1149b1656],
47	and	CC	O	and	_	0	SENT_15	[p3l1174t1603r1261b1648],
48	PRU	NNP	ORGANIZATION	PRU	appos	42	SENT_15	[p3l1289t1606r1405b1656],
49	,	,	O	,	_	0	SENT_15	[p3l1289t1606r1405b1656],
50	0.94	CD	NUMBER	0.94	appos	48	SENT_15	[p3l1430t1606r1552b1656],
51	;	:	O	;	_	0	SENT_15	[p3l1430t1606r1552b1656],
52	90	CD	PERCENT	90	number	53	SENT_15	[p3l1576t1605r1690b1649],
53	%	NN	PERCENT	%	amod	54	SENT_15	[p3l1576t1605r1690b1649],
54	CI	NN	O	ci	dep	30	SENT_15	[p3l1719t1606r1782b1656],
55	,	,	O	,	_	0	SENT_15	[p3l1719t1606r1782b1656],
56	0.84-1	CD	NUMBER	0.84-1	num	58	SENT_15	[p3l1807t1605r2080b1654],
57	.04	CD	NUMBER	.04	num	58	SENT_15	[p3l1807t1605r2080b1654],
58	)	NN	O	)	appos	54	SENT_15	[p3l1807t1605r2080b1654],
59	.	.	O	.	_	0	SENT_15	[p3l1807t1605r2080b1654],

1	In	IN	O	in	_	0	SENT_16	[p3l2109t1606r2148b1647],
2	C	NN	O	c	nn	3	SENT_16	[p3l36t1673r72b1716],
3	YP2C	NN	O	yp2c	prep_in	18	SENT_16	[p3l77t1671r330b1716],
4	’	CD	NUMBER	’	num	6	SENT_16	[p3l77t1671r330b1716],
5	I9	NN	O	i9	nn	6	SENT_16	[p3l77t1671r330b1716],
6	*	NN	O	*	dep	3	SENT_16	[p3l77t1671r330b1716],
7	2	CD	NUMBER	2	num	8	SENT_16	[p3l77t1671r330b1716],
8	homozygotes	NNS	O	homozygote	dep	6	SENT_16	[p3l351t1670r689b1729],
9	,	,	O	,	_	0	SENT_16	[p3l351t1670r689b1729],
10	even	RB	O	even	advmod	6	SENT_16	[p3l709t1685r821b1716],
11	with	IN	O	with	_	0	SENT_16	[p3l841t1670r943b1716],
12	300	CD	NUMBER	300	num	14	SENT_16	[p3l963t1674r1056b1716],
13	mg	NN	O	mg	nn	14	SENT_16	[p3l1075t1685r1151b1729],
14	daily	NN	SET	daily	prep_with	10	SENT_16	[p3l1167t1670r1278b1729],
15	of	IN	O	of	_	0	SENT_16	[p3l1295t1670r1344b1716],
16	clopidogrel	NN	O	clopidogrel	prep_of	14	SENT_16	[p3l1360t1670r1638b1730],
17	,	,	O	,	_	0	SENT_16	[p3l1360t1670r1638b1730],
18	mean	VB	O	mean	_	0	SENT_16	[p3l1660t1685r1790b1716],
19	VASP	NN	ORGANIZATION	vasp	dobj	18	SENT_16	[p3l1808t1673r1943b1716],
20	PRI	NNP	ORGANIZATION	PRI	nsubj	23	SENT_16	[p3l1963t1674r2037b1716],
21	was	VBD	O	be	cop	23	SENT_16	[p3l2057t1685r2150b1716],
22	68.3	CD	PERCENT	68.3	num	23	SENT_16	[p3l35t1738r196b1782],
23	%	NN	PERCENT	%	rcmod	19	SENT_16	[p3l35t1738r196b1782],
24	(	CD	PERCENT	(	num	27	SENT_16	[p3l219t1738r350b1787],
25	95	CD	PERCENT	95	number	26	SENT_16	[p3l219t1738r350b1787],
26	%	NN	PERCENT	%	amod	27	SENT_16	[p3l219t1738r350b1787],
27	Cl	NN	O	cl	attr	23	SENT_16	[p3l373t1739r436b1789],
28	,	,	O	,	_	0	SENT_16	[p3l373t1739r436b1789],
29	44.9	CD	PERCENT	44.9	num	30	SENT_16	[p3l454t1738r829b1787],
30	%	NN	PERCENT	%	appos	27	SENT_16	[p3l454t1738r829b1787],
31	-91.6	CD	PERCENT	-91.6	num	32	SENT_16	[p3l454t1738r829b1787],
32	%	NN	PERCENT	%	dep	30	SENT_16	[p3l454t1738r829b1787],
33	)	CD	NUMBER	)	dep	30	SENT_16	[p3l454t1738r829b1787],
34	and	CC	O	and	_	0	SENT_16	[p3l848t1736r935b1781],
35	mean	VB	O	mean	conj_and	18	SENT_16	[p3l956t1750r1086b1781],
36	PRU	NNP	ORGANIZATION	PRU	dobj	35	SENT_16	[p3l1108t1740r1224b1789],
37	,	,	O	,	_	0	SENT_16	[p3l1108t1740r1224b1789],
38	287.0	CD	PERCENT	287.0	num	42	SENT_16	[p3l1243t1740r1384b1781],
39	(	CD	PERCENT	(	number	40	SENT_16	[p3l1402t1738r1532b1787],
40	95	CD	PERCENT	95	dep	41	SENT_16	[p3l1402t1738r1532b1787],
41	%	NN	PERCENT	%	dep	42	SENT_16	[p3l1402t1738r1532b1787],
42	Cl	NN	O	cl	appos	36	SENT_16	[p3l1555t1739r1618b1789],
43	,	,	O	,	_	0	SENT_16	[p3l1555t1739r1618b1789],
44	170.2-403	CD	NUMBER	170.2-403	num	46	SENT_16	[p3l1640t1738r1973b1787],
45	.8	CD	NUMBER	.8	num	46	SENT_16	[p3l1640t1738r1973b1787],
46	)	NN	O	)	appos	36	SENT_16	[p3l1640t1738r1973b1787],
47	.	.	O	.	_	0	SENT_16	[p3l1640t1738r1973b1787],

1	Conclusion	NN	O	conclusion	npadvmod	59	SENT_17	[p3l35t1829r350b1875],
2	Among	IN	O	among	_	0	SENT_17	[p3l393t1833r579b1888],
3	patients	NNS	O	patient	prep_among	59	SENT_17	[p3l597t1833r790b1889],
4	with	IN	O	with	_	0	SENT_17	[p3l807t1829r913b1875],
5	stable	JJ	O	stable	amod	7	SENT_17	[p3l932t1829r1075b1875],
6	cardiovascular	JJ	O	cardiovascular	amod	7	SENT_17	[p3l1093t1829r1448b1875],
7	disease	NN	O	disease	prep_with	3	SENT_17	[p3l1463t1829r1653b1882],
8	,	,	O	,	_	0	SENT_17	[p3l1463t1829r1653b1882],
9	tripling	VBG	O	triple	partmod	59	SENT_17	[p3l1672t1829r1847b1889],
10	the	DT	O	the	det	12	SENT_17	[p3l1862t1829r1940b1875],
11	maintenance	NN	O	maintenance	nn	12	SENT_17	[p3l1960t1833r2148b1875, p3l37t1911r181b1942],
12	dose	NN	O	dose	dobj	9	SENT_17	[p3l197t1897r311b1942],
13	of	IN	O	of	_	0	SENT_17	[p3l327t1896r378b1942],
14	clopidogrel	NN	O	clopidogrel	prep_of	12	SENT_17	[p3l392t1897r663b1956],
15	to	TO	O	to	_	0	SENT_17	[p3l680t1901r729b1942],
16	225	CD	NUMBER	225	num	17	SENT_17	[p3l745t1900r839b1942],
17	mg	NN	O	mg	prep_to	14	SENT_17	[p3l858t1911r935b1955],
18	daily	RB	SET	daily	advmod	17	SENT_17	[p3l950t1897r1064b1955],
19	in	IN	O	in	_	0	SENT_17	[p3l1081t1900r1119b1941],
20	CYP2C19	NN	O	cyp2c19	nn	21	SENT_17	[p3l1139t1897r1439b1942],
21	*	NN	O	*	prep_in	17	SENT_17	[p3l1139t1897r1439b1942],
22	2	CD	NUMBER	2	num	23	SENT_17	[p3l1139t1897r1439b1942],
23	heterozygotes	NNS	O	heterozygote	tmod	9	SENT_17	[p3l1459t1897r1809b1955],
24	achieved	VBN	O	achieve	partmod	23	SENT_17	[p3l1825t1897r2041b1942],
25	levels	NNS	O	level	nsubj	29	SENT_17	[p3l2061t1897r2148b1942, p3l35t1963r96b2009],
26	of	IN	O	of	_	0	SENT_17	[p3l116t1963r166b2009],
27	platelet	NN	O	platelet	nn	28	SENT_17	[p3l185t1963r368b2023],
28	reactivity	NN	O	reactivity	prep_of	25	SENT_17	[p3l387t1967r611b2022],
29	similar	JJ	O	similar	xcomp	24	SENT_17	[p3l629t1963r788b2009],
30	to	TO	O	to	_	0	SENT_17	[p3l804t1967r853b2009],
31	that	DT	O	that	prep_to	29	SENT_17	[p3l872t1963r972b2009],
32	seen	VBN	O	see	partmod	31	SENT_17	[p3l990t1977r1098b2009],
33	with	IN	O	with	_	0	SENT_17	[p3l1119t1963r1224b2009],
34	the	DT	O	the	det	37	SENT_17	[p3l1245t1963r1324b2009],
35	standard	JJ	O	standard	amod	37	SENT_17	[p3l1343t1963r1556b2009],
36	75-mg	JJ	O	75-mg	amod	37	SENT_17	[p3l1578t1967r1746b2022],
37	dose	NN	O	dose	prep_with	32	SENT_17	[p3l1764t1963r1877b2009],
38	in	IN	O	in	_	0	SENT_17	[p3l1898t1967r1936b2008],
39	noncarriers	NNS	O	noncarrier	prep_in	37	SENT_17	[p3l1960t1977r2148b2009, p3l37t2033r150b2082],
40	;	:	O	;	_	0	SENT_17	[p3l1960t1977r2148b2009, p3l37t2033r150b2082],
41	in	IN	O	in	_	0	SENT_17	[p3l170t2033r208b2074],
42	contrast	NN	O	contrast	prep_in	31	SENT_17	[p3l227t2033r440b2082],
43	,	,	O	,	_	0	SENT_17	[p3l227t2033r440b2082],
44	for	IN	O	for	_	0	SENT_17	[p3l458t2029r530b2074],
45	CYP2C79	NN	O	cyp2c79	nn	46	SENT_17	[p3l545t2030r846b2074],
46	*	NN	O	*	prep_for	31	SENT_17	[p3l545t2030r846b2074],
47	2	CD	NUMBER	2	num	48	SENT_17	[p3l545t2030r846b2074],
48	homozygotes	NNS	O	homozygote	dep	23	SENT_17	[p3l867t2029r1215b2087],
49	,	,	O	,	_	0	SENT_17	[p3l867t2029r1215b2087],
50	doses	NNS	O	dose	nsubj	59	SENT_17	[p3l1234t2029r1370b2074],
51	as	RB	O	as	advmod	52	SENT_17	[p3l1387t2043r1436b2074],
52	high	JJ	O	high	amod	50	SENT_17	[p3l1454t2029r1557b2087],
53	as	IN	O	as	_	0	SENT_17	[p3l1577t2043r1625b2074],
54	300	CD	NUMBER	300	num	55	SENT_17	[p3l1641t2033r1736b2074],
55	mg	NN	O	mg	prep_as	52	SENT_17	[p3l1755t2043r1832b2087],
56	daily	RB	SET	daily	advmod	59	SENT_17	[p3l1847t2029r1962b2087],
57	did	VBD	O	do	aux	59	SENT_17	[p3l1978t2029r2050b2074],
58	not	RB	O	not	neg	59	SENT_17	[p3l2071t2033r2152b2074],
59	result	VB	O	result	_	0	SENT_17	[p3l37t2097r170b2142],
60	in	IN	O	in	_	0	SENT_17	[p3l190t2100r228b2141],
61	comparable	JJ	O	comparable	amod	62	SENT_17	[p3l251t2097r541b2156],
62	degrees	NNS	O	degree	prep_in	59	SENT_17	[p3l562t2097r754b2155],
63	of	IN	O	of	_	0	SENT_17	[p3l774t2096r824b2142],
64	platelet	NN	O	platelet	nn	65	SENT_17	[p3l845t2097r1027b2156],
65	inhibition	NN	O	inhibition	prep_of	62	SENT_17	[p3l1047t2097r1290b2142],
66	.	.	O	.	_	0	SENT_17	[p3l1047t2097r1290b2142],

1	Trial	NN	O	trial	nn	6	SENT_18	[p3l33t2177r156b2222],
2	Registration	NN	O	registration	nn	6	SENT_18	[p3l181t2178r526b2236],
3	clinicaltria	NN	O	clinicaltrium	nn	6	SENT_18	[p3l571t2176r963b2235],
4	|	CD	NUMBER	|	num	6	SENT_18	[p3l571t2176r963b2235],
5	s.	NN	O	s.	nn	6	SENT_18	[p3l571t2176r963b2235],
6	gov	NN	O	gov	_	0	SENT_18	[p3l571t2176r963b2235],
7	Identifier	NNP	O	Identifier	dep	6	SENT_18	[p3l987t2176r1218b2222],
8	:	:	O	:	_	0	SENT_18	[p3l987t2176r1218b2222],
9	NCT01235351	NN	O	nct01235351	dep	7	SENT_18	[p3l1245t2179r1606b2222],

1	JAMA	NN	O	jama	_	0	SENT_19	[p3l31t2266r170b2301],
2	.	.	O	.	_	0	SENT_19	[p3l31t2266r170b2301],

1	201	CD	NUMBER	201	number	2	SENT_20	[p3l191t2266r267b2301],
2	1	CD	NUMBER	1	nsubj	10	SENT_20	[p3l277t2265r599b2308],
3	;	:	O	;	_	0	SENT_20	[p3l277t2265r599b2308],
4	306	CD	NUMBER	306	number	5	SENT_20	[p3l277t2265r599b2308],
5	(	CD	NUMBER	(	dep	2	SENT_20	[p3l277t2265r599b2308],
6	20	CD	NUMBER	20	num	7	SENT_20	[p3l277t2265r599b2308],
7	)	NN	O	)	dep	5	SENT_20	[p3l277t2265r599b2308],
8	:2221	CD	DURATION	:2221	num	9	SENT_20	[p3l277t2265r599b2308],
9	-2228	CD	DURATION	-2228	dep	2	SENT_20	[p3l608t2266r733b2301],
10	Published	VBN	O	publish	_	0	SENT_20	[p3l37t2313r227b2351],
11	online	JJ	O	online	acomp	10	SENT_20	[p3l243t2313r366b2351],
12	November	NNP	DATE	November	tmod	11	SENT_20	[p3l382t2313r596b2351],
13	16	CD	DATE	16	num	12	SENT_20	[p3l610t2315r670b2357],
14	,	,	DATE	,	_	0	SENT_20	[p3l610t2315r670b2357],
15	2011	CD	DATE	2011	num	12	SENT_20	[p3l686t2315r801b2350],
16	.	.	O	.	_	0	SENT_20	[p3l686t2315r801b2350],

1	doi	FW	O	doi	nn	2	SENT_21	[p3l818t2313r1425b2361],
2	:10.1001	FW	O	:10.1001	nsubj	9	SENT_21	[p3l818t2313r1425b2361],
3	/	:	O	/	punct	4	SENT_21	[p3l818t2313r1425b2361],
4	jama	NN	O	jama	dep	2	SENT_21	[p3l818t2313r1425b2361],
5	.2011.1703	CD	NUMBER	.2011.1703	num	7	SENT_21	[p3l818t2313r1425b2361],
6	www.jama.com	NNP	O	www.jama.com	nn	7	SENT_21	[p3l1827t2315r2150b2361],
7	formation	NN	O	formation	dep	4	SENT_21	[p3l35t2479r305b2527],
8	to	TO	O	to	aux	9	SENT_21	[p3l331t2491r380b2527],
9	form	VB	O	form	dep	17	SENT_21	[p3l407t2479r536b2527],
10	an	DT	O	a	det	12	SENT_21	[p3l561t2496r624b2527],
11	active	JJ	O	active	amod	12	SENT_21	[p3l649t2484r805b2527],
12	metabo	NN	O	metabo	dobj	9	SENT_21	[p3l830t2479r1051b2527],
13	—	CD	NUMBER	—	num	15	SENT_21	[p3l830t2479r1051b2527],
14	Author	NN	O	author	nn	15	SENT_21	[p3l1132t2484r1267b2520],
15	Affiliations	NNS	O	affiliation	nsubjpass	17	SENT_21	[p3l1279t2484r1493b2520],
16	are	VBP	O	be	auxpass	17	SENT_21	[p3l1507t2495r1564b2520],
17	listed	VBN	O	list	_	0	SENT_21	[p3l1580t2484r1674b2520],
18	at	IN	O	at	_	0	SENT_21	[p3l1690t2487r1726b2520],
19	the	DT	O	the	det	20	SENT_21	[p3l1738t2484r1798b2520],
20	end	NN	O	end	prep_at	17	SENT_21	[p3l1813t2484r1881b2520],
21	of	IN	O	of	_	0	SENT_21	[p3l1897t2484r1936b2520],
22	this	DT	O	this	det	23	SENT_21	[p3l1948t2484r2013b2520],
23	article	NN	O	article	prep_of	20	SENT_21	[p3l2028t2484r2149b2520],
24	.	.	O	.	_	0	SENT_21	[p3l2028t2484r2149b2520],

1	-	:	O	-	_	0	SENT_22	[p3l58t2559r65b2565],
2	-	:	O	-	_	0	SENT_22	[p3l300t2559r306b2565],
3	-	:	O	-	_	0	SENT_22	[p3l436t2559r442b2565],
4	-	:	O	-	_	0	SENT_22	[p3l530t2559r536b2565],
5	-	:	O	-	_	0	SENT_22	[p3l583t2559r589b2565],
6	-	:	O	-	_	0	SENT_22	[p3l786t2559r792b2565],
7	Corresponding	VBG	O	correspond	csubj	24	SENT_22	[p3l1135t2536r1427b2582],
8	Author	NN	O	author	dobj	7	SENT_22	[p3l1441t2536r1587b2572],
9	:	:	O	:	_	0	SENT_22	[p3l1441t2536r1587b2572],
10	Jessica	NNP	PERSON	Jessica	nn	11	SENT_22	[p3l1604t2539r1731b2572],
11	L.	NNP	PERSON	L.	dobj	7	SENT_22	[p3l1748t2539r1777b2571],
12	Mega	JJ	PERSON	mega	amod	11	SENT_22	[p3l1796t2539r1918b2582],
13	,	,	O	,	_	0	SENT_22	[p3l1796t2539r1918b2582],
14	MD	NN	O	md	dobj	7	SENT_22	[p3l1937t2539r2021b2578],
15	,	,	O	,	_	0	SENT_22	[p3l1937t2539r2021b2578],
16	MPH	NN	O	mph	dobj	7	SENT_22	[p3l2040t2539r2149b2578],
17	,	,	O	,	_	0	SENT_22	[p3l2040t2539r2149b2578],
18	lite	NN	O	lite	dobj	7	SENT_22	[p3l34t2554r139b2611],
19	,	,	O	,	_	0	SENT_22	[p3l34t2554r139b2611],
20	and	CC	O	and	_	0	SENT_22	[p3l168t2554r269b2602],
21	1nt	JJ	O	1nt	amod	23	SENT_22	[p3l295t2554r719b2602],
22	€	NN	O	€	nn	23	SENT_22	[p3l295t2554r719b2602],
23	f1nd1V1dual	NN	O	f1nd1v1dual	conj_and	8	SENT_22	[p3l295t2554r719b2602],
24	dlfferences	VBZ	O	dlfference	parataxis	40	SENT_22	[p3l746t2553r1052b2602],
25	Brigham	NNP	ORGANIZATION	Brigham	dobj	24	SENT_22	[p3l1135t2589r1291b2634],
26	and	CC	ORGANIZATION	and	_	0	SENT_22	[p3l1310t2589r1379b2624],
27	Women	NNP	ORGANIZATION	Women	poss	29	SENT_22	[p3l1397t2591r1584b2624],
28	's	POS	ORGANIZATION	's	_	0	SENT_22	[p3l1397t2591r1584b2624],
29	Hospital	NNP	ORGANIZATION	Hospital	conj_and	25	SENT_22	[p3l1603t2589r1769b2635],
30	,	,	O	,	_	0	SENT_22	[p3l1603t2589r1769b2635],
31	75	CD	NUMBER	75	num	33	SENT_22	[p3l1788t2592r1835b2624],
32	Francis	NNP	PERSON	Francis	nn	33	SENT_22	[p3l1855t2591r1985b2624],
33	St	NNP	PERSON	St	conj_and	25	SENT_22	[p3l2003t2591r2048b2630],
34	,	,	O	,	_	0	SENT_22	[p3l2003t2591r2048b2630],
35	Bosin	NNP	PERSON	Bosin	nn	37	SENT_22	[p3l2069t2591r2149b2624, p3l34t2634r92b2676],
36	clopidogrel	NN	O	clopidogrel	nn	37	SENT_22	[p3l126t2629r478b2692],
37	metabolism	NN	O	metabolism	nsubj	40	SENT_22	[p3l511t2629r869b2677],
38	are	VBP	O	be	cop	40	SENT_22	[p3l903t2646r991b2677],
39	a	DT	O	a	det	40	SENT_22	[p3l1026t2646r1051b2677],
40	ton	NN	O	ton	_	0	SENT_22	[p3l1132t2644r1296b2683],
41	,	,	O	,	_	0	SENT_22	[p3l1132t2644r1296b2683],
42	MA	NNP	O	MA	appos	40	SENT_22	[p3l1132t2644r1296b2683],
43	02115	CD	DATE	02115	number	44	SENT_22	[p3l1311t2642r1884b2687],
44	(	CD	NUMBER	(	num	46	SENT_22	[p3l1311t2642r1884b2687],
45	jmega@partners.org	NN	O	jmega@partners.org	nn	46	SENT_22	[p3l1311t2642r1884b2687],
46	)	NN	O	)	dep	42	SENT_22	[p3l1311t2642r1884b2687],
47	.	.	O	.	_	0	SENT_22	[p3l1311t2642r1884b2687],

1	©	RB	O	©	advmod	2	SENT_23	[p3l195t2732r291b2755],
2	2011	CD	DATE	2011	_	0	SENT_23	[p3l195t2732r291b2755],
3	American	NNP	ORGANIZATION	American	nn	5	SENT_23	[p3l302t2733r442b2755],
4	Medical	NNP	ORGANIZATION	Medical	nn	5	SENT_23	[p3l451t2731r567b2755],
5	Association	NNP	ORGANIZATION	Association	dep	2	SENT_23	[p3l574t2733r753b2755],
6	.	.	O	.	_	0	SENT_23	[p3l574t2733r753b2755],

1	All	DT	O	all	det	2	SENT_24	[p3l763t2731r805b2755],
2	rights	NNS	O	rights	nsubj	3	SENT_24	[p3l814t2731r898b2763],
3	reserved	VBN	O	reserve	_	0	SENT_24	[p3l907t2731r1037b2755],
4	.	.	O	.	_	0	SENT_24	[p3l907t2731r1037b2755],

1	JAMA	NNP	O	JAMA	_	0	SENT_25	[p3l1513t2734r1595b2759],
2	,	,	O	,	_	0	SENT_25	[p3l1513t2734r1595b2759],
3	November	NNP	DATE	November	appos	1	SENT_25	[p3l1606t2732r1736b2755],
4	23/30	CD	DATE	23/30	num	3	SENT_25	[p3l1747t2734r1825b2759],
5	,	,	DATE	,	_	0	SENT_25	[p3l1747t2734r1825b2759],
6	2011	CD	DATE	2011	num	3	SENT_25	[p3l1837t2732r1973b2755],
7	.	.	O	.	_	0	SENT_25	[p3l1837t2732r1973b2755],

1	—	NN	O	—	_	0	SENT_26	[p3l1837t2732r1973b2755],
2	.	.	O	.	_	0	SENT_26	[p3l1837t2732r1973b2755],

1	Vo1	NN	O	vo1	_	0	SENT_27	[p3l1837t2732r1973b2755],
2	306	CD	NUMBER	306	num	1	SENT_27	[p3l1984t2734r2038b2759],
3	,	,	O	,	_	0	SENT_27	[p3l1984t2734r2038b2759],
4	No.	NN	O	no.	appos	1	SENT_27	[p3l2049t2734r2091b2755],
5	20	CD	NUMBER	20	num	4	SENT_27	[p3l2104t2734r2134b2755],

1	2221	CD	DATE	2221	_	0	SENT_28	[p3l6t2775r74b2796],
2	Downloaded	NNP	O	Downloaded	dep	1	SENT_28	[p3l84t2773r261b2796],
3	From	IN	O	from	prep	2	SENT_28	[p3l271t2773r358b2796],
4	:	:	O	:	_	0	SENT_28	[p3l271t2773r358b2796],
5	http://jama.jamanetwork.com/	NN	O	http://jama.jamanetwork.com/	dep	2	SENT_28	[p3l370t2772r807b2803],
6	by	IN	O	by	_	0	SENT_28	[p3l815t2773r849b2803],
7	a	DT	O	a	det	8	SENT_28	[p3l859t2780r874b2796],
8	University	NNP	ORGANIZATION	University	prep_by	5	SENT_28	[p3l883t2772r1031b2803],
9	of	IN	ORGANIZATION	of	_	0	SENT_28	[p3l1040t2772r1069b2796],
10	Wisconsin	NNP	ORGANIZATION	Wisconsin	prep_of	8	SENT_28	[p3l1076t2772r1222b2797],
11	-	:	O	-	_	0	SENT_28	[p3l1232t2772r1365b2796],
12	Madison	NNP	O	Madison	nn	13	SENT_28	[p3l1232t2772r1365b2796],
13	User	NN	O	user	dep	2	SENT_28	[p3l1374t2773r1440b2797],
14	on	IN	O	on	_	0	SENT_28	[p3l1458t2780r1492b2796],
15	01/05/2014	CD	DATE	01/05/2014	prep_on	13	SENT_28	[p3l1501t2772r1652b2797],

1	CLOPIDOGREL	NN	O	clopidogrel	_	0	SENT_29	[p3l59t2903r311b2929],
2	DOSES	NNS	O	dose	dep	1	SENT_29	[p3l322t2903r432b2929],
3	AND	CC	O	and	_	0	SENT_29	[p3l443t2903r519b2928],
4	CYP2C19	NN	O	cyp2c19	nn	5	SENT_29	[p3l532t2903r675b2929],
5	GENOTYPE	NN	O	genotype	dep	1	SENT_29	[p3l688t2903r877b2929],

1	Figure	NNP	O	Figure	_	0	SENT_30	[p3l59t3034r159b3067],
2	1	CD	NUMBER	1	dep	1	SENT_30	[p3l172t3035r200b3059],
3	.	.	O	.	_	0	SENT_30	[p3l172t3035r200b3059],

1	Patient	NN	O	patient	_	0	SENT_31	[p3l214t3035r311b3059],
2	Flow	NN	O	flow	nn	3	SENT_31	[p3l323t3033r388b3059],
3	Diagram	NN	O	diagram	dep	1	SENT_31	[p3l401t3035r519b3067],

1	247	CD	NUMBER	247	num	5	SENT_32	[p4l307t386r393b425],
2	CYP2C79	NN	O	cyp2c79	nn	5	SENT_32	[p4l421t384r708b426],
3	*	NN	O	*	nn	5	SENT_32	[p4l421t384r708b426],
4	2	CD	NUMBER	2	num	5	SENT_32	[p4l421t384r708b426],
5	noncarriers	NNS	O	noncarrier	_	0	SENT_32	[p4l727t385r984b426],
6	allocated	VBN	O	allocate	partmod	5	SENT_32	[p4l1001t385r1208b426],
7	to	TO	O	to	_	0	SENT_32	[p4l1226t387r1270b426],
8	treatment	NN	O	treatment	prep_to	6	SENT_32	[p4l1287t387r1509b426],
9	with	IN	O	with	_	0	SENT_32	[p4l1526t385r1618b425],
10	blinded	JJ	O	blinded	amod	12	SENT_32	[p4l1639t385r1804b426],
11	daily	JJ	SET	daily	amod	12	SENT_32	[p4l421t449r524b499],
12	clopidogrel	NN	O	clopidogrel	prep_with	6	SENT_32	[p4l540t449r792b500],
13	(	CD	NUMBER	(	dep	21	SENT_32	[p4l812t448r934b499],
14	each	DT	O	each	det	16	SENT_32	[p4l812t448r934b499],
15	dose	NN	O	dose	nn	16	SENT_32	[p4l953t449r1165b489],
16	~	NN	O	~	dep	13	SENT_32	[p4l953t449r1165b489],
17	14	CD	DURATION	14	num	18	SENT_32	[p4l953t449r1165b489],
18	days	NNS	NUMBER	day	dep	21	SENT_32	[p4l1184t448r1316b499],
19	)	CD	NUMBER	)	num	21	SENT_32	[p4l1184t448r1316b499],
20	:	:	O	:	_	0	SENT_32	[p4l1184t448r1316b499],
21	75	CD	NUMBER	75	dep	5	SENT_32	[p4l1339t450r1394b489],
22	mg	NN	O	mg	dep	21	SENT_32	[p4l1414t459r1484b500],
23	and	CC	O	and	_	0	SENT_32	[p4l1504t449r1588b489],
24	150	CD	NUMBER	150	num	25	SENT_32	[p4l1611t449r1695b489],
25	mg	NN	O	mg	dep	21	SENT_32	[p4l1714t459r1784b500],

1	14	CD	NUMBER	14	nsubj	2	SENT_33	[p4l1200t653r1253b691],
2	Allocated	VBN	O	allocate	_	0	SENT_33	[p4l1278t652r1492b692],
3	to	TO	O	to	_	0	SENT_33	[p4l1510t654r1555b692],
4	initial	JJ	O	initial	amod	5	SENT_33	[p4l1575t652r1683b692],
5	treatment	NN	O	treatment	prep_to	2	SENT_33	[p4l1700t654r1923b692],
6	but	CC	O	but	_	0	SENT_33	[p4l1942t652r2014b692],
7	discontinued	VBN	O	discontinue	conj_but	2	SENT_33	[p4l1280t715r1575b755],
8	before	IN	O	before	_	0	SENT_33	[p4l1596t715r1740b755],
9	randomization	NN	O	randomization	prep_before	7	SENT_33	[p4l1758t715r2083b755],
10	to	TO	O	to	_	0	SENT_33	[p4l1279t781r1323b819],
11	subsequent	JJ	O	subsequent	amod	12	SENT_33	[p4l1342t778r1613b828],
12	sequences	NNS	O	sequence	prep_to	7	SENT_33	[p4l1631t789r1883b828],

1	233	CD	NUMBER	233	nsubj	2	SENT_34	[p4l861t996r948b1036],
2	Randomized	VBN	O	randomize	_	0	SENT_34	[p4l977t996r1265b1036],

1	116	CD	NUMBER	116	_	0	SENT_35	[p4l263t1218r347b1258],
2	Randomized	VBN	O	randomize	partmod	1	SENT_35	[p4l375t1218r664b1258],
3	to	TO	O	to	aux	4	SENT_35	[p4l682t1220r727b1258],
4	receive	VB	O	receive	xcomp	2	SENT_35	[p4l746t1218r907b1258],
5	117	CD	NUMBER	117	nsubj	20	SENT_35	[p4l1164t1218r1247b1257],
6	Randomized	VBN	O	randomize	partmod	5	SENT_35	[p4l1276t1218r1565b1258],
7	to	TO	O	to	aux	8	SENT_35	[p4l1583t1220r1628b1258],
8	receive	VB	O	receive	xcomp	6	SENT_35	[p4l1647t1218r1807b1258],
9	the	DT	O	the	det	11	SENT_35	[p4l372t1281r444b1321],
10	following	JJ	O	following	amod	11	SENT_35	[p4l461t1281r662b1332],
11	sequence	NN	O	sequence	dobj	8	SENT_35	[p4l682t1291r907b1331],
12	of	IN	O	of	_	0	SENT_35	[p4l925t1281r969b1321],
13	the	DT	O	the	det	15	SENT_35	[p4l1273t1281r1346b1321],
14	following	VBG	O	follow	amod	15	SENT_35	[p4l1362t1281r1563b1332],
15	sequence	NN	O	sequence	prep_of	11	SENT_35	[p4l1582t1291r1808b1331],
16	of	IN	O	of	_	0	SENT_35	[p4l1826t1281r1870b1321],
17	blinded	JJ	O	blinded	amod	19	SENT_35	[p4l375t1344r540b1385],
18	daily	JJ	SET	daily	amod	19	SENT_35	[p4l560t1344r662b1394],
19	clopidogrel	NN	O	clopidogrel	prep_of	15	SENT_35	[p4l679t1344r931b1395],
20	blinded	VBD	O	blind	ccomp	4	SENT_35	[p4l1276t1344r1441b1385],
21	daily	JJ	SET	daily	amod	22	SENT_35	[p4l1461t1344r1563b1394],
22	clopidogrel	NN	O	clopidogrel	dobj	20	SENT_35	[p4l1580t1344r1832b1395],
23	(	CD	NUMBER	(	dep	31	SENT_35	[p4l374t1407r496b1458],
24	each	DT	O	each	det	26	SENT_35	[p4l374t1407r496b1458],
25	dose	NN	O	dose	nn	26	SENT_35	[p4l531t1408r743b1448],
26	~	NN	O	~	dep	23	SENT_35	[p4l531t1408r743b1448],
27	14	CD	DURATION	14	num	28	SENT_35	[p4l531t1408r743b1448],
28	days	NNS	NUMBER	day	dep	31	SENT_35	[p4l761t1407r893b1458],
29	)	CD	NUMBER	)	num	31	SENT_35	[p4l761t1407r893b1458],
30	:	:	O	:	_	0	SENT_35	[p4l761t1407r893b1458],
31	(	CD	NUMBER	(	dep	45	SENT_35	[p4l1275t1407r1397b1458],
32	each	DT	O	each	det	34	SENT_35	[p4l1275t1407r1397b1458],
33	dose	NN	O	dose	nn	34	SENT_35	[p4l1417t1408r1628b1448],
34	~	NN	O	~	dep	31	SENT_35	[p4l1417t1408r1628b1448],
35	14	CD	DURATION	14	num	36	SENT_35	[p4l1417t1408r1628b1448],
36	days	NNS	NUMBER	day	tmod	34	SENT_35	[p4l1647t1407r1779b1458],
37	)	CD	NUMBER	)	dep	34	SENT_35	[p4l1647t1407r1779b1458],
38	:	:	O	:	_	0	SENT_35	[p4l1647t1407r1779b1458],
39	75	CD	NUMBER	75	num	40	SENT_35	[p4l374t1472r430b1512],
40	mg	NN	O	mg	dep	34	SENT_35	[p4l450t1481r520b1522],
41	and	CC	O	and	_	0	SENT_35	[p4l539t1471r624b1512],
42	150	CD	NUMBER	150	num	43	SENT_35	[p4l647t1472r731b1512],
43	mg	NN	O	mg	dep	34	SENT_35	[p4l750t1481r820b1522],
44	150	CD	NUMBER	150	num	45	SENT_35	[p4l1278t1472r1362b1512],
45	mg	NN	O	mg	dep	1	SENT_35	[p4l1381t1481r1451b1522],
46	and	CC	O	and	_	0	SENT_35	[p4l1471t1471r1555b1512],
47	75	CD	NUMBER	75	num	48	SENT_35	[p4l1576t1472r1631b1512],
48	mg	NN	O	mg	dep	1	SENT_35	[p4l1651t1481r1721b1522],

1	237	CD	NUMBER	237	advmod	2	SENT_36	[p4l278t1766r365b1806],
2	Included	VBN	O	include	_	0	SENT_36	[p4l394t1766r587b1806],
3	in	IN	O	in	_	0	SENT_36	[p4l608t1766r641b1805],
4	the	DT	O	the	det	7	SENT_36	[p4l659t1766r732b1806],
5	primary	JJ	O	primary	amod	7	SENT_36	[p4l750t1766r922b1815],
6	analysis	NN	O	analysis	nn	7	SENT_36	[p4l938t1766r1119b1815],
7	(	NN	O	(	prep_in	2	SENT_36	[p4l1138t1765r1197b1815],
8	21	CD	NUMBER	21	dep	7	SENT_36	[p4l1138t1765r1197b1815],
9	follow	VBP	O	follow	dep	2	SENT_36	[p4l1223t1766r1437b1815],
10	—	CD	NUMBER	—	dobj	9	SENT_36	[p4l1223t1766r1437b1815],
11	up	IN	O	up	_	0	SENT_36	[p4l1223t1766r1437b1815],
12	platelet	NN	O	platelet	nn	13	SENT_36	[p4l1456t1766r1620b1815],
13	sample	NN	O	sample	prep_up	9	SENT_36	[p4l1639t1765r1816b1815],
14	)	CD	NUMBER	)	number	15	SENT_36	[p4l1639t1765r1816b1815],
15	10	CD	NUMBER	10	nsubj	2	SENT_36	[p4l311t1832r366b1872],
16	Excluded	VBD	O	exclude	rcmod	15	SENT_36	[p4l394t1831r604b1872],

1	9	CD	NUMBER	9	_	0	SENT_37	[p4l392t1898r419b1938],
2	No	DT	O	no	nsubj	3	SENT_37	[p4l448t1897r511b1938],
3	follow	VB	O	follow	rcmod	1	SENT_37	[p4l528t1897r741b1947],
4	—	CD	NUMBER	—	dobj	3	SENT_37	[p4l528t1897r741b1947],
5	up	IN	O	up	dep	7	SENT_37	[p4l528t1897r741b1947],
6	platelet	NN	O	platelet	nn	7	SENT_37	[p4l761t1897r925b1947],
7	samples	NNS	O	sample	dep	8	SENT_37	[p4l943t1897r1135b1947],
8	1	CD	NUMBER	1	dep	1	SENT_37	[p4l395t1964r409b2003],
9	Determined	VBN	O	determine	partmod	8	SENT_37	[p4l448t1964r712b2004],
10	to	TO	O	to	aux	11	SENT_37	[p4l730t1966r774b2004],
11	have	VB	O	have	xcomp	9	SENT_37	[p4l794t1964r901b2004],
12	another	DT	O	another	det	14	SENT_37	[p4l919t1964r1096b2004],
13	loss	NN	O	loss	nn	14	SENT_37	[p4l1113t1964r1471b2004],
14	—	NN	O	—	dobj	11	SENT_37	[p4l1113t1964r1471b2004],
15	of	IN	O	of	_	0	SENT_37	[p4l1113t1964r1471b2004],
16	—	CD	NUMBER	—	num	19	SENT_37	[p4l1113t1964r1471b2004],
17	function	NN	O	function	nn	19	SENT_37	[p4l1113t1964r1471b2004],
18	CYP2C19	NN	O	cyp2c19	nn	19	SENT_37	[p4l1490t1963r1719b2004],
19	allele	NN	O	allele	prep_of	14	SENT_37	[p4l1738t1964r1850b2004],

1	The	DT	O	the	det	2	SENT_38	[p4l7t2133r106b2182],
2	number	NN	O	number	nsubjpass	10	SENT_38	[p4l131t2133r338b2182],
3	of	IN	O	of	_	0	SENT_38	[p4l357t2133r411b2182],
4	individuals	NNS	O	individual	prep_of	2	SENT_38	[p4l433t2133r711b2182],
5	screened	VBN	O	screen	partmod	4	SENT_38	[p4l733t2133r965b2182],
6	for	IN	O	for	_	0	SENT_38	[p4l989t2133r1065b2182],
7	eligibility	NN	O	eligibility	prep_for	5	SENT_38	[p4l1085t2133r1320b2196],
8	is	VBZ	O	be	auxpass	10	SENT_38	[p4l1343t2136r1375b2182],
9	not	RB	O	not	neg	10	SENT_38	[p4l1400t2137r1487b2182],
10	known	VBN	O	know	_	0	SENT_38	[p4l1509t2133r1702b2182],
11	.	.	O	.	_	0	SENT_38	[p4l1509t2133r1702b2182],

1	source	NN	O	source	_	0	SENT_39	[p4l10t2426r377b2489],
2	of	IN	O	of	_	0	SENT_39	[p4l424t2390r538b2489],
3	the	DT	O	the	det	5	SENT_39	[p4l575t2390r746b2489],
4	Variable	JJ	O	variable	amod	5	SENT_39	[p4l788t2390r1232b2491],
5	response	NN	O	response	prep_of	1	SENT_39	[p4l1276t2426r1770b2522],
6	to	TO	O	to	_	0	SENT_39	[p4l1818t2415r1920b2489],
7	the	DT	O	the	det	9	SENT_39	[p4l1971t2390r2142b2489],
8	antiplatelet	JJ	O	antiplatelet	amod	9	SENT_39	[p4l10t2548r643b2678],
9	medication	NN	O	medication	prep_to	1	SENT_39	[p4l686t2548r1342b2647],
10	.	.	O	.	_	0	SENT_39	[p4l686t2548r1342b2647],

1	Cytochrome	NN	O	cytochrome	nn	2	SENT_40	[p4l153t2705r856b2837],
2	P450	NN	O	p450	nsubj	7	SENT_40	[p4l909t2713r1192b2806],
3	(	CD	NUMBER	(	num	6	SENT_40	[p4l1255t2705r1591b2821],
4	CYP	NN	O	cyp	nn	6	SENT_40	[p4l1255t2705r1591b2821],
5	)	NN	O	)	nn	6	SENT_40	[p4l1255t2705r1591b2821],
6	enzymes	NNS	O	enzyme	dep	2	SENT_40	[p4l1654t2741r2140b2837],
7	play	VBP	O	play	_	0	SENT_40	[p4l8t2864r239b2996],
8	a	DT	O	a	det	10	SENT_40	[p4l274t2900r327b2963],
9	critical	JJ	O	critical	amod	10	SENT_40	[p4l366t2864r736b2963],
10	role	NN	O	role	dobj	7	SENT_40	[p4l770t2864r980b2963],
11	in	IN	O	in	_	0	SENT_40	[p4l1016t2874r1124b2961],
12	the	DT	O	the	det	13	SENT_40	[p4l1162t2864r1329b2963],
13	metabolism	NN	O	metabolism	prep_in	10	SENT_40	[p4l1365t2864r2003b2963],
14	of	IN	O	of	_	0	SENT_40	[p4l2041t2862r2153b2963],
15	clopidogrel	NN	O	clopidogrel	prep_of	13	SENT_40	[p4l12t3023r648b3153],
16	.	.	O	.	_	0	SENT_40	[p4l12t3023r648b3153],

1	Multiple	JJ	O	multiple	amod	2	SENT_41	[p4l684t3023r1148b3153],
2	studies	NNS	O	study	nsubj	4	SENT_41	[p4l1177t3023r1555b3122],
3	have	VBP	O	have	aux	4	SENT_41	[p4l1584t3023r1835b3122],
4	demonstrated	VBN	O	demonstrate	_	0	SENT_41	[p4l1866t3023r2142b3122, p4l12t3180r527b3279],
5	that	IN	O	that	complm	14	SENT_41	[p4l575t3180r788b3279],
6	both	CC	O	both	preconj	7	SENT_41	[p4l831t3180r1085b3280],
7	heterozygotes	NNS	O	heterozygote	nsubj	14	SENT_41	[p4l1131t3180r1891b3312],
8	and	CC	O	and	_	0	SENT_41	[p4l1940t3180r2142b3279],
9	homozygotes	NNS	O	homozygote	nsubj	14	SENT_41	[p4l9t3339r830b3471],
10	for	IN	O	for	_	0	SENT_41	[p4l898t3337r1069b3438],
11	loss-of-function	JJ	O	loss-of-function	amod	13	SENT_41	[p4l1133t3337r2143b3438],
12	CYP2C19	NN	O	cyp2c19	nn	13	SENT_41	[p4l13t3505r521b3599],
13	alleles	NNS	O	allele	prep_for	9	SENT_41	[p4l551t3498r877b3599],
14	have	VBP	O	have	ccomp	4	SENT_41	[p4l907t3498r1156b3599],
15	lower	JJR	O	lower	amod	16	SENT_41	[p4l1184t3499r1490b3599],
16	levels	NNS	O	level	dobj	14	SENT_41	[p4l1517t3498r1814b3599],
17	of	IN	O	of	_	0	SENT_41	[p4l1846t3498r1957b3599],
18	the	DT	O	the	det	21	SENT_41	[p4l1977t3498r2143b3599],
19	active	JJ	O	active	amod	21	SENT_41	[p4l10t3666r324b3755],
20	clopidogrel	NN	O	clopidogrel	nn	21	SENT_41	[p4l368t3656r981b3788],
21	metabolite	NN	O	metabolite	prep_of	16	SENT_41	[p4l1022t3651r1733b3775],
22	,	,	O	,	_	0	SENT_41	[p4l1022t3651r1733b3775],
23	“	NN	O	“	appos	21	SENT_41	[p4l1022t3651r1733b3775],
24	diminished	VBD	O	diminish	partmod	23	SENT_41	[p4l1777t3656r2140b3755, p5l9t22r302b121],

1	platelet	NN	O	platelet	nn	2	SENT_42	[p5l348t22r755b153],
2	inhibition	NN	O	inhibition	nsubj	13	SENT_42	[p5l800t17r1487b141],
3	,	,	O	,	_	0	SENT_42	[p5l800t17r1487b141],
4	”	NN	O	”	conj_and	2	SENT_42	[p5l800t17r1487b141],
5	and	CC	O	and	_	0	SENT_42	[p5l1538t22r1741b121],
6	higher	JJR	O	higher	amod	7	SENT_42	[p5l1787t22r2143b154],
7	rates	NNS	O	rate	conj_and	2	SENT_42	[p5l9t204r261b280],
8	of	IN	O	of	_	0	SENT_42	[p5l294t179r404b280],
9	adverse	JJ	O	adverse	amod	11	SENT_42	[p5l424t180r827b280],
10	cardiovascular	JJ	O	cardiovascular	amod	11	SENT_42	[p5l857t179r1641b280],
11	events	NNS	O	event	prep_of	7	SENT_42	[p5l1670t204r2008b280],
12	as	IN	O	as	amod	11	SENT_42	[p5l2038t215r2142b280],
13	compared	VBN	O	compare	_	0	SENT_42	[p5l12t340r559b470],
14	with	IN	O	with	_	0	SENT_42	[p5l602t340r853b439],
15	noncarriers	NNS	O	noncarrier	prep_with	13	SENT_42	[p5l898t350r1528b439],
16	in	IN	O	in	_	0	SENT_42	[p5l1576t350r1684b437],
17	the	DT	O	the	det	18	SENT_42	[p5l1733t340r1901b439],
18	setting	NN	O	setting	prep_in	13	SENT_42	[p5l1949t364r2140b439, p5l12t507r223b628],
19	of	IN	O	of	_	0	SENT_42	[p5l268t496r380b597],
20	treatment	NN	O	treatment	prep_of	18	SENT_42	[p5l416t521r945b597],
21	with	IN	O	with	_	0	SENT_42	[p5l983t497r1232b597],
22	standard	JJ	O	standard	amod	25	SENT_42	[p5l1274t497r1748b597],
23	75-mg	JJ	O	75-mg	amod	25	SENT_42	[p5l1797t504r2143b628],
24	maintenance	NN	O	maintenance	nn	25	SENT_42	[p5l10t666r757b754],
25	doses	NNS	O	dose	prep_with	13	SENT_42	[p5l813t655r1128b754],
26	of	IN	O	of	_	0	SENT_42	[p5l1187t655r1303b754],
27	clopidogrel	NN	O	clopidogrel	prep_of	25	SENT_42	[p5l1350t650r2141b787],
28	.	.	O	.	_	0	SENT_42	[p5l1350t650r2141b787],

1	”	NNP	O	”	nn	3	SENT_43	[p5l1350t650r2141b787],
2	Regulatory	NNP	O	Regulatory	nn	3	SENT_43	[p5l12t813r610b945],
3	agencies	NNS	O	agency	nsubj	22	SENT_43	[p5l656t823r1145b945],
4	,	,	O	,	_	0	SENT_43	[p5l656t823r1145b945],
5	including	VBG	O	include	_	0	SENT_43	[p5l1195t813r1724b945],
6	the	DT	O	the	det	8	SENT_43	[p5l1772t813r1940b912],
7	US	NNP	ORGANIZATION	US	nn	8	SENT_43	[p5l1986t820r2140b912],
8	Food	NNP	ORGANIZATION	Food	prep_including	3	SENT_43	[p5l10t971r294b1072],
9	and	CC	ORGANIZATION	and	_	0	SENT_43	[p5l340t972r540b1072],
10	Drug	NNP	ORGANIZATION	Drug	nn	14	SENT_43	[p5l585t981r864b1103],
11	Administration	NNP	ORGANIZATION	Administration	nn	14	SENT_43	[p5l905t971r1741b1072],
12	(	CD	NUMBER	(	num	14	SENT_43	[p5l1794t971r2133b1087],
13	FDA	NNP	ORGANIZATION	FDA	nn	14	SENT_43	[p5l1794t971r2133b1087],
14	)	NN	O	)	prep_including	3	SENT_43	[p5l1794t971r2133b1087],
15	and	CC	O	and	_	0	SENT_43	[p5l10t1129r215b1228],
16	the	DT	O	the	det	19	SENT_43	[p5l266t1129r436b1228],
17	European	JJ	ORGANIZATION	european	amod	19	SENT_43	[p5l486t1139r1029b1260],
18	Medicines	NNP	ORGANIZATION	Medicines	nn	19	SENT_43	[p5l1076t1129r1645b1228],
19	Agency	NNP	ORGANIZATION	Agency	prep_including	3	SENT_43	[p5l1693t1135r2137b1261],
20	,	,	O	,	_	0	SENT_43	[p5l1693t1135r2137b1261],
21	have	VBP	O	have	aux	22	SENT_43	[p5l10t1288r258b1387],
22	responded	VBN	O	respond	_	0	SENT_43	[p5l284t1288r848b1418],
23	to	TO	O	to	_	0	SENT_43	[p5l875t1311r975b1387],
24	these	DT	O	these	det	25	SENT_43	[p5l1007t1288r1280b1387],
25	data	NNS	O	datum	prep_to	22	SENT_43	[p5l1309t1288r1553b1387],
26	.	.	O	.	_	0	SENT_43	[p5l1309t1288r1553b1387],

1	In	IN	O	in	_	0	SENT_44	[p5l1591t1296r1702b1385],
2	the	DT	O	the	det	3	SENT_44	[p5l1731t1288r1896b1387],
3	case	NN	O	case	prep_in	12	SENT_44	[p5l1925t1324r2142b1387],
4	of	IN	O	of	_	0	SENT_44	[p5l12t1445r124b1546],
5	the	DT	O	the	det	6	SENT_44	[p5l145t1446r312b1546],
6	FDA	NNP	ORGANIZATION	FDA	prep_of	3	SENT_44	[p5l343t1452r625b1565],
7	,	,	O	,	_	0	SENT_44	[p5l343t1452r625b1565],
8	a	DT	O	a	det	10	SENT_44	[p5l659t1481r713b1546],
9	boxed	JJ	O	boxed	amod	10	SENT_44	[p5l739t1446r1077b1546],
10	warning	NN	O	warning	nsubjpass	12	SENT_44	[p5l1101t1456r1555b1577],
11	was	VBD	O	be	auxpass	12	SENT_44	[p5l1579t1481r1784b1546],
12	added	VBN	O	add	_	0	SENT_44	[p5l1815t1445r2145b1546],
13	to	TO	O	to	_	0	SENT_44	[p5l12t1628r113b1703],
14	the	DT	O	the	det	17	SENT_44	[p5l157t1604r324b1703],
15	clopidogrel	NN	O	clopidogrel	nn	17	SENT_44	[p5l365t1604r979b1736],
16	prescribing	VBG	O	prescribe	amod	17	SENT_44	[p5l1015t1604r1631b1736],
17	information	NN	O	information	prep_to	12	SENT_44	[p5l1667t1602r2140b1703, p5l12t1772r225b1861],
18	that	IN	O	that	nsubj	19	SENT_44	[p5l252t1762r461b1861],
19	recommends	VBZ	O	recommend	rcmod	17	SENT_44	[p5l485t1762r1181b1861],
20	considering	VBG	O	consider	xcomp	19	SENT_44	[p5l1212t1762r1840b1892],
21	alternative	JJ	O	alternative	amod	23	SENT_44	[p5l1866t1762r2140b1861, p5l10t1930r345b2020],
22	treatment	NN	O	treatment	nn	23	SENT_44	[p5l396t1944r935b2018],
23	strategies	NNS	O	strategy	dobj	20	SENT_44	[p5l981t1929r1499b2051],
24	in	IN	O	in	_	0	SENT_44	[p5l1548t1930r1657b2017],
25	patients	NNS	O	patient	prep_in	20	SENT_44	[p5l1703t1930r2141b2051],
26	with	IN	O	with	_	0	SENT_44	[p5l7t2077r256b2176],
27	particular	JJ	O	particular	amod	29	SENT_44	[p5l290t2077r822b2208],
28	C	NN	O	c	nn	29	SENT_44	[p5l861t2083r940b2176],
29	YP2C	NN	O	yp2c	prep_with	25	SENT_44	[p5l948t2083r1240b2177],
30	19	CD	NUMBER	19	num	31	SENT_44	[p5l1251t2083r1372b2176],
31	genotypes	NNS	O	genotype	dep	29	SENT_44	[p5l1410t2101r1985b2209],
32	.	.	O	.	_	0	SENT_44	[p5l1410t2101r1985b2209],

1	As	IN	O	as	_	0	SENT_45	[p5l144t2243r285b2336],
2	such	JJ	O	such	prep_such_as	6	SENT_45	[p5l343t2237r646b2356],
3	,	,	O	,	_	0	SENT_45	[p5l343t2237r646b2356],
4	data	NNS	O	datum	nsubjpass	6	SENT_45	[p5l709t2237r948b2336],
5	are	VBP	O	be	auxpass	6	SENT_45	[p5l1006t2272r1176b2336],
6	needed	VBN	O	need	_	0	SENT_45	[p5l1233t2237r1649b2336],
7	to	TO	O	to	aux	8	SENT_45	[p5l1708t2261r1812b2336],
8	offer	VB	O	offer	xcomp	6	SENT_45	[p5l1874t2236r2143b2336],
9	guidance	NN	O	guidance	dobj	8	SENT_45	[p5l10t2393r516b2525],
10	as	IN	O	as	_	0	SENT_45	[p5l567t2429r673b2492],
11	to	TO	O	to	prepc_as_to	8	SENT_45	[p5l727t2418r828b2492],
12	what	WP	O	what	nsubj	14	SENT_45	[p5l879t2393r1158b2492],
13	might	MD	O	might	aux	14	SENT_45	[p5l1203t2393r1535b2525],
14	constitute	VB	O	constitute	pcomp	8	SENT_45	[p5l1584t2403r2143b2492],
15	optimal	JJ	O	optimal	amod	17	SENT_45	[p5l12t2551r467b2681],
16	treatment	NN	O	treatment	nn	17	SENT_45	[p5l528t2574r1108b2650],
17	strategies	NNS	O	strategy	dobj	14	SENT_45	[p5l1164t2561r1726b2681],
18	in	IN	O	in	_	0	SENT_45	[p5l1787t2561r1901b2648],
19	patients	NNS	O	patient	prep_in	14	SENT_45	[p5l1957t2587r2140b2681, p5l12t2718r317b2807],
20	with	IN	O	with	_	0	SENT_45	[p5l366t2707r620b2808],
21	loss-of-function	JJ	O	loss-of-function	amod	22	SENT_45	[p5l669t2707r1566b2807],
22	CYP2C19	NN	O	cyp2c19	prep_with	19	SENT_45	[p5l1619t2714r2142b2808],

1	41	CD	NUMBER	41	_	0	SENT_46	[p6l421t821r466b857],
2	Randomized	VBN	O	randomize	rcmod	1	SENT_46	[p6l502t820r771b857],
3	to	TO	O	to	aux	4	SENT_46	[p6l788t822r830b857],
4	receive	VB	O	receive	xcomp	2	SENT_46	[p6l848t820r998b857],
5	the	DT	O	the	det	7	SENT_46	[p6l498t879r566b917],
6	following	JJ	O	following	amod	7	SENT_46	[p6l581t879r769b926],
7	sequence	NN	O	sequence	dobj	4	SENT_46	[p6l788t889r999b926],
8	of	IN	O	of	_	0	SENT_46	[p6l1015t879r1056b917],
9	blinded	JJ	O	blinded	amod	11	SENT_46	[p6l501t938r656b976],
10	daily	JJ	SET	daily	amod	11	SENT_46	[p6l674t938r770b985],
11	clopidogrel	NN	O	clopidogrel	prep_of	7	SENT_46	[p6l786t938r1020b986],
12	(	CD	NUMBER	(	dep	18	SENT_46	[p6l501t997r614b1044],
13	each	DT	O	each	det	15	SENT_46	[p6l501t997r614b1044],
14	dose	NN	O	dose	nn	15	SENT_46	[p6l633t998r830b1035],
15	~	NN	O	~	dep	12	SENT_46	[p6l633t998r830b1035],
16	14	CD	DURATION	14	num	17	SENT_46	[p6l633t998r830b1035],
17	days	NNS	NUMBER	day	dep	18	SENT_46	[p6l848t997r972b1044],
18	)	CD	NUMBER	)	dep	29	SENT_46	[p6l848t997r972b1044],
19	:	:	O	:	_	0	SENT_46	[p6l848t997r972b1044],
20	225	CD	NUMBER	225	num	21	SENT_46	[p6l500t1057r581b1095],
21	mg	NN	O	mg	dep	18	SENT_46	[p6l600t1066r665b1104],
22	and	CC	O	and	_	0	SENT_46	[p6l683t1057r762b1095],
23	300	CD	NUMBER	300	num	24	SENT_46	[p6l780t1057r862b1095],
24	mg	NN	O	mg	dep	29	SENT_46	[p6l880t1066r945b1104],
25	86	CD	NUMBER	86	num	27	SENT_46	[p6l483t43r536b80],
26	CYP2C79	NN	O	cyp2c79	nn	27	SENT_46	[p6l561t42r829b80],
27	*	NN	O	*	dep	24	SENT_46	[p6l561t42r829b80],
28	2	CD	NUMBER	2	num	29	SENT_46	[p6l561t42r829b80],
29	carriers	NNS	O	carrier	dep	1	SENT_46	[p6l846t42r1004b80],
30	allocated	VBN	O	allocate	partmod	29	SENT_46	[p6l1021t42r1213b80],
31	to	TO	O	to	_	0	SENT_46	[p6l1230t45r1272b80],
32	treatment	NN	O	treatment	dep	40	SENT_46	[p6l1288t45r1495b80],
33	with	IN	O	with	_	0	SENT_46	[p6l1510t42r1597b80],
34	blinded	JJ	O	blinded	amod	36	SENT_46	[p6l1616t42r1771b80],
35	daily	JJ	SET	daily	amod	36	SENT_46	[p6l561t102r657b149],
36	clopidogrel	NN	O	clopidogrel	prep_with	32	SENT_46	[p6l673t102r908b149],
37	(	CD	NUMBER	(	dep	40	SENT_46	[p6l927t101r1040b149],
38	each	DT	O	each	det	40	SENT_46	[p6l927t101r1040b149],
39	dose	NN	O	dose	nn	40	SENT_46	[p6l1059t102r1255b140],
40	~	NN	O	~	dep	43	SENT_46	[p6l1059t102r1255b140],
41	i4	NN	O	i4	nn	42	SENT_46	[p6l1059t102r1255b140],
42	days	NNS	DURATION	day	dep	40	SENT_46	[p6l1273t101r1396b149],
43	)	CD	NUMBER	)	dep	46	SENT_46	[p6l1273t101r1396b149],
44	:	:	O	:	_	0	SENT_46	[p6l1273t101r1396b149],
45	75	CD	NUMBER	75	num	46	SENT_46	[p6l1417t103r1469b140],
46	mg	NN	O	mg	prep_to	30	SENT_46	[p6l1488t111r1553b149],
47	and	CC	O	and	_	0	SENT_46	[p6l1572t102r1650b140],
48	150	CD	NUMBER	150	num	49	SENT_46	[p6l1672t102r1750b140],
49	mg	NN	O	mg	prep_to	30	SENT_46	[p6l1768t111r1833b149],

1	82	CD	NUMBER	82	nsubj	2	SENT_47	[p6l983t613r1036b651],
2	Randomized	VBN	O	randomize	_	0	SENT_47	[p6l1064t613r1333b651],

1	82	CD	NUMBER	82	nsubj	2	SENT_48	[p6l454t1332r506b1369],
2	Included	VBN	O	include	_	0	SENT_48	[p6l535t1332r714b1369],
3	in	IN	O	in	_	0	SENT_48	[p6l734t1332r765b1369],
4	the	DT	O	the	det	6	SENT_48	[p6l782t1332r849b1369],
5	primary	JJ	O	primary	amod	6	SENT_48	[p6l867t1332r1027b1378],
6	analysis	NN	O	analysis	prep_in	2	SENT_48	[p6l1042t1332r1211b1378],
7	(	CD	NUMBER	(	number	8	SENT_48	[p6l1229t1331r1284b1378],
8	21	CD	NUMBER	21	num	12	SENT_48	[p6l1229t1331r1284b1378],
9	follow-up	NN	O	follow-up	nn	12	SENT_48	[p6l1309t1332r1508b1378],
10	platelet	NN	O	platelet	nn	12	SENT_48	[p6l1527t1332r1680b1378],
11	sample	NN	O	sample	nn	12	SENT_48	[p6l1697t1331r1863b1378],
12	)	NN	O	)	dep	6	SENT_48	[p6l1697t1331r1863b1378],

1	77	CD	NUMBER	77	num	3	SENT_49	[p6l533t1394r585b1430],
2	CYP2C79	NN	O	cyp2c79	nn	3	SENT_49	[p6l611t1394r877b1432],
3	*	NN	O	*	dep	9	SENT_49	[p6l611t1394r877b1432],
4	2	CD	NUMBER	2	num	5	SENT_49	[p6l611t1394r877b1432],
5	heterozygotes	NNS	O	heterozygote	dep	3	SENT_49	[p6l897t1394r1200b1442],
6	5	CD	NUMBER	5	num	7	SENT_49	[p6l561t1456r585b1492],
7	CYP2C19	NN	O	cyp2c19	dep	9	SENT_49	[p6l611t1455r877b1494],
8	=	JJ	O	=	amod	9	SENT_49	[p6l611t1455r877b1494],
9	t	NN	O	t	dep	12	SENT_49	[p6l611t1455r877b1494],
10	<	JJR	O	<	dep	9	SENT_49	[p6l611t1455r877b1494],
11	2	CD	NUMBER	2	num	12	SENT_49	[p6l611t1455r877b1494],
12	homozygotes	NNS	O	homozygote	_	0	SENT_49	[p6l897t1456r1188b1503],

1	4	CD	NUMBER	4	nsubj	2	SENT_50	[p6l482t1516r507b1552],
2	Excluded	VBD	O	exclude	_	0	SENT_50	[p6l534t1515r730b1553],
3	(	CD	NUMBER	(	iobj	2	SENT_50	[p6l749t1515r813b1562],
4	no	DT	O	no	det	7	SENT_50	[p6l749t1515r813b1562],
5	fol	NN	O	fol	nn	7	SENT_50	[p6l829t1515r1028b1562],
6	|	NN	O	|	nn	7	SENT_50	[p6l829t1515r1028b1562],
7	ow	NN	O	ow	dobj	2	SENT_50	[p6l829t1515r1028b1562],
8	—	CD	NUMBER	—	nsubj	12	SENT_50	[p6l829t1515r1028b1562],
9	up	RP	O	up	prep	8	SENT_50	[p6l829t1515r1028b1562],
10	platelet	NN	O	platelet	nn	11	SENT_50	[p6l1047t1515r1200b1562],
11	samples	NNS	O	sample	dep	9	SENT_50	[p6l1217t1515r1407b1562],
12	)	VBP	O	)	rcmod	7	SENT_50	[p6l1217t1515r1407b1562],

1	4	CD	NUMBER	4	nsubj	2	SENT_51	[p6l1296t292r1321b328],
2	Allocated	VBN	O	allocate	_	0	SENT_51	[p6l1345t292r1544b329],
3	to	TO	O	to	_	0	SENT_51	[p6l1561t294r1603b329],
4	initial	JJ	O	initial	amod	5	SENT_51	[p6l1621t292r1722b329],
5	treatment	NN	O	treatment	prep_to	2	SENT_51	[p6l1739t294r1946b329],
6	but	CC	O	but	_	0	SENT_51	[p6l1964t292r2032b329],
7	discontinued	VBN	O	discontinue	conj_but	2	SENT_51	[p6l1347t351r1621b388],
8	before	IN	O	before	_	0	SENT_51	[p6l1641t351r1776b388],
9	randomization	NN	O	randomization	prep_before	7	SENT_51	[p6l1793t350r2096b388],
10	to	TO	O	to	_	0	SENT_51	[p6l1345t412r1387b447],
11	subsequent	JJ	O	subsequent	amod	12	SENT_51	[p6l1404t410r1658b456],
12	sequences	NNS	O	sequence	prep_to	7	SENT_51	[p6l1674t419r1909b456],

1	41	CD	NUMBER	41	_	0	SENT_52	[p6l1263t821r1308b857],
2	Randomized	VBN	O	randomize	partmod	1	SENT_52	[p6l1344t820r1613b857],
3	to	TO	O	to	aux	4	SENT_52	[p6l1630t822r1672b857],
4	receive	VB	O	receive	xcomp	2	SENT_52	[p6l1690t820r1839b857],
5	the	DT	O	the	det	7	SENT_52	[p6l1340t879r1408b917],
6	following	JJ	O	following	amod	7	SENT_52	[p6l1423t879r1611b926],
7	sequence	NN	O	sequence	dobj	4	SENT_52	[p6l1629t889r1840b926],
8	of	IN	O	of	_	0	SENT_52	[p6l1857t879r1898b917],
9	blinded	JJ	O	blinded	amod	11	SENT_52	[p6l1343t938r1497b976],
10	daily	JJ	SET	daily	amod	11	SENT_52	[p6l1516t938r1612b985],
11	clopidogrel	NN	O	clopidogrel	prep_of	7	SENT_52	[p6l1627t938r1862b986],
12	(	CD	NUMBER	(	dep	1	SENT_52	[p6l1343t997r1456b1044],
13	each	DT	O	each	det	15	SENT_52	[p6l1343t997r1456b1044],
14	dose	NN	O	dose	nn	15	SENT_52	[p6l1475t998r1672b1035],
15	~	NN	O	~	dep	12	SENT_52	[p6l1475t998r1672b1035],
16	14	CD	DURATION	14	num	17	SENT_52	[p6l1475t998r1672b1035],
17	days	NNS	NUMBER	day	tmod	12	SENT_52	[p6l1690t997r1813b1044],
18	)	CD	NUMBER	)	dep	12	SENT_52	[p6l1690t997r1813b1044],
19	:	:	O	:	_	0	SENT_52	[p6l1690t997r1813b1044],
20	300	CD	NUMBER	300	num	21	SENT_52	[p6l1342t1057r1423b1095],
21	mg	NN	O	mg	dep	1	SENT_52	[p6l1442t1066r1507b1104],
22	and	CC	O	and	_	0	SENT_52	[p6l1525t1057r1604b1095],
23	225	CD	NUMBER	225	num	25	SENT_52	[p6l1622t1057r1703b1095],
24	mg	NN	O	mg	nn	25	SENT_52	[p6l1722t1066r1787b1104],
25	alleles	NNS	O	allele	conj_and	21	SENT_52	[p6l9t1763r188b1810],
26	.	.	O	.	_	0	SENT_52	[p6l9t1763r188b1810],

1	Although	IN	O	although	mark	6	SENT_53	[p6l214t1763r472b1826],
2	newer	JJR	O	newer	amod	4	SENT_53	[p6l495t1780r660b1811],
3	P2Y12	NN	O	p2y12	nn	4	SENT_53	[p6l684t1766r831b1819],
4	inhibitors	NNS	O	inhibitor	nsubj	6	SENT_53	[p6l855t1763r1036b1811, p6l10t1849r109b1885],
5	are	VBP	O	be	cop	6	SENT_53	[p6l125t1855r204b1885],
6	available	JJ	O	available	advcl	18	SENT_53	[p6l219t1838r451b1885],
7	that	WDT	O	that	nsubj	9	SENT_53	[p6l468t1838r572b1885],
8	are	VBP	O	be	cop	9	SENT_53	[p6l586t1855r664b1885],
9	unaffected	JJ	O	unaffected	ccomp	6	SENT_53	[p6l679t1837r960b1885],
10	by	IN	O	by	_	0	SENT_53	[p6l973t1838r1038b1901],
11	CYP2C19	NN	O	cyp2c19	nn	12	SENT_53	[p6l10t1916r279b1962],
12	genotype	NN	O	genotype	prep_by	9	SENT_53	[p6l309t1925r593b1977],
13	,	,	O	,	_	0	SENT_53	[p6l309t1925r593b1977],
14	these	DT	O	these	det	15	SENT_53	[p6l626t1913r775b1962],
15	medications	NNS	O	medication	nsubj	18	SENT_53	[p6l805t1913r1036b1962, p6l10t1994r141b2037],
16	can	MD	O	can	aux	18	SENT_53	[p6l161t2006r253b2037],
17	be	VB	O	be	cop	18	SENT_53	[p6l269t1989r331b2037],
18	expensive	JJ	O	expensive	_	0	SENT_53	[p6l351t1994r618b2052],
19	and	CC	O	and	_	0	SENT_53	[p6l636t1989r735b2037],
20	are	VBP	O	be	cop	22	SENT_53	[p6l753t2006r833b2037],
21	not	RB	O	not	neg	22	SENT_53	[p6l851t2001r942b2037],
22	accessible	JJ	O	accessible	conj_and	18	SENT_53	[p6l959t2006r1036b2037, p6l9t2065r220b2113],
23	in	IN	O	in	_	0	SENT_53	[p6l245t2070r299b2112],
24	all	DT	O	all	det	25	SENT_53	[p6l324t2065r389b2113],
25	countries	NNS	O	country	prep_in	22	SENT_53	[p6l415t2070r685b2113],
26	.	.	O	.	_	0	SENT_53	[p6l415t2070r685b2113],

1	In	IN	O	in	_	0	SENT_54	[p6l715t2069r771b2112],
2	contrast	NN	O	contrast	prep_in	7	SENT_54	[p6l797t2076r1035b2122],
3	,	,	O	,	_	0	SENT_54	[p6l797t2076r1035b2122],
4	clopidogrel	NN	O	clopidogrel	nsubj	16	SENT_54	[p6l9t2140r340b2204],
5	is	VBZ	O	be	cop	7	SENT_54	[p6l368t2145r412b2188],
6	widely	RB	O	widely	advmod	7	SENT_54	[p6l440t2140r633b2204],
7	available	JJ	O	available	_	0	SENT_54	[p6l661t2140r934b2198],
8	,	,	O	,	_	0	SENT_54	[p6l661t2140r934b2198],
9	already	RB	O	already	advmod	10	SENT_54	[p6l966t2140r1036b2188, p6l8t2217r157b2281],
10	generic	JJ	O	generic	dep	7	SENT_54	[p6l180t2222r377b2281],
11	in	IN	O	in	_	0	SENT_54	[p6l401t2222r454b2264],
12	some	DT	O	some	det	13	SENT_54	[p6l478t2234r618b2265],
13	countries	NNS	O	country	prep_in	7	SENT_54	[p6l644t2222r911b2275],
14	,	,	O	,	_	0	SENT_54	[p6l644t2222r911b2275],
15	and	CC	O	and	_	0	SENT_54	[p6l938t2217r1037b2265],
16	anticipated	VBN	O	anticipate	conj_and	7	SENT_54	[p6l9t2293r310b2357],
17	to	TO	O	to	aux	19	SENT_54	[p6l327t2305r376b2341],
18	be	VB	O	be	cop	19	SENT_54	[p6l392t2293r454b2341],
19	generic	JJ	O	generic	xcomp	16	SENT_54	[p6l471t2298r667b2357],
20	in	IN	O	in	_	0	SENT_54	[p6l683t2298r736b2340],
21	the	DT	O	the	det	23	SENT_54	[p6l754t2293r836b2341],
22	United	NNP	LOCATION	United	nn	23	SENT_54	[p6l851t2293r1038b2342],
23	States	NNPS	LOCATION	States	prep_in	19	SENT_54	[p6l9t2373r157b2418],
24	in	IN	O	in	_	0	SENT_54	[p6l171t2374r224b2416],
25	2012	CD	DATE	2012	prep_in	23	SENT_54	[p6l238t2373r382b2427],
26	,	,	O	,	_	0	SENT_54	[p6l238t2373r382b2427],
27	which	WDT	O	which	nsubj	29	SENT_54	[p6l397t2369r561b2417],
28	may	MD	O	may	aux	29	SENT_54	[p6l574t2387r685b2433],
29	inﬂuence	VB	O	inﬂuence	rcmod	23	SENT_54	[p6l697t2369r941b2417],
30	the	DT	O	the	det	31	SENT_54	[p6l957t2369r1037b2417],
31	cost	NN	O	cost	dobj	29	SENT_54	[p6l9t2458r129b2494],

1	Therefore	RB	O	therefore	advmod	4	SENT_55	[p6l75t2521r466b2579],
2	,	,	O	,	_	0	SENT_55	[p6l75t2521r466b2579],
3	we	PRP	O	we	nsubj	4	SENT_55	[p6l516t2539r603b2570],
4	conducted	VBD	O	conduct	_	0	SENT_55	[p6l654t2521r1037b2570],
5	ELEVATE-TIMI	NN	O	elevate-timus	dobj	4	SENT_55	[p6l9t2599r474b2644],
6	56	CD	NUMBER	56	num	5	SENT_55	[p6l506t2599r590b2653],
7	,	,	O	,	_	0	SENT_55	[p6l506t2599r590b2653],
8	a	DT	O	a	det	9	SENT_55	[p6l622t2613r648b2644],
9	multicenter	NN	O	multicenter	appos	5	SENT_55	[p6l677t2596r1034b2653],
10	,	,	O	,	_	0	SENT_55	[p6l677t2596r1034b2653],
11	randomized	VBN	O	randomize	partmod	9	SENT_55	[p6l8t2672r373b2729],
12	,	,	O	,	_	0	SENT_55	[p6l8t2672r373b2729],
13	double-blind	JJ	O	double-blind	amod	14	SENT_55	[p6l405t2672r785b2720],
14	trial	NN	O	trial	appos	9	SENT_55	[p6l815t2672r950b2729],
15	,	,	O	,	_	0	SENT_55	[p6l815t2672r950b2729],
16	to	TO	O	to	aux	17	SENT_55	[p6l983t2684r1035b2720],
17	test	VB	O	test	xcomp	4	SENT_55	[p6l10t2759r110b2795],
18	whether	IN	O	whether	complm	30	SENT_55	[p6l136t2747r373b2796],
19	maintenance	NN	O	maintenance	nn	20	SENT_55	[p6l401t2752r770b2795],
20	doses	NNS	O	dose	nsubj	30	SENT_55	[p6l799t2747r954b2795],
21	of	IN	O	of	_	0	SENT_55	[p6l985t2747r1041b2795],
22	up	RB	O	up	quantmod	24	SENT_55	[p6l8t2839r77b2884],
23	to	TO	O	to	dep	24	SENT_55	[p6l100t2833r149b2869],
24	300	CD	NUMBER	300	num	26	SENT_55	[p6l171t2825r270b2869],
25	mg	NN	O	mg	nn	26	SENT_55	[p6l291t2839r375b2885],
26	daily	NN	SET	daily	prep_of	20	SENT_55	[p6l395t2822r526b2885],
27	of	IN	O	of	_	0	SENT_55	[p6l547t2821r601b2869],
28	clopidogrel	NN	O	clopidogrel	prep_of	26	SENT_55	[p6l618t2822r924b2885],
29	can	MD	O	can	aux	30	SENT_55	[p6l945t2839r1037b2869],
30	improve	VB	O	improve	ccomp	17	SENT_55	[p6l8t2902r233b2961],
31	platelet	NN	O	platelet	nn	32	SENT_55	[p6l257t2897r458b2961],
32	reactivity	NN	O	reactivity	dobj	30	SENT_55	[p6l481t2902r734b2961],
33	in	IN	O	in	_	0	SENT_55	[p6l756t2902r809b2945],
34	the	DT	O	the	det	35	SENT_55	[p6l834t2897r917b2946],
35	setting	NN	O	setting	prep_in	30	SENT_55	[p6l941t2909r1035b2946, p6l10t2977r123b3035],
36	of	IN	O	of	_	0	SENT_55	[p6l154t2971r212b3019],
37	the	DT	O	the	det	46	SENT_55	[p6l239t2972r327b3019],
38	major	JJ	O	major	amod	46	SENT_55	[p6l358t2977r529b3035],
39	loss-of	JJ	O	loss-of	amod	46	SENT_55	[p6l558t2971r1038b3019],
40	—	NN	O	—	nn	46	SENT_55	[p6l558t2971r1038b3019],
41	function	NN	O	function	nn	46	SENT_55	[p6l558t2971r1038b3019],
42	CYP2C19	NN	O	cyp2c19	nn	46	SENT_55	[p6l10t3050r281b3095],
43	genotype	NN	O	genotype	nn	46	SENT_55	[p6l313t3059r582b3110],
44	(	CD	NUMBER	(	num	46	SENT_55	[p6l616t3045r1034b3104],
45	CYP2C19	NN	O	cyp2c19	nn	46	SENT_55	[p6l616t3045r1034b3104],
46	*	NN	O	*	prep_of	35	SENT_55	[p6l616t3045r1034b3104],
47	2	CD	NUMBER	2	num	48	SENT_55	[p6l616t3045r1034b3104],
48	)	NN	O	)	dep	46	SENT_55	[p6l616t3045r1034b3104],
49	,	,	O	,	_	0	SENT_55	[p6l616t3045r1034b3104],
50	particularly	RB	O	particularly	advmod	46	SENT_55	[p6l8t3122r355b3186],
51	among	IN	O	among	_	0	SENT_55	[p6l384t3139r579b3186],
52	heterozygotes	NNS	O	heterozygote	prep_among	50	SENT_55	[p6l607t3122r1035b3186],
53	,	,	O	,	_	0	SENT_55	[p6l607t3122r1035b3186],
54	who	WP	O	who	nsubj	55	SENT_55	[p6l7t3197r123b3245],
55	constitute	VBP	O	constitute	rcmod	46	SENT_55	[p6l146t3202r415b3244],
56	approximately	RB	O	approximately	quantmod	61	SENT_55	[p6l436t3197r829b3260],
57	25	CD	PERCENT	25	number	61	SENT_55	[p6l850t3198r963b3246],
58	%	NN	PERCENT	%	dep	61	SENT_55	[p6l850t3198r963b3246],
59	to	TO	O	to	dep	61	SENT_55	[p6l986t3208r1035b3244],
60	45	CD	PERCENT	45	number	61	SENT_55	[p6l8t3274r123b3322],
61	%	NN	PERCENT	%	dobj	55	SENT_55	[p6l8t3274r123b3322],
62	of	IN	O	of	_	0	SENT_55	[p6l150t3272r205b3321],
63	the	DT	O	the	det	64	SENT_55	[p6l226t3273r309b3321],
64	population	NN	O	population	prep_of	61	SENT_55	[p6l333t3273r633b3336],
65	depending	VBG	O	depend	_	0	SENT_55	[p6l657t3273r945b3336],
66	on	IN	O	on	prepc_depending_on	55	SENT_55	[p6l970t3290r1037b3321],
67	racial	JJ	O	racial	amod	68	SENT_55	[p6l8t3348r158b3396],
68	background	NN	O	background	pobj	55	SENT_55	[p6l181t3348r526b3412],
69	.	.	O	.	_	0	SENT_55	[p6l181t3348r526b3412],

1	We	PRP	O	we	nsubj	2	SENT_56	[p6l553t3353r645b3396],
2	hypothesized	VBD	O	hypothesize	_	0	SENT_56	[p6l671t3348r1038b3412],
3	that	IN	O	that	advmod	2	SENT_56	[p6l10t3424r128b3472],
4	:	:	O	:	_	0	SENT_56	[p6l10t3424r128b3472],
5	(	CD	NUMBER	(	number	6	SENT_56	[p6l162t3424r237b3479],
6	1	CD	NUMBER	1	num	7	SENT_56	[p6l162t3424r237b3479],
7	)	NN	O	)	nsubj	25	SENT_56	[p6l162t3424r237b3479],
8	increasing	VBG	O	increase	partmod	7	SENT_56	[p6l267t3429r549b3488],
9	the	DT	O	the	det	11	SENT_56	[p6l575t3424r659b3472],
10	maintenance	NN	O	maintenance	nn	11	SENT_56	[p6l684t3429r1036b3472],
11	doses	NNS	O	dose	dobj	8	SENT_56	[p6l9t3499r176b3548],
12	of	IN	O	of	_	0	SENT_56	[p6l212t3499r272b3548],
13	clopidogrel	NN	O	clopidogrel	prep_of	11	SENT_56	[p6l303t3499r661b3563],
14	in	IN	O	in	_	0	SENT_56	[p6l694t3504r753b3547],
15	patients	NNS	O	patient	prep_in	8	SENT_56	[p6l786t3504r1036b3563],
16	who	WP	O	who	nsubj	17	SENT_56	[p6l7t3573r127b3621],
17	carry	VBP	O	carry	rcmod	15	SENT_56	[p6l158t3591r303b3637],
18	a	DT	O	a	det	22	SENT_56	[p6l331t3591r356b3621],
19	CYP2C19	NN	O	cyp2c19	nn	22	SENT_56	[p6l387t3571r720b3622],
20	*	NN	O	*	nn	22	SENT_56	[p6l387t3571r720b3622],
21	2	CD	NUMBER	2	num	22	SENT_56	[p6l387t3571r720b3622],
22	allele	NN	O	allele	dobj	17	SENT_56	[p6l751t3573r902b3621],
23	will	MD	O	will	aux	25	SENT_56	[p6l929t3573r1037b3621],
24	correspondingly	RB	O	correspondingly	advmod	25	SENT_56	[p6l9t3650r454b3713],
25	reduce	VB	O	reduce	parataxis	2	SENT_56	[p6l476t3650r658b3698],
26	platelet	NN	O	platelet	nn	27	SENT_56	[p6l682t3650r883b3713],
27	reactivity	NN	O	reactivity	dobj	25	SENT_56	[p6l905t3667r1036b3698, p6l10t3730r187b3789],
28	,	,	O	,	_	0	SENT_56	[p6l905t3667r1036b3698, p6l10t3730r187b3789],
29	and	CC	O	and	_	0	SENT_56	[p6l222t3725r330b3774],
30	(	NN	O	(	nn	32	SENT_56	[p6l365t3725r448b3781],
31	2	CD	NUMBER	2	num	32	SENT_56	[p6l365t3725r448b3781],
32	)	NN	O	)	nsubjpass	48	SENT_56	[p6l365t3725r448b3781],
33	among	IN	O	among	_	0	SENT_56	[p6l485t3742r685b3789],
34	carriers	NNS	O	carrier	prep_among	32	SENT_56	[p6l718t3730r948b3774],
35	of	IN	O	of	_	0	SENT_56	[p6l982t3725r1041b3774],
36	CYP2C19	NN	O	cyp2c19	nn	37	SENT_56	[p6l1121t1760r1475b1820],
37	*	NN	O	*	prep_of	34	SENT_56	[p6l1121t1760r1475b1820],
38	2	CD	NUMBER	2	num	37	SENT_56	[p6l1121t1760r1475b1820],
39	,	,	O	,	_	0	SENT_56	[p6l1121t1760r1475b1820],
40	a	DT	O	a	det	43	SENT_56	[p6l1507t1780r1533b1810],
41	higher	JJR	O	higher	amod	43	SENT_56	[p6l1561t1763r1748b1826],
42	maintenance	NN	O	maintenance	nn	43	SENT_56	[p6l1777t1768r2147b1810],
43	dose	NN	O	dose	appos	34	SENT_56	[p6l1120t1838r1241b1885],
44	of	IN	O	of	_	0	SENT_56	[p6l1264t1837r1318b1885],
45	clopidogrel	NN	O	clopidogrel	prep_of	43	SENT_56	[p6l1337t1838r1643b1901],
46	can	MD	O	can	aux	48	SENT_56	[p6l1665t1855r1757b1885],
47	be	VB	O	be	auxpass	48	SENT_56	[p6l1777t1838r1839b1885],
48	found	VBN	O	find	parataxis	2	SENT_56	[p6l1862t1837r2022b1885],
49	that	IN	O	that	complm	50	SENT_56	[p6l2044t1838r2149b1885],
50	reduces	VBZ	O	reduce	ccomp	48	SENT_56	[p6l1119t1913r1328b1962],
51	platelet	NN	O	platelet	nn	52	SENT_56	[p6l1353t1913r1557b1977],
52	reactivity	NN	O	reactivity	dobj	50	SENT_56	[p6l1580t1918r1836b1977],
53	to	TO	O	to	_	0	SENT_56	[p6l1861t1925r1911b1962],
54	the	DT	O	the	det	55	SENT_56	[p6l1939t1913r2022b1962],
55	levels	NNS	O	level	prep_to	50	SENT_56	[p6l2047t1913r2146b1962, p6l1120t1989r1193b2037],
56	achieved	VBN	O	achieve	partmod	55	SENT_56	[p6l1223t1989r1475b2037],
57	in	IN	O	in	_	0	SENT_56	[p6l1503t1994r1558b2036],
58	noncarriers	NNS	O	noncarrier	prep_in	56	SENT_56	[p6l1586t1994r1918b2037],
59	treated	VBN	O	treat	partmod	58	SENT_56	[p6l1948t1989r2148b2037],
60	with	IN	O	with	_	0	SENT_56	[p6l1117t2065r1240b2113],
61	the	DT	O	the	det	68	SENT_56	[p6l1265t2065r1348b2113],
62	established	VBN	O	establish	amod	68	SENT_56	[p6l1374t2065r1689b2122],
63	,	,	O	,	_	0	SENT_56	[p6l1374t2065r1689b2122],
64	standard	JJ	O	standard	amod	68	SENT_56	[p6l1715t2065r1950b2113],
65	75-mg	JJ	O	75-mg	amod	68	SENT_56	[p6l1976t2068r2148b2128],
66	daily	JJ	SET	daily	amod	68	SENT_56	[p6l1120t2140r1258b2204],
67	maintenance	NN	O	maintenance	nn	68	SENT_56	[p6l1284t2145r1648b2188],
68	dose	NN	O	dose	prep_with	59	SENT_56	[p6l1676t2140r1802b2188],
69	of	IN	O	of	_	0	SENT_56	[p6l1831t2140r1888b2188],
70	clopidogrel	NN	O	clopidogrel	prep_of	68	SENT_56	[p6l1912t2140r2146b2204, p6l1119t2217r1233b2281],
71	.	.	O	.	_	0	SENT_56	[p6l1912t2140r2146b2204, p6l1119t2217r1233b2281],

1	METHODS	NNS	O	method	_	0	SENT_57	[p6l1119t2349r1458b2398],

1	In	IN	O	in	_	0	SENT_58	[p6l1120t2450r1175b2493],
2	total	NN	O	total	prep_in	10	SENT_58	[p6l1190t2446r1321b2503],
3	,	,	O	,	_	0	SENT_58	[p6l1190t2446r1321b2503],
4	335	CD	NUMBER	335	num	5	SENT_58	[p6l1337t2449r1433b2494],
5	patients	NNS	O	patient	nsubjpass	10	SENT_58	[p6l1449t2450r1658b2509],
6	from	IN	O	from	_	0	SENT_58	[p6l1674t2445r1801b2494],
7	32	CD	NUMBER	32	num	8	SENT_58	[p6l1815t2449r1879b2494],
8	sites	NNS	O	site	prep_from	5	SENT_58	[p6l1894t2450r2008b2494],
9	were	VBD	O	be	auxpass	10	SENT_58	[p6l2021t2463r2148b2494],
10	enrolled	VBN	O	enrol	_	0	SENT_58	[p6l1120t2521r1343b2569],
11	from	IN	O	from	_	0	SENT_58	[p6l1359t2521r1488b2569],
12	October	NNP	DATE	October	prep_from	10	SENT_58	[p6l1505t2521r1723b2570],
13	2010	CD	DATE	2010	num	12	SENT_58	[p6l1739t2525r1871b2570],
14	until	IN	O	until	_	0	SENT_58	[p6l1887t2521r2017b2569],
15	September	NNP	DATE	September	prep_until	10	SENT_58	[p6l2032t2525r2147b2585, p6l1120t2596r1302b2644],
16	2011	CD	DATE	2011	num	15	SENT_58	[p6l1316t2599r1440b2644],
17	in	IN	O	in	_	0	SENT_58	[p6l1458t2601r1509b2643],
18	the	DT	O	the	det	19	SENT_58	[p6l1523t2596r1603b2644],
19	trial	NN	O	trial	prep_in	10	SENT_58	[p6l1618t2596r1733b2653],
20	,	,	O	,	_	0	SENT_58	[p6l1618t2596r1733b2653],
21	which	WDT	O	which	dep	23	SENT_58	[p6l1747t2596r1910b2644],
22	was	VBD	O	be	auxpass	23	SENT_58	[p6l1921t2613r2019b2644],
23	conducted	VBN	O	conduct	rcmod	19	SENT_58	[p6l2034t2613r2147b2644, p6l1120t2672r1304b2720],
24	in	IN	O	in	_	0	SENT_58	[p6l1319t2677r1372b2719],
25	patients	NNS	O	patient	prep_in	23	SENT_58	[p6l1386t2677r1600b2735],
26	with	IN	O	with	_	0	SENT_58	[p6l1615t2672r1738b2720],
27	known	JJ	O	known	amod	29	SENT_58	[p6l1753t2672r1942b2720],
28	cardiovascular	JJ	O	cardiovascular	amod	29	SENT_58	[p6l1958t2672r2147b2720, p6l1118t2747r1370b2795],
29	disease	NN	O	disease	prep_with	25	SENT_58	[p6l1403t2747r1616b2795],
30	taking	VBG	O	take	xcomp	23	SENT_58	[p6l1650t2747r1840b2811],
31	75	CD	NUMBER	75	num	32	SENT_58	[p6l1874t2751r1938b2796],
32	mg	NN	O	mg	dobj	30	SENT_58	[p6l1973t2764r2061b2811],
33	of	IN	O	of	_	0	SENT_58	[p6l2093t2747r2152b2795],
34	clopidogrel	NN	O	clopidogrel	prep_of	32	SENT_58	[p6l1120t2822r1422b2885],
35	daily	JJ	SET	daily	amod	34	SENT_58	[p6l1437t2822r1566b2885],
36	(	CD	NUMBER	(	num	39	SENT_58	[p6l1584t2821r1798b2876],
37	FIGURE	NN	O	figure	nn	39	SENT_58	[p6l1584t2821r1798b2876],
38	1	CD	NUMBER	1	num	39	SENT_58	[p6l1818t2821r1884b2877],
39	)	NN	O	)	nsubjpass	23	SENT_58	[p6l1818t2821r1884b2877],
40	.	.	O	.	_	0	SENT_58	[p6l1818t2821r1884b2877],

1	To	TO	O	to	aux	3	SENT_59	[p6l1903t2826r1973b2869],
2	be	VB	O	be	cop	3	SENT_59	[p6l1987t2822r2049b2869],
3	eligible	JJ	O	eligible	purpcl	6	SENT_59	[p6l2065t2822r2147b2869, p6l1119t2897r1263b2961],
4	,	,	O	,	_	0	SENT_59	[p6l2065t2822r2147b2869, p6l1119t2897r1263b2961],
5	patients	NNS	O	patient	nsubj	6	SENT_59	[p6l1283t2902r1496b2961],
6	needed	VBD	O	need	_	0	SENT_59	[p6l1515t2897r1709b2946],
7	to	TO	O	to	aux	8	SENT_59	[p6l1727t2909r1777b2946],
8	have	VB	O	have	xcomp	6	SENT_59	[p6l1796t2897r1920b2946],
9	an	DT	O	a	det	10	SENT_59	[p6l1939t2915r2002b2946],
10	indication	NN	O	indication	dobj	8	SENT_59	[p6l2019t2897r2147b2946, p6l1120t2977r1283b3019],
11	for	IN	O	for	_	0	SENT_59	[p6l1298t2971r1372b3019],
12	the	DT	O	the	det	13	SENT_59	[p6l1388t2972r1469b3019],
13	use	NN	O	use	prep_for	10	SENT_59	[p6l1484t2989r1572b3019],
14	of	IN	O	of	_	0	SENT_59	[p6l1588t2971r1642b3019],
15	clopidogrel	NN	O	clopidogrel	prep_of	13	SENT_59	[p6l1653t2972r1954b3035],
16	(	CD	NUMBER	(	num	15	SENT_59	[p6l1973t2971r2148b3027],
17	either	CC	O	either	dep	10	SENT_59	[p6l1973t2971r2148b3027],
18	a	DT	O	a	det	20	SENT_59	[p6l1119t3064r1145b3095],
19	myocardial	JJ	O	myocardial	amod	20	SENT_59	[p6l1158t3047r1450b3110],
20	infarction	NN	O	infarction	conj	10	SENT_59	[p6l1462t3046r1717b3095],
21	[	CD	NUMBER	[	dep	20	SENT_59	[p6l1737t3047r1845b3102],
22	MI	NNP	O	MI	dep	24	SENT_59	[p6l1737t3047r1845b3102],
23	]	CD	NUMBER	]	num	22	SENT_59	[p6l1737t3047r1845b3102],
24	and/or	JJ	O	and/or	amod	25	SENT_59	[p6l1867t3047r2037b3095],
25	PCI	NN	O	pcus	dep	21	SENT_59	[p6l2050t3050r2147b3095],
26	24	CD	DURATION	24	num	27	SENT_59	[p6l1123t3126r1205b3171],
27	weeks	NNS	NUMBER	week	dep	25	SENT_59	[p6l1220t3122r1386b3171],
28	and	CC	O	and	_	0	SENT_59	[p6l1403t3122r1503b3170],
29	S6	NN	O	s6	nn	30	SENT_59	[p6l1522t3126r1604b3171],
30	months	NNS	DURATION	month	dep	20	SENT_59	[p6l1621t3122r1826b3170],
31	prior	RB	O	prior	_	0	SENT_59	[p6l1842t3127r1978b3186],
32	to	TO	O	to	_	0	SENT_59	[p6l1995t3134r2044b3170],
33	enrollment	NN	O	enrollment	nn	34	SENT_59	[p6l2063t3140r2146b3170, p6l1119t3196r1374b3252],
34	)	NN	O	)	prep_prior_to	8	SENT_59	[p6l2063t3140r2146b3170, p6l1119t3196r1374b3252],
35	and	CC	O	and	_	0	SENT_59	[p6l1402t3197r1500b3244],
36	be	VB	O	be	cop	38	SENT_59	[p6l1522t3197r1584b3244],
37	clinically	RB	O	clinically	advmod	38	SENT_59	[p6l1608t3197r1854b3259],
38	stable	JJ	O	stable	conj_and	8	SENT_59	[p6l1876t3197r2044b3244],
39	.	.	O	.	_	0	SENT_59	[p6l1876t3197r2044b3244],

1	All	DT	O	all	det	2	SENT_60	[p6l2069t3197r2148b3243],
2	patients	NNS	O	patient	nsubj	3	SENT_60	[p6l1118t3277r1337b3336],
3	took	VBD	O	take	_	0	SENT_60	[p6l1365t3273r1489b3321],
4	aspirin	NN	O	aspirin	dobj	3	SENT_60	[p6l1514t3277r1720b3336],
5	,	,	O	,	_	0	SENT_60	[p6l1514t3277r1720b3336],
6	81	CD	NUMBER	81	number	8	SENT_60	[p6l1748t3276r1810b3321],
7	to	TO	O	to	dep	8	SENT_60	[p6l1841t3284r1891b3321],
8	325	CD	NUMBER	325	num	9	SENT_60	[p6l1919t3276r2018b3321],
9	mg	NN	O	mg	rcmod	4	SENT_60	[p6l2046t3290r2145b3336],
10	,	,	O	,	_	0	SENT_60	[p6l2046t3290r2145b3336],
11	daily	RB	SET	daily	advmod	9	SENT_60	[p6l1120t3348r1265b3412],
12	,	,	O	,	_	0	SENT_60	[p6l1120t3348r1265b3412],
13	and	CC	O	and	_	0	SENT_60	[p6l1283t3348r1382b3396],
14	they	PRP	O	they	nsubjpass	16	SENT_60	[p6l1399t3348r1515b3412],
15	were	VBD	O	be	auxpass	16	SENT_60	[p6l1528t3366r1657b3396],
16	requested	VBN	O	request	conj_and	3	SENT_60	[p6l1673t3348r1937b3412],
17	to	TO	O	to	aux	18	SENT_60	[p6l1954t3360r2003b3396],
18	keep	VB	O	keep	xcomp	16	SENT_60	[p6l2021t3348r2147b3412],
19	taking	VBG	O	take	xcomp	18	SENT_60	[p6l1120t3424r1289b3488],
20	a	DT	O	a	det	22	SENT_60	[p6l1313t3441r1339b3472],
21	stable	JJ	O	stable	amod	22	SENT_60	[p6l1363t3424r1518b3472],
22	dose	NN	O	dose	dobj	19	SENT_60	[p6l1542t3424r1663b3472],
23	during	IN	O	during	_	0	SENT_60	[p6l1688t3424r1869b3488],
24	the	DT	O	the	det	25	SENT_60	[p6l1893t3424r1976b3472],
25	study	NN	O	study	prep_during	19	SENT_60	[p6l2000t3424r2149b3487],
26	if	IN	O	if	mark	28	SENT_60	[p6l1119t3499r1159b3547],
27	medically	RB	O	medically	advmod	28	SENT_60	[p6l1178t3499r1442b3563],
28	indicated	VBN	O	indicate	advcl	18	SENT_60	[p6l1465t3499r1730b3548],
29	.	.	O	.	_	0	SENT_60	[p6l1465t3499r1730b3548],

1	Key	NN	O	key	nn	3	SENT_61	[p6l1759t3504r1863b3563],
2	exclusion	NN	O	exclusion	nn	3	SENT_61	[p6l1887t3499r2147b3548],
3	criteria	NNS	O	criterion	nsubj	5	SENT_61	[p6l1120t3578r1310b3621],
4	were	VBD	O	be	cop	5	SENT_61	[p6l1333t3591r1462b3621],
5	use	NN	O	use	_	0	SENT_61	[p6l1485t3591r1575b3621],
6	of	IN	O	of	_	0	SENT_61	[p6l1599t3573r1654b3621],
7	anticoagulants	NNS	O	anticoagulant	prep_of	5	SENT_61	[p6l1673t3573r2068b3637],
8	or	CC	O	or	_	0	SENT_61	[p6l2093t3591r2148b3621],
9	proton	NN	O	proton	nn	11	SENT_61	[p6l1118t3661r1307b3713],
10	pump	NN	O	pump	nn	11	SENT_61	[p6l1331t3667r1492b3713],
11	inhibitors	NNS	O	inhibitor	prep_of	5	SENT_61	[p6l1519t3650r1791b3698],
12	(	CD	NUMBER	(	num	13	SENT_61	[p6l1822t3649r2007b3707],
13	PPIs	NNS	O	ppi	nsubj	14	SENT_61	[p6l1822t3649r2007b3707],
14	)	VBP	O	)	rcmod	11	SENT_61	[p6l1822t3649r2007b3707],
15	,	,	O	,	_	0	SENT_61	[p6l1822t3649r2007b3707],
16	current	JJ	DATE	current	amod	17	SENT_61	[p6l2036t3667r2146b3698, p6l1119t3737r1229b3773],
17	smoking	NN	O	smoking	appos	11	SENT_61	[p6l1248t3725r1496b3789],
18	,	,	O	,	_	0	SENT_61	[p6l1248t3725r1496b3789],
19	prior	RB	O	prior	advmod	17	SENT_61	[p6l1518t3730r1654b3789],
20	stent	JJ	O	stent	amod	21	SENT_61	[p6l1674t3737r1806b3773],
21	thrombosis	NN	O	thrombosis	pobj	19	SENT_61	[p6l1826t3725r2146b3783],
22	,	,	O	,	_	0	SENT_61	[p6l1826t3725r2146b3783],

1	22	CD	NUMBER	22	num	2	SENT_62	[p7l233t29r266b50],
2	JAMA	NN	O	jama	_	0	SENT_62	[p7l298t29r380b54],
3	,	,	O	,	_	0	SENT_62	[p7l298t29r380b54],
4	November	NNP	DATE	November	appos	2	SENT_62	[p7l392t27r522b50],
5	23/30	CD	DATE	23/30	num	4	SENT_62	[p7l532t29r603b50],
6	2011	CD	DATE	2011	dep	4	SENT_62	[p7l622t27r759b50],
7	.	.	O	.	_	0	SENT_62	[p7l622t27r759b50],

1	—	NN	O	—	_	0	SENT_63	[p7l622t27r759b50],
2	.	.	O	.	_	0	SENT_63	[p7l622t27r759b50],

1	Vol	NN	O	vol	_	0	SENT_64	[p7l622t27r759b50],
2	306	CD	NUMBER	306	num	1	SENT_64	[p7l769t29r815b50],
3	N	NN	O	n	nn	9	SENT_64	[p7l834t29r854b50],
4	20	CD	NUMBER	20	num	9	SENT_64	[p7l889t29r919b50],
5	©	CD	NUMBER	©	num	9	SENT_64	[p7l1396t27r1492b50],
6	2011	CD	DATE	2011	num	9	SENT_64	[p7l1396t27r1492b50],
7	American	NNP	ORGANIZATION	American	nn	9	SENT_64	[p7l1503t28r1643b50],
8	Medical	NNP	ORGANIZATION	Medical	nn	9	SENT_64	[p7l1652t26r1768b50],
9	Association	NNP	ORGANIZATION	Association	dep	1	SENT_64	[p7l1776t28r1954b50],
10	.	.	O	.	_	0	SENT_64	[p7l1776t28r1954b50],

1	All	DT	O	all	_	0	SENT_65	[p7l1964t26r2006b50],
2	rights	NNS	O	rights	dep	1	SENT_65	[p7l2015t26r2099b58],

1	,	,	O	,	_	0	SENT_66	[p7l607t47r610b54],
2	,	,	O	,	_	0	SENT_66	[p7l819t47r823b54],
3	o.	IN	O	o.	dep	1	SENT_66	[p7l857t35r877b50],

1	reserved	VBN	O	reserve	_	0	SENT_67	[p7l6t67r135b92],
2	.	.	O	.	_	0	SENT_67	[p7l6t67r135b92],

1	Downloaded	NNP	O	Downloaded	_	0	SENT_68	[p7l145t68r322b92],
2	From	IN	O	from	dep	1	SENT_68	[p7l331t68r419b91],
3	:	:	O	:	_	0	SENT_68	[p7l331t68r419b91],
4	http://jama.jaInanetwork.com/	NN	O	http://jama.jainanetwork.com/	pobj	2	SENT_68	[p7l430t67r868b98],
5	by	IN	O	by	_	0	SENT_68	[p7l876t68r910b98],
6	a	DT	O	a	det	7	SENT_68	[p7l920t75r935b91],
7	University	NNP	ORGANIZATION	University	prep_by	4	SENT_68	[p7l944t67r1092b98],
8	of	IN	ORGANIZATION	of	_	0	SENT_68	[p7l1101t67r1130b91],
9	Wisconsin	NNP	ORGANIZATION	Wisconsin	prep_of	7	SENT_68	[p7l1137t67r1283b91],
10	-	:	O	-	_	0	SENT_68	[p7l1292t67r1426b91],
11	Madison	NNP	O	Madison	nn	12	SENT_68	[p7l1292t67r1426b91],
12	User	NN	O	user	dep	4	SENT_68	[p7l1435t68r1501b92],
13	on	IN	O	on	_	0	SENT_68	[p7l1519t75r1553b91],
14	01/05/2014	CD	DATE	01/05/2014	prep_on	12	SENT_68	[p7l1562t67r1713b92],

1	heightened	VBN	O	heighten	amod	2	SENT_69	[p7l9t576r607b702],
2	risk	NN	O	risk	nsubj	17	SENT_69	[p7l639t576r842b671],
3	of	IN	O	of	_	0	SENT_69	[p7l876t575r984b671],
4	bleeding	NN	O	bleeding	prep_of	2	SENT_69	[p7l1005t576r1494b702],
5	,	,	O	,	_	0	SENT_69	[p7l1005t576r1494b702],
6	end-stage	JJ	O	end-stage	amod	10	SENT_69	[p7l1534t576r2041b702],
7	renal	JJ	O	renal	amod	10	SENT_69	[p7l9t727r285b821],
8	or	CC	O	or	_	0	SENT_69	[p7l338t760r450b821],
9	hepatic	JJ	O	hepatic	amod	10	SENT_69	[p7l499t727r897b851],
10	disease	NN	O	disease	conj_or	4	SENT_69	[p7l952t727r1368b840],
11	,	,	O	,	_	0	SENT_69	[p7l952t727r1368b840],
12	or	CC	O	or	_	0	SENT_69	[p7l1426t760r1536b821],
13	a	DT	O	a	det	14	SENT_69	[p7l1588t760r1639b821],
14	procedure	NN	O	procedure	conj_or	4	SENT_69	[p7l1690t760r2038b851, p7l11t876r253b972],
15	or	CC	O	or	_	0	SENT_69	[p7l291t911r401b971],
16	hospitalization	NN	O	hospitalization	conj_or	14	SENT_69	[p7l434t876r1233b1002],
17	planned	VBN	O	plan	_	0	SENT_69	[p7l1266t876r1701b1002],
18	in	IN	O	in	_	0	SENT_69	[p7l1735t887r1839b969],
19	the	DT	DURATION	the	det	22	SENT_69	[p7l1878t876r2040b971],
20	next	JJ	DURATION	next	amod	22	SENT_69	[p7l9t1049r246b1120],
21	12	CD	DURATION	12	num	22	SENT_69	[p7l294t1032r411b1118],
22	weeks	NNS	NUMBER	week	prep_in	17	SENT_69	[p7l450t1026r803b1120],
23	.	.	O	.	_	0	SENT_69	[p7l450t1026r803b1120],

1	Study	NNP	O	Study	nn	2	SENT_70	[p7l12t1303r335b1421],
2	Protocol	NNP	O	Protocol	dep	14	SENT_70	[p7l382t1303r854b1394],
3	At	IN	O	at	_	0	SENT_70	[p7l7t1467r128b1555],
4	the	DT	O	the	det	5	SENT_70	[p7l148t1460r302b1555],
5	time	NN	O	time	prep_at	14	SENT_70	[p7l325t1470r547b1555],
6	of	IN	O	of	_	0	SENT_70	[p7l569t1459r673b1555],
7	enrollment	NN	O	enrollment	prep_of	5	SENT_70	[p7l685t1460r1265b1574],
8	,	,	O	,	_	0	SENT_70	[p7l685t1460r1265b1574],
9	a	DT	O	a	det	12	SENT_70	[p7l1289t1495r1340b1555],
10	baseline	NN	O	baseline	nn	12	SENT_70	[p7l1357t1460r1764b1555],
11	clinical	JJ	O	clinical	amod	12	SENT_70	[p7l1786t1460r2040b1555, p7l12t1612r153b1708],
12	evaluation	NN	O	evaluation	nsubjpass	14	SENT_70	[p7l186t1612r724b1708],
13	Was	VBD	O	be	auxpass	14	SENT_70	[p7l751t1647r946b1708],
14	performed	VBN	O	perform	_	0	SENT_70	[p7l977t1612r1549b1738],
15	,	,	O	,	_	0	SENT_70	[p7l977t1612r1549b1738],
16	and	CC	O	and	_	0	SENT_70	[p7l1585t1612r1776b1707],
17	each	DT	O	each	det	18	SENT_70	[p7l1808t1612r2042b1708],
18	patient	NN	O	patient	nsubj	19	SENT_70	[p7l8t1773r373b1888],
19	underwent	VBD	O	undergo	conj_and	14	SENT_70	[p7l416t1763r985b1858],
20	blood	NN	O	blood	nn	21	SENT_70	[p7l1028t1763r1328b1858],
21	sampling	NN	O	sampling	dobj	19	SENT_70	[p7l1374t1763r1850b1889],
22	for	IN	O	for	_	0	SENT_70	[p7l1897t1762r2042b1858],
23	blinded	JJ	O	blinded	amod	24	SENT_70	[p7l7t1913r398b2009],
24	genotyping	NN	O	genotyping	prep_for	19	SENT_70	[p7l417t1924r991b2039],
25	and	CC	O	and	_	0	SENT_70	[p7l1010t1913r1200b2009],
26	platelet	NN	O	platelet	nn	28	SENT_70	[p7l1217t1914r1592b2039],
27	function	NN	O	function	nn	28	SENT_70	[p7l1611t1913r2043b2009],
28	testing	NN	O	testing	prep_for	19	SENT_70	[p7l12t2072r379b2188],
29	.	.	O	.	_	0	SENT_70	[p7l12t2072r379b2188],

1	A	DT	O	a	det	3	SENT_71	[p7l456t2069r538b2155],
2	pyrosequencing	NN	O	pyrosequencing	nn	3	SENT_71	[p7l608t2073r1439b2188],
3	assay	NN	O	assay	nsubjpass	5	SENT_71	[p7l1509t2097r1778b2188],
4	was	VBD	O	be	auxpass	5	SENT_71	[p7l1845t2097r2040b2158],
5	performed	VBN	O	perform	_	0	SENT_71	[p7l8t2212r529b2338],
6	at	IN	O	at	_	0	SENT_71	[p7l545t2237r635b2308],
7	the	DT	O	the	det	8	SENT_71	[p7l651t2213r803b2308],
8	Center	NNP	ORGANIZATION	Center	prep_at	5	SENT_71	[p7l826t2220r1156b2308],
9	for	IN	ORGANIZATION	for	_	0	SENT_71	[p7l1173t2212r1312b2308],
10	Advanced	NNP	ORGANIZATION	Advanced	nn	12	SENT_71	[p7l1324t2213r1819b2308],
11	Molecular	JJ	ORGANIZATION	molecular	amod	12	SENT_71	[p7l1834t2223r2039b2308, p7l9t2365r348b2461],
12	Diagnostics	NNPS	ORGANIZATION	Diagnostics	prep_for	5	SENT_71	[p7l365t2374r941b2491],
13	at	IN	O	at	_	0	SENT_71	[p7l961t2389r1053b2461],
14	Brigham	NNP	LOCATION	Brigham	prep_at	12	SENT_71	[p7l1066t2365r1494b2491],
15	and	CC	O	and	_	0	SENT_71	[p7l1512t2365r1699b2461],
16	Women	NNP	O	Women	poss	18	SENT_71	[p7l1712t2374r2040b2461, p7l12t2522r197b2610],
17	’s	POS	O	’s	_	0	SENT_71	[p7l1712t2374r2040b2461, p7l12t2522r197b2610],
18	Hospital	NN	O	hospital	nsubj	34	SENT_71	[p7l216t2516r638b2640],
19	to	TO	O	to	aux	20	SENT_71	[p7l659t2539r753b2610],
20	assess	VB	O	assess	infmod	18	SENT_71	[p7l775t2550r1067b2610],
21	for	IN	O	for	_	0	SENT_71	[p7l1088t2514r1229b2610],
22	CYP2C19	NN	O	cyp2c19	nn	23	SENT_71	[p7l1250t2511r1842b2612],
23	*	NN	O	*	prep_for	20	SENT_71	[p7l1250t2511r1842b2612],
24	2	CD	NUMBER	2	num	23	SENT_71	[p7l1250t2511r1842b2612],
25	status	NN	O	status	nn	28	SENT_71	[p7l1866t2539r2040b2610, p7l12t2689r164b2761],
26	(	CD	NUMBER	(	num	28	SENT_71	[p7l206t2665r696b2775],
27	National	NNP	ORGANIZATION	National	nn	28	SENT_71	[p7l206t2665r696b2775],
28	Center	NNP	ORGANIZATION	Center	dobj	20	SENT_71	[p7l735t2673r1083b2761],
29	for	IN	ORGANIZATION	for	_	0	SENT_71	[p7l1117t2665r1262b2761],
30	Biotechnology	NNP	ORGANIZATION	Biotechnology	nn	33	SENT_71	[p7l1292t2666r2043b2791],
31	Information	NNP	ORGANIZATION	Information	nn	33	SENT_71	[p7l11t2818r635b2914],
32	[	NNP	O	[	nn	33	SENT_71	[p7l671t2818r1026b2927],
33	NCBI	NNP	O	NCBI	prep_for	28	SENT_71	[p7l671t2818r1026b2927],
34	]	VBD	O	]	conj_and	5	SENT_71	[p7l671t2818r1026b2927],
35	genome	NN	O	genome	nsubj	36	SENT_71	[p7l1065t2852r1472b2944],
36	build	VB	O	build	ccomp	34	SENT_71	[p7l1492t2818r1764b2914],
37	37.1	CD	NUMBER	37.1	dobj	36	SENT_71	[p7l1786t2825r2037b2932],
38	,	,	O	,	_	0	SENT_71	[p7l1786t2825r2037b2932],
39	NG_0O8384	NN	O	ng_0o8384	nn	40	SENT_71	[p7l10t2967r803b3077],
40	)	NN	O	)	dobj	36	SENT_71	[p7l10t2967r803b3077],
41	.	.	O	.	_	0	SENT_71	[p7l10t2967r803b3077],

1	Genotyping	VBG	O	genotype	nsubjpass	3	SENT_72	[p7l874t2975r1558b3094],
2	was	VBD	O	be	auxpass	3	SENT_72	[p7l1613t3003r1824b3063],
3	repeated	VBN	O	repeat	_	0	SENT_72	[p7l1884t3003r2039b3063, p7l8t3118r365b3244],
4	using	VBG	O	use	xcomp	3	SENT_72	[p7l412t3129r707b3244],
5	a	DT	O	a	det	8	SENT_72	[p7l756t3153r808b3214],
6	Nanosphere	NNP	MISC	Nanosphere	nn	8	SENT_72	[p7l858t3118r1512b3244],
7	Verigene	NNP	MISC	Verigene	nn	8	SENT_72	[p7l1559t3127r2040b3244],
8	ZC19/CBS	NN	O	zc19/cbs	dobj	4	SENT_72	[p7l12t3275r561b3365],
9	nucleic	JJ	O	nucleic	amod	12	SENT_72	[p7l610t3269r1001b3364],
10	acid	NN	O	acid	nn	12	SENT_72	[p7l1051t3269r1270b3364],
11	researchuseonly	JJ	O	researchuseonly	amod	12	SENT_72	[p7l1318t3269r2039b3364, p7l12t3419r246b3544],
12	assay	NN	O	assay	dep	8	SENT_72	[p7l291t3454r589b3544],
13	.	.	O	.	_	0	SENT_72	[p7l291t3454r589b3544],

1	A	DT	O	a	det	2	SENT_73	[p7l641t3426r723b3513],
2	total	NN	O	total	nsubjpass	8	SENT_73	[p7l773t3419r1009b3514],
3	of	IN	O	of	_	0	SENT_73	[p7l1057t3418r1164b3514],
4	333	CD	NUMBER	333	num	5	SENT_73	[p7l1202t3426r1395b3514],
5	individuals	NNS	O	individual	prep_of	2	SENT_73	[p7l1445t3419r2039b3514],
6	were	VBD	O	be	auxpass	8	SENT_73	[p8l7t54r258b115],
7	successfully	RB	O	successfully	advmod	8	SENT_73	[p8l304t19r933b145],
8	genotyped	VBN	O	genotype	_	0	SENT_73	[p8l977t20r1525b145],
9	and	CC	O	and	_	0	SENT_73	[p8l1570t19r1764b115],
10	confirmed	VBN	O	confirm	conj_and	8	SENT_73	[p8l1809t54r2039b115, p8l11t168r354b264],
11	for	IN	O	for	_	0	SENT_73	[p8l390t168r534b264],
12	CYP2C19	NN	O	cyp2c19	nn	13	SENT_73	[p8l572t165r1181b265],
13	*	NN	O	*	prep_for	8	SENT_73	[p8l572t165r1181b265],
14	2	CD	NUMBER	2	num	15	SENT_73	[p8l572t165r1181b265],
15	status	NN	O	status	dep	13	SENT_73	[p8l1221t193r1544b264],
16	.	.	O	.	_	0	SENT_73	[p8l1221t193r1544b264],

1	Patients	NNS	O	patient	nsubjpass	3	SENT_74	[p8l142t328r555b414],
2	were	VBD	O	be	auxpass	3	SENT_74	[p8l588t353r840b414],
3	allocated	VBN	O	allocate	_	0	SENT_74	[p8l877t320r1371b433],
4	,	,	O	,	_	0	SENT_74	[p8l877t320r1371b433],
5	using	VBG	O	use	xcomp	3	SENT_74	[p8l1410t329r1696b444],
6	a	DT	O	a	det	11	SENT_74	[p8l1732t353r1783b414],
7	central	JJ	O	central	amod	11	SENT_74	[p8l1820t353r2040b414, p8l12t469r185b565],
8	interactive	JJ	O	interactive	amod	11	SENT_74	[p8l236t480r789b565],
9	voice	NN	O	voice	nn	11	SENT_74	[p8l840t480r1114b565],
10	response	NN	O	response	nn	11	SENT_74	[p8l1167t504r1629b595],
11	system	NN	O	system	dobj	5	SENT_74	[p8l1683t492r2042b595],
12	(	CD	NUMBER	(	num	15	SENT_74	[p8l18t618r635b729],
13	Worldwide	NNP	O	Worldwide	nn	15	SENT_74	[p8l18t618r635b729],
14	Clinical	JJ	O	clinical	amod	15	SENT_74	[p8l661t619r1053b714],
15	Trials	NNS	O	trial	nsubj	16	SENT_74	[p8l1073t618r1436b733],
16	)	VBP	O	)	rcmod	11	SENT_74	[p8l1073t618r1436b733],
17	,	,	O	,	_	0	SENT_74	[p8l1073t618r1436b733],
18	to	TO	O	to	_	0	SENT_74	[p8l1462t643r1558b714],
19	a	DT	O	a	det	21	SENT_74	[p8l1582t654r1633b714],
20	blinded	JJ	O	blinded	amod	21	SENT_74	[p8l1651t619r2043b714],
21	sequence	NN	O	sequence	prep_to	3	SENT_74	[p8l10t806r486b897],
22	of	IN	O	of	_	0	SENT_74	[p8l511t771r616b867],
23	maintenance	NN	O	maintenance	nn	24	SENT_74	[p8l629t782r1295b867],
24	doses	NNS	O	dose	prep_of	21	SENT_74	[p8l1319t771r1601b867],
25	of	IN	O	of	_	0	SENT_74	[p8l1627t771r1732b867],
26	clopido	NN	O	clopido	nn	27	SENT_74	[p8l1748t771r2040b897, p8l11t923r138b1017],
27	grel	NN	O	grel	prep_of	24	SENT_74	[p8l145t922r342b1048],
28	for	IN	O	for	_	0	SENT_74	[p8l370t921r516b1017],
29	4	CD	NUMBER	4	num	31	SENT_74	[p8l540t929r603b1018],
30	treatment	NN	O	treatment	nn	31	SENT_74	[p8l633t946r1142b1017],
31	periods	NNS	O	period	prep_for	27	SENT_74	[p8l1164t923r1582b1047],
32	,	,	O	,	_	0	SENT_74	[p8l1164t923r1582b1047],
33	each	DT	O	each	det	37	SENT_74	[p8l1616t923r1852b1017],
34	approximately	RB	O	approximately	quantmod	35	SENT_74	[p8l1878t957r2039b1047, p8l8t1073r646b1198],
35	14	CD	NUMBER	14	num	37	SENT_74	[p8l682t1080r800b1169],
36	(	CD	NUMBER	(	number	37	SENT_74	[p8l834t1072r1045b1182],
37	:3	CD	NUMBER	:3	appos	31	SENT_74	[p8l834t1072r1045b1182],
38	)	CD	NUMBER	)	num	39	SENT_74	[p8l834t1072r1045b1182],
39	days	NNS	NUMBER	day	tmod	27	SENT_74	[p8l1082t1073r1337b1198],
40	.	.	O	.	_	0	SENT_74	[p8l1082t1073r1337b1198],

1	Patients	NNS	O	patient	nsubj	12	SENT_75	[p8l1373t1082r1786b1168],
2	who	WP	O	who	nsubj	4	SENT_75	[p8l1811t1073r2037b1168],
3	were	VBD	O	be	cop	4	SENT_75	[p8l7t1258r255b1319],
4	carriers	NNS	O	carrier	rcmod	1	SENT_75	[p8l279t1234r658b1319],
5	of	IN	O	of	_	0	SENT_75	[p8l683t1224r789b1319],
6	C	NN	O	c	nn	7	SENT_75	[p8l804t1230r879b1319],
7	YPZC	NN	O	ypzc	prep_of	4	SENT_75	[p8l886t1230r1161b1319],
8	1	CD	NUMBER	1	number	9	SENT_75	[p8l1172t1230r1210b1316],
9	9	CD	NUMBER	9	dep	7	SENT_75	[p8l1229t1219r1409b1319],
10	*	NN	O	*	dep	9	SENT_75	[p8l1229t1219r1409b1319],
11	2	CD	NUMBER	2	num	10	SENT_75	[p8l1229t1219r1409b1319],
12	received	VBD	O	receive	_	0	SENT_75	[p8l1434t1225r1861b1319],
13	75	CD	NUMBER	75	dobj	12	SENT_75	[p8l1887t1231r2037b1338],
14	,	,	O	,	_	0	SENT_75	[p8l1887t1231r2037b1338],
15	150	CD	NUMBER	150	dobj	12	SENT_75	[p8l21t1381r233b1488],
16	,	,	O	,	_	0	SENT_75	[p8l21t1381r233b1488],
17	225	CD	NUMBER	225	dobj	12	SENT_75	[p8l274t1381r495b1488],
18	,	,	O	,	_	0	SENT_75	[p8l274t1381r495b1488],
19	and	CC	NUMBER	and	_	0	SENT_75	[p8l534t1375r726b1469],
20	300	CD	NUMBER	300	num	22	SENT_75	[p8l760t1381r952b1470],
21	mg	NN	O	mg	nn	22	SENT_75	[p8l988t1409r1153b1500],
22	daily	NN	SET	daily	dobj	12	SENT_75	[p8l1186t1375r1440b1500],
23	of	IN	O	of	_	0	SENT_75	[p8l1474t1373r1581b1469],
24	clopido	NN	O	clopido	nn	27	SENT_75	[p8l1608t1374r2039b1499],
25	—	CD	NUMBER	—	num	27	SENT_75	[p8l1608t1374r2039b1499],
26	grel	NN	O	grel	nn	27	SENT_75	[p8l10t1525r203b1650],
27	(	NN	O	(	prep_of	22	SENT_75	[p8l233t1524r376b1634],
28	in	IN	O	in	_	0	SENT_75	[p8l233t1524r376b1634],
29	various	JJ	O	various	amod	31	SENT_75	[p8l395t1535r775b1620],
30	sequences	NNS	O	sequence	nn	31	SENT_75	[p8l798t1524r1395b1651],
31	)	NN	O	)	prep_in	12	SENT_75	[p8l798t1524r1395b1651],
32	.	.	O	.	_	0	SENT_75	[p8l798t1524r1395b1651],

1	Noncarriers	NNS	O	noncarrier	nsubj	2	SENT_76	[p8l1426t1534r2040b1620],
2	received	VBD	O	receive	_	0	SENT_76	[p8l9t1677r445b1773],
3	75	CD	NUMBER	75	dobj	2	SENT_76	[p8l473t1684r591b1773],
4	and	CC	O	and	_	0	SENT_76	[p8l621t1677r814b1772],
5	1	CD	NUMBER	1	number	6	SENT_76	[p8l847t1685r889b1770],
6	50	CD	NUMBER	50	conj_and	3	SENT_76	[p8l906t1684r1029b1773],
7	mg	NN	O	mg	nn	9	SENT_76	[p8l1055t1711r1219b1803],
8	daily	JJ	SET	daily	amod	9	SENT_76	[p8l1243t1677r1497b1803],
9	(	NN	O	(	dep	6	SENT_76	[p8l1525t1677r1627b1787],
10	2	CD	NUMBER	2	num	11	SENT_76	[p8l1525t1677r1627b1787],
11	periods	NNS	O	period	tmod	6	SENT_76	[p8l1652t1677r2040b1803],
12	of	IN	O	of	_	0	SENT_76	[p8l12t1826r119b1922],
13	each	DT	O	each	det	15	SENT_76	[p8l142t1827r378b1922],
14	dose	NN	O	dose	nn	15	SENT_76	[p8l408t1826r684b1936],
15	)	NN	O	)	prep_of	6	SENT_76	[p8l408t1826r684b1936],
16	of	IN	O	of	_	0	SENT_76	[p8l726t1826r832b1922],
17	clopidogrel	NN	O	clopidogrel	nn	18	SENT_76	[p8l855t1827r1447b1953],
18	(	NN	O	(	prep_of	6	SENT_76	[p8l1484t1826r1629b1936],
19	in	IN	O	in	_	0	SENT_76	[p8l1484t1826r1629b1936],
20	various	JJ	O	various	amod	22	SENT_76	[p8l1655t1837r2040b1922],
21	sequences	NNS	O	sequence	nn	22	SENT_76	[p8l10t1979r604b2105],
22	)	NN	O	)	prep_in	2	SENT_76	[p8l10t1979r604b2105],
23	.	.	O	.	_	0	SENT_76	[p8l10t1979r604b2105],

1	At	IN	O	at	_	0	SENT_77	[p8l630t1985r753b2075],
2	the	DT	O	the	det	3	SENT_77	[p8l775t1979r933b2075],
3	end	NN	O	end	prep_at	12	SENT_77	[p8l958t1979r1147b2075],
4	of	IN	O	of	_	0	SENT_77	[p8l1169t1979r1275b2075],
5	each	DT	O	each	det	7	SENT_77	[p8l1289t1980r1522b2075],
6	treatment	NN	O	treatment	nn	7	SENT_77	[p8l1545t2003r2045b2075],
7	period	NN	O	period	prep_of	3	SENT_77	[p8l8t2130r370b2255],
8	,	,	O	,	_	0	SENT_77	[p8l8t2130r370b2255],
9	platelet	NN	O	platelet	nn	11	SENT_77	[p8l395t2130r776b2255],
10	function	NN	O	function	nn	11	SENT_77	[p8l797t2129r1233b2225],
11	testing	NN	O	testing	nsubj	12	SENT_77	[p8l1258t2140r1599b2256],
12	was	VBD	O	be	_	0	SENT_77	[p8l1617t2165r1811b2226],
13	performed	VBN	O	perform	dep	12	SENT_77	[p8l1833t2165r2040b2255, p8l11t2280r375b2376],
14	and	CC	O	and	_	0	SENT_77	[p8l393t2281r581b2376],
15	ischemic	JJ	O	ischemic	amod	17	SENT_77	[p8l599t2281r1068b2395],
16	,	,	O	,	_	0	SENT_77	[p8l599t2281r1068b2395],
17	bleeding	JJ	O	bleeding	dep	12	SENT_77	[p8l1088t2281r1546b2406],
18	,	,	O	,	_	0	SENT_77	[p8l1088t2281r1546b2406],
19	and	CC	O	and	_	0	SENT_77	[p8l1569t2281r1757b2376],
20	other	JJ	O	other	amod	22	SENT_77	[p8l1776t2281r2042b2376],
21	adverse	JJ	O	adverse	amod	22	SENT_77	[p8l10t2433r387b2529],
22	events	NNS	O	event	nsubjpass	24	SENT_77	[p8l407t2456r723b2529],
23	were	VBD	O	be	auxpass	24	SENT_77	[p8l740t2468r984b2529],
24	ascertained	VBN	O	ascertain	conj_and	12	SENT_77	[p8l1004t2433r1589b2529],
25	.	.	O	.	_	0	SENT_77	[p8l1004t2433r1589b2529],

1	After	IN	O	after	_	0	SENT_78	[p8l1613t2433r1866b2529],
2	the	DT	O	the	det	7	SENT_78	[p8l1886t2433r2042b2529],
3	last	JJ	O	last	amod	7	SENT_78	[p8l9t2584r183b2679],
4	study	NN	O	study	nn	7	SENT_78	[p8l200t2584r480b2710],
5	drug	NN	O	drug	nn	7	SENT_78	[p8l498t2584r737b2710],
6	treatment	NN	O	treatment	nn	7	SENT_78	[p8l757t2607r1249b2679],
7	period	NN	O	period	prep_after	10	SENT_78	[p8l1264t2584r1619b2709],
8	,	,	O	,	_	0	SENT_78	[p8l1264t2584r1619b2709],
9	patients	NNS	O	patient	nsubjpass	19	SENT_78	[p8l1643t2593r2040b2709],
10	resumed	VBD	O	resume	_	0	SENT_78	[p8l9t2735r445b2829],
11	their	PRP$	O	they	poss	14	SENT_78	[p8l465t2735r698b2829],
12	prestudy	JJ	O	prestudy	amod	14	SENT_78	[p8l715t2735r1158b2859],
13	antiplatelet	JJ	O	antiplatelet	amod	14	SENT_78	[p8l1175t2735r1734b2859],
14	medication	NN	O	medication	dobj	10	SENT_78	[p8l1749t2735r2040b2829, p8l12t2897r321b2982],
15	if	IN	O	if	mark	16	SENT_78	[p8l338t2886r414b2979],
16	indicated	VBN	O	indicate	advcl	10	SENT_78	[p8l423t2886r890b2982],
17	and	CC	O	and	_	0	SENT_78	[p8l908t2886r1097b2981],
18	were	VBD	O	be	auxpass	19	SENT_78	[p8l1111t2921r1356b2982],
19	contacted	VBN	O	contact	conj_and	10	SENT_78	[p8l1377t2886r1866b2982],
20	approximately	RB	O	approximately	quantmod	21	SENT_78	[p8l1884t2921r2040b3012, p8l8t3036r623b3161],
21	30	CD	DATE	30	num	22	SENT_78	[p8l639t3043r763b3131],
22	days	NNS	DATE	day	npadvmod	23	SENT_78	[p8l786t3036r1009b3161],
23	later	RB	DATE	later	advmod	19	SENT_78	[p8l1029t3036r1251b3131],
24	to	TO	O	to	aux	25	SENT_78	[p8l1272t3060r1365b3131],
25	assess	VB	O	assess	xcomp	19	SENT_78	[p8l1388t3071r1681b3131],
26	for	IN	O	for	_	0	SENT_78	[p8l1704t3035r1844b3131],
27	any	DT	O	any	det	29	SENT_78	[p8l1864t3071r2045b3161],
28	adverse	JJ	O	adverse	amod	29	SENT_78	[p8l10t3161r401b3257],
29	events	NNS	O	event	prep_for	25	SENT_78	[p8l439t3185r792b3257],
30	.	.	O	.	_	0	SENT_78	[p8l439t3185r792b3257],

1	The	DT	O	the	det	2	SENT_79	[p8l140t3312r345b3407],
2	trial	NN	O	trial	nsubjpass	4	SENT_79	[p8l384t3312r596b3407],
3	was	VBD	O	be	auxpass	4	SENT_79	[p8l629t3346r828b3408],
4	approved	VBN	O	approve	_	0	SENT_79	[p8l867t3312r1367b3437],
5	by	IN	O	by	_	0	SENT_79	[p8l1399t3312r1530b3438],
6	the	DT	O	the	det	9	SENT_79	[p8l1566t3312r1729b3407],
7	institutional	JJ	O	institutional	amod	9	SENT_79	[p8l1765t3321r2039b3407, p8l12t3462r431b3557],
8	review	NN	O	review	nn	9	SENT_79	[p8l475t3472r828b3557],
9	board	NN	O	board	agent	4	SENT_79	[p8l869t3462r1180b3557],
10	of	IN	O	of	_	0	SENT_79	[p8l1225t3461r1334b3557],
11	each	DT	O	each	det	13	SENT_79	[p8l1371t3462r1610b3557],
12	participating	VBG	O	participate	amod	13	SENT_79	[p8l1654t3472r2040b3587, p8l8t3625r346b3740],
13	site	NN	O	site	prep_of	9	SENT_79	[p8l388t3625r599b3728],
14	,	,	O	,	_	0	SENT_79	[p8l388t3625r599b3728],
15	and	CC	O	and	_	0	SENT_79	[p8l647t3614r842b3710],
16	participants	NNS	O	participant	agent	4	SENT_79	[p8l883t3625r1519b3740],
17	provided	VBN	O	provide	partmod	16	SENT_79	[p8l1561t3614r2042b3740],
18	written	VBN	O	write	amod	20	SENT_79	[p9l7t29r389b114],
19	informed	VBN	O	inform	amod	20	SENT_79	[p9l416t18r902b114],
20	consent	NN	O	consent	dobj	17	SENT_79	[p9l931t43r1360b114],
21	.	.	O	.	_	0	SENT_79	[p9l931t43r1360b114],

1	An	DT	O	a	det	3	SENT_80	[p9l1395t26r1548b113],
2	independent	JJ	O	independent	amod	3	SENT_80	[p9l1575t19r2040b144, p9l11t170r249b265],
3	data	NNS	O	datum	nsubj	7	SENT_80	[p9l280t170r499b265],
4	and	CC	O	and	_	0	SENT_80	[p9l533t170r728b265],
5	safety	NN	O	safety	nn	6	SENT_80	[p9l759t169r1065b295],
6	monitor	NN	O	monitor	conj_and	3	SENT_80	[p9l1093t180r1530b265],
7	reviewed	VBN	O	review	_	0	SENT_80	[p9l1561t170r2042b265],
8	unblinded	JJ	O	unblinded	amod	9	SENT_80	[p9l8t322r561b418],
9	data	NNS	O	datum	dobj	7	SENT_80	[p9l602t322r847b418],
10	.	.	O	.	_	0	SENT_80	[p9l602t322r847b418],

1	End	NN	O	end	nn	2	SENT_81	[p9l15t600r222b691],
2	Points	NNS	O	point	_	0	SENT_81	[p9l272t603r621b691],

1	The	DT	O	the	det	3	SENT_82	[p9l10t759r219b854],
2	outcome	NN	O	outcome	nn	3	SENT_82	[p9l274t782r751b854],
3	measurement	NN	O	measurement	nsubj	5	SENT_82	[p9l803t782r1554b854],
4	was	VBD	O	be	cop	5	SENT_82	[p9l1600t793r1805b854],
5	ontreatment	JJ	O	ontreatment	_	0	SENT_82	[p9l1860t793r2039b854, p9l12t932r513b1004],

1	platelet	NN	O	platelet	nn	3	SENT_83	[p9l536t909r916b1034],
2	reactivity	NN	O	reactivity	nn	3	SENT_83	[p9l939t919r1419b1034],
3	index	NN	O	index	_	0	SENT_83	[p9l1442t909r1734b1004],
4	(	CD	NUMBER	(	num	5	SENT_83	[p9l1767t908r2032b1018],
5	PRI	NNP	ORGANIZATION	PRI	dep	3	SENT_83	[p9l1767t908r2032b1018],
6	)	CD	NUMBER	)	num	5	SENT_83	[p9l1767t908r2032b1018],
7	determined	VBN	O	determine	partmod	3	SENT_83	[p9l11t1061r602b1157],
8	through	IN	O	through	_	0	SENT_83	[p9l630t1061r1046b1187],
9	ﬂow	NN	O	ﬂow	nn	11	SENT_83	[p9l1073t1061r1298b1157],
10	cytometric	JJ	O	cytometric	amod	11	SENT_83	[p9l1325t1072r1872b1187],
11	assessment	NN	O	assessment	prep_through	7	SENT_83	[p9l1900t1096r2040b1157, p9l10t1235r466b1306],
12	of	IN	O	of	_	0	SENT_83	[p9l489t1210r593b1306],
13	phosphorylation	NN	O	phosphorylation	nn	14	SENT_83	[p9l605t1211r1439b1336],
14	status	NN	O	status	prep_of	11	SENT_83	[p9l1461t1235r1747b1306],
15	of	IN	O	of	_	0	SENT_83	[p9l1773t1210r1878b1306],
16	vasodilator-stimulated	JJ	O	vasodilator-stimulated	amod	17	SENT_83	[p9l1889t1246r2040b1306, p9l10t1363r1117b1459],
17	phosphoprotein	NN	O	phosphoprotein	prep_of	14	SENT_83	[p9l1164t1363r2042b1489],

1	CLOPIDOGREL	NN	O	clopidogrel	nn	2	SENT_84	[p9l863t1632r1260b1672],
2	DOSES	NNS	O	dose	_	0	SENT_84	[p9l1277t1632r1450b1672],
3	AND	CC	O	and	_	0	SENT_84	[p9l1467t1632r1588b1671],
4	CYPZC	NN	O	cypzc	conj_and	2	SENT_84	[p9l1609t1632r1775b1672],
5	19	CD	NUMBER	19	num	6	SENT_84	[p9l1781t1632r1834b1672],
6	GENOTYPE	NN	O	genotype	dep	2	SENT_84	[p9l1853t1632r2151b1672],

1	(	RB	O	(	dep	2	SENT_85	[p9l35t1790r239b1846],
2	VASP	NN	ORGANIZATION	vasp	_	0	SENT_85	[p9l35t1790r239b1846],
3	)	CD	NUMBER	)	num	2	SENT_85	[p9l35t1790r239b1846],
4	.	.	O	.	_	0	SENT_85	[p9l35t1790r239b1846],

1	The	DT	O	the	det	3	SENT_86	[p9l257t1791r358b1838],
2	VASP	NN	ORGANIZATION	vasp	nn	3	SENT_86	[p9l371t1794r518b1838],
3	PR1	NN	O	pr1	nsubjpass	5	SENT_86	[p9l533t1795r625b1837],
4	was	VBD	O	be	auxpass	5	SENT_86	[p9l639t1808r737b1838],
5	determined	VBN	O	determine	_	0	SENT_86	[p9l752t1791r1051b1838],
6	from	IN	O	from	_	0	SENT_86	[p9l32t1866r157b1914],
7	ambient	JJ	O	ambient	amod	9	SENT_86	[p9l171t1866r384b1914],
8	blood	NN	O	blood	nn	9	SENT_86	[p9l397t1866r547b1914],
9	samples	NNS	O	sample	prep_from	5	SENT_86	[p9l561t1866r768b1929],
10	sent	VBN	O	send	partmod	9	SENT_86	[p9l783t1878r890b1914],
11	to	TO	O	to	_	0	SENT_86	[p9l905t1878r953b1914],
12	the	DT	O	the	det	13	SENT_86	[p9l971t1866r1050b1914],
13	Center	NNP	O	Center	prep_to	10	SENT_86	[p9l34t1944r218b1989],
14	for	IN	O	for	mark	18	SENT_86	[p9l244t1941r321b1989],
15	Platelet	NN	ORGANIZATION	platelet	nn	17	SENT_86	[p9l347t1941r553b1989],
16	Research	NN	ORGANIZATION	research	nn	17	SENT_86	[p9l578t1941r825b1989],
17	Studies	NNS	ORGANIZATION	study	nsubj	18	SENT_86	[p9l851t1941r1050b1989],
18	(	VBP	O	(	advcl	10	SENT_86	[p9l35t2016r317b2071],
19	Children	NNP	O	Children	poss	23	SENT_86	[p9l35t2016r317b2071],
20	’s	POS	O	’s	_	0	SENT_86	[p9l35t2016r317b2071],
21	Hospital	NNP	ORGANIZATION	Hospital	nn	23	SENT_86	[p9l330t2017r545b2079],
22	Boston	NNP	ORGANIZATION	Boston	nn	23	SENT_86	[p9l556t2016r770b2073],
23	)	NN	O	)	dobj	18	SENT_86	[p9l556t2016r770b2073],
24	,	,	O	,	_	0	SENT_86	[p9l556t2016r770b2073],
25	which	WDT	O	which	nsubjpass	27	SENT_86	[p9l783t2017r943b2064],
26	was	VBD	O	be	auxpass	27	SENT_86	[p9l954t2034r1050b2064],
27	blinded	VBN	O	blind	rcmod	23	SENT_86	[p9l30t2091r236b2138],
28	to	TO	O	to	_	0	SENT_86	[p9l261t2102r310b2138],
29	patient	NN	O	patient	nn	31	SENT_86	[p9l335t2096r524b2153],
30	treatment	NN	O	treatment	nn	31	SENT_86	[p9l548t2102r809b2138],
31	group	NN	O	group	prep_to	27	SENT_86	[p9l832t2088r1048b2153],
32	.	.	O	.	_	0	SENT_86	[p9l832t2088r1048b2153],

1	”	NN	O	”	nn	2	SENT_87	[p9l832t2088r1048b2153],
2	Platelet	NN	O	platelet	nsubjpass	28	SENT_87	[p9l32t2165r226b2212],
3	function	NN	O	function	nn	4	SENT_87	[p9l248t2164r470b2212],
4	testing	NN	O	testing	dep	2	SENT_87	[p9l494t2170r668b2228],
5	was	VBD	O	be	auxpass	7	SENT_87	[p9l688t2182r787b2213],
6	also	RB	O	also	advmod	7	SENT_87	[p9l810t2165r910b2212],
7	conducted	VBN	O	conduct	_	0	SENT_87	[p9l935t2182r1049b2212, p9l32t2239r212b2286],
8	at	IN	O	at	_	0	SENT_87	[p9l235t2250r282b2286],
9	each	DT	O	each	det	10	SENT_87	[p9l305t2239r424b2286],
10	site	NN	O	site	prep_at	7	SENT_87	[p9l447t2244r536b2286],
11	with	IN	O	with	_	0	SENT_87	[p9l558t2239r678b2286],
12	an	DT	O	a	det	15	SENT_87	[p9l701t2256r764b2286],
13	encrypted	JJ	O	encrypted	amod	15	SENT_87	[p9l787t2239r1051b2301],
14	point	NN	O	point	nn	15	SENT_87	[p9l30t2314r370b2377],
15	—	NN	O	—	prep_with	7	SENT_87	[p9l30t2314r370b2377],
16	of	IN	O	of	_	0	SENT_87	[p9l30t2314r370b2377],
17	—	CD	NUMBER	—	num	19	SENT_87	[p9l30t2314r370b2377],
18	care	NN	O	care	nn	19	SENT_87	[p9l30t2314r370b2377],
19	device	NN	O	device	prep_of	15	SENT_87	[p9l392t2314r556b2362],
20	(	CD	NUMBER	(	num	23	SENT_87	[p9l581t2314r887b2377],
21	VerifyNow	NNP	O	VerifyNow	nn	23	SENT_87	[p9l581t2314r887b2377],
22	P2Y12	NN	O	p2y12	nn	23	SENT_87	[p9l908t2318r1050b2371],
23	test	NN	O	test	dep	19	SENT_87	[p9l32t2401r133b2447],
24	;	:	O	;	_	0	SENT_87	[p9l32t2401r133b2447],
25	Accumetrics	NNP	O	Accumetrics	dep	19	SENT_87	[p9l147t2389r489b2444],
26	)	CD	NUMBER	)	num	25	SENT_87	[p9l147t2389r489b2444],
27	and	CC	O	and	_	0	SENT_87	[p9l506t2390r602b2437],
28	reported	VBD	O	report	conj_and	7	SENT_87	[p9l614t2390r834b2452],
29	as	IN	O	as	mark	33	SENT_87	[p9l847t2407r896b2437],
30	PZYH	NN	O	pzyh	nn	32	SENT_87	[p9l910t2393r1051b2446],
31	reaction	NN	O	reaction	nn	32	SENT_87	[p9l31t2469r256b2512],
32	units	NNS	O	unit	nsubj	33	SENT_87	[p9l280t2469r418b2512],
33	(	VBP	O	(	advcl	28	SENT_87	[p9l448t2464r634b2521],
34	PRU	NNP	ORGANIZATION	PRU	dobj	33	SENT_87	[p9l448t2464r634b2521],
35	)	CD	NUMBER	)	num	34	SENT_87	[p9l448t2464r634b2521],
36	,	,	O	,	_	0	SENT_87	[p9l448t2464r634b2521],
37	indicating	VBG	O	indicate	partmod	33	SENT_87	[p9l661t2464r940b2527],
38	the	DT	O	the	det	39	SENT_87	[p9l967t2464r1050b2512],
39	amount	NN	O	amount	dobj	37	SENT_87	[p9l31t2551r232b2587],
40	of	IN	O	of	_	0	SENT_87	[p9l244t2538r297b2587],
41	ADP	NN	O	adp	prep_of	39	SENT_87	[p9l304t2539r683b2587],
42	—	CD	NUMBER	—	num	41	SENT_87	[p9l304t2539r683b2587],
43	mediated	VBN	O	mediate	partmod	41	SENT_87	[p9l304t2539r683b2587],
44	platelet	NN	O	platelet	nn	45	SENT_87	[p9l694t2539r883b2602],
45	aggregation	NN	O	aggregation	nsubj	46	SENT_87	[p9l895t2556r1050b2602, p9l31t2618r194b2677],
46	specific	JJ	O	specific	xcomp	43	SENT_87	[p9l215t2613r408b2676],
47	to	TO	O	to	_	0	SENT_87	[p9l431t2625r479b2661],
48	the	DT	O	the	det	51	SENT_87	[p9l503t2614r583b2661],
49	platelet	NN	O	platelet	nn	51	SENT_87	[p9l603t2614r796b2676],
50	P2Y12	NN	O	p2y12	nn	51	SENT_87	[p9l817t2617r959b2670],
51	receptor	NN	O	receptor	prep_to	46	SENT_87	[p9l980t2631r1050b2661, p9l32t2701r211b2752],
52	.	.	O	.	_	0	SENT_87	[p9l980t2631r1050b2661, p9l32t2701r211b2752],

1	Nonresponder	JJ	O	nonresponder	amod	2	SENT_88	[p9l238t2689r624b2752],
2	status	NN	O	status	nsubjpass	4	SENT_88	[p9l646t2701r799b2737],
3	was	VBD	O	be	auxpass	4	SENT_88	[p9l821t2706r920b2737],
4	prespecified	VBN	O	prespecify	_	0	SENT_88	[p9l943t2706r1050b2752, p9l31t2763r260b2826],
5	at	IN	O	at	_	0	SENT_88	[p9l275t2775r322b2811],
6	230	CD	NUMBER	230	num	7	SENT_88	[p9l338t2767r432b2811],
7	PRU	NN	O	pru	prep_at	4	SENT_88	[p9l449t2768r566b2811],
8	or	CC	O	or	_	0	SENT_88	[p9l583t2780r637b2811],
9	greater	JJR	O	greater	prep_at	4	SENT_88	[p9l652t2761r887b2826],
10	.	.	O	.	_	0	SENT_88	[p9l652t2761r887b2826],

1	”	RB	O	”	advmod	23	SENT_89	[p9l652t2761r887b2826],
2	Based	VBN	O	base	_	0	SENT_89	[p9l901t2763r1051b2811],
3	on	IN	O	on	prepc_based_on	23	SENT_89	[p9l32t2856r98b2886],
4	data	NNS	O	datum	pobj	23	SENT_89	[p9l118t2839r225b2886],
5	that	WDT	O	that	nsubj	6	SENT_89	[p9l246t2839r347b2886],
6	emerged	VBD	O	emerge	rcmod	4	SENT_89	[p9l366t2839r589b2901],
7	after	IN	O	after	_	0	SENT_89	[p9l608t2838r724b2886],
8	initiation	NN	O	initiation	prep_after	6	SENT_89	[p9l743t2843r982b2886],
9	of	IN	O	of	_	0	SENT_89	[p9l1002t2838r1056b2886],
10	ELEVATE-TIMI	NN	O	elevate-timus	prep_of	8	SENT_89	[p9l31t2916r456b2961],
11	56,13	CD	NUMBER	56,13	num	10	SENT_89	[p9l475t2911r592b2970],
12	an	DT	O	a	det	15	SENT_89	[p9l611t2931r673b2961],
13	additional	JJ	O	additional	amod	15	SENT_89	[p9l690t2913r953b2961],
14	cut	NN	O	cut	nn	15	SENT_89	[p9l970t2925r1052b2961],
15	point	NN	O	point	dobj	6	SENT_89	[p9l30t2992r169b3050],
16	of	IN	O	of	_	0	SENT_89	[p9l183t2987r236b3035],
17	208	CD	NUMBER	208	num	18	SENT_89	[p9l246t2991r341b3035],
18	PRU	NN	O	pru	prep_of	15	SENT_89	[p9l356t2992r472b3035],
19	or	CC	O	or	_	0	SENT_89	[p9l487t3005r541b3035],
20	greater	JJR	O	greater	conj_or	18	SENT_89	[p9l554t2999r733b3051],
21	was	VBD	O	be	auxpass	23	SENT_89	[p9l745t3005r842b3035],
22	also	RB	O	also	advmod	23	SENT_89	[p9l857t2988r956b3035],
23	explored	VBN	O	explore	_	0	SENT_89	[p9l972t3005r1050b3035, p9l30t3063r214b3126],
24	.	.	O	.	_	0	SENT_89	[p9l972t3005r1050b3035, p9l30t3063r214b3126],

1	Fatal	JJ	O	fatal	nsubjpass	12	SENT_90	[p9l241t3063r384b3120],
2	,	,	O	,	_	0	SENT_90	[p9l241t3063r384b3120],
3	cardiovascular	JJ	O	cardiovascular	appos	1	SENT_90	[p9l410t3063r806b3120],
4	,	,	O	,	_	0	SENT_90	[p9l410t3063r806b3120],
5	cerebrovascular	JJ	O	cerebrovascular	appos	1	SENT_90	[p9l832t3063r1049b3111, p9l30t3138r258b3195],
6	,	,	O	,	_	0	SENT_90	[p9l832t3063r1049b3111, p9l30t3138r258b3195],
7	and	CC	O	and	_	0	SENT_90	[p9l277t3138r374b3185],
8	bleeding	VBG	O	bleed	amod	9	SENT_90	[p9l388t3138r612b3201],
9	events	NNS	O	event	appos	1	SENT_90	[p9l629t3149r792b3186],
10	were	VBD	O	be	auxpass	12	SENT_90	[p9l808t3155r933b3186],
11	also	RB	O	also	advmod	12	SENT_90	[p9l950t3138r1049b3185],
12	assessed	VBN	O	assess	_	0	SENT_90	[p9l31t3213r245b3260],
13	at	IN	O	at	_	0	SENT_90	[p9l258t3224r305b3260],
14	each	DT	O	each	det	15	SENT_90	[p9l318t3213r435b3260],
15	visit	NN	O	visit	prep_at	12	SENT_90	[p9l447t3218r567b3260],
16	.	.	O	.	_	0	SENT_90	[p9l447t3218r567b3260],

1	These	DT	O	these	det	2	SENT_91	[p9l584t3213r737b3260],
2	events	NNS	O	event	nsubjpass	4	SENT_91	[p9l751t3225r913b3260],
3	were	VBD	O	be	auxpass	4	SENT_91	[p9l926t3230r1051b3260],
4	adjudicated	VBN	O	adjudicate	_	0	SENT_91	[p9l31t3288r335b3351],
5	by	IN	O	by	_	0	SENT_91	[p9l353t3288r418b3351],
6	a	DT	O	a	det	10	SENT_91	[p9l438t3305r463b3336],
7	blinded	JJ	O	blinded	amod	10	SENT_91	[p9l483t3288r683b3336],
8	clinical	JJ	O	clinical	amod	10	SENT_91	[p9l704t3288r890b3336],
9	event	NN	O	event	nn	10	SENT_91	[p9l912t3300r1052b3336],
10	adjudicator	NN	O	adjudicator	agent	4	SENT_91	[p9l31t3363r352b3426],
11	.	.	O	.	_	0	SENT_91	[p9l31t3363r352b3426],

1	Adverse	JJ	O	adverse	amod	2	SENT_92	[p9l378t3363r594b3411],
2	events	NNS	O	event	nsubjpass	8	SENT_92	[p9l619t3375r788b3411],
3	and	CC	O	and	_	0	SENT_92	[p9l813t3363r911b3410],
4	serious	JJ	O	serious	amod	6	SENT_92	[p9l934t3368r1050b3410, p9l32t3455r122b3485],
5	adverse	JJ	O	adverse	amod	6	SENT_92	[p9l141t3438r335b3485],
6	events	NNS	O	event	conj_and	2	SENT_92	[p9l354t3449r517b3485],
7	were	VBD	O	be	auxpass	8	SENT_92	[p9l534t3455r659b3486],
8	collected	VBN	O	collect	_	0	SENT_92	[p9l678t3438r921b3485],
9	.	.	O	.	_	0	SENT_92	[p9l678t3438r921b3485],

1	ences	NNS	O	ence	nsubjpass	6	SENT_93	[p9l1133t1808r1282b1838],
2	among	IN	O	among	_	0	SENT_93	[p9l1308t1808r1494b1854],
3	the	DT	O	the	det	4	SENT_93	[p9l1520t1791r1604b1838],
4	means	NNS	O	means	prep_among	1	SENT_93	[p9l1630t1808r1804b1838],
5	were	VBD	O	be	auxpass	6	SENT_93	[p9l1829t1808r1960b1838],
6	calculated	VBN	O	calculate	_	0	SENT_93	[p9l1987t1791r2150b1838, p9l1132t1866r1267b1914],
7	.	.	O	.	_	0	SENT_93	[p9l1987t1791r2150b1838, p9l1132t1866r1267b1914],

1	Pairwise	JJ	O	pairwise	amod	2	SENT_94	[p9l1284t1871r1498b1914],
2	differences	NNS	O	difference	dep	6	SENT_94	[p9l1511t1866r1787b1914],
3	among	IN	O	among	_	0	SENT_94	[p9l1800t1883r1976b1929],
4	means	NNS	O	means	prep_among	2	SENT_94	[p9l1987t1883r2152b1914],
5	(	CD	NUMBER	(	dep	6	SENT_94	[p9l1136t1941r1222b1998],
6	ie	FW	O	ie	dep	13	SENT_94	[p9l1136t1941r1222b1998],
7	,	,	O	,	_	0	SENT_94	[p9l1136t1941r1222b1998],
8	between	IN	O	between	_	0	SENT_94	[p9l1250t1941r1486b1989],
9	individual	JJ	O	individual	amod	12	SENT_94	[p9l1512t1941r1803b1989],
10	clopidogrel	NN	O	clopidogrel	nn	12	SENT_94	[p9l1831t1941r2152b2004],
11	maintenance	NN	O	maintenance	nn	12	SENT_94	[p9l1132t2021r1497b2064],
12	doses	NNS	O	dose	prep_between	6	SENT_94	[p9l1526t2016r1703b2071],
13	)	CD	NUMBER	)	dep	15	SENT_94	[p9l1526t2016r1703b2071],
14	were	VBD	O	be	auxpass	15	SENT_94	[p9l1734t2034r1868b2064],
15	assessed	VBN	O	assess	_	0	SENT_94	[p9l1897t2017r2147b2064],
16	.	.	O	.	_	0	SENT_94	[p9l1897t2017r2147b2064],

1	Tukey-Kramer	NN	O	tukey-kramer	nn	2	SENT_95	[p9l1132t2091r1528b2153],
2	correction	NN	O	correction	nsubjpass	7	SENT_95	[p9l1544t2096r1820b2138],
3	for	IN	O	for	_	0	SENT_95	[p9l1835t2090r1910b2138],
4	multiple	JJ	O	multiple	amod	5	SENT_95	[p9l1925t2091r2152b2153],
5	testing	NN	O	testing	prep_for	2	SENT_95	[p9l1133t2170r1312b2228],
6	was	VBD	O	be	auxpass	7	SENT_95	[p9l1331t2182r1431b2213],
7	used	VBN	O	use	_	0	SENT_95	[p9l1451t2165r1589b2212],
8	.	.	O	.	_	0	SENT_95	[p9l1451t2165r1589b2212],

1	Proportions	NNS	O	proportion	nsubjpass	5	SENT_96	[p9l1614t2169r1933b2228],
2	of	IN	O	of	_	0	SENT_96	[p9l1956t2164r2010b2212],
3	nonresponders	NNS	O	nonresponder	prep_of	1	SENT_96	[p9l2026t2182r2151b2212, p9l1132t2239r1420b2301],
4	were	VBD	O	be	auxpass	5	SENT_96	[p9l1433t2256r1559b2286],
5	compared	VBN	O	compare	_	0	SENT_96	[p9l1574t2239r1835b2301],
6	within	IN	O	within	_	0	SENT_96	[p9l1847t2239r2020b2286],
7	each	DT	O	each	det	9	SENT_96	[p9l2034t2239r2152b2286],
8	genotype	NN	O	genotype	nn	9	SENT_96	[p9l1132t2326r1371b2377],
9	group	NN	O	group	prep_within	5	SENT_96	[p9l1385t2331r1539b2377],
10	using	VBG	O	use	partmod	9	SENT_96	[p9l1554t2319r1697b2377],
11	a	DT	O	a	dobj	10	SENT_96	[p9l1711t2331r1737b2362],
12	generalized	VBN	O	generalize	partmod	11	SENT_96	[p9l1751t2314r2050b2377],
13	linear	JJ	O	linear	amod	14	SENT_96	[p9l2063t2314r2152b2361, p9l1133t2407r1211b2437],
14	model	NN	O	model	dobj	12	SENT_96	[p9l1225t2390r1391b2437],
15	to	TO	O	to	aux	16	SENT_96	[p9l1407t2401r1456b2437],
16	account	VB	O	account	xcomp	12	SENT_96	[p9l1472t2401r1683b2437],
17	for	IN	O	for	_	0	SENT_96	[p9l1697t2389r1771b2437],
18	correlated	VBN	O	correlate	prepc_for	16	SENT_96	[p9l1786t2390r2052b2437],
19	observations	NNS	O	observation	dobj	18	SENT_96	[p9l2067t2390r2151b2437, p9l1132t2469r1404b2512],
20	.	.	O	.	_	0	SENT_96	[p9l2067t2390r2151b2437, p9l1132t2469r1404b2512],

1	A	DT	O	a	det	4	SENT_97	[p9l1419t2467r1460b2511],
2	2-sided	JJ	O	2-sided	amod	4	SENT_97	[p9l1475t2464r1662b2512],
3	P	NN	O	p	nn	4	SENT_97	[p9l1674t2469r1708b2511],
4	value	NN	O	value	nsubjpass	10	SENT_97	[p9l1718t2464r1856b2512],
5	of	IN	O	of	_	0	SENT_97	[p9l1870t2464r1924b2512],
6	less	JJR	O	less	mwe	7	SENT_97	[p9l1931t2464r2023b2512],
7	than	IN	O	than	quantmod	8	SENT_97	[p9l2038t2464r2153b2512],
8	.05	CD	NUMBER	.05	prep_of	4	SENT_97	[p9l1136t2542r1212b2587],
9	was	VBD	O	be	auxpass	10	SENT_97	[p9l1230t2556r1330b2587],
10	set	VBN	O	set	_	0	SENT_97	[p9l1348t2551r1422b2586],
11	as	IN	O	as	_	0	SENT_97	[p9l1439t2556r1489b2586],
12	the	DT	O	the	det	13	SENT_97	[p9l1509t2539r1591b2586],
13	level	NN	O	level	prep_as	10	SENT_97	[p9l1608t2539r1732b2587],
14	of	IN	O	of	_	0	SENT_97	[p9l1750t2538r1805b2586],
15	significance	NN	O	significance	prep_of	13	SENT_97	[p9l1817t2538r2148b2602],
16	.	.	O	.	_	0	SENT_97	[p9l1817t2538r2148b2602],

1	The	DT	O	the	det	4	SENT_98	[p9l1198t2614r1304b2661],
2	least	JJS	O	least	amod	4	SENT_98	[p9l1331t2614r1460b2661],
3	square	JJ	O	square	amod	4	SENT_98	[p9l1486t2631r1670b2677],
4	means	NNS	O	means	nsubjpass	10	SENT_98	[p9l1698t2631r1875b2661],
5	from	IN	O	from	_	0	SENT_98	[p9l1904t2613r2037b2661],
6	the	DT	O	the	det	8	SENT_98	[p9l2066t2614r2151b2661],
7	mixed	JJ	O	mixed	amod	8	SENT_98	[p9l1132t2689r1295b2737],
8	models	NNS	O	model	prep_from	4	SENT_98	[p9l1306t2689r1492b2737],
9	were	VBD	O	be	auxpass	10	SENT_98	[p9l1504t2706r1629b2737],
10	used	VBN	O	use	_	0	SENT_98	[p9l1641t2689r1762b2737],
11	to	TO	O	to	aux	12	SENT_98	[p9l1776t2701r1823b2737],
12	test	VB	O	test	xcomp	10	SENT_98	[p9l1839t2701r1928b2737],
13	whether	IN	O	whether	complm	29	SENT_98	[p9l1938t2689r2153b2737],
14	higher	JJR	O	higher	amod	16	SENT_98	[p9l1132t2763r1306b2826],
15	maintenance	NN	O	maintenance	nn	16	SENT_98	[p9l1325t2768r1670b2811],
16	doses	NNS	O	dose	nsubj	29	SENT_98	[p9l1691t2763r1836b2811],
17	of	IN	O	of	_	0	SENT_98	[p9l1859t2763r1913b2811],
18	clopidogrel	NN	O	clopidogrel	prep_of	16	SENT_98	[p9l1930t2763r2151b2826, p9l1132t2839r1236b2901],
19	in	IN	O	in	_	0	SENT_98	[p9l1261t2843r1315b2885],
20	carriers	NNS	O	carrier	prep_in	18	SENT_98	[p9l1342t2843r1549b2886],
21	of	IN	O	of	_	0	SENT_98	[p9l1577t2838r1632b2886],
22	a	DT	O	a	det	27	SENT_98	[p9l1654t2856r1680b2886],
23	loss-of-function	NN	O	loss-of-function	nn	27	SENT_98	[p9l1706t2838r2152b2886],
24	C	NN	O	c	nn	27	SENT_98	[p9l1134t2917r1171b2961],
25	YP2C	NN	O	yp2c	nn	27	SENT_98	[p9l1176t2917r1318b2961],
26	19	CD	NUMBER	19	num	27	SENT_98	[p9l1325t2916r1384b2961],
27	allele	NN	O	allele	prep_of	20	SENT_98	[p9l1403t2914r1541b2961],
28	could	MD	O	could	aux	29	SENT_98	[p9l1561t2914r1710b2961],
29	result	VB	O	result	ccomp	12	SENT_98	[p9l1728t2914r1881b2961],
30	in	IN	O	in	_	0	SENT_98	[p9l1897t2918r1950b2960],
31	similar	JJ	O	similar	amod	33	SENT_98	[p9l1968t2914r2152b2961],
32	platelet	NN	O	platelet	nn	33	SENT_98	[p9l1131t2988r1331b3050],
33	inhibition	NN	O	inhibition	prep_in	29	SENT_98	[p9l1347t2988r1616b3035],
34	as	IN	O	as	_	0	SENT_98	[p9l1634t3005r1685b3035],
35	compared	VBN	O	compare	prepc_as	29	SENT_98	[p9l1704t2988r1970b3050],
36	with	IN	O	with	pcomp	35	SENT_98	[p9l1986t2988r2108b3035],
37	a	DT	O	a	det	40	SENT_98	[p9l2126t3005r2152b3035],
38	standard	JJ	O	standard	amod	40	SENT_98	[p9l1132t3063r1363b3111],
39	maintenance	NN	O	maintenance	nn	40	SENT_98	[p9l1376t3068r1717b3111],
40	dose	NN	O	dose	pobj	36	SENT_98	[p9l1733t3063r1852b3111],
41	of	IN	O	of	_	0	SENT_98	[p9l1868t3063r1922b3111],
42	clopidogrel	NN	O	clopidogrel	prep_of	40	SENT_98	[p9l1933t3063r2151b3126, p9l1132t3138r1232b3201],
43	in	IN	O	in	_	0	SENT_98	[p9l1247t3143r1300b3185],
44	noncarriers	NNS	O	noncarrier	prep_in	42	SENT_98	[p9l1314t3143r1634b3185],
45	.	.	O	.	_	0	SENT_98	[p9l1314t3143r1634b3185],

1	Differences	NNS	O	difference	nsubjpass	10	SENT_99	[p9l1654t3137r1955b3185],
2	among	IN	O	among	_	0	SENT_99	[p9l1971t3155r2153b3201],
3	the	DT	O	the	det	6	SENT_99	[p9l1133t3213r1219b3260],
4	least	JJS	O	least	amod	6	SENT_99	[p9l1246t3213r1375b3260],
5	square	JJ	O	square	amod	6	SENT_99	[p9l1402t3230r1587b3276],
6	means	NNS	O	means	prep_among	1	SENT_99	[p9l1615t3230r1792b3260],
7	were	VBD	O	be	auxpass	8	SENT_99	[p9l1819t3230r1953b3260],
8	calculated	VBN	O	calculate	_	0	SENT_99	[p9l1982t3213r2150b3260, p9l1132t3288r1262b3336],
9	and	CC	O	and	_	0	SENT_99	[p9l1283t3288r1381b3336],
10	reported	VBN	O	report	conj_and	8	SENT_99	[p9l1401t3288r1631b3351],
11	with	IN	O	with	_	0	SENT_99	[p9l1650t3288r1772b3336],
12	the	DT	O	the	det	16	SENT_99	[p9l1794t3288r1876b3336],
13	95	CD	PERCENT	95	number	14	SENT_99	[p9l1898t3290r2011b3338],
14	%	NN	PERCENT	%	amod	16	SENT_99	[p9l1898t3290r2011b3338],
15	confidence	NN	O	confidence	nn	16	SENT_99	[p9l2034t3305r2151b3336, p9l1133t3362r1326b3410],
16	intervals	NNS	O	interval	prep_with	8	SENT_99	[p9l1347t3363r1591b3411],
17	.	.	O	.	_	0	SENT_99	[p9l1347t3363r1591b3411],

1	Ratios	NNS	O	ratio	nsubjpass	6	SENT_100	[p9l1617t3367r1781b3410],
2	of	IN	O	of	_	0	SENT_100	[p9l1804t3362r1859b3410],
3	the	DT	O	the	det	4	SENT_100	[p9l1877t3363r1959b3410],
4	means	NNS	O	means	prep_of	1	SENT_100	[p9l1981t3380r2151b3410],
5	were	VBD	O	be	auxpass	6	SENT_100	[p9l1131t3455r1259b3486],
6	calculated	VBN	O	calculate	_	0	SENT_100	[p9l1283t3438r1554b3485],
7	with	IN	O	with	_	0	SENT_100	[p9l1576t3438r1697b3486],
8	90	CD	PERCENT	90	number	9	SENT_100	[p9l1721t3439r1834b3487],
9	%	NN	PERCENT	%	amod	10	SENT_100	[p9l1721t3439r1834b3487],
10	confidence	NN	O	confidence	prep_with	6	SENT_100	[p9l1860t3437r2152b3485],

1	Statistical	JJ	O	statistical	amod	2	SENT_101	[p10l32t85r307b130],
2	Analysis	NN	O	analysis	_	0	SENT_101	[p10l329t85r562b144],

1	Continuous	JJ	O	continuous	amod	2	SENT_102	[p10l34t174r337b218],
2	data	NNS	O	datum	nsubjpass	4	SENT_102	[p10l352t171r458b218],
3	are	VBP	O	be	auxpass	4	SENT_102	[p10l471t188r547b218],
4	presented	VBN	O	present	_	0	SENT_102	[p10l559t171r811b233],
5	as	IN	O	as	_	0	SENT_102	[p10l823t188r873b218],
6	means	NNS	O	means	prep_as	4	SENT_102	[p10l886t188r1050b218],
7	and	CC	O	and	_	0	SENT_102	[p10l31t246r128b293],
8	95	CD	PERCENT	95	number	9	SENT_102	[p10l146t247r258b295],
9	%	NN	PERCENT	%	amod	11	SENT_102	[p10l146t247r258b295],
10	confidence	NN	O	confidence	nn	11	SENT_102	[p10l278t245r564b293],
11	intervals	NNS	O	interval	conj_and	6	SENT_102	[p10l581t246r821b303],
12	,	,	O	,	_	0	SENT_102	[p10l581t246r821b303],
13	and	CC	O	and	_	0	SENT_102	[p10l841t246r938b293],
14	categorical	JJ	O	categorical	amod	15	SENT_102	[p10l956t257r1050b293, p10l32t321r230b383],
15	data	NNS	O	datum	nsubjpass	17	SENT_102	[p10l243t320r348b368],
16	are	VBP	O	be	auxpass	17	SENT_102	[p10l361t338r437b368],
17	presented	VBN	O	present	conj_and	4	SENT_102	[p10l449t321r699b383],
18	as	IN	O	as	_	0	SENT_102	[p10l711t338r760b368],
19	counts	NNS	O	count	prep_as	17	SENT_102	[p10l774t332r943b368],
20	and	CC	O	and	_	0	SENT_102	[p10l957t321r1052b368],
21	percentages	NNS	O	percentage	conj_and	19	SENT_102	[p10l30t407r360b458],
22	unless	IN	O	unless	mark	24	SENT_102	[p10l386t395r562b443],
23	otherwise	RB	O	otherwise	advmod	24	SENT_102	[p10l590t395r861b443],
24	specified	VBN	O	specify	advcl	17	SENT_102	[p10l888t400r1050b458, p10l32t469r140b517],
25	.	.	O	.	_	0	SENT_102	[p10l888t400r1050b458, p10l32t469r140b517],

1	The	DT	O	the	det	4	SENT_103	[p10l165t470r266b517],
2	analytic	JJ	O	analytic	amod	4	SENT_103	[p10l287t470r492b533],
3	data	NN	O	datum	nn	4	SENT_103	[p10l514t470r622b517],
4	set	NN	O	set	dep	5	SENT_103	[p10l643t481r715b517],
5	consisted	VBD	O	consist	_	0	SENT_103	[p10l735t470r981b517],
6	of	IN	O	of	_	0	SENT_103	[p10l1002t469r1056b517],
7	all	DT	O	all	det	8	SENT_103	[p10l31t545r92b593],
8	patients	NNS	O	patient	prep_of	5	SENT_103	[p10l104t550r308b608],
9	who	WP	O	who	nsubjpass	12	SENT_103	[p10l320t546r433b593],
10	were	VBD	O	be	auxpass	12	SENT_103	[p10l446t563r571b593],
11	successfully	RB	O	successfully	advmod	12	SENT_103	[p10l585t545r894b608],
12	genotyped	VBN	O	genotype	rcmod	8	SENT_103	[p10l906t562r1051b608, p10l32t620r191b683],
13	,	,	O	,	_	0	SENT_103	[p10l906t562r1051b608, p10l32t620r191b683],
14	with	IN	O	with	_	0	SENT_103	[p10l215t620r335b668],
15	the	DT	O	the	det	16	SENT_103	[p10l358t620r438b668],
16	exception	NN	O	exception	prep_with	12	SENT_103	[p10l462t625r720b683],
17	of	IN	O	of	_	0	SENT_103	[p10l743t620r797b668],
18	1	CD	NUMBER	1	num	19	SENT_103	[p10l819t624r841b667],
19	patient	NN	O	patient	prep_of	16	SENT_103	[p10l867t625r1052b683],
20	who	WP	O	who	nsubjpass	23	SENT_103	[p10l29t695r146b742],
21	was	VBD	O	be	auxpass	23	SENT_103	[p10l172t712r274b742],
22	ultimately	RB	O	ultimately	advmod	23	SENT_103	[p10l299t695r582b758],
23	found	VBN	O	find	rcmod	19	SENT_103	[p10l607t694r769b742],
24	to	TO	O	to	aux	25	SENT_103	[p10l795t706r845b742],
25	have	VB	O	have	xcomp	23	SENT_103	[p10l872t695r998b742],
26	a	DT	O	a	det	29	SENT_103	[p10l1024t712r1050b742],
27	non	JJ	O	non	amod	29	SENT_103	[p10l31t767r234b817],
28	—	NN	O	—	nn	29	SENT_103	[p10l31t767r234b817],
29	*	NN	O	*	dobj	25	SENT_103	[p10l31t767r234b817],
30	2	CD	NUMBER	2	num	33	SENT_103	[p10l31t767r234b817],
31	loss-of-function	JJ	O	loss-of-function	amod	33	SENT_103	[p10l258t769r686b817],
32	CYP2C19	NN	O	cyp2c19	nn	33	SENT_103	[p10l711t773r961b817],
33	allele	NN	O	allele	nsubj	5	SENT_103	[p10l985t770r1050b817, p10l31t844r121b891],

1	(	NN	O	(	nsubj	5	SENT_104	[p10l149t844r268b899],
2	and	CC	O	and	_	0	SENT_104	[p10l149t844r268b899],
3	therefore	RB	O	therefore	conj_and	1	SENT_104	[p10l292t843r531b891],
4	never	RB	O	never	neg	5	SENT_104	[p10l554t861r701b892],
5	received	VBD	O	receive	_	0	SENT_104	[p10l724t844r945b892],
6	the	DT	O	the	det	7	SENT_104	[p10l969t844r1050b891],
7	225	CD	NUMBER	225	dobj	5	SENT_104	[p10l32t923r147b967],
8	-	:	O	-	_	0	SENT_104	[p10l32t923r147b967],
9	or	CC	O	or	_	0	SENT_104	[p10l162t937r215b967],
10	300-mg	JJ	O	300-mg	amod	11	SENT_104	[p10l228t923r427b982],
11	dose	NN	O	dose	dobj	5	SENT_104	[p10l440t920r556b967],
12	of	IN	O	of	_	0	SENT_104	[p10l570t919r622b967],
13	clopidogrel	NN	O	clopidogrel	nn	14	SENT_104	[p10l632t919r956b982],
14	)	NN	O	)	prep_of	11	SENT_104	[p10l632t919r956b982],
15	.	.	O	.	_	0	SENT_104	[p10l632t919r956b982],

1	No	DT	O	no	det	2	SENT_105	[p10l973t924r1050b967],
2	imputation	NN	O	imputation	nsubjpass	4	SENT_105	[p10l31t999r316b1057],
3	was	VBD	O	be	auxpass	4	SENT_105	[p10l327t1011r424b1042],
4	applied	VBN	O	apply	_	0	SENT_105	[p10l437t994r625b1057],
5	for	IN	O	for	_	0	SENT_105	[p10l637t994r709b1042],
6	missing	VBG	O	miss	amod	7	SENT_105	[p10l721t999r918b1057],
7	data	NNS	O	datum	prep_for	4	SENT_105	[p10l930t994r1049b1051],
8	,	,	O	,	_	0	SENT_105	[p10l930t994r1049b1051],
9	and	CC	O	and	_	0	SENT_105	[p10l31t1070r131b1117],
10	platelet	NN	O	platelet	nn	12	SENT_105	[p10l155t1070r359b1132],
11	function	NN	O	function	nn	12	SENT_105	[p10l384t1069r617b1117],
12	data	NNS	O	datum	nsubjpass	14	SENT_105	[p10l642t1070r755b1117],
13	were	VBD	O	be	auxpass	14	SENT_105	[p10l779t1087r909b1117],
14	analyzed	VBN	O	analyze	conj_and	4	SENT_105	[p10l935t1087r1050b1117, p10l31t1145r169b1207],
15	per-protocol	NN	O	per-protocol	dobj	14	SENT_105	[p10l186t1144r530b1207],
16	.	.	O	.	_	0	SENT_105	[p10l186t1144r530b1207],

1	The	DT	O	the	det	2	SENT_106	[p10l97t1219r199b1267],
2	association	NN	O	association	dep	18	SENT_106	[p10l215t1224r512b1267],
3	of	IN	O	of	_	0	SENT_106	[p10l528t1219r583b1267],
4	different	JJ	O	different	amod	5	SENT_106	[p10l594t1219r824b1267],
5	doses	NNS	O	dose	prep_of	2	SENT_106	[p10l839t1219r984b1267],
6	of	IN	O	of	_	0	SENT_106	[p10l1001t1219r1056b1267],
7	clopidogrel	NN	O	clopidogrel	nn	9	SENT_106	[p10l32t1294r335b1357],
8	(	CD	NUMBER	(	num	9	SENT_106	[p10l361t1293r477b1349],
9	test	NN	O	test	prep_of	5	SENT_106	[p10l361t1293r477b1349],
10	of	IN	O	of	_	0	SENT_106	[p10l498t1293r552b1341],
11	trend	NN	O	trend	nn	12	SENT_106	[p10l570t1293r732b1348],
12	)	NN	O	)	prep_of	2	SENT_106	[p10l570t1293r732b1348],
13	with	IN	O	with	_	0	SENT_106	[p10l757t1294r879b1341],
14	platelet	NN	O	platelet	nn	15	SENT_106	[p10l899t1294r1050b1356, p10l31t1369r97b1417],
15	reactivity	NN	O	reactivity	prep_with	12	SENT_106	[p10l111t1374r361b1432],
16	among	IN	O	among	_	0	SENT_106	[p10l375t1386r557b1432],
17	carriers	NNS	O	carrier	prep_among	15	SENT_106	[p10l572t1374r771b1417],
18	(	VBP	O	(	_	0	SENT_106	[p10l790t1369r932b1424],
19	with	IN	O	with	_	0	SENT_106	[p10l790t1369r932b1424],
20	heterozygotes	NNS	O	heterozygote	prep_with	18	SENT_106	[p10l946t1369r1051b1417, p10l32t1456r330b1507],
21	and	CC	O	and	_	0	SENT_106	[p10l358t1444r460b1491],
22	homozygotes	NNS	O	homozygote	conj_and	20	SENT_106	[p10l486t1444r858b1507],
23	tested	VBN	O	test	partmod	20	SENT_106	[p10l887t1444r1051b1491],
24	separately	RB	O	separately	advmod	23	SENT_106	[p10l31t1520r299b1582],
25	and	CC	O	and	_	0	SENT_106	[p10l313t1520r411b1567],
26	combined	VBN	O	combine	amod	27	SENT_106	[p10l427t1519r712b1574],
27	)	NN	O	)	conj_and	20	SENT_106	[p10l427t1519r712b1574],
28	and	CC	O	and	_	0	SENT_106	[p10l732t1520r830b1567],
29	noncarriers	NNS	O	noncarrier	conj_and	20	SENT_106	[p10l844t1537r1050b1567, p10l31t1598r170b1641],
30	of	IN	O	of	_	0	SENT_106	[p10l206t1593r265b1641],
31	the	DT	O	the	det	33	SENT_106	[p10l296t1594r388b1641],
32	CYP2C19	NN	O	cyp2c19	nn	33	SENT_106	[p10l425t1591r780b1641],
33	*	NN	O	*	prep_of	29	SENT_106	[p10l425t1591r780b1641],
34	2	CD	NUMBER	2	num	35	SENT_106	[p10l425t1591r780b1641],
35	lossoffunction	NN	O	lossoffunction	nsubj	18	SENT_106	[p10l816t1593r1050b1641, p10l32t1667r267b1715],

1	allele	NN	O	allele	nsubjpass	3	SENT_107	[p10l293t1668r436b1715],
2	was	VBD	O	be	auxpass	3	SENT_107	[p10l461t1685r563b1715],
3	evaluated	VBN	O	evaluate	_	0	SENT_107	[p10l591t1668r854b1715],
4	by	IN	O	by	_	0	SENT_107	[p10l879t1668r945b1731],
5	fitting	NN	O	fitting	agent	3	SENT_107	[p10l971t1667r1049b1715, p10l32t1748r144b1806],
6	a	DT	O	a	det	9	SENT_107	[p10l173t1761r199b1791],
7	repeated	VBN	O	repeat	amod	9	SENT_107	[p10l228t1744r478b1806],
8	mixed	JJ	O	mixed	amod	9	SENT_107	[p10l506t1743r685b1791],
9	model	NN	O	model	dobj	3	SENT_107	[p10l714t1744r893b1791],
10	with	IN	O	with	_	0	SENT_107	[p10l920t1744r1051b1791],
11	patient	NN	O	patient	prep_with	9	SENT_107	[p10l30t1823r218b1881],
12	as	IN	O	as	_	0	SENT_107	[p10l233t1835r284b1866],
13	a	DT	O	a	det	15	SENT_107	[p10l300t1835r326b1866],
14	random	JJ	O	random	amod	15	SENT_107	[p10l341t1818r551b1866],
15	effect	NN	O	effect	prep_as	11	SENT_107	[p10l567t1818r710b1866],
16	and	CC	O	and	_	0	SENT_107	[p10l725t1818r823b1866],
17	doses	NNS	O	dose	prep_with	9	SENT_107	[p10l838t1818r983b1866],
18	as	IN	O	as	_	0	SENT_107	[p10l1000t1835r1050b1866],
19	fixed	JJ	O	fixed	amod	20	SENT_107	[p10l32t1892r165b1940],
20	effects	NNS	O	effect	prep_as	17	SENT_107	[p10l185t1892r368b1950],
21	,	,	O	,	_	0	SENT_107	[p10l185t1892r368b1950],
22	and	CC	O	and	_	0	SENT_107	[p10l391t1893r503b1950],
23	,	,	O	,	_	0	SENT_107	[p10l391t1893r503b1950],
24	in	IN	O	in	conj_and	11	SENT_107	[p10l525t1897r578b1939],
25	the	DT	O	the	det	26	SENT_107	[p10l598t1893r680b1940],
26	case	NN	O	case	pobj	24	SENT_107	[p10l701t1910r810b1940],
27	of	IN	O	of	_	0	SENT_107	[p10l831t1892r886b1940],
28	VASP	NN	ORGANIZATION	vasp	nn	29	SENT_107	[p10l899t1896r1050b1940],
29	PR1	NN	O	pr1	prep_of	26	SENT_107	[p10l32t1973r139b2025],
30	,	,	O	,	_	0	SENT_107	[p10l32t1973r139b2025],
31	adjusting	VBG	O	adjust	partmod	9	SENT_107	[p10l156t1968r399b2031],
32	for	IN	O	for	_	0	SENT_107	[p10l413t1968r486b2016],
33	the	DT	O	the	det	34	SENT_107	[p10l501t1968r582b2016],
34	time	NN	O	time	prep_for	31	SENT_107	[p10l597t1973r712b2016],
35	from	IN	O	from	_	0	SENT_107	[p10l727t1968r853b2016],
36	sample	NN	O	sample	nn	37	SENT_107	[p10l867t1968r1051b2031],
37	collection	NN	O	collection	prep_from	34	SENT_107	[p10l32t2043r301b2090],
38	to	TO	O	to	_	0	SENT_107	[p10l327t2054r376b2090],
39	analysis	NN	O	analysis	prep_to	31	SENT_107	[p10l403t2043r631b2106],
40	.	.	O	.	_	0	SENT_107	[p10l403t2043r631b2106],

1	No	DT	O	no	det	4	SENT_108	[p10l660t2047r738b2090],
2	significant	JJ	O	significant	amod	4	SENT_108	[p10l765t2042r1052b2106],
3	carryover	NN	O	carryover	nn	4	SENT_108	[p10l32t2136r286b2181],
4	effects	NNS	O	effect	nsubjpass	6	SENT_108	[p10l304t2118r471b2166],
5	were	VBD	O	be	auxpass	6	SENT_108	[p10l487t2136r616b2166],
6	detected	VBN	O	detect	_	0	SENT_108	[p10l634t2119r859b2166],
7	for	IN	O	for	_	0	SENT_108	[p10l876t2118r951b2166],
8	the	DT	O	the	det	10	SENT_108	[p10l969t2119r1051b2166],
9	dose	NN	O	dose	nn	10	SENT_108	[p10l32t2193r158b2240],
10	sequences	NNS	O	sequence	prep_for	6	SENT_108	[p10l186t2209r472b2255],
11	among	IN	O	among	_	0	SENT_108	[p10l501t2209r690b2255],
12	CYP2C19	NN	O	cyp2c19	nn	13	SENT_108	[p10l719t2190r1048b2240],
13	*	NN	O	*	prep_among	10	SENT_108	[p10l719t2190r1048b2240],
14	2	CD	NUMBER	2	num	15	SENT_108	[p10l719t2190r1048b2240],
15	noncarriers	NNS	O	noncarrier	tmod	6	SENT_108	[p10l31t2272r324b2315],
16	(	CD	NUMBER	(	num	17	SENT_108	[p10l341t2267r432b2322],
17	P	NN	O	p	dep	15	SENT_108	[p10l341t2267r432b2322],
18	:	:	O	:	_	0	SENT_108	[p10l341t2267r432b2322],
19	.82	CD	NUMBER	.82	num	20	SENT_108	[p10l445t2267r540b2322],
20	)	CD	NUMBER	)	nsubj	23	SENT_108	[p10l445t2267r540b2322],
21	or	CC	O	or	_	0	SENT_108	[p10l559t2285r612b2315],
22	carriers	NNS	O	carrier	conj_or	20	SENT_108	[p10l625t2272r815b2315],
23	(	VBP	O	(	parataxis	6	SENT_108	[p10l832t2267r922b2322],
24	P	NN	O	p	dobj	23	SENT_108	[p10l832t2267r922b2322],
25	:	:	O	:	_	0	SENT_108	[p10l832t2267r922b2322],
26	.46	CD	NUMBER	.46	num	27	SENT_108	[p10l935t2267r1047b2322],
27	)	NN	O	)	dep	24	SENT_108	[p10l935t2267r1047b2322],
28	.	.	O	.	_	0	SENT_108	[p10l935t2267r1047b2322],

1	Least	NNP	O	Least	nn	3	SENT_109	[p10l31t2347r178b2390],
2	square	JJ	O	square	amod	3	SENT_109	[p10l206t2359r391b2405],
3	means	NNS	O	means	nsubj	6	SENT_109	[p10l420t2359r598b2390],
4	and	CC	O	and	_	0	SENT_109	[p10l628t2342r730b2390],
5	the	DT	O	the	conj_and	3	SENT_109	[p10l759t2342r845b2390],
6	differ	VBP	O	differ	_	0	SENT_109	[p10l874t2342r1050b2390, p10l195t2445r291b2468],
7	©	CD	NUMBER	©	num	8	SENT_109	[p10l874t2342r1050b2390, p10l195t2445r291b2468],
8	2011	CD	DATE	2011	dobj	6	SENT_109	[p10l874t2342r1050b2390, p10l195t2445r291b2468],

1	American	NNP	ORGANIZATION	American	nn	3	SENT_110	[p10l302t2446r442b2468],
2	Medical	NNP	ORGANIZATION	Medical	nn	3	SENT_110	[p10l451t2444r567b2468],
3	Association	NNP	ORGANIZATION	Association	_	0	SENT_110	[p10l574t2446r753b2468],
4	.	.	O	.	_	0	SENT_110	[p10l574t2446r753b2468],

1	All	DT	O	all	det	2	SENT_111	[p10l763t2444r805b2468],
2	rights	NNS	O	rights	nsubj	3	SENT_111	[p10l814t2444r898b2476],
3	reserved	VBN	O	reserve	_	0	SENT_111	[p10l907t2444r1037b2468],
4	.	.	O	.	_	0	SENT_111	[p10l907t2444r1037b2468],

1	intervals	NNS	O	interval	nsubjpass	11	SENT_112	[p10l1132t20r1377b77],
2	,	,	O	,	_	0	SENT_112	[p10l1132t20r1377b77],
3	and	CC	O	and	_	0	SENT_112	[p10l1399t20r1497b68],
4	equivalence	JJ	O	equivalence	amod	5	SENT_112	[p10l1517t20r1833b83],
5	boundaries	NNS	O	boundary	nsubjpass	11	SENT_112	[p10l1851t20r2151b68],
6	of	IN	O	of	_	0	SENT_112	[p10l1133t95r1187b143],
7	0.8	CD	NUMBER	0.8	number	9	SENT_112	[p10l1199t99r1279b144],
8	to	TO	O	to	dep	9	SENT_112	[p10l1297t107r1346b143],
9	1.25	CD	NUMBER	1.25	prep_of	5	SENT_112	[p10l1369t99r1477b144],
10	were	VBD	O	be	auxpass	11	SENT_112	[p10l1494t113r1622b143],
11	used	VBN	O	use	_	0	SENT_112	[p10l1637t96r1776b153],
12	,	,	O	,	_	0	SENT_112	[p10l1637t96r1776b153],
13	extrapolating	VBG	O	extrapolate	xcomp	11	SENT_112	[p10l1795t96r2153b159],
14	from	IN	O	from	_	0	SENT_112	[p10l1133t170r1261b218],
15	prior	JJ	O	prior	amod	17	SENT_112	[p10l1279t176r1414b233],
16	FDA	NNP	ORGANIZATION	FDA	nn	17	SENT_112	[p10l1433t174r1557b217],
17	guidance	NN	O	guidance	prep_from	13	SENT_112	[p10l1576t168r1877b233],
18	.	.	O	.	_	0	SENT_112	[p10l1576t168r1877b233],

1	”	NN	O	”	_	0	SENT_113	[p10l1576t168r1877b233],

1	To	TO	O	to	aux	2	SENT_114	[p10l1198t250r1267b293],
2	obtain	VB	O	obtain	csubj	19	SENT_114	[p10l1288t246r1457b293],
3	at	IN	O	at	quantmod	5	SENT_114	[p10l1476t257r1523b293],
4	least	JJS	O	least	mwe	3	SENT_114	[p10l1540t246r1662b293],
5	80	CD	PERCENT	80	dep	6	SENT_114	[p10l1680t247r1792b295],
6	%	NN	PERCENT	%	dep	7	SENT_114	[p10l1680t247r1792b295],
7	power	NN	O	power	dobj	2	SENT_114	[p10l1812t263r1980b308],
8	to	TO	O	to	aux	9	SENT_114	[p10l1999t257r2048b293],
9	detect	VB	O	detect	xcomp	2	SENT_114	[p10l2069t246r2151b293, p10l1134t332r1234b368],
10	a	DT	O	a	det	13	SENT_114	[p10l1260t338r1286b368],
11	7.5	CD	PERCENT	7.5	number	12	SENT_114	[p10l1316t322r1448b370],
12	%	NN	PERCENT	%	amod	13	SENT_114	[p10l1316t322r1448b370],
13	difference	NN	O	difference	dobj	9	SENT_114	[p10l1477t320r1756b368],
14	in	IN	O	in	_	0	SENT_114	[p10l1782t325r1836b367],
15	the	DT	O	the	det	18	SENT_114	[p10l1864t321r1949b368],
16	paired	JJ	O	paired	amod	18	SENT_114	[p10l1975t321r2152b383],
17	VASP	NN	ORGANIZATION	vasp	nn	18	SENT_114	[p10l1131t398r1282b443],
18	PR1	NN	O	pr1	prep_in	13	SENT_114	[p10l1310t400r1405b442],
19	means	VBZ	O	mean	_	0	SENT_114	[p10l1431t412r1604b443],
20	of	IN	O	of	_	0	SENT_114	[p10l1631t395r1686b443],
21	the	DT	O	the	det	23	SENT_114	[p10l1708t395r1791b443],
22	tested	VBN	O	test	amod	23	SENT_114	[p10l1818t395r1978b443],
23	doses	NNS	O	dose	prep_of	19	SENT_114	[p10l2003t395r2151b443],

1	(	NN	O	(	_	0	SENT_115	[p10l1136t469r1323b525],
2	which	WDT	O	which	nsubj	3	SENT_115	[p10l1136t469r1323b525],
3	corresponds	VBZ	O	correspond	rcmod	1	SENT_115	[p10l1342t470r1670b533],
4	to	TO	O	to	_	0	SENT_115	[p10l1691t481r1740b517],
5	50	CD	PERCENT	50	num	6	SENT_115	[p10l1761t471r1873b519],
6	%	NN	PERCENT	%	prep_to	3	SENT_115	[p10l1761t471r1873b519],
7	of	IN	O	of	_	0	SENT_115	[p10l1894t469r1949b517],
8	the	DT	O	the	det	10	SENT_115	[p10l1964t470r2046b517],
9	observed	VBN	O	observe	amod	10	SENT_115	[p10l2066t470r2151b517, p10l1132t546r1304b593],
10	difference	NN	O	difference	prep_of	6	SENT_115	[p10l1322t545r1587b593],
11	seen	VBN	O	see	partmod	10	SENT_115	[p10l1605t563r1723b593],
12	with	IN	O	with	_	0	SENT_115	[p10l1738t545r1860b593],
13	increasing	VBG	O	increase	prepc_with	11	SENT_115	[p10l1876t550r2153b608],
14	the	DT	O	the	det	16	SENT_115	[p10l1133t620r1216b668],
15	maintenance	NN	O	maintenance	nn	16	SENT_115	[p10l1242t625r1592b668],
16	dose	NN	O	dose	dobj	13	SENT_115	[p10l1618t620r1740b668],
17	of	IN	O	of	_	0	SENT_115	[p10l1766t620r1821b668],
18	clopidogrel	NN	O	clopidogrel	prep_of	16	SENT_115	[p10l1843t620r2152b683],
19	from	IN	O	from	_	0	SENT_115	[p10l1133t694r1261b742],
20	75	CD	NUMBER	75	number	22	SENT_115	[p10l1286t698r1346b743],
21	to	TO	NUMBER	to	dep	22	SENT_115	[p10l1373t706r1422b742],
22	150	CD	NUMBER	150	num	23	SENT_115	[p10l1453t698r1545b742],
23	mg	NN	O	mg	prep_from	13	SENT_115	[p10l1570t712r1653b758],
24	in	IN	O	in	_	0	SENT_115	[p10l1675t699r1728b741],
25	patients	NNS	O	patient	prep_in	1	SENT_115	[p10l1750t699r1962b757],
26	of	IN	O	of	_	0	SENT_115	[p10l1987t694r2041b742],
27	unknown	JJ	O	unknown	amod	28	SENT_115	[p10l2059t712r2151b742, p10l1132t770r1314b817],
28	genotype	NN	O	genotype	prep_of	25	SENT_115	[p10l1327t769r1584b832],
29	)	NN	O	)	dep	25	SENT_115	[p10l1327t769r1584b832],
30	,5	CD	NUMBER	,5	num	29	SENT_115	[p10l1593t767r1641b826],
31	and	CC	O	and	_	0	SENT_115	[p10l1656t770r1751b817],
32	maintaining	VBG	O	maintain	dep	25	SENT_115	[p10l1764t775r2078b832],
33	an	DT	O	a	det	34	SENT_115	[p10l2091t787r2152b817],
34	overall	JJ	O	overall	dobj	32	SENT_115	[p10l1133t844r1314b891],
35	or	CC	O	or	_	0	SENT_115	[p10l1336t862r1372b891],
36	of	IN	O	of	_	0	SENT_115	[p10l1397t843r1451b891],
37	.05	CD	NUMBER	.05	prep_of	38	SENT_115	[p10l1472t847r1549b892],
38	for	IN	O	for	conj_or	25	SENT_115	[p10l1574t843r1649b891],
39	the	DT	O	the	det	40	SENT_115	[p10l1672t844r1754b891],
40	study	NN	O	study	pobj	38	SENT_115	[p10l1777t844r1938b907],
41	,	,	O	,	_	0	SENT_115	[p10l1777t844r1938b907],
42	at	IN	O	at	quantmod	44	SENT_115	[p10l1963t855r2011b891],
43	least	JJS	O	least	mwe	42	SENT_115	[p10l2032t844r2153b891],
44	76	CD	NUMBER	76	num	48	SENT_115	[p10l1135t923r1195b968],
45	CYP2C19	NN	O	cyp2c19	nn	48	SENT_115	[p10l1212t923r1458b967],
46	loss-of-function	NN	O	loss-of-function	nn	48	SENT_115	[p10l1472t919r1890b967],
47	allele	NN	O	allele	nn	48	SENT_115	[p10l1903t919r2038b967],
48	carriers	NNS	O	carrier	appos	40	SENT_115	[p10l2054t937r2151b967, p10l1132t999r1255b1042],

1	were	VBD	O	be	auxpass	2	SENT_116	[p10l1281t1011r1413b1042],
2	required	VBN	O	require	_	0	SENT_116	[p10l1440t994r1691b1057],
3	.	.	O	.	_	0	SENT_116	[p10l1440t994r1691b1057],

1	In	IN	O	in	_	0	SENT_117	[p10l1722t999r1779b1041],
2	this	DT	O	this	det	3	SENT_117	[p10l1807t994r1907b1042],
3	calculation	NN	O	calculation	prep_in	12	SENT_117	[p10l1935t994r2150b1042, p10l1133t1075r1253b1127],
4	,	,	O	,	_	0	SENT_117	[p10l1935t994r2150b1042, p10l1133t1075r1253b1127],
5	the	DT	O	the	det	7	SENT_117	[p10l1274t1070r1356b1117],
6	standard	JJ	O	standard	amod	7	SENT_117	[p10l1374t1070r1607b1117],
7	deviation	NN	O	deviation	nsubjpass	12	SENT_117	[p10l1625t1070r1874b1117],
8	of	IN	O	of	_	0	SENT_117	[p10l1892t1069r1947b1117],
9	the	DT	O	the	det	10	SENT_117	[p10l1961t1070r2042b1117],
10	difference	NN	O	difference	prep_of	7	SENT_117	[p10l2061t1069r2151b1117, p10l1133t1144r1325b1192],
11	was	VBD	O	be	auxpass	12	SENT_117	[p10l1341t1162r1441b1192],
12	assumed	VBN	O	assume	_	0	SENT_117	[p10l1458t1145r1690b1192],
13	to	TO	O	to	aux	16	SENT_117	[p10l1707t1156r1756b1192],
14	be	VB	O	be	cop	16	SENT_117	[p10l1773t1145r1834b1192],
15	20	CD	PERCENT	20	num	16	SENT_117	[p10l1853t1146r1979b1194],
16	%	NN	PERCENT	%	xcomp	12	SENT_117	[p10l1853t1146r1979b1194],
17	.	.	O	.	_	0	SENT_117	[p10l1853t1146r1979b1194],

1	Based	VBN	O	base	_	0	SENT_118	[p10l1998t1145r2152b1192],
2	on	IN	O	on	prepc_based_on	20	SENT_118	[p10l1133t1236r1200b1267],
3	an	DT	O	a	det	4	SENT_118	[p10l1215t1236r1278b1267],
4	estimate	NN	O	estimate	pobj	20	SENT_118	[p10l1294t1224r1515b1267],
5	of	IN	O	of	_	0	SENT_118	[p10l1532t1219r1586b1267],
6	the	DT	O	the	det	7	SENT_118	[p10l1598t1219r1680b1267],
7	proportion	NN	O	proportion	prep_of	4	SENT_118	[p10l1694t1224r1988b1282],
8	of	IN	O	of	_	0	SENT_118	[p10l2004t1219r2059b1267],
9	patients	NNS	O	patient	prep_of	7	SENT_118	[p10l2068t1236r2151b1282, p10l1133t1298r1291b1341],
10	carrying	VBG	O	carry	partmod	9	SENT_118	[p10l1321t1298r1559b1357],
11	a	DT	O	a	det	14	SENT_118	[p10l1588t1311r1613b1341],
12	CYPZCI9	NN	O	cypzci9	nn	14	SENT_118	[p10l1644t1297r1908b1342],
13	lossoffunction	NN	O	lossoffunction	nn	14	SENT_118	[p10l1937t1293r2151b1341, p10l1133t1369r1365b1417],
14	allele	NN	O	allele	dobj	10	SENT_118	[p10l1391t1369r1548b1426],
15	,	,	O	,	_	0	SENT_118	[p10l1391t1369r1548b1426],
16	the	DT	O	the	det	19	SENT_118	[p10l1577t1369r1660b1417],
17	total	JJ	O	total	amod	19	SENT_118	[p10l1687t1369r1809b1417],
18	sample	NN	O	sample	nn	19	SENT_118	[p10l1834t1369r2025b1432],
19	size	NN	O	size	nsubj	20	SENT_118	[p10l2050t1374r2151b1417],
20	needed	VBN	O	need	_	0	SENT_118	[p10l1132t1444r1324b1491],
21	to	TO	O	to	aux	25	SENT_118	[p10l1344t1456r1393b1491],
22	be	VB	O	be	cop	25	SENT_118	[p10l1413t1444r1475b1492],
23	at	IN	O	at	quantmod	25	SENT_118	[p10l1495t1456r1543b1491],
24	least	JJS	O	least	mwe	23	SENT_118	[p10l1561t1444r1683b1491],
25	254	CD	NUMBER	254	xcomp	20	SENT_118	[p10l1702t1447r1813b1492],
26	.	.	O	.	_	0	SENT_118	[p10l1702t1447r1813b1492],

1	The	DT	O	the	det	4	SENT_119	[p10l1198t1520r1297b1567],
2	following	VBG	O	follow	amod	4	SENT_119	[p10l1311t1519r1556b1582],
3	clinical	JJ	O	clinical	amod	4	SENT_119	[p10l1569t1519r1753b1567],
4	outcomes	NNS	O	outcome	nsubjpass	6	SENT_119	[p10l1767t1531r2015b1567],
5	were	VBD	O	be	auxpass	6	SENT_119	[p10l2027t1537r2152b1567],
6	assessed	VBN	O	assess	_	0	SENT_119	[p10l1132t1594r1354b1641],
7	by	IN	O	by	_	0	SENT_119	[p10l1368t1594r1433b1656],
8	dose	NN	O	dose	agent	6	SENT_119	[p10l1448t1593r1568b1641],
9	for	IN	O	for	_	0	SENT_119	[p10l1585t1593r1660b1641],
10	CYP2C19	NN	O	cyp2c19	nn	11	SENT_119	[p10l1676t1591r1990b1641],
11	*	NN	O	*	prep_for	8	SENT_119	[p10l1676t1591r1990b1641],
12	2	CD	NUMBER	2	num	13	SENT_119	[p10l1676t1591r1990b1641],
13	carriers	NNS	O	carrier	tmod	6	SENT_119	[p10l2009t1598r2151b1641, p10l1133t1685r1207b1715],
14	and	CC	O	and	_	0	SENT_119	[p10l1222t1668r1319b1715],
15	noncarriers	NNS	O	noncarrier	tmod	6	SENT_119	[p10l1333t1672r1637b1715],
16	using	VBG	O	use	dep	13	SENT_119	[p10l1651t1672r1796b1731],
17	an	DT	O	a	det	19	SENT_119	[p10l1810t1685r1873b1715],
18	intentionto-treat	JJ	O	intentionto-treat	amod	19	SENT_119	[p10l1887t1672r2151b1715, p10l1134t1755r1330b1791],
19	approach	NN	O	approach	dobj	16	SENT_119	[p10l1344t1744r1606b1806],
20	:	:	O	:	_	0	SENT_119	[p10l1344t1744r1606b1806],
21	death	NN	O	death	dep	19	SENT_119	[p10l1626t1744r1773b1791],
22	(	CD	NUMBER	(	number	23	SENT_119	[p10l1791t1743r2151b1798, p10l1132t1818r1204b1866],
23	cardiovascular	JJ	O	cardiovascular	dep	21	SENT_119	[p10l1791t1743r2151b1798, p10l1132t1818r1204b1866],
24	and	CC	O	and	_	0	SENT_119	[p10l1231t1818r1332b1866],
25	noncardiovascular	JJ	O	noncardiovascular	amod	26	SENT_119	[p10l1358t1818r1922b1875],
26	)	NN	O	)	conj_and	23	SENT_119	[p10l1358t1818r1922b1875],
27	,	,	O	,	_	0	SENT_119	[p10l1358t1818r1922b1875],
28	cardiac	JJ	O	cardiac	amod	30	SENT_119	[p10l1953t1818r2151b1866],
29	ischemic	JJ	O	ischemic	amod	30	SENT_119	[p10l1132t1893r1368b1940],
30	events	NNS	O	event	nsubj	31	SENT_119	[p10l1388t1904r1556b1940],
31	(	VBP	O	(	parataxis	16	SENT_119	[p10l1579t1892r1690b1950],
32	Ml	NN	O	ml	dobj	31	SENT_119	[p10l1579t1892r1690b1950],
33	,	,	O	,	_	0	SENT_119	[p10l1579t1892r1690b1950],
34	unstable	JJ	O	unstable	amod	35	SENT_119	[p10l1711t1893r1938b1940],
35	angina	NN	O	angina	appos	32	SENT_119	[p10l1957t1898r2150b1956],
36	,	,	O	,	_	0	SENT_119	[p10l1957t1898r2150b1956],
37	urgent	JJ	O	urgent	amod	40	SENT_119	[p10l1131t1980r1317b2031],
38	coronary	JJ	O	coronary	amod	40	SENT_119	[p10l1344t1985r1595b2031],
39	revascularization	NN	O	revascularization	nn	40	SENT_119	[p10l1621t1968r2150b2025],
40	)	NN	O	)	appos	32	SENT_119	[p10l1621t1968r2150b2025],
41	,	,	O	,	_	0	SENT_119	[p10l1621t1968r2150b2025],
42	cerebrovascular	JJ	O	cerebrovascular	amod	43	SENT_119	[p10l1133t2043r1537b2090],
43	events	NNS	O	event	appos	32	SENT_119	[p10l1551t2055r1711b2091],
44	(	JJ	O	(	amod	45	SENT_119	[p10l1729t2043r1907b2098],
45	stroke	NN	O	stroke	dep	43	SENT_119	[p10l1729t2043r1907b2098],
46	and	CC	O	and	_	0	SENT_119	[p10l1921t2043r2016b2090],
47	transient	JJ	O	transient	amod	50	SENT_119	[p10l2030t2054r2151b2090, p10l1132t2123r1264b2166],
48	ischemic	JJ	O	ischemic	amod	50	SENT_119	[p10l1288t2119r1530b2166],
49	attack	NN	O	attack	nn	50	SENT_119	[p10l1556t2118r1763b2175],
50	)	NN	O	)	appos	32	SENT_119	[p10l1556t2118r1763b2175],
51	,	,	O	,	_	0	SENT_119	[p10l1556t2118r1763b2175],
52	and	CC	O	and	_	0	SENT_119	[p10l1792t2119r1891b2166],
53	bleeding	VBG	O	bleed	dep	13	SENT_119	[p10l1915t2119r2152b2181],
54	(	CD	NUMBER	(	num	55	SENT_119	[p10l1136t2192r1535b2255],
55	Thrombolysis	NNPS	O	Thrombolysis	dobj	53	SENT_119	[p10l1136t2192r1535b2255],
56	in	IN	O	in	_	0	SENT_119	[p10l1561t2197r1614b2239],
57	Myocardial	JJ	O	myocardial	amod	60	SENT_119	[p10l1638t2193r1945b2255],
58	Infarction	NN	O	infarction	nn	60	SENT_119	[p10l1970t2192r2151b2240, p10l1133t2268r1417b2322],
59	[	NN	O	[	nn	60	SENT_119	[p10l1970t2192r2151b2240, p10l1133t2268r1417b2322],
60	TlMI	NN	O	tlmus	prep_in	53	SENT_119	[p10l1970t2192r2151b2240, p10l1133t2268r1417b2322],
61	]	CD	NUMBER	]	num	62	SENT_119	[p10l1970t2192r2151b2240, p10l1133t2268r1417b2322],
62	scales	NNS	O	scale	dep	60	SENT_119	[p10l1440t2267r1629b2322],
63	)	CD	NUMBER	)	dep	13	SENT_119	[p10l1440t2267r1629b2322],
64	.	.	O	.	_	0	SENT_119	[p10l1440t2267r1629b2322],

1	Analyses	NNS	O	analysis	nsubjpass	3	SENT_120	[p10l1646t2268r1879b2330],
2	were	VBD	O	be	auxpass	3	SENT_120	[p10l1893t2285r2020b2315],
3	conducted	VBN	O	conduct	_	0	SENT_120	[p10l2036t2285r2151b2315, p10l1133t2342r1315b2390],
4	using	VBG	O	use	xcomp	3	SENT_120	[p10l1334t2347r1481b2405],
5	SAS	NNP	O	SAS	nn	6	SENT_120	[p10l1500t2345r1601b2390],
6	version	NN	O	version	dobj	4	SENT_120	[p10l1620t2347r1818b2390],
7	9.2	CD	NUMBER	9.2	advmod	4	SENT_120	[p10l1838t2346r1933b2390],
8	.	.	O	.	_	0	SENT_120	[p10l1838t2346r1933b2390],

1	JAMA	NNP	O	JAMA	_	0	SENT_121	[p10l1513t2447r1595b2472],
2	,	,	O	,	_	0	SENT_121	[p10l1513t2447r1595b2472],
3	November	NNP	DATE	November	appos	1	SENT_121	[p10l1606t2445r1736b2468],
4	23/30	CD	DATE	23/30	num	3	SENT_121	[p10l1746t2447r1825b2472],
5	,	,	O	,	_	0	SENT_121	[p10l1746t2447r1825b2472],
6	201l	CD	NUMBER	201l	num	3	SENT_121	[p10l1837t2445r1973b2468],
7	.	.	O	.	_	0	SENT_121	[p10l1837t2445r1973b2468],

1	—	NN	O	—	_	0	SENT_122	[p10l1837t2445r1973b2468],
2	.	.	O	.	_	0	SENT_122	[p10l1837t2445r1973b2468],

1	Vol	NN	O	vol	_	0	SENT_123	[p10l1837t2445r1973b2468],
2	306	CD	NUMBER	306	num	1	SENT_123	[p10l1984t2447r2038b2472],
3	,	,	O	,	_	0	SENT_123	[p10l1984t2447r2038b2472],
4	No.	NN	O	no.	appos	1	SENT_123	[p10l2049t2447r2092b2468],
5	20	CD	NUMBER	20	num	4	SENT_123	[p10l2104t2447r2134b2468],

1	2223	CD	DATE	2223	_	0	SENT_124	[p10l6t2488r77b2509],
2	Downloaded	NNP	O	Downloaded	dep	1	SENT_124	[p10l87t2486r264b2510],
3	From	IN	O	from	prep	2	SENT_124	[p10l273t2486r361b2509],
4	:	:	O	:	_	0	SENT_124	[p10l273t2486r361b2509],
5	http://jama.jaInanetwork.com/	NN	O	http://jama.jainanetwork.com/	dep	2	SENT_124	[p10l372t2485r810b2516],
6	by	IN	O	by	_	0	SENT_124	[p10l818t2486r852b2516],
7	a	DT	O	a	det	8	SENT_124	[p10l862t2493r877b2509],
8	University	NNP	ORGANIZATION	University	prep_by	5	SENT_124	[p10l886t2485r1034b2516],
9	of	IN	ORGANIZATION	of	_	0	SENT_124	[p10l1043t2485r1072b2509],
10	Wisconsin	NNP	ORGANIZATION	Wisconsin	prep_of	8	SENT_124	[p10l1079t2485r1225b2509],
11	-	:	O	-	_	0	SENT_124	[p10l1234t2485r1368b2509],
12	Madison	NNP	O	Madison	nn	13	SENT_124	[p10l1234t2485r1368b2509],
13	User	NN	O	user	dep	2	SENT_124	[p10l1377t2486r1443b2510],
14	on	IN	O	on	_	0	SENT_124	[p10l1461t2493r1495b2509],
15	01/05/2014	CD	DATE	01/05/2014	prep_on	13	SENT_124	[p10l1504t2485r1655b2510],

1	CLOPIDOGREL	NN	O	clopidogrel	_	0	SENT_125	[p10l59t2610r311b2636],
2	DOSES	NNS	O	dose	dep	1	SENT_125	[p10l321t2610r431b2636],
3	AND	CC	O	and	_	0	SENT_125	[p10l442t2610r519b2636],
4	CYPZCI9	NN	O	cypzci9	nn	5	SENT_125	[p10l532t2610r675b2636],
5	GENOTYPE	NN	O	genotype	dep	1	SENT_125	[p10l687t2610r876b2636],

1	RESULTS	NNS	O	result	nsubjpass	8	SENT_126	[p10l59t2713r238b2743],
2	In	IN	O	in	_	0	SENT_126	[p10l58t2763r92b2790],
3	total	JJ	O	total	prep_in	8	SENT_126	[p10l103t2760r184b2796],
4	,	,	O	,	_	0	SENT_126	[p10l103t2760r184b2796],
5	333	CD	NUMBER	333	num	6	SENT_126	[p10l196t2762r256b2791],
6	patients	NNS	O	patient	appos	3	SENT_126	[p10l267t2763r398b2800],
7	were	VBD	O	be	auxpass	8	SENT_126	[p10l407t2771r487b2791],
8	enrolled	VBN	O	enrol	_	0	SENT_126	[p10l498t2760r634b2791],
9	and	CC	O	and	_	0	SENT_126	[p10l644t2760r705b2791],
10	underwent	VBD	O	undergo	conj_and	8	SENT_126	[p10l57t2807r234b2837],
11	genotyping	NN	O	genotyping	dobj	10	SENT_126	[p10l240t2810r428b2847],
12	.	.	O	.	_	0	SENT_126	[p10l240t2810r428b2847],

1	Their	PRP$	O	they	poss	6	SENT_127	[p10l438t2807r525b2837],
2	mean	JJ	O	mean	amod	6	SENT_127	[p10l532t2818r621b2837],
3	(	JJ	O	(	amod	6	SENT_127	[p10l631t2807r702b2842],
4	SD	NN	O	sd	nn	6	SENT_127	[p10l631t2807r702b2842],
5	)	NN	O	)	nn	6	SENT_127	[p10l631t2807r702b2842],
6	age	NN	O	age	nsubj	9	SENT_127	[p10l58t2865r112b2895],
7	was	VBD	O	be	cop	9	SENT_127	[p10l126t2865r190b2885],
8	60.2	CD	NUMBER	60.2	number	9	SENT_127	[p10l206t2856r278b2885],
9	(	CD	NUMBER	(	_	0	SENT_127	[p10l295t2854r374b2890],
10	9.9	CD	NUMBER	9.9	number	11	SENT_127	[p10l295t2854r374b2890],
11	)	CD	NUMBER	)	num	12	SENT_127	[p10l295t2854r374b2890],
12	years	NNS	NUMBER	year	nsubj	17	SENT_127	[p10l391t2865r488b2895],
13	,	,	O	,	_	0	SENT_127	[p10l391t2865r488b2895],
14	74.8	CD	PERCENT	74.8	num	15	SENT_127	[p10l505t2855r608b2886],
15	%	NN	PERCENT	%	appos	12	SENT_127	[p10l505t2855r608b2886],
16	were	VBD	O	be	cop	17	SENT_127	[p10l623t2865r704b2885],
17	male	JJ	O	male	rcmod	9	SENT_127	[p10l57t2902r147b2938],
18	,	,	O	,	_	0	SENT_127	[p10l57t2902r147b2938],
19	57.1	CD	PERCENT	57.1	num	20	SENT_127	[p10l164t2903r267b2933],
20	%	NN	PERCENT	%	nsubj	21	SENT_127	[p10l164t2903r267b2933],
21	had	VBD	O	have	dep	9	SENT_127	[p10l282t2902r344b2932],
22	a	DT	O	a	det	23	SENT_127	[p10l359t2913r375b2932],
23	history	NN	O	history	dobj	21	SENT_127	[p10l390t2902r509b2942],
24	of	IN	O	of	_	0	SENT_127	[p10l524t2901r558b2932],
25	MI	NNP	O	MI	prep_of	23	SENT_127	[p10l569t2905r626b2938],
26	,	,	O	,	_	0	SENT_127	[p10l569t2905r626b2938],
27	and	CC	O	and	_	0	SENT_127	[p10l642t2902r704b2932],
28	97.3	CD	PERCENT	97.3	num	29	SENT_127	[p10l58t2950r157b2981],
29	%	NN	PERCENT	%	nsubj	30	SENT_127	[p10l58t2950r157b2981],
30	had	VBD	O	have	conj_and	9	SENT_127	[p10l165t2949r226b2980],
31	a	DT	O	a	det	32	SENT_127	[p10l233t2961r249b2980],
32	history	NN	O	history	dobj	30	SENT_127	[p10l257t2950r370b2990],
33	of	IN	O	of	_	0	SENT_127	[p10l377t2949r411b2980],
34	PCI	NN	O	pcus	prep_of	32	SENT_127	[p10l416t2952r484b2980],
35	.	.	O	.	_	0	SENT_127	[p10l416t2952r484b2980],

1	A	DT	O	a	quantmod	2	SENT_128	[p10l493t2951r519b2980],
2	total	NN	O	total	num	5	SENT_128	[p10l527t2950r598b2980],
3	of	IN	O	of	quantmod	2	SENT_128	[p10l606t2949r639b2980],
4	247	CD	NUMBER	247	number	2	SENT_128	[p10l645t2952r704b2980],
5	patients	NNS	O	patient	nsubj	7	SENT_128	[p10l57t3000r219b3037],
6	were	VBD	O	be	cop	7	SENT_128	[p10l245t3008r338b3028],
7	noncarriers	NNS	O	noncarrier	_	0	SENT_128	[p10l364t3000r598b3028],
8	of	IN	O	of	_	0	SENT_128	[p10l626t2997r664b3028],
9	a	DT	O	a	det	13	SENT_128	[p10l688t3008r704b3028],
10	CYP2C19	NN	O	cyp2c19	nn	13	SENT_128	[p10l58t3043r253b3075],
11	*	NN	O	*	nn	13	SENT_128	[p10l58t3043r253b3075],
12	2	CD	NUMBER	2	num	13	SENT_128	[p10l58t3043r253b3075],
13	allele	NN	O	allele	prep_of	7	SENT_128	[p10l264t3045r349b3075],
14	whereas	IN	O	whereas	mark	17	SENT_128	[p10l358t3045r493b3075],
15	86	CD	NUMBER	86	nsubj	17	SENT_128	[p10l503t3047r543b3075],
16	were	VBD	O	be	cop	17	SENT_128	[p10l552t3056r632b3075],
17	carriers	NNS	O	carrier	advcl	7	SENT_128	[p10l642t3056r704b3075, p10l756t2716r828b2743],
18	(	VBP	O	(	rcmod	17	SENT_128	[p10l843t2713r896b2748],
19	80	CD	NUMBER	80	num	20	SENT_128	[p10l843t2713r896b2748],
20	heterozygotes	NNS	O	heterozygote	dobj	18	SENT_128	[p10l909t2713r1138b2753],
21	and	CC	O	and	_	0	SENT_128	[p10l1151t2713r1212b2743],
22	6	CD	NUMBER	6	num	23	SENT_128	[p10l1224t2715r1243b2743],
23	homozygotes	NNS	O	homozygote	dobj	18	SENT_128	[p10l1255t2713r1402b2753, p10l756t2760r859b2800],
24	)	CD	NUMBER	)	dep	23	SENT_128	[p10l1255t2713r1402b2753, p10l756t2760r859b2800],
25	.	.	O	.	_	0	SENT_128	[p10l1255t2713r1402b2753, p10l756t2760r859b2800],

1	Clinical	JJ	O	clinical	amod	2	SENT_129	[p10l870t2760r992b2791],
2	characteristics	NNS	O	characteristic	nsubj	5	SENT_129	[p10l999t2760r1223b2791],
3	did	VBD	O	do	aux	5	SENT_129	[p10l1231t2760r1282b2791],
4	not	RB	O	not	neg	5	SENT_129	[p10l1289t2768r1343b2791],
5	differ	VB	O	differ	dep	12	SENT_129	[p10l1349t2760r1402b2791, p10l756t2807r800b2837],
6	between	IN	O	between	_	0	SENT_129	[p10l812t2807r952b2837],
7	the	DT	O	the	det	11	SENT_129	[p10l966t2807r1017b2837],
8	carrier	NN	O	carrier	nn	11	SENT_129	[p10l1032t2810r1140b2837],
9	and	CC	O	and	_	0	SENT_129	[p10l1154t2807r1215b2837],
10	noncarrier	NN	O	noncarrier	nn	11	SENT_129	[p10l1228t2810r1403b2837],
11	groups	NNS	O	group	prep_between	5	SENT_129	[p10l756t2865r869b2895],
12	(	VBP	O	(	_	0	SENT_129	[p10l884t2854r999b2890],
13	TABLE	NN	O	table	dobj	12	SENT_129	[p10l884t2854r999b2890],
14	1	CD	NUMBER	1	num	15	SENT_129	[p10l1014t2854r1055b2890],
15	)	NN	O	)	nsubj	12	SENT_129	[p10l1014t2854r1055b2890],
16	.	.	O	.	_	0	SENT_129	[p10l1014t2854r1055b2890],

1	The	DT	O	the	det	3	SENT_130	[p10l1069t2854r1133b2885],
2	adherence	NN	O	adherence	nn	3	SENT_130	[p10l1145t2854r1314b2885],
3	rates	NNS	O	rate	nsubj	30	SENT_130	[p10l1325t2862r1402b2885],
4	for	IN	O	for	_	0	SENT_130	[p10l756t2901r801b2932],
5	the	DT	O	the	det	6	SENT_130	[p10l809t2902r859b2932],
6	75	CD	NUMBER	75	prep_for	3	SENT_130	[p10l868t2904r927b2938],
7	-	:	O	-	_	0	SENT_130	[p10l868t2904r927b2938],
8	,	,	O	,	_	0	SENT_130	[p10l868t2904r927b2938],
9	150	CD	NUMBER	150	dep	3	SENT_130	[p10l939t2904r1017b2938],
10	-	:	O	-	_	0	SENT_130	[p10l939t2904r1017b2938],
11	,	,	O	,	_	0	SENT_130	[p10l939t2904r1017b2938],
12	225	CD	NUMBER	225	dep	9	SENT_130	[p10l1027t2904r1107b2938],
13	-	:	O	-	_	0	SENT_130	[p10l1027t2904r1107b2938],
14	,	,	O	,	_	0	SENT_130	[p10l1027t2904r1107b2938],
15	and	CC	O	and	_	0	SENT_130	[p10l1116t2902r1176b2932],
16	300-mg	JJ	O	300-mg	amod	17	SENT_130	[p10l1183t2904r1308b2942],
17	doses	NNS	O	dose	conj_and	3	SENT_130	[p10l1315t2902r1403b2932],
18	of	IN	O	of	_	0	SENT_130	[p10l757t2949r790b2980],
19	clopidogrel	NN	O	clopidogrel	prep_of	17	SENT_130	[p10l802t2949r989b2990],
20	among	IN	O	among	_	0	SENT_130	[p10l1003t2960r1116b2990],
21	CYP2C19	NN	O	cyp2c19	nn	22	SENT_130	[p10l1130t2948r1325b2980],
22	*	NN	O	*	prep_among	30	SENT_130	[p10l1130t2948r1325b2980],
23	2	CD	NUMBER	2	num	24	SENT_130	[p10l1130t2948r1325b2980],
24	carriers	NNS	O	carrier	nsubj	30	SENT_130	[p10l1341t2960r1402b2980, p10l756t3000r828b3028],
25	on	IN	O	on	_	0	SENT_130	[p10l839t3008r881b3028],
26	study	NN	O	study	nn	27	SENT_130	[p10l891t2997r982b3037],
27	drug	NN	O	drug	prep_on	24	SENT_130	[p10l992t2997r1069b3037],
28	were	VBD	O	be	cop	30	SENT_130	[p10l1077t3008r1157b3028],
29	97.3	CD	PERCENT	97.3	num	30	SENT_130	[p10l1167t2998r1278b3033],
30	%	NN	PERCENT	%	_	0	SENT_130	[p10l1167t2998r1278b3033],
31	,	,	O	,	_	0	SENT_130	[p10l1167t2998r1278b3033],
32	98.1	CD	PERCENT	98.1	num	33	SENT_130	[p10l1290t2998r1401b3033],
33	%	NN	PERCENT	%	conj_and	30	SENT_130	[p10l1290t2998r1401b3033],
34	,	,	O	,	_	0	SENT_130	[p10l1290t2998r1401b3033],
35	98.6	CD	PERCENT	98.6	num	36	SENT_130	[p10l756t3046r868b3081],
36	%	NN	PERCENT	%	conj_and	30	SENT_130	[p10l756t3046r868b3081],
37	,	,	O	,	_	0	SENT_130	[p10l756t3046r868b3081],
38	and	CC	O	and	_	0	SENT_130	[p10l880t3045r941b3075],
39	98.3	CD	PERCENT	98.3	num	40	SENT_130	[p10l953t3046r1064b3081],
40	%	NN	PERCENT	%	conj_and	30	SENT_130	[p10l953t3046r1064b3081],
41	,	,	O	,	_	0	SENT_130	[p10l953t3046r1064b3081],
42	respectively	RB	O	respectively	advmod	30	SENT_130	[p10l1076t3045r1280b3085],
43	.	.	O	.	_	0	SENT_130	[p10l1076t3045r1280b3085],

1	Table	NNP	O	Table	_	0	SENT_131	[p10l56t3158r145b3184],
2	1	CD	NUMBER	1	dep	1	SENT_131	[p10l158t3160r186b3183],
3	.	.	O	.	_	0	SENT_131	[p10l158t3160r186b3183],

1	Patient	NN	O	patient	nn	3	SENT_132	[p10l200t3160r297b3184],
2	Baseline	NN	O	baseline	nn	3	SENT_132	[p10l309t3158r420b3184],
3	Characteristics	NNS	O	characteristic	nsubj	4	SENT_132	[p10l432t3158r651b3184],
4	“	VBP	O	“	_	0	SENT_132	[p10l432t3158r651b3184],

1	CYP2C19	NN	O	cyp2c19	nn	2	SENT_133	[p10l795t3210r964b3234],
2	*	NN	O	*	_	0	SENT_133	[p10l795t3210r964b3234],
3	2	CD	NUMBER	2	num	4	SENT_133	[p10l795t3210r964b3234],
4	CYP2C19	NN	O	cyp2c19	dep	2	SENT_133	[p10l1013t3210r1183b3234],
5	*	NN	O	*	nn	8	SENT_133	[p10l1013t3210r1183b3234],
6	2	CD	NUMBER	2	num	8	SENT_133	[p10l1013t3210r1183b3234],
7	P	NN	O	p	nn	8	SENT_133	[p10l1260t3211r1280b3233],
8	Value	NN	O	value	dep	2	SENT_133	[p10l1293t3211r1372b3234],

1	Response	NN	O	response	_	0	SENT_134	[p10l1456t2713r1628b2749],
2	to	TO	O	to	dep	1	SENT_134	[p10l1640t2714r1678b2740],
3	Higher	JJR	O	higher	amod	4	SENT_134	[p10l1693t2711r1812b2749],
4	Doses	NNS	O	dose	pobj	2	SENT_134	[p10l1825t2713r1933b2740],
5	of	IN	O	of	_	0	SENT_134	[p10l1455t2761r1492b2791],
6	Clopidogrel	NNP	O	Clopidogrel	prep_of	4	SENT_134	[p10l1505t2761r1711b2799],
7	When	WRB	O	when	advmod	8	SENT_134	[p10l1453t2807r1557b2837],
8	treated	VBN	O	treat	dep	2	SENT_134	[p10l1567t2807r1684b2837],
9	with	IN	O	with	_	0	SENT_134	[p10l1692t2807r1769b2837],
10	a	DT	O	a	det	14	SENT_134	[p10l1778t2818r1795b2837],
11	standard	JJ	O	standard	amod	14	SENT_134	[p10l1804t2807r1951b2837],
12	clopidogrel	NN	O	clopidogrel	nn	14	SENT_134	[p10l1961t2807r2101b2847, p10l1454t2854r1518b2895],
13	maintenance	NN	O	maintenance	nn	14	SENT_134	[p10l1529t2857r1748b2885],
14	dose	NN	O	dose	prep_with	8	SENT_134	[p10l1760t2854r1836b2885],
15	of	IN	O	of	_	0	SENT_134	[p10l1849t2854r1883b2885],
16	75	CD	NUMBER	75	num	17	SENT_134	[p10l1893t2856r1931b2885],
17	mg	NN	O	mg	prep_of	14	SENT_134	[p10l1944t2865r1997b2895],
18	daily	RB	SET	daily	advmod	8	SENT_134	[p10l2009t2854r2100b2895],
19	,	,	O	,	_	0	SENT_134	[p10l2009t2854r2100b2895],
20	both	DT	O	both	det	22	SENT_134	[p10l1453t2902r1530b2932],
21	CYP2C19	NN	O	cyp2c19	nn	22	SENT_134	[p10l1539t2900r1732b2933],
22	*	NN	O	*	dep	1	SENT_134	[p10l1539t2900r1732b2933],
23	2	CD	NUMBER	2	num	24	SENT_134	[p10l1539t2900r1732b2933],
24	heterozygotes	NNS	O	heterozygote	nsubj	27	SENT_134	[p10l1742t2902r1968b2942],
25	and	CC	O	and	_	0	SENT_134	[p10l1977t2902r2038b2932],
26	homozygotes	NNS	O	homozygote	nsubj	27	SENT_134	[p10l2046t2902r2101b2932, p10l1454t2957r1633b2990],
27	had	VBD	O	have	rcmod	22	SENT_134	[p10l1642t2949r1704b2980],
28	significantly	RB	O	significantly	advmod	29	SENT_134	[p10l1713t2949r1920b2990],
29	higher	JJR	O	higher	amod	30	SENT_134	[p10l1928t2949r2037b2990],
30	ontreatment	NN	O	ontreatment	dobj	27	SENT_134	[p10l2046t2960r2101b2980, p10l1455t3005r1622b3028],
31	platelet	NN	O	platelet	nn	32	SENT_134	[p10l1636t2997r1764b3037],
32	reactivity	NN	O	reactivity	dep	22	SENT_134	[p10l1778t3000r1939b3037],
33	than	IN	O	than	mark	34	SENT_134	[p10l1955t2997r2031b3028],
34	did	VBD	O	do	dep	32	SENT_134	[p10l2047t2997r2101b3028],
35	noncarrier	NN	O	noncarrier	nn	36	SENT_134	[p10l1454t3048r1634b3075],
36	patients	NNS	O	patient	dobj	34	SENT_134	[p10l1648t3048r1782b3085],
37	(	FW	O	(	nsubj	38	SENT_134	[p10l1800t3044r1906b3080],
38	mean	VB	O	mean	rcmod	36	SENT_134	[p10l1800t3044r1906b3080],
39	VASP	NN	ORGANIZATION	vasp	nn	40	SENT_134	[p10l1919t3046r2015b3075],
40	PRI	NNP	ORGANIZATION	PRI	dobj	38	SENT_134	[p10l2030t3047r2100b3081],
41	,	,	O	,	_	0	SENT_134	[p10l2030t3047r2100b3081],
42	70.0	CD	PERCENT	70.0	num	43	SENT_134	[p10l1456t3094r1577b3129],
43	%	NN	PERCENT	%	appos	40	SENT_134	[p10l1456t3094r1577b3129],
44	;	:	O	;	_	0	SENT_134	[p10l1456t3094r1577b3129],
45	95	CD	PERCENT	95	number	46	SENT_134	[p10l1597t3094r1672b3124],
46	%	NN	PERCENT	%	amod	47	SENT_134	[p10l1597t3094r1672b3124],
47	Cl	NN	O	cl	dep	40	SENT_134	[p10l1692t3095r1744b3129],
48	,	,	O	,	_	0	SENT_134	[p10l1692t3095r1744b3129],
49	66.0	CD	PERCENT	66.0	num	50	SENT_134	[p10l1764t3094r2016b3129],
50	%	NN	PERCENT	%	appos	47	SENT_134	[p10l1764t3094r2016b3129],
51	-74.0	CD	PERCENT	-74.0	num	52	SENT_134	[p10l1764t3094r2016b3129],
52	%	NN	PERCENT	%	dep	50	SENT_134	[p10l1764t3094r2016b3129],
53	,	,	O	,	_	0	SENT_134	[p10l1764t3094r2016b3129],
54	and	CC	O	and	_	0	SENT_134	[p10l2036t3093r2101b3123],
55	86.6	CD	PERCENT	86.6	num	56	SENT_134	[p10l1455t3142r1565b3177],
56	%	NN	PERCENT	%	conj_and	50	SENT_134	[p10l1455t3142r1565b3177],
57	;	:	O	;	_	0	SENT_134	[p10l1455t3142r1565b3177],
58	95	CD	PERCENT	95	number	59	SENT_134	[p10l1575t3142r1645b3172],
59	%	NN	PERCENT	%	amod	60	SENT_134	[p10l1575t3142r1645b3172],
60	Cl	NN	O	cl	dep	40	SENT_134	[p10l1656t3143r1702b3177],
61	,	,	O	,	_	0	SENT_134	[p10l1656t3143r1702b3177],
62	80.7	CD	PERCENT	80.7	num	63	SENT_134	[p10l1712t3142r1938b3177],
63	%	NN	PERCENT	%	appos	60	SENT_134	[p10l1712t3142r1938b3177],
64	-92.5	CD	PERCENT	-92.5	num	65	SENT_134	[p10l1712t3142r1938b3177],
65	%	NN	PERCENT	%	dep	63	SENT_134	[p10l1712t3142r1938b3177],
66	,	,	O	,	_	0	SENT_134	[p10l1712t3142r1938b3177],
67	vs	CC	O	vs	_	0	SENT_134	[p10l1947t3152r1981b3171],
68	57.5	CD	PERCENT	57.5	num	69	SENT_134	[p10l1990t3142r2100b3177],
69	%	NN	PERCENT	%	conj_vs	60	SENT_134	[p10l1990t3142r2100b3177],
70	;	:	O	;	_	0	SENT_134	[p10l1990t3142r2100b3177],
71	95	CD	PERCENT	95	number	72	SENT_134	[p10l1455t3190r1525b3220],
72	%	NN	PERCENT	%	amod	73	SENT_134	[p10l1455t3190r1525b3220],
73	CI	NN	O	ci	dep	40	SENT_134	[p10l1536t3191r1582b3225],
74	,	,	O	,	_	0	SENT_134	[p10l1536t3191r1582b3225],
75	55.1	CD	PERCENT	55.1	num	76	SENT_134	[p10l1593t3190r1819b3225],
76	%	NN	PERCENT	%	appos	73	SENT_134	[p10l1593t3190r1819b3225],
77	-59.9	CD	PERCENT	-59.9	num	78	SENT_134	[p10l1593t3190r1819b3225],
78	%	NN	PERCENT	%	dep	76	SENT_134	[p10l1593t3190r1819b3225],
79	;	:	O	;	_	0	SENT_134	[p10l1593t3190r1819b3225],
80	P	NN	O	p	dep	40	SENT_134	[p10l1828t3192r1850b3219],
81	<	JJR	O	<	amod	80	SENT_134	[p10l1857t3193r1885b3217],
82	.001	CD	NUMBER	.001	dep	81	SENT_134	[p10l1895t3191r1961b3219],
83	for	IN	O	for	dep	82	SENT_134	[p10l1972t3189r2018b3219],
84	both	CC	O	both	advmod	40	SENT_134	[p10l2025t3189r2102b3219],

1	Overall	JJ	O	overall	amod	2	SENT_135	[p10l625t3243r722b3267],
2	Noncarriers	NNS	O	noncarrier	_	0	SENT_135	[p10l798t3244r963b3267],

1	Carriers	NNS	O	carrier	_	0	SENT_136	[p10l1042t3243r1154b3267],

1	(	NN	O	(	_	0	SENT_137	[p10l1236t3243r1356b3272],
2	Carriers	NNS	O	carrier	dep	1	SENT_137	[p10l1236t3243r1356b3272],
3	vs	CC	O	vs	_	0	SENT_137	[p10l1366t3249r1397b3267],
4	comparisons	NNS	O	comparison	dep	1	SENT_137	[p10l1455t3236r1689b3276],
5	)	CD	NUMBER	)	num	4	SENT_137	[p10l1455t3236r1689b3276],
6	.	.	O	.	_	0	SENT_137	[p10l1455t3236r1689b3276],

1	Among	IN	O	among	_	0	SENT_138	[p10l1699t3238r1822b3276],
2	CYP2C19	NN	O	cyp2c19	nn	3	SENT_138	[p10l1831t3235r2026b3267],
3	*	NN	O	*	prep_among	60	SENT_138	[p10l1831t3235r2026b3267],
4	2	CD	NUMBER	2	num	5	SENT_138	[p10l1831t3235r2026b3267],
5	het	NN	O	het	dep	13	SENT_138	[p10l2036t3236r2101b3267, p10l611t3276r639b3305],
6	(	CD	NUMBER	(	num	7	SENT_138	[p10l2036t3236r2101b3267, p10l611t3276r639b3305],
7	N	NN	O	n	dep	5	SENT_138	[p10l2036t3236r2101b3267, p10l611t3276r639b3305],
8	=	JJ	O	=	quantmod	9	SENT_138	[p10l651t3286r667b3296],
9	333	CD	NUMBER	333	dep	7	SENT_138	[p10l678t3276r736b3305],
10	)	NN	O	)	dep	13	SENT_138	[p10l678t3276r736b3305],
11	(	CD	NUMBER	(	num	10	SENT_138	[p10l819t3276r843b3305],
12	"	``	O	"	punct	13	SENT_138	[p10l819t3276r843b3305],
13	=	JJ	O	=	dep	28	SENT_138	[p10l854t3286r871b3296],
14	247	CD	NUMBER	247	number	15	SENT_138	[p10l882t3276r940b3305],
15	)	NN	O	)	num	16	SENT_138	[p10l882t3276r940b3305],
16	(	CD	NUMBER	(	dep	13	SENT_138	[p10l1046t3276r1070b3305],
17	"	``	O	"	punct	16	SENT_138	[p10l1046t3276r1070b3305],
18	=	JJ	O	=	dep	16	SENT_138	[p10l1081t3286r1098b3296],
19	86	CD	NUMBER	86	number	20	SENT_138	[p10l1108t3276r1149b3305],
20	)	CD	NUMBER	)	num	21	SENT_138	[p10l1108t3276r1149b3305],
21	N	NN	O	n	dep	18	SENT_138	[p10l1229t3276r1402b3305],
22	°	CD	NUMBER	°	nsubj	28	SENT_138	[p10l1229t3276r1402b3305],
23	"	``	O	"	punct	22	SENT_138	[p10l1229t3276r1402b3305],
24	°	CD	NUMBER	°	dep	22	SENT_138	[p10l1229t3276r1402b3305],
25	a	DT	O	a	dep	22	SENT_138	[p10l1229t3276r1402b3305],
26	"	``	O	"	punct	28	SENT_138	[p10l1229t3276r1402b3305],
27	'	''	O	'	_	0	SENT_138	[p10l1229t3276r1402b3305],
28	ie	FW	O	ie	dep	60	SENT_138	[p10l1229t3276r1402b3305],
29	'	''	O	'	_	0	SENT_138	[p10l1229t3276r1402b3305],
30	5	CD	NUMBER	5	num	32	SENT_138	[p10l1229t3276r1402b3305],
31	)	NN	O	)	nn	32	SENT_138	[p10l1229t3276r1402b3305],
32	erozygotes	NNS	O	erozygote	dobj	28	SENT_138	[p10l1455t3292r1647b3324],
33	,	,	O	,	_	0	SENT_138	[p10l1455t3292r1647b3324],
34	higher	JJR	O	higher	amod	36	SENT_138	[p10l1664t3284r1775b3324],
35	clopidogrel	NN	O	clopidogrel	nn	36	SENT_138	[p10l1791t3284r1986b3324],
36	mainAge	NN	O	mainage	appos	32	SENT_138	[p10l2001t3287r2100b3315, p10l56t3324r115b3353],
37	,	,	O	,	_	0	SENT_138	[p10l2001t3287r2100b3315, p10l56t3324r115b3353],
38	mean	VB	O	mean	dep	32	SENT_138	[p10l128t3329r200b3347],
39	(	JJ	O	(	amod	41	SENT_138	[p10l212t3323r298b3352],
40	sD	NN	O	sd	nn	41	SENT_138	[p10l212t3323r298b3352],
41	)	NN	O	)	dobj	38	SENT_138	[p10l212t3323r298b3352],
42	,	,	O	,	_	0	SENT_138	[p10l212t3323r298b3352],
43	y	NN	O	y	nn	45	SENT_138	[p10l212t3323r298b3352],
44	6o	CD	NUMBER	6o	num	45	SENT_138	[p10l605t3323r730b3352],
45	.2	NN	NUMBER	.2	appos	41	SENT_138	[p10l605t3323r730b3352],
46	(	CD	NUMBER	(	number	47	SENT_138	[p10l605t3323r730b3352],
47	9.9	CD	NUMBER	9.9	num	49	SENT_138	[p10l605t3323r730b3352],
48	)	CD	NUMBER	)	number	49	SENT_138	[p10l605t3323r730b3352],
49	60.8	CD	NUMBER	60.8	dep	45	SENT_138	[p10l817t3324r875b3347],
50	(	NN	O	(	num	49	SENT_138	[p10l886t3323r942b3352],
51	9.9	CD	NUMBER	9.9	number	50	SENT_138	[p10l886t3323r942b3352],
52	)	CD	NUMBER	)	number	50	SENT_138	[p10l886t3323r942b3352],
53	58.6	CD	NUMBER	58.6	number	50	SENT_138	[p10l1008t3324r1067b3347],
54	(	NN	O	(	num	59	SENT_138	[p10l1078t3323r1133b3352],
55	9.7	CD	NUMBER	9.7	number	54	SENT_138	[p10l1078t3323r1133b3352],
56	)	CD	NUMBER	)	number	54	SENT_138	[p10l1078t3323r1133b3352],
57	.07	CD	NUMBER	.07	number	54	SENT_138	[p10l1310t3324r1349b3347],
58	tenance	NN	O	tenance	nn	59	SENT_138	[p10l1455t3340r1592b3362],
59	doses	NNS	O	dose	nsubj	60	SENT_138	[p10l1610t3332r1707b3362],
60	(	VBP	O	(	_	0	SENT_138	[p10l1727t3332r1786b3372],
61	up	RP	O	up	dep	63	SENT_138	[p10l1727t3332r1786b3372],
62	to	TO	O	to	dep	63	SENT_138	[p10l1805t3340r1837b3362],
63	300	CD	NUMBER	300	num	64	SENT_138	[p10l1856t3334r1920b3362],
64	mg	NN	O	mg	dobj	60	SENT_138	[p10l1938t3332r2006b3372],
65	)	NN	O	)	nn	66	SENT_138	[p10l1938t3332r2006b3372],
66	pm	NN	O	pm	nsubj	67	SENT_138	[p10l2026t3343r2101b3372],
67	_	VBD	O	_	rcmod	64	SENT_138	[p10l2026t3343r2101b3372],
68	Male	JJ	O	male	amod	69	SENT_138	[p10l58t3370r120b3394],
69	sex	NN	O	sex	dobj	67	SENT_138	[p10l130t3376r175b3394],
70	249	CD	NUMBER	249	advmod	67	SENT_138	[p10l613t3371r663b3394],
71	(	CD	NUMBER	(	number	72	SENT_138	[p10l674t3370r747b3399],
72	74.8	CD	NUMBER	74.8	dep	78	SENT_138	[p10l674t3370r747b3399],
73	)	NN	O	)	prep	72	SENT_138	[p10l674t3370r747b3399],
74	186	CD	NUMBER	186	dep	73	SENT_138	[p10l827t3371r875b3394],
75	(	NN	O	(	dep	78	SENT_138	[p10l886t3370r959b3399],
76	75-3	CD	NUMBER	75-3	num	75	SENT_138	[p10l886t3370r959b3399],
77	)	CD	NUMBER	)	number	78	SENT_138	[p10l886t3370r959b3399],
78	53	CD	NUMBER	53	dep	83	SENT_138	[p10l1034t3371r1066b3394],
79	(	NN	O	(	prep	78	SENT_138	[p10l1078t3370r1150b3399],
80	73-3	CD	NUMBER	73-3	num	81	SENT_138	[p10l1078t3370r1150b3399],
81	)	CD	NUMBER	)	dep	79	SENT_138	[p10l1078t3370r1150b3399],
82	'71	CD	NUMBER	'71	nsubj	83	SENT_138	[p10l1310t3371r1344b3393],
83	duced	VBD	O	duce	dep	70	SENT_138	[p10l1455t3380r1556b3410],
84	significant	JJ	O	significant	amod	85	SENT_138	[p10l1565t3380r1740b3420],
85	reductions	NNS	O	reduction	dobj	83	SENT_138	[p10l1749t3380r1927b3410],
86	in	IN	O	in	prep	85	SENT_138	[p10l1936t3383r1970b3410],
87	platelet	NN	O	platelet	dep	88	SENT_138	[p10l1978t3380r2102b3420],
88	R	NN	O	r	dep	90	SENT_138	[p10l58t3417r76b3440],
89	/	:	O	/	punct	90	SENT_138	[p10l125t3417r136b3441],
90	th	DT	O	th	dep	86	SENT_138	[p10l152t3417r177b3440],
91	'	''	O	'	_	0	SENT_138	[p10l197t3417r199b3421],
92	'	''	O	'	_	0	SENT_138	[p10l219t3417r231b3440],
93	1	CD	NUMBER	1	num	94	SENT_138	[p10l219t3417r231b3440],
94	b	NN	O	b	dep	85	SENT_138	[p10l250t3411r262b3429],
95	.	.	O	.	_	0	SENT_138	[p10l1537t3431r1541b3435],

1	.	.	O	.	_	0	SENT_139	[p10l1567t3431r1571b3435],

1	aC	NN	O	ac	nsubj	26	SENT_140	[p10l78t3423r221b3474],
2	\	SYM	O	\	dep	5	SENT_140	[p10l78t3423r221b3474],
3	7VflitemC	NNP	O	7VflitemC	nn	5	SENT_140	[p10l78t3423r221b3474],
4	|	CD	NUMBER	|	num	5	SENT_140	[p10l78t3423r221b3474],
5	y	NN	O	y	dep	11	SENT_140	[p10l232t3423r246b3446],
6	293	CD	NUMBER	293	number	7	SENT_140	[p10l613t3451r663b3474],
7	(	CD	NUMBER	(	dep	5	SENT_140	[p10l674t3450r747b3479],
8	88.0	CD	NUMBER	88.0	num	9	SENT_140	[p10l674t3450r747b3479],
9	)	NN	O	)	dep	7	SENT_140	[p10l674t3450r747b3479],
10	224	CD	NUMBER	224	num	11	SENT_140	[p10l825t3451r875b3473],
11	(	NN	O	(	dep	17	SENT_140	[p10l886t3450r959b3479],
12	90.7	CD	NUMBER	90.7	number	13	SENT_140	[p10l886t3450r959b3479],
13	)	CD	NUMBER	)	dep	11	SENT_140	[p10l886t3450r959b3479],
14	69	CD	NUMBER	69	num	15	SENT_140	[p10l1034t3451r1066b3474],
15	(	NN	O	(	dep	13	SENT_140	[p10l1078t3450r1150b3479],
16	802	CD	NUMBER	802	num	17	SENT_140	[p10l1078t3450r1150b3479],
17	)	NN	O	)	dep	25	SENT_140	[p10l1078t3450r1150b3479],
18	1	CD	MONEY	1	number	19	SENT_140	[p10l1454t3435r1606b3468],
19	‘	CD	MONEY	‘	num	23	SENT_140	[p10l1454t3435r1606b3468],
20	€	NN	MONEY	€	nn	23	SENT_140	[p10l1454t3435r1606b3468],
21	aCt1V1ty	NN	O	act1v1ty	nn	23	SENT_140	[p10l1454t3435r1606b3468],
22	(	CD	NUMBER	(	num	23	SENT_140	[p10l1616t3428r1650b3463],
23	P	NN	O	p	dep	17	SENT_140	[p10l1616t3428r1650b3463],
24	<	JJR	O	<	dep	23	SENT_140	[p10l1657t3432r1685b3456],
25	.001	CD	NUMBER	.001	dep	26	SENT_140	[p10l1695t3430r1762b3458],
26	for	IN	O	for	_	0	SENT_140	[p10l1773t3427r1819b3458],
27	trend	NN	O	trend	dep	38	SENT_140	[p10l1828t3428r1927b3463],
28	)	CD	NUMBER	)	number	29	SENT_140	[p10l1828t3428r1927b3463],
29	(	CD	NUMBER	(	num	30	SENT_140	[p10l1941t3428r2072b3463],
30	FIGURE	NN	O	figure	dep	27	SENT_140	[p10l1941t3428r2072b3463],
31	2	CD	NUMBER	2	num	33	SENT_140	[p10l2081t3430r2101b3457],
32	Black	JJ	O	black	amod	33	SENT_140	[p10l108t3497r181b3521],
33	3O	NN	O	3o	dep	30	SENT_140	[p10l630t3497r730b3526],
34	(	CD	NUMBER	(	num	35	SENT_140	[p10l630t3497r730b3526],
35	9_O	NN	O	9_o	dep	38	SENT_140	[p10l630t3497r730b3526],
36	)	CD	NUMBER	)	num	38	SENT_140	[p10l630t3497r730b3526],
37	18	CD	NUMBER	18	num	38	SENT_140	[p10l845t3497r942b3526],
38	(	NN	O	(	dep	42	SENT_140	[p10l845t3497r942b3526],
39	7_3	CD	NUMBER	7_3	number	40	SENT_140	[p10l845t3497r942b3526],
40	)	CD	NUMBER	)	dep	38	SENT_140	[p10l845t3497r942b3526],
41	12	CD	NUMBER	12	dep	40	SENT_140	[p10l1036t3498r1066b3520],
42	(	NN	O	(	dep	45	SENT_140	[p10l1078t3497r1150b3526],
43	140	CD	NUMBER	140	num	42	SENT_140	[p10l1078t3497r1150b3526],
44	)	CD	NUMBER	)	num	45	SENT_140	[p10l1078t3497r1150b3526],
45	O2	CD	NUMBER	o2	pobj	26	SENT_140	[p10l1317t3517r1349b3540],
46	and	CC	O	and	_	0	SENT_140	[p10l1455t3476r1519b3506],
47	TABLE	NN	O	table	nn	49	SENT_140	[p10l1535t3478r1644b3505],
48	2	CD	NUMBER	2	num	49	SENT_140	[p10l1661t3476r1708b3511],
49	)	NN	O	)	pobj	26	SENT_140	[p10l1661t3476r1708b3511],
50	.	.	O	.	_	0	SENT_140	[p10l1661t3476r1708b3511],

1	Each	DT	O	each	det	2	SENT_141	[p10l1728t3476r1814b3506],
2	75-mg	JJ	O	75-mg	dep	11	SENT_141	[p10l1832t3478r1944b3516],
3	more	JJR	O	more	dep	2	SENT_141	[p10l1960t3487r2051b3506],
4	of	IN	O	of	_	0	SENT_141	[p10l2069t3475r2104b3506],
5	Asian	JJ	MISC	asian	amod	7	SENT_141	[p10l106t3544r178b3567],
6	8	CD	NUMBER	8	num	7	SENT_141	[p10l648t3545r663b3567],
7	(	CD	NUMBER	(	prep_of	2	SENT_141	[p10l674t3544r730b3573],
8	24	CD	NUMBER	24	num	9	SENT_141	[p10l674t3544r730b3573],
9	)	NN	O	)	dep	11	SENT_141	[p10l674t3544r730b3573],
10	3	CD	NUMBER	3	num	11	SENT_141	[p10l860t3545r875b3567],
11	(	NN	O	(	dep	16	SENT_141	[p10l886t3544r942b3573],
12	12	CD	NUMBER	12	num	13	SENT_141	[p10l886t3544r942b3573],
13	)	NN	O	)	dep	11	SENT_141	[p10l886t3544r942b3573],
14	5	CD	NUMBER	5	number	15	SENT_141	[p10l1051t3545r1066b3567],
15	(	CD	NUMBER	(	dep	13	SENT_141	[p10l1078t3544r1133b3573],
16	58	CD	NUMBER	58	_	0	SENT_141	[p10l1078t3544r1133b3573],
17	)	SYM	O	)	dep	19	SENT_141	[p10l1078t3544r1133b3573],
18	-	:	O	-	_	0	SENT_141	[p10l1310t3536r1313b3540],
19	clopidogrel	NN	O	clopidogrel	dep	16	SENT_141	[p10l1455t3523r1657b3578],
20	daily	JJ	SET	daily	dep	19	SENT_141	[p10l1674t3524r1761b3563],
21	resulted	VBD	O	result	dep	19	SENT_141	[p10l1777t3523r1921b3554],
22	in	IN	O	in	mark	36	SENT_141	[p10l1937t3527r1972b3553],
23	an	DT	O	a	det	34	SENT_141	[p10l1989t3534r2029b3554],
24	apother	NN	O	apother	nn	34	SENT_141	[p10l2046t3534r2100b3563, p10l107t3591r182b3614],
25	2	CD	NUMBER	2	num	34	SENT_141	[p10l648t3591r663b3614],
26	(	CD	NUMBER	(	num	34	SENT_141	[p10l674t3590r730b3620],
27	0,6	CD	NUMBER	0,6	num	34	SENT_141	[p10l674t3590r730b3620],
28	)	NN	O	)	nn	34	SENT_141	[p10l674t3590r730b3620],
29	2	CD	NUMBER	2	num	34	SENT_141	[p10l860t3591r875b3614],
30	(	CD	NUMBER	(	num	34	SENT_141	[p10l886t3590r942b3620],
31	0,8	CD	NUMBER	0,8	num	34	SENT_141	[p10l886t3590r942b3620],
32	)	NN	O	)	nn	34	SENT_141	[p10l886t3590r942b3620],
33	o	NN	O	o	nn	34	SENT_141	[p10l1051t3591r1067b3614],
34	proximate	NN	O	proximate	dep	36	SENT_141	[p10l1454t3579r1631b3626],
35	8	CD	PERCENT	8	number	36	SENT_141	[p10l1647t3572r1697b3603],
36	%	NN	PERCENT	%	advcl	21	SENT_141	[p10l1647t3572r1697b3603],
37	to	TO	O	to	_	0	SENT_141	[p10l1715t3579r1746b3602],
38	9	CD	PERCENT	9	number	39	SENT_141	[p10l1763t3572r1814b3626],
39	%	NN	PERCENT	%	amod	43	SENT_141	[p10l1763t3572r1814b3626],
40	absolute	JJ	O	absolute	amod	43	SENT_141	[p10l1830t3571r1974b3602],
41	reducSystolic	JJ	O	reducsystolic	amod	43	SENT_141	[p10l1990t3571r2101b3602, p10l57t3637r159b3666],
42	blood	NN	O	blood	nn	43	SENT_141	[p10l170t3638r243b3661],
43	pressure	NN	O	pressure	prep_to	36	SENT_141	[p10l255t3644r376b3667],
44	,	,	O	,	_	0	SENT_141	[p10l255t3644r376b3667],
45	126.8	CD	NUMBER	126.8	num	46	SENT_141	[p10l589t3638r663b3661],
46	(	NN	O	(	dep	56	SENT_141	[p10l674t3637r747b3667],
47	14.5	CD	NUMBER	14.5	dep	46	SENT_141	[p10l674t3637r747b3667],
48	)	CD	NUMBER	)	number	49	SENT_141	[p10l674t3637r747b3667],
49	126.6	CD	NUMBER	126.6	num	50	SENT_141	[p10l801t3638r875b3661],
50	(	NN	O	(	dep	47	SENT_141	[p10l886t3637r959b3667],
51	13.3	CD	NUMBER	13.3	number	52	SENT_141	[p10l886t3637r959b3667],
52	)	CD	NUMBER	)	num	50	SENT_141	[p10l886t3637r959b3667],
53	127.3	CD	NUMBER	127.3	num	54	SENT_141	[p10l992t3638r1066b3661],
54	(	NN	O	(	dep	56	SENT_141	[p10l1078t3637r1150b3667],
55	16.3	CD	NUMBER	16.3	num	56	SENT_141	[p10l1078t3637r1150b3667],
56	)	CD	NUMBER	)	dep	69	SENT_141	[p10l1078t3637r1150b3667],
57	.67	CD	NUMBER	.67	num	59	SENT_141	[p10l1310t3638r1349b3661],
58	11	CD	NUMBER	11	num	59	SENT_141	[p10l1455t3627r1522b3650],
59	°	NN	O	°	dep	56	SENT_141	[p10l1455t3627r1522b3650],
60	11	CD	NUMBER	11	number	61	SENT_141	[p10l1455t3627r1522b3650],
61	111	CD	NUMBER	111	num	65	SENT_141	[p10l1534t3630r1568b3649],
62	VASP	NN	O	vasp	nn	65	SENT_141	[p10l1579t3621r1674b3650],
63	PR1	NN	O	pr1	nn	65	SENT_141	[p10l1688t3622r1758b3655],
64	»	CD	NUMBER	»	num	65	SENT_141	[p10l1688t3622r1758b3655],
65	W1111	NN	O	w1111	dep	59	SENT_141	[p10l1771t3619r1848b3650],
66	501119	CD	NUMBER	501119	num	67	SENT_141	[p10l1860t3630r1948b3650],
67	311911113	CD	NUMBER	311911113	nsubj	69	SENT_141	[p10l1962t3627r2101b3650],
68	"	``	O	"	punct	69	SENT_141	[p10l1962t3627r2101b3650],
69	mean	VB	O	mean	dep	19	SENT_141	[p10l108t3677r180b3694],
70	(	JJ	O	(	amod	72	SENT_141	[p10l191t3671r252b3700],
71	SD	NN	O	sd	nn	72	SENT_141	[p10l191t3671r252b3700],
72	)	NN	O	)	dobj	69	SENT_141	[p10l191t3671r252b3700],
73	,	,	O	,	_	0	SENT_141	[p10l191t3671r252b3700],
74	mm	NN	O	mm	nn	76	SENT_141	[p10l265t3677r314b3694],
75	Hg	NN	O	hg	nn	76	SENT_141	[p10l326t3671r362b3700],
76	tion	NN	O	tion	appos	72	SENT_141	[p10l1455t3670r1528b3697],
77	between	IN	O	between	_	0	SENT_141	[p10l1546t3667r1700b3697],
78	the	DT	O	the	det	81	SENT_141	[p10l1720t3667r1775b3697],
79	2	CD	NUMBER	2	num	81	SENT_141	[p10l1795t3669r1814b3697],
80	highest	JJS	O	highest	amod	81	SENT_141	[p10l1833t3667r1970b3707],
81	doses	NNS	O	dose	prep_between	76	SENT_141	[p10l1988t3667r2099b3697],
82	.	.	O	.	_	0	SENT_141	[p10l1988t3667r2099b3697],

1	Diastolic	JJ	MISC	diastolic	amod	2	SENT_142	[p11l58t14r168b37],
2	blood	NN	O	blood	_	0	SENT_142	[p11l179t14r252b37],
3	pressure	NN	O	pressure	dep	2	SENT_142	[p11l264t20r385b43],
4	,	,	O	,	_	0	SENT_142	[p11l264t20r385b43],
5	76.0	CD	NUMBER	76.0	num	6	SENT_142	[p11l605t14r663b37],
6	(	NN	O	(	appos	3	SENT_142	[p11l674t13r730b43],
7	9.4	CD	NUMBER	9.4	number	8	SENT_142	[p11l674t13r730b43],
8	)	CD	NUMBER	)	dep	2	SENT_142	[p11l674t13r730b43],
9	75.4	CD	NUMBER	75.4	num	10	SENT_142	[p11l817t14r875b37],
10	(	NN	O	(	dep	8	SENT_142	[p11l886t13r942b43],
11	9.3	CD	NUMBER	9.3	number	12	SENT_142	[p11l886t13r942b43],
12	)	CD	NUMBER	)	dep	2	SENT_142	[p11l886t13r942b43],
13	77.5	CD	NUMBER	77.5	num	14	SENT_142	[p11l1008t15r1066b37],
14	(	NN	O	(	dep	12	SENT_142	[p11l1078t13r1133b43],
15	9.7	CD	NUMBER	9.7	number	16	SENT_142	[p11l1078t13r1133b43],
16	)	CD	NUMBER	)	num	17	SENT_142	[p11l1078t13r1133b43],
17	.12	CD	NUMBER	.12	dep	2	SENT_142	[p11l1310t14r1349b37],
18	Moreover	RB	O	moreover	advmod	17	SENT_142	[p11l1454t14r1634b47],
19	,	,	O	,	_	0	SENT_142	[p11l1454t14r1634b47],
20	individual	JJ	O	individual	amod	23	SENT_142	[p11l1652t11r1832b41],
21	pairwise	JJ	O	pairwise	amod	23	SENT_142	[p11l1848t14r1996b51],
22	Commean	JJ	O	commean	amod	23	SENT_142	[p11l2013t22r2100b41, p11l108t53r180b70],
23	(	NN	O	(	appos	2	SENT_142	[p11l191t47r252b76],
24	Sm	NN	O	sm	nn	26	SENT_142	[p11l191t47r252b76],
25	mm	NN	O	mm	nn	26	SENT_142	[p11l265t53r314b70],
26	Hg	NN	O	hg	dep	23	SENT_142	[p11l326t47r362b76],
27	_	CD	NUMBER	_	num	28	SENT_142	[p11l402t94r405b98],
28	parisons	NNS	O	parison	dep	2	SENT_142	[p11l1454t62r1592b99],
29	between	IN	O	between	_	0	SENT_142	[p11l1600t59r1739b89],
30	the	DT	O	the	det	33	SENT_142	[p11l1748t59r1799b89],
31	higher	JJR	O	higher	amod	33	SENT_142	[p11l1807t59r1915b99],
32	daily	JJ	SET	daily	amod	33	SENT_142	[p11l1923t59r2003b99],
33	doses	NNS	O	dose	prep_between	28	SENT_142	[p11l2011t59r2101b89],
34	Heart	NNP	O	Heart	nn	35	SENT_142	[p11l58t94r129b117],
35	rate	NN	O	rate	dep	2	SENT_142	[p11l140t95r196b121],
36	,	,	O	,	_	0	SENT_142	[p11l140t95r196b121],
37	rgearg	NN	O	rgearg	nn	40	SENT_142	[p11l209t100r282b164],
38	(	CD	NUMBER	(	num	40	SENT_142	[p11l292t94r353b123],
39	SD	NN	O	sd	nn	40	SENT_142	[p11l292t94r353b123],
40	)	NN	O	)	appos	35	SENT_142	[p11l292t94r353b123],
41	,	,	O	,	_	0	SENT_142	[p11l292t94r353b123],
42	/	:	O	/	punct	43	SENT_142	[p11l364t94r421b117],
43	min	NN	DURATION	min	dep	35	SENT_142	[p11l364t94r421b117],
44	68.6	CD	NUMBER	68.6	num	43	SENT_142	[p11l605t94r663b117],
45	(	NN	O	(	dep	35	SENT_142	[p11l674t94r747b123],
46	10.6	CD	NUMBER	10.6	num	45	SENT_142	[p11l674t94r747b123],
47	)	CD	NUMBER	)	number	48	SENT_142	[p11l674t94r747b123],
48	68.4	CD	NUMBER	68.4	dep	2	SENT_142	[p11l817t94r875b117],
49	(	NN	O	(	dep	48	SENT_142	[p11l886t94r959b123],
50	10.4	CD	NUMBER	10.4	num	49	SENT_142	[p11l886t94r959b123],
51	)	CD	NUMBER	)	number	52	SENT_142	[p11l886t94r959b123],
52	69.1	CD	NUMBER	69.1	dep	2	SENT_142	[p11l1008t94r1061b117],
53	(	NN	O	(	dep	52	SENT_142	[p11l1078t94r1150b123],
54	11.2	CD	NUMBER	11.2	num	53	SENT_142	[p11l1078t94r1150b123],
55	)	CD	NUMBER	)	number	56	SENT_142	[p11l1078t94r1150b123],
56	.38	CD	NUMBER	.38	dep	2	SENT_142	[p11l1310t94r1350b117],
57	OfC1OpidOg1_e1	NN	O	ofc1opidog1_e1	dep	56	SENT_142	[p11l1455t106r1790b147],
58	(	CD	NUMBER	(	num	57	SENT_142	[p11l1455t106r1790b147],
59	15O	NN	O	15o	dep	2	SENT_142	[p11l1455t106r1790b147],
60	,	,	O	,	_	0	SENT_142	[p11l1455t106r1790b147],
61	225	CD	NUMBER	225	num	59	SENT_142	[p11l1803t109r1874b143],
62	,	,	O	,	_	0	SENT_142	[p11l1803t109r1874b143],
63	and	CC	NUMBER	and	_	0	SENT_142	[p11l1886t107r1949b137],
64	300	CD	NUMBER	300	conj_and	59	SENT_142	[p11l1959t109r2021b137],
65	mg	NN	O	mg	nn	69	SENT_142	[p11l2033t107r2098b147],
66	)	NN	O	)	nn	69	SENT_142	[p11l2033t107r2098b147],
67	BMLmah	NN	O	bmlmah	nn	69	SENT_142	[p11l58t140r266b191],
68	(	NN	O	(	nn	69	SENT_142	[p11l58t140r266b191],
69	D	NN	O	d	dep	59	SENT_142	[p11l58t140r266b191],
70	)	CD	NUMBER	)	num	71	SENT_142	[p11l58t140r266b191],
71	3o7@3	NN	O	3o7@3	dep	2	SENT_142	[p11l604t140r730b170],
72	)	CD	NUMBER	)	num	74	SENT_142	[p11l604t140r730b170],
73	3o4@a	NN	O	3o4@a	nn	74	SENT_142	[p11l817t140r942b170],
74	3t4BJ	NN	O	3t4bj	dep	71	SENT_142	[p11l1008t140r1133b169],
75	)	CD	NUMBER	)	number	76	SENT_142	[p11l1008t140r1133b169],
76	93	CD	NUMBER	93	num	77	SENT_142	[p11l1310t141r1350b164],
77	andthe75qngdaﬂyd0gEOfdOp	NN	O	andthe75qngdaﬂyd0geofdop	dep	2	SENT_142	[p11l1455t154r2101b194],
78	_	CD	NUMBER	_	num	79	SENT_142	[p11l1455t154r2101b194],
79	Hypertension	NN	O	hypertension	dep	77	SENT_142	[p11l58t188r232b216],
80	287	CD	NUMBER	287	number	81	SENT_142	[p11l613t188r663b211],
81	(	CD	NUMBER	(	dep	2	SENT_142	[p11l674t187r747b216],
82	86.2	CD	NUMBER	86.2	num	83	SENT_142	[p11l674t187r747b216],
83	)	NN	O	)	dep	81	SENT_142	[p11l674t187r747b216],
84	214	CD	NUMBER	214	number	85	SENT_142	[p11l825t188r875b210],
85	(	CD	NUMBER	(	dep	2	SENT_142	[p11l886t187r959b216],
86	86.6	CD	NUMBER	86.6	num	87	SENT_142	[p11l886t187r959b216],
87	)	NN	O	)	dep	85	SENT_142	[p11l886t187r959b216],
88	78	CD	NUMBER	78	dep	2	SENT_142	[p11l1034t188r1066b211],
89	(	CD	NUMBER	(	number	90	SENT_142	[p11l1078t187r1150b216],
90	84.9	CD	NUMBER	84.9	num	91	SENT_142	[p11l1078t187r1150b216],
91	)	NN	O	)	dep	88	SENT_142	[p11l1078t187r1150b216],
92	.68	CD	NUMBER	.68	num	93	SENT_142	[p11l1310t188r1350b211],
93	ido	NN	O	ido	dep	2	SENT_142	[p11l1454t202r1509b233],
94	1	CD	NUMBER	1	number	95	SENT_142	[p11l1569t202r1579b232],
95	11	CD	NUMBER	11	dep	93	SENT_142	[p11l1716t202r1739b232],
96	.	.	O	.	_	0	SENT_142	[p11l1823t205r1827b209],

1	.	.	O	.	_	0	SENT_143	[p11l1867t205r1871b209],

1	11	CD	NUMBER	11	_	0	SENT_144	[p11l1915t202r1938b232],
2	.	.	O	.	_	0	SENT_144	[p11l1996t205r2000b209],

1	.	.	O	.	_	0	SENT_145	[p11l2053t202r2083b232],

1	f.	NN	O	f.	nsubj	32	SENT_146	[p11l2053t202r2083b232],
2	_	CD	NUMBER	_	num	3	SENT_146	[p11l326t234r328b238],
3	gre	NN	O	gre	nsubj	4	SENT_146	[p11l1513t213r1566b242],
4	were	VBD	O	be	rcmod	1	SENT_146	[p11l1595t213r1680b233],
5	a	DT	O	a	det	25	SENT_146	[p11l1697t213r1714b233],
6	statistlca	NN	O	statistlca	nn	25	SENT_146	[p11l1756t210r1913b233],
7	y	NN	O	y	nn	25	SENT_146	[p11l1940t214r1960b242],
8	s1gn1	CD	NUMBER	s1gn1	num	25	SENT_146	[p11l1976t213r2061b242],
9	1Hypercholesterolemla	NN	O	1hypercholesterolemlum	nn	25	SENT_146	[p11l2076t213r2101b232, p11l58t234r346b263],
10	315	CD	NUMBER	315	num	25	SENT_146	[p11l613t234r747b263],
11	(	CD	NUMBER	(	num	25	SENT_146	[p11l613t234r747b263],
12	94.6	CD	NUMBER	94.6	num	25	SENT_146	[p11l613t234r747b263],
13	)	NN	O	)	nn	25	SENT_146	[p11l613t234r747b263],
14	232	CD	NUMBER	232	num	25	SENT_146	[p11l825t235r875b258],
15	(	NN	O	(	nn	25	SENT_146	[p11l886t234r959b263],
16	93.9	CD	NUMBER	93.9	num	25	SENT_146	[p11l886t234r959b263],
17	)	CD	NUMBER	)	num	25	SENT_146	[p11l886t234r959b263],
18	83	CD	NUMBER	83	num	25	SENT_146	[p11l1034t235r1066b258],
19	(	NN	O	(	nn	25	SENT_146	[p11l1078t234r1150b263],
20	96.5	CD	NUMBER	96.5	num	25	SENT_146	[p11l1078t234r1150b263],
21	)	CD	NUMBER	)	num	25	SENT_146	[p11l1078t234r1150b263],
22	.58	CD	NUMBER	.58	num	25	SENT_146	[p11l1310t235r1350b258],
23	Cant	NN	O	cant	nn	25	SENT_146	[p11l1455t258r1528b280],
24	(	CD	NUMBER	(	num	25	SENT_146	[p11l1545t250r1580b285],
25	P	NN	O	p	nsubj	26	SENT_146	[p11l1545t250r1580b285],
26	<	JJR	O	<	xcomp	4	SENT_146	[p11l1589t254r1617b278],
27	001	CD	NUMBER	001	num	28	SENT_146	[p11l1637t250r1714b285],
28	)	NN	O	)	npadvmod	29	SENT_146	[p11l1637t250r1714b285],
29	as	IN	O	as	advmod	32	SENT_146	[p11l1733t261r1766b280],
30	were	VBD	O	be	cop	32	SENT_146	[p11l1781t261r1864b281],
31	Comparisons	NNPS	MISC	Comparisons	nn	32	SENT_146	[p11l1881t253r2101b290],
32	Diabetes	NNP	MISC	Diabetes	_	0	SENT_146	[p11l58t281r173b304],
33	mellitus	NN	O	mellitus	nn	35	SENT_146	[p11l184t281r282b304],
34	118	CD	NUMBER	118	num	35	SENT_146	[p11l615t281r747b310],
35	(	NN	O	(	attr	32	SENT_146	[p11l615t281r747b310],
36	35.4	CD	NUMBER	35.4	number	37	SENT_146	[p11l615t281r747b310],
37	)	CD	NUMBER	)	num	35	SENT_146	[p11l615t281r747b310],
38	90	CD	NUMBER	90	num	39	SENT_146	[p11l843t282r875b304],
39	(	NN	O	(	dep	46	SENT_146	[p11l886t281r959b310],
40	36.4	CD	NUMBER	36.4	number	41	SENT_146	[p11l886t281r959b310],
41	)	CD	NUMBER	)	dep	39	SENT_146	[p11l886t281r959b310],
42	28	CD	NUMBER	28	dep	41	SENT_146	[p11l1034t282r1067b304],
43	(	NN	O	(	dep	46	SENT_146	[p11l1078t281r1150b310],
44	32.6	CD	NUMBER	32.6	number	45	SENT_146	[p11l1078t281r1150b310],
45	)	CD	NUMBER	)	num	46	SENT_146	[p11l1078t281r1150b310],
46	.52	NN	NUMBER	.52	dep	54	SENT_146	[p11l1310t282r1349b304],
47	between	IN	O	between	_	0	SENT_146	[p11l1453t298r1609b328],
48	'	''	O	'	_	0	SENT_146	[p11l1628t276r1711b328],
49	eaCh	NN	O	each	prep_between	46	SENT_146	[p11l1628t276r1711b328],
50	of	IN	O	of	_	0	SENT_146	[p11l1731t298r1767b328],
51	the	DT	O	the	prep_of	46	SENT_146	[p11l1784t298r1841b328],
52	hi	UH	O	hi	dep	51	SENT_146	[p11l1860t298r1895b328],
53	her	PRP$	O	she	poss	54	SENT_146	[p11l1921t298r1981b328],
54	doses	NNS	O	dose	dep	35	SENT_146	[p11l2000t298r2101b328],
55	Family	NNP	O	Family	nn	56	SENT_146	[p11l58t328r141b357],
56	history	NN	O	history	dep	54	SENT_146	[p11l152t328r238b357],
57	of	IN	O	of	_	0	SENT_146	[p11l248t328r273b351],
58	CAD	NN	O	cad	nn	60	SENT_146	[p11l282t328r343b351],
59	137	CD	NUMBER	137	num	60	SENT_146	[p11l615t328r663b351],
60	(	NN	O	(	prep_of	56	SENT_146	[p11l674t328r747b357],
61	41.1	CD	NUMBER	41.1	num	60	SENT_146	[p11l674t328r747b357],
62	)	CD	NUMBER	)	number	63	SENT_146	[p11l674t328r747b357],
63	99	CD	NUMBER	99	num	64	SENT_146	[p11l843t328r875b351],
64	(	NN	O	(	attr	32	SENT_146	[p11l886t328r959b357],
65	40.1	CD	NUMBER	40.1	number	66	SENT_146	[p11l886t328r959b357],
66	)	CD	NUMBER	)	num	67	SENT_146	[p11l886t328r959b357],
67	38	CD	NUMBER	38	attr	32	SENT_146	[p11l1034t328r1067b351],
68	(	CD	NUMBER	(	number	69	SENT_146	[p11l1078t328r1150b357],
69	44.2	CD	NUMBER	44.2	num	70	SENT_146	[p11l1078t328r1150b357],
70	)	NN	O	)	attr	32	SENT_146	[p11l1078t328r1150b357],
71	.51	CD	NUMBER	.51	number	72	SENT_146	[p11l1310t328r1344b351],
72	(	CD	NUMBER	(	num	73	SENT_146	[p11l1457t346r1527b381],
73	P	NN	O	p	attr	32	SENT_146	[p11l1457t346r1527b381],
74	<	JJR	O	<	amod	76	SENT_146	[p11l1457t346r1527b381],
75	001	CD	NUMBER	001	num	76	SENT_146	[p11l1547t346r1624b381],
76	)	NN	O	)	attr	32	SENT_146	[p11l1547t346r1624b381],
77	except	IN	O	except	prep	76	SENT_146	[p11l1642t353r1753b386],
78	for	IN	O	for	_	0	SENT_146	[p11l1768t346r1816b376],
79	the	DT	O	the	det	81	SENT_146	[p11l1832t346r1884b376],
80	Eomparison	NN	O	eomparison	nn	81	SENT_146	[p11l1899t309r2101b386],
81	HbKMyofMl	NN	O	hbkmyofml	prep_for	32	SENT_146	[p11l58t375r223b404],
82	19o	CD	NUMBER	19o	num	83	SENT_146	[p11l615t374r747b404],
83	(	NN	O	(	dep	91	SENT_146	[p11l615t374r747b404],
84	571	CD	NUMBER	571	num	85	SENT_146	[p11l615t374r747b404],
85	)	NN	O	)	dep	83	SENT_146	[p11l615t374r747b404],
86	134	CD	NUMBER	134	number	87	SENT_146	[p11l827t374r959b404],
87	(	CD	NUMBER	(	num	88	SENT_146	[p11l827t374r959b404],
88	54s	NNS	O	54	dep	85	SENT_146	[p11l827t374r959b404],
89	)	CD	NUMBER	)	dep	91	SENT_146	[p11l827t374r959b404],
90	56	CD	NUMBER	56	num	91	SENT_146	[p11l1034t374r1150b404],
91	(	NN	O	(	dep	81	SENT_146	[p11l1034t374r1150b404],
92	651	CD	NUMBER	651	number	93	SENT_146	[p11l1034t374r1150b404],
93	)	CD	NUMBER	)	dep	91	SENT_146	[p11l1034t374r1150b404],
94	.08	CD	NUMBER	.08	num	95	SENT_146	[p11l1310t375r1350b398],
95	‘	NN	O	‘	dep	93	SENT_146	[p11l1538t372r1542b376],
96	.	.	O	.	_	0	SENT_146	[p11l1942t397r1946b401],

1	History	NN	O	history	_	0	SENT_147	[p11l58t422r150b450],
2	of	IN	O	of	_	0	SENT_147	[p11l159t422r185b445],
3	PCI	NN	O	pcus	prep_of	5	SENT_147	[p11l195t421r239b445],
4	324	CD	NUMBER	324	number	5	SENT_147	[p11l613t422r663b445],
5	(	CD	NUMBER	(	dep	1	SENT_147	[p11l674t421r747b450],
6	97.3	CD	NUMBER	97.3	num	7	SENT_147	[p11l674t421r747b450],
7	)	NN	O	)	dep	5	SENT_147	[p11l674t421r747b450],
8	240	CD	NUMBER	240	num	9	SENT_147	[p11l825t422r875b445],
9	(	NN	O	(	dep	1	SENT_147	[p11l886t421r959b450],
10	97.2	CD	NUMBER	97.2	number	11	SENT_147	[p11l886t421r959b450],
11	)	CD	NUMBER	)	dep	9	SENT_147	[p11l886t421r959b450],
12	84	CD	NUMBER	84	num	13	SENT_147	[p11l1034t422r1066b445],
13	(	NN	O	(	dep	1	SENT_147	[p11l1078t421r1150b450],
14	97.7	CD	NUMBER	97.7	number	15	SENT_147	[p11l1078t421r1150b450],
15	)	CD	NUMBER	)	npadvmod	16	SENT_147	[p11l1078t421r1150b450],
16	>	JJR	O	>	amod	13	SENT_147	[p11l1284t422r1350b445],
17	99	CD	NUMBER	99	dep	1	SENT_147	[p11l1284t422r1350b445],
18	betT	NN	O	bett	dep	17	SENT_147	[p11l1453t394r1596b472],
19	"	''	O	"	punct	18	SENT_147	[p11l1453t394r1596b472],
20	:1	CD	NUMBER	:1	num	23	SENT_147	[p11l1453t394r1596b472],
21	ee	NN	O	ee	nn	23	SENT_147	[p11l1453t394r1596b472],
22	\	NN	O	\	nn	23	SENT_147	[p11l1453t394r1596b472],
23	r	NN	O	r	dep	1	SENT_147	[p11l1453t394r1596b472],
24	]	CD	NUMBER	]	number	25	SENT_147	[p11l1453t394r1596b472],
25	‘	CD	NUMBER	‘	dep	23	SENT_147	[p11l1453t394r1596b472],
26	2,2	CD	NUMBER	2,2	num	27	SENT_147	[p11l1609t394r1746b472],
27	f513nd	NN	O	f513nd	dep	1	SENT_147	[p11l1609t394r1746b472],
28	30011513	CD	NUMBER	30011513	dep	27	SENT_147	[p11l1758t396r1886b472],
29	da11y	NN	O	da11y	nn	31	SENT_147	[p11l1899t394r1989b434],
30	'	''	O	'	_	0	SENT_147	[p11l1899t394r1989b434],
31	db	NN	O	db	dep	1	SENT_147	[p11l2033t442r2082b472],
32	QEGpmwmm	NN	O	qegpmwmm	nn	34	SENT_147	[p11l57t468r288b497],
33	wh7n	NN	O	wh7n	nn	34	SENT_147	[p11l631t468r747b497],
34	43h7m	NN	O	43h7m	dep	31	SENT_147	[p11l842t468r959b497],
35	1ehaa	CD	NUMBER	1ehaa	dep	1	SENT_147	[p11l1036t468r1150b497],
36	so	RB	O	so	quantmod	37	SENT_147	[p11l1310t469r1350b492],
37	6	CD	NUMBER	6	num	41	SENT_147	[p11l1544t452r1560b472],
38	eny	NN	O	eny	nn	41	SENT_147	[p11l1596t452r1670b482],
39	m	NN	O	m	nn	41	SENT_147	[p11l1701t452r2032b472],
40	”	NN	O	”	nn	41	SENT_147	[p11l1701t452r2032b472],
41	m	NN	O	m	dep	35	SENT_147	[p11l1701t452r2032b472],
42	“‘	CD	NUMBER	“‘	num	43	SENT_147	[p11l1701t452r2032b472],
43	S	NN	O	s	dep	1	SENT_147	[p11l1701t452r2032b472],
44	”	CD	NUMBER	”	dep	43	SENT_147	[p11l1701t452r2032b472],
45	a	DT	O	a	det	47	SENT_147	[p11l1701t452r2032b472],
46	““	NN	O	““	nn	47	SENT_147	[p11l1701t452r2032b472],
47	“	NN	O	“	dep	1	SENT_147	[p11l1701t452r2032b472],
48	:	:	O	:	_	0	SENT_147	[p11l1701t452r2032b472],
49	7	CD	NUMBER	7	num	50	SENT_147	[p11l2082t453r2102b482],
50	Abbreviations	NNS	O	abbreviation	dep	47	SENT_147	[p11l56t516r219b536],
51	:	:	O	:	_	0	SENT_147	[p11l56t516r219b536],
52	BMI	NN	O	bmus	dep	47	SENT_147	[p11l231t516r281b539],
53	,	,	O	,	_	0	SENT_147	[p11l231t516r281b539],
54	body	NN	O	body	nn	56	SENT_147	[p11l293t516r350b541],
55	mass	NN	O	mass	nn	56	SENT_147	[p11l360t521r420b536],
56	index	NN	O	index	appos	52	SENT_147	[p11l431t516r496b540],
57	;	:	O	;	_	0	SENT_147	[p11l431t516r496b540],
58	CABG	NNP	O	CABG	dep	47	SENT_147	[p11l508t516r586b540],
59	,	,	O	,	_	0	SENT_147	[p11l508t516r586b540],
60	coronary	JJ	O	coronary	amod	63	SENT_147	[p11l598t521r699b541],
61	artery	NN	O	artery	nn	63	SENT_147	[p11l708t518r773b541],
62	bypass	NN	O	bypass	nn	63	SENT_147	[p11l782t516r864b541],
63	graft	NN	O	graft	appos	58	SENT_147	[p11l874t516r930b542],
64	;	:	O	;	_	0	SENT_147	[p11l874t516r930b542],
65	CAD	NNP	O	CAD	dep	47	SENT_147	[p11l942t516r1001b540],
66	,	,	O	,	_	0	SENT_147	[p11l942t516r1001b540],
67	coronary	JJ	O	coronary	amod	69	SENT_147	[p11l1012t521r1113b541],
68	artery	NN	O	artery	nn	69	SENT_147	[p11l1122t518r1187b541],
69	disease	NN	O	disease	appos	65	SENT_147	[p11l1196t516r1289b540],
70	;	:	O	;	_	0	SENT_147	[p11l1196t516r1289b540],
71	Ml	NN	O	ml	dep	47	SENT_147	[p11l1301t516r1333b539],
72	,	,	O	,	_	0	SENT_147	[p11l1301t516r1333b539],
73	myocardial	JJ	O	myocardial	amod	74	SENT_147	[p11l1345t521r1403b541, p11l84t545r158b566],
74	infarction	NN	O	infarction	appos	71	SENT_147	[p11l168t545r278b569],
75	;	:	O	;	_	0	SENT_147	[p11l168t545r278b569],
76	PCI	NNP	O	PCI	dep	47	SENT_147	[p11l289t545r335b569],
77	,	,	O	,	_	0	SENT_147	[p11l289t545r335b569],
78	percutaneous	JJ	O	percutaneous	amod	80	SENT_147	[p11l346t547r504b570],
79	coronary	JJ	O	coronary	amod	80	SENT_147	[p11l513t550r614b570],
80	intervention	NN	O	intervention	appos	76	SENT_147	[p11l623t545r760b566],
81	.	.	O	.	_	0	SENT_147	[p11l623t545r760b566],

1	aunless	JJ	O	aunless	nsubj	3	SENT_148	[p11l57t571r150b595],
2	otherwise	RB	O	otherwise	advmod	3	SENT_148	[p11l159t575r270b595],
3	indicated	VBN	O	indicate	dep	7	SENT_148	[p11l279t575r388b598],
4	,	,	O	,	_	0	SENT_148	[p11l279t575r388b598],
5	data	NNS	O	datum	nsubjpass	7	SENT_148	[p11l399t575r450b595],
6	are	VBP	O	be	auxpass	7	SENT_148	[p11l458t580r494b595],
7	presented	VBN	O	present	_	0	SENT_148	[p11l503t575r617b600],
8	as	IN	O	as	_	0	SENT_148	[p11l627t580r652b595],
9	No.	NN	O	no.	nn	12	SENT_148	[p11l662t575r700b595],
10	(	CD	NUMBER	(	num	12	SENT_148	[p11l711t574r860b600],
11	percentage	NN	O	percentage	nn	12	SENT_148	[p11l711t574r860b600],
12	)	NN	O	)	prep_as	7	SENT_148	[p11l711t574r860b600],
13	.	.	O	.	_	0	SENT_148	[p11l711t574r860b600],

1	PRU	NNP	ORGANIZATION	PRU	nsubj	3	SENT_149	[p11l1455t492r1532b520],
2	were	VBD	O	be	cop	3	SENT_149	[p11l1548t500r1633b520],
3	similar	JJ	O	similar	_	0	SENT_149	[p11l1650t489r1773b520],
4	to	TO	O	to	_	0	SENT_149	[p11l1790t497r1822b520],
5	the	DT	O	the	det	7	SENT_149	[p11l1842t489r1895b520],
6	VASP	NN	ORGANIZATION	vasp	nn	7	SENT_149	[p11l1912t491r2010b520],
7	data	NNS	O	datum	prep_to	3	SENT_149	[p11l2028t489r2101b520],
8	across	IN	O	across	_	0	SENT_149	[p11l1454t548r1561b568],
9	dose	NN	O	dose	prep_across	7	SENT_149	[p11l1578t537r1655b568],
10	and	CC	O	and	_	0	SENT_149	[p11l1672t537r1735b568],
11	genotype	NN	O	genotype	nn	13	SENT_149	[p11l1751t545r1909b577],
12	(	CD	NUMBER	(	num	13	SENT_149	[p11l1928t537r2037b572],
13	Table	NNP	O	Table	prep_to	3	SENT_149	[p11l1928t537r2037b572],
14	2	CD	NUMBER	2	number	15	SENT_149	[p11l2054t537r2099b572],
15	)	CD	NUMBER	)	dep	13	SENT_149	[p11l2054t537r2099b572],
16	.	.	O	.	_	0	SENT_149	[p11l2054t537r2099b572],

1	b	NN	O	b	nn	2	SENT_150	[p11l58t596r70b614],
2	Data	NNS	O	datum	nsubjpass	8	SENT_150	[p11l76t604r129b624],
3	on	IN	O	on	_	0	SENT_150	[p11l137t609r164b624],
4	race	NN	O	race	prep_on	2	SENT_150	[p11l175t609r223b624],
5	were	VBD	O	be	auxpass	8	SENT_150	[p11l231t609r287b624],
6	patient	JJ	O	patient	acomp	8	SENT_150	[p11l297t604r489b629],
7	—	RB	O	—	advmod	8	SENT_150	[p11l297t604r489b629],
8	reported	VBN	O	report	_	0	SENT_150	[p11l297t604r489b629],
9	.	.	O	.	_	0	SENT_150	[p11l297t604r489b629],

1	Ccalculated	VBN	O	ccalculate	csubj	11	SENT_151	[p11l57t630r194b653],
2	as	IN	O	as	_	0	SENT_151	[p11l204t638r230b653],
3	weight	NN	O	weight	prep_as	1	SENT_151	[p11l238t633r314b658],
4	in	IN	O	in	_	0	SENT_151	[p11l323t633r340b653],
5	kilograms	NNS	O	kilogram	prep_in	1	SENT_151	[p11l350t633r460b658],
6	divided	VBN	O	divide	partmod	5	SENT_151	[p11l469t633r550b653],
7	by	IN	O	by	_	0	SENT_151	[p11l560t633r586b658],
8	height	NN	O	height	agent	6	SENT_151	[p11l596t633r665b658],
9	in	IN	O	in	_	0	SENT_151	[p11l674t633r691b653],
10	meters	NNS	O	meter	prep_in	8	SENT_151	[p11l701t634r779b653],
11	squared	VBD	O	square	_	0	SENT_151	[p11l788t633r887b658],
12	.	.	O	.	_	0	SENT_151	[p11l788t633r887b658],

1	Figure	NN	O	figure	_	0	SENT_152	[p11l59t728r158b761],
2	2	CD	NUMBER	2	dep	1	SENT_152	[p11l170t728r199b752],
3	.	.	O	.	_	0	SENT_152	[p11l170t728r199b752],

1	On-Treatment	JJ	O	on-treatment	amod	3	SENT_153	[p11l212t728r417b753],
2	Platelet	NN	O	platelet	nn	3	SENT_153	[p11l429t727r532b753],
3	Reactivity	NN	O	reactivity	_	0	SENT_153	[p11l544t729r679b760],
4	Across	IN	O	across	dep	3	SENT_153	[p11l690t729r781b753],
5	Genotype	NN	O	genotype	nn	9	SENT_153	[p11l793t728r930b761],
6	and	CC	O	and	_	0	SENT_153	[p11l942t727r992b753],
7	Clopidogrel	NNP	O	Clopidogrel	conj_and	5	SENT_153	[p11l1005t727r1166b761],
8	Daily	NNP	SET	Daily	nn	9	SENT_153	[p11l1180t727r1249b760],
9	Dose	NN	O	dose	pobj	4	SENT_153	[p11l1262t729r1330b753],

1	Noncarriers	NNS	O	noncarrier	_	0	SENT_154	[p11l414t847r705b890],

1	P	NN	O	p	nn	2	SENT_155	[p11l523t2051r560b2092],
2	trend	NN	O	trend	dep	3	SENT_155	[p11l574t2051r699b2093],
3	<	JJR	O	<	_	0	SENT_155	[p11l726t2052r856b2093],
4	.	.	O	.	_	0	SENT_155	[p11l726t2052r856b2093],

1	OO1	NN	O	oo1	_	0	SENT_156	[p11l726t2052r856b2093],

1	lO	NNP	O	lO	_	0	SENT_157	[p11l679t1590r729b1651],
2	|	IN	O	|	dep	1	SENT_157	[p11l679t1590r729b1651],

1	When	WRB	O	when	advmod	21	SENT_158	[p11l1453t585r1558b615],
2	treated	VBN	O	treat	partmod	21	SENT_158	[p11l1568t585r1685b615],
3	with	IN	O	with	_	0	SENT_158	[p11l1694t585r1771b615],
4	the	DT	O	the	det	7	SENT_158	[p11l1782t585r1834b615],
5	standard	JJ	O	standard	amod	7	SENT_158	[p11l1844t585r1992b615],
6	maintenance	NN	O	maintenance	nn	7	SENT_158	[p11l2002t588r2101b615, p11l1455t640r1592b663],
7	dose	NN	O	dose	prep_with	2	SENT_158	[p11l1609t633r1688b663],
8	of	IN	O	of	_	0	SENT_158	[p11l1706t633r1742b663],
9	Clopidogrel	NNP	MISC	Clopidogrel	prep_of	7	SENT_158	[p11l1757t633r1969b673],
10	,	,	O	,	_	0	SENT_158	[p11l1757t633r1969b673],
11	75-mg	JJ	O	75-mg	amod	12	SENT_158	[p11l1989t635r2101b673],
12	daily	RB	SET	daily	nsubj	21	SENT_158	[p11l1455t680r1546b720],
13	,	,	O	,	_	0	SENT_158	[p11l1455t680r1546b720],
14	both	DT	O	both	det	16	SENT_158	[p11l1559t680r1638b711],
15	CYP2C19	NN	O	cyp2c19	nn	16	SENT_158	[p11l1652t679r1851b711],
16	*	NN	O	*	appos	12	SENT_158	[p11l1652t679r1851b711],
17	2	CD	NUMBER	2	num	18	SENT_158	[p11l1652t679r1851b711],
18	heterozygotes	NNS	O	heterozygote	dep	16	SENT_158	[p11l1865t680r2101b720],
19	and	CC	O	and	_	0	SENT_158	[p11l1455t733r1519b763],
20	homozygotes	NNS	O	homozygote	conj_and	18	SENT_158	[p11l1537t733r1776b773],
21	had	VBD	O	have	_	0	SENT_158	[p11l1793t733r1859b763],
22	significantly	RB	O	significantly	advmod	21	SENT_158	[p11l1876t733r2102b773],

1	CYP2C19	NN	O	cyp2c19	nn	2	SENT_159	[p11l1302t847r1609b890],
2	*	NN	O	*	_	0	SENT_159	[p11l1302t847r1609b890],
3	2	CD	NUMBER	2	num	4	SENT_159	[p11l1302t847r1609b890],
4	heterozygotes	NNS	O	heterozygote	dep	13	SENT_159	[p11l1629t848r1985b901],
5	o	NN	O	o	nn	7	SENT_159	[p11l15t1195r62b1242],
6	\	CD	NUMBER	\	num	7	SENT_159	[p11l15t1195r62b1242],
7	O	NN	O	o	dep	4	SENT_159	[p11l15t1195r62b1242],
8	80	CD	NUMBER	80	number	9	SENT_159	[p11l128t1202r187b1244],
9	5	CD	NUMBER	5	dep	7	SENT_159	[p11l15t1283r72b1350],
10	70	CD	NUMBER	70	num	11	SENT_159	[p11l128t1321r187b1362],
11	o	NN	O	o	dep	13	SENT_159	[p11l15t1374r62b1421],
12	\	CD	PERCENT	\	num	13	SENT_159	[p11l15t1374r62b1421],
13	°	CD	PERCENT	°	dep	2	SENT_159	[p11l15t1374r62b1421],
14	3	CD	PERCENT	3	num	16	SENT_159	[p11l15t1427r72b1505],
15	60	CD	PERCENT	60	num	16	SENT_159	[p11l128t1440r187b1481],
16	%	NN	PERCENT	%	dep	13	SENT_159	[p11l27t1529r61b1589],
17	(	NN	O	(	dep	16	SENT_159	[p11l27t1592r61b1621],
18	D	NN	O	d	prep	17	SENT_159	[p11l27t1592r61b1621],
19	50	CD	NUMBER	50	num	20	SENT_159	[p11l128t1559r187b1600],
20	2	CD	NUMBER	2	dep	18	SENT_159	[p11l16t1627r60b1671],
21	_	SYM	O	_	dep	17	SENT_159	[p11l16t1697r68b1718],
22	-	:	O	-	_	0	SENT_159	[p11l16t1697r68b1718],
23	40	CD	DATE	40	num	25	SENT_159	[p11l127t1678r187b1720],
24	E	NN	O	e	nn	25	SENT_159	[p11l16t1725r60b1799],
25	o	NN	O	o	dep	2	SENT_159	[p11l16t1821r60b1855],
26	-	:	O	-	_	0	SENT_159	[p11l16t1821r60b1855],
27	30	CD	NUMBER	30	num	30	SENT_159	[p11l127t1797r187b1838],
28	(	NN	O	(	nn	30	SENT_159	[p11l15t1861r61b1896],
29	D	NN	O	d	nn	30	SENT_159	[p11l15t1861r61b1896],
30	g	NN	O	g	dep	25	SENT_159	[p11l16t1898r60b1971],
31	‘	CD	NUMBER	‘	number	32	SENT_159	[p11l16t1898r60b1971],
32	20	CD	NUMBER	20	dep	30	SENT_159	[p11l127t1916r187b1957],

1	30VASP	CD	NUMBER	30vasp	_	0	SENT_160	[p11l132t3362r209b3398, p11l37t3383r76b3510],
2	PRI	NNP	ORGANIZATION	PRI	dep	1	SENT_160	[p11l37t3277r82b3364],
3	,	,	O	,	_	0	SENT_160	[p11l37t3277r82b3364],
4	Mean	NN	O	mean	appos	2	SENT_160	[p11l37t3134r76b3255],
5	(	CD	PERCENT	(	number	7	SENT_160	[p11l37t3002r86b3114],
6	95	CD	PERCENT	95	number	7	SENT_160	[p11l37t3002r86b3114],
7	%	NN	PERCENT	%	amod	9	SENT_160	[p11l37t3002r86b3114],
8	Cl	NN	O	cl	nn	9	SENT_160	[p11l37t2913r86b2983],
9	)	NN	O	)	dep	4	SENT_160	[p11l37t2913r86b2983],
10	,	,	O	,	_	0	SENT_160	[p11l37t2913r86b2983],
11	%	NN	O	%	appos	2	SENT_160	[p11l37t2850r77b2890],

1	Clopidogrel	NNP	O	Clopidogrel	nn	2	SENT_161	[p11l271t2293r568b2351],
2	Dose	NNP	O	Dose	_	0	SENT_161	[p11l593t2293r739b2346],
3	,	,	O	,	_	0	SENT_161	[p11l593t2293r739b2346],
4	mg	NN	O	mg	appos	2	SENT_161	[p11l765t2304r844b2351],

1	CYP2C19	NN	O	cyp2c19	nn	2	SENT_162	[p11l215t2555r475b2591],
2	*	NN	O	*	_	0	SENT_162	[p11l215t2555r475b2591],
3	2	CD	NUMBER	2	num	4	SENT_162	[p11l215t2555r475b2591],
4	homozygotes	NNS	O	homozygote	dep	2	SENT_162	[p11l493t2556r781b2601],

1	T	NN	O	t	_	0	SENT_163	[p11l244t2747r286b2790],
2	o	NN	O	o	nn	3	SENT_163	[p11l248t2792r281b2825],
3	L	NN	O	l	dep	1	SENT_163	[p11l244t2827r286b2871],

1	I	PRP	O	I	_	0	SENT_164	[p11l399t2792r441b2912],
2	l	NN	O	l	dep	1	SENT_164	[p11l399t2913r441b3004],

1	O	NN	O	o	nn	2	SENT_165	[p11l559t2927r592b2960],
2	O	NN	O	o	_	0	SENT_165	[p11l714t2975r747b3008],

1	P	NN	O	p	nn	2	SENT_166	[p11l469t3578r500b3613],
2	trend	NN	O	trend	_	0	SENT_166	[p11l512t3578r617b3614],
3	=	JJ	O	=	amod	2	SENT_166	[p11l629t3594r654b3607],
4	.003	CD	NUMBER	.003	tmod	3	SENT_166	[p11l667t3579r755b3614],

1	o	NN	O	o	_	0	SENT_167	[p11l1101t1194r1149b1242],
2	\	SYM	O	\	dep	4	SENT_167	[p11l1101t1194r1149b1242],
3	°	CD	NUMBER	°	num	4	SENT_167	[p11l1101t1194r1149b1242],
4	80	CD	NUMBER	80	dep	8	SENT_167	[p11l1213t1202r1273b1244],
5	5	CD	NUMBER	5	number	6	SENT_167	[p11l1101t1283r1158b1350],
6	70	CD	NUMBER	70	dep	4	SENT_167	[p11l1214t1321r1273b1362],
7	I	PRP	O	I	dep	6	SENT_167	[p11l1345t1294r1394b1361],
8	o	NN	O	o	dep	22	SENT_167	[p11l1101t1374r1149b1421],
9	\	CD	NUMBER	\	num	8	SENT_167	[p11l1101t1374r1149b1421],
10	°	CD	NUMBER	°	number	11	SENT_167	[p11l1101t1374r1149b1421],
11	71	CD	NUMBER	71	dep	8	SENT_167	[p11l1345t1362r1394b1394],
12	-	:	O	-	_	0	SENT_167	[p11l1345t1362r1394b1394],
13	T	NN	O	t	dep	11	SENT_167	[p11l1527t1388r1577b1422],
14	5	CD	NUMBER	5	num	13	SENT_167	[p11l1101t1427r1158b1505],
15	:	:	O	:	_	0	SENT_167	[p11l1101t1427r1158b1505],
16	60	CD	NUMBER	60	number	17	SENT_167	[p11l1214t1440r1273b1481],
17	1	CD	NUMBER	1	num	21	SENT_167	[p11l1527t1424r1577b1499],
18	T	NN	O	t	nn	21	SENT_167	[p11l1710t1490r1760b1525],
19	c	NN	O	c	nn	21	SENT_167	[p11l1113t1529r1146b1555],
20	o	NN	O	o	nn	21	SENT_167	[p11l1716t1527r1755b1566],
21	g	NN	O	g	dep	13	SENT_167	[p11l1113t1559r1147b1621],
22	50	CD	NUMBER	50	dep	1	SENT_167	[p11l1214t1559r1273b1600],
23	i	FW	O	i	dep	22	SENT_167	[p11l1710t1568r1760b1608],
24	I	PRP	O	I	rcmod	23	SENT_167	[p11l1893t1541r1943b1615],
25	2	CD	NUMBER	2	num	26	SENT_167	[p11l1102t1627r1146b1671],
26	J.	NNP	O	J.	dep	24	SENT_167	[p11l1893t1616r1943b1647],
27	_	SYM	O	_	dep	24	SENT_167	[p11l1102t1697r1154b1718],
28	-	:	O	-	_	0	SENT_167	[p11l1102t1697r1154b1718],
29	40	CD	DATE	40	num	30	SENT_167	[p11l1213t1678r1273b1720],
30	E	NN	O	e	dep	1	SENT_167	[p11l1102t1724r1146b1799],
31	83	CD	NUMBER	83	number	32	SENT_167	[p11l1101t1821r1147b1896],
32	30	CD	NUMBER	30	dep	30	SENT_167	[p11l1213t1797r1273b1838],
33	§	NN	O	§	dep	32	SENT_167	[p11l1102t1897r1146b1971],
34	20	CD	NUMBER	20	num	33	SENT_167	[p11l1213t1916r1273b1957],

1	10	CD	NUMBER	10	num	2	SENT_168	[p11l1217t2035r1273b2076],
2	Ptrend	NN	O	ptrend	dep	3	SENT_168	[p11l1609t2051r1784b2093],
3	<	JJR	O	<	_	0	SENT_168	[p11l1813t2052r1942b2093],
4	.	.	O	.	_	0	SENT_168	[p11l1813t2052r1942b2093],

1	OO1	NN	O	oo1	_	0	SENT_169	[p11l1813t2052r1942b2093],

1	75 150 225 300	CD	NUMBER	75 150 225 300	num	3	SENT_170	[p11l1872t2214r1964b2255],[p11l1340t2215r1399b2255],
2	Clopidogrel	NNP	O	Clopidogrel	nn	3	SENT_170	[p11l1356t2293r1653b2350],
3	Dose	NNP	O	Dose	nsubj	10	SENT_170	[p11l1678t2293r1824b2346],
4	,	,	O	,	_	0	SENT_170	[p11l1678t2293r1824b2346],
5	mg	NN	O	mg	appos	3	SENT_170	[p11l1850t2304r1929b2350],
6	higher	JJR	O	higher	amod	8	SENT_170	[p11l896t2500r1109b2577],
7	platelet	NN	O	platelet	nn	8	SENT_170	[p11l1126t2500r1369b2577],
8	reactivity	NN	O	reactivity	dep	5	SENT_170	[p11l1386t2506r1692b2577],
9	than	IN	O	than	advmod	10	SENT_170	[p11l1711t2500r1857b2558],
10	did	VBD	O	do	_	0	SENT_170	[p11l1875t2500r1980b2558],
11	noncarrier	NN	O	noncarrier	nn	12	SENT_170	[p11l1998t2521r2151b2558, p11l898t2599r1106b2651],
12	patients	NNS	O	patient	dobj	10	SENT_170	[p11l1121t2599r1374b2670],
13	(	FW	O	(	nsubj	14	SENT_170	[p11l1397t2592r1598b2660],
14	mean	VB	O	mean	rcmod	12	SENT_170	[p11l1397t2592r1598b2660],
15	PRU	NNP	ORGANIZATION	PRU	dobj	14	SENT_170	[p11l1615t2598r1777b2663],
16	,	,	O	,	_	0	SENT_170	[p11l1615t2598r1777b2663],
17	225.6	CD	NUMBER	225.6	appos	15	SENT_170	[p11l1798t2597r1993b2663],
18	;	:	O	;	_	0	SENT_170	[p11l1798t2597r1993b2663],
19	95	CD	PERCENT	95	number	20	SENT_170	[p11l2014t2595r2150b2653],
20	%	NN	PERCENT	%	amod	21	SENT_170	[p11l2014t2595r2150b2653],
21	CI	NN	O	ci	dep	15	SENT_170	[p11l900t2690r994b2755],
22	,	,	O	,	_	0	SENT_170	[p11l900t2690r994b2755],
23	207.7-243	CD	NUMBER	207.7-243	num	24	SENT_170	[p11l1029t2690r1452b2755],
24	.4	NN	NUMBER	.4	appos	21	SENT_170	[p11l1029t2690r1452b2755],
25	,	,	O	,	_	0	SENT_170	[p11l1029t2690r1452b2755],
26	and	CC	O	and	_	0	SENT_170	[p11l1486t2685r1608b2744],
27	328.8	CD	NUMBER	328.8	dep	15	SENT_170	[p11l1638t2690r1844b2755],
28	;	:	O	;	_	0	SENT_170	[p11l1638t2690r1844b2755],
29	95	CD	PERCENT	95	number	30	SENT_170	[p11l1877t2687r2017b2746],
30	%	NN	PERCENT	%	amod	31	SENT_170	[p11l1877t2687r2017b2746],
31	CI	NN	O	ci	dep	15	SENT_170	[p11l2053t2690r2148b2755],
32	,	,	O	,	_	0	SENT_170	[p11l2053t2690r2148b2755],
33	247.9-409	CD	NUMBER	247.9-409	num	34	SENT_170	[p11l898t2782r1315b2848],
34	.7	CD	NUMBER	.7	appos	31	SENT_170	[p11l898t2782r1315b2848],
35	,	,	O	,	_	0	SENT_170	[p11l898t2782r1315b2848],
36	VS	NNP	O	VS	dep	31	SENT_170	[p11l1337t2799r1405b2837],
37	163.6	CD	NUMBER	163.6	num	36	SENT_170	[p11l1434t2782r1630b2848],
38	;	:	O	;	_	0	SENT_170	[p11l1434t2782r1630b2848],
39	95	CD	PERCENT	95	number	40	SENT_170	[p11l1656t2780r1795b2839],
40	%	NN	PERCENT	%	amod	41	SENT_170	[p11l1656t2780r1795b2839],
41	CI	NN	O	ci	dep	15	SENT_170	[p11l1822t2782r1915b2848],
42	,	,	O	,	_	0	SENT_170	[p11l1822t2782r1915b2848],
43	154.4	CD	NUMBER	154.4	num	45	SENT_170	[p11l1946t2782r2150b2838, p11l903t2875r1120b2941],
44	l73	NN	O	l73	nn	45	SENT_170	[p11l1946t2782r2150b2838, p11l903t2875r1120b2941],
45	.9	NN	NUMBER	.9	appos	41	SENT_170	[p11l1946t2782r2150b2838, p11l903t2875r1120b2941],
46	;	:	O	;	_	0	SENT_170	[p11l1946t2782r2150b2838, p11l903t2875r1120b2941],
47	P	NN	O	p	dep	15	SENT_170	[p11l1159t2876r1274b2928],
48	<	JJR	O	<	amod	47	SENT_170	[p11l1159t2876r1274b2928],
49	.001	CD	NUMBER	.001	dep	48	SENT_170	[p11l1299t2875r1444b2930],
50	for	IN	O	for	dep	49	SENT_170	[p11l1488t2870r1588b2930],
51	both	CC	O	both	dep	15	SENT_170	[p11l1623t2871r1788b2930],
52	comparisons	NNS	O	comparison	conj	15	SENT_170	[p11l1826t2877r2150b2948, p11l896t2963r1097b3031],
53	)	CD	NUMBER	)	dep	52	SENT_170	[p11l1826t2877r2150b2948, p11l896t2963r1097b3031],
54	.	.	O	.	_	0	SENT_170	[p11l1826t2877r2150b2948, p11l896t2963r1097b3031],

1	Analogous	JJ	O	analogous	dep	11	SENT_171	[p11l1133t2964r1497b3041],
2	to	TO	O	to	_	0	SENT_171	[p11l1532t2978r1593b3022],
3	the	DT	O	the	det	5	SENT_171	[p11l1629t2964r1733b3022],
4	VASP	NN	ORGANIZATION	vasp	nn	5	SENT_171	[p11l1764t2968r1953b3022],
5	findings	NNS	O	finding	prep_to	1	SENT_171	[p11l1989t2963r2150b3022, p11l896t3063r1068b3134],
6	,	,	O	,	_	0	SENT_171	[p11l1989t2963r2150b3022, p11l896t3063r1068b3134],
7	higher	JJR	O	higher	amod	8	SENT_171	[p11l1109t3057r1347b3134],
8	doses	NNS	O	dose	appos	5	SENT_171	[p11l1386t3057r1584b3115],
9	of	IN	O	of	_	0	SENT_171	[p11l1625t3056r1696b3115],
10	Clopidogrel	NNP	MISC	Clopidogrel	prep_of	8	SENT_171	[p11l1731t3057r2152b3134],
11	resulted	VBD	O	result	_	0	SENT_171	[p11l896t3149r1166b3208],
12	in	IN	O	in	_	0	SENT_171	[p11l1195t3155r1260b3207],
13	a	DT	O	a	det	15	SENT_171	[p11l1290t3170r1322b3208],
14	significant	JJ	O	significant	amod	15	SENT_171	[p11l1352t3149r1703b3227],
15	reduction	NN	O	reduction	prep_in	11	SENT_171	[p11l1732t3149r2057b3208],
16	in	IN	O	in	_	0	SENT_171	[p11l2086t3155r2151b3207],
17	platelet	NN	O	platelet	nn	18	SENT_171	[p11l895t3242r1141b3319],
18	reactivity	NN	O	reactivity	prep_in	15	SENT_171	[p11l1169t3248r1478b3319],
19	among	IN	O	among	_	0	SENT_171	[p11l1507t3263r1731b3319],
20	CYP2C19	NN	O	cyp2c19	nn	21	SENT_171	[p11l1762t3239r2148b3301],
21	*	NN	O	*	prep_among	11	SENT_171	[p11l1762t3239r2148b3301],
22	2	CD	NUMBER	2	num	23	SENT_171	[p11l1762t3239r2148b3301],
23	heterozygotes	NNS	O	heterozygote	nsubj	11	SENT_171	[p11l896t3335r1354b3412],
24	(	CD	NUMBER	(	num	25	SENT_171	[p11l1383t3334r1520b3403],
25	P	NN	O	p	npadvmod	26	SENT_171	[p11l1383t3334r1520b3403],
26	<	JJR	O	<	amod	23	SENT_171	[p11l1383t3334r1520b3403],
27	.001	CD	NUMBER	.001	dep	26	SENT_171	[p11l1541t3339r1674b3394],
28	for	IN	O	for	dep	27	SENT_171	[p11l1705t3334r1797b3394],
29	trend	NN	O	trend	nn	30	SENT_171	[p11l1822t3335r2044b3403],
30	)	NN	O	)	pobj	28	SENT_171	[p11l1822t3335r2044b3403],
31	.	.	O	.	_	0	SENT_171	[p11l1822t3335r2044b3403],

1	Using	VBG	O	use	_	0	SENT_172	[p11l976t3433r1160b3505],
2	a	DT	O	a	det	5	SENT_172	[p11l1174t3449r1205b3486],
3	prespecified	JJ	O	prespecified	amod	5	SENT_172	[p11l1220t3427r1595b3505],
4	cut	NN	O	cut	nn	5	SENT_172	[p11l1611t3442r1709b3486],
5	point	NN	O	point	dobj	1	SENT_172	[p11l1721t3434r1889b3505],
6	for	IN	O	for	_	0	SENT_172	[p11l1903t3427r1990b3486],
7	nonresponder	JJ	O	nonresponder	amod	8	SENT_172	[p11l2004t3449r2151b3486, p11l896t3521r1272b3597],
8	status	NN	O	status	prep_for	1	SENT_172	[p11l1311t3535r1527b3579],
9	(	RB	O	(	advmod	10	SENT_172	[p11l1573t3520r1882b3588],
10	defined	VBN	O	define	partmod	8	SENT_172	[p11l1573t3520r1882b3588],
11	as	IN	O	as	_	0	SENT_172	[p11l1922t3542r1990b3579],
12	ontreatment	JJ	O	ontreatment	amod	15	SENT_172	[p11l2032t3542r2150b3579, p11l898t3627r1202b3672],
13	platelet	NN	O	platelet	nn	15	SENT_172	[p11l1215t3613r1445b3690],
14	reactivity	NN	O	reactivity	nn	15	SENT_172	[p11l1459t3619r1749b3690],
15	Z230	NN	O	z230	prep_as	10	SENT_172	[p11l1767t3617r1944b3672],
16	PRU	NNP	ORGANIZATION	PRU	nsubj	28	SENT_172	[p11l1962t3613r2150b3683],
17	)	CD	NUMBER	)	num	16	SENT_172	[p11l1962t3613r2150b3683],
18	,	,	O	,	_	0	SENT_172	[p11l1962t3613r2150b3683],
19	53	CD	NUMBER	53	num	16	SENT_172	[p11l898t3710r972b3765],
20	of	IN	O	of	_	0	SENT_172	[p11l997t3705r1063b3765],
21	234	CD	NUMBER	234	num	22	SENT_172	[p11l1080t3710r1198b3765],
22	noncarriers	NNS	O	noncarrier	prep_of	16	SENT_172	[p11l1218t3712r1585b3765],
23	(	CD	PERCENT	(	number	24	SENT_172	[p11l1611t3706r1800b3774],
24	23	CD	PERCENT	23	num	25	SENT_172	[p11l1611t3706r1800b3774],
25	%	NN	PERCENT	%	dep	22	SENT_172	[p11l1611t3706r1800b3774],
26	)	CD	NUMBER	)	dep	25	SENT_172	[p11l1611t3706r1800b3774],
27	were	VBD	O	be	cop	28	SENT_172	[p11l1825t3727r1979b3765],
28	nonClopidogrel	JJ	O	nonclopidogrel	rcmod	15	SENT_172	[p11l2000t3727r2150b3765, p12l254t12r506b61],

1	Dose	NN	O	dose	_	0	SENT_173	[p12l527t12r651b57],
2	,	,	O	,	_	0	SENT_173	[p12l527t12r651b57],
3	mg	NN	O	mg	appos	1	SENT_173	[p12l673t22r741b61],

1	No.	NN	O	no.	_	0	SENT_174	[p12l195t112r230b130],
2	of	IN	O	of	_	0	SENT_174	[p12l240t112r260b130],
3	237	CD	NUMBER	237	number	4	SENT_174	[p12l345t112r385b130],
4	232	CD	NUMBER	232	num	6	SENT_174	[p12l479t112r519b130],
5	75	CD	NUMBER	75	num	6	SENT_174	[p12l777t112r803b130],
6	patients	NNS	O	patient	prep_of	1	SENT_174	[p12l209t142r292b165],
7	of	IN	O	of	_	0	SENT_174	[p12l8t199r42b229],
8	227	CD	PERCENT	227	number	9	SENT_174	[p12l56t201r118b230],
9	(	CD	PERCENT	(	prep_of	6	SENT_174	[p12l136t199r238b234],
10	12	CD	PERCENT	12	number	11	SENT_174	[p12l136t199r238b234],
11	%	NN	PERCENT	%	amod	6	SENT_174	[p12l136t199r238b234],
12	)	CD	NUMBER	)	dep	1	SENT_174	[p12l136t199r238b234],
13	with	IN	O	with	dep	1	SENT_174	[p12l255t199r333b229],
14	the	DT	O	the	det	16	SENT_174	[p12l349t199r402b229],
15	150-mg	JJ	O	150-mg	amod	16	SENT_174	[p12l421t201r550b239],
16	dose	NN	O	dose	pobj	13	SENT_174	[p12l565t199r651b229],
17	.	.	O	.	_	0	SENT_174	[p12l565t199r651b229],

1	Among	IN	O	among	dep	5	SENT_175	[p12l6t249r127b287],
2	CYP2C19	NN	O	cyp2c19	nn	3	SENT_175	[p12l135t245r325b277],
3	*	NN	O	*	pobj	1	SENT_175	[p12l135t245r325b277],
4	2	CD	NUMBER	2	num	5	SENT_175	[p12l135t245r325b277],
5	heterozygotes	NNS	O	heterozygote	_	0	SENT_175	[p12l334t247r566b287],
6	,	,	O	,	_	0	SENT_175	[p12l334t247r566b287],
7	40	CD	NUMBER	40	appos	5	SENT_175	[p12l574t249r614b277],
8	of	IN	O	of	prep	5	SENT_175	[p12l624t247r657b277],

1	VASP	NN	ORGANIZATION	vasp	nn	2	SENT_176	[p12l194t303r262b324],
2	PRI	NNP	ORGANIZATION	PRI	nsubj	3	SENT_176	[p12l278t303r315b324],
3	indicates	VBZ	O	indicate	_	0	SENT_176	[p12l332t302r438b324],
4	vasodilator-stimulated	JJ	O	vasodilator-stimulated	amod	7	SENT_176	[p12l452t302r726b324],
5	phosphoprotein	NN	O	phosphoprotein	nn	7	SENT_176	[p12l743t302r937b331],
6	phosphorylation	NN	O	phosphorylation	nn	7	SENT_176	[p12l953t302r1152b331],
7	assay	NN	O	assay	dobj	3	SENT_176	[p12l1168t309r1233b331],
8	platelet	NN	O	platelet	nn	10	SENT_176	[p12l1248t302r1338b331],
9	reactivity	NN	O	reactivity	nn	10	SENT_176	[p12l1353t303r1464b331],
10	index	NN	O	index	dep	7	SENT_176	[p12l1478t302r1550b324],
11	.	.	O	.	_	0	SENT_176	[p12l1478t302r1550b324],

1	with	IN	O	with	_	0	SENT_177	[p12l6t334r82b365],
2	the	DT	O	the	pobj	1	SENT_177	[p12l92t334r143b365],

1	2224	CD	DATE	2224	_	0	SENT_178	[p12l195t387r268b408],
2	JAMA	NNP	O	JAMA	nn	4	SENT_178	[p12l301t387r383b412],
3	,	,	O	,	_	0	SENT_178	[p12l301t387r383b412],
4	November	NNP	DATE	November	dep	1	SENT_178	[p12l399t385r529b408],
5	23/30	CD	DATE	23/30	num	4	SENT_178	[p12l543t387r621b412],
6	,	,	O	,	_	0	SENT_178	[p12l543t387r621b412],
7	201l	CD	NUMBER	201l	num	4	SENT_178	[p12l637t385r777b408],
8	.	.	O	.	_	0	SENT_178	[p12l637t385r777b408],

1	—	NN	O	—	_	0	SENT_179	[p12l637t385r777b408],
2	.	.	O	.	_	0	SENT_179	[p12l637t385r777b408],

1	Vol	NN	O	vol	_	0	SENT_180	[p12l637t385r777b408],
2	306	CD	NUMBER	306	num	1	SENT_180	[p12l791t387r845b412],
3	,	,	O	,	_	0	SENT_180	[p12l791t387r845b412],
4	No.	NN	O	no.	appos	1	SENT_180	[p12l860t387r902b408],
5	20	CD	NUMBER	20	num	4	SENT_180	[p12l918t387r948b408],

1	reserved	VBN	O	reserve	_	0	SENT_181	[p12l6t428r135b453],
2	.	.	O	.	_	0	SENT_181	[p12l6t428r135b453],

1	Downloaded	NNP	O	Downloaded	_	0	SENT_182	[p12l145t429r322b453],
2	From	IN	O	from	dep	1	SENT_182	[p12l331t429r419b452],
3	:	:	O	:	_	0	SENT_182	[p12l331t429r419b452],
4	http://jama.jamanetwork.com/	NN	O	http://jama.jamanetwork.com/	pobj	2	SENT_182	[p12l430t428r868b459],
5	by	IN	O	by	_	0	SENT_182	[p12l876t429r910b459],
6	a	DT	O	a	det	7	SENT_182	[p12l920t436r935b452],
7	University	NNP	ORGANIZATION	University	prep_by	4	SENT_182	[p12l944t428r1092b459],
8	of	IN	ORGANIZATION	of	_	0	SENT_182	[p12l1101t428r1130b452],
9	Wisconsin	NNP	ORGANIZATION	Wisconsin	prep_of	7	SENT_182	[p12l1137t428r1283b453],
10	-	:	O	-	_	0	SENT_182	[p12l1292t428r1426b452],
11	Madison	NNP	O	Madison	nn	12	SENT_182	[p12l1292t428r1426b452],
12	User	NN	O	user	dep	4	SENT_182	[p12l1435t429r1501b453],
13	on	IN	O	on	_	0	SENT_182	[p12l1519t436r1553b452],
14	01/05/2014	CD	DATE	01/05/2014	prep_on	12	SENT_182	[p12l1562t428r1713b453],

1	responders	NNS	O	responder	_	0	SENT_183	[p12l896t27r1249b104],
2	with	IN	O	with	_	0	SENT_183	[p12l1266t27r1412b86],
3	the	DT	O	the	det	5	SENT_183	[p12l1431t27r1529b86],
4	75-mg	JJ	O	75-mg	amod	5	SENT_183	[p12l1551t31r1756b104],
5	dose	NN	O	dose	prep_with	1	SENT_183	[p12l1774t27r1918b86],
6	and	CC	O	and	_	0	SENT_183	[p12l1937t27r2055b86],
7	28	CD	NUMBER	28	conj_and	5	SENT_183	[p12l2074t31r2150b86],

1	76	CD	PERCENT	76	number	2	SENT_184	[p12l1641t296r1679b325],
2	(	CD	PERCENT	(	nsubj	7	SENT_184	[p12l1697t294r1795b329],
3	52	CD	PERCENT	52	num	4	SENT_184	[p12l1697t294r1795b329],
4	%	NN	PERCENT	%	dep	2	SENT_184	[p12l1697t294r1795b329],
5	)	CD	NUMBER	)	dep	2	SENT_184	[p12l1697t294r1795b329],
6	were	VBD	O	be	cop	7	SENT_184	[p12l1812t305r1891b324],
7	nonresponders	NNS	O	nonresponder	_	0	SENT_184	[p12l1906t294r2154b334],

1	©	NN	O	©	_	0	SENT_185	[p12l1429t385r1507b408],
2	201	CD	NUMBER	201	number	3	SENT_185	[p12l1429t385r1507b408],
3	1	CD	NUMBER	1	dep	1	SENT_185	[p12l1516t386r1529b408],
4	American	NNP	ORGANIZATION	American	nn	6	SENT_185	[p12l1543t386r1683b408],
5	Medical	NNP	ORGANIZATION	Medical	nn	6	SENT_185	[p12l1696t384r1812b408],
6	Association	NNP	ORGANIZATION	Association	dep	3	SENT_185	[p12l1823t386r2001b408],
7	.	.	O	.	_	0	SENT_185	[p12l1823t386r2001b408],

1	All	DT	O	all	_	0	SENT_186	[p12l2015t384r2057b408],
2	rights	NNS	O	rights	dep	1	SENT_186	[p12l2070t384r2154b416],

1	CLOPIDOGREL	NN	O	clopidogrel	nn	2	SENT_187	[p12l1285t559r1536b585],
2	DOSES	NNS	O	dose	_	0	SENT_187	[p12l1547t559r1657b585],
3	AND	CC	O	and	_	0	SENT_187	[p12l1668t559r1745b584],
4	CYPZC	NN	O	cypzc	conj_and	2	SENT_187	[p12l1758t559r1863b585],
5	19	CD	NUMBER	19	num	6	SENT_187	[p12l1867t559r1900b585],
6	GENOTYPE	NN	O	genotype	dep	2	SENT_187	[p12l1913t559r2102b585],

1	Table	NNP	O	Table	_	0	SENT_188	[p12l57t689r146b715],
2	2	CD	NUMBER	2	dep	1	SENT_188	[p12l158t690r187b714],
3	.	.	O	.	_	0	SENT_188	[p12l158t690r187b714],

1	On-Treatment	JJ	O	on-treatment	amod	3	SENT_189	[p12l200t691r405b715],
2	Platelet	NN	O	platelet	nn	3	SENT_189	[p12l417t689r520b715],
3	Reactivitya	NN	O	reactivitya	_	0	SENT_189	[p12l532t690r683b722],

1	Mean	NN	O	mean	_	0	SENT_190	[p12l1132t745r1209b768],
2	(	CD	PERCENT	(	number	3	SENT_190	[p12l1220t745r1291b774],
3	95	CD	PERCENT	95	num	4	SENT_190	[p12l1220t745r1291b774],
4	%	NN	PERCENT	%	dep	1	SENT_190	[p12l1220t745r1291b774],
5	CI	NN	O	ci	nn	6	SENT_190	[p12l1303t745r1341b774],
6	)	NN	O	)	dep	4	SENT_190	[p12l1303t745r1341b774],

1	P	NN	O	p	nn	2	SENT_191	[p12l1980t778r2001b801],
2	Value	NN	O	value	dep	8	SENT_191	[p12l2009t778r2088b801],
3	75	CD	NUMBER	75	num	4	SENT_191	[p12l665t807r698b830],
4	mg	NN	O	mg	dep	2	SENT_191	[p12l709t813r751b836],
5	150	CD	NUMBER	150	num	6	SENT_191	[p12l1008t807r1058b830],
6	mg	NN	O	mg	dep	8	SENT_191	[p12l1069t813r1112b836],
7	225	CD	NUMBER	225	num	8	SENT_191	[p12l1360t807r1410b830],
8	mg	NN	O	mg	_	0	SENT_191	[p12l1421t813r1463b836],
9	300	CD	NUMBER	300	num	10	SENT_191	[p12l1711t807r1761b830],
10	mg	NN	O	mg	dep	8	SENT_191	[p12l1773t813r1815b836],
11	for	IN	O	for	_	0	SENT_191	[p12l1968t807r2008b830],
12	Trend	NNP	O	Trend	prep_for	10	SENT_191	[p12l2016t807r2098b830],

1	VASP	NN	ORGANIZATION	vasp	_	0	SENT_192	[p12l1009t857r1090b881],
2	PRI	NNP	O	PRI	dep	1	SENT_192	[p12l1101t858r1148b881],

1	Noncarriers	NNS	O	noncarrier	_	0	SENT_193	[p12l59t904r211b928],
2	57.5	CD	NUMBER	57.5	number	3	SENT_193	[p12l592t905r651b928],
3	55.1	CD	NUMBER	55.1	dep	1	SENT_193	[p12l669t905r722b928],
4	-59.9	CD	NUMBER	-59.9	num	5	SENT_193	[p12l730t904r807b933],
5	)	NN	O	)	dep	3	SENT_193	[p12l730t904r807b933],
6	46.9	CD	NUMBER	46.9	number	7	SENT_193	[p12l944t905r1002b928],
7	44.3-49	CD	NUMBER	44.3-49	dep	10	SENT_193	[p12l1020t904r1159b933],
8	.1	CD	NUMBER	.1	num	9	SENT_193	[p12l1020t904r1159b933],
9	)	NN	O	)	npadvmod	10	SENT_193	[p12l1020t904r1159b933],
10	<	JJR	O	<	amod	1	SENT_193	[p12l1993t905r2071b928],
11	.	.	O	.	_	0	SENT_193	[p12l1993t905r2071b928],

1	OO1	NN	O	oo1	_	0	SENT_194	[p12l1993t905r2071b928],

1	l	NN	O	l	nn	4	SENT_195	[p12l109t955r152b979],
2	\	CD	NUMBER	\	num	4	SENT_195	[p12l109t955r152b979],
3	o.	NN	O	o.	nn	4	SENT_195	[p12l109t955r152b979],
4	o	NN	O	o	_	0	SENT_195	[p12l165t961r180b979],
5	pa	NN	O	pa	dep	4	SENT_195	[p12l200t961r232b984],
6	‘	CD	NUMBER	‘	num	5	SENT_195	[p12l243t955r278b979],
7	en	IN	O	en	_	0	SENT_195	[p12l243t955r278b979],
8	s	NNS	O	s	prep_en	5	SENT_195	[p12l290t961r303b979],
9	237	CD	NUMBER	237	num	10	SENT_195	[p12l683t955r733b979],
10	232	CD	NUMBER	232	dep	4	SENT_195	[p12l1035t955r1085b979],

1	Carriers	NNS	O	carrier	dep	7	SENT_196	[p12l58t1006r161b1030],
2	71.0	CD	NUMBER	71.0	num	3	SENT_196	[p12l593t1007r651b1030],
3	67.1	CD	NUMBER	67.1	dep	1	SENT_196	[p12l669t1007r722b1030],
4	-74.9	CD	NUMBER	-74.9	num	5	SENT_196	[p12l730t1006r807b1035],
5	)	NN	O	)	dep	7	SENT_196	[p12l730t1006r807b1035],
6	62.4	CD	NUMBER	62.4	num	7	SENT_196	[p12l944t1007r1003b1030],
7	58.1	CD	NUMBER	58.1	dep	13	SENT_196	[p12l1021t1007r1074b1030],
8	-66.7	CD	NUMBER	-66.7	num	9	SENT_196	[p12l1082t1006r1159b1035],
9	)	NN	O	)	dep	7	SENT_196	[p12l1082t1006r1159b1035],
10	54.0	CD	NUMBER	54.0	number	11	SENT_196	[p12l1296t1007r1354b1030],
11	(	CD	NUMBER	(	dep	9	SENT_196	[p12l1365t1006r1510b1035],
12	49.4-58	CD	NUMBER	49.4-58	num	13	SENT_196	[p12l1365t1006r1510b1035],
13	.5	CD	NUMBER	.5	dep	21	SENT_196	[p12l1365t1006r1510b1035],
14	)	NN	O	)	dep	13	SENT_196	[p12l1365t1006r1510b1035],
15	50.1	CD	NUMBER	50.1	num	14	SENT_196	[p12l1647t1007r1701b1030],
16	(	CD	NUMBER	(	number	17	SENT_196	[p12l1717t1006r1862b1035],
17	45.9-54	CD	NUMBER	45.9-54	num	19	SENT_196	[p12l1717t1006r1862b1035],
18	.3	NN	NUMBER	.3	nn	19	SENT_196	[p12l1717t1006r1862b1035],
19	)	NN	O	)	npadvmod	20	SENT_196	[p12l1717t1006r1862b1035],
20	<	JJR	O	<	amod	14	SENT_196	[p12l1993t1007r2071b1030],
21	.001	CD	NUMBER	.001	_	0	SENT_196	[p12l1993t1007r2071b1030],

1	l	NN	O	l	_	0	SENT_197	[p12l109t1053r152b1076],
2	\	CD	NUMBER	\	num	5	SENT_197	[p12l109t1053r152b1076],
3	o.	NN	O	o.	nn	5	SENT_197	[p12l109t1053r152b1076],
4	o	NN	O	o	nn	5	SENT_197	[p12l165t1059r180b1076],
5	pa	NN	O	pa	dep	1	SENT_197	[p12l200t1059r232b1082],
6	"	''	O	"	punct	5	SENT_197	[p12l243t1053r278b1076],
7	en	IN	O	en	_	0	SENT_197	[p12l243t1053r278b1076],
8	s	NNS	O	s	prep_en	5	SENT_197	[p12l290t1059r303b1076],
9	80	CD	NUMBER	80	number	10	SENT_197	[p12l692t1053r725b1076],
10	80	CD	NUMBER	80	num	8	SENT_197	[p12l1044t1053r1077b1076],
11	81	CD	NUMBER	81	num	12	SENT_197	[p12l1396t1053r1423b1076],
12	81	CD	NUMBER	81	dep	1	SENT_197	[p12l1747t1053r1775b1076],

1	CYP2C79	NN	O	cyp2c79	nn	2	SENT_198	[p12l58t1103r223b1127],
2	*	NN	O	*	_	0	SENT_198	[p12l58t1103r223b1127],
3	2	CD	NUMBER	2	num	4	SENT_198	[p12l58t1103r223b1127],
4	heterozygotes	NNS	O	heterozygote	dep	2	SENT_198	[p12l234t1104r421b1133],
5	70.0	CD	NUMBER	70.0	number	6	SENT_198	[p12l593t1104r651b1127],
6	66.0-74	CD	NUMBER	66.0-74	dep	4	SENT_198	[p12l669t1103r807b1133],
7	.0	CD	NUMBER	.0	num	8	SENT_198	[p12l669t1103r807b1133],
8	)	NN	O	)	dep	6	SENT_198	[p12l669t1103r807b1133],
9	61.4	CD	NUMBER	61.4	number	10	SENT_198	[p12l944t1104r1002b1127],
10	57.0-65	CD	NUMBER	57.0-65	dep	2	SENT_198	[p12l1021t1103r1159b1133],
11	.9	CD	NUMBER	.9	num	12	SENT_198	[p12l1021t1103r1159b1133],
12	)	NN	O	)	dep	10	SENT_198	[p12l1021t1103r1159b1133],
13	52.7	CD	NUMBER	52.7	number	14	SENT_198	[p12l1296t1104r1354b1127],
14	(	CD	NUMBER	(	dep	2	SENT_198	[p12l1365t1103r1510b1133],
15	48.0-57	CD	NUMBER	48.0-57	num	16	SENT_198	[p12l1365t1103r1510b1133],
16	.4	NN	NUMBER	.4	dep	14	SENT_198	[p12l1365t1103r1510b1133],
17	)	CD	NUMBER	)	num	19	SENT_198	[p12l1365t1103r1510b1133],
18	48.9	CD	NUMBER	48.9	num	19	SENT_198	[p12l1647t1104r1706b1127],
19	(	NN	O	(	dep	2	SENT_198	[p12l1717t1103r1862b1133],
20	44.6	CD	NUMBER	44.6	number	21	SENT_198	[p12l1717t1103r1862b1133],
21	—	CD	NUMBER	—	dep	24	SENT_198	[p12l1717t1103r1862b1133],
22	53.2	CD	NUMBER	53.2	num	23	SENT_198	[p12l1717t1103r1862b1133],
23	)	NN	O	)	npadvmod	24	SENT_198	[p12l1717t1103r1862b1133],
24	<	JJR	O	<	amod	19	SENT_198	[p12l1993t1104r2071b1127],
25	.	.	O	.	_	0	SENT_198	[p12l1993t1104r2071b1127],

1	OO1	NN	O	oo1	_	0	SENT_199	[p12l1993t1104r2071b1127],

1	l	NN	O	l	_	0	SENT_200	[p12l109t1155r152b1178],
2	\	CD	NUMBER	\	num	5	SENT_200	[p12l109t1155r152b1178],
3	o.	NN	O	o.	nn	5	SENT_200	[p12l109t1155r152b1178],
4	o	NN	O	o	nn	5	SENT_200	[p12l165t1161r180b1178],
5	pa	NN	O	pa	dep	1	SENT_200	[p12l200t1161r232b1184],
6	"	''	O	"	punct	5	SENT_200	[p12l243t1155r278b1178],
7	en	IN	O	en	_	0	SENT_200	[p12l243t1155r278b1178],
8	s	NNS	O	s	prep_en	5	SENT_200	[p12l290t1161r303b1178],
9	75	CD	NUMBER	75	number	10	SENT_200	[p12l692t1155r724b1178],
10	75	CD	NUMBER	75	num	8	SENT_200	[p12l1044t1155r1076b1178],
11	76	CD	NUMBER	76	num	12	SENT_200	[p12l1396t1155r1428b1178],
12	76	CD	NUMBER	76	dep	1	SENT_200	[p12l1748t1155r1780b1178],

1	CYP2C79	NN	O	cyp2c79	nn	2	SENT_201	[p12l58t1205r223b1229],
2	*	NN	O	*	dep	8	SENT_201	[p12l58t1205r223b1229],
3	2	CD	NUMBER	2	num	4	SENT_201	[p12l58t1205r223b1229],
4	homozygotes	NNS	O	homozygote	dep	2	SENT_201	[p12l234t1206r413b1235],
5	86.6	CD	NUMBER	86.6	dep	8	SENT_201	[p12l592t1206r651b1229],
6	80.7-92	CD	NUMBER	80.7-92	num	8	SENT_201	[p12l669t1205r807b1235],
7	.5	CD	NUMBER	.5	num	8	SENT_201	[p12l669t1205r807b1235],
8	)	NN	O	)	dep	14	SENT_201	[p12l669t1205r807b1235],
9	77.8	CD	NUMBER	77.8	num	11	SENT_201	[p12l944t1206r1003b1229],
10	67.4-88	CD	NUMBER	67.4-88	num	11	SENT_201	[p12l1021t1205r1159b1235],
11	.1	NN	NUMBER	.1	dep	8	SENT_201	[p12l1021t1205r1159b1235],
12	)	CD	NUMBER	)	number	13	SENT_201	[p12l1021t1205r1159b1235],
13	73.0	CD	NUMBER	73.0	dep	11	SENT_201	[p12l1296t1206r1354b1229],
14	(	NN	O	(	dep	17	SENT_201	[p12l1365t1205r1510b1235],
15	50.6-95	CD	NUMBER	50.6-95	num	14	SENT_201	[p12l1365t1205r1510b1235],
16	.5	CD	NUMBER	.5	num	17	SENT_201	[p12l1365t1205r1510b1235],
17	)	NN	O	)	dep	21	SENT_201	[p12l1365t1205r1510b1235],
18	68.3	CD	NUMBER	68.3	dep	17	SENT_201	[p12l1647t1206r1706b1229],
19	(	CD	NUMBER	(	number	20	SENT_201	[p12l1717t1205r1862b1235],
20	44.9	CD	NUMBER	44.9	dep	18	SENT_201	[p12l1717t1205r1862b1235],
21	—	NN	O	—	dep	24	SENT_201	[p12l1717t1205r1862b1235],
22	91.6	CD	NUMBER	91.6	num	21	SENT_201	[p12l1717t1205r1862b1235],
23	)	CD	NUMBER	)	num	24	SENT_201	[p12l1717t1205r1862b1235],
24	.003	CD	NUMBER	.003	_	0	SENT_201	[p12l2020t1206r2076b1229],

1	l	NN	O	l	_	0	SENT_202	[p12l109t1257r152b1280],
2	\	CD	NUMBER	\	num	5	SENT_202	[p12l109t1257r152b1280],
3	o.	NN	O	o.	nn	5	SENT_202	[p12l109t1257r152b1280],
4	o	NN	O	o	nn	5	SENT_202	[p12l165t1263r180b1280],
5	pa	NN	O	pa	dep	1	SENT_202	[p12l200t1263r232b1286],
6	"	''	O	"	punct	5	SENT_202	[p12l243t1257r278b1280],
7	en	IN	O	en	_	0	SENT_202	[p12l243t1257r278b1280],
8	s	NNS	O	s	prep_en	5	SENT_202	[p12l290t1263r303b1280],
9	5	CD	NUMBER	5	number	10	SENT_202	[p12l701t1258r716b1280],
10	5	CD	NUMBER	5	amod	8	SENT_202	[p12l1053t1258r1068b1280],
11	5	CD	NUMBER	5	number	12	SENT_202	[p12l1404t1258r1419b1280],
12	5	CD	NUMBER	5	amod	8	SENT_202	[p12l1756t1258r1771b1280],

1	VerifyNow	NNP	O	VerifyNow	nn	2	SENT_203	[p12l970t1305r1116b1334],
2	PRU	NNP	O	PRU	_	0	SENT_203	[p12l1127t1305r1188b1328],

1	Noncarriers	NNS	O	noncarrier	_	0	SENT_204	[p12l59t1351r211b1374],
2	163.6	CD	NUMBER	163.6	number	3	SENT_204	[p12l577t1352r651b1374],
3	154.4-173	CD	NUMBER	154.4-173	num	5	SENT_204	[p12l671t1351r842b1380],
4	.9	CD	NUMBER	.9	number	5	SENT_204	[p12l671t1351r842b1380],
5	)	CD	NUMBER	)	dep	1	SENT_204	[p12l671t1351r842b1380],
6	126.7	CD	NUMBER	126.7	number	7	SENT_204	[p12l928t1352r1002b1374],
7	117.7	CD	NUMBER	117.7	dep	11	SENT_204	[p12l1023t1351r1193b1380],
8	—	CD	NUMBER	—	number	9	SENT_204	[p12l1023t1351r1193b1380],
9	137.5	CD	NUMBER	137.5	num	10	SENT_204	[p12l1023t1351r1193b1380],
10	)	NN	O	)	npadvmod	11	SENT_204	[p12l1023t1351r1193b1380],
11	<	JJR	O	<	amod	5	SENT_204	[p12l1993t1352r2071b1374],
12	.	.	O	.	_	0	SENT_204	[p12l1993t1352r2071b1374],

1	OO1	NN	O	oo1	_	0	SENT_205	[p12l1993t1352r2071b1374],

1	l	NN	O	l	nn	4	SENT_206	[p12l109t1402r152b1426],
2	\	CD	NUMBER	\	num	4	SENT_206	[p12l109t1402r152b1426],
3	o.	NN	O	o.	nn	4	SENT_206	[p12l109t1402r152b1426],
4	o	NN	O	o	_	0	SENT_206	[p12l165t1408r180b1426],
5	pa	NN	O	pa	dep	4	SENT_206	[p12l200t1408r232b1431],
6	‘	CD	NUMBER	‘	num	5	SENT_206	[p12l243t1402r278b1426],
7	en	IN	O	en	_	0	SENT_206	[p12l243t1402r278b1426],
8	s	NNS	O	s	prep_en	5	SENT_206	[p12l290t1408r303b1426],
9	236	CD	NUMBER	236	number	10	SENT_206	[p12l683t1402r734b1426],
10	230	CD	NUMBER	230	num	8	SENT_206	[p12l1035t1402r1085b1426],

1	Carriers	NNS	O	carrier	_	0	SENT_207	[p12l58t1453r161b1476],
2	231.9	CD	NUMBER	231.9	number	3	SENT_207	[p12l575t1454r651b1476],
3	214.0-249	CD	NUMBER	214.0-249	dep	1	SENT_207	[p12l669t1453r842b1482],
4	.8	CD	NUMBER	.8	num	5	SENT_207	[p12l669t1453r842b1482],
5	)	NN	O	)	dep	3	SENT_207	[p12l669t1453r842b1482],
6	195.9	CD	NUMBER	195.9	number	7	SENT_207	[p12l928t1454r1002b1476],
7	178.2	CD	NUMBER	178.2	dep	1	SENT_207	[p12l1023t1453r1193b1482],
8	—	NN	O	—	dep	7	SENT_207	[p12l1023t1453r1193b1482],
9	213.7	CD	NUMBER	213.7	number	10	SENT_207	[p12l1023t1453r1193b1482],
10	)	CD	NUMBER	)	dep	1	SENT_207	[p12l1023t1453r1193b1482],
11	161.2	CD	NUMBER	161.2	num	12	SENT_207	[p12l1280t1454r1354b1476],
12	(	NN	O	(	dep	10	SENT_207	[p12l1365t1453r1545b1482],
13	142.6-179	CD	NUMBER	142.6-179	num	15	SENT_207	[p12l1365t1453r1545b1482],
14	.8	CD	NUMBER	.8	num	15	SENT_207	[p12l1365t1453r1545b1482],
15	)	NN	O	)	dep	1	SENT_207	[p12l1365t1453r1545b1482],
16	137.7	CD	NUMBER	137.7	number	17	SENT_207	[p12l1632t1454r1706b1476],
17	(	CD	NUMBER	(	dep	21	SENT_207	[p12l1717t1453r1897b1482],
18	118.4-157	CD	NUMBER	118.4-157	number	19	SENT_207	[p12l1717t1453r1897b1482],
19	.1	CD	NUMBER	.1	num	20	SENT_207	[p12l1717t1453r1897b1482],
20	)	NN	O	)	npadvmod	21	SENT_207	[p12l1717t1453r1897b1482],
21	<	JJR	O	<	amod	15	SENT_207	[p12l1993t1454r2071b1476],
22	.	.	O	.	_	0	SENT_207	[p12l1993t1454r2071b1476],

1	OO1	NN	O	oo1	_	0	SENT_208	[p12l1993t1454r2071b1476],

1	l	NN	O	l	nn	4	SENT_209	[p12l109t1504r152b1528],
2	\	CD	NUMBER	\	num	4	SENT_209	[p12l109t1504r152b1528],
3	o.	NN	O	o.	nn	4	SENT_209	[p12l109t1504r152b1528],
4	o	NN	O	o	_	0	SENT_209	[p12l165t1510r180b1528],
5	pa	NN	O	pa	dep	4	SENT_209	[p12l200t1510r232b1533],
6	‘	CD	NUMBER	‘	num	5	SENT_209	[p12l243t1504r278b1528],
7	en	IN	O	en	_	0	SENT_209	[p12l243t1504r278b1528],
8	s	NNS	O	s	prep_en	5	SENT_209	[p12l290t1510r303b1528],
9	81	CD	NUMBER	81	number	10	SENT_209	[p12l692t1504r719b1528],
10	78	CD	NUMBER	78	num	8	SENT_209	[p12l1044t1504r1076b1528],
11	80	CD	NUMBER	80	num	12	SENT_209	[p12l1395t1504r1428b1528],
12	78	CD	NUMBER	78	dep	4	SENT_209	[p12l1748t1504r1780b1528],

1	C	NN	O	c	_	0	SENT_210	[p12l58t1555r223b1579],
2	)	CD	NUMBER	)	dep	1	SENT_210	[p12l58t1555r223b1579],
3	/	:	O	/	punct	5	SENT_210	[p12l58t1555r223b1579],
4	P2C79	CD	NUMBER	p2c79	num	5	SENT_210	[p12l58t1555r223b1579],
5	*	NN	O	*	dep	2	SENT_210	[p12l58t1555r223b1579],
6	2	CD	NUMBER	2	num	7	SENT_210	[p12l58t1555r223b1579],
7	heterozygotes	NNS	O	heterozygote	dep	5	SENT_210	[p12l234t1555r421b1585],
8	225.6	CD	NUMBER	225.6	num	10	SENT_210	[p12l575t1556r651b1579],
9	207.7-243	CD	NUMBER	207.7-243	num	10	SENT_210	[p12l669t1555r842b1585],
10	.4	NN	NUMBER	.4	dep	2	SENT_210	[p12l669t1555r842b1585],
11	)	CD	NUMBER	)	number	12	SENT_210	[p12l669t1555r842b1585],
12	188.1	CD	NUMBER	188.1	dep	1	SENT_210	[p12l928t1556r997b1579],
13	170.8-205	CD	NUMBER	170.8-205	num	14	SENT_210	[p12l1023t1555r1193b1585],
14	.4	NN	NUMBER	.4	dep	12	SENT_210	[p12l1023t1555r1193b1585],
15	)	CD	NUMBER	)	number	16	SENT_210	[p12l1023t1555r1193b1585],
16	152.9	CD	NUMBER	152.9	dep	1	SENT_210	[p12l1280t1556r1354b1579],
17	(	NN	O	(	dep	16	SENT_210	[p12l1365t1555r1545b1585],
18	135.2-170	CD	NUMBER	135.2-170	num	17	SENT_210	[p12l1365t1555r1545b1585],
19	.6	CD	NUMBER	.6	num	20	SENT_210	[p12l1365t1555r1545b1585],
20	)	NN	O	)	dep	1	SENT_210	[p12l1365t1555r1545b1585],
21	127.5	CD	NUMBER	127.5	number	22	SENT_210	[p12l1632t1556r1706b1579],
22	(	CD	NUMBER	(	dep	20	SENT_210	[p12l1717t1555r1897b1585],
23	109.9-145	CD	NUMBER	109.9-145	num	25	SENT_210	[p12l1717t1555r1897b1585],
24	.2	NN	NUMBER	.2	nn	25	SENT_210	[p12l1717t1555r1897b1585],
25	)	NN	O	)	dep	1	SENT_210	[p12l1717t1555r1897b1585],
26	<	JJR	O	<	dep	25	SENT_210	[p12l1993t1556r2071b1579],
27	.	.	O	.	_	0	SENT_210	[p12l1993t1556r2071b1579],

1	OO1	NN	O	oo1	_	0	SENT_211	[p12l1993t1556r2071b1579],

1	l	NN	O	l	_	0	SENT_212	[p12l109t1607r152b1630],
2	\	CD	NUMBER	\	num	5	SENT_212	[p12l109t1607r152b1630],
3	o.	NN	O	o.	nn	5	SENT_212	[p12l109t1607r152b1630],
4	o	NN	O	o	nn	5	SENT_212	[p12l165t1613r180b1630],
5	pa	NN	O	pa	dep	1	SENT_212	[p12l200t1613r232b1636],
6	"	''	O	"	punct	5	SENT_212	[p12l243t1607r278b1630],
7	en	IN	O	en	_	0	SENT_212	[p12l243t1607r278b1630],
8	s	NNS	O	s	prep_en	5	SENT_212	[p12l290t1613r303b1630],
9	76	CD	NUMBER	76	number	10	SENT_212	[p12l692t1607r725b1630],
10	73	CD	NUMBER	73	num	8	SENT_212	[p12l1044t1607r1076b1630],
11	75	CD	NUMBER	75	num	12	SENT_212	[p12l1396t1607r1428b1630],
12	78	CD	NUMBER	78	dep	1	SENT_212	[p12l1748t1607r1780b1630],

1	C	NN	O	c	_	0	SENT_213	[p12l58t1657r223b1681],
2	)	CD	NUMBER	)	dep	1	SENT_213	[p12l58t1657r223b1681],
3	/	:	O	/	punct	1	SENT_213	[p12l58t1657r223b1681],
4	P2C79	CD	NUMBER	p2c79	num	5	SENT_213	[p12l58t1657r223b1681],
5	*	NN	O	*	dep	13	SENT_213	[p12l58t1657r223b1681],
6	2	CD	NUMBER	2	num	7	SENT_213	[p12l58t1657r223b1681],
7	homozygotes	NNS	O	homozygote	dep	5	SENT_213	[p12l234t1657r413b1687],
8	328.8	CD	NUMBER	328.8	num	9	SENT_213	[p12l575t1658r651b1681],
9	247.9-409	CD	NUMBER	247.9-409	dep	7	SENT_213	[p12l669t1657r842b1687],
10	.7	CD	NUMBER	.7	num	11	SENT_213	[p12l669t1657r842b1687],
11	)	NN	O	)	dep	13	SENT_213	[p12l669t1657r842b1687],
12	310.2	CD	NUMBER	310.2	num	13	SENT_213	[p12l926t1658r1002b1681],
13	247.5-372	CD	NUMBER	247.5-372	dep	19	SENT_213	[p12l1021t1657r1193b1687],
14	.9	CD	NUMBER	.9	num	15	SENT_213	[p12l1021t1657r1193b1687],
15	)	NN	O	)	dep	13	SENT_213	[p12l1021t1657r1193b1687],
16	286.0	CD	NUMBER	286.0	number	17	SENT_213	[p12l1278t1658r1354b1681],
17	(	CD	NUMBER	(	dep	15	SENT_213	[p12l1365t1657r1545b1687],
18	177.9-394	CD	NUMBER	177.9-394	num	19	SENT_213	[p12l1365t1657r1545b1687],
19	.1	NN	NUMBER	.1	dep	25	SENT_213	[p12l1365t1657r1545b1687],
20	)	CD	NUMBER	)	number	21	SENT_213	[p12l1365t1657r1545b1687],
21	287.0	CD	NUMBER	287.0	dep	19	SENT_213	[p12l1630t1658r1706b1681],
22	(	NN	O	(	dep	21	SENT_213	[p12l1717t1657r1897b1687],
23	1702-4038	CD	DURATION	1702-4038	num	22	SENT_213	[p12l1717t1657r1897b1687],
24	)	CD	NUMBER	)	num	25	SENT_213	[p12l1717t1657r1897b1687],
25	.32	CD	NUMBER	.32	dep	1	SENT_213	[p12l2020t1658r2059b1681],

1	l	NN	O	l	_	0	SENT_214	[p12l109t1705r152b1728],
2	\	CD	NUMBER	\	num	5	SENT_214	[p12l109t1705r152b1728],
3	o.	NN	O	o.	nn	5	SENT_214	[p12l109t1705r152b1728],
4	o	NN	O	o	nn	5	SENT_214	[p12l165t1711r180b1728],
5	pa	NN	O	pa	dep	1	SENT_214	[p12l200t1711r232b1734],
6	"	''	O	"	punct	5	SENT_214	[p12l243t1705r278b1728],
7	en	IN	O	en	_	0	SENT_214	[p12l243t1705r278b1728],
8	s	NNS	O	s	prep_en	5	SENT_214	[p12l290t1711r303b1728],
9	5	CD	NUMBER	5	number	10	SENT_214	[p12l701t1705r716b1728],
10	5	CD	NUMBER	5	amod	8	SENT_214	[p12l1053t1705r1068b1728],
11	5	CD	NUMBER	5	number	12	SENT_214	[p12l1404t1705r1419b1728],
12	5	CD	NUMBER	5	amod	8	SENT_214	[p12l1756t1705r1771b1728],

1	Abbreviations	NNS	O	abbreviation	_	0	SENT_215	[p12l57t1757r220b1777],
2	:	:	O	:	_	0	SENT_215	[p12l57t1757r220b1777],
3	DRI	NNP	ORGANIZATION	DRI	dep	1	SENT_215	[p12l234t1757r276b1780],
4	,	,	O	,	_	0	SENT_215	[p12l234t1757r276b1780],
5	platelet	NN	O	platelet	nn	7	SENT_215	[p12l288t1757r369b1782],
6	reactivity	NN	O	reactivity	nn	7	SENT_215	[p12l379t1757r479b1782],
7	index	NN	O	index	appos	3	SENT_215	[p12l488t1757r554b1781],
8	;	:	O	;	_	0	SENT_215	[p12l488t1757r554b1781],
9	PRU	NNP	ORGANIZATION	PRU	dep	3	SENT_215	[p12l565t1757r622b1780],
10	,	,	O	,	_	0	SENT_215	[p12l565t1757r622b1780],
11	platelet	NN	O	platelet	nn	13	SENT_215	[p12l633t1757r715b1782],
12	reactivity	NN	O	reactivity	nn	13	SENT_215	[p12l725t1757r825b1782],
13	units	NNS	O	unit	appos	9	SENT_215	[p12l834t1757r892b1780],
14	;	:	O	;	_	0	SENT_215	[p12l834t1757r892b1780],
15	VASP	NN	ORGANIZATION	vasp	nn	20	SENT_215	[p12l902t1757r974b1780],
16	,	,	O	,	_	0	SENT_215	[p12l902t1757r974b1780],
17	vasodilator	NN	O	vasodilator	dep	20	SENT_215	[p12l985t1757r1238b1777],
18	—	NN	O	—	nn	20	SENT_215	[p12l985t1757r1238b1777],
19	stimu	NN	O	stimu	nn	20	SENT_215	[p12l985t1757r1238b1777],
20	|	NN	O	|	nsubj	21	SENT_215	[p12l985t1757r1238b1777],
21	ated	VBD	O	ate	dep	3	SENT_215	[p12l985t1757r1238b1777],
22	phosphoprotein	NN	O	phosphoprotein	nn	23	SENT_215	[p12l1249t1757r1429b1782],
23	phosphorylation	NN	O	phosphorylation	dobj	21	SENT_215	[p12l1440t1757r1629b1782],
24	.	.	O	.	_	0	SENT_215	[p12l1440t1757r1629b1782],

1	5A	NN	O	5a	nsubjpass	14	SENT_216	[p12l58t1783r91b1806],
2	to	TO	O	to	_	0	SENT_216	[p12l97t1788r120b1807],
3	al	NNP	O	al	prep_to	1	SENT_216	[p12l129t1786r146b1807],
4	of	IN	O	of	_	0	SENT_216	[p12l155t1786r177b1807],
5	246	CD	NUMBER	246	num	6	SENT_216	[p12l184t1787r228b1807],
6	noncarriers	NNS	O	noncarrier	prep_of	3	SENT_216	[p12l237t1786r364b1807],
7	had	VBD	O	have	_	0	SENT_216	[p12l373t1786r414b1807],
8	baseline	NN	O	baseline	nn	11	SENT_216	[p12l424t1786r517b1807],
9	platelet	NN	O	platelet	nn	11	SENT_216	[p12l526t1786r608b1812],
10	function	NN	O	function	nn	11	SENT_216	[p12l615t1786r706b1807],
11	data	NNS	O	datum	dobj	7	SENT_216	[p12l715t1786r766b1807],
12	and	CC	O	and	_	0	SENT_216	[p12l774t1786r816b1807],
13	were	VBD	O	be	auxpass	14	SENT_216	[p12l824t1792r880b1807],
14	entered	VBN	O	enter	conj_and	7	SENT_216	[p12l888t1786r975b1807],
15	into	IN	O	into	_	0	SENT_216	[p12l984t1786r1025b1807],
16	the	DT	O	the	det	17	SENT_216	[p12l1032t1786r1068b1807],
17	model	NN	O	model	prep_into	14	SENT_216	[p12l1077t1786r1153b1810],
18	;	:	O	;	_	0	SENT_216	[p12l1077t1786r1153b1810],
19	237	CD	NUMBER	237	nsubj	21	SENT_216	[p12l1163t1787r1206b1807],
20	also	RB	O	also	advmod	21	SENT_216	[p12l1215t1786r1260b1807],
21	had	VBD	O	have	parataxis	7	SENT_216	[p12l1269t1786r1311b1807],
22	21	CD	NUMBER	21	dobj	21	SENT_216	[p12l1321t1787r1351b1806],
23	follow	VBP	O	follow	rcmod	22	SENT_216	[p12l1363t1786r1470b1812],
24	—	CD	NUMBER	—	dobj	23	SENT_216	[p12l1363t1786r1470b1812],
25	up	IN	O	up	_	0	SENT_216	[p12l1363t1786r1470b1812],
26	platelet	NN	O	platelet	nn	28	SENT_216	[p12l1479t1786r1560b1812],
27	function	NN	O	function	nn	28	SENT_216	[p12l1568t1786r1659b1807],
28	value	NN	O	value	prep_up	23	SENT_216	[p12l1667t1786r1732b1807],
29	.	.	O	.	_	0	SENT_216	[p12l1667t1786r1732b1807],

1	A	DT	O	a	det	2	SENT_217	[p12l1742t1786r1759b1806],
2	total	NN	O	total	nsubj	10	SENT_217	[p12l1766t1786r1814b1807],
3	of	IN	O	of	_	0	SENT_217	[p12l1823t1786r1845b1807],
4	80	CD	NUMBER	80	num	5	SENT_217	[p12l1852t1787r1881b1807],
5	heterozygotes	NNS	O	heterozygote	prep_of	2	SENT_217	[p12l1890t1786r2052b1812],
6	and	CC	O	and	_	0	SENT_217	[p12l2060t1786r2102b1807],
7	6	CD	NUMBER	6	num	9	SENT_217	[p12l85t1816r99b1836],
8	homozygo	NN	O	homozygo	nn	9	SENT_217	[p12l108t1816r228b1841],
9	es	NNS	O	e	conj_and	5	SENT_217	[p12l238t1821r263b1836],
10	had	VBD	O	have	_	0	SENT_217	[p12l272t1816r314b1836],
11	baseline	NN	O	baseline	nn	14	SENT_217	[p12l324t1816r417b1836],
12	platelet	NN	O	platelet	nn	14	SENT_217	[p12l426t1816r508b1841],
13	function	NN	O	function	nn	14	SENT_217	[p12l516t1816r607b1836],
14	data	NNS	O	datum	dobj	10	SENT_217	[p12l616t1816r667b1836],
15	and	CC	O	and	_	0	SENT_217	[p12l675t1816r717b1836],
16	were	VBD	O	be	auxpass	17	SENT_217	[p12l726t1821r782b1836],
17	entered	VBN	O	enter	conj_and	10	SENT_217	[p12l790t1816r877b1836],
18	into	IN	O	into	_	0	SENT_217	[p12l887t1816r927b1836],
19	the	DT	O	the	det	20	SENT_217	[p12l935t1816r971b1836],
20	model	NN	O	model	prep_into	17	SENT_217	[p12l980t1816r1056b1839],
21	;	:	O	;	_	0	SENT_217	[p12l980t1816r1056b1839],
22	77	CD	NUMBER	77	num	23	SENT_217	[p12l1067t1816r1095b1836],
23	heterozygotes	NNS	O	heterozygote	nsubj	28	SENT_217	[p12l1104t1816r1267b1841],
24	and	CC	O	and	_	0	SENT_217	[p12l1275t1816r1317b1836],
25	5	CD	NUMBER	5	num	26	SENT_217	[p12l1327t1816r1340b1836],
26	homozygotes	NNS	O	homozygote	conj_and	23	SENT_217	[p12l1349t1816r1505b1841],
27	also	RB	O	also	advmod	28	SENT_217	[p12l1513t1816r1559b1836],
28	had	VBD	O	have	parataxis	10	SENT_217	[p12l1568t1816r1610b1836],
29	at	IN	O	at	quantmod	31	SENT_217	[p12l1619t1817r1640b1836],
30	least	JJS	O	least	mwe	29	SENT_217	[p12l1649t1816r1701b1836],
31	1	CD	NUMBER	1	dobj	28	SENT_217	[p12l1711t1816r1718b1836],
32	follow-up	NN	O	follow-up	nn	35	SENT_217	[p12l1731t1816r1837b1841],
33	platelet	NN	O	platelet	nn	35	SENT_217	[p12l1847t1816r1928b1841],
34	function	NN	O	function	nn	35	SENT_217	[p12l1936t1816r2028b1836],
35	value	NN	O	value	dep	31	SENT_217	[p12l2036t1816r2101b1836],
36	.	.	O	.	_	0	SENT_217	[p12l2036t1816r2101b1836],

1	75-mg	JJ	O	75-mg	amod	2	SENT_218	[p12l14t2097r357b2223],
2	dose	NN	O	dose	_	0	SENT_218	[p12l383t2090r625b2190],
3	of	IN	O	of	_	0	SENT_218	[p12l654t2089r764b2190],
4	Clopidogrel	NNP	O	Clopidogrel	prep_of	2	SENT_218	[p12l782t2090r1407b2223],
5	.	.	O	.	_	0	SENT_218	[p12l782t2090r1407b2223],

1	Higher	JJR	O	higher	amod	3	SENT_219	[p12l1441t2090r1810b2223],
2	maintenance	NN	O	maintenance	nn	3	SENT_219	[p12l1835t2100r2147b2190, p12l11t2273r512b2349],
3	doses	NNS	O	dose	nsubj	12	SENT_219	[p12l586t2248r937b2349],
4	of	IN	O	of	_	0	SENT_219	[p12l1013t2248r1139b2349],
5	clopidogrel	NN	O	clopidogrel	prep_of	3	SENT_219	[p12l1205t2248r1956b2380],
6	in	IN	O	in	_	0	SENT_219	[p12l2027t2259r2149b2346],
7	CYP2C19	NN	O	cyp2c19	nn	8	SENT_219	[p12l12t2401r654b2507],
8	*	NN	O	*	prep_in	5	SENT_219	[p12l12t2401r654b2507],
9	2	CD	NUMBER	2	num	10	SENT_219	[p12l12t2401r654b2507],
10	heterozygotes	NNS	O	heterozygote	npadvmod	11	SENT_219	[p12l692t2406r1447b2538],
11	significantly	RB	O	significantly	advmod	12	SENT_219	[p12l1481t2405r2151b2538],
12	reduced	VBD	O	reduce	_	0	SENT_219	[p12l8t2564r504b2664],
13	the	DT	O	the	det	14	SENT_219	[p12l569t2564r755b2664],
14	proportion	NN	O	proportion	dobj	12	SENT_219	[p12l818t2574r1498b2695],
15	of	IN	O	of	_	0	SENT_219	[p12l1562t2563r1683b2664],
16	nonresponders	NNS	O	nonresponder	prep_of	14	SENT_219	[p12l1737t2601r2146b2664, p12l9t2722r502b2854],
17	to	TO	O	to	_	0	SENT_219	[p12l543t2747r644b2821],
18	10	CD	PERCENT	10	num	19	SENT_219	[p12l697t2725r920b2826],
19	%	NN	PERCENT	%	prep_to	12	SENT_219	[p12l697t2725r920b2826],
20	with	IN	O	with	prep	19	SENT_219	[p12l957t2722r1207b2823],
21	225	CD	NUMBER	225	num	22	SENT_219	[p12l1246t2729r1443b2823],
22	mg	NN	O	mg	dep	20	SENT_219	[p12l1486t2758r1658b2854],
23	daily	JJ	SET	daily	amod	24	SENT_219	[p12l1696t2722r1960b2854],
24	(	NN	O	(	dep	22	SENT_219	[p12l2003t2722r2154b2838],
25	8	CD	NUMBER	8	num	24	SENT_219	[p12l2003t2722r2154b2838],
26	/	:	O	/	punct	22	SENT_219	[p12l2003t2722r2154b2838],
27	75	CD	NUMBER	75	dep	22	SENT_219	[p12l14t2887r175b3000],
28	,	,	O	,	_	0	SENT_219	[p12l14t2887r175b3000],
29	P	NN	O	p	dep	30	SENT_219	[p12l226t2890r413b2978],
30	<	JJR	O	<	appos	27	SENT_219	[p12l226t2890r413b2978],
31	.001	CD	NUMBER	.001	num	32	SENT_219	[p12l447t2879r724b2995],
32	)	NN	O	)	dep	30	SENT_219	[p12l447t2879r724b2995],
33	and	CC	O	and	_	0	SENT_219	[p12l781t2880r985b2980],
34	300	CD	NUMBER	300	num	35	SENT_219	[p12l1031t2887r1235b2980],
35	mg	NN	O	mg	dep	22	SENT_219	[p12l1284t2915r1458b3013],
36	daily	JJ	SET	daily	amod	37	SENT_219	[p12l1506t2880r1774b3012],
37	(	NN	O	(	dep	35	SENT_219	[p12l1826t2879r2143b3000],
38	7/73	CD	NUMBER	7/73	num	37	SENT_219	[p12l1826t2879r2143b3000],
39	,	,	O	,	_	0	SENT_219	[p12l1826t2879r2143b3000],
40	P	NN	O	p	dep	45	SENT_219	[p12l7t3050r78b3138],
41	<	JJR	O	<	dep	40	SENT_219	[p12l100t3055r193b3133],
42	.001	CD	NUMBER	.001	num	43	SENT_219	[p12l226t3040r493b3156],
43	)	NN	O	)	dep	45	SENT_219	[p12l226t3040r493b3156],
44	(	CD	NUMBER	(	num	45	SENT_219	[p12l538t3040r969b3156],
45	FIGURE	NN	O	figure	dep	19	SENT_219	[p12l538t3040r969b3156],
46	3	CD	NUMBER	3	num	47	SENT_219	[p12l999t3040r1142b3156],
47	)	NN	O	)	dep	45	SENT_219	[p12l999t3040r1142b3156],
48	.	.	O	.	_	0	SENT_219	[p12l999t3040r1142b3156],

1	The	DT	O	the	det	3	SENT_220	[p12l1180t3040r1392b3141],
2	risk	NN	O	risk	nn	3	SENT_220	[p12l1423t3041r1632b3141],
3	ratios	NNS	O	ratio	nsubj	10	SENT_220	[p12l1658t3051r1964b3141],
4	for	IN	O	for	_	0	SENT_220	[p12l1997t3040r2151b3141],
5	nonresponder	JJ	O	nonresponder	amod	6	SENT_220	[p12l8t3199r768b3330],
6	status	NN	O	status	prep_for	3	SENT_220	[p12l793t3224r1101b3299],
7	were	VBD	O	be	cop	10	SENT_220	[p12l1127t3235r1387b3299],
8	0.5	CD	NUMBER	0.5	number	9	SENT_220	[p12l1415t3206r1574b3300],
9	1	CD	NUMBER	1	num	10	SENT_220	[p12l1593t3206r1638b3297],
10	(	NN	O	(	_	0	SENT_220	[p12l1683t3199r1957b3315],
11	95	CD	PERCENT	95	number	12	SENT_220	[p12l1683t3199r1957b3315],
12	%	NN	PERCENT	%	amod	10	SENT_220	[p12l1683t3199r1957b3315],
13	CI	NN	O	ci	dep	39	SENT_220	[p12l1992t3206r2146b3319],
14	,	,	O	,	_	0	SENT_220	[p12l1992t3206r2146b3319],
15	0.37-0	CD	NUMBER	0.37-0	num	17	SENT_220	[p12l11t3356r633b3477],
16	.69	CD	NUMBER	.69	num	17	SENT_220	[p12l11t3356r633b3477],
17	)	NN	O	)	appos	13	SENT_220	[p12l11t3356r633b3477],
18	,	,	O	,	_	0	SENT_220	[p12l11t3356r633b3477],
19	0.21	CD	PERCENT	0.21	num	23	SENT_220	[p12l682t3364r915b3457],
20	(	CD	PERCENT	(	number	21	SENT_220	[p12l976t3356r1260b3472],
21	95	CD	PERCENT	95	dep	22	SENT_220	[p12l976t3356r1260b3472],
22	%	NN	PERCENT	%	dep	23	SENT_220	[p12l976t3356r1260b3472],
23	CI	NN	O	ci	appos	13	SENT_220	[p12l1312t3364r1471b3477],
24	,	,	O	,	_	0	SENT_220	[p12l1312t3364r1471b3477],
25	0.11-0	CD	NUMBER	0.11-0	number	26	SENT_220	[p12l1521t3356r2144b3477],
26	.39	CD	NUMBER	.39	num	27	SENT_220	[p12l1521t3356r2144b3477],
27	)	NN	O	)	conj_and	23	SENT_220	[p12l1521t3356r2144b3477],
28	,	,	O	,	_	0	SENT_220	[p12l1521t3356r2144b3477],
29	and	CC	O	and	_	0	SENT_220	[p12l9t3517r213b3618],
30	0.20	CD	PERCENT	0.20	num	34	SENT_220	[p12l242t3525r477b3618],
31	(	CD	PERCENT	(	number	32	SENT_220	[p12l517t3517r797b3633],
32	95	CD	PERCENT	95	dep	33	SENT_220	[p12l517t3517r797b3633],
33	%	NN	PERCENT	%	dep	34	SENT_220	[p12l517t3517r797b3633],
34	CI	NN	O	ci	appos	13	SENT_220	[p12l836t3525r992b3638],
35	,	,	O	,	_	0	SENT_220	[p12l836t3525r992b3638],
36	0.1	CD	NUMBER	0.1	appos	13	SENT_220	[p12l1027t3525r1185b3618],
37	1-0	CD	NUMBER	1-0	dep	39	SENT_220	[p12l1210t3517r1595b3633],
38	.38	CD	NUMBER	.38	num	39	SENT_220	[p12l1210t3517r1595b3633],
39	)	NN	O	)	dep	10	SENT_220	[p12l1210t3517r1595b3633],
40	with	IN	O	with	_	0	SENT_220	[p12l1631t3517r1881b3618],
41	150	CD	NUMBER	150	prep_with	39	SENT_220	[p12l1921t3525r2144b3638],
42	,	,	O	,	_	0	SENT_220	[p12l1921t3525r2144b3638],
43	225	CD	NUMBER	225	conj_and	41	SENT_220	[p12l11t3682r248b3795],
44	,	,	O	,	_	0	SENT_220	[p12l11t3682r248b3795],
45	and	CC	NUMBER	and	_	0	SENT_220	[p12l297t3676r502b3775],
46	300	CD	NUMBER	300	num	48	SENT_220	[p12l545t3682r750b3775],
47	mg	NN	O	mg	nn	48	SENT_220	[p12l795t3712r969b3808],
48	daily	NN	SET	daily	conj_and	41	SENT_220	[p12l1013t3676r1284b3808],
49	of	IN	O	of	_	0	SENT_220	[p12l1327t3674r1441b3775],
50	clopidogrel	NN	O	clopidogrel	prep_of	48	SENT_220	[p12l1477t3676r2144b3808],
51	,	,	O	,	_	0	SENT_220	[p12l1477t3676r2144b3808],

1	respectively	RB	O	respectively	_	0	SENT_221	[p13l8t23r705b154],
2	.	.	O	.	_	0	SENT_221	[p13l8t23r705b154],

1	Among	IN	O	among	_	0	SENT_222	[p13l757t29r1170b154],
2	the	DT	O	the	det	3	SENT_222	[p13l1218t23r1390b123],
3	CYP2C19	NN	O	cyp2c19	pobj	1	SENT_222	[p13l1440t18r2146b123, p13l9t181r736b313],
4	*	CD	NUMBER	*	num	6	SENT_222	[p13l1440t18r2146b123, p13l9t181r736b313],
5	2heterozygote	JJ	O	2heterozygote	amod	6	SENT_222	[p13l1440t18r2146b123, p13l9t181r736b313],
6	nonresponders	NNS	O	nonresponder	dep	3	SENT_222	[p13l781t181r1625b313],
7	to	TO	O	to	_	0	SENT_222	[p13l1674t206r1777b280],
8	clopidogrel	NN	O	clopidogrel	prep_to	6	SENT_222	[p13l1828t181r2147b313, p13l11t387r395b519],
9	,	,	O	,	_	0	SENT_222	[p13l1828t181r2147b313, p13l11t387r395b519],

1	75	CD	NUMBER	75	num	2	SENT_223	[p13l456t394r582b488],
2	mg	NN	O	mg	nsubj	13	SENT_223	[p13l637t422r841b519],
3	,	,	O	,	_	0	SENT_223	[p13l637t422r841b519],
4	daily	RB	SET	daily	advmod	13	SENT_223	[p13l897t387r1198b518],
5	,	,	O	,	_	0	SENT_223	[p13l897t387r1198b518],
6	the	DT	O	the	det	7	SENT_223	[p13l1256t387r1428b486],
7	proportions	NNS	O	proportion	nsubj	13	SENT_223	[p13l1478t397r2146b518],
8	who	WP	O	who	nsubj	10	SENT_223	[p13l6t544r244b645],
9	became	VBD	O	become	cop	10	SENT_223	[p13l275t544r692b645],
10	responders	NNS	O	responder	rcmod	7	SENT_223	[p13l722t544r1331b676],
11	were	VBD	O	be	cop	13	SENT_223	[p13l1359t580r1625b645],
12	49	CD	PERCENT	49	num	13	SENT_223	[p13l1654t549r1891b648],
13	%	NN	PERCENT	%	_	0	SENT_223	[p13l1654t549r1891b648],
14	(	CD	NUMBER	(	number	15	SENT_223	[p13l1932t544r2154b660],
15	18	CD	NUMBER	18	num	13	SENT_223	[p13l1932t544r2154b660],
16	/	:	O	/	punct	18	SENT_223	[p13l1932t544r2154b660],
17	37	CD	NUMBER	37	num	18	SENT_223	[p13l9t701r239b820],
18	)	CD	NUMBER	)	dep	13	SENT_223	[p13l9t701r239b820],
19	,	,	O	,	_	0	SENT_223	[p13l9t701r239b820],
20	79	CD	PERCENT	79	num	21	SENT_223	[p13l305t704r543b804],
21	%	NN	PERCENT	%	dep	13	SENT_223	[p13l305t704r543b804],
22	(	CD	NUMBER	(	number	23	SENT_223	[p13l610t701r1076b820],
23	31/39	CD	NUMBER	31/39	num	24	SENT_223	[p13l610t701r1076b820],
24	)	NN	O	)	dep	21	SENT_223	[p13l610t701r1076b820],
25	,	,	O	,	_	0	SENT_223	[p13l610t701r1076b820],
26	and	CC	O	and	_	0	SENT_223	[p13l1138t701r1349b800],
27	81	CD	PERCENT	81	num	28	SENT_223	[p13l1405t704r1648b804],
28	%	NN	PERCENT	%	conj_and	18	SENT_223	[p13l1405t704r1648b804],
29	(	CD	NUMBER	(	number	30	SENT_223	[p13l1714t701r2139b815],
30	30/37	CD	NUMBER	30/37	num	31	SENT_223	[p13l1714t701r2139b815],
31	)	NN	O	)	dep	28	SENT_223	[p13l1714t701r2139b815],
32	when	WRB	O	when	advmod	33	SENT_223	[p13l6t862r317b962],
33	treated	VBN	O	treat	dep	13	SENT_223	[p13l370t862r788b981],
34	,	,	O	,	_	0	SENT_223	[p13l370t862r788b981],
35	respectively	RB	O	respectively	dep	33	SENT_223	[p13l843t862r1546b993],
36	,	,	O	,	_	0	SENT_223	[p13l843t862r1546b993],
37	with	IN	O	with	_	0	SENT_223	[p13l1598t862r1853b962],
38	150	CD	NUMBER	150	prep_with	33	SENT_223	[p13l1915t868r2144b982],
39	,	,	O	,	_	0	SENT_223	[p13l1915t868r2144b982],
40	225	CD	NUMBER	225	prep_with	33	SENT_223	[p13l11t1027r248b1139],
41	,	,	O	,	_	0	SENT_223	[p13l11t1027r248b1139],
42	and	CC	NUMBER	and	_	0	SENT_223	[p13l297t1020r502b1119],
43	300	CD	NUMBER	300	num	45	SENT_223	[p13l545t1027r750b1121],
44	mg	NN	O	mg	nn	45	SENT_223	[p13l795t1056r969b1152],
45	daily	NN	SET	daily	prep_with	33	SENT_223	[p13l1013t1020r1284b1152],
46	of	IN	O	of	_	0	SENT_223	[p13l1327t1020r1441b1119],
47	clopidogrel	NN	O	clopidogrel	prep_of	45	SENT_223	[p13l1477t1020r2139b1152],
48	.	.	O	.	_	0	SENT_223	[p13l1477t1020r2139b1152],

1	Similar	JJ	O	similar	amod	2	SENT_224	[p13l9t1179r408b1280],
2	results	NNS	O	result	nsubjpass	4	SENT_224	[p13l457t1179r828b1279],
3	were	VBD	O	be	auxpass	4	SENT_224	[p13l876t1215r1145b1280],
4	obtained	VBN	O	obtain	_	0	SENT_224	[p13l1198t1179r1686b1279],
5	when	WRB	O	when	advmod	18	SENT_224	[p13l1732t1179r2044b1280],
6	a	DT	O	a	det	8	SENT_224	[p13l2094t1215r2148b1279],
7	cut	NN	O	cut	nn	8	SENT_224	[p13l11t1361r180b1437],
8	point	NN	O	point	nsubjpass	18	SENT_224	[p13l203t1347r493b1468],
9	for	IN	O	for	_	0	SENT_224	[p13l519t1336r669b1437],
10	nonresponder	JJ	O	nonresponder	amod	11	SENT_224	[p13l694t1337r1455b1468],
11	status	NN	O	status	prep_for	8	SENT_224	[p13l1481t1361r1790b1437],
12	of	IN	O	of	_	0	SENT_224	[p13l1820t1336r1931b1437],
13	208	CD	NUMBER	208	num	14	SENT_224	[p13l1950t1344r2148b1437],
14	PRU	NN	O	pru	prep_of	11	SENT_224	[p13l11t1505r259b1596],
15	or	CC	O	or	_	0	SENT_224	[p13l317t1531r433b1594],
16	greater	JJR	O	greater	conj_or	14	SENT_224	[p13l484t1520r879b1627],
17	was	VBD	O	be	auxpass	18	SENT_224	[p13l927t1531r1139b1596],
18	used	VBN	O	use	advcl	4	SENT_224	[p13l1191t1495r1455b1594],
19	(	CD	NUMBER	(	num	20	SENT_224	[p13l1514t1495r1992b1627],
20	eFigure	NN	O	efigure	dobj	18	SENT_224	[p13l1514t1495r1992b1627],
21	1	CD	NUMBER	1	dep	20	SENT_224	[p13l2056t1503r2143b1614],
22	,	,	O	,	_	0	SENT_224	[p13l2056t1503r2143b1614],
23	available	JJ	O	available	amod	20	SENT_224	[p13l9t1653r499b1753],
24	at	IN	O	at	_	0	SENT_224	[p13l542t1678r641b1753],
25	http://wWw.jama.com	NNP	O	http://wWw.jama.com	prep_at	23	SENT_224	[p13l680t1652r1990b1786],
26	)	CD	NUMBER	)	num	25	SENT_224	[p13l680t1652r1990b1786],
27	.	.	O	.	_	0	SENT_224	[p13l680t1652r1990b1786],

1	When	WRB	O	when	advmod	2	SENT_225	[p13l142t1813r481b1913],
2	evaluating	VBG	O	evaluate	advcl	10	SENT_225	[p13l510t1813r1069b1944],
3	the	DT	O	the	det	4	SENT_225	[p13l1097t1812r1264b1913],
4	CYP2C19	NN	O	cyp2c19	dobj	2	SENT_225	[p13l1296t1807r1934b1913],
5	*	NN	O	*	dep	2	SENT_225	[p13l1296t1807r1934b1913],
6	2	CD	NUMBER	2	num	7	SENT_225	[p13l1296t1807r1934b1913],
7	homozygotes	NNS	O	homozygote	dep	5	SENT_225	[p13l1967t1812r2148b1913, p13l8t1995r640b2102],
8	,	,	O	,	_	0	SENT_225	[p13l1967t1812r2148b1913, p13l8t1995r640b2102],
9	we	PRP	O	we	nsubj	10	SENT_225	[p13l674t2006r831b2069],
10	saw	VBD	O	see	_	0	SENT_225	[p13l864t2006r1074b2069],
11	a	DT	O	a	det	12	SENT_225	[p13l1104t2006r1159b2069],
12	trend	NN	O	trend	dobj	10	SENT_225	[p13l1195t1970r1492b2069],
13	toward	IN	O	toward	_	0	SENT_225	[p13l1526t1970r1918b2069],
14	less	JJR	O	less	amod	16	SENT_225	[p13l1949t1970r2149b2069],
15	platelet	NN	O	platelet	nn	16	SENT_225	[p13l7t2128r426b2259],
16	reactivity	NN	O	reactivity	prep_toward	10	SENT_225	[p13l461t2138r988b2259],
17	with	IN	O	with	_	0	SENT_225	[p13l1021t2128r1276b2228],
18	higher	JJR	O	higher	amod	20	SENT_225	[p13l1314t2128r1679b2259],
19	maintenance	NN	O	maintenance	nn	20	SENT_225	[p13l1716t2138r2147b2228, p13l8t2322r339b2385],
20	doses	NNS	O	dose	prep_with	10	SENT_225	[p13l391t2286r697b2385],
21	of	IN	O	of	_	0	SENT_225	[p13l751t2286r865b2385],
22	clopidogrel	NN	O	clopidogrel	prep_of	20	SENT_225	[p13l907t2286r1575b2418],
23	;	:	O	;	_	0	SENT_225	[p13l907t2286r1575b2418],
24	however	RB	O	however	advmod	36	SENT_225	[p13l1630t2286r2143b2405],
25	,	,	O	,	_	0	SENT_225	[p13l1630t2286r2143b2405],
26	even	RB	O	even	advmod	36	SENT_225	[p13l11t2481r269b2544],
27	with	IN	O	with	_	0	SENT_225	[p13l297t2444r553b2544],
28	300	CD	NUMBER	300	num	30	SENT_225	[p13l585t2451r790b2544],
29	mg	NN	O	mg	nn	30	SENT_225	[p13l826t2479r1000b2577],
30	daily	NN	SET	daily	prep_with	26	SENT_225	[p13l1033t2444r1306b2576],
31	of	IN	O	of	_	0	SENT_225	[p13l1338t2443r1452b2544],
32	clopidogrel	NN	O	clopidogrel	prep_of	30	SENT_225	[p13l1477t2444r2144b2577],
33	,	,	O	,	_	0	SENT_225	[p13l1477t2444r2144b2577],
34	these	DT	O	these	det	35	SENT_225	[p13l11t2603r292b2702],
35	individuals	NNS	O	individual	nsubj	36	SENT_225	[p13l322t2603r934b2702],
36	had	VBD	O	have	parataxis	10	SENT_225	[p13l965t2603r1169b2702],
37	a	DT	O	a	det	40	SENT_225	[p13l1198t2639r1251b2702],
38	mean	JJ	O	mean	amod	40	SENT_225	[p13l1281t2638r1583b2702],
39	VASP	NN	O	vasp	nn	40	SENT_225	[p13l1609t2609r1919b2702],
40	PR1	NN	O	pr1	dobj	36	SENT_225	[p13l1952t2611r2146b2700],

1	of	IN	O	of	_	0	SENT_226	[p13l11t2760r125b2860],
2	68.3	CD	PERCENT	68.3	num	3	SENT_226	[p13l161t2763r504b2864],
3	%	NN	PERCENT	%	pobj	1	SENT_226	[p13l161t2763r504b2864],
4	(	CD	PERCENT	(	num	7	SENT_226	[p13l557t2760r841b2876],
5	95	CD	PERCENT	95	number	6	SENT_226	[p13l557t2760r841b2876],
6	%	NN	PERCENT	%	amod	7	SENT_226	[p13l557t2760r841b2876],
7	CI	NN	O	ci	dep	3	SENT_226	[p13l892t2767r1051b2879],
8	,	,	O	,	_	0	SENT_226	[p13l892t2767r1051b2879],
9	44.9	CD	PERCENT	44.9	num	10	SENT_226	[p13l1097t2760r1891b2876],
10	%	NN	PERCENT	%	conj_and	3	SENT_226	[p13l1097t2760r1891b2876],
11	-91.6	CD	PERCENT	-91.6	num	12	SENT_226	[p13l1097t2760r1891b2876],
12	%	NN	PERCENT	%	dep	10	SENT_226	[p13l1097t2760r1891b2876],
13	)	CD	NUMBER	)	dep	10	SENT_226	[p13l1097t2760r1891b2876],
14	and	CC	O	and	_	0	SENT_226	[p13l1944t2760r2149b2860],
15	VerifyNow	NNP	O	VerifyNow	nn	16	SENT_226	[p13l6t2919r661b3051],
16	PRU	NNP	O	PRU	conj_and	3	SENT_226	[p13l719t2930r975b3020],
17	of	IN	O	of	_	0	SENT_226	[p13l1040t2919r1159b3020],
18	287.0	CD	PERCENT	287.0	number	19	SENT_226	[p13l1211t2927r1539b3021],
19	(	CD	PERCENT	(	amod	22	SENT_226	[p13l1610t2919r1906b3035],
20	95	CD	PERCENT	95	num	21	SENT_226	[p13l1610t2919r1906b3035],
21	%	NN	PERCENT	%	dep	19	SENT_226	[p13l1610t2919r1906b3035],
22	CI	NN	O	ci	prep_of	16	SENT_226	[p13l1975t2927r2143b3040],
23	,	,	O	,	_	0	SENT_226	[p13l1975t2927r2143b3040],

1	170.2-403	CD	NUMBER	170.2-403	num	2	SENT_227	[p14l14t66r397b121],
2	.8	CD	NUMBER	.8	_	0	SENT_227	[p14l14t66r397b121],
3	)	NN	O	)	dep	2	SENT_227	[p14l14t66r397b121],
4	.	.	O	.	_	0	SENT_227	[p14l14t66r397b121],

1	Similarly	RB	O	similarly	advmod	12	SENT_228	[p14l430t66r703b129],
2	,	,	O	,	_	0	SENT_228	[p14l430t66r703b129],
3	the	DT	O	the	det	5	SENT_228	[p14l734t66r821b114],
4	nonresponder	JJ	O	nonresponder	amod	5	SENT_228	[p14l848t83r1038b114, p14l8t142r237b206],
5	rate	NN	O	rate	nsubj	12	SENT_228	[p14l263t154r369b190],
6	(	CD	NUMBER	(	number	7	SENT_228	[p14l400t142r582b198],
7	2230	CD	DATE	2230	dep	5	SENT_228	[p14l400t142r582b198],
8	PRU	NNP	O	PRU	nn	9	SENT_228	[p14l611t142r758b197],
9	)	NN	O	)	dep	5	SENT_228	[p14l611t142r758b197],
10	was	VBD	O	be	cop	12	SENT_228	[p14l788t159r892b190],
11	80	CD	PERCENT	80	num	12	SENT_228	[p14l920t144r1037b192],
12	%	NN	PERCENT	%	_	0	SENT_228	[p14l920t144r1037b192],
13	(	CD	NUMBER	(	number	14	SENT_228	[p14l12t218r136b274],
14	4/5	CD	NUMBER	4/5	num	15	SENT_228	[p14l12t218r136b274],
15	)	NN	O	)	npadvmod	12	SENT_228	[p14l12t218r136b274],
16	with	IN	O	with	_	0	SENT_228	[p14l152t218r272b266],
17	clopidogrel	NN	O	clopidogrel	prep_with	12	SENT_228	[p14l286t218r596b282],
18	,	,	O	,	_	0	SENT_228	[p14l286t218r596b282],
19	75	CD	NUMBER	75	num	20	SENT_228	[p14l615t222r675b267],
20	mg	NN	O	mg	appos	17	SENT_228	[p14l690t235r787b282],
21	,	,	O	,	_	0	SENT_228	[p14l690t235r787b282],
22	daily	JJ	SET	daily	advmod	17	SENT_228	[p14l803t218r930b282],
23	and	CC	O	and	_	0	SENT_228	[p14l943t218r1040b266],
24	remained	VBD	O	remain	cop	31	SENT_228	[p14l8t295r272b343],
25	high	JJ	O	high	amod	31	SENT_228	[p14l298t295r424b358],
26	at	IN	O	at	_	0	SENT_228	[p14l451t306r500b342],
27	60	CD	PERCENT	60	num	28	SENT_228	[p14l527t296r643b344],
28	%	NN	PERCENT	%	prep_at	25	SENT_228	[p14l527t296r643b344],
29	(	CD	NUMBER	(	number	30	SENT_228	[p14l675t294r808b350],
30	3/5	CD	NUMBER	3/5	num	28	SENT_228	[p14l675t294r808b350],
31	)	NN	O	)	conj_and	12	SENT_228	[p14l675t294r808b350],
32	despite	IN	O	despite	_	0	SENT_228	[p14l840t295r1038b358],
33	clopidogrel	NN	O	clopidogrel	prep_despite	31	SENT_228	[p14l9t370r331b434],
34	,	,	O	,	_	0	SENT_228	[p14l9t370r331b434],
35	300	CD	NUMBER	300	num	36	SENT_228	[p14l353t374r452b419],
36	mg	NN	O	mg	appos	33	SENT_228	[p14l473t388r571b434],
37	,	,	O	,	_	0	SENT_228	[p14l473t388r571b434],
38	daily	RB	SET	daily	advmod	31	SENT_228	[p14l594t370r737b434],
39	.	.	O	.	_	0	SENT_228	[p14l594t370r737b434],

1	High-Dose	JJ	O	high-dose	amod	2	SENT_229	[p14l11t506r311b566],
2	Clopidogrel	NNP	O	Clopidogrel	_	0	SENT_229	[p14l334t506r663b566],
3	in	IN	O	in	_	0	SENT_229	[p14l10t584r58b628],
4	CYP2C19	NNP	O	CYP2C19	prep_in	2	SENT_229	[p14l82t583r423b628],
5	*	CD	NUMBER	*	num	4	SENT_229	[p14l82t583r423b628],
6	2	CD	NUMBER	2	num	7	SENT_229	[p14l82t583r423b628],
7	Carriers	NNS	O	carrier	dep	2	SENT_229	[p14l445t584r666b629],
8	vs	CC	O	vs	_	0	SENT_229	[p14l7t672r66b705],
9	Standard-Dose	NNP	O	Standard-Dose	nn	10	SENT_229	[p14l89t659r522b705],
10	Clopidogrel	NNP	O	Clopidogrel	conj_vs	7	SENT_229	[p14l544t659r874b719],
11	in	IN	O	in	_	0	SENT_229	[p14l10t741r58b785],
12	Noncarriers	NNP	O	Noncarriers	prep_in	10	SENT_229	[p14l84t741r414b786],

1	In	IN	O	in	_	0	SENT_230	[p14l9t832r64b875],
2	CYP2C19	NN	O	cyp2c19	nn	3	SENT_230	[p14l78t825r387b876],
3	*	NN	O	*	prep_in	15	SENT_230	[p14l78t825r387b876],
4	2	CD	NUMBER	2	num	5	SENT_230	[p14l78t825r387b876],
5	heterozygotes	NNS	O	heterozygote	dep	3	SENT_230	[p14l403t827r780b891],
6	,	,	O	,	_	0	SENT_230	[p14l403t827r780b891],
7	a	DT	O	a	det	11	SENT_230	[p14l797t845r823b876],
8	150-mg	JJ	O	150-mg	amod	11	SENT_230	[p14l842t831r1040b891],
9	daily	JJ	SET	daily	amod	11	SENT_230	[p14l9t904r140b967],
10	maintenance	NN	O	maintenance	nn	11	SENT_230	[p14l157t909r505b952],
11	dose	NN	O	dose	nsubj	15	SENT_230	[p14l523t904r645b952],
12	of	IN	O	of	_	0	SENT_230	[p14l664t903r719b952],
13	clopidogrel	NN	O	clopidogrel	prep_of	11	SENT_230	[p14l733t904r1039b967],
14	still	RB	O	still	advmod	15	SENT_230	[p14l8t980r108b1028],
15	resulted	VBD	O	result	_	0	SENT_230	[p14l128t980r347b1028],
16	in	IN	O	in	_	0	SENT_230	[p14l367t985r420b1027],
17	platelet	NN	O	platelet	nn	18	SENT_230	[p14l440t980r641b1043],
18	reactivity	NN	O	reactivity	prep_in	15	SENT_230	[p14l661t985r914b1043],
19	that	WDT	O	that	nsubj	20	SENT_230	[p14l935t980r1040b1028],
20	tended	VBD	O	tend	rcmod	18	SENT_230	[p14l10t1056r194b1104],
21	to	TO	O	to	aux	23	SENT_230	[p14l217t1068r267b1104],
22	be	VB	O	be	cop	23	SENT_230	[p14l290t1056r352b1104],
23	higher	JJR	O	higher	xcomp	20	SENT_230	[p14l375t1056r551b1120],
24	than	IN	O	than	_	0	SENT_230	[p14l574t1056r695b1104],
25	that	DT	O	that	prep_than	23	SENT_230	[p14l718t1056r823b1104],
26	seen	VBN	O	see	partmod	25	SENT_230	[p14l845t1073r964b1104],
27	in	IN	O	in	_	0	SENT_230	[p14l986t1061r1039b1103],
28	noncarrier	NN	O	noncarrier	nn	29	SENT_230	[p14l8t1137r293b1180],
29	patients	NNS	O	patient	prep_in	26	SENT_230	[p14l307t1137r521b1196],
30	treated	VBN	O	treat	partmod	29	SENT_230	[p14l539t1132r724b1180],
31	with	IN	O	with	_	0	SENT_230	[p14l737t1132r860b1180],
32	75	CD	NUMBER	75	num	33	SENT_230	[p14l878t1136r938b1181],
33	mg	NN	O	mg	prep_with	30	SENT_230	[p14l956t1149r1040b1196],
34	daily	JJ	SET	daily	advmod	38	SENT_230	[p14l9t1208r153b1272],
35	(	CD	NUMBER	(	num	36	SENT_230	[p14l186t1208r422b1264],
36	FIGURE	NN	O	figure	dep	34	SENT_230	[p14l186t1208r422b1264],
37	4	CD	NUMBER	4	num	38	SENT_230	[p14l453t1208r532b1264],
38	)	NN	O	)	rcmod	33	SENT_230	[p14l453t1208r532b1264],
39	.	.	O	.	_	0	SENT_230	[p14l453t1208r532b1264],

1	In	IN	O	in	_	0	SENT_231	[p14l567t1213r626b1255],
2	contrast	NN	O	contrast	prep_in	8	SENT_231	[p14l657t1220r916b1266],
3	,	,	O	,	_	0	SENT_231	[p14l657t1220r916b1266],
4	the	DT	O	the	det	7	SENT_231	[p14l950t1208r1039b1256],
5	225-mg	JJ	O	225-mg	amod	7	SENT_231	[p14l10t1288r217b1348],
6	daily	JJ	SET	daily	amod	7	SENT_231	[p14l237t1285r369b1348],
7	dose	NN	O	dose	nsubj	8	SENT_231	[p14l388t1285r509b1333],
8	resulted	VBD	O	result	dep	19	SENT_231	[p14l529t1285r748b1333],
9	in	IN	O	in	_	0	SENT_231	[p14l767t1289r820b1332],
10	platelet	NN	O	platelet	nn	11	SENT_231	[p14l839t1285r1040b1348],
11	reactivity	NN	O	reactivity	prep_in	8	SENT_231	[p14l8t1366r262b1425],
12	at	IN	O	at	_	0	SENT_231	[p14l281t1373r329b1409],
13	least	JJS	O	least	prep_at	8	SENT_231	[p14l348t1361r470b1409],
14	as	RB	O	as	advmod	8	SENT_231	[p14l489t1378r541b1409],
15	good	JJ	O	good	prep_at	8	SENT_231	[p14l561t1361r695b1425],
16	as	IN	O	as	_	0	SENT_231	[p14l715t1378r766b1409],
17	what	WP	O	what	prep_as	8	SENT_231	[p14l785t1361r920b1409],
18	was	VBD	O	be	auxpass	19	SENT_231	[p14l937t1378r1038b1409],
19	observed	VBN	O	observe	_	0	SENT_231	[p14l9t1438r247b1486],
20	in	IN	O	in	_	0	SENT_231	[p14l261t1443r313b1485],
21	response	NN	O	response	prep_in	19	SENT_231	[p14l327t1455r561b1501],
22	to	TO	O	to	_	0	SENT_231	[p14l577t1450r626b1486],
23	standard	JJ	O	standard	amod	25	SENT_231	[p14l642t1438r874b1486],
24	clopidogrel	NN	O	clopidogrel	nn	25	SENT_231	[p14l889t1438r1039b1501, p14l9t1514r184b1577],
25	dosing	NN	O	dosing	prep_to	19	SENT_231	[p14l211t1514r395b1577],
26	in	IN	O	in	_	0	SENT_231	[p14l420t1519r474b1561],
27	noncarrier	JJ	O	noncarrier	amod	28	SENT_231	[p14l499t1519r793b1562],
28	patients	NNS	O	patient	prep_in	25	SENT_231	[p14l818t1519r1038b1577],
29	(	IN	O	(	_	0	SENT_231	[p14l12t1590r177b1646],
30	mean	JJ	O	mean	amod	31	SENT_231	[p14l12t1590r177b1646],
31	ratios	NNS	O	ratio	prep_(	19	SENT_231	[p14l190t1595r335b1638],
32	of	IN	O	of	_	0	SENT_231	[p14l350t1590r404b1638],
33	platelet	NN	O	platelet	nn	34	SENT_231	[p14l412t1590r606b1654],
34	reactivity	NN	O	reactivity	prep_of	31	SENT_231	[p14l618t1595r875b1654],
35	,	,	O	,	_	0	SENT_231	[p14l618t1595r875b1654],
36	VASP	NN	ORGANIZATION	vasp	nn	37	SENT_231	[p14l889t1593r1038b1639],
37	PR1	NN	O	pr1	appos	34	SENT_231	[p14l9t1670r118b1724],
38	,	,	O	,	_	0	SENT_231	[p14l9t1670r118b1724],
39	0.92	CD	NUMBER	0.92	appos	37	SENT_231	[p14l135t1669r264b1724],
40	;	:	O	;	_	0	SENT_231	[p14l135t1669r264b1724],
41	90	CD	PERCENT	90	number	42	SENT_231	[p14l282t1667r394b1716],
42	%	NN	PERCENT	%	amod	43	SENT_231	[p14l282t1667r394b1716],
43	CI	NN	O	ci	dep	37	SENT_231	[p14l413t1669r489b1724],
44	,	,	O	,	_	0	SENT_231	[p14l413t1669r489b1724],
45	0.85-0	CD	NUMBER	0.85-0	number	46	SENT_231	[p14l506t1669r774b1724],
46	.99	CD	NUMBER	.99	appos	43	SENT_231	[p14l506t1669r774b1724],
47	,	,	O	,	_	0	SENT_231	[p14l506t1669r774b1724],
48	and	CC	O	and	_	0	SENT_231	[p14l791t1666r889b1714],
49	PRU	NNP	ORGANIZATION	PRU	appos	43	SENT_231	[p14l903t1670r1037b1724],
50	,	,	O	,	_	0	SENT_231	[p14l903t1670r1037b1724],
51	0.94	CD	NUMBER	0.94	appos	49	SENT_231	[p14l9t1745r141b1799],
52	;	:	O	;	_	0	SENT_231	[p14l9t1745r141b1799],
53	90	CD	PERCENT	90	number	54	SENT_231	[p14l165t1743r279b1792],
54	%	NN	PERCENT	%	amod	55	SENT_231	[p14l165t1743r279b1792],
55	CI	NN	O	ci	dep	37	SENT_231	[p14l305t1745r381b1799],
56	,	,	O	,	_	0	SENT_231	[p14l305t1745r381b1799],
57	0.84-1	CD	NUMBER	0.84-1	num	59	SENT_231	[p14l406t1741r686b1797],
58	.04	CD	NUMBER	.04	num	59	SENT_231	[p14l406t1741r686b1797],
59	)	NN	O	)	appos	55	SENT_231	[p14l406t1741r686b1797],
60	(	CD	NUMBER	(	num	63	SENT_231	[p14l716t1741r943b1805],
61	eFigure	NN	O	efigure	nn	63	SENT_231	[p14l716t1741r943b1805],
62	2	CD	NUMBER	2	num	63	SENT_231	[p14l966t1741r1035b1797],
63	)	NN	O	)	nsubjpass	19	SENT_231	[p14l966t1741r1035b1797],
64	.	.	O	.	_	0	SENT_231	[p14l966t1741r1035b1797],

1	A	DT	O	a	det	4	SENT_232	[p14l7t1820r49b1864],
2	300-mg	JJ	O	300-mg	amod	4	SENT_232	[p14l65t1820r274b1881],
3	daily	JJ	SET	daily	amod	4	SENT_232	[p14l290t1817r421b1881],
4	dose	NN	O	dose	nsubj	7	SENT_232	[p14l437t1817r558b1865],
5	of	IN	O	of	_	0	SENT_232	[p14l576t1816r631b1865],
6	clopidogrel	NN	O	clopidogrel	prep_of	4	SENT_232	[p14l643t1817r950b1881],
7	resulted	VBD	O	result	_	0	SENT_232	[p14l965t1834r1038b1865, p14l8t1893r173b1941],
8	in	IN	O	in	_	0	SENT_232	[p14l191t1898r244b1940],
9	superior	JJ	O	superior	amod	10	SENT_232	[p14l262t1898r489b1956],
10	reductions	NNS	O	reduction	prep_in	7	SENT_232	[p14l507t1893r796b1941],
11	in	IN	O	in	_	0	SENT_232	[p14l815t1898r868b1940],
12	platelet	NN	O	platelet	nn	13	SENT_232	[p14l885t1893r1038b1956, p14l8t1968r76b2016],
13	reactivity	NN	O	reactivity	prep_in	10	SENT_232	[p14l100t1973r358b2032],
14	as	IN	O	as	prep	7	SENT_232	[p14l382t1986r434b2016],
15	compared	VBN	O	compare	_	0	SENT_232	[p14l461t1968r733b2032],
16	with	IN	O	with	prepc_compared_with	7	SENT_232	[p14l756t1968r880b2016],
17	standard	JJ	O	standard	amod	20	SENT_232	[p14l905t1980r1038b2016, p14l9t2045r141b2093],
18	75-mg	JJ	O	75-mg	amod	20	SENT_232	[p14l173t2048r358b2109],
19	clopidogrel	NN	O	clopidogrel	nn	20	SENT_232	[p14l388t2045r727b2109],
20	dosing	NN	O	dosing	pobj	7	SENT_232	[p14l757t2045r953b2109],
21	in	IN	O	in	_	0	SENT_232	[p14l983t2050r1039b2092],
22	noncarrier	NN	O	noncarrier	nn	23	SENT_232	[p14l8t2127r294b2170],
23	patients	NNS	O	patient	prep_in	20	SENT_232	[p14l316t2127r531b2185],
24	as	IN	O	as	prep	23	SENT_232	[p14l555t2139r606b2170],
25	measured	VBN	O	measure	dep	24	SENT_232	[p14l630t2122r893b2170],
26	both	CC	O	both	dep	25	SENT_232	[p14l914t2122r1040b2170],
27	by	IN	O	by	_	0	SENT_232	[p14l7t2197r74b2261],
28	VASP	NN	ORGANIZATION	vasp	nn	29	SENT_232	[p14l98t2200r252b2246],
29	PR1	NN	O	pr1	prep_by	25	SENT_232	[p14l280t2202r377b2244],
30	and	CC	O	and	_	0	SENT_232	[p14l405t2197r506b2245],
31	PRU	NNP	O	PRU	nn	33	SENT_232	[p14l533t2202r654b2246],
32	(	CD	NUMBER	(	num	33	SENT_232	[p14l685t2197r800b2253],
33	P	NN	O	p	prep_by	25	SENT_232	[p14l685t2197r800b2253],
34	<	JJR	O	<	amod	35	SENT_232	[p14l685t2197r800b2253],
35	.001	CD	NUMBER	.001	dobj	25	SENT_232	[p14l818t2201r930b2246],
36	for	IN	O	for	prep	35	SENT_232	[p14l962t2197r1039b2245],
37	both	CC	O	both	dep	25	SENT_232	[p14l7t2272r171b2327],
38	)	RB	O	)	conj	25	SENT_232	[p14l7t2272r171b2327],
39	.	.	O	.	_	0	SENT_232	[p14l7t2272r171b2327],

1	For	IN	O	for	_	0	SENT_233	[p14l199t2277r293b2320],
2	CYP2Cl9	NN	O	cyp2cl9	nn	3	SENT_233	[p14l318t2270r636b2321],
3	*	NN	O	*	pobj	1	SENT_233	[p14l318t2270r636b2321],
4	2	CD	NUMBER	2	num	5	SENT_233	[p14l318t2270r636b2321],
5	homozygotes	NNS	O	homozygote	dep	3	SENT_233	[p14l661t2272r1037b2336],
6	,	,	O	,	_	0	SENT_233	[p14l661t2272r1037b2336],

1	©	RB	O	©	advmod	2	SENT_234	[p14l195t2376r291b2399],
2	2011	CD	DATE	2011	_	0	SENT_234	[p14l195t2376r291b2399],
3	American	NNP	ORGANIZATION	American	nn	5	SENT_234	[p14l302t2377r442b2399],
4	Medical	NNP	ORGANIZATION	Medical	nn	5	SENT_234	[p14l451t2375r567b2399],
5	Association	NNP	ORGANIZATION	Association	dep	2	SENT_234	[p14l574t2377r753b2399],
6	.	.	O	.	_	0	SENT_234	[p14l574t2377r753b2399],

1	All	DT	O	all	det	2	SENT_235	[p14l763t2375r805b2399],
2	rights	NNS	O	rights	nsubj	3	SENT_235	[p14l814t2375r898b2407],
3	reserved	VBN	O	reserve	_	0	SENT_235	[p14l907t2375r1037b2399],
4	.	.	O	.	_	0	SENT_235	[p14l907t2375r1037b2399],

1	Figure	NNP	O	Figure	_	0	SENT_236	[p14l1123t114r1282b167],
2	3	CD	NUMBER	3	dep	1	SENT_236	[p14l1302t115r1347b154],
3	.	.	O	.	_	0	SENT_236	[p14l1302t115r1347b154],

1	Clopidogrel	NNP	O	Clopidogrel	nn	2	SENT_237	[p14l1368t113r1624b167],
2	Nonresponders	NNPS	O	Nonresponders	_	0	SENT_237	[p14l1648t113r1986b167],
3	Among	IN	O	among	dep	2	SENT_237	[p14l1120t176r1287b225],
4	C	NNP	O	C	nn	6	SENT_237	[p14l1305t175r1337b214],
5	YP2C79	NNP	O	YP2C79	nn	6	SENT_237	[p14l1343t173r1576b214],
6	*	NN	O	*	pobj	3	SENT_237	[p14l1343t173r1576b214],
7	2	CD	NUMBER	2	num	8	SENT_237	[p14l1343t173r1576b214],
8	Heterozygotes	NNS	O	heterozygote	dep	6	SENT_237	[p14l1598t176r1922b225],
9	Across	IN	O	across	dep	2	SENT_237	[p14l1939t176r2084b214],
10	Daily	NNP	SET	Daily	nn	11	SENT_237	[p14l1124t232r1233b285],
11	Doses	NNP	O	Doses	pobj	9	SENT_237	[p14l1253t235r1383b273],
12	of	IN	O	of	_	0	SENT_237	[p14l1401t232r1446b273],
13	Clopidogrel	NNP	O	Clopidogrel	prep_of	11	SENT_237	[p14l1463t232r1720b286],

1	60	CD	NUMBER	60	_	0	SENT_238	[p14l1205t360r1267b389],
2	-	:	O	-	_	0	SENT_238	[p14l1205t360r1267b389],
3	P	NN	O	p	dep	1	SENT_238	[p14l1474t360r1594b389],
4	<	JJR	O	<	dep	3	SENT_238	[p14l1474t360r1594b389],
5	.	.	O	.	_	0	SENT_238	[p14l1474t360r1594b389],

1	OO	NN	O	oo	_	0	SENT_239	[p14l1474t360r1594b389],
2	‘	CD	NUMBER	‘	num	3	SENT_239	[p14l1474t360r1594b389],
3	|	NN	O	|	dep	1	SENT_239	[p14l1474t360r1594b389],

1	°	NN	O	°	nn	3	SENT_240	[p14l1126t459r1163b515],
2	\	CD	NUMBER	\	num	3	SENT_240	[p14l1126t459r1163b515],
3	o.	NN	O	o.	_	0	SENT_240	[p14l1126t459r1163b515],
4	505	CD	NUMBER	505	number	5	SENT_240	[p14l1204t483r1267b512, p14l1126t521r1166b556],
5	‘	CD	NUMBER	‘	num	10	SENT_240	[p14l1204t483r1267b512, p14l1126t521r1166b556],
6	EE	NN	O	ee	nn	10	SENT_240	[p14l1126t560r1158b612],
7	o	NN	O	o	nn	10	SENT_240	[p14l1127t628r1158b649],
8	4000	CD	NUMBER	4000	num	10	SENT_240	[p14l1204t606r1267b635, p14l1127t652r1158b673],
9	fl	NN	O	fl	nn	10	SENT_240	[p14l1126t677r1166b731],
10	P	NN	O	p	dep	3	SENT_240	[p14l1638t682r1773b712],
11	=	JJ	O	=	amod	10	SENT_240	[p14l1638t682r1773b712],
12	.	.	O	.	_	0	SENT_240	[p14l1638t682r1773b712],

1	OO2	CD	NUMBER	oo2	num	4	SENT_241	[p14l1638t682r1773b712],
2	U	NNP	O	U	nn	4	SENT_241	[p14l1134t746r1158b764],
3	,	,	O	,	_	0	SENT_241	[p14l1134t746r1158b764],
4	30E	NNP	O	30E	_	0	SENT_241	[p14l1204t729r1267b758, p14l1134t765r1158b800],
5	"	``	O	"	punct	6	SENT_241	[p14l1126t804r1158b825],
6	O	NN	O	o	dep	15	SENT_241	[p14l1126t804r1158b825],
7	8	CD	PERCENT	8	number	9	SENT_241	[p14l1134t829r1158b872],
8	20	CD	PERCENT	20	number	9	SENT_241	[p14l1204t852r1267b881, p14l1134t875r1166b918],
9	%	NN	PERCENT	%	amod	10	SENT_241	[p14l1204t852r1267b881, p14l1134t875r1166b918],
10	P	NN	O	p	dep	6	SENT_241	[p14l1817t884r1931b913],
11	=	JJ	O	=	amod	10	SENT_241	[p14l1817t884r1931b913],
12	.9	CD	NUMBER	.9	tmod	11	SENT_241	[p14l1817t884r1931b913],
13	O	NN	O	o	dep	15	SENT_241	[p14l1817t884r1931b913],
14	9	CD	NUMBER	9	num	13	SENT_241	[p14l1134t920r1158b952],
15	C	NN	O	c	dep	4	SENT_241	[p14l1134t956r1158b975],
16	(	CD	NUMBER	(	num	15	SENT_241	[p14l1126t979r1158b1029],
17	Z3	NN	O	z3	dep	15	SENT_241	[p14l1126t979r1158b1029],
18	10	CD	NUMBER	10	num	17	SENT_241	[p14l1207t975r1267b1004],
19	-	:	O	-	_	0	SENT_241	[p14l1207t975r1267b1004],
20	I	PRP	O	I	dep	4	SENT_241	[p14l1749t989r1831b1114],
21	I	PRP	O	I	dep	20	SENT_241	[p14l1917t989r1999b1114],

1	O	NN	O	o	_	0	SENT_242	[p14l1226t1098r1246b1127],

1	Clopidogrel	NNP	O	Clopidogrel	nn	2	SENT_243	[p14l1505t1194r1713b1235],
2	Dose	NNP	O	Dose	_	0	SENT_243	[p14l1730t1195r1832b1232],
3	,	,	O	,	_	0	SENT_243	[p14l1730t1195r1832b1232],
4	mg	NN	O	mg	appos	2	SENT_243	[p14l1850t1203r1905b1235],

1	No.	NN	O	no.	_	0	SENT_244	[p14l1144t1271r1199b1301],
2	of	IN	O	of	_	0	SENT_244	[p14l1215t1271r1247b1301],
3	patients	NNS	O	patient	prep_of	1	SENT_244	[p14l1259t1271r1392b1308],
4	76	CD	NUMBER	76	number	5	SENT_244	[p14l1434t1272r1475b1301],
5	73	CD	NUMBER	73	dep	1	SENT_244	[p14l1602t1272r1643b1301],
6	75	CD	NUMBER	75	num	7	SENT_244	[p14l1769t1272r1810b1301],
7	73	CD	NUMBER	73	dep	5	SENT_244	[p14l1937t1272r1978b1301],

1	Nonresponders	NNS	O	nonresponder	nsubjpass	3	SENT_245	[p14l1123t1380r1425b1427],
2	were	VBD	O	be	auxpass	3	SENT_245	[p14l1445t1391r1541b1416],
3	defined	VBN	O	define	_	0	SENT_245	[p14l1561t1380r1709b1416],
4	using	VBG	O	use	xcomp	3	SENT_245	[p14l1732t1383r1836b1426],
5	the	DT	O	the	det	8	SENT_245	[p14l1854t1380r1917b1416],
6	VerifyNow	NNP	O	VerifyNow	nn	8	SENT_245	[p14l1936t1380r2152b1426],
7	P2Y12	NN	O	p2y12	nn	8	SENT_245	[p14l1123t1436r1224b1476],
8	assay	NN	O	assay	nsubj	19	SENT_245	[p14l1236t1445r1335b1480],
9	with	IN	O	with	_	0	SENT_245	[p14l1345t1434r1426b1469],
10	a	DT	O	a	det	13	SENT_245	[p14l1438t1445r1460b1469],
11	prespecified	JJ	O	prespecified	amod	13	SENT_245	[p14l1471t1433r1691b1480],
12	cut	NN	O	cut	nn	13	SENT_245	[p14l1704t1437r1763b1469],
13	point	NN	O	point	prep_with	8	SENT_245	[p14l1774t1436r1870b1480],
14	of	IN	O	of	_	0	SENT_245	[p14l1879t1433r1918b1469],
15	2230	CD	DATE	2230	num	18	SENT_245	[p14l1929t1436r2038b1469],
16	P2Y12	NN	O	p2y12	nn	18	SENT_245	[p14l2050t1436r2152b1476],
17	reaction	NN	O	reaction	nn	18	SENT_245	[p14l1123t1489r1276b1522],
18	units	NNS	O	unit	prep_of	13	SENT_245	[p14l1295t1489r1386b1522],
19	(	VBP	O	(	ccomp	4	SENT_245	[p14l1403t1488r1528b1527],
20	PRU	NNP	O	PRU	dobj	19	SENT_245	[p14l1403t1488r1528b1527],
21	)	CD	NUMBER	)	num	20	SENT_245	[p14l1403t1488r1528b1527],
22	.	.	O	.	_	0	SENT_245	[p14l1403t1488r1528b1527],

1	even	RB	O	even	advmod	9	SENT_246	[p14l1122t1684r1242b1715],
2	300	CD	NUMBER	300	num	4	SENT_246	[p14l1255t1670r1351b1715],
3	mg	NN	O	mg	nn	4	SENT_246	[p14l1365t1684r1448b1730],
4	daily	NN	SET	daily	nsubj	9	SENT_246	[p14l1461t1666r1587b1730],
5	of	IN	O	of	_	0	SENT_246	[p14l1600t1666r1653b1715],
6	clopidogrel	NN	O	clopidogrel	prep_of	4	SENT_246	[p14l1663t1666r1956b1730],
7	did	VBD	O	do	aux	9	SENT_246	[p14l1969t1666r2053b1715],
8	not	RB	O	not	neg	9	SENT_246	[p14l2065t1678r2153b1715],
9	result	VB	O	result	_	0	SENT_246	[p14l1121t1742r1275b1790],
10	in	IN	O	in	_	0	SENT_246	[p14l1291t1747r1344b1789],
11	platelet	NN	O	platelet	nn	13	SENT_246	[p14l1361t1742r1562b1806],
12	reactivity	NN	O	reactivity	nn	13	SENT_246	[p14l1578t1747r1832b1806],
13	levels	NNS	O	level	prep_in	9	SENT_246	[p14l1848t1742r1998b1790],
14	similar	JJ	O	similar	amod	13	SENT_246	[p14l2016t1747r2151b1790, p14l1121t1817r1192b1866],
15	to	TO	O	to	_	0	SENT_246	[p14l1217t1829r1267b1866],
16	standard	JJ	O	standard	amod	18	SENT_246	[p14l1294t1817r1532b1866],
17	clopidogrel	NN	O	clopidogrel	nn	18	SENT_246	[p14l1557t1817r1867b1881],
18	dosing	NN	O	dosing	prep_to	14	SENT_246	[p14l1893t1817r2074b1881],
19	in	IN	O	in	_	0	SENT_246	[p14l2098t1822r2152b1865],
20	noncarriers	NNS	O	noncarrier	prep_in	18	SENT_246	[p14l1121t1898r1432b1941],
21	(	CD	NUMBER	(	num	22	SENT_246	[p14l1456t1893r1627b1949],
22	Table	NNP	O	Table	dep	20	SENT_246	[p14l1456t1893r1627b1949],
23	2	CD	NUMBER	2	num	22	SENT_246	[p14l1649t1893r1718b1949],
24	)	CD	NUMBER	)	tmod	14	SENT_246	[p14l1649t1893r1718b1949],
25	.	.	O	.	_	0	SENT_246	[p14l1649t1893r1718b1949],

1	Clinical	JJ	O	clinical	amod	2	SENT_247	[p14l1122t2034r1325b2080],
2	Events	NNS	O	event	_	0	SENT_247	[p14l1351t2038r1538b2080],

1	There	EX	O	there	expl	2	SENT_248	[p14l1121t2122r1280b2170],
2	were	VBD	O	be	_	0	SENT_248	[p14l1303t2139r1434b2170],
3	no	DT	O	no	det	4	SENT_248	[p14l1458t2139r1525b2170],
4	deaths	NNS	O	death	nsubj	2	SENT_248	[p14l1552t2122r1743b2180],
5	,	,	O	,	_	0	SENT_248	[p14l1552t2122r1743b2180],
6	cerebrovascular	JJ	O	cerebrovascular	amod	7	SENT_248	[p14l1771t2122r2151b2170, p14l1121t2198r1194b2246],
7	events	NNS	O	event	nsubj	2	SENT_248	[p14l1222t2209r1417b2255],
8	,	,	O	,	_	0	SENT_248	[p14l1222t2209r1417b2255],
9	or	CC	O	or	_	0	SENT_248	[p14l1448t2215r1505b2246],
10	TIMI	NNP	O	TIMI	conj_or	4	SENT_248	[p14l1532t2202r1674b2245],
11	major	JJ	O	major	amod	15	SENT_248	[p14l1702t2202r1868b2261],
12	or	CC	O	or	_	0	SENT_248	[p14l1896t2215r1953b2246],
13	minor	JJ	O	minor	conj_or	11	SENT_248	[p14l1979t2202r2152b2246],
14	bleeding	NN	O	bleeding	nn	15	SENT_248	[p14l1120t2273r1358b2336],
15	events	NNS	O	event	dep	10	SENT_248	[p14l1383t2284r1571b2321],
16	.	.	O	.	_	0	SENT_248	[p14l1383t2284r1571b2321],

1	Among	IN	O	among	_	0	SENT_249	[p14l1599t2276r1801b2336],
2	CYP2C19	NN	O	cyp2c19	nn	3	SENT_249	[p14l1827t2270r2149b2321],
3	*	NN	O	*	pobj	1	SENT_249	[p14l1827t2270r2149b2321],
4	2	CD	NUMBER	2	num	3	SENT_249	[p14l1827t2270r2149b2321],

1	JAMA	NNP	O	JAMA	_	0	SENT_250	[p14l1513t2378r1595b2403],
2	,	,	O	,	_	0	SENT_250	[p14l1513t2378r1595b2403],
3	November	NNP	DATE	November	appos	1	SENT_250	[p14l1606t2376r1736b2399],
4	23/30	CD	DATE	23/30	num	3	SENT_250	[p14l1747t2378r1825b2403],
5	,	,	DATE	,	_	0	SENT_250	[p14l1747t2378r1825b2403],
6	2011	CD	DATE	2011	num	3	SENT_250	[p14l1837t2376r1973b2399],
7	.	.	O	.	_	0	SENT_250	[p14l1837t2376r1973b2399],

1	—	NN	O	—	_	0	SENT_251	[p14l1837t2376r1973b2399],
2	.	.	O	.	_	0	SENT_251	[p14l1837t2376r1973b2399],

1	Vol	NN	O	vol	_	0	SENT_252	[p14l1837t2376r1973b2399],
2	306	CD	NUMBER	306	num	1	SENT_252	[p14l1984t2378r2038b2403],
3	,	,	O	,	_	0	SENT_252	[p14l1984t2378r2038b2403],
4	No.	NN	O	no.	appos	1	SENT_252	[p14l2049t2378r2091b2399],
5	20	CD	NUMBER	20	num	4	SENT_252	[p14l2104t2378r2134b2399],

1	2225	CD	DATE	2225	_	0	SENT_253	[p14l6t2419r77b2440],
2	Downloaded	NNP	O	Downloaded	dep	1	SENT_253	[p14l87t2417r264b2441],
3	From	IN	O	from	prep	2	SENT_253	[p14l274t2417r361b2440],
4	:	:	O	:	_	0	SENT_253	[p14l274t2417r361b2440],
5	http://jama.jamanetwork.com/	NN	O	http://jama.jamanetwork.com/	dep	2	SENT_253	[p14l373t2416r810b2447],
6	by	IN	O	by	_	0	SENT_253	[p14l818t2417r852b2447],
7	a	DT	O	a	det	8	SENT_253	[p14l862t2424r877b2440],
8	University	NNP	ORGANIZATION	University	prep_by	5	SENT_253	[p14l886t2416r1034b2447],
9	of	IN	ORGANIZATION	of	_	0	SENT_253	[p14l1043t2416r1072b2440],
10	Wisconsin	NNP	ORGANIZATION	Wisconsin	prep_of	8	SENT_253	[p14l1079t2416r1225b2441],
11	-	:	O	-	_	0	SENT_253	[p14l1235t2416r1368b2441],
12	Madison	NNP	O	Madison	nn	13	SENT_253	[p14l1235t2416r1368b2441],
13	User	NN	O	user	dep	2	SENT_253	[p14l1377t2417r1443b2441],
14	on	IN	O	on	_	0	SENT_253	[p14l1461t2424r1495b2440],
15	01/05/2014	CD	DATE	01/05/2014	prep_on	13	SENT_253	[p14l1504t2416r1655b2441],

1	CLOPIDOGREL	NN	O	clopidogrel	_	0	SENT_254	[p14l59t2541r311b2567],
2	DOSES	NNS	O	dose	dep	1	SENT_254	[p14l322t2541r432b2567],
3	AND	CC	O	and	_	0	SENT_254	[p14l443t2541r519b2566],
4	CYP2C19	NN	O	cyp2c19	nn	5	SENT_254	[p14l532t2541r675b2567],
5	GENOTYPE	NN	O	genotype	dep	1	SENT_254	[p14l688t2541r877b2567],

1	Figure	NNP	O	Figure	_	0	SENT_255	[p14l59t2672r159b2705],
2	4	CD	NUMBER	4	dep	1	SENT_255	[p14l170t2673r199b2697],
3	.	.	O	.	_	0	SENT_255	[p14l170t2673r199b2697],

1	Difference	NN	O	difference	nsubj	34	SENT_256	[p14l213t2671r358b2697],
2	in	IN	O	in	_	0	SENT_256	[p14l370t2673r392b2697],
3	Platelet	NN	O	platelet	nn	4	SENT_256	[p14l406t2671r509b2697],
4	Reactivity	NN	O	reactivity	prep_in	1	SENT_256	[p14l521t2673r656b2704],
5	Between	IN	O	between	_	0	SENT_256	[p14l669t2673r788b2697],
6	C	NN	O	c	nn	7	SENT_256	[p14l801t2673r821b2697],
7	YP2C	NN	O	yp2c	prep_between	30	SENT_256	[p14l825t2673r901b2697],
8	79	CD	NUMBER	79	num	11	SENT_256	[p14l904t2672r971b2697],
9	*	NN	O	*	nn	11	SENT_256	[p14l904t2672r971b2697],
10	2	CD	NUMBER	2	num	11	SENT_256	[p14l904t2672r971b2697],
11	Heterozygotes	NNS	O	heterozygote	nsubj	30	SENT_256	[p14l985t2673r1188b2704],
12	Treated	VBN	O	treat	partmod	11	SENT_256	[p14l1199t2671r1305b2697],
13	With	IN	O	with	_	0	SENT_256	[p14l1318t2671r1385b2697],
14	Increasing	VBG	O	increase	amod	15	SENT_256	[p14l60t2711r201b2742],
15	Doses	NNS	O	dose	prep_with	12	SENT_256	[p14l213t2711r294b2735],
16	of	IN	O	of	_	0	SENT_256	[p14l306t2708r334b2735],
17	Clopidogrel	NNP	O	Clopidogrel	nn	20	SENT_256	[p14l345t2709r506b2743],
18	vs	CC	O	vs	_	0	SENT_256	[p14l518t2717r546b2735],
19	Noncarriers	NNP	O	Noncarriers	nn	20	SENT_256	[p14l559t2710r718b2735],
20	Treated	NNP	O	Treated	prep_of	15	SENT_256	[p14l728t2709r835b2735],
21	With	IN	O	with	_	0	SENT_256	[p14l846t2709r914b2735],
22	75	CD	NUMBER	75	num	23	SENT_256	[p14l927t2711r961b2734],
23	mg	NN	O	mg	prep_with	20	SENT_256	[p14l974t2717r1018b2742],
24	of	IN	O	of	_	0	SENT_256	[p14l1029t2708r1057b2735],
25	Clopidogrel	NNP	O	Clopidogrel	nn	26	SENT_256	[p14l1068t2709r1229b2743],
26	Daily	NNP	SET	Daily	prep_of	23	SENT_256	[p14l1243t2709r1311b2742],
27	to	TO	O	to	_	0	SENT_256	[p14l1456t2651r1487b2674],
28	150	CD	NUMBER	150	num	29	SENT_256	[p14l1506t2646r1565b2674],
29	mg	NN	O	mg	prep_to	26	SENT_256	[p14l1581t2655r1633b2684],
30	did	VBD	O	do	rcmod	4	SENT_256	[p14l1648t2644r1703b2674],
31	not	RB	O	not	neg	30	SENT_256	[p14l1717t2651r1774b2674],
32	on	IN	O	on	_	0	SENT_256	[p14l1789t2655r1831b2674],
33	average	JJ	O	average	prep_on	30	SENT_256	[p14l1846t2655r1973b2684],
34	inhibit	VBP	O	inhibit	_	0	SENT_256	[p14l1988t2644r2103b2674],
35	platelet	NN	O	platelet	nn	36	SENT_256	[p14l1455t2692r1577b2732],
36	reactivity	NN	O	reactivity	dobj	34	SENT_256	[p14l1585t2695r1738b2732],
37	to	TO	O	to	_	0	SENT_256	[p14l1747t2699r1777b2722],
38	the	DT	O	the	det	39	SENT_256	[p14l1788t2692r1839b2722],
39	levels	NNS	O	level	prep_to	34	SENT_256	[p14l1847t2692r1938b2722],
40	seen	VBN	O	see	partmod	39	SENT_256	[p14l1947t2703r2020b2722],
41	with	IN	O	with	_	0	SENT_256	[p14l2028t2692r2103b2722],
42	75	CD	NUMBER	75	num	43	SENT_256	[p14l1457t2742r1495b2771],
43	mg	NN	O	mg	prep_with	40	SENT_256	[p14l1507t2751r1560b2780],
44	of	IN	O	of	_	0	SENT_256	[p14l1570t2740r1605b2770],
45	clopidogrel	NN	O	clopidogrel	prep_of	43	SENT_256	[p14l1613t2740r1806b2780],
46	in	IN	O	in	_	0	SENT_256	[p14l1816t2743r1849b2770],
47	noncarrier	JJ	O	noncarrier	amod	48	SENT_256	[p14l1859t2743r2039b2770],
48	paVASP	NN	O	pavasp	prep_in	40	SENT_256	[p14l2049t2751r2102b2780, p14l571t2828r843b2911],

1	platelet	NN	O	platelet	nn	3	SENT_257	[p14l885t2830r1234b2931],
2	reactivity	NN	O	reactivity	nn	3	SENT_257	[p14l1273t2830r1705b2931],
3	index	NN	O	index	_	0	SENT_257	[p14l1742t2830r2001b2909],
4	i	FW	O	i	nn	5	SENT_257	[p14l361t3012r401b3161],
5	P	NN	O	p	dep	3	SENT_257	[p14l574t3078r644b3157],
6	<	JJR	O	<	dep	5	SENT_257	[p14l675t3078r924b3159],
7	.001	CD	NUMBER	.001	dep	3	SENT_257	[p14l675t3078r924b3159],

1	Least	NNP	O	Least	nn	3	SENT_258	[p15l8t1805r96b2072],
2	Squares	NNP	O	Squares	nn	3	SENT_258	[p15l8t1349r118b1763],
3	Diiﬁferences	NNP	O	Diiﬁferences	_	0	SENT_258	[p15l8t750r96b1305],
4	(	CD	PERCENT	(	number	6	SENT_258	[p15l8t454r118b709],
5	95	CD	PERCENT	95	number	6	SENT_258	[p15l8t454r118b709],
6	%	NN	PERCENT	%	amod	8	SENT_258	[p15l8t454r118b709],
7	Cl	NN	O	cl	nn	8	SENT_258	[p15l8t255r118b411],
8	)	NN	O	)	dep	3	SENT_258	[p15l8t255r118b411],
9	,	,	O	,	_	0	SENT_258	[p15l8t255r118b411],
10	%	NN	O	%	appos	8	SENT_258	[p15l8t112r98b202],

1	C	NN	O	c	_	0	SENT_259	[p15l111t3206r131b3235],
2	)	SYM	O	)	dep	1	SENT_259	[p15l111t3206r131b3235],

1	Least	NNP	O	Least	nn	3	SENT_260	[p15l8t3439r41b3539],
2	Squares	NNP	O	Squares	nn	3	SENT_260	[p15l7t3269r49b3424],
3	Differences	NNS	O	difference	nsubj	4	SENT_260	[p15l8t3046r41b3253],
4	(	VBP	O	(	_	0	SENT_260	[p15l7t2936r49b3031],
5	95	CD	PERCENT	95	number	6	SENT_260	[p15l7t2936r49b3031],
6	%	NN	PERCENT	%	amod	8	SENT_260	[p15l7t2936r49b3031],
7	Cl	NN	O	cl	nn	8	SENT_260	[p15l7t2862r49b2920],
8	)	NN	O	)	dobj	4	SENT_260	[p15l7t2862r49b2920],
9	,	,	O	,	_	0	SENT_260	[p15l7t2862r49b2920],
10	%	NN	O	%	nn	11	SENT_260	[p15l8t2809r42b2842],
11	I	NN	O	i	appos	8	SENT_260	[p15l66t3411r87b3414],
12	-	:	O	-	_	0	SENT_260	[p15l88t3395r108b3424],
13	P	NN	O	p	nn	14	SENT_260	[p15l88t3395r108b3424],
14	O	NN	O	o	dep	8	SENT_260	[p15l111t3395r131b3425],

1	®	NN	O	®	nn	2	SENT_261	[p15l88t2827r108b2857],
2	C	NN	O	c	dep	6	SENT_261	[p15l111t2827r131b2857],
3	)	CD	NUMBER	)	dep	2	SENT_261	[p15l111t2827r131b2857],
4	I	PRP	O	I	dep	6	SENT_261	[p15l139t2842r152b2844],
5	CD	NNP	O	CD	nn	6	SENT_261	[p15l88t2922r108b2952],
6	(	NNP	O	(	dep	12	SENT_261	[p15l111t2922r131b2952],
7	3	CD	NUMBER	3	num	6	SENT_261	[p15l111t2922r131b2952],
8	I	PRP	O	I	dep	6	SENT_261	[p15l139t2937r152b2939],
9	-	:	O	-	_	0	SENT_261	[p15l88t3017r108b3046],
10	B	NN	O	b	nn	11	SENT_261	[p15l88t3017r108b3046],
11	C	NN	O	c	dep	8	SENT_261	[p15l111t3016r131b3046],
12	)	CD	NUMBER	)	_	0	SENT_261	[p15l111t3016r131b3046],
13	I	PRP	O	I	nsubj	14	SENT_261	[p15l139t3031r152b3033],
14	[	VBP	O	[	rcmod	12	SENT_261	[p15l88t3111r108b3140],
15	U	NNP	O	U	nn	16	SENT_261	[p15l88t3111r108b3140],
16	(	NNP	O	(	nsubj	18	SENT_261	[p15l111t3111r131b3141],
17	3	CD	NUMBER	3	num	16	SENT_261	[p15l111t3111r131b3141],
18	I	PRP	O	I	xcomp	14	SENT_261	[p15l140t3126r152b3128],

1	I	PRP	O	I	nsubj	2	SENT_262	[p15l66t3317r87b3319],
2	|	VBP	O	|	_	0	SENT_262	[p15l88t3300r108b3329],
3	\	CD	NUMBER	\	number	4	SENT_262	[p15l88t3300r108b3329],
4	3	CD	NUMBER	3	nsubj	7	SENT_262	[p15l88t3300r108b3329],
5	C	NN	O	c	prep	4	SENT_262	[p15l111t3300r131b3330],
6	)	CD	NUMBER	)	dep	5	SENT_262	[p15l111t3300r131b3330],
7	I	PRP	O	I	xcomp	2	SENT_262	[p15l140t3315r152b3317],

1	I	PRP	O	I	_	0	SENT_263	[p15l66t3506r87b3509],
2	CD	NNP	O	CD	nn	3	SENT_263	[p15l88t3489r108b3519],
3	CD	NNP	O	CD	dep	1	SENT_263	[p15l111t3489r131b3519],
4	I	PRP	O	I	dep	1	SENT_263	[p15l139t3504r152b3506],

1	_	NN	O	_	nn	2	SENT_264	[p15l230t235r258b312],
2	L	NN	O	l	_	0	SENT_264	[p15l230t235r258b312],

1	OW	NN	O	ow	_	0	SENT_265	[p15l284t235r337b314],

1	_	NN	O	_	nn	2	SENT_266	[p15l230t562r258b639],
2	L	NN	O	l	_	0	SENT_266	[p15l230t562r258b639],

1	O	NN	O	o	_	0	SENT_267	[p15l284t562r339b641],

1	O	NN	O	o	_	0	SENT_268	[p15l284t889r337b968],
2	‘	CD	NUMBER	‘	dep	1	SENT_268	[p15l284t889r337b968],
3	!	.	O	!	_	0	SENT_268	[p15l284t889r337b968],

1	S	NN	O	s	_	0	SENT_269	[p15l284t1213r339b1294],

1	P2Y12	NN	O	p2y12	_	0	SENT_270	[p15l304t2679r409b2723],
2	reaction	NN	O	reaction	nn	3	SENT_270	[p15l424t2679r566b2709],
3	units	NNS	O	unit	dep	1	SENT_270	[p15l582t2679r667b2709],

1	P	NN	O	p	dep	2	SENT_271	[p15l219t2791r245b2820],
2	<	JJR	O	<	_	0	SENT_271	[p15l257t2791r349b2821],
3	.	.	O	.	_	0	SENT_271	[p15l257t2791r349b2821],

1	OO1	NN	O	oo1	_	0	SENT_272	[p15l257t2791r349b2821],

1	75 150 225 800	CD	NUMBER	75 150 225 800	num	3	SENT_273	[p15l648t3627r714b3657],[p15l267t3627r309b3657],
2	Clopidogrel	NNP	O	Clopidogrel	nn	3	SENT_273	[p15l279t3683r491b3724],
3	Dose	NNP	O	Dose	_	0	SENT_273	[p15l509t3683r613b3721],
4	,	,	O	,	_	0	SENT_273	[p15l509t3683r613b3721],
5	mg	NN	O	mg	appos	3	SENT_273	[p15l632t3691r689b3724],

1	Clopidogrel	NNP	O	Clopidogrel	nn	2	SENT_274	[p15l736t2439r1306b2549],
2	Dose	NNP	O	Dose	_	0	SENT_274	[p15l1354t2439r1633b2540],
3	,	,	O	,	_	0	SENT_274	[p15l1354t2439r1633b2540],
4	rng	NN	O	rng	nn	5	SENT_274	[p15l1683t2461r1834b2551],
5	tients	NNS	O	tient	appos	2	SENT_274	[p15l1095t2679r1261b2723],
6	.	.	O	.	_	0	SENT_274	[p15l1095t2679r1261b2723],

1	Rather	RB	O	rather	advmod	4	SENT_275	[p15l1287t2674r1485b2733],
2	,	,	O	,	_	0	SENT_275	[p15l1287t2674r1485b2733],
3	we	PRP	O	we	nsubj	4	SENT_275	[p15l1507t2692r1585b2723],
4	found	VBD	O	find	_	0	SENT_275	[p15l1607t2673r1771b2723],
5	that	IN	O	that	complm	10	SENT_275	[p15l1793t2674r1901b2723],
6	on	IN	O	on	_	0	SENT_275	[p15l1922t2692r1992b2723],
7	average	NN	O	average	prep_on	10	SENT_275	[p15l2013t2692r2150b2723, p15l1094t2769r1199b2817],
8	,	,	O	,	_	0	SENT_275	[p15l2013t2692r2150b2723, p15l1094t2769r1199b2817],
9	it	PRP	O	it	nsubj	10	SENT_275	[p15l1222t2757r1261b2801],
10	required	VBD	O	require	ccomp	4	SENT_275	[p15l1280t2752r1517b2817],
11	a	DT	O	a	dobj	10	SENT_275	[p15l1537t2770r1563b2801],
12	tripling	VBG	O	triple	amod	11	SENT_275	[p15l1585t2752r1792b2817],
13	of	IN	O	of	_	0	SENT_275	[p15l1813t2751r1869b2801],
14	the	DT	O	the	det	17	SENT_275	[p15l1886t2752r1971b2801],
15	Clopidogrel	NNP	MISC	Clopidogrel	nn	17	SENT_275	[p15l1993t2752r2150b2817, p15l1095t2830r1276b2895],
16	maintenance	NN	O	maintenance	nn	17	SENT_275	[p15l1302t2835r1671b2879],
17	dose	NN	O	dose	prep_of	11	SENT_275	[p15l1699t2830r1827b2879],
18	to	TO	O	to	aux	19	SENT_275	[p15l1855t2842r1907b2879],
19	achieve	VB	O	achieve	infmod	11	SENT_275	[p15l1936t2830r2150b2879],
20	platelet	NN	O	platelet	nn	21	SENT_275	[p15l1093t2908r1295b2973],
21	reactivity	NN	O	reactivity	dobj	19	SENT_275	[p15l1308t2913r1561b2973],
22	that	WDT	O	that	nsubj	27	SENT_275	[p15l1576t2908r1682b2957],
23	is	VBZ	O	be	cop	27	SENT_275	[p15l1694t2913r1736b2957],
24	at	IN	O	at	advmod	27	SENT_275	[p15l1751t2920r1800b2957],
25	least	JJS	O	least	pobj	24	SENT_275	[p15l1813t2908r1936b2957],
26	as	RB	O	as	advmod	27	SENT_275	[p15l1950t2926r2002b2957],
27	good	JJ	O	good	rcmod	21	SENT_275	[p15l2017t2908r2152b2973],
28	as	IN	O	as	mark	30	SENT_275	[p15l1094t3004r1147b3035],
29	that	DT	O	that	nsubj	30	SENT_275	[p15l1171t2986r1279b3035],
30	observed	VBN	O	observe	advcl	27	SENT_275	[p15l1302t2986r1550b3035],
31	with	IN	O	with	_	0	SENT_275	[p15l1570t2986r1696b3036],
32	75	CD	NUMBER	75	num	33	SENT_275	[p15l1721t2990r1783b3036],
33	mg	NN	O	mg	prep_with	30	SENT_275	[p15l1808t3004r1895b3051],
34	of	IN	O	of	_	0	SENT_275	[p15l1917t2986r1974b3035],
35	Clopidogrel	NNP	MISC	Clopidogrel	prep_of	33	SENT_275	[p15l1993t2986r2150b3051, p15l1095t3064r1270b3129],
36	in	IN	O	in	_	0	SENT_275	[p15l1290t3069r1344b3113],
37	CYP2C19	NNP	O	CYP2C19	prep_in	35	SENT_275	[p15l1366t3062r1691b3114],
38	*	CD	NUMBER	*	number	39	SENT_275	[p15l1366t3062r1691b3114],
39	2	CD	NUMBER	2	num	40	SENT_275	[p15l1366t3062r1691b3114],
40	noncarriers	NNS	O	noncarrier	dobj	30	SENT_275	[p15l1713t3069r2046b3113],
41	.	.	O	.	_	0	SENT_275	[p15l1713t3069r2046b3113],

1	Interestingly	RB	O	interestingly	advmod	4	SENT_276	[p15l2071t3069r2150b3113, p15l1095t3142r1388b3207],
2	,	,	O	,	_	0	SENT_276	[p15l2071t3069r2150b3113, p15l1095t3142r1388b3207],
3	CLOVIS-2	NN	O	clovis-2	nsubj	20	SENT_276	[p15l1407t3146r1684b3192],
4	studied	VBD	O	study	_	0	SENT_276	[p15l1698t3142r1896b3192],
5	the	DT	O	the	det	7	SENT_276	[p15l1911t3142r1993b3192],
6	pharmacologic	JJ	O	pharmacologic	amod	7	SENT_276	[p15l2006t3142r2150b3207, p15l1094t3220r1377b3286],
7	efficacy	NN	O	efficacy	dobj	4	SENT_276	[p15l1395t3220r1605b3285],
8	of	IN	O	of	_	0	SENT_276	[p15l1622t3220r1678b3270],
9	different	JJ	O	different	amod	11	SENT_276	[p15l1690t3220r1928b3270],
10	loading	NN	O	loading	nn	11	SENT_276	[p15l1943t3220r2152b3286],
11	doses	NNS	O	dose	prep_of	7	SENT_276	[p15l1095t3299r1242b3348],
12	of	IN	O	of	_	0	SENT_276	[p15l1258t3298r1313b3348],
13	Clopidogrel	NNP	O	Clopidogrel	prep_of	11	SENT_276	[p15l1324t3299r1630b3364],
14	based	VBN	O	base	_	0	SENT_276	[p15l1643t3299r1797b3348],
15	on	IN	O	on	prepc_based_on	4	SENT_276	[p15l1812t3316r1881b3348],
16	CYP2C19	NN	O	cyp2c19	nn	17	SENT_276	[p15l1896t3302r2150b3348],
17	genotype	NN	O	genotype	pobj	4	SENT_276	[p15l1094t3389r1359b3442],
18	and	CC	O	and	_	0	SENT_276	[p15l1389t3377r1494b3426],
19	also	RB	O	also	advmod	20	SENT_276	[p15l1522t3377r1633b3426],
20	found	VBD	O	find	conj_and	4	SENT_276	[p15l1664t3376r1835b3426],
21	that	IN	O	that	complm	36	SENT_276	[p15l1864t3377r1977b3426],
22	a	DT	O	a	nsubj	36	SENT_276	[p15l2005t3394r2031b3426],
23	tripling	VBG	O	triple	amod	22	SENT_276	[p15l2061t3382r2149b3426, p15l1093t3455r1237b3520],
24	of	IN	O	of	_	0	SENT_276	[p15l1262t3454r1318b3504],
25	the	DT	O	the	det	27	SENT_276	[p15l1340t3455r1424b3504],
26	dose	NN	O	dose	nn	27	SENT_276	[p15l1450t3455r1575b3504],
27	(	NN	O	(	prep_of	22	SENT_276	[p15l1604t3455r1688b3514],
28	ie	FW	O	ie	dep	27	SENT_276	[p15l1604t3455r1688b3514],
29	,	,	O	,	_	0	SENT_276	[p15l1604t3455r1688b3514],
30	a	DT	O	a	det	34	SENT_276	[p15l1716t3473r1742b3504],
31	900	CD	NUMBER	900	number	32	SENT_276	[p15l1768t3458r1982b3520],
32	—	CD	NUMBER	—	num	34	SENT_276	[p15l1768t3458r1982b3520],
33	mg	NN	O	mg	nn	34	SENT_276	[p15l1768t3458r1982b3520],
34	load	NN	O	load	appos	27	SENT_276	[p15l2006t3454r2146b3511],
35	)	RB	O	)	advmod	36	SENT_276	[p15l2006t3454r2146b3511],
36	achieved	VBD	O	achieve	ccomp	20	SENT_276	[p15l1094t3533r1345b3582],
37	a	DT	O	a	det	38	SENT_276	[p15l1372t3551r1398b3582],
38	degree	NN	O	degree	nsubj	42	SENT_276	[p15l1426t3533r1612b3598],
39	of	IN	O	of	_	0	SENT_276	[p15l1640t3532r1697b3582],
40	platelet	NN	O	platelet	nn	41	SENT_276	[p15l1718t3533r1932b3598],
41	inhibition	NN	O	inhibition	prep_of	38	SENT_276	[p15l1957t3533r2149b3582, p15l1095t3616r1209b3660],
42	comparable	JJ	O	comparable	xcomp	36	SENT_276	[p15l1237t3611r1573b3676],
43	with	IN	O	with	_	0	SENT_276	[p15l1599t3611r1729b3660],
44	what	WP	O	what	nsubjpass	46	SENT_276	[p15l1755t3611r1897b3660],
45	was	VBD	O	be	auxpass	46	SENT_276	[p15l1922t3629r2029b3660],
46	observed	VBN	O	observe	prepc_with	42	SENT_276	[p15l2058t3611r2149b3660, p15l1094t3689r1284b3738],
47	in	IN	O	in	_	0	SENT_276	[p15l1312t3694r1369b3737],
48	response	NN	O	response	prep_in	46	SENT_276	[p15l1398t3706r1658b3753],
49	to	TO	O	to	_	0	SENT_276	[p15l1689t3701r1742b3738],
50	the	DT	O	the	det	51	SENT_276	[p15l1775t3689r1864b3738],
51	standard	NN	O	standard	prep_to	46	SENT_276	[p15l1894t3689r2151b3738],

1	Data	NNS	O	datum	_	0	SENT_277	[p16l58t35r116b56],
2	are	VBP	O	be	cop	3	SENT_277	[p16l126t40r163b56],
3	repo	JJ	O	repo	rcmod	1	SENT_277	[p16l176t40r229b63],
4	e	SYM	O	e	dep	7	SENT_277	[p16l251t40r263b56],
5	as	IN	O	as	num	7	SENT_277	[p16l291t40r315b56],
6	least	JJS	O	least	quantmod	5	SENT_277	[p16l327t33r382b56],
7	squares	NNS	O	square	dep	23	SENT_277	[p16l392t40r484b63],
8	differences	NNS	O	difference	dep	7	SENT_277	[p16l496t33r630b56],
9	and	CC	O	and	_	0	SENT_277	[p16l641t33r685b56],
10	95	CD	PERCENT	95	number	11	SENT_277	[p16l697t34r755b56],
11	%	NN	PERCENT	%	amod	13	SENT_277	[p16l697t34r755b56],
12	confidence	NN	O	confidence	nn	13	SENT_277	[p16l769t33r902b56],
13	intervals	NNS	O	interval	conj_and	7	SENT_277	[p16l915t33r1016b56],
14	for	IN	O	for	_	0	SENT_277	[p16l1026t33r1062b56],
15	platelet	NN	O	platelet	nn	17	SENT_277	[p16l1073t33r1163b63],
16	reac	NN	O	reac	nn	17	SENT_277	[p16l1175t40r1224b56],
17	ivi	NN	O	ivi	prep_for	13	SENT_277	[p16l1236t35r1260b55],
18	between	IN	O	between	_	0	SENT_277	[p16l1297t33r1402b56],
19	oo	NN	O	oo	prep_between	17	SENT_277	[p16l1454t13r1530b66],
20	'	''	O	'	_	0	SENT_277	[p16l1454t13r1530b66],
21	loadlng	JJ	O	loadlng	amod	22	SENT_277	[p16l1594t11r1722b66],
22	(	NN	O	(	nsubj	23	SENT_277	[p16l1731t11r1807b66],
23	lose	VBP	O	lose	ccomp	3	SENT_277	[p16l1731t11r1807b66],
24	In	IN	O	in	_	0	SENT_277	[p16l1817t22r1850b41],
25	nqncarrler	NN	O	nqncarrler	nn	26	SENT_277	[p16l1860t22r2039b66],
26	paCYP2C79	NN	O	pacyp2c79	prep_in	23	SENT_277	[p16l2048t22r2101b51, p16l57t67r206b89],
27	*	NN	O	*	dep	1	SENT_277	[p16l2048t22r2101b51, p16l57t67r206b89],
28	2	CD	NUMBER	2	num	27	SENT_277	[p16l2048t22r2101b51, p16l57t67r206b89],
29	e	SYM	O	e	dep	30	SENT_277	[p16l233t73r245b89],
30	erozygotes	NNS	O	erozygote	dep	61	SENT_277	[p16l257t68r391b95],
31	at	IN	O	at	_	0	SENT_277	[p16l400t68r423b89],
32	clo	NN	O	clo	nn	34	SENT_277	[p16l432t66r465b89],
33	idogrel	NN	O	idogrel	nn	34	SENT_277	[p16l484t66r566b95],
34	doses	NNS	O	dose	prep_at	30	SENT_277	[p16l577t66r644b89],
35	o	NN	O	o	nn	38	SENT_277	[p16l654t73r668b89],
36	mg	NN	O	mg	nn	38	SENT_277	[p16l727t73r766b95],
37	(	NN	O	(	nn	38	SENT_277	[p16l775t67r871b93],
38	n	NN	O	n	nsubj	61	SENT_277	[p16l775t67r871b93],
39	=	JJ	O	=	amod	41	SENT_277	[p16l775t67r871b93],
40	76	CD	NUMBER	76	tmod	39	SENT_277	[p16l775t67r871b93],
41	)	NN	O	)	dep	38	SENT_277	[p16l775t67r871b93],
42	,	,	O	,	_	0	SENT_277	[p16l775t67r871b93],
43	150	CD	NUMBER	150	num	46	SENT_277	[p16l882t68r928b89],
44	mg	NN	O	mg	nn	46	SENT_277	[p16l938t73r976b95],
45	(	NN	O	(	nn	46	SENT_277	[p16l986t67r1081b93],
46	n	NN	O	n	appos	41	SENT_277	[p16l986t67r1081b93],
47	=	JJ	O	=	amod	49	SENT_277	[p16l986t67r1081b93],
48	73	CD	NUMBER	73	tmod	47	SENT_277	[p16l986t67r1081b93],
49	)	NN	O	)	dep	46	SENT_277	[p16l986t67r1081b93],
50	,	,	O	,	_	0	SENT_277	[p16l986t67r1081b93],
51	225	CD	NUMBER	225	num	54	SENT_277	[p16l1091t68r1138b89],
52	mg	NN	O	mg	nn	54	SENT_277	[p16l1148t73r1187b95],
53	(	NN	O	(	nn	54	SENT_277	[p16l1196t67r1240b92],
54	n	NN	O	n	appos	41	SENT_277	[p16l1196t67r1240b92],
55	:	:	O	:	_	0	SENT_277	[p16l1196t67r1240b92],
56	,	,	O	,	_	0	SENT_277	[p16l1288t66r1346b93],
57	and	CC	O	and	_	0	SENT_277	[p16l1288t66r1346b93],
58	Hen	NN	O	hen	conj_and	38	SENT_277	[p16l1455t66r1519b89],
59	.22	CD	NUMBER	.22	num	60	SENT_277	[p16l1552t57r1585b89],
60	Patients	NNS	O	patient	dep	58	SENT_277	[p16l1599t62r1734b89],
61	1n	VBP	O	1n	dep	27	SENT_277	[p16l1748t70r1782b89],
62	our	PRP$	O	we	poss	63	SENT_277	[p16l1796t70r1854b89],
63	t1	NN	O	t1	nsubj	66	SENT_277	[p16l1869t59r1937b89],
64	‘	CD	NUMBER	‘	npadvmod	65	SENT_277	[p16l1869t59r1937b89],
65	1al	JJ	O	1al	dep	66	SENT_277	[p16l1869t59r1937b89],
66	tolerated	VBN	O	tolerate	xcomp	61	SENT_277	[p16l1951t59r2102b89],

1	P	NN	O	p	_	0	SENT_278	[p16l468t73r481b96],

1	mg	NN	O	mg	nn	3	SENT_279	[p16l58t106r96b128],
2	(	NN	O	(	nn	3	SENT_279	[p16l106t100r194b125],
3	n	NN	O	n	_	0	SENT_279	[p16l106t100r194b125],
4	=	JJ	O	=	amod	6	SENT_279	[p16l106t100r194b125],
5	73	CD	NUMBER	73	tmod	4	SENT_279	[p16l106t100r194b125],
6	)	NN	O	)	dep	3	SENT_279	[p16l106t100r194b125],
7	and	CC	O	and	_	0	SENT_279	[p16l204t99r248b122],
8	noncarriers	NNS	O	noncarrier	dep	3	SENT_279	[p16l260t101r394b122],
9	at	IN	O	at	_	0	SENT_279	[p16l404t101r427b122],
10	75	CD	NUMBER	75	num	11	SENT_279	[p16l436t101r466b122],
11	mg	NN	O	mg	prep_at	8	SENT_279	[p16l477t106r515b128],
12	of	IN	O	of	_	0	SENT_279	[p16l524t99r549b122],
13	clopidogre	NN	O	clopidogre	nn	14	SENT_279	[p16l558t99r687b129],
14	n	NN	O	n	prep_of	11	SENT_279	[p16l714t100r815b125],
15	=	JJ	O	=	quantmod	16	SENT_279	[p16l714t100r815b125],
16	237	CD	NUMBER	237	dep	3	SENT_279	[p16l714t100r815b125],
17	)	NN	O	)	dep	16	SENT_279	[p16l714t100r815b125],
18	.	.	O	.	_	0	SENT_279	[p16l714t100r815b125],

1	Differences	NNS	O	difference	nsubj	10	SENT_280	[p16l828t99r965b122],
2	in	IN	O	in	advmod	10	SENT_280	[p16l976t101r994b122],
3	least	JJS	O	least	dep	2	SENT_280	[p16l1006t99r1061b122],
4	squares	NNS	O	square	nn	5	SENT_280	[p16l1070t106r1162b129],
5	means	NNS	O	means	nsubj	10	SENT_280	[p16l1172t106r1250b122],
6	were	VBD	O	be	cop	10	SENT_280	[p16l1259t106r1319b122],
7	tes	NNS	O	te	attr	10	SENT_280	[p16l1328t101r1363b122],
8	e	LS	O	e	advmod	10	SENT_280	[p16l1374t106r1387b122],
9	'	''	O	'	_	0	SENT_280	[p16l1593t109r1597b114],
10	using	VBG	O	use	dep	13	SENT_280	[p16l1758t110r1762b114, p16l58t134r122b162],
11	asymptotic	JJ	O	asymptotic	amod	12	SENT_280	[p16l130t134r265b162],
12	methods	NNS	O	method	dobj	10	SENT_280	[p16l274t133r379b155],
13	(	VBP	O	(	_	0	SENT_280	[p16l389t133r482b158],
14	normal	JJ	O	normal	acomp	13	SENT_280	[p16l389t133r482b158],
15	2	CD	NUMBER	2	num	17	SENT_280	[p16l491t140r503b155],
16	test	NN	O	test	nn	17	SENT_280	[p16l511t134r571b158],
17	)	NN	O	)	nsubj	13	SENT_280	[p16l511t134r571b158],
18	.	.	O	.	_	0	SENT_280	[p16l511t134r571b158],

1	VASP	NN	ORGANIZATION	vasp	nsubj	2	SENT_281	[p16l581t134r649b155],
2	indicates	VBZ	O	indicate	dep	7	SENT_281	[p16l659t133r765b155],
3	vasodilator	NN	O	vasodilator	nn	6	SENT_281	[p16l773t133r1047b155],
4	—	NN	O	—	nn	6	SENT_281	[p16l773t133r1047b155],
5	stimu	NN	O	stimu	nn	6	SENT_281	[p16l773t133r1047b155],
6	|	NN	O	|	dobj	2	SENT_281	[p16l773t133r1047b155],
7	ated	VBD	O	ate	_	0	SENT_281	[p16l773t133r1047b155],
8	phosphoprotein	NN	O	phosphoprotein	nn	9	SENT_281	[p16l1058t133r1251b162],
9	phosphory	NN	O	phosphory	dobj	7	SENT_281	[p16l1262t133r1402b162],
10	—	CD	NUMBER	—	num	9	SENT_281	[p16l1262t133r1402b162],
11	these	DT	O	these	det	14	SENT_281	[p16l1455t106r1547b137],
12	hlgher	NN	O	hlgher	nn	14	SENT_281	[p16l1565t106r1683b147],
13	malntenance	NN	O	malntenance	nn	14	SENT_281	[p16l1700t114r1933b137],
14	doses	NNS	O	dose	nsubj	7	SENT_281	[p16l1951t106r2049b137],
15	of	IN	O	of	_	0	SENT_281	[p16l2068t106r2104b137],
16	iauon	NN	O	iauon	nn	17	SENT_281	[p16l58t166r123b189],
17	a55ay	NN	O	a55ay	prep_of	14	SENT_281	[p16l135t173r205b195],
18	_	CD	NUMBER	_	num	19	SENT_281	[p16l135t173r205b195],
19	clopidogrel	NN	O	clopidogrel	dep	14	SENT_281	[p16l1455t154r1648b195],
20	during	IN	O	during	_	0	SENT_281	[p16l1661t154r1775b195],
21	the	DT	O	the	det	23	SENT_281	[p16l1789t155r1841b185],
22	approximately	RB	O	approximately	advmod	23	SENT_281	[p16l1855t154r2102b195],
23	noncarriers	JJ	O	noncarriers	prep_during	19	SENT_281	[p16l9t501r621b586],
24	taking	VBG	O	take	partmod	23	SENT_281	[p16l664t492r998b616],
25	the	DT	O	the	det	27	SENT_281	[p16l1037t492r1200b586],
26	75	CD	NUMBER	75	num	27	SENT_281	[p16l1244t498r1364b588],
27	mg	NN	O	mg	dobj	24	SENT_281	[p16l1407t525r1572b616],
28	and	CC	O	and	_	0	SENT_281	[p16l1610t492r1806b586],
29	150	CD	NUMBER	150	num	31	SENT_281	[p16l1854t498r2038b586],
30	mg	NN	O	mg	nn	31	SENT_281	[p16l9t675r175b767],
31	doses	NNS	O	dose	conj_and	27	SENT_281	[p16l205t641r522b755],
32	,	,	O	,	_	0	SENT_281	[p16l205t641r522b755],
33	2	CD	NUMBER	2	num	34	SENT_281	[p16l559t648r616b734],
34	patients	NNS	O	patient	appos	27	SENT_281	[p16l647t652r1067b767],
35	had	VBD	O	have	partmod	34	SENT_281	[p16l1098t641r1293b736],
36	cardiac	JJ	O	cardiac	amod	38	SENT_281	[p16l1324t641r1700b737],
37	ischemic	JJ	O	ischemic	amod	38	SENT_281	[p16l1729t641r2040b737, p16l9t801r200b887],
38	events	NNS	O	event	dobj	35	SENT_281	[p16l231t815r557b887],
39	while	IN	O	while	_	0	SENT_281	[p16l583t792r870b887],
40	taking	VBG	O	take	prepc_while	35	SENT_281	[p16l900t792r1226b918],
41	the	DT	O	the	det	43	SENT_281	[p16l1255t792r1414b887],
42	75-mg	JJ	O	75-mg	amod	43	SENT_281	[p16l1448t798r1780b918],
43	dose	NN	O	dose	dobj	40	SENT_281	[p16l1807t792r2041b887],
44	and	CC	O	and	_	0	SENT_281	[p16l10t944r200b1039],
45	3	CD	NUMBER	3	conj_and	43	SENT_281	[p16l225t951r282b1039],
46	with	IN	O	with	_	0	SENT_281	[p16l310t944r545b1039],
47	the	DT	O	the	det	49	SENT_281	[p16l572t943r731b1039],
48	150-mg	JJ	O	150-mg	amod	49	SENT_281	[p16l767t951r1155b1069],
49	dose	NN	O	dose	prep_with	35	SENT_281	[p16l1181t943r1436b1039],
50	.	.	O	.	_	0	SENT_281	[p16l1181t943r1436b1039],

1	There	EX	O	there	expl	2	SENT_282	[p16l1470t943r1770b1039],
2	were	VBD	O	be	_	0	SENT_282	[p16l1793t978r2040b1039],
3	o	NN	O	o	nsubj	2	SENT_282	[p16l11t1100r70b1190],
4	and	CC	O	and	_	0	SENT_282	[p16l110t1094r305b1189],
5	5	CD	NUMBER	5	num	6	SENT_282	[p16l344t1102r398b1190],
6	patients	NNS	O	patient	nsubj	2	SENT_282	[p16l440t1103r862b1219],
7	with	IN	O	with	_	0	SENT_282	[p16l897t1094r1140b1190],
8	bleeding	JJ	O	bleeding	amod	9	SENT_282	[p16l1173t1094r1634b1220],
9	events	NNS	O	event	prep_with	2	SENT_282	[p16l1672t1117r2037b1208],
10	,	,	O	,	_	0	SENT_282	[p16l1672t1117r2037b1208],
11	respectively	RB	O	respectively	advmod	2	SENT_282	[p16l9t1244r659b1369],
12	,	,	O	,	_	0	SENT_282	[p16l9t1244r659b1369],
13	that	IN	O	that	complm	14	SENT_282	[p16l693t1244r897b1339],
14	met	VBD	O	meet	ccomp	2	SENT_282	[p16l922t1267r1122b1339],
15	criteria	NNS	O	criterion	dobj	14	SENT_282	[p16l1150t1254r1517b1339],
16	for	IN	O	for	_	0	SENT_282	[p16l1547t1243r1693b1339],
17	bleeding	VBG	O	bleed	prepc_for	14	SENT_282	[p16l1718t1244r2040b1339, p16l9t1405r173b1520],
18	requiring	VBG	O	require	xcomp	17	SENT_282	[p16l198t1405r681b1520],
19	medical	JJ	O	medical	amod	20	SENT_282	[p16l705t1394r1111b1490],
20	attention	NN	O	attention	dobj	18	SENT_282	[p16l1139t1405r1627b1490],
21	.	.	O	.	_	0	SENT_282	[p16l1139t1405r1627b1490],

1	Among	IN	O	among	_	0	SENT_283	[p16l1660t1400r2043b1520],
2	carriers	NNS	O	carrier	prep_among	11	SENT_283	[p16l12t1554r414b1639],
3	of	IN	O	of	_	0	SENT_283	[p16l465t1543r574b1639],
4	a	DT	O	a	det	8	SENT_283	[p16l615t1579r666b1639],
5	CYP2C19	NN	O	cyp2c19	nn	8	SENT_283	[p16l718t1540r1349b1641],
6	*	NN	O	*	nn	8	SENT_283	[p16l718t1540r1349b1641],
7	2	CD	NUMBER	2	num	8	SENT_283	[p16l718t1540r1349b1641],
8	allele	NN	O	allele	prep_of	2	SENT_283	[p16l1403t1545r1712b1658],
9	,	,	O	,	_	0	SENT_283	[p16l1403t1545r1712b1658],
10	there	EX	O	there	expl	11	SENT_283	[p16l1768t1545r2040b1639],
11	was	VBD	O	be	_	0	SENT_283	[p16l7t1729r206b1790],
12	1	CD	NUMBER	1	num	13	SENT_283	[p16l263t1702r305b1789],
13	patient	NN	O	patient	nsubj	11	SENT_283	[p16l357t1705r732b1820],
14	who	WP	O	who	nsubj	15	SENT_283	[p16l771t1696r1001b1790],
15	experienced	VBD	O	experience	rcmod	13	SENT_283	[p16l1051t1696r1698b1820],
16	a	DT	O	a	det	19	SENT_283	[p16l1743t1729r1794b1790],
17	cardiac	JJ	O	cardiac	amod	19	SENT_283	[p16l1841t1729r2039b1790, p16l11t1845r226b1940],
18	ischemic	JJ	O	ischemic	amod	19	SENT_283	[p16l261t1845r732b1941],
19	event	NN	O	event	dobj	15	SENT_283	[p16l771t1868r1057b1941],
20	at	IN	O	at	_	0	SENT_283	[p16l1092t1869r1186b1941],
21	the	DT	O	the	det	23	SENT_283	[p16l1222t1845r1386b1941],
22	75-mg	JJ	O	75-mg	amod	23	SENT_283	[p16l1427t1852r1765b1971],
23	dose	NN	O	dose	prep_at	15	SENT_283	[p16l1801t1845r2040b1941],
24	of	IN	O	of	_	0	SENT_283	[p16l12t1994r119b2090],
25	clopidogrel	NN	O	clopidogrel	prep_of	23	SENT_283	[p16l140t1995r754b2121],
26	.	.	O	.	_	0	SENT_283	[p16l140t1995r754b2121],

1	A	DT	O	a	det	3	SENT_284	[p16l787t2002r869b2088],
2	bleeding	VBG	O	bleed	amod	3	SENT_284	[p16l895t1995r1346b2121],
3	event	NN	O	event	nsubj	7	SENT_284	[p16l1374t2019r1656b2090],
4	requiring	VBG	O	require	partmod	3	SENT_284	[p16l1682t2005r2040b2121, p16l9t2158r177b2273],
5	medical	JJ	O	medical	amod	6	SENT_284	[p16l213t2147r631b2243],
6	attention	NN	O	attention	dobj	4	SENT_284	[p16l668t2158r1152b2243],
7	occurred	VBD	O	occur	_	0	SENT_284	[p16l1190t2148r1664b2243],
8	in	IN	O	in	_	0	SENT_284	[p16l1699t2158r1805b2240],
9	1	CD	NUMBER	1	prep_in	7	SENT_284	[p16l1851t2155r1894b2240],
10	of	IN	O	of	_	0	SENT_284	[p16l1942t2147r2051b2243],
11	the	DT	O	the	det	12	SENT_284	[p16l13t2298r178b2392],
12	patients	NNS	O	patient	prep_of	9	SENT_284	[p16l227t2307r656b2422],
13	in	IN	O	in	_	0	SENT_284	[p16l707t2307r812b2390],
14	each	DT	O	each	prep_in	7	SENT_284	[p16l864t2298r1106b2392],
15	of	IN	O	of	_	0	SENT_284	[p16l1157t2296r1266b2392],
16	the	DT	O	the	det	19	SENT_284	[p16l1310t2297r1475b2392],
17	following	VBG	O	follow	amod	19	SENT_284	[p16l1526t2296r2042b2423],
18	dosing	NN	O	dosing	nn	19	SENT_284	[p16l11t2449r364b2573],
19	regimens	NNS	O	regimen	prep_of	14	SENT_284	[p16l392t2458r902b2573],
20	:	:	O	:	_	0	SENT_284	[p16l392t2458r902b2573],
21	75	CD	NUMBER	75	dep	14	SENT_284	[p16l946t2455r1100b2562],
22	,	,	O	,	_	0	SENT_284	[p16l946t2455r1100b2562],
23	225	CD	NUMBER	225	num	21	SENT_284	[p16l1136t2455r1359b2562],
24	,	,	O	,	_	0	SENT_284	[p16l1136t2455r1359b2562],
25	and	CC	NUMBER	and	_	0	SENT_284	[p16l1395t2449r1589b2543],
26	300	CD	NUMBER	300	dep	14	SENT_284	[p16l1619t2455r1812b2543],
27	mg	NN	O	mg	dep	21	SENT_284	[p16l1845t2482r2034b2573],
28	.	.	O	.	_	0	SENT_284	[p16l1845t2482r2034b2573],

1	No	DT	O	no	det	3	SENT_285	[p16l10t2609r166b2696],
2	adverse	JJ	O	adverse	amod	3	SENT_285	[p16l217t2600r618b2696],
3	events	NNS	O	event	nsubj	27	SENT_285	[p16l668t2623r1003b2696],
4	or	CC	O	or	_	0	SENT_285	[p16l1054t2635r1164b2696],
5	serious	JJ	O	serious	amod	7	SENT_285	[p16l1211t2611r1590b2696],
6	adverse	JJ	O	adverse	amod	7	SENT_285	[p16l1640t2600r2040b2696],
7	events	NNS	O	event	conj_or	3	SENT_285	[p16l12t2774r357b2845],
8	that	WDT	O	that	nsubj	11	SENT_285	[p16l414t2751r627b2845],
9	were	VBD	O	be	aux	11	SENT_285	[p16l675t2785r937b2846],
10	not	RB	O	not	neg	11	SENT_285	[p16l990t2774r1172b2845],
11	end	VB	O	end	rcmod	7	SENT_285	[p16l1225t2751r1423b2845],
12	points	NNS	O	point	dobj	11	SENT_285	[p16l1473t2760r1819b2875],
13	occurred	VBD	O	occur	_	0	SENT_285	[p16l1874t2785r2038b2845, p16l12t2901r360b2996],
14	at	IN	O	at	_	0	SENT_285	[p16l399t2924r495b2996],
15	a	DT	O	a	det	16	SENT_285	[p16l533t2936r583b2996],
16	frequency	NN	O	frequency	prep_at	13	SENT_285	[p16l625t2900r1156b3027],
17	greater	JJR	O	greater	mwe	18	SENT_285	[p16l1194t2924r1563b3026],
18	than	IN	O	than	quantmod	19	SENT_285	[p16l1604t2901r1841b2996],
19	3	CD	PERCENT	3	num	20	SENT_285	[p16l1880t2904r2038b2999],
20	%	NN	PERCENT	%	dobj	13	SENT_285	[p16l1880t2904r2038b2999],
21	per	IN	O	per	_	0	SENT_285	[p16l8t3088r180b3179],
22	treatment	NN	O	treatment	nn	23	SENT_285	[p16l209t3076r717b3149],
23	group	NN	O	group	prep_per	20	SENT_285	[p16l743t3087r1082b3179],
24	,	,	O	,	_	0	SENT_285	[p16l743t3087r1082b3179],
25	and	CC	O	and	_	0	SENT_285	[p16l1115t3053r1308b3149],
26	there	EX	O	there	expl	27	SENT_285	[p16l1338t3053r1602b3149],
27	were	VBD	O	be	conj_and	13	SENT_285	[p16l1627t3088r1880b3149],
28	no	DT	O	no	det	30	SENT_285	[p16l1908t3088r2038b3149],
29	significant	JJ	O	significant	amod	30	SENT_285	[p16l10t3202r569b3329],
30	imbalances	NNS	O	imbalance	npadvmod	31	SENT_285	[p16l611t3203r1208b3298],
31	specifically	RB	O	specifically	advmod	27	SENT_285	[p16l1253t3202r1850b3328],
32	for	IN	O	for	_	0	SENT_285	[p16l1894t3202r2042b3298],
33	hematologic	JJ	O	hematologic	amod	35	SENT_285	[p16l9t3353r698b3479],
34	,	,	O	,	_	0	SENT_285	[p16l9t3353r698b3479],
35	gastrointestinal	JJ	O	gastrointestinal	prep_for	27	SENT_285	[p16l737t3354r1591b3479],
36	,	,	O	,	_	0	SENT_285	[p16l737t3354r1591b3479],
37	or	CC	O	or	_	0	SENT_285	[p16l1632t3388r1742b3449],
38	musculoskeletal	JJ	O	musculoskeletal	amod	39	SENT_285	[p16l1773t3388r2040b3449, p16l12t3504r648b3598],
39	disorders	NNS	O	disorder	conj_or	35	SENT_285	[p16l688t3504r1180b3598],
40	for	IN	O	for	_	0	SENT_285	[p16l1222t3502r1370b3598],
41	CYP2C19	NN	O	cyp2c19	nn	42	SENT_285	[p16l1412t3499r2037b3599],
42	*	NN	O	*	prep_for	39	SENT_285	[p16l1412t3499r2037b3599],
43	2	CD	NUMBER	2	num	42	SENT_285	[p16l1412t3499r2037b3599],

1	carriers	NNS	O	carrier	nsubj	6	SENT_286	[p16l12t3663r406b3748],
2	at	IN	O	at	_	0	SENT_286	[p16l437t3676r533b3748],
3	the	DT	O	the	det	5	SENT_286	[p16l563t3653r725b3748],
4	different	JJ	O	different	amod	5	SENT_286	[p16l757t3652r1210b3748],
5	doses	NNS	O	dose	prep_at	1	SENT_286	[p16l1239t3653r1527b3748],
6	(	VBP	O	(	_	0	SENT_286	[p16l1566t3652r2034b3762],
7	eTable	JJ	O	etable	amod	8	SENT_286	[p16l1566t3652r2034b3762],
8	)	NN	O	)	dobj	6	SENT_286	[p16l1566t3652r2034b3762],
9	.	.	O	.	_	0	SENT_286	[p16l1566t3652r2034b3762],

1	COMMENT	JJ	O	comment	_	0	SENT_287	[p17l12t147r724b243],

1	Clopidogrel	NNP	O	Clopidogrel	_	0	SENT_288	[p17l15t308r722b433],
2	,	,	O	,	_	0	SENT_288	[p17l15t308r722b433],
3	one	CD	NUMBER	one	appos	1	SENT_288	[p17l784t343r982b403],
4	of	IN	O	of	_	0	SENT_288	[p17l1041t307r1153b403],
5	the	DT	O	the	prep_of	1	SENT_288	[p17l1202t308r1373b403],
6	most	RBS	O	most	advmod	5	SENT_288	[p17l1429t331r1704b403],
7	commonly	RB	O	commonly	advmod	5	SENT_288	[p17l1760t342r2038b403, p17l9t460r348b586],

1	prescribed	VBN	O	prescribe	dep	9	SENT_289	[p17l372t460r922b586],
2	cardiovascular	JJ	O	cardiovascular	amod	3	SENT_289	[p17l952t460r1710b556],
3	medications	NNS	O	medication	dobj	1	SENT_289	[p17l1737t460r2040b556, p17l12t620r379b705],
4	in	IN	O	in	_	0	SENT_289	[p17l421t620r525b704],
5	the	DT	O	the	det	6	SENT_289	[p17l567t611r728b705],
6	world	NN	O	world	prep_in	3	SENT_289	[p17l767t610r1103b724],
7	,	,	O	,	_	0	SENT_289	[p17l767t610r1103b724],
8	is	VBZ	O	be	auxpass	9	SENT_289	[p17l1148t620r1227b705],
9	approved	VBN	O	approve	_	0	SENT_289	[p17l1271t611r1761b735],
10	for	IN	O	for	_	0	SENT_289	[p17l1803t609r1949b705],
11	a	DT	O	a	det	14	SENT_289	[p17l1989t645r2040b705],
12	single	JJ	O	single	amod	14	SENT_289	[p17l10t761r310b886],
13	maintenance	NN	O	maintenance	nn	14	SENT_289	[p17l337t771r1002b856],
14	dose	NN	O	dose	prep_for	9	SENT_289	[p17l1031t761r1263b856],
15	of	IN	O	of	_	0	SENT_289	[p17l1294t760r1400b856],
16	75	CD	NUMBER	75	num	17	SENT_289	[p17l1423t768r1539b858],
17	mg	NN	O	mg	prep_of	14	SENT_289	[p17l1572t795r1735b886],
18	daily	RB	SET	daily	advmod	9	SENT_289	[p17l1762t761r2034b886],
19	.	.	O	.	_	0	SENT_289	[p17l1762t761r2034b886],

1	However	RB	O	however	advmod	8	SENT_290	[p17l10t922r505b1027],
2	,	,	O	,	_	0	SENT_290	[p17l10t922r505b1027],
3	the	DT	O	the	det	4	SENT_290	[p17l540t913r700b1008],
4	response	NN	O	response	nsubj	8	SENT_290	[p17l727t948r1186b1039],
5	to	TO	O	to	_	0	SENT_290	[p17l1217t937r1313b1009],
6	clopidogrel	NN	O	clopidogrel	prep_to	4	SENT_290	[p17l1346t913r1934b1039],
7	is	VBZ	O	be	cop	8	SENT_290	[p17l1961t924r2040b1008],
8	variable	JJ	O	variable	_	0	SENT_290	[p17l7t1064r448b1178],
9	,	,	O	,	_	0	SENT_290	[p17l7t1064r448b1178],
10	and	CC	O	and	_	0	SENT_290	[p17l495t1064r688b1159],
11	as	IN	O	as	_	0	SENT_290	[p17l729t1098r830b1159],
12	a	DT	O	a	det	13	SENT_290	[p17l873t1098r924b1159],
13	group	NN	O	group	prep_as	15	SENT_290	[p17l966t1097r1305b1190],
14	,	,	O	,	_	0	SENT_290	[p17l966t1097r1305b1190],
15	patients	NNS	O	patient	conj_and	8	SENT_290	[p17l1349t1073r1764b1189],
16	with	IN	O	with	_	0	SENT_290	[p17l1803t1064r2042b1159],
17	either	CC	O	either	preconj	18	SENT_290	[p17l12t1215r313b1310],
18	1	CD	NUMBER	1	prep_with	15	SENT_290	[p17l357t1222r398b1307],
19	or	CC	O	or	_	0	SENT_290	[p17l443t1249r552b1310],
20	2	CD	NUMBER	2	conj_or	18	SENT_290	[p17l586t1222r644b1307],
21	loss	NN	O	loss	dep	18	SENT_290	[p17l679t1214r1514b1310],
22	—	CD	NUMBER	—	num	21	SENT_290	[p17l679t1214r1514b1310],
23	of-function	JJ	O	of-function	amod	24	SENT_290	[p17l679t1214r1514b1310],
24	CYPZC	NN	O	cypzc	dep	21	SENT_290	[p17l1550t1220r1913b1310],
25	19	CD	NUMBER	19	num	24	SENT_290	[p17l1924t1220r2040b1310],

1	alleles	NNS	O	allele	nsubj	4	SENT_291	[p17l10t1365r337b1459],
2	have	VBP	O	have	aux	4	SENT_291	[p17l385t1365r630b1459],
3	an	DT	O	a	advmod	4	SENT_291	[p17l679t1399r805b1459],
4	attenuated	VBN	O	attenuate	_	0	SENT_291	[p17l852t1365r1417b1459],
5	pharmacologic	JJ	O	pharmacologic	acomp	4	SENT_291	[p17l1462t1365r2039b1489, p17l31t1754r156b1816],

1	response	NN	O	response	_	0	SENT_292	[p17l179t1771r411b1816],
2	and	CC	O	and	_	0	SENT_292	[p17l434t1754r531b1801],
3	worse	JJR	O	worse	conj_and	1	SENT_292	[p17l551t1771r708b1801],
4	clinical	JJ	O	clinical	amod	5	SENT_292	[p17l731t1754r920b1801],
5	outcomes	NNS	O	outcome	dep	1	SENT_292	[p17l943t1765r1050b1801, p17l32t1847r196b1877],
6	in	IN	O	in	_	0	SENT_292	[p17l217t1835r269b1877],
7	the	DT	O	the	det	8	SENT_292	[p17l290t1830r370b1877],
8	setting	NN	O	setting	prep_in	5	SENT_292	[p17l391t1835r567b1893],
9	of	IN	O	of	_	0	SENT_292	[p17l588t1829r642b1877],
10	treatment	NN	O	treatment	prep_of	8	SENT_292	[p17l658t1841r914b1877],
11	with	IN	O	with	_	0	SENT_292	[p17l931t1830r1051b1878],
12	the	DT	O	the	det	14	SENT_292	[p17l32t1906r114b1954],
13	standard	JJ	O	standard	amod	14	SENT_292	[p17l138t1906r372b1954],
14	dose	NN	O	dose	prep_with	10	SENT_292	[p17l396t1906r516b1954],
15	of	IN	O	of	_	0	SENT_292	[p17l542t1906r596b1954],
16	clopidogrel	NN	O	clopidogrel	prep_of	14	SENT_292	[p17l616t1906r933b1970],
17	.	.	O	.	_	0	SENT_292	[p17l616t1906r933b1970],

1	We	PRP	O	we	nsubj	3	SENT_293	[p17l959t1911r1050b1954],
2	now	RB	DATE	now	advmod	3	SENT_293	[p17l31t2016r146b2047],
3	show	VBP	O	show	_	0	SENT_293	[p17l160t1999r299b2047],
4	that	IN	O	that	complm	22	SENT_293	[p17l315t1999r417b2046],
5	(	NN	O	(	nsubj	22	SENT_293	[p17l435t1999r508b2054],
6	1	CD	NUMBER	1	number	7	SENT_293	[p17l435t1999r508b2054],
7	)	CD	NUMBER	)	npadvmod	8	SENT_293	[p17l435t1999r508b2054],
8	higher	JJR	O	higher	amod	10	SENT_293	[p17l527t1999r698b2062],
9	maintenance	NN	O	maintenance	nn	10	SENT_293	[p17l713t2004r1050b2046],
10	doses	NNS	O	dose	npadvmod	5	SENT_293	[p17l32t2090r175b2138],
11	of	IN	O	of	_	0	SENT_293	[p17l199t2090r253b2138],
12	clopidogrel	NN	O	clopidogrel	prep_of	5	SENT_293	[p17l272t2090r570b2153],
13	in	IN	O	in	_	0	SENT_293	[p17l591t2095r644b2137],
14	patients	NNS	O	patient	prep_in	12	SENT_293	[p17l665t2095r873b2153],
15	carrying	VBG	O	carry	partmod	5	SENT_293	[p17l897t2107r1050b2153, p17l31t2170r114b2229],
16	a	DT	O	a	det	18	SENT_293	[p17l128t2183r153b2213],
17	CYP2C19	NN	O	cyp2c19	nn	18	SENT_293	[p17l169t2163r478b2213],
18	*	NN	O	*	dobj	15	SENT_293	[p17l169t2163r478b2213],
19	2	CD	NUMBER	2	num	20	SENT_293	[p17l169t2163r478b2213],
20	allele	NN	O	allele	npadvmod	21	SENT_293	[p17l495t2165r630b2213],
21	significantly	RB	O	significantly	advmod	15	SENT_293	[p17l644t2165r967b2229],
22	reduce	VB	O	reduce	ccomp	3	SENT_293	[p17l980t2183r1050b2213, p17l32t2241r158b2289],
23	platelet	NN	O	platelet	nn	24	SENT_293	[p17l181t2241r380b2304],
24	reactivity	NN	O	reactivity	dobj	22	SENT_293	[p17l403t2246r667b2304],
25	,	,	O	,	_	0	SENT_293	[p17l403t2246r667b2304],
26	and	CC	O	and	_	0	SENT_293	[p17l694t2241r792b2289],
27	(	NN	O	(	nn	44	SENT_293	[p17l819t2241r893b2296],
28	2	CD	NUMBER	2	number	29	SENT_293	[p17l819t2241r893b2296],
29	)	CD	NUMBER	)	num	32	SENT_293	[p17l819t2241r893b2296],
30	daily	JJ	SET	daily	amod	32	SENT_293	[p17l922t2241r1052b2304],
31	maintenance	NN	O	maintenance	nn	32	SENT_293	[p17l31t2320r369b2363],
32	doses	NNS	O	dose	dep	27	SENT_293	[p17l388t2316r530b2363],
33	of	IN	O	of	_	0	SENT_293	[p17l550t2315r604b2363],
34	225	CD	NUMBER	225	num	35	SENT_293	[p17l618t2319r712b2363],
35	mg	NN	O	mg	prep_of	32	SENT_293	[p17l732t2332r815b2378],
36	of	IN	O	of	_	0	SENT_293	[p17l833t2315r887b2363],
37	clopidogrel	NN	O	clopidogrel	prep_of	35	SENT_293	[p17l901t2316r1050b2378, p17l32t2391r197b2455],
38	or	CC	O	or	_	0	SENT_293	[p17l211t2409r266b2439],
39	greater	JJR	O	greater	nn	44	SENT_293	[p17l279t2403r460b2455],
40	in	IN	O	in	_	0	SENT_293	[p17l473t2396r525b2438],
41	CYP2C19	NN	O	cyp2c19	nn	42	SENT_293	[p17l540t2389r847b2440],
42	*	NN	O	*	prep_in	39	SENT_293	[p17l540t2389r847b2440],
43	2	CD	NUMBER	2	num	42	SENT_293	[p17l540t2389r847b2440],
44	heterozygotes	NNS	O	heterozygote	nsubj	46	SENT_293	[p17l863t2392r1050b2439, p17l30t2478r223b2530],
45	can	MD	O	can	aux	46	SENT_293	[p17l239t2484r328b2514],
46	achieve	VB	O	achieve	conj_and	3	SENT_293	[p17l341t2467r535b2515],
47	on-treatment	JJ	O	on-treatment	amod	49	SENT_293	[p17l550t2478r892b2514],
48	platelet	NN	O	platelet	nn	49	SENT_293	[p17l904t2467r1050b2530, p17l31t2543r97b2591],
49	reactivity	NN	O	reactivity	dobj	46	SENT_293	[p17l118t2548r366b2606],
50	at	IN	O	at	advmod	52	SENT_293	[p17l388t2555r436b2591],
51	least	JJS	O	least	pobj	50	SENT_293	[p17l457t2543r577b2591],
52	comparable	JJ	O	comparable	amod	49	SENT_293	[p17l600t2543r908b2606],
53	with	IN	O	with	_	0	SENT_293	[p17l930t2543r1051b2591],
54	what	WP	O	what	nsubjpass	56	SENT_293	[p17l29t2618r163b2666],
55	is	VBZ	O	be	auxpass	56	SENT_293	[p17l185t2623r226b2666],
56	achieved	VBN	O	achieve	prepc_with	46	SENT_293	[p17l250t2618r485b2666],
57	with	IN	O	with	_	0	SENT_293	[p17l507t2618r629b2666],
58	75	CD	NUMBER	75	num	60	SENT_293	[p17l654t2622r714b2666],
59	mg	NN	O	mg	nn	60	SENT_293	[p17l740t2635r824b2681],
60	daily	NN	SET	daily	prep_with	56	SENT_293	[p17l848t2618r977b2681],
61	of	IN	O	of	_	0	SENT_293	[p17l1001t2618r1055b2666],
62	clopidogrel	NN	O	clopidogrel	prep_of	60	SENT_293	[p17l32t2693r329b2756],
63	in	IN	O	in	_	0	SENT_293	[p17l346t2698r398b2739],
64	noncarrier	NN	O	noncarrier	nn	65	SENT_293	[p17l414t2698r692b2740],
65	patients	NNS	O	patient	prep_in	62	SENT_293	[p17l707t2698r915b2755],
66	with	IN	O	with	_	0	SENT_293	[p17l931t2693r1051b2740],
67	cardiovascular	JJ	O	cardiovascular	amod	68	SENT_293	[p17l32t2768r414b2816],
68	disease	NN	O	disease	prep_with	56	SENT_293	[p17l432t2768r629b2816],
69	.	.	O	.	_	0	SENT_293	[p17l432t2768r629b2816],

1	Prior	RB	O	prior	advmod	6	SENT_294	[p17l97t2847r235b2891],
2	systematic	JJ	O	systematic	amod	3	SENT_294	[p17l261t2848r549b2906],
3	pharmacogenetic	JJ	O	pharmacogenetic	amod	4	SENT_294	[p17l574t2843r1050b2906],
4	studies	NNS	O	study	pobj	1	SENT_294	[p17l31t2919r218b2967],
5	have	VBP	O	have	aux	6	SENT_294	[p17l241t2919r365b2967],
6	tested	VBN	O	test	_	0	SENT_294	[p17l389t2919r546b2967],
7	clopidogrel	NN	O	clopidogrel	nn	9	SENT_294	[p17l569t2919r872b2982],
8	maintenance	NN	O	maintenance	nn	9	SENT_294	[p17l894t2924r1050b2967, p17l32t3006r238b3041],
9	doses	NNS	O	dose	dobj	6	SENT_294	[p17l260t2994r406b3041],
10	of	IN	O	of	_	0	SENT_294	[p17l429t2993r483b3041],
11	150	CD	NUMBER	150	num	12	SENT_294	[p17l505t2997r598b3041],
12	mg	NN	O	mg	prep_of	9	SENT_294	[p17l621t3011r704b3057],
13	daily	RB	SET	daily	advmod	6	SENT_294	[p17l725t2994r856b3056],
14	in	IN	O	in	_	0	SENT_294	[p17l875t2999r928b3040],
15	carriers	NNS	O	carrier	prep_in	6	SENT_294	[p17l950t3011r1050b3041, p17l31t3074r149b3117],
16	of	IN	O	of	_	0	SENT_294	[p17l166t3069r220b3117],
17	a	DT	O	a	det	20	SENT_294	[p17l232t3086r258b3117],
18	loss-of-function	NN	O	loss-of-function	nn	20	SENT_294	[p17l273t3069r702b3117],
19	C	NN	O	c	nn	20	SENT_294	[p17l718t3072r756b3117],
20	YPZC	NN	O	ypzc	prep_of	15	SENT_294	[p17l761t3072r903b3117],
21	19	CD	NUMBER	19	num	22	SENT_294	[p17l910t3072r969b3117],
22	allele	NN	O	allele	nsubj	6	SENT_294	[p17l985t3069r1050b3117, p17l31t3144r123b3191],

1	and	CC	O	and	cc	3	SENT_295	[p17l147t3144r245b3191],
2	have	VBP	O	have	aux	3	SENT_295	[p17l267t3144r391b3192],
3	reported	VBN	O	report	_	0	SENT_295	[p17l414t3144r644b3207],
4	mixed	JJ	O	mixed	amod	5	SENT_295	[p17l666t3144r834b3191],
5	results	NNS	O	result	dobj	3	SENT_295	[p17l857t3144r1047b3191],
6	.	.	O	.	_	0	SENT_295	[p17l857t3144r1047b3191],

1	In	IN	O	in	_	0	SENT_296	[p17l32t3223r87b3265],
2	one	CD	NUMBER	one	num	3	SENT_296	[p17l109t3236r204b3266],
3	study	NN	O	study	prep_in	17	SENT_296	[p17l226t3219r374b3281],
4	of	IN	O	of	_	0	SENT_296	[p17l395t3218r450b3266],
5	healthy	JJ	O	healthy	amod	6	SENT_296	[p17l466t3219r666b3281],
6	individuals	NNS	O	individual	prep_of	3	SENT_296	[p17l686t3218r1001b3276],
7	,	,	O	,	_	0	SENT_296	[p17l686t3218r1001b3276],
8	a	DT	O	a	det	13	SENT_296	[p17l1025t3236r1051b3266],
9	150	CD	NUMBER	150	number	10	SENT_296	[p17l36t3297r238b3357],
10	—	CD	NUMBER	—	num	13	SENT_296	[p17l36t3297r238b3357],
11	mg	NN	O	mg	nn	13	SENT_296	[p17l36t3297r238b3357],
12	maintenance	NN	O	maintenance	nn	13	SENT_296	[p17l256t3299r600b3342],
13	dose	NN	O	dose	nsubj	17	SENT_296	[p17l619t3294r739b3342],
14	of	IN	O	of	_	0	SENT_296	[p17l760t3294r814b3342],
15	clopidogrel	NN	O	clopidogrel	prep_of	13	SENT_296	[p17l829t3294r1050b3357, p17l31t3369r131b3432],
16	adequately	RB	O	adequately	advmod	17	SENT_296	[p17l153t3369r444b3432],
17	reduced	VBD	O	reduce	_	0	SENT_296	[p17l464t3369r680b3416],
18	platelet	NN	O	platelet	nn	19	SENT_296	[p17l700t3369r900b3431],
19	reactivity	NN	O	reactivity	iobj	17	SENT_296	[p17l920t3386r1050b3416, p17l32t3448r183b3506],
20	in	IN	O	in	_	0	SENT_296	[p17l211t3448r266b3490],
21	carriers	NNS	O	carrier	prep_in	19	SENT_296	[p17l296t3448r514b3491],
22	of	IN	O	of	_	0	SENT_296	[p17l545t3443r602b3491],
23	1	CD	NUMBER	1	num	28	SENT_296	[p17l631t3447r653b3490],
24	or	CC	O	or	_	0	SENT_296	[p17l688t3460r745b3491],
25	2	CD	NUMBER	2	conj_or	23	SENT_296	[p17l775t3447r804b3490],
26	lossoffunction	NN	O	lossoffunction	nn	28	SENT_296	[p17l834t3443r1049b3491, p17l32t3517r282b3565],
27	CYPZCI9	NN	O	cypzci9	nn	28	SENT_296	[p17l314t3520r583b3565],
28	alleles	NNS	O	allele	prep_of	21	SENT_296	[p17l614t3515r863b3574],
29	”	NN	O	”	dobj	17	SENT_296	[p17l614t3515r863b3574],
30	;	:	O	;	_	0	SENT_296	[p17l614t3515r863b3574],
31	other	JJ	O	other	amod	32	SENT_296	[p17l897t3517r1051b3565],
32	studies	NNS	O	study	dep	29	SENT_296	[p17l31t3592r216b3639],
33	conducted	VBN	O	conduct	partmod	32	SENT_296	[p17l233t3592r512b3639],
34	in	IN	O	in	_	0	SENT_296	[p17l526t3597r578b3638],
35	patients	NNS	O	patient	prep_in	33	SENT_296	[p17l592t3597r802b3654],
36	with	IN	O	with	_	0	SENT_296	[p17l816t3592r936b3639],
37	cardiovascular	JJ	O	cardiovascular	amod	38	SENT_296	[p17l952t3609r1050b3639, p17l32t3667r331b3715],
38	disease	NN	O	disease	prep_with	35	SENT_296	[p17l345t3667r527b3715],
39	with	IN	O	with	_	0	SENT_296	[p17l540t3667r659b3715],
40	CYP2C19	NN	O	cyp2c19	nn	42	SENT_296	[p17l674t3670r919b3715],
41	loss2-week	JJ	DURATION	loss2-week	amod	42	SENT_296	[p17l933t3667r1051b3715, p17l1134t1608r1327b1656],
42	duration	NN	O	duration	prep_with	33	SENT_296	[p17l1343t1608r1574b1655],
43	of	IN	O	of	_	0	SENT_296	[p17l1591t1607r1646b1655],
44	each	DT	O	each	det	45	SENT_296	[p17l1659t1608r1779b1655],
45	therapy	NN	O	therapy	prep_of	42	SENT_296	[p17l1796t1608r2013b1671],
46	,	,	O	,	_	0	SENT_296	[p17l1796t1608r2013b1671],
47	with	IN	O	with	_	0	SENT_296	[p17l2031t1608r2152b1656],
48	low	JJ	O	low	amod	49	SENT_296	[p17l1132t1672r1233b1719],
49	rates	NNS	O	rate	prep_with	33	SENT_296	[p17l1260t1683r1393b1719],
50	of	IN	O	of	_	0	SENT_296	[p17l1422t1671r1478b1719],
51	discontinuation	NN	O	discontinuation	prep_of	49	SENT_296	[p17l1502t1672r1967b1719],
52	.	.	O	.	_	0	SENT_296	[p17l1502t1672r1967b1719],

1	However	RB	O	however	_	0	SENT_297	[p17l1998t1676r2151b1719, p17l1133t1781r1262b1821],
2	,	,	O	,	_	0	SENT_297	[p17l1998t1676r2151b1719, p17l1133t1781r1262b1821],

1	further	RB	O	further	advmod	6	SENT_298	[p17l1291t1764r1484b1812],
2	long-term	JJ	O	long-term	amod	4	SENT_298	[p17l1509t1764r1784b1827],
3	intervention	NN	O	intervention	nn	4	SENT_298	[p17l1809t1769r2152b1812],
4	trials	NNS	O	trial	nsubjpass	6	SENT_298	[p17l1133t1840r1265b1888],
5	are	VBP	O	be	auxpass	6	SENT_298	[p17l1285t1857r1364b1888],
6	warranted	VBN	O	warrant	_	0	SENT_298	[p17l1383t1840r1670b1888],
7	.	.	O	.	_	0	SENT_298	[p17l1383t1840r1670b1888],

1	Prasugrel	NNP	O	Prasugrel	nsubj	5	SENT_299	[p17l1198t1916r1452b1979],
2	and	CC	O	and	_	0	SENT_299	[p17l1477t1916r1576b1964],
3	ticagrelor	NN	O	ticagrelor	conj_and	1	SENT_299	[p17l1600t1916r1858b1979],
4	are	VBP	O	be	cop	5	SENT_299	[p17l1883t1933r1962b1964],
5	newer	JJR	O	newer	_	0	SENT_299	[p17l1986t1933r2152b1964],

1	PZYH	NN	O	pzyh	dep	99	SENT_300	[p17l1133t2011r1270b2064],
2	ADP	NN	O	adp	dep	99	SENT_300	[p17l1281t2011r1399b2054],
3	receptor	NN	O	receptor	dep	99	SENT_300	[p17l1411t2019r1620b2070],
4	blockers	NNS	O	blocker	dep	99	SENT_300	[p17l1630t2008r1843b2055],
5	that	WDT	O	that	dep	99	SENT_300	[p17l1856t2008r1954b2055],
6	achieve	VBP	O	achieve	dep	99	SENT_300	[p17l1965t2008r2152b2055],
7	significantly	RB	O	significantly	dep	99	SENT_300	[p17l1132t2098r1451b2161],
8	higher	JJR	O	higher	dep	99	SENT_300	[p17l1465t2098r1635b2161],
9	levels	NNS	O	level	dep	99	SENT_300	[p17l1649t2098r1793b2146],
10	of	IN	O	of	dep	99	SENT_300	[p17l1810t2098r1863b2146],
11	platelet	NN	O	platelet	dep	99	SENT_300	[p17l1873t2098r2066b2161],
12	inhibition	NN	O	inhibition	dep	99	SENT_300	[p17l2080t2103r2151b2145, p17l1132t2173r1334b2221],
13	than	IN	O	than	dep	99	SENT_300	[p17l1347t2173r1461b2221],
14	does	VBZ	O	do	dep	99	SENT_300	[p17l1474t2173r1588b2221],
15	clopidogrel	NN	O	clopidogrel	dep	99	SENT_300	[p17l1602t2170r1989b2236],
16	.23	CD	NUMBER	.23	dep	99	SENT_300	[p17l1602t2170r1989b2236],
17	’24	CD	NUMBER	’24	dep	99	SENT_300	[p17l1602t2170r1989b2236],
18	These	DT	O	these	dep	99	SENT_300	[p17l2002t2173r2152b2221],
19	agents	NNS	O	agent	dep	99	SENT_300	[p17l1132t2260r1299b2311],
20	have	VBP	O	have	dep	99	SENT_300	[p17l1322t2248r1444b2296],
21	been	VBN	O	be	dep	99	SENT_300	[p17l1466t2248r1593b2296],
22	shown	VBN	O	show	dep	99	SENT_300	[p17l1615t2248r1791b2296],
23	to	TO	O	to	dep	99	SENT_300	[p17l1815t2260r1864b2296],
24	reduce	VB	O	reduce	dep	99	SENT_300	[p17l1888t2248r2066b2296],
25	ischemic	JJ	O	ischemic	dep	99	SENT_300	[p17l2089t2253r2150b2296, p17l1133t2322r1319b2369],
26	events	NNS	O	event	dep	99	SENT_300	[p17l1339t2333r1502b2369],
27	as	IN	O	as	dep	99	SENT_300	[p17l1521t2339r1571b2369],
28	compared	VBN	O	compare	dep	99	SENT_300	[p17l1591t2322r1850b2384],
29	with	IN	O	with	dep	99	SENT_300	[p17l1866t2322r1985b2369],
30	clopidogrel	NN	O	clopidogrel	dep	99	SENT_300	[p17l2004t2322r2151b2384, p17l1133t2397r1298b2460],
31	in	IN	O	in	dep	99	SENT_300	[p17l1320t2402r1372b2444],
32	patients	NNS	O	patient	dep	99	SENT_300	[p17l1393t2402r1600b2460],
33	with	IN	O	with	dep	99	SENT_300	[p17l1622t2397r1742b2445],
34	ACS	NN	ORGANIZATION	ac	dep	99	SENT_300	[p17l1762t2400r1892b2454],
35	,	,	O	,	_	0	SENT_300	[p17l1762t2400r1892b2454],
36	although	IN	O	although	dep	99	SENT_300	[p17l1917t2397r2152b2460],
37	with	IN	O	with	dep	99	SENT_300	[p17l1131t2472r1246b2519],
38	increased	VBN	O	increase	dep	99	SENT_300	[p17l1256t2472r1493b2519],
39	rates	NNS	O	rate	dep	99	SENT_300	[p17l1503t2483r1620b2519],
40	of	IN	O	of	dep	99	SENT_300	[p17l1633t2471r1686b2519],
41	nonsurgical	JJ	O	nonsurgical	dep	99	SENT_300	[p17l1692t2472r1987b2535],
42	bleedir1g	NN	O	bleedir1g	dep	99	SENT_300	[p17l1997t2472r2151b2519, p17l1132t2545r1314b2610],
43	.25	CD	NUMBER	.25	dep	99	SENT_300	[p17l1997t2472r2151b2519, p17l1132t2545r1314b2610],
44	’26	CD	NUMBER	’26	dep	99	SENT_300	[p17l1997t2472r2151b2519, p17l1132t2545r1314b2610],
45	In	IN	O	in	dep	99	SENT_300	[p17l1328t2552r1382b2594],
46	contrast	NN	O	contrast	dep	99	SENT_300	[p17l1395t2559r1602b2595],
47	to	TO	O	to	dep	99	SENT_300	[p17l1615t2559r1662b2595],
48	clopidogrel	NN	O	clopidogrel	dep	99	SENT_300	[p17l1678t2547r1979b2610],
49	,	,	O	,	_	0	SENT_300	[p17l1678t2547r1979b2610],
50	the	DT	O	the	dep	99	SENT_300	[p17l1996t2547r2075b2595],
51	effects	NNS	O	effect	dep	99	SENT_300	[p17l2089t2547r2151b2595, p17l1133t2621r1248b2669],
52	of	IN	O	of	dep	99	SENT_300	[p17l1267t2621r1320b2669],
53	prasugrel	NN	O	prasugrel	dep	99	SENT_300	[p17l1331t2622r1575b2685],
54	and	CC	O	and	dep	99	SENT_300	[p17l1592t2622r1688b2669],
55	ticagrelor	NN	O	ticagrelor	dep	99	SENT_300	[p17l1705t2622r1952b2685],
56	are	VBP	O	be	dep	99	SENT_300	[p17l1968t2639r2045b2669],
57	unaffected	JJ	O	unaffected	dep	99	SENT_300	[p17l2061t2639r2151b2669, p17l1132t2695r1329b2743],
58	by	IN	O	by	dep	99	SENT_300	[p17l1339t2696r1402b2758],
59	variants	NNS	O	variant	dep	99	SENT_300	[p17l1412t2701r1613b2743],
60	in	IN	O	in	dep	99	SENT_300	[p17l1625t2701r1676b2742],
61	the	DT	O	the	dep	99	SENT_300	[p17l1689t2696r1767b2743],
62	CYP2C19	NN	O	cyp2c19	dep	99	SENT_300	[p17l1782t2699r2021b2743],
63	gene	NN	O	gene	dep	99	SENT_300	[p17l2034t2713r2152b2758],
64	(	NN	O	(	dep	99	SENT_300	[p17l1136t2770r1251b2825],
65	and	CC	O	and	dep	99	SENT_300	[p17l1136t2770r1251b2825],
66	correspondingly	RB	O	correspondingly	dep	99	SENT_300	[p17l1263t2770r1690b2833],
67	,	,	O	,	_	0	SENT_300	[p17l1263t2770r1690b2833],
68	no	DT	O	no	dep	99	SENT_300	[p17l1704t2788r1769b2818],
69	association	NN	O	association	dep	99	SENT_300	[p17l1783t2775r2062b2818],
70	between	IN	O	between	dep	99	SENT_300	[p17l2072t2771r2151b2818, p17l1133t2856r1289b2893],
71	CYP2C	NN	O	cyp2c	dep	99	SENT_300	[p17l1313t2848r1495b2893],
72	19	CD	NUMBER	19	dep	99	SENT_300	[p17l1500t2848r1559b2893],
73	genotype	NN	O	genotype	dep	99	SENT_300	[p17l1581t2856r1821b2908],
74	and	CC	O	and	dep	99	SENT_300	[p17l1844t2845r1941b2892],
75	clinical	JJ	O	clinical	dep	99	SENT_300	[p17l1963t2845r2152b2892],
76	events	NNS	O	event	dep	99	SENT_300	[p17l1133t2932r1303b2968],
77	has	VBZ	O	have	dep	99	SENT_300	[p17l1328t2920r1416b2968],
78	been	VBN	O	be	dep	99	SENT_300	[p17l1440t2920r1569b2968],
79	observed	VBN	O	observe	dep	99	SENT_300	[p17l1594t2920r1836b2968],
80	in	IN	O	in	dep	99	SENT_300	[p17l1860t2925r1913b2967],
81	patients	NNS	O	patient	dep	99	SENT_300	[p17l1936t2925r2151b2983],
82	treated	VBN	O	treat	dep	99	SENT_300	[p17l1133t2995r1312b3042],
83	with	IN	O	with	dep	99	SENT_300	[p17l1327t2994r1446b3042],
84	these	DT	O	these	dep	99	SENT_300	[p17l1464t2995r1597b3042],
85	agents	NNS	O	agent	dep	99	SENT_300	[p17l1615t2994r1799b3057],
86	)	VBP	O	)	dep	99	SENT_300	[p17l1615t2994r1799b3057],
87	3738	CD	NUMBER	3738	dep	99	SENT_300	[p17l1809t2992r1908b3051],
88	and	CC	O	and	dep	99	SENT_300	[p17l1926t2995r2022b3042],
89	thus	RB	O	thus	dep	99	SENT_300	[p17l2040t2995r2151b3042],
90	these	DT	O	these	dep	99	SENT_300	[p17l1133t3070r1266b3117],
91	medications	NNS	O	medication	dep	99	SENT_300	[p17l1279t3070r1595b3117],
92	represent	VBP	O	represent	dep	99	SENT_300	[p17l1609t3081r1853b3132],
93	other	JJ	O	other	dep	99	SENT_300	[p17l1867t3070r2004b3117],
94	alternative	JJ	O	alternative	dep	99	SENT_300	[p17l2017t3070r2151b3117, p17l1132t3149r1290b3192],
95	treatment	NN	O	treatment	dep	99	SENT_300	[p17l1313t3156r1567b3192],
96	strategies	NNS	O	strategy	dep	99	SENT_300	[p17l1588t3149r1830b3207],
97	in	IN	O	in	dep	99	SENT_300	[p17l1852t3149r1904b3191],
98	such	JJ	O	such	dep	99	SENT_300	[p17l1926t3144r2048b3192],
99	patients	NNS	O	patient	_	0	SENT_300	[p17l2069t3161r2151b3207, p17l1133t3224r1287b3266],
100	.	.	O	.	_	0	SENT_300	[p17l2069t3161r2151b3207, p17l1133t3224r1287b3266],

1	However	RB	O	however	advmod	6	SENT_301	[p17l1310t3223r1558b3276],
2	,	,	O	,	_	0	SENT_301	[p17l1310t3223r1558b3276],
3	clopidogrel	NN	O	clopidogrel	nsubj	6	SENT_301	[p17l1581t3219r1874b3282],
4	will	MD	O	will	aux	6	SENT_301	[p17l1892t3219r1990b3267],
5	likely	RB	O	likely	advmod	6	SENT_301	[p17l2009t3219r2153b3282],
6	continue	VB	O	continue	_	0	SENT_301	[p17l1133t3299r1377b3342],
7	to	TO	O	to	aux	9	SENT_301	[p17l1405t3306r1455b3342],
8	be	VB	O	be	auxpass	9	SENT_301	[p17l1481t3295r1543b3342],
9	used	VBN	O	use	xcomp	6	SENT_301	[p17l1569t3295r1697b3342],
10	throughout	IN	O	throughout	_	0	SENT_301	[p17l1723t3294r2041b3357],
11	the	DT	O	the	det	12	SENT_301	[p17l2067t3294r2151b3342],
12	world	NN	O	world	prep_throughout	9	SENT_301	[p17l1131t3369r1292b3426],
13	,	,	O	,	_	0	SENT_301	[p17l1131t3369r1292b3426],
14	and	CC	O	and	_	0	SENT_301	[p17l1306t3369r1399b3417],
15	it	PRP	O	it	nsubj	18	SENT_301	[p17l1410t3374r1445b3417],
16	is	VBZ	O	be	cop	18	SENT_301	[p17l1455t3374r1493b3417],
17	therefore	RB	O	therefore	advmod	18	SENT_301	[p17l1506t3369r1730b3417],
18	important	JJ	O	important	conj_and	6	SENT_301	[p17l1741t3374r1994b3432],
19	to	TO	O	to	aux	20	SENT_301	[p17l2005t3381r2052b3417],
20	understand	VB	O	understand	xcomp	18	SENT_301	[p17l2064t3386r2151b3417, p17l1133t3444r1373b3491],
21	clopidogrel	NN	O	clopidogrel	poss	23	SENT_301	[p17l1399t3444r1753b3507],
22	’s	POS	O	’s	_	0	SENT_301	[p17l1399t3444r1753b3507],
23	effects	NNS	O	effect	dobj	20	SENT_301	[p17l1780t3443r1955b3491],
24	across	IN	O	across	_	0	SENT_301	[p17l1982t3461r2151b3491],
25	CYP2C19	NN	O	cyp2c19	nn	26	SENT_301	[p17l1134t3521r1386b3565],
26	genotypes	NNS	O	genotype	prep_across	20	SENT_301	[p17l1411t3529r1683b3580],
27	and	CC	O	and	_	0	SENT_301	[p17l1708t3518r1807b3565],
28	with	IN	O	with	_	0	SENT_301	[p17l1830t3518r1953b3565],
29	higher	JJR	O	higher	amod	31	SENT_301	[p17l1976t3518r2152b3580],
30	maintenance	NN	O	maintenance	nn	31	SENT_301	[p17l1132t3597r1466b3639],
31	doses	NNS	O	dose	prep_with	20	SENT_301	[p17l1485t3592r1639b3640],
32	.	.	O	.	_	0	SENT_301	[p17l1485t3592r1639b3640],

1	Studies	NNS	O	study	nsubj	3	SENT_302	[p17l1198t3668r1391b3715],
2	have	VBP	O	have	aux	3	SENT_302	[p17l1409t3668r1533b3715],
3	evaluated	VBN	O	evaluate	_	0	SENT_302	[p17l1553t3668r1808b3715],
4	whether	IN	O	whether	_	0	SENT_302	[p17l1824t3668r2047b3715],
5	taiof-function	NN	O	taiof-function	prep_whether	3	SENT_302	[p17l2066t3672r2151b3715, p18l32t20r345b68],

1	alleles	NNS	O	allele	nsubj	4	SENT_303	[p18l371t21r542b68],
2	have	VBP	O	have	aux	4	SENT_303	[p18l568t21r695b68],
3	not	RB	O	not	neg	4	SENT_303	[p18l721t32r813b68],
4	demonstrated	VBN	O	demonstrate	_	0	SENT_303	[p18l838t21r1049b68, p18l31t96r226b143],
5	as	IN	O	as	_	0	SENT_303	[p18l253t113r306b143],
6	significant	JJ	O	significant	amod	7	SENT_303	[p18l335t95r637b158],
7	reductions	NNS	O	reduction	prep_as	4	SENT_303	[p18l664t96r968b143],
8	in	IN	O	in	_	0	SENT_303	[p18l996t100r1051b142],
9	platelet	NN	O	platelet	nn	10	SENT_303	[p18l30t171r223b234],
10	reactivity	NN	O	reactivity	prep_in	7	SENT_303	[p18l236t176r478b234],
11	with	IN	O	with	_	0	SENT_303	[p18l489t171r609b219],
12	the	DT	O	the	det	14	SENT_303	[p18l623t171r703b219],
13	150-mg	JJ	O	150-mg	amod	14	SENT_303	[p18l722t174r919b234],
14	dose	NN	O	dose	prep_with	10	SENT_303	[p18l933t171r1050b219],
15	of	IN	O	of	_	0	SENT_303	[p18l32t245r86b292],
16	clopidogrel	NN	O	clopidogrel	prep_of	14	SENT_303	[p18l96t243r495b308],
17	.17	CD	NUMBER	.17	number	18	SENT_303	[p18l96t243r495b308],
18	'21	CD	NUMBER	'21	num	19	SENT_303	[p18l96t243r495b308],
19	Concordant	NN	O	concordant	dobj	4	SENT_303	[p18l514t245r826b293],
20	with	IN	O	with	_	0	SENT_303	[p18l837t245r956b293],
21	the	DT	O	the	det	23	SENT_303	[p18l971t245r1051b292],
22	latter	JJ	O	latter	amod	23	SENT_303	[p18l31t319r173b367],
23	observation	NN	O	observation	prep_with	19	SENT_303	[p18l199t319r533b376],
24	,	,	O	,	_	0	SENT_303	[p18l199t319r533b376],
25	we	PRP	O	we	nsubj	26	SENT_303	[p18l558t336r634b367],
26	found	VBD	O	find	rcmod	19	SENT_303	[p18l660t319r820b367],
27	that	IN	O	that	complm	28	SENT_303	[p18l846t319r952b367],
28	increasing	VBG	O	increase	ccomp	26	SENT_303	[p18l975t324r1050b366, p18l32t400r248b458],
29	the	DT	O	the	det	31	SENT_303	[p18l263t395r344b442],
30	maintenance	NN	O	maintenance	nn	31	SENT_303	[p18l358t400r697b442],
31	dose	NN	O	dose	dobj	28	SENT_303	[p18l712t395r831b442],
32	from	IN	O	from	_	0	SENT_303	[p18l846t394r972b442],
33	75	CD	NUMBER	75	prep_from	28	SENT_303	[p18l989t398r1048b443],

1	2226	CD	DATE	2226	_	0	SENT_304	[p18l195t500r268b521],
2	JAMA	NNP	O	JAMA	nn	4	SENT_304	[p18l298t500r380b525],
3	,	,	O	,	_	0	SENT_304	[p18l298t500r380b525],
4	November	NNP	DATE	November	dep	1	SENT_304	[p18l392t498r522b521],
5	23/30	CD	DATE	23/30	num	4	SENT_304	[p18l532t500r610b525],
6	,	,	O	,	_	0	SENT_304	[p18l532t500r610b525],
7	20l1	CD	NUMBER	20l1	num	4	SENT_304	[p18l622t498r759b521],
8	.	.	O	.	_	0	SENT_304	[p18l622t498r759b521],

1	—	NN	O	—	_	0	SENT_305	[p18l622t498r759b521],
2	.	.	O	.	_	0	SENT_305	[p18l622t498r759b521],

1	Vol	NN	O	vol	_	0	SENT_306	[p18l622t498r759b521],
2	306	CD	NUMBER	306	num	1	SENT_306	[p18l769t500r823b525],
3	,	,	O	,	_	0	SENT_306	[p18l769t500r823b525],
4	No.	NN	O	no.	appos	1	SENT_306	[p18l834t500r877b521],
5	20	CD	NUMBER	20	num	4	SENT_306	[p18l889t500r919b521],

1	loring	VBG	O	lore	amod	3	SENT_307	[p18l1132t21r1292b84],
2	clopidogrel	NN	O	clopidogrel	nn	3	SENT_307	[p18l1307t21r1609b84],
3	therapy	NN	O	therapy	nsubj	8	SENT_307	[p18l1626t21r1828b84],
4	using	VBG	O	use	partmod	3	SENT_307	[p18l1841t26r1988b84],
5	platelet	NN	O	platelet	nn	7	SENT_307	[p18l2001t21r2152b84, p18l1132t96r1199b143],
6	function	NN	O	function	nn	7	SENT_307	[p18l1223t95r1452b143],
7	testing	NN	O	testing	dobj	4	SENT_307	[p18l1477t101r1658b159],
8	improves	VBZ	O	improve	_	0	SENT_307	[p18l1681t101r1931b159],
9	clinical	JJ	O	clinical	amod	10	SENT_307	[p18l1957t96r2152b143],
10	outcomes	NNS	O	outcome	dobj	8	SENT_307	[p18l1133t183r1393b219],
11	.	.	O	.	_	0	SENT_307	[p18l1133t183r1393b219],

1	Bonello	NNP	PERSON	Bonello	nsubj	5	SENT_308	[p18l1408t171r1602b219],
2	and	CC	O	and	_	0	SENT_308	[p18l1616t171r1712b219],
3	colleagues	NNS	O	colleague	conj_and	1	SENT_308	[p18l1725t169r2025b234],
4	”	CD	NUMBER	”	num	3	SENT_308	[p18l1725t169r2025b234],
5	gave	VBD	O	give	_	0	SENT_308	[p18l2038t188r2152b234],
6	patients	NNS	O	patient	nsubj	20	SENT_308	[p18l1131t250r1335b308],
7	repeated	VBN	O	repeat	partmod	6	SENT_308	[p18l1348t246r1569b308],
8	loading	VBG	O	load	xcomp	7	SENT_308	[p18l1581t245r1775b308],
9	doses	NNS	O	dose	dobj	8	SENT_308	[p18l1788t245r1928b293],
10	of	IN	O	of	_	0	SENT_308	[p18l1943t245r1996b293],
11	clopidogrel	NN	O	clopidogrel	prep_of	9	SENT_308	[p18l2005t246r2151b308, p18l1133t320r1300b383],
12	(	CD	NUMBER	(	num	11	SENT_308	[p18l1318t319r1406b382],
13	up	RP	O	up	prt	8	SENT_308	[p18l1318t319r1406b382],
14	to	TO	O	to	_	0	SENT_308	[p18l1423t331r1472b367],
15	2400	CD	DATE	2400	num	16	SENT_308	[p18l1490t323r1619b368],
16	mg	NN	O	mg	prep_to	8	SENT_308	[p18l1634t337r1717b383],
17	total	JJ	O	total	amod	16	SENT_308	[p18l1733t319r1870b375],
18	)	CD	NUMBER	)	tmod	17	SENT_308	[p18l1733t319r1870b375],
19	to	TO	O	to	aux	20	SENT_308	[p18l1890t331r1939b367],
20	achieve	VB	O	achieve	xcomp	5	SENT_308	[p18l1956t320r2152b367],
21	a	DT	O	a	det	23	SENT_308	[p18l1132t412r1158b443],
22	target	NN	O	target	nn	23	SENT_308	[p18l1176t407r1328b458],
23	level	NN	O	level	dobj	20	SENT_308	[p18l1343t395r1467b443],
24	of	IN	O	of	_	0	SENT_308	[p18l1483t395r1538b443],
25	suppression	NN	O	suppression	prep_of	23	SENT_308	[p18l1549t400r1872b458],
26	of	IN	O	of	_	0	SENT_308	[p18l1889t395r1943b443],
27	platelet	NN	O	platelet	prep_of	25	SENT_308	[p18l1954t395r2153b458],

1	©	RB	O	©	advmod	2	SENT_309	[p18l1396t498r1492b521],
2	2011	CD	DATE	2011	_	0	SENT_309	[p18l1396t498r1492b521],
3	American	NNP	ORGANIZATION	American	nn	5	SENT_309	[p18l1503t499r1643b521],
4	Medical	NNP	ORGANIZATION	Medical	nn	5	SENT_309	[p18l1652t497r1768b521],
5	Association	NNP	ORGANIZATION	Association	dep	2	SENT_309	[p18l1776t499r1954b521],
6	.	.	O	.	_	0	SENT_309	[p18l1776t499r1954b521],

1	All	DT	O	all	det	2	SENT_310	[p18l1964t497r2006b521],
2	rights	NNS	O	rights	nsubj	3	SENT_310	[p18l2015t497r2099b529],
3	reserved	VBN	O	reserve	_	0	SENT_310	[p18l6t538r135b563],
4	.	.	O	.	_	0	SENT_310	[p18l6t538r135b563],

1	Downloaded	NNP	O	Downloaded	_	0	SENT_311	[p18l145t539r322b563],
2	From	IN	O	from	dep	1	SENT_311	[p18l331t539r419b562],
3	:	:	O	:	_	0	SENT_311	[p18l331t539r419b562],
4	http://jama.jamanetwork.com/	NN	O	http://jama.jamanetwork.com/	pobj	2	SENT_311	[p18l430t538r868b569],
5	by	IN	O	by	_	0	SENT_311	[p18l876t539r910b569],
6	a	DT	O	a	det	7	SENT_311	[p18l920t546r935b562],
7	University	NNP	ORGANIZATION	University	prep_by	4	SENT_311	[p18l944t538r1092b569],
8	of	IN	ORGANIZATION	of	_	0	SENT_311	[p18l1101t538r1130b562],
9	Wisconsin	NNP	ORGANIZATION	Wisconsin	prep_of	7	SENT_311	[p18l1137t538r1283b563],
10	-	:	O	-	_	0	SENT_311	[p18l1292t538r1426b562],
11	Madison	NNP	O	Madison	nn	12	SENT_311	[p18l1292t538r1426b562],
12	User	NN	O	user	dep	4	SENT_311	[p18l1435t539r1501b563],
13	on	IN	O	on	_	0	SENT_311	[p18l1519t546r1553b562],
14	01/05/2014	CD	DATE	01/05/2014	prep_on	12	SENT_311	[p18l1562t538r1713b563],

1	reactivity	NN	O	reactivity	nsubj	11	SENT_312	[p18l17t1055r519b1169],
2	in	IN	O	in	_	0	SENT_312	[p18l564t1055r669b1138],
3	each	DT	O	each	det	4	SENT_312	[p18l718t1045r958b1139],
4	patient	NN	O	patient	prep_in	1	SENT_312	[p18l1004t1055r1380b1169],
5	before	IN	O	before	_	0	SENT_312	[p18l1424t1044r1759b1139],
6	PCI	NNP	O	PCI	prep_before	4	SENT_312	[p18l1809t1052r2037b1158],
7	,	,	O	,	_	0	SENT_312	[p18l1809t1052r2037b1158],
8	and	CC	O	and	_	0	SENT_312	[p18l19t1195r214b1289],
9	this	DT	O	this	det	10	SENT_312	[p18l259t1195r450b1289],
10	strategy	NN	O	strategy	conj_and	4	SENT_312	[p18l496t1218r914b1319],
11	resulted	VBD	O	result	_	0	SENT_312	[p18l956t1195r1385b1289],
12	in	IN	O	in	_	0	SENT_312	[p18l1428t1205r1532b1288],
13	a	DT	O	a	det	15	SENT_312	[p18l1577t1229r1628b1289],
14	significant	JJ	O	significant	amod	15	SENT_312	[p18l1673t1194r2042b1319, p18l20t1369r244b1441],
15	decrease	NN	O	decrease	prep_in	11	SENT_312	[p18l280t1346r731b1441],
16	in	IN	O	in	_	0	SENT_312	[p18l768t1356r873b1438],
17	adverse	JJ	O	adverse	amod	18	SENT_312	[p18l910t1346r1308b1441],
18	outcomes	NNS	O	outcome	prep_in	11	SENT_312	[p18l1349t1369r1887b1441],
19	.	.	O	.	_	0	SENT_312	[p18l1349t1369r1887b1441],

1	In	IN	O	in	_	0	SENT_313	[p18l1934t1355r2044b1438],
2	contrast	NN	O	contrast	pobj	1	SENT_313	[p18l20t1519r474b1609],
3	,	,	O	,	_	0	SENT_313	[p18l20t1519r474b1609],
4	in	IN	O	in	_	0	SENT_313	[p18l508t1505r612b1589],
5	GRAVITAS	NNP	O	GRAVITAS	prep_in	2	SENT_313	[p18l644t1502r1242b1590],
6	and	CC	O	and	_	0	SENT_313	[p18l1275t1496r1469b1590],
7	RECLOSE	NNP	O	RECLOSE	prep_in	2	SENT_313	[p18l1499t1502r2042b1590],

1	2	LS	NUMBER	2	_	0	SENT_314	[p18l20t1652r394b1759],
2	.	.	O	.	_	0	SENT_314	[p18l20t1652r394b1759],

1	—	NN	O	—	_	0	SENT_315	[p18l20t1652r394b1759],
2	.	.	O	.	_	0	SENT_315	[p18l20t1652r394b1759],

1	ACS	NN	ORGANIZATION	ac	nsubj	33	SENT_316	[p18l20t1652r394b1759],
2	,	,	O	,	_	0	SENT_316	[p18l20t1652r394b1759],
3	higher	JJR	O	higher	amod	5	SENT_316	[p18l449t1646r800b1771],
4	maintenance	NN	O	maintenance	nn	5	SENT_316	[p18l848t1657r1544b1741],
5	doses	NNS	O	dose	nsubj	33	SENT_316	[p18l1596t1646r1889b1741],
6	of	IN	O	of	_	0	SENT_316	[p18l1943t1646r2051b1741],
7	clopidogrel	NN	O	clopidogrel	prep_of	5	SENT_316	[p18l20t1797r623b1922],
8	after	IN	O	after	mark	21	SENT_316	[p18l668t1795r906b1891],
9	PCI	NNP	O	PCI	nsubj	21	SENT_316	[p18l950t1803r1145b1892],
10	in	IN	O	in	_	0	SENT_316	[p18l1192t1806r1296b1889],
11	patients	NNS	O	patient	prep_in	9	SENT_316	[p18l1339t1806r1759b1921],
12	with	IN	O	with	_	0	SENT_316	[p18l1802t1796r2044b1891],
13	high	JJ	O	high	amod	16	SENT_316	[p18l17t1948r255b2072],
14	on-treatment	JJ	O	on-treatment	amod	16	SENT_316	[p18l287t1970r984b2042],
15	platelet	NN	O	platelet	nn	16	SENT_316	[p18l1009t1948r1402b2072],
16	reactivity	NN	O	reactivity	prep_with	11	SENT_316	[p18l1430t1957r1925b2072],
17	at	IN	O	at	_	0	SENT_316	[p18l1953t1970r2047b2042],
18	baseline	NN	O	baseline	prep_at	16	SENT_316	[p18l15t2098r440b2193],
19	did	VBD	O	do	aux	21	SENT_316	[p18l469t2098r637b2192],
20	not	RB	O	not	neg	21	SENT_316	[p18l664t2121r840b2192],
21	improve	VB	O	improve	dep	7	SENT_316	[p18l865t2108r1300b2223],
22	outcomes	NNS	O	outcome	nn	23	SENT_316	[p18l1331t2093r2039b2192],
23	.3	NN	NUMBER	.3	dobj	21	SENT_316	[p18l1331t2093r2039b2192],
24	°	CD	NUMBER	°	number	25	SENT_316	[p18l1331t2093r2039b2192],
25	’31	CD	NUMBER	’31	dep	23	SENT_316	[p18l1331t2093r2039b2192],
26	The	DT	O	the	det	29	SENT_316	[p18l18t2248r240b2342],
27	higher	JJR	O	higher	amod	29	SENT_316	[p18l305t2248r695b2373],
28	maintenance	NN	O	maintenance	nn	29	SENT_316	[p18l759t2257r1532b2342],
29	dose	NN	O	dose	dep	25	SENT_316	[p18l1599t2248r1865b2342],
30	in	IN	O	in	_	0	SENT_316	[p18l1931t2257r2044b2340],
31	GRAVITAS	NNP	O	GRAVITAS	prep_in	21	SENT_316	[p18l21t2404r623b2493],
32	was	VBD	O	be	cop	33	SENT_316	[p18l668t2432r867b2493],
33	clopidogrel	NN	O	clopidogrel	_	0	SENT_316	[p18l918t2398r1549b2523],
34	,	,	O	,	_	0	SENT_316	[p18l918t2398r1549b2523],
35	150	CD	NUMBER	150	num	36	SENT_316	[p18l1612t2406r1796b2493],
36	mg	NN	O	mg	appos	33	SENT_316	[p18l1846t2432r2039b2523],
37	,	,	O	,	_	0	SENT_316	[p18l1846t2432r2039b2523],
38	daily	RB	SET	daily	advmod	36	SENT_316	[p18l20t2548r305b2673],
39	,	,	O	,	_	0	SENT_316	[p18l20t2548r305b2673],
40	which	WDT	O	which	nsubj	41	SENT_316	[p18l338t2548r668b2643],
41	resulted	VBD	O	result	rcmod	36	SENT_316	[p18l699t2548r1130b2642],
42	in	IN	O	in	_	0	SENT_316	[p18l1159t2559r1264b2640],
43	a	DT	O	a	det	45	SENT_316	[p18l1295t2582r1347b2642],
44	median	JJ	O	median	amod	45	SENT_316	[p18l1378t2548r1774b2642],
45	PRU	NNP	O	PRU	prep_in	41	SENT_316	[p18l1807t2557r2041b2643],
46	of	IN	O	of	_	0	SENT_316	[p18l20t2697r128b2793],
47	211	CD	NUMBER	211	num	50	SENT_316	[p18l161t2705r346b2791],
48	(	NN	O	(	nn	50	SENT_316	[p18l402t2697r1111b2824],
49	interquartile	NN	O	interquartile	nn	50	SENT_316	[p18l402t2697r1111b2824],
50	range	NN	O	range	prep_of	45	SENT_316	[p18l1150t2732r1472b2824],
51	,	,	O	,	_	0	SENT_316	[p18l1150t2732r1472b2824],
52	155-262	CD	NUMBER	155-262	num	53	SENT_316	[p18l1527t2697r2039b2812],
53	)	NN	O	)	appos	50	SENT_316	[p18l1527t2697r2039b2812],
54	,	,	O	,	_	0	SENT_316	[p18l1527t2697r2039b2812],
55	and	CC	O	and	_	0	SENT_316	[p18l19t2850r211b2946],
56	therefore	RB	O	therefore	advmod	53	SENT_316	[p18l239t2850r707b2946],
57	somewhere	RB	O	somewhere	advmod	58	SENT_316	[p18l735t2851r1329b2946],
58	between	IN	O	between	quantmod	59	SENT_316	[p18l1355t2850r1792b2946],
59	25	CD	PERCENT	25	num	60	SENT_316	[p18l1821t2854r2040b2949],
60	%	NN	PERCENT	%	appos	50	SENT_316	[p18l1821t2854r2040b2949],

1	and	CC	O	and	cc	2	SENT_317	[p18l19t3001r214b3095],
2	50	CD	PERCENT	50	num	3	SENT_317	[p18l264t3004r488b3098],
3	%	NN	PERCENT	%	nsubj	8	SENT_317	[p18l264t3004r488b3098],
4	of	IN	O	of	_	0	SENT_317	[p18l541t2999r649b3095],
5	the	DT	O	the	det	6	SENT_317	[p18l691t3001r854b3095],
6	population	NN	O	population	prep_of	3	SENT_317	[p18l901t3001r1493b3124],
7	remained	VBD	O	remain	cop	8	SENT_317	[p18l1539t3000r2044b3095],
8	nonresponders	NNS	O	nonresponder	_	0	SENT_317	[p18l17t3151r901b3275],
9	with	IN	O	with	_	0	SENT_317	[p18l960t3151r1224b3245],
10	this	DT	O	this	det	11	SENT_317	[p18l1286t3151r1499b3245],
11	dose	NN	O	dose	prep_with	8	SENT_317	[p18l1563t3151r1856b3245],
12	.	.	O	.	_	0	SENT_317	[p18l1563t3151r1856b3245],

1	In	IN	O	in	_	0	SENT_318	[p18l1926t3159r2043b3243],
2	RECLOSE	NNP	O	RECLOSE	nn	3	SENT_318	[p18l20t3308r557b3396],
3	2-ACS	NN	O	2-ac	pobj	1	SENT_318	[p18l589t3307r950b3414],
4	,	,	O	,	_	0	SENT_318	[p18l589t3307r950b3414],
5	despite	IN	O	despite	dep	3	SENT_318	[p18l984t3301r1352b3426],
6	treating	VBG	O	treat	pcomp	5	SENT_318	[p18l1383t3311r1782b3426],
7	with	IN	O	with	_	0	SENT_318	[p18l1807t3301r2044b3396],
8	higher	JJR	O	higher	amod	10	SENT_318	[p18l17t3451r363b3577],
9	maintenance	NN	O	maintenance	nn	10	SENT_318	[p18l402t3461r1086b3546],
10	doses	NNS	O	dose	prep_with	6	SENT_318	[p18l1128t3451r1416b3546],
11	of	IN	O	of	_	0	SENT_318	[p18l1461t3450r1569b3546],
12	clopidogrel	NN	O	clopidogrel	prep_of	10	SENT_318	[p18l1602t3451r2041b3576, p18l18t3603r219b3727],
13	or	CC	O	or	_	0	SENT_318	[p18l270t3636r380b3697],
14	switching	NN	O	switching	prep_of	10	SENT_318	[p18l427t3602r950b3727],
15	to	TO	O	to	_	0	SENT_318	[p18l1000t3625r1097b3697],
16	ticlopidine	NN	O	ticlopidine	prep_to	6	SENT_318	[p18l1151t3602r1759b3727],
17	,	,	O	,	_	0	SENT_318	[p18l1151t3602r1759b3727],
18	38	CD	PERCENT	38	number	19	SENT_318	[p18l1813t3606r2039b3701],
19	%	NN	PERCENT	%	amod	3	SENT_318	[p18l1813t3606r2039b3701],

1	of	IN	O	of	_	0	SENT_319	[p19l20t19r133b115],
2	patients	NNS	O	patient	prep_of	3	SENT_319	[p19l178t30r629b144],
3	continued	VBD	O	continue	_	0	SENT_319	[p19l690t21r1264b115],
4	to	TO	O	to	aux	6	SENT_319	[p19l1322t44r1424b115],
5	be	VB	O	be	cop	6	SENT_319	[p19l1481t20r1607b115],
6	nonresponders	NNS	O	nonresponder	dep	3	SENT_319	[p19l1663t55r2040b115, p19l18t171r526b295],
7	.	.	O	.	_	0	SENT_319	[p19l1663t55r2040b115, p19l18t171r526b295],

1	ELEVATE-TIMI	NN	O	elevate-timus	_	0	SENT_320	[p19l569t177r1433b265],
2	56	CD	NUMBER	56	num	1	SENT_320	[p19l1472t177r1629b284],
3	,	,	O	,	_	0	SENT_320	[p19l1472t177r1629b284],
4	in	IN	O	in	_	0	SENT_320	[p19l1668t180r1773b264],
5	conjunction	NN	O	conjunction	prep_in	1	SENT_320	[p19l1810t205r2041b265, p19l6t332r469b446],
6	with	IN	O	with	_	0	SENT_320	[p19l513t321r754b416],
7	the	DT	O	the	det	9	SENT_320	[p19l802t322r965b416],
8	important	JJ	O	important	amod	9	SENT_320	[p19l1012t332r1549b446],
9	observations	NNS	O	observation	prep_with	5	SENT_320	[p19l1596t321r2042b416, p19l20t481r279b566],
10	from	IN	O	from	_	0	SENT_320	[p19l322t470r576b566],
11	GRAVITAS	NN	O	gravitas	prep_from	9	SENT_320	[p19l618t478r1219b567],
12	and	CC	O	and	_	0	SENT_320	[p19l1261t472r1455b566],
13	RECLOSE	VB	O	reclose	conj_and	5	SENT_320	[p19l1496t478r2041b567],

1	2-AC5	NN	O	2-ac5	_	0	SENT_321	[p19l20t628r416b735],
2	,	,	O	,	_	0	SENT_321	[p19l20t628r416b735],
3	highlights	VBZ	O	highlight	dep	1	SENT_321	[p19l480t622r1066b746],
4	that	IN	O	that	complm	18	SENT_321	[p19l1128t622r1352b716],
5	doses	NNS	O	dose	nsubj	18	SENT_321	[p19l1410t622r1720b716],
6	even	RB	O	even	advmod	7	SENT_321	[p19l1782t655r2043b716],
7	higher	JJR	O	higher	amod	5	SENT_321	[p19l17t772r363b897],
8	than	IN	O	than	_	0	SENT_321	[p19l410t772r645b866],
9	150	CD	NUMBER	150	num	10	SENT_321	[p19l700t779r884b867],
10	mg	NN	O	mg	prep_than	7	SENT_321	[p19l931t806r1095b897],
11	of	IN	O	of	_	0	SENT_321	[p19l1141t772r1249b866],
12	clopidogrel	NN	O	clopidogrel	nn	15	SENT_321	[p19l1286t772r1889b897],
13	or	CC	O	or	_	0	SENT_321	[p19l1935t806r2044b866],
14	other	JJ	O	other	nn	15	SENT_321	[p19l20t922r304b1016],
15	agents	NNS	O	agent	prep_of	10	SENT_321	[p19l353t945r691b1047],
16	may	MD	O	may	aux	18	SENT_321	[p19l741t956r967b1046],
17	be	VB	O	be	cop	18	SENT_321	[p19l1011t922r1134b1016],
18	necessary	JJ	O	necessary	ccomp	3	SENT_321	[p19l1183t956r1702b1046],
19	when	WRB	O	when	advmod	20	SENT_321	[p19l1746t922r2043b1016],
20	tailoring	VBG	O	tailor	dep	3	SENT_321	[p19l20t1117r472b1242],
21	antiplatelet	JJ	O	antiplatelet	amod	22	SENT_321	[p19l519t1117r1120b1242],
22	therapy	NN	O	therapy	dobj	20	SENT_321	[p19l1169t1118r1573b1242],
23	to	TO	O	to	aux	24	SENT_321	[p19l1621t1140r1718b1212],
24	overcome	VB	O	overcome	xcomp	20	SENT_321	[p19l1771t1151r2040b1212, p19l20t1333r302b1393],

1	resistance	NN	O	resistance	_	0	SENT_322	[p19l335t1308r859b1393],
2	in	IN	O	in	_	0	SENT_322	[p19l893t1308r998b1391],
3	some	DT	O	some	det	4	SENT_322	[p19l1031t1333r1307b1393],
4	patients	NNS	O	patient	prep_in	1	SENT_322	[p19l1339t1308r1791b1422],
5	,	,	O	,	_	0	SENT_322	[p19l1339t1308r1791b1422],
6	particularly	RB	O	particularly	advmod	4	SENT_322	[p19l1828t1333r2041b1422, p19l20t1448r490b1572],
7	those	DT	O	those	dep	4	SENT_322	[p19l544t1448r839b1542],
8	who	WP	O	who	nsubj	9	SENT_322	[p19l891t1448r1126b1542],
9	carry	VBP	O	carry	rcmod	7	SENT_322	[p19l1186t1482r1468b1572],
10	a	DT	O	a	det	13	SENT_322	[p19l1521t1482r1572b1542],
11	lossoffunction	NN	O	lossoffunction	nn	13	SENT_322	[p19l1627t1447r2041b1542, p19l20t1599r471b1694],
12	CYP2C19	NN	O	cyp2c19	nn	13	SENT_322	[p19l513t1605r1009b1694],
13	allele	NN	O	allele	dobj	9	SENT_322	[p19l1050t1599r1352b1694],
14	.	.	O	.	_	0	SENT_322	[p19l1050t1599r1352b1694],

1	Patients	NNS	O	patient	nsubj	18	SENT_323	[p19l150t1757r571b1842],
2	who	WP	O	who	nsubj	3	SENT_323	[p19l602t1748r831b1843],
3	carry	VBP	O	carry	rcmod	1	SENT_323	[p19l870t1782r1139b1873],
4	2	CD	NUMBER	2	num	10	SENT_323	[p19l1173t1754r1230b1840],
5	CYPZC	NNP	ORGANIZATION	CYPZC	nn	10	SENT_323	[p19l1269t1754r1635b1843],
6	19	CD	NUMBER	19	num	10	SENT_323	[p19l1649t1754r1765b1843],
7	lossof	JJ	O	lossof	amod	10	SENT_323	[p19l1799t1748r2041b1842, p19l20t1897r616b1992],
8	—	NN	O	—	nn	10	SENT_323	[p19l1799t1748r2041b1842, p19l20t1897r616b1992],
9	function	NN	O	function	nn	10	SENT_323	[p19l1799t1748r2041b1842, p19l20t1897r616b1992],
10	alleles	NNS	O	allele	dobj	3	SENT_323	[p19l646t1898r998b2011],
11	,	,	O	,	_	0	SENT_323	[p19l646t1898r998b2011],
12	also	RB	O	also	advmod	13	SENT_323	[p19l1033t1898r1234b1992],
13	known	VBN	O	know	partmod	1	SENT_323	[p19l1267t1898r1637b1993],
14	as	IN	O	as	_	0	SENT_323	[p19l1666t1932r1767b1992],
15	poor	JJ	O	poor	amod	16	SENT_323	[p19l1796t1932r2045b2022],
16	metabolizers	NNS	O	metabolizer	prep_as	13	SENT_323	[p19l17t2048r740b2161],
17	,	,	O	,	_	0	SENT_323	[p19l17t2048r740b2161],
18	face	VBP	O	face	_	0	SENT_323	[p19l796t2048r1003b2142],
19	particular	JJ	O	particular	amod	20	SENT_323	[p19l1053t2048r1585b2173],
20	hurdles	NNS	O	hurdle	dobj	18	SENT_323	[p19l1633t2048r2041b2142],
21	when	WRB	O	when	advmod	23	SENT_323	[p19l15t2198r304b2292],
22	it	PRP	O	it	nsubj	23	SENT_323	[p19l330t2207r402b2292],
23	comes	VBZ	O	come	advcl	18	SENT_323	[p19l428t2232r751b2292],
24	to	TO	O	to	_	0	SENT_323	[p19l782t2221r878b2292],
25	generating	VBG	O	generate	prepc_to	23	SENT_323	[p19l907t2207r1454b2323],
26	enough	RB	O	enough	advmod	27	SENT_323	[p19l1481t2198r1869b2323],
27	active	JJ	O	active	acomp	25	SENT_323	[p19l1896t2232r2042b2292, p19l20t2359r210b2443],
28	clopidogrel	NN	O	clopidogrel	nn	29	SENT_323	[p19l255t2348r857b2473],
29	metabolite	NN	O	metabolite	dep	27	SENT_323	[p19l899t2348r1463b2443],
30	and	CC	O	and	_	0	SENT_323	[p19l1506t2348r1701b2443],
31	platelet	NN	O	platelet	nn	32	SENT_323	[p19l1741t2348r2042b2473, p19l17t2499r152b2592],
32	inhibition	NN	O	inhibition	dep	27	SENT_323	[p19l198t2498r740b2592],
33	with	IN	O	with	_	0	SENT_323	[p19l786t2498r1031b2592],
34	standard	JJ	O	standard	amod	35	SENT_323	[p19l1079t2498r1549b2592],
35	doses	NNS	O	dose	prep_with	29	SENT_323	[p19l1599t2498r1890b2592],
36	of	IN	O	of	_	0	SENT_323	[p19l1943t2497r2051b2592],
37	clopidogrel	NN	O	clopidogrel	prep_of	35	SENT_323	[p19l20t2649r712b2773],
38	,	,	O	,	_	0	SENT_323	[p19l20t2649r712b2773],
39	as	IN	O	as	mark	40	SENT_323	[p19l775t2682r881b2743],
40	noted	VBN	O	note	advcl	18	SENT_323	[p19l940t2649r1266b2743],
41	by	IN	O	by	_	0	SENT_323	[p19l1322t2649r1457b2773],
42	the	DT	O	the	det	43	SENT_323	[p19l1515t2649r1688b2743],
43	FDA	NNP	ORGANIZATION	FDA	prep_by	40	SENT_323	[p19l1748t2655r2034b2743],
44	.	.	O	.	_	0	SENT_323	[p19l1748t2655r2034b2743],

1	ELEVATE-TIMI	NN	O	elevate-timus	nsubjpass	6	SENT_324	[p19l19t2805r911b2894],
2	56	CD	NUMBER	56	num	1	SENT_324	[p19l969t2806r1096b2894],
3	was	VBD	O	be	auxpass	6	SENT_324	[p19l1148t2833r1352b2894],
4	not	RB	O	not	neg	6	SENT_324	[p19l1405t2822r1588b2893],
5	specifically	RB	O	specifically	advmod	6	SENT_324	[p19l1640t2799r2040b2924, p19l20t2949r267b3074],
6	powered	VBN	O	power	_	0	SENT_324	[p19l312t2949r776b3073],
7	to	TO	O	to	aux	8	SENT_324	[p19l826t2972r923b3043],
8	evaluate	VB	O	evaluate	xcomp	6	SENT_324	[p19l978t2949r1416b3043],
9	these	DT	O	these	det	10	SENT_324	[p19l1466t2949r1740b3043],
10	individuals	NNS	O	individual	dobj	8	SENT_324	[p19l1787t2949r2040b3043, p19l15t3099r427b3212],
11	,	,	O	,	_	0	SENT_324	[p19l1787t2949r2040b3043, p19l15t3099r427b3212],
12	as	IN	O	as	mark	14	SENT_324	[p19l475t3133r576b3193],
13	they	PRP	O	they	nsubj	14	SENT_324	[p19l622t3099r850b3223],
14	constitute	VBP	O	constitute	advcl	6	SENT_324	[p19l892t3109r1421b3193],
15	only	RB	O	only	quantmod	16	SENT_324	[p19l1466t3099r1699b3223],
16	2	CD	PERCENT	2	num	17	SENT_324	[p19l1742t3102r1898b3197],
17	%	NN	PERCENT	%	dobj	14	SENT_324	[p19l1742t3102r1898b3197],
18	of	IN	O	of	_	0	SENT_324	[p19l1945t3098r2053b3193],
19	the	DT	O	the	det	21	SENT_324	[p19l20t3249r183b3343],
20	tested	VBN	O	test	amod	21	SENT_324	[p19l220t3249r532b3343],
21	population	NN	O	population	prep_of	17	SENT_324	[p19l563t3249r1175b3374],
22	.	.	O	.	_	0	SENT_324	[p19l563t3249r1175b3374],

1	Nonetheless	RB	O	nonetheless	_	0	SENT_325	[p19l1218t3249r1901b3362],
2	,	,	O	,	_	0	SENT_325	[p19l1218t3249r1901b3362],
3	in	IN	O	in	dep	1	SENT_325	[p19l1940t3260r2044b3341],
4	ELEVATE-TIMI	NN	O	elevate-timus	pobj	3	SENT_325	[p19l18t3405r882b3493],
5	56	CD	NUMBER	56	num	4	SENT_325	[p19l921t3405r1078b3512],
6	,	,	O	,	_	0	SENT_325	[p19l921t3405r1078b3512],
7	among	IN	O	among	_	0	SENT_325	[p19l1117t3432r1477b3524],
8	the	DT	O	the	det	9	SENT_325	[p19l1511t3399r1674b3493],
9	subset	NN	O	subset	prep_among	4	SENT_325	[p19l1708t3399r2045b3493],
10	of	IN	O	of	_	0	SENT_325	[p19l20t3549r128b3644],
11	CYP2C19	NN	O	cyp2c19	nn	15	SENT_325	[p19l170t3544r798b3644],
12	*	NN	O	*	nn	15	SENT_325	[p19l170t3544r798b3644],
13	2	CD	NUMBER	2	num	15	SENT_325	[p19l170t3544r798b3644],
14	homozygous	JJ	O	homozygous	amod	15	SENT_325	[p19l849t3550r1535b3674],
15	patients	NNS	O	patient	prep_of	9	SENT_325	[p19l1583t3559r2038b3674],
16	,	,	O	,	_	0	SENT_325	[p19l1583t3559r2038b3674],

1	even	RB	O	even	advmod	4	SENT_326	[p20l20t55r266b115],
2	the	DT	O	the	det	4	SENT_326	[p20l316t20r480b115],
3	300-mg	JJ	O	300-mg	amod	4	SENT_326	[p20l530t27r943b146],
4	dose	NN	O	dose	nsubj	9	SENT_326	[p20l992t20r1233b115],
5	of	IN	O	of	_	0	SENT_326	[p20l1284t19r1393b115],
6	clopidogrel	NN	O	clopidogrel	prep_of	4	SENT_326	[p20l1433t20r2042b146],
7	was	VBD	O	be	cop	9	SENT_326	[p20l15t204r214b265],
8	not	RB	O	not	neg	9	SENT_326	[p20l262t193r441b265],
9	able	JJ	O	able	_	0	SENT_326	[p20l486t171r699b265],
10	to	TO	O	to	aux	11	SENT_326	[p20l749t193r847b265],
11	achieve	VB	O	achieve	xcomp	9	SENT_326	[p20l898t171r1294b265],
12	on-treatment	JJ	O	on-treatment	amod	14	SENT_326	[p20l1344t193r2045b265],
13	platelet	NN	O	platelet	nn	14	SENT_326	[p20l17t321r441b446],
14	reactivity	NN	O	reactivity	dobj	11	SENT_326	[p20l493t331r1028b446],
15	comparable	JJ	O	comparable	dep	11	SENT_326	[p20l1083t321r1737b446],
16	with	IN	O	with	_	0	SENT_326	[p20l1790t321r2044b416],
17	clopidogrel	NN	O	clopidogrel	prep_with	15	SENT_326	[p20l20t471r651b596],
18	,	,	O	,	_	0	SENT_326	[p20l20t471r651b596],
19	75	CD	NUMBER	75	num	20	SENT_326	[p20l702t477r820b566],
20	mg	NN	O	mg	appos	17	SENT_326	[p20l866t504r1059b596],
21	,	,	O	,	_	0	SENT_326	[p20l866t504r1059b596],
22	daily	RB	SET	daily	advmod	11	SENT_326	[p20l1106t471r1363b595],
23	in	IN	O	in	_	0	SENT_326	[p20l1401t480r1505b563],
24	noncarriers	NNS	O	noncarrier	prep_in	11	SENT_326	[p20l1544t480r2041b565, p20l20t654r195b715],
25	.	.	O	.	_	0	SENT_326	[p20l1544t480r2041b565, p20l20t654r195b715],

1	Similarly	RB	O	similarly	advmod	15	SENT_327	[p20l252t621r756b745],
2	,	,	O	,	_	0	SENT_327	[p20l252t621r756b745],
3	in	IN	O	in	_	0	SENT_327	[p20l807t630r911b713],
4	CLOVIS-2	NN	O	clovis-2	prep_in	15	SENT_327	[p20l964t627r1540b734],
5	,	,	O	,	_	0	SENT_327	[p20l964t627r1540b734],
6	the	DT	O	the	det	8	SENT_327	[p20l1594t621r1757b715],
7	high	JJ	O	high	amod	8	SENT_327	[p20l1804t621r2044b745],
8	clopidogrel	NN	O	clopidogrel	nsubj	15	SENT_327	[p20l20t771r607b896],
9	loading	VBG	O	load	partmod	8	SENT_327	[p20l633t771r1023b896],
10	dose	NN	O	dose	dobj	9	SENT_327	[p20l1051t771r1285b865],
11	of	IN	O	of	_	0	SENT_327	[p20l1315t771r1421b865],
12	900	CD	NUMBER	900	num	13	SENT_327	[p20l1441t778r1631b866],
13	mg	NN	O	mg	prep_of	10	SENT_327	[p20l1660t805r1824b896],
14	was	VBD	O	be	cop	15	SENT_327	[p20l1848t805r2042b866],
15	able	JJ	O	able	_	0	SENT_327	[p20l19t921r232b1015],
16	to	TO	O	to	aux	18	SENT_327	[p20l269t944r366b1015],
17	adequately	RB	O	adequately	advmod	18	SENT_327	[p20l403t921r979b1046],
18	lower	VB	O	lower	xcomp	15	SENT_327	[p20l1010t921r1310b1015],
19	on	IN	O	on	_	0	SENT_327	[p20l1344t944r2045b1015],
20	—	NN	O	—	nn	23	SENT_327	[p20l1344t944r2045b1015],
21	treatment	NN	O	treatment	nn	23	SENT_327	[p20l1344t944r2045b1015],
22	platelet	NN	O	platelet	nn	23	SENT_327	[p20l17t1070r413b1194],
23	reactivity	NN	O	reactivity	prep_on	18	SENT_327	[p20l452t1080r951b1194],
24	among	IN	O	among	_	0	SENT_327	[p20l992t1103r1354b1194],
25	carriers	NNS	O	carrier	prep_among	18	SENT_327	[p20l1397t1080r1793b1164],
26	of	IN	O	of	_	0	SENT_327	[p20l1840t1069r1948b1164],
27	1	CD	NUMBER	1	prep_of	25	SENT_327	[p20l1992t1077r2034b1161],

1	CLOPIDOGREL	NN	O	clopidogrel	_	0	SENT_328	[p20l864t1342r1260b1382],
2	DOSES	NNS	O	dose	dep	1	SENT_328	[p20l1277t1342r1450b1382],
3	AND	CC	O	and	_	0	SENT_328	[p20l1467t1342r1587b1381],
4	CYP2C19	NN	O	cyp2c19	nn	5	SENT_328	[p20l1608t1342r1833b1382],
5	GENOTYPE	NN	O	genotype	dep	1	SENT_328	[p20l1852t1342r2149b1382],

1	affected	VBN	O	affect	_	0	SENT_329	[p20l34t1500r242b1548],
2	significantly	RB	O	significantly	advmod	1	SENT_329	[p20l262t1500r593b1564],
3	by	IN	O	by	_	0	SENT_329	[p20l611t1501r676b1564],
4	the	DT	O	the	det	7	SENT_329	[p20l697t1501r779b1548],
5	CYPZC	NNP	O	CYPZC	nn	7	SENT_329	[p20l801t1504r986b1549],
6	19	CD	NUMBER	19	num	7	SENT_329	[p20l992t1504r1051b1548],
7	variants	NNS	O	variant	prep_by	1	SENT_329	[p20l32t1581r258b1624],
8	.	.	O	.	_	0	SENT_329	[p20l32t1581r258b1624],

1	There	EX	O	there	expl	2	SENT_330	[p20l99t1642r252b1690],
2	are	VBP	O	be	_	0	SENT_330	[p20l275t1659r353b1690],
3	some	DT	O	some	det	4	SENT_330	[p20l376t1659r513b1690],
4	limitations	NNS	O	limitation	nsubj	2	SENT_330	[p20l536t1642r819b1690],
5	to	TO	O	to	_	0	SENT_330	[p20l843t1654r892b1690],
6	these	DT	O	these	det	7	SENT_330	[p20l917t1642r1051b1690],
7	analyses	NNS	O	analysis	prep_to	4	SENT_330	[p20l34t1709r259b1771],
8	.	.	O	.	_	0	SENT_330	[p20l34t1709r259b1771],

1	First	RB	ORDINAL	first	advmod	6	SENT_331	[p20l276t1713r408b1766],
2	,	,	O	,	_	0	SENT_331	[p20l276t1713r408b1766],
3	treatment	NN	O	treatment	nn	4	SENT_331	[p20l425t1720r676b1756],
4	allocation	NN	O	allocation	nsubjpass	6	SENT_331	[p20l688t1709r942b1756],
5	was	VBD	O	be	auxpass	6	SENT_331	[p20l953t1726r1051b1756],
6	based	VBN	O	base	_	0	SENT_331	[p20l32t1784r201b1831],
7	on	IN	O	on	_	0	SENT_331	[p20l234t1801r305b1831],
8	carriage	NN	O	carriage	prep_on	6	SENT_331	[p20l338t1789r578b1846],
9	of	IN	O	of	_	0	SENT_331	[p20l611t1783r670b1831],
10	only	RB	O	only	advmod	14	SENT_331	[p20l698t1784r828b1846],
11	the	DT	O	the	det	14	SENT_331	[p20l860t1784r951b1831],
12	*	NN	O	*	nn	14	SENT_331	[p20l986t1781r1050b1830],
13	2	CD	NUMBER	2	num	14	SENT_331	[p20l986t1781r1050b1830],
14	CYPZC	NN	ORGANIZATION	cypzc	prep_of	8	SENT_331	[p20l35t1862r224b1907],
15	19	CD	NUMBER	19	num	17	SENT_331	[p20l231t1862r291b1907],
16	loss-of-function	JJ	O	loss-of-function	amod	17	SENT_331	[p20l317t1858r761b1906],
17	allele	NN	O	allele	tmod	6	SENT_331	[p20l786t1859r946b1916],
18	,	,	O	,	_	0	SENT_331	[p20l786t1859r946b1916],
19	for	IN	O	for	_	0	SENT_331	[p20l975t1858r1051b1906],
20	which	WDT	O	which	rel	23	SENT_331	[p20l32t1934r196b1982],
21	we	PRP	O	we	nsubj	23	SENT_331	[p20l212t1951r286b1982],
22	could	MD	O	could	aux	23	SENT_331	[p20l306t1934r453b1982],
23	engage	VB	O	engage	rcmod	17	SENT_331	[p20l472t1951r651b1997],
24	in	IN	O	in	_	0	SENT_331	[p20l669t1939r721b1981],
25	timely	JJ	O	timely	amod	28	SENT_331	[p20l740t1934r918b1997],
26	,	,	O	,	_	0	SENT_331	[p20l740t1934r918b1997],
27	Validated	JJ	O	validated	amod	28	SENT_331	[p20l937t1934r1050b1982, p20l34t2009r182b2057],
28	genotyping	NN	O	genotyping	prep_in	23	SENT_331	[p20l207t2014r526b2072],
29	.	.	O	.	_	0	SENT_331	[p20l207t2014r526b2072],

1	More	JJR	O	more	amod	4	SENT_332	[p20l554t2014r696b2057],
2	comprehensive	JJ	O	comprehensive	amod	4	SENT_332	[p20l722t2010r1050b2072, p20l34t2090r133b2132],
3	genotyping	NN	O	genotyping	nn	4	SENT_332	[p20l150t2089r446b2147],
4	panels	NNS	O	panel	nsubj	6	SENT_332	[p20l461t2085r628b2147],
5	are	VBP	O	be	cop	6	SENT_332	[p20l646t2102r724b2132],
6	available	JJ	O	available	_	0	SENT_332	[p20l741t2085r983b2141],
7	;	:	O	;	_	0	SENT_332	[p20l741t2085r983b2141],
8	of	IN	O	of	_	0	SENT_332	[p20l1003t2084r1056b2132],
9	note	NN	O	note	prep_of	10	SENT_332	[p20l33t2171r145b2207],
10	though	IN	O	though	advmod	19	SENT_332	[p20l159t2160r355b2223],
11	,	,	O	,	_	0	SENT_332	[p20l159t2160r355b2223],
12	CYP2C19	NN	O	cyp2c19	nn	13	SENT_332	[p20l371t2158r670b2208],
13	*	NN	O	*	nsubj	19	SENT_332	[p20l371t2158r670b2208],
14	2	CD	NUMBER	2	dep	13	SENT_332	[p20l371t2158r670b2208],
15	is	VBZ	O	be	cop	19	SENT_332	[p20l684t2165r723b2207],
16	the	DT	O	the	det	19	SENT_332	[p20l737t2160r815b2207],
17	most	RBS	O	most	advmod	18	SENT_332	[p20l828t2171r954b2207],
18	frequent	JJ	O	frequent	amod	19	SENT_332	[p20l966t2159r1051b2207, p20l34t2247r189b2298],
19	variant	NN	O	variant	parataxis	6	SENT_332	[p20l211t2240r415b2292],
20	,	,	O	,	_	0	SENT_332	[p20l211t2240r415b2292],
21	accounting	VBG	O	account	prep	19	SENT_332	[p20l442t2240r742b2298],
22	for	IN	O	for	pcomp	21	SENT_332	[p20l766t2235r841b2283],
23	greater	JJR	O	greater	mwe	24	SENT_332	[p20l865t2247r1052b2298],
24	than	IN	O	than	quantmod	25	SENT_332	[p20l35t2311r152b2359],
25	95	CD	PERCENT	95	num	26	SENT_332	[p20l172t2312r284b2360],
26	%	NN	PERCENT	%	pobj	22	SENT_332	[p20l172t2312r284b2360],
27	of	IN	O	of	_	0	SENT_332	[p20l307t2310r360b2359],
28	the	DT	O	the	det	32	SENT_332	[p20l377t2311r457b2359],
29	loss-of-function	JJ	O	loss-of-function	amod	32	SENT_332	[p20l477t2310r896b2359],
30	allele	NN	O	allele	nn	32	SENT_332	[p20l916t2311r1051b2359],
31	carrier	NN	O	carrier	nn	32	SENT_332	[p20l35t2391r198b2434],
32	status	NN	O	status	prep_of	26	SENT_332	[p20l209t2398r365b2434],
33	.	.	O	.	_	0	SENT_332	[p20l209t2398r365b2434],

1	Second	RB	ORDINAL	second	advmod	6	SENT_333	[p20l381t2387r576b2443],
2	,	,	O	,	_	0	SENT_333	[p20l381t2387r576b2443],
3	each	DT	O	each	det	5	SENT_333	[p20l591t2387r705b2434],
4	treatment	NN	O	treatment	nn	5	SENT_333	[p20l718t2398r962b2434],
5	period	NN	O	period	nsubj	6	SENT_333	[p20l972t2404r1051b2449, p20l34t2462r139b2509],
6	consisted	VBD	O	consist	_	0	SENT_333	[p20l152t2462r390b2509],
7	of	IN	O	of	_	0	SENT_333	[p20l403t2461r455b2509],
8	approximately	RB	O	approximately	quantmod	9	SENT_333	[p20l464t2462r835b2524],
9	14	CD	DURATION	14	num	10	SENT_333	[p20l852t2465r910b2510],
10	days	NNS	NUMBER	day	prep_of	6	SENT_333	[p20l923t2462r1048b2524],
11	.	.	O	.	_	0	SENT_333	[p20l923t2462r1048b2524],

1	This	DT	O	this	det	3	SENT_334	[p20l34t2537r149b2585],
2	time	NN	O	time	nn	3	SENT_334	[p20l173t2542r288b2585],
3	frame	NN	O	frame	nsubj	4	SENT_334	[p20l312t2536r461b2585],
4	allowed	VBN	O	allow	_	0	SENT_334	[p20l485t2537r690b2585],
5	for	IN	O	for	_	0	SENT_334	[p20l713t2536r786b2585],
6	a	DT	O	a	det	8	SENT_334	[p20l809t2554r834b2585],
7	reasonable	JJ	O	reasonable	amod	8	SENT_334	[p20l857t2554r1050b2585, p20l34t2612r139b2660],
8	window	NN	O	window	prep_for	4	SENT_334	[p20l152t2612r367b2660],
9	to	TO	O	to	aux	10	SENT_334	[p20l381t2624r430b2660],
10	achieve	VB	O	achieve	xcomp	4	SENT_334	[p20l446t2612r641b2660],
11	steady	JJ	O	steady	amod	14	SENT_334	[p20l655t2612r821b2675],
12	state	NN	O	state	nn	14	SENT_334	[p20l835t2624r954b2660],
13	antiplatelet	JJ	O	antiplatelet	amod	14	SENT_334	[p20l969t2629r1051b2660, p20l35t2687r265b2750],
14	effect	NN	O	effect	dobj	10	SENT_334	[p20l281t2687r421b2735],
15	with	IN	O	with	_	0	SENT_334	[p20l434t2688r553b2735],
16	each	DT	O	each	det	17	SENT_334	[p20l570t2687r688b2735],
17	regimen	NN	O	regimen	prep_with	10	SENT_334	[p20l703t2692r918b2750],
18	with	IN	O	with	_	0	SENT_334	[p20l932t2688r1052b2735],
19	no	DT	O	no	det	22	SENT_334	[p20l33t2780r99b2810],
20	significant	JJ	O	significant	amod	22	SENT_334	[p20l117t2762r391b2825],
21	carryover	NN	O	carryover	nn	22	SENT_334	[p20l407t2780r655b2825],
22	effect	NN	O	effect	prep_with	17	SENT_334	[p20l672t2762r812b2810],
23	from	IN	O	from	_	0	SENT_334	[p20l828t2762r954b2810],
24	the	DT	O	the	det	26	SENT_334	[p20l971t2763r1051b2810],
25	prior	JJ	O	prior	amod	26	SENT_334	[p20l33t2917r165b2975],
26	treatment	NN	O	treatment	prep_from	10	SENT_334	[p20l182t2924r448b2960],
27	.	.	O	.	_	0	SENT_334	[p20l182t2924r448b2960],

1	However	RB	O	however	advmod	3	SENT_335	[p20l468t2917r718b2969],
2	,	,	O	,	_	0	SENT_335	[p20l468t2917r718b2969],
3	defining	VBG	O	define	_	0	SENT_335	[p20l737t2912r954b2975],
4	the	DT	O	the	det	6	SENT_335	[p20l971t2913r1051b2960],
5	long-term	JJ	O	long-term	amod	6	SENT_335	[p20l33t2988r308b3050],
6	tolerability	NN	O	tolerability	dobj	3	SENT_335	[p20l335t2988r638b3050],
7	of	IN	O	of	_	0	SENT_335	[p20l664t2987r719b3035],
8	the	DT	O	the	det	10	SENT_335	[p20l741t2988r825b3035],
9	higherdose	NN	O	higherdose	nn	10	SENT_335	[p20l851t2988r1050b3050, p20l34t3063r150b3111],
10	regimens	NNS	O	regimen	prep_of	6	SENT_335	[p20l163t3068r397b3126],
11	will	MD	O	will	aux	12	SENT_335	[p20l409t3063r506b3111],
12	require	VB	O	require	dep	3	SENT_335	[p20l518t3068r703b3126],
13	gathering	NN	O	gathering	nn	15	SENT_335	[p20l716t3063r959b3126],
14	additional	JJ	O	additional	amod	15	SENT_335	[p20l972t3063r1051b3111, p20l34t3139r239b3186],
15	experience	NN	O	experience	dobj	12	SENT_335	[p20l263t3144r562b3201],
16	.	.	O	.	_	0	SENT_335	[p20l263t3144r562b3201],

1	Third	NNP	ORDINAL	Third	nsubj	10	SENT_336	[p20l589t3139r754b3195],
2	,	,	O	,	_	0	SENT_336	[p20l589t3139r754b3195],
3	PPI	NNP	O	PPI	nn	4	SENT_336	[p20l780t3143r869b3185],
4	use	NN	O	use	appos	1	SENT_336	[p20l893t3156r981b3186],
5	at	IN	O	at	_	0	SENT_336	[p20l1005t3150r1052b3186],
6	baseline	NN	O	baseline	prep_at	4	SENT_336	[p20l32t3214r258b3262],
7	was	VBD	O	be	cop	10	SENT_336	[p20l282t3231r385b3262],
8	an	DT	O	a	det	10	SENT_336	[p20l411t3231r475b3262],
9	exclusion	NN	O	exclusion	nn	10	SENT_336	[p20l502t3214r768b3262],
10	criterion	NN	O	criterion	_	0	SENT_336	[p20l795t3219r1047b3262],
11	.	.	O	.	_	0	SENT_336	[p20l795t3219r1047b3262],

1	Whereas	IN	O	whereas	mark	4	SENT_337	[p20l31t3289r260b3337],
2	this	DT	O	this	det	3	SENT_337	[p20l276t3289r369b3337],
3	approach	NN	O	approach	nsubj	4	SENT_337	[p20l384t3289r626b3352],
4	allowed	VBD	O	allow	csubj	14	SENT_337	[p20l639t3289r842b3337],
5	for	IN	O	for	_	0	SENT_337	[p20l855t3289r928b3337],
6	a	DT	O	a	det	8	SENT_337	[p20l941t3306r967b3337],
7	focused	JJ	O	focused	amod	8	SENT_337	[p20l982t3289r1050b3337, p20l35t3364r179b3412],
8	evaluation	NN	O	evaluation	prep_for	4	SENT_337	[p20l191t3364r452b3412],
9	of	IN	O	of	_	0	SENT_337	[p20l464t3364r516b3412],
10	higher	JJR	O	higher	amod	11	SENT_337	[p20l523t3364r687b3427],
11	doses	NNS	O	dose	prep_of	8	SENT_337	[p20l699t3364r836b3412],
12	of	IN	O	of	_	0	SENT_337	[p20l849t3364r901b3412],
13	clopitypes	NNS	O	clopitype	prep_of	11	SENT_337	[p20l909t3364r1051b3427, p20l1134t1512r1271b1564],
14	respond	VBP	O	respond	_	0	SENT_337	[p20l1296t1501r1514b1563],
15	to	TO	O	to	_	0	SENT_337	[p20l1539t1512r1588b1548],
16	clopidogrel	NN	O	clopidogrel	nn	19	SENT_337	[p20l1615t1501r1919b1564],
17	maintenance	NN	O	maintenance	nn	19	SENT_337	[p20l1943t1505r2148b1548, p20l1132t1593r1290b1624],
18	dosing	NN	O	dosing	nn	19	SENT_337	[p20l1316t1576r1495b1639],
19	strategies	NNS	O	strategy	prep_to	14	SENT_337	[p20l1519t1581r1770b1639],
20	and	CC	O	and	_	0	SENT_337	[p20l1796t1576r1894b1624],
21	provides	VBZ	O	provide	conj_and	14	SENT_337	[p20l1917t1576r2149b1639],
22	useful	JJ	O	useful	amod	23	SENT_337	[p20l1132t1642r1302b1690],
23	information	NN	O	information	dobj	21	SENT_337	[p20l1329t1642r1666b1690],
24	to	TO	O	to	aux	25	SENT_337	[p20l1693t1654r1744b1690],
25	guide	VB	O	guide	xcomp	21	SENT_337	[p20l1773t1642r1926b1705],
26	further	JJ	O	further	amod	28	SENT_337	[p20l1954t1642r2150b1690],
27	clinical	JJ	O	clinical	amod	28	SENT_337	[p20l1133t1709r1326b1756],
28	studies	NNS	O	study	dobj	25	SENT_337	[p20l1345t1709r1546b1756],
29	.	.	O	.	_	0	SENT_337	[p20l1345t1709r1546b1756],

1	Published	VBN	O	publish	_	0	SENT_338	[p20l1134t1841r1324b1876],
2	Online	NN	O	online	dobj	1	SENT_338	[p20l1339t1841r1484b1876],
3	:	:	O	:	_	0	SENT_338	[p20l1339t1841r1484b1876],
4	November	NNP	DATE	November	dep	2	SENT_338	[p20l1501t1841r1704b1876],
5	16	CD	DATE	16	num	4	SENT_338	[p20l1717t1844r1774b1882],
6	,	,	O	,	_	0	SENT_338	[p20l1717t1844r1774b1882],
7	201	CD	NUMBER	201	num	4	SENT_338	[p20l1789t1844r1855b1876],
8	1	CD	NUMBER	1	dep	4	SENT_338	[p20l1868t1844r1898b1876],
9	.	.	O	.	_	0	SENT_338	[p20l1868t1844r1898b1876],

1	doi	FW	O	doi	dep	171	SENT_339	[p20l1914t1841r2143b1876],
2	:10.1001	FW	O	:10.1001	dep	171	SENT_339	[p20l1914t1841r2143b1876],
3	/	:	O	/	dep	171	SENT_339	[p20l1132t1895r1470b1939],
4	jama	NN	O	jama	dep	171	SENT_339	[p20l1132t1895r1470b1939],
5	.2011.1703	CD	NUMBER	.2011.1703	dep	171	SENT_339	[p20l1132t1895r1470b1939],
6	Author	NN	O	author	dep	171	SENT_339	[p20l1132t1946r1269b1981],
7	Affiliations	NNS	O	affiliation	dep	171	SENT_339	[p20l1279t1945r1509b1981],
8	:	:	O	:	_	0	SENT_339	[p20l1279t1945r1509b1981],
9	TIMI	NNP	ORGANIZATION	TIMI	dep	171	SENT_339	[p20l1522t1948r1612b1981],
10	Study	NNP	ORGANIZATION	Study	dep	171	SENT_339	[p20l1628t1946r1737b1991],
11	Group	NNP	ORGANIZATION	Group	dep	171	SENT_339	[p20l1749t1948r1882b1992],
12	,	,	O	,	_	0	SENT_339	[p20l1749t1948r1882b1992],
13	Cardiovascular	NNP	O	Cardiovascular	dep	171	SENT_339	[p20l1897t1946r2148b1981, p20l1134t1998r1180b2033],
14	Division	NNP	O	Division	dep	171	SENT_339	[p20l1199t2001r1360b2039],
15	,	,	O	,	_	0	SENT_339	[p20l1199t2001r1360b2039],
16	Department	NNP	ORGANIZATION	Department	dep	171	SENT_339	[p20l1383t2001r1616b2044],
17	of	IN	ORGANIZATION	of	dep	171	SENT_339	[p20l1634t1998r1673b2033],
18	Medicine	NNP	ORGANIZATION	Medicine	dep	171	SENT_339	[p20l1691t1998r1879b2039],
19	,	,	O	,	_	0	SENT_339	[p20l1691t1998r1879b2039],
20	Brigham	NNP	ORGANIZATION	Brigham	dep	171	SENT_339	[p20l1902t1998r2058b2044],
21	and	CC	ORGANIZATION	and	dep	171	SENT_339	[p20l2079t1998r2148b2033],
22	Women	NNP	ORGANIZATION	Women	dep	171	SENT_339	[p20l1131t2053r1318b2086],
23	's	POS	ORGANIZATION	's	dep	171	SENT_339	[p20l1131t2053r1318b2086],
24	Hospital	NNP	ORGANIZATION	Hospital	dep	171	SENT_339	[p20l1332t2050r1486b2097],
25	and	CC	O	and	dep	171	SENT_339	[p20l1500t2050r1569b2086],
26	Harvard	NNP	ORGANIZATION	Harvard	dep	171	SENT_339	[p20l1585t2050r1736b2086],
27	Medical	NNP	ORGANIZATION	Medical	dep	171	SENT_339	[p20l1751t2050r1901b2086],
28	School	NNP	ORGANIZATION	School	dep	171	SENT_339	[p20l1916t2050r2053b2092],
29	,	,	O	,	_	0	SENT_339	[p20l1916t2050r2053b2092],
30	Boston	NNP	LOCATION	Boston	dep	171	SENT_339	[p20l2069t2053r2149b2086, p20l1132t2106r1206b2144],
31	,	,	O	,	_	0	SENT_339	[p20l2069t2053r2149b2086, p20l1132t2106r1206b2144],
32	Massachusetts	NNP	LOCATION	Massachusetts	dep	171	SENT_339	[p20l1223t2103r1504b2138],
33	(	NNP	O	(	dep	171	SENT_339	[p20l1520t2104r1597b2143],
34	Drs	NNP	O	Drs	dep	171	SENT_339	[p20l1520t2104r1597b2143],
35	Mega	JJ	O	mega	dep	171	SENT_339	[p20l1612t2105r1734b2148],
36	,	,	O	,	_	0	SENT_339	[p20l1612t2105r1734b2148],
37	Ruff	NN	PERSON	ruff	dep	171	SENT_339	[p20l1752t2102r1842b2144],
38	,	,	O	,	_	0	SENT_339	[p20l1752t2102r1842b2144],
39	Scirica	NNP	PERSON	Scirica	dep	171	SENT_339	[p20l1858t2105r1988b2144],
40	,	,	O	,	_	0	SENT_339	[p20l1858t2105r1988b2144],
41	and	CC	O	and	dep	171	SENT_339	[p20l2004t2103r2073b2138],
42	Sabatine	NNP	PERSON	Sabatine	dep	171	SENT_339	[p20l2090t2105r2148b2138, p20l1134t2155r1279b2197],
43	)	CD	NUMBER	)	dep	171	SENT_339	[p20l2090t2105r2148b2138, p20l1134t2155r1279b2197],
44	;	:	O	;	_	0	SENT_339	[p20l2090t2105r2148b2138, p20l1134t2155r1279b2197],
45	Herz-Zentrum	NNP	PERSON	Herz-Zentrum	dep	171	SENT_339	[p20l1303t2158r1576b2190],
46	Bad	NNP	PERSON	Bad	dep	171	SENT_339	[p20l1599t2155r1667b2190],
47	Krozingen	NNP	PERSON	Krozingen	dep	171	SENT_339	[p20l1690t2157r1897b2201],
48	,	,	O	,	_	0	SENT_339	[p20l1690t2157r1897b2201],
49	Bad	NNP	LOCATION	Bad	dep	171	SENT_339	[p20l1920t2155r1987b2190],
50	Krozingen	NNP	LOCATION	Krozingen	dep	171	SENT_339	[p20l2011t2157r2148b2190, p20l1133t2218r1215b2253],
51	,	,	O	,	_	0	SENT_339	[p20l2011t2157r2148b2190, p20l1133t2218r1215b2253],
52	Germany	NNP	LOCATION	Germany	dep	171	SENT_339	[p20l1236t2210r1415b2253],
53	(	CD	NUMBER	(	dep	171	SENT_339	[p20l1435t2209r1497b2248],
54	Dr	NNP	O	Dr	dep	171	SENT_339	[p20l1435t2209r1497b2248],
55	Hochholzer	NNP	O	Hochholzer	dep	171	SENT_339	[p20l1516t2207r1763b2249],
56	)	NN	O	)	dep	171	SENT_339	[p20l1516t2207r1763b2249],
57	;	:	O	;	_	0	SENT_339	[p20l1516t2207r1763b2249],
58	Center	NNP	ORGANIZATION	Center	dep	171	SENT_339	[p20l1785t2210r1916b2243],
59	for	IN	ORGANIZATION	for	dep	171	SENT_339	[p20l1933t2207r1989b2243],
60	Platelet	NN	ORGANIZATION	platelet	dep	171	SENT_339	[p20l2008t2207r2151b2243],
61	Research	NN	ORGANIZATION	research	dep	171	SENT_339	[p20l1134t2260r1303b2295],
62	Studies	NNS	ORGANIZATION	study	dep	171	SENT_339	[p20l1319t2260r1466b2301],
63	,	,	O	,	_	0	SENT_339	[p20l1319t2260r1466b2301],
64	Children	NNP	ORGANIZATION	Children	dep	171	SENT_339	[p20l1483t2260r1675b2295],
65	's	POS	ORGANIZATION	's	dep	171	SENT_339	[p20l1483t2260r1675b2295],
66	Hospital	NNP	ORGANIZATION	Hospital	dep	171	SENT_339	[p20l1691t2260r1845b2306],
67	Boston	NNP	ORGANIZATION	Boston	dep	171	SENT_339	[p20l1862t2262r2003b2301],
68	,	,	O	,	_	0	SENT_339	[p20l1862t2262r2003b2301],
69	Boston	NNP	LOCATION	Boston	dep	171	SENT_339	[p20l2020t2262r2148b2295],
70	(	NNP	O	(	dep	171	SENT_339	[p20l1134t2314r1211b2353],
71	Drs	NNP	PERSON	Drs	dep	171	SENT_339	[p20l1134t2314r1211b2353],
72	Frelinger	NNP	PERSON	Frelinger	dep	171	SENT_339	[p20l1229t2312r1397b2358],
73	and	CC	O	and	dep	171	SENT_339	[p20l1412t2312r1481b2348],
74	Michelson	NNP	PERSON	Michelson	dep	171	SENT_339	[p20l1499t2312r1723b2354],
75	)	CD	NUMBER	)	dep	171	SENT_339	[p20l1499t2312r1723b2354],
76	;	:	O	;	_	0	SENT_339	[p20l1499t2312r1723b2354],
77	Center	NNP	ORGANIZATION	Center	dep	171	SENT_339	[p20l1742t2314r1873b2348],
78	for	IN	ORGANIZATION	for	dep	171	SENT_339	[p20l1887t2312r1942b2348],
79	Advanced	NNP	ORGANIZATION	Advanced	dep	171	SENT_339	[p20l1956t2312r2148b2348],
80	Molecular	JJ	ORGANIZATION	molecular	dep	171	SENT_339	[p20l1133t2365r1333b2401],
81	Diagnostics	NNPS	ORGANIZATION	Diagnostics	dep	171	SENT_339	[p20l1354t2368r1592b2411],
82	,	,	O	,	_	0	SENT_339	[p20l1354t2368r1592b2411],
83	Department	NNP	ORGANIZATION	Department	dep	171	SENT_339	[p20l1617t2368r1857b2412],
84	of	IN	ORGANIZATION	of	dep	171	SENT_339	[p20l1876t2365r1916b2401],
85	Pathology	NNP	ORGANIZATION	Pathology	dep	171	SENT_339	[p20l1936t2365r2148b2411],
86	,	,	O	,	_	0	SENT_339	[p20l1936t2365r2148b2411],
87	Brigham	NNP	ORGANIZATION	Brigham	dep	171	SENT_339	[p20l1134t2418r1288b2463],
88	and	CC	ORGANIZATION	and	dep	171	SENT_339	[p20l1302t2418r1370b2453],
89	Women	NNP	ORGANIZATION	Women	dep	171	SENT_339	[p20l1382t2420r1566b2453],
90	's	POS	ORGANIZATION	's	dep	171	SENT_339	[p20l1382t2420r1566b2453],
91	Hospital	NNP	ORGANIZATION	Hospital	dep	171	SENT_339	[p20l1580t2418r1743b2464],
92	,	,	O	,	_	0	SENT_339	[p20l1580t2418r1743b2464],
93	Boston	NNP	LOCATION	Boston	dep	171	SENT_339	[p20l1758t2420r1884b2453],
94	(	NNP	O	(	dep	171	SENT_339	[p20l1899t2419r1975b2458],
95	Drs	NNP	O	Drs	dep	171	SENT_339	[p20l1899t2419r1975b2458],
96	Kluk	NNP	PERSON	Kluk	dep	171	SENT_339	[p20l1989t2418r2069b2453],
97	and	CC	O	and	dep	171	SENT_339	[p20l2080t2418r2149b2453],
98	Longtine	NNP	LOCATION	Longtine	dep	171	SENT_339	[p20l1134t2471r1329b2516],
99	)	NN	O	)	dep	171	SENT_339	[p20l1134t2471r1329b2516],
100	;	:	O	;	_	0	SENT_339	[p20l1134t2471r1329b2516],
101	University	NNP	ORGANIZATION	University	dep	171	SENT_339	[p20l1347t2473r1538b2516],
102	of	IN	ORGANIZATION	of	dep	171	SENT_339	[p20l1552t2470r1592b2505],
103	Florida	NNP	ORGANIZATION	Florida	dep	171	SENT_339	[p20l1607t2470r1735b2505],
104	College	NNP	ORGANIZATION	College	dep	171	SENT_339	[p20l1749t2470r1893b2516],
105	of	IN	ORGANIZATION	of	dep	171	SENT_339	[p20l1908t2470r1947b2505],
106	Medicine	NNP	ORGANIZATION	Medicine	dep	171	SENT_339	[p20l1960t2470r2148b2511],
107	,	,	O	,	_	0	SENT_339	[p20l1960t2470r2148b2511],
108	Jacksonville	NNP	LOCATION	Jacksonville	dep	171	SENT_339	[p20l1131t2522r1355b2558],
109	(	CD	NUMBER	(	dep	171	SENT_339	[p20l1372t2524r1434b2562],
110	Dr	NNP	O	Dr	dep	171	SENT_339	[p20l1372t2524r1434b2562],
111	Angiolillo	NNP	O	Angiolillo	dep	171	SENT_339	[p20l1446t2522r1653b2568],
112	)	NN	O	)	dep	171	SENT_339	[p20l1446t2522r1653b2568],
113	;	:	O	;	_	0	SENT_339	[p20l1446t2522r1653b2568],
114	Heart	NNP	O	Heart	dep	171	SENT_339	[p20l1673t2525r1779b2558],
115	and	CC	O	and	dep	171	SENT_339	[p20l1792t2522r1861b2558],
116	Vascular	JJ	ORGANIZATION	vascular	dep	171	SENT_339	[p20l1878t2522r2043b2558],
117	Center	NN	ORGANIZATION	center	dep	171	SENT_339	[p20l2057t2524r2148b2558, p20l1132t2578r1185b2610],
118	and	CC	O	and	dep	171	SENT_339	[p20l1202t2575r1271b2610],
119	Lindner	NNP	ORGANIZATION	Lindner	dep	171	SENT_339	[p20l1293t2575r1438b2610],
120	Research	NNP	ORGANIZATION	Research	dep	171	SENT_339	[p20l1457t2575r1639b2616],
121	,	,	O	,	_	0	SENT_339	[p20l1457t2575r1639b2616],
122	The	DT	O	the	dep	171	SENT_339	[p20l1658t2575r1730b2610],
123	Christ	NNP	ORGANIZATION	Christ	dep	171	SENT_339	[p20l1750t2575r1862b2610],
124	Hospital	NNP	ORGANIZATION	Hospital	dep	171	SENT_339	[p20l1882t2575r2048b2621],
125	,	,	O	,	_	0	SENT_339	[p20l1882t2575r2048b2621],
126	Cincinnati	NNP	LOCATION	Cincinnati	dep	171	SENT_339	[p20l2069t2577r2148b2610, p20l1133t2630r1267b2668],
127	,	,	O	,	_	0	SENT_339	[p20l2069t2577r2148b2610, p20l1133t2630r1267b2668],
128	Ohio	NNP	LOCATION	Ohio	dep	171	SENT_339	[p20l1282t2627r1376b2662],
129	(	CD	NUMBER	(	dep	171	SENT_339	[p20l1389t2628r1450b2667],
130	Dr	NNP	O	Dr	dep	171	SENT_339	[p20l1389t2628r1450b2667],
131	Kereiakes	NNPS	O	Kereiakes	dep	171	SENT_339	[p20l1462t2627r1665b2668],
132	)	NN	O	)	dep	171	SENT_339	[p20l1462t2627r1665b2668],
133	;	:	O	;	_	0	SENT_339	[p20l1462t2627r1665b2668],
134	Clinical	JJ	O	clinical	dep	171	SENT_339	[p20l1679t2627r1812b2663],
135	Trials	NNS	O	trial	dep	171	SENT_339	[p20l1824t2627r1922b2663],
136	of	IN	O	of	dep	171	SENT_339	[p20l1934t2627r1973b2662],
137	America	NNP	LOCATION	America	dep	171	SENT_339	[p20l1982t2630r2148b2668],
138	,	,	O	,	_	0	SENT_339	[p20l1982t2630r2148b2668],
139	Hickory	NNP	PERSON	Hickory	dep	171	SENT_339	[p20l1134t2679r1290b2725],
140	,	,	O	,	_	0	SENT_339	[p20l1134t2679r1290b2725],
141	North	NNP	LOCATION	North	dep	171	SENT_339	[p20l1310t2679r1418b2715],
142	Carolina	NNP	LOCATION	Carolina	dep	171	SENT_339	[p20l1437t2679r1598b2715],
143	(	CD	NUMBER	(	dep	171	SENT_339	[p20l1614t2681r1675b2719],
144	Dr	NNP	O	Dr	dep	171	SENT_339	[p20l1614t2681r1675b2719],
145	Isserman	NNP	PERSON	Isserman	dep	171	SENT_339	[p20l1692t2681r1885b2721],
146	)	NN	O	)	dep	171	SENT_339	[p20l1692t2681r1885b2721],
147	;	:	O	;	_	0	SENT_339	[p20l1692t2681r1885b2721],
148	University	NNP	ORGANIZATION	University	dep	171	SENT_339	[p20l1906t2682r2096b2725],
149	of	IN	ORGANIZATION	of	dep	171	SENT_339	[p20l2113t2679r2152b2715],
150	Alabama	NNP	ORGANIZATION	Alabama	dep	171	SENT_339	[p20l1131t2732r1304b2767],
151	at	IN	O	at	dep	171	SENT_339	[p20l1315t2735r1352b2767],
152	Birmingham	NNP	ORGANIZATION	Birmingham	dep	171	SENT_339	[p20l1365t2732r1595b2777],
153	Medical	NNP	ORGANIZATION	Medical	dep	171	SENT_339	[p20l1610t2732r1760b2767],
154	Center	NNP	ORGANIZATION	Center	dep	171	SENT_339	[p20l1775t2734r1906b2767],
155	(	CD	NUMBER	(	dep	171	SENT_339	[p20l1918t2733r1979b2772],
156	Dr	NNP	O	Dr	dep	171	SENT_339	[p20l1918t2733r1979b2772],
157	Rogers	NNP	ORGANIZATION	Rogers	dep	171	SENT_339	[p20l1992t2733r2148b2777],
158	)	NN	O	)	dep	171	SENT_339	[p20l1992t2733r2148b2777],
159	;	:	O	;	_	0	SENT_339	[p20l1992t2733r2148b2777],
160	TIMI	NNP	ORGANIZATION	TIMI	dep	171	SENT_339	[p20l1131t2787r1222b2819],
161	Study	NNP	ORGANIZATION	Study	dep	171	SENT_339	[p20l1245t2784r1355b2830],
162	Group	NNP	ORGANIZATION	Group	dep	171	SENT_339	[p20l1375t2786r1508b2830],
163	,	,	O	,	_	0	SENT_339	[p20l1375t2786r1508b2830],
164	Boston	NNP	LOCATION	Boston	dep	171	SENT_339	[p20l1532t2787r1662b2819],
165	(	CD	NUMBER	(	dep	171	SENT_339	[p20l1684t2786r1746b2824],
166	Dr	NNP	O	Dr	dep	171	SENT_339	[p20l1684t2786r1746b2824],
167	Contant	NNP	PERSON	Contant	dep	171	SENT_339	[p20l1765t2786r1950b2825],
168	)	NN	O	)	dep	171	SENT_339	[p20l1765t2786r1950b2825],
169	;	:	O	;	_	0	SENT_339	[p20l1765t2786r1950b2825],
170	and	CC	O	and	dep	171	SENT_339	[p20l1972t2784r2041b2819],
171	Harvard	NNP	ORGANIZATION	Harvard	_	0	SENT_339	[p20l2065t2787r2148b2819, p20l1132t2911r1214b2946],

1	Clinical	JJ	ORGANIZATION	clinical	amod	3	SENT_340	[p20l1236t2911r1372b2946],
2	Research	NNP	ORGANIZATION	Research	nn	3	SENT_340	[p20l1394t2911r1564b2946],
3	Institute	NNP	ORGANIZATION	Institute	_	0	SENT_340	[p20l1587t2914r1743b2946],
4	and	CC	O	and	_	0	SENT_340	[p20l1762t2911r1832b2946],
5	Boston	NNP	ORGANIZATION	Boston	nn	6	SENT_340	[p20l1855t2914r1983b2946],
6	University	NNP	ORGANIZATION	University	conj_and	3	SENT_340	[p20l2006t2914r2148b2946, p20l1132t2966r1206b3009],
7	,	,	O	,	_	0	SENT_340	[p20l2006t2914r2148b2946, p20l1132t2966r1206b3009],
8	Boston	NNP	LOCATION	Boston	nn	11	SENT_340	[p20l1226t2966r1354b2999],
9	(	CD	NUMBER	(	num	11	SENT_340	[p20l1373t2965r1434b3003],
10	Dr	NNP	O	Dr	nn	11	SENT_340	[p20l1373t2965r1434b3003],
11	Pencina	NNP	PERSON	Pencina	appos	3	SENT_340	[p20l1450t2965r1623b3003],
12	)	NN	O	)	dep	11	SENT_340	[p20l1450t2965r1623b3003],
13	.	.	O	.	_	0	SENT_340	[p20l1450t2965r1623b3003],

1	Author	NN	O	author	nn	2	SENT_341	[p20l1132t3015r1269b3051],
2	Contributions	NNS	O	contribution	_	0	SENT_341	[p20l1283t3015r1564b3051],
3	:	:	O	:	_	0	SENT_341	[p20l1283t3015r1564b3051],
4	Dr	NN	O	dr	nsubj	18	SENT_341	[p20l1582t3018r1627b3050],
5	Mega	JJ	PERSON	mega	amod	4	SENT_341	[p20l1641t3018r1753b3061],
6	had	VBD	O	have	dep	2	SENT_341	[p20l1768t3015r1835b3051],
7	full	JJ	O	full	amod	8	SENT_341	[p20l1851t3015r1908b3051],
8	access	NN	O	access	dobj	6	SENT_341	[p20l1924t3026r2043b3051],
9	to	TO	O	to	_	0	SENT_341	[p20l2057t3019r2095b3051],
10	all	DT	O	all	prep_to	6	SENT_341	[p20l2110t3015r2149b3051],
11	of	IN	O	of	_	0	SENT_341	[p20l1132t3068r1172b3104],
12	the	DT	O	the	det	13	SENT_341	[p20l1188t3068r1249b3104],
13	data	NNS	O	datum	prep_of	10	SENT_341	[p20l1267t3068r1352b3104],
14	in	IN	O	in	_	0	SENT_341	[p20l1370t3071r1400b3103],
15	the	DT	O	the	det	16	SENT_341	[p20l1419t3068r1480b3104],
16	study	NN	O	study	prep_in	6	SENT_341	[p20l1499t3068r1603b3114],
17	and	CC	O	and	_	0	SENT_341	[p20l1621t3068r1690b3104],
18	takes	VBZ	O	take	conj_and	6	SENT_341	[p20l1710t3068r1809b3104],
19	responsibility	NN	O	responsibility	dobj	18	SENT_341	[p20l1829t3068r2079b3115],
20	for	IN	O	for	_	0	SENT_341	[p20l2096t3068r2152b3104],
21	the	DT	O	the	det	22	SENT_341	[p20l1132t3121r1193b3156],
22	integrity	NN	O	integrity	prep_for	18	SENT_341	[p20l1208t3123r1367b3166],
23	of	IN	O	of	_	0	SENT_341	[p20l1380t3120r1419b3156],
24	the	DT	O	the	det	25	SENT_341	[p20l1430t3121r1491b3156],
25	data	NNS	O	datum	prep_of	22	SENT_341	[p20l1505t3121r1590b3156],
26	and	CC	O	and	_	0	SENT_341	[p20l1602t3121r1671b3156],
27	the	DT	O	the	det	28	SENT_341	[p20l1685t3121r1747b3156],
28	accuracy	NN	O	accuracy	prep_for	18	SENT_341	[p20l1760t3132r1928b3166],
29	of	IN	O	of	_	0	SENT_341	[p20l1941t3120r1981b3156],
30	the	DT	O	the	det	32	SENT_341	[p20l1992t3121r2053b3156],
31	data	NN	O	datum	nn	32	SENT_341	[p20l2067t3121r2151b3156],
32	analysis	NN	O	analysis	prep_of	28	SENT_341	[p20l1132t3173r1290b3219],
33	.	.	O	.	_	0	SENT_341	[p20l1132t3173r1290b3219],

1	Study	NNP	O	Study	nn	2	SENT_342	[p20l1131t3226r1243b3271],
2	concept	NN	O	concept	_	0	SENT_342	[p20l1257t3228r1411b3271],
3	and	CC	O	and	_	0	SENT_342	[p20l1423t3226r1498b3261],
4	design	NN	O	design	conj_and	2	SENT_342	[p20l1511t3226r1647b3271],
5	:	:	O	:	_	0	SENT_342	[p20l1511t3226r1647b3271],
6	Mega	JJ	O	mega	dep	2	SENT_342	[p20l1664t3228r1786b3271],
7	,	,	O	,	_	0	SENT_342	[p20l1664t3228r1786b3271],
8	Sabatine	NNP	PERSON	Sabatine	appos	6	SENT_342	[p20l1805t3225r1979b3261],
9	.	.	O	.	_	0	SENT_342	[p20l1805t3225r1979b3261],

1	Acquisition	NN	O	acquisition	_	0	SENT_343	[p20l1131t3280r1352b3323],
2	of	IN	O	of	_	0	SENT_343	[p20l1371t3278r1414b3313],
3	data	NNS	O	datum	prep_of	1	SENT_343	[p20l1427t3278r1522b3313],
4	:	:	O	:	_	0	SENT_343	[p20l1427t3278r1522b3313],
5	Angiolillo	NNP	O	Angiolillo	nn	11	SENT_343	[p20l1541t3278r1733b3323],
6	,	,	O	,	_	0	SENT_343	[p20l1541t3278r1733b3323],
7	Kereiakes	NNP	LOCATION	Kereiakes	appos	11	SENT_343	[p20l1756t3278r1947b3319],
8	,	,	O	,	_	0	SENT_343	[p20l1756t3278r1947b3319],
9	Isserman	NNP	PERSON	Isserman	appos	11	SENT_343	[p20l1970t3280r2148b3319],
10	,	,	O	,	_	0	SENT_343	[p20l1970t3280r2148b3319],
11	Rogers	NNP	PERSON	Rogers	dep	1	SENT_343	[p20l1134t3333r1274b3376],
12	.	.	O	.	_	0	SENT_343	[p20l1134t3333r1274b3376],

1	Analysis	NN	O	analysis	_	0	SENT_344	[p20l1131t3383r1287b3428],
2	and	CC	O	and	_	0	SENT_344	[p20l1295t3383r1368b3418],
3	interpretation	NN	O	interpretation	conj_and	1	SENT_344	[p20l1376t3385r1632b3428],
4	of	IN	O	of	_	0	SENT_344	[p20l1644t3383r1685b3418],
5	data	NNS	O	datum	prep_of	1	SENT_344	[p20l1691t3383r1783b3418],
6	:	:	O	:	_	0	SENT_344	[p20l1691t3383r1783b3418],
7	Mega	JJ	O	mega	amod	5	SENT_344	[p20l1795t3385r1914b3428],
8	,	,	O	,	_	0	SENT_344	[p20l1795t3385r1914b3428],
9	Hochholzer	NNP	PERSON	Hochholzer	appos	5	SENT_344	[p20l1928t3382r2149b3424],
10	,	,	O	,	_	0	SENT_344	[p20l1928t3382r2149b3424],

1	dogrel	NN	O	dogrel	nsubjpass	14	SENT_345	[p21l34t58r206b121],
2	in	IN	O	in	_	0	SENT_345	[p21l229t63r283b104],
3	patients	NNS	O	patient	prep_in	1	SENT_345	[p21l306t63r521b121],
4	with	IN	O	with	_	0	SENT_345	[p21l544t58r667b106],
5	CYPZC	NN	ORGANIZATION	cypzc	prep_with	3	SENT_345	[p21l693t61r879b106],
6	19	CD	NUMBER	19	num	8	SENT_345	[p21l886t61r945b106],
7	genetic	JJ	O	genetic	amod	8	SENT_345	[p21l971t75r1050b121, p21l33t138r164b181],
8	variants	NNS	O	variant	tmod	3	SENT_345	[p21l187t138r416b190],
9	,	,	O	,	_	0	SENT_345	[p21l187t138r416b190],
10	further	JJ	O	further	amod	11	SENT_345	[p21l443t133r631b181],
11	studies	NNS	O	study	appos	8	SENT_345	[p21l655t133r843b181],
12	will	MD	O	will	aux	14	SENT_345	[p21l866t133r967b181],
13	be	VB	O	be	auxpass	14	SENT_345	[p21l989t133r1051b181],
14	needed	VBN	O	need	_	0	SENT_345	[p21l33t209r222b256],
15	to	TO	O	to	aux	16	SENT_345	[p21l238t220r286b256],
16	address	VB	O	address	xcomp	14	SENT_345	[p21l303t209r499b256],
17	questions	NNS	O	question	dobj	16	SENT_345	[p21l515t214r766b272],
18	pertaining	VBG	O	pertain	partmod	17	SENT_345	[p21l781t214r1052b271],
19	to	TO	O	to	_	0	SENT_345	[p21l35t295r83b331],
20	possible	JJ	O	possible	amod	21	SENT_345	[p21l103t284r315b346],
21	interactions	NNS	O	interaction	prep_to	18	SENT_345	[p21l334t289r645b331],
22	between	IN	O	between	_	0	SENT_345	[p21l662t284r883b331],
23	clopidogrel	NN	O	clopidogrel	nn	24	SENT_345	[p21l902t284r1050b346, p21l34t359r200b422],
24	dosing	NN	O	dosing	prep_between	21	SENT_345	[p21l223t359r412b422],
25	,	,	O	,	_	0	SENT_345	[p21l223t359r412b422],
26	PPI	NNP	O	PPI	nn	27	SENT_345	[p21l437t364r526b406],
27	use	NN	O	use	prep_between	21	SENT_345	[p21l549t376r651b416],
28	,	,	O	,	_	0	SENT_345	[p21l549t376r651b416],
29	and	CC	O	and	_	0	SENT_345	[p21l676t359r773b407],
30	genotype	NN	O	genotype	prep_between	21	SENT_345	[p21l795t371r1047b422],
31	.	.	O	.	_	0	SENT_345	[p21l795t371r1047b422],

1	Fourth	JJ	ORDINAL	fourth	advmod	5	SENT_346	[p21l34t434r231b491],
2	,	,	O	,	_	0	SENT_346	[p21l34t434r231b491],
3	this	DT	O	this	det	4	SENT_346	[p21l250t434r344b482],
4	study	NN	O	study	nsubj	5	SENT_346	[p21l361t434r506b497],
5	focused	VBD	O	focus	_	0	SENT_346	[p21l521t434r723b482],
6	on	IN	O	on	_	0	SENT_346	[p21l739t451r806b482],
7	achieved	VBN	O	achieve	prepc_on	5	SENT_346	[p21l822t434r1052b482],
8	platelet	NN	O	platelet	nn	9	SENT_346	[p21l33t509r231b572],
9	reactivity	NN	O	reactivity	dobj	7	SENT_346	[p21l253t514r502b572],
10	as	IN	O	as	_	0	SENT_346	[p21l525t526r576b557],
11	the	DT	O	the	det	13	SENT_346	[p21l601t509r682b557],
12	primary	JJ	O	primary	amod	13	SENT_346	[p21l705t514r919b572],
13	outcome	NN	O	outcome	prep_as	7	SENT_346	[p21l943t521r1050b557, p21l35t602r174b632],
14	of	IN	O	of	_	0	SENT_346	[p21l189t584r243b632],
15	interest	NN	O	interest	prep_of	13	SENT_346	[p21l252t589r460b632],
16	.	.	O	.	_	0	SENT_346	[p21l252t589r460b632],

1	While	IN	O	while	mark	7	SENT_347	[p21l475t585r636b632],
2	platelet	NN	O	platelet	nn	3	SENT_347	[p21l650t585r843b647],
3	reactivity	NN	O	reactivity	nsubj	7	SENT_347	[p21l856t589r1050b632, p21l34t665r101b722],
4	is	VBZ	O	be	cop	7	SENT_347	[p21l117t665r156b707],
5	a	DT	O	a	det	7	SENT_347	[p21l174t677r200b707],
6	well-validated	JJ	O	well-validated	amod	7	SENT_347	[p21l216t660r587b707],
7	predictor	NN	O	predictor	advcl	17	SENT_347	[p21l603t660r846b722],
8	of	IN	O	of	_	0	SENT_347	[p21l863t659r916b707],
9	poor	JJ	O	poor	amod	11	SENT_347	[p21l928t677r1052b722],
10	clinical	JJ	O	clinical	amod	11	SENT_347	[p21l35t735r222b782],
11	outcomes	NNS	O	outcome	prep_of	7	SENT_347	[p21l237t746r502b791],
12	,	,	O	,	_	0	SENT_347	[p21l237t746r502b791],
13	large-scale	JJ	O	large-scale	amod	16	SENT_347	[p21l518t735r792b798],
14	and	CC	O	and	_	0	SENT_347	[p21l806t735r903b782],
15	longterm	JJ	O	longterm	amod	16	SENT_347	[p21l916t735r1051b797, p21l35t822r161b857],
16	trials	NNS	O	trial	nsubj	17	SENT_347	[p21l187t810r323b857],
17	powered	VBD	O	power	_	0	SENT_347	[p21l348t810r586b873],
18	for	IN	O	for	mark	23	SENT_347	[p21l612t809r688b857],
19	clinical	JJ	O	clinical	amod	20	SENT_347	[p21l714t810r913b857],
20	outcomes	NNS	O	outcome	nsubj	23	SENT_347	[p21l939t822r1050b857, p21l35t902r202b933],
21	will	MD	O	will	aux	23	SENT_347	[p21l225t885r327b933],
22	be	VB	O	be	cop	23	SENT_347	[p21l349t885r411b933],
23	necessary	JJ	O	necessary	advcl	17	SENT_347	[p21l435t902r695b948],
24	to	TO	O	to	aux	25	SENT_347	[p21l719t897r768b933],
25	assess	VB	O	assess	xcomp	23	SENT_347	[p21l794t902r951b933],
26	for	IN	O	for	_	0	SENT_347	[p21l977t885r1052b933],
27	adverse	JJ	O	adverse	amod	28	SENT_347	[p21l34t960r230b1008],
28	events	NNS	O	event	prep_for	25	SENT_347	[p21l254t972r418b1008],
29	and	CC	O	and	_	0	SENT_347	[p21l441t960r538b1008],
30	establish	VB	O	establish	conj_and	25	SENT_347	[p21l561t960r788b1008],
31	preferred	JJ	O	preferred	amod	33	SENT_347	[p21l809t960r1052b1023],
32	treatment	NN	O	treatment	nn	33	SENT_347	[p21l35t1047r335b1083],
33	regimens	NNS	O	regimen	dobj	30	SENT_347	[p21l368t1041r666b1098],
34	.	.	O	.	_	0	SENT_347	[p21l368t1041r666b1098],

1	Until	IN	O	until	_	0	SENT_348	[p21l703t1036r861b1083],
2	then	RB	O	then	pobj	1	SENT_348	[p21l896t1036r1049b1093],
3	,	,	O	,	_	0	SENT_348	[p21l896t1036r1049b1093],

1	ELEVATE-TIMI	NN	O	elevate-timus	nsubj	12	SENT_349	[p21l34t1189r461b1234],
2	56	CD	NUMBER	56	num	1	SENT_349	[p21l480t1189r542b1234],
3	offers	VBZ	O	offer	_	0	SENT_349	[p21l561t1186r704b1233],
4	a	DT	O	a	det	5	SENT_349	[p21l721t1203r747b1233],
5	framework	NN	O	framework	dobj	3	SENT_349	[p21l764t1186r1052b1234],
6	to	TO	O	to	_	0	SENT_349	[p21l35t1273r83b1309],
7	rationally	RB	O	rationally	advmod	8	SENT_349	[p21l98t1261r346b1324],
8	select	JJ	O	select	amod	10	SENT_349	[p21l358t1261r503b1309],
9	alternative	JJ	O	alternative	amod	10	SENT_349	[p21l515t1261r787b1309],
10	doses	NNS	O	dose	prep_to	3	SENT_349	[p21l802t1261r942b1309],
11	and	CC	O	and	_	0	SENT_349	[p21l957t1261r1053b1309],
12	lays	VBZ	O	lay	conj_and	3	SENT_349	[p21l33t1412r132b1475],
13	the	DT	O	the	det	14	SENT_349	[p21l153t1412r233b1459],
14	foundation	NN	O	foundation	dobj	12	SENT_349	[p21l253t1412r543b1459],
15	for	IN	O	for	_	0	SENT_349	[p21l562t1412r635b1459],
16	future	JJ	DATE	future	amod	17	SENT_349	[p21l654t1412r813b1459],
17	studies	NNS	O	study	prep_for	14	SENT_349	[p21l831t1412r1027b1459],
18	.	.	O	.	_	0	SENT_349	[p21l831t1412r1027b1459],

1	In	IN	O	in	_	0	SENT_350	[p21l100t1492r155b1534],
2	conclusion	NN	O	conclusion	prep_in	6	SENT_350	[p21l181t1487r493b1544],
3	,	,	O	,	_	0	SENT_350	[p21l181t1487r493b1544],
4	ELEVATE-TIMI	NN	O	elevate-timus	nsubj	6	SENT_350	[p21l520t1490r959b1535],
5	56	CD	NUMBER	56	num	4	SENT_350	[p21l987t1490r1050b1535],
6	demonstrates	VBZ	O	demonstrate	_	0	SENT_350	[p21l34t1562r386b1609],
7	that	IN	O	that	advmod	6	SENT_350	[p21l403t1562r505b1609],
8	among	IN	O	among	_	0	SENT_350	[p21l518t1579r698b1624],
9	patients	NNS	O	patient	prep_among	7	SENT_350	[p21l711t1567r919b1624],
10	with	IN	O	with	_	0	SENT_350	[p21l932t1562r1052b1609],
11	stable	JJ	O	stable	amod	13	SENT_350	[p21l34t1637r187b1684],
12	cardiovascular	JJ	O	cardiovascular	amod	13	SENT_350	[p21l212t1637r600b1684],
13	disease	NN	O	disease	prep_with	6	SENT_350	[p21l624t1637r827b1694],
14	,	,	O	,	_	0	SENT_350	[p21l624t1637r827b1694],
15	tripling	VBG	O	triple	xcomp	6	SENT_350	[p21l853t1637r1052b1700],
16	the	DT	O	the	det	18	SENT_350	[p21l35t1712r116b1759],
17	maintenance	NN	O	maintenance	nn	18	SENT_350	[p21l131t1717r471b1759],
18	dose	NN	O	dose	dobj	15	SENT_350	[p21l487t1712r605b1759],
19	of	IN	O	of	_	0	SENT_350	[p21l621t1711r675b1759],
20	clopidogrel	NN	O	clopidogrel	prep_of	18	SENT_350	[p21l686t1712r986b1775],
21	to	TO	O	to	_	0	SENT_350	[p21l1001t1724r1050b1759],
22	225	CD	NUMBER	225	num	23	SENT_350	[p21l35t1790r130b1835],
23	mg	NN	O	mg	prep_to	20	SENT_350	[p21l150t1804r233b1850],
24	daily	RB	SET	daily	advmod	20	SENT_350	[p21l250t1787r379b1850],
25	in	IN	O	in	_	0	SENT_350	[p21l395t1792r448b1834],
26	CYP2C19	NN	O	cyp2c19	nn	27	SENT_350	[p21l466t1785r779b1835],
27	*	NN	O	*	prep_in	24	SENT_350	[p21l466t1785r779b1835],
28	2	CD	NUMBER	2	num	29	SENT_350	[p21l466t1785r779b1835],
29	heterozygotes	NNS	O	heterozygote	dep	20	SENT_350	[p21l798t1787r1050b1850, p21l34t1874r171b1925],
30	achieved	VBN	O	achieve	partmod	29	SENT_350	[p21l196t1862r430b1910],
31	levels	NNS	O	level	nsubj	35	SENT_350	[p21l453t1862r601b1910],
32	of	IN	O	of	_	0	SENT_350	[p21l627t1862r681b1910],
33	platelet	NN	O	platelet	nn	34	SENT_350	[p21l699t1862r898b1925],
34	reactivity	NN	O	reactivity	prep_of	31	SENT_350	[p21l921t1880r1051b1910, p21l35t1942r170b2000],
35	similar	JJ	O	similar	xcomp	30	SENT_350	[p21l184t1938r366b1985],
36	to	TO	O	to	_	0	SENT_350	[p21l381t1949r429b1985],
37	that	DT	O	that	prep_to	35	SENT_350	[p21l447t1938r549b1985],
38	seen	VBN	O	see	partmod	37	SENT_350	[p21l563t1955r679b1985],
39	with	IN	O	with	_	0	SENT_350	[p21l692t1938r812b1985],
40	the	DT	O	the	det	43	SENT_350	[p21l827t1938r908b1985],
41	standard	JJ	O	standard	amod	43	SENT_350	[p21l923t1949r1051b1985, p21l34t2013r155b2060],
42	75-mg	JJ	O	75-mg	amod	43	SENT_350	[p21l176t2016r346b2075],
43	dose	NN	O	dose	prep_with	38	SENT_350	[p21l365t2013r485b2060],
44	in	IN	O	in	_	0	SENT_350	[p21l504t2018r556b2059],
45	noncarriers	NNS	O	noncarrier	prep_in	43	SENT_350	[p21l575t2018r895b2060],
46	.	.	O	.	_	0	SENT_350	[p21l575t2018r895b2060],

1	Even	RB	O	even	advmod	2	SENT_351	[p21l919t2017r1052b2060],
2	Frelinger	NNP	PERSON	Frelinger	_	0	SENT_351	[p21l1134t53r1305b99],
3	,	,	O	,	_	0	SENT_351	[p21l1134t53r1305b99],
4	Kluk	NNP	PERSON	Kluk	nn	26	SENT_351	[p21l1320t53r1410b95],
5	,	,	O	,	_	0	SENT_351	[p21l1320t53r1410b95],
6	Angiolillo	NNP	O	Angiolillo	appos	26	SENT_351	[p21l1422t53r1607b99],
7	,	,	O	,	_	0	SENT_351	[p21l1422t53r1607b99],
8	Kereiakes	NNP	LOCATION	Kereiakes	appos	26	SENT_351	[p21l1622t53r1808b95],
9	,	,	O	,	_	0	SENT_351	[p21l1622t53r1808b95],
10	Isserman	NNP	PERSON	Isserman	appos	26	SENT_351	[p21l1824t56r1997b95],
11	,	,	O	,	_	0	SENT_351	[p21l1824t56r1997b95],
12	Rogers	NNP	ORGANIZATION	Rogers	appos	26	SENT_351	[p21l2012t56r2149b99],
13	,	,	O	,	_	0	SENT_351	[p21l2012t56r2149b99],
14	Ruff	NNP	PERSON	Ruff	appos	26	SENT_351	[p21l1134t105r1224b147],
15	,	,	O	,	_	0	SENT_351	[p21l1134t105r1224b147],
16	Contant	NNP	PERSON	Contant	appos	26	SENT_351	[p21l1240t108r1407b147],
17	,	,	O	,	_	0	SENT_351	[p21l1240t108r1407b147],
18	Pencina	NNP	PERSON	Pencina	appos	26	SENT_351	[p21l1425t108r1583b147],
19	,	,	O	,	_	0	SENT_351	[p21l1425t108r1583b147],
20	Scirica	NNP	PERSON	Scirica	appos	26	SENT_351	[p21l1599t108r1728b147],
21	,	,	O	,	_	0	SENT_351	[p21l1599t108r1728b147],
22	Longtine	NNP	LOCATION	Longtine	appos	26	SENT_351	[p21l1745t108r1924b151],
23	,	,	O	,	_	0	SENT_351	[p21l1745t108r1924b151],
24	Michelson	NNP	PERSON	Michelson	appos	26	SENT_351	[p21l1940t106r2148b147],
25	,	,	O	,	_	0	SENT_351	[p21l1940t106r2148b147],
26	Sabatine	NNP	PERSON	Sabatine	appos	2	SENT_351	[p21l1133t158r1307b193],
27	.	.	O	.	_	0	SENT_351	[p21l1133t158r1307b193],

1	Drafting	VBG	O	draft	_	0	SENT_352	[p21l1132t211r1294b256],
2	of	IN	O	of	_	0	SENT_352	[p21l1307t211r1350b246],
3	the	DT	O	the	det	4	SENT_352	[p21l1361t211r1421b246],
4	manuscript	NN	O	manuscript	prep_of	1	SENT_352	[p21l1436t213r1665b256],
5	:	:	O	:	_	0	SENT_352	[p21l1436t213r1665b256],
6	Mega	JJ	O	mega	dep	1	SENT_352	[p21l1682t213r1804b256],
7	,	,	O	,	_	0	SENT_352	[p21l1682t213r1804b256],
8	Sabatine	NNP	PERSON	Sabatine	appos	6	SENT_352	[p21l1822t210r1997b246],
9	.	.	O	.	_	0	SENT_352	[p21l1822t210r1997b246],

1	Critical	JJ	O	critical	amod	2	SENT_353	[p21l1133t263r1273b298],
2	revision	NN	O	revision	_	0	SENT_353	[p21l1287t265r1439b298],
3	of	IN	O	of	_	0	SENT_353	[p21l1456t263r1498b298],
4	the	DT	O	the	det	5	SENT_353	[p21l1510t263r1570b298],
5	manuscript	NN	O	manuscript	prep_of	2	SENT_353	[p21l1586t265r1805b308],
6	for	IN	O	for	_	0	SENT_353	[p21l1819t263r1875b298],
7	important	JJ	O	important	amod	9	SENT_353	[p21l1888t265r2083b308],
8	intellectual	JJ	O	intellectual	amod	9	SENT_353	[p21l2097t265r2148b298, p21l1132t315r1331b350],
9	content	NN	O	content	prep_for	5	SENT_353	[p21l1352t318r1525b350],
10	:	:	O	:	_	0	SENT_353	[p21l1352t318r1525b350],
11	Hochholzer	NNP	PERSON	Hochholzer	nn	35	SENT_353	[p21l1551t315r1800b356],
12	,	,	O	,	_	0	SENT_353	[p21l1551t315r1800b356],
13	Frelinger	NNP	PERSON	Frelinger	appos	35	SENT_353	[p21l1827t315r2021b361],
14	,	,	O	,	_	0	SENT_353	[p21l1827t315r2021b361],
15	Kluk	NNP	PERSON	Kluk	appos	35	SENT_353	[p21l2047t315r2148b356],
16	,	,	O	,	_	0	SENT_353	[p21l2047t315r2148b356],
17	Angiolillo	NNP	O	Angiolillo	appos	35	SENT_353	[p21l1131t367r1319b413],
18	,	,	O	,	_	0	SENT_353	[p21l1131t367r1319b413],
19	Kereiakes	NNP	LOCATION	Kereiakes	appos	35	SENT_353	[p21l1335t367r1522b409],
20	,	,	O	,	_	0	SENT_353	[p21l1335t367r1522b409],
21	Isserman	NNP	PERSON	Isserman	appos	35	SENT_353	[p21l1538t370r1713b409],
22	,	,	O	,	_	0	SENT_353	[p21l1538t370r1713b409],
23	Rogers	NNP	ORGANIZATION	Rogers	appos	35	SENT_353	[p21l1728t370r1866b413],
24	,	,	O	,	_	0	SENT_353	[p21l1728t370r1866b413],
25	Ruff	NNP	PERSON	Ruff	appos	35	SENT_353	[p21l1882t367r1970b409],
26	,	,	O	,	_	0	SENT_353	[p21l1882t367r1970b409],
27	Contant	NNP	PERSON	Contant	appos	35	SENT_353	[p21l1984t369r2148b409],
28	,	,	O	,	_	0	SENT_353	[p21l1984t369r2148b409],
29	Pencina	NNP	PERSON	Pencina	appos	35	SENT_353	[p21l1134t422r1293b461],
30	,	,	O	,	_	0	SENT_353	[p21l1134t422r1293b461],
31	Scirica	NNP	PERSON	Scirica	appos	35	SENT_353	[p21l1311t422r1440b461],
32	,	,	O	,	_	0	SENT_353	[p21l1311t422r1440b461],
33	Longtine	NNP	LOCATION	Longtine	appos	35	SENT_353	[p21l1460t422r1639b465],
34	,	,	O	,	_	0	SENT_353	[p21l1460t422r1639b465],
35	Michelson	NNP	PERSON	Michelson	dep	2	SENT_353	[p21l1657t420r1864b455],
36	.	.	O	.	_	0	SENT_353	[p21l1657t420r1864b455],

1	Statistical	JJ	O	statistical	amod	2	SENT_354	[p21l1131t472r1321b507],
2	analysis	NN	O	analysis	_	0	SENT_354	[p21l1334t472r1499b517],
3	:	:	O	:	_	0	SENT_354	[p21l1334t472r1499b517],
4	Contant	NNP	PERSON	Contant	nn	6	SENT_354	[p21l1517t474r1685b513],
5	,	,	O	,	_	0	SENT_354	[p21l1517t474r1685b513],
6	Pencina	NNP	PERSON	Pencina	dep	2	SENT_354	[p21l1704t475r1862b507],
7	.	.	O	.	_	0	SENT_354	[p21l1704t475r1862b507],

1	Obtained	VBN	O	obtain	_	0	SENT_355	[p21l1133t525r1320b560],
2	funding	NN	O	funding	nsubj	6	SENT_355	[p21l1334t525r1494b570],
3	:	:	O	:	_	0	SENT_355	[p21l1334t525r1494b570],
4	Mega	JJ	O	mega	amod	2	SENT_355	[p21l1512t527r1634b570],
5	,	,	O	,	_	0	SENT_355	[p21l1512t527r1634b570],
6	Sabatine	NNP	PERSON	Sabatine	xcomp	1	SENT_355	[p21l1652t524r1826b560],
7	.	.	O	.	_	0	SENT_355	[p21l1652t524r1826b560],

1	Conflict	NN	O	conflict	_	0	SENT_356	[p21l1134t576r1285b612],
2	of	IN	O	of	_	0	SENT_356	[p21l1295t576r1333b612],
3	Interest	NN	O	interest	nn	4	SENT_356	[p21l1345t579r1488b612],
4	Disclosures	NNS	O	disclosure	prep_of	1	SENT_356	[p21l1499t576r1728b612],
5	:	:	O	:	_	0	SENT_356	[p21l1499t576r1728b612],
6	All	DT	O	all	det	7	SENT_356	[p21l1740t576r1787b612],
7	authors	NNS	O	author	nsubj	9	SENT_356	[p21l1800t576r1941b612],
8	have	VBP	O	have	aux	9	SENT_356	[p21l1954t576r2041b612],
9	completed	VBN	O	complete	dep	1	SENT_356	[p21l2053t587r2148b612, p21l1134t629r1250b675],
10	and	CC	O	and	_	0	SENT_356	[p21l1267t629r1336b664],
11	submitted	VBN	O	submit	dep	1	SENT_356	[p21l1352t629r1543b664],
12	the	DT	O	the	det	14	SENT_356	[p21l1560t629r1621b664],
13	ICMJE	NN	O	icmje	nn	14	SENT_356	[p21l1638t631r1757b664],
14	Form	NN	O	form	dobj	9	SENT_356	[p21l1775t631r1870b664],
15	for	IN	O	for	_	0	SENT_356	[p21l1886t628r1942b664],
16	Disclosure	NN	O	disclosure	prep_for	14	SENT_356	[p21l1957t629r2150b664],
17	of	IN	O	of	_	0	SENT_356	[p21l1133t681r1172b716],
18	Potential	JJ	O	potential	amod	19	SENT_356	[p21l1190t681r1357b716],
19	Conflicts	NNS	O	conflict	prep_of	9	SENT_356	[p21l1377t681r1543b716],
20	of	IN	O	of	_	0	SENT_356	[p21l1562t681r1601b716],
21	Interest	NN	O	interest	prep_of	19	SENT_356	[p21l1620t684r1772b716],
22	.	.	O	.	_	0	SENT_356	[p21l1620t684r1772b716],

1	Dr	NN	O	dr	nsubj	3	SENT_357	[p21l1795t684r1840b716],
2	Mega	JJ	PERSON	mega	amod	1	SENT_357	[p21l1856t684r1969b727],
3	reported	VBN	O	report	_	0	SENT_357	[p21l1987t681r2148b727],
4	receiving	VBG	O	receive	ccomp	3	SENT_357	[p21l1134t736r1306b779],
5	research	NN	O	research	nn	6	SENT_357	[p21l1320t733r1476b769],
6	grants	NNS	O	grant	dobj	4	SENT_357	[p21l1491t736r1610b779],
7	from	IN	O	from	_	0	SENT_357	[p21l1623t733r1713b769],
8	Bristol-Myers	NNP	O	Bristol-Myers	nn	9	SENT_357	[p21l1730t733r1985b779],
9	Squibb	NNP	O	Squibb	prep_from	4	SENT_357	[p21l1998t733r2150b780],
10	/	:	O	/	punct	11	SENT_357	[p21l1998t733r2150b780],
11	sanofi-aventis	NN	O	sanofi-aventi	dep	9	SENT_357	[p21l1132t785r1412b827],
12	,	,	O	,	_	0	SENT_357	[p21l1132t785r1412b827],
13	Eli	NNP	ORGANIZATION	Eli	nn	14	SENT_357	[p21l1433t785r1470b820],
14	Lilly	NNP	ORGANIZATION	Lilly	dep	9	SENT_357	[p21l1490t786r1572b831],
15	,	,	O	,	_	0	SENT_357	[p21l1490t786r1572b831],
16	Daiichi	NNP	ORGANIZATION	Daiichi	nn	17	SENT_357	[p21l1593t786r1718b821],
17	Sankyo	NNP	ORGANIZATION	Sankyo	dep	9	SENT_357	[p21l1737t785r1887b831],
18	,	,	O	,	_	0	SENT_357	[p21l1737t785r1887b831],
19	and	CC	O	and	_	0	SENT_357	[p21l1905t786r1974b821],
20	Johnson	NNP	PERSON	Johnson	dep	9	SENT_357	[p21l1991t786r2148b821],
21	&	CC	O	&	_	0	SENT_357	[p21l1134t841r1163b873],
22	Johnson/Bayer	NNP	O	Johnson/Bayer	conj_and	11	SENT_357	[p21l1180t838r1481b884],
23	,	,	O	,	_	0	SENT_357	[p21l1180t838r1481b884],
24	and	CC	O	and	_	0	SENT_357	[p21l1502t838r1571b873],
25	other	JJ	O	other	amod	27	SENT_357	[p21l1592t838r1695b873],
26	research	NN	O	research	nn	27	SENT_357	[p21l1714t838r1871b873],
27	support	NN	O	support	prep_from	4	SENT_357	[p21l1892t841r2041b884],
28	from	IN	O	from	_	0	SENT_357	[p21l2058t838r2148b873],
29	Nanosphere	NNP	LOCATION	Nanosphere	prep_from	27	SENT_357	[p21l1134t890r1366b937],
30	and	CC	O	and	_	0	SENT_357	[p21l1380t890r1449b926],
31	Accumetrics	NNP	O	Accumetrics	prep_from	27	SENT_357	[p21l1464t893r1698b926],
32	and	CC	O	and	_	0	SENT_357	[p21l1713t890r1782b926],
33	serving	VBG	O	serve	ccomp	3	SENT_357	[p21l1798t893r1936b936],
34	on	IN	O	on	_	0	SENT_357	[p21l1949t901r1995b926],
35	consultant/advisory	NN	O	consultant/advisory	nn	36	SENT_357	[p21l2011t890r2148b926, p21l1132t943r1387b988],
36	boards	NNS	O	board	prep_on	33	SENT_357	[p21l1400t943r1526b978],
37	for	IN	O	for	_	0	SENT_357	[p21l1537t942r1592b978],
38	Bristol-Myers	NNP	MISC	Bristol-Myers	nn	39	SENT_357	[p21l1604t943r1854b988],
39	Squibb	NNP	MISC	Squibb	prep_for	36	SENT_357	[p21l1867t943r2007b989],
40	,	,	O	,	_	0	SENT_357	[p21l1867t943r2007b989],
41	sanofiaventis	NN	O	sanofiaventi	conj_and	39	SENT_357	[p21l2020t942r2149b978, p21l1132t997r1278b1036],
42	,	,	O	,	_	0	SENT_357	[p21l2020t942r2149b978, p21l1132t997r1278b1036],
43	AstraZeneca	NNP	ORGANIZATION	AstraZeneca	nn	47	SENT_357	[p21l1291t997r1542b1036],
44	,	,	O	,	_	0	SENT_357	[p21l1291t997r1542b1036],
45	Bayer	NNP	ORGANIZATION	Bayer	appos	47	SENT_357	[p21l1559t997r1674b1040],
46	,	,	O	,	_	0	SENT_357	[p21l1559t997r1674b1040],
47	Novartis	NNP	ORGANIZATION	Novartis	prep_for	36	SENT_357	[p21l1690t997r1859b1036],
48	,	,	O	,	_	0	SENT_357	[p21l1690t997r1859b1036],
49	and	CC	O	and	_	0	SENT_357	[p21l1874t995r1943b1030],
50	Merck	NNP	PERSON	Merck	prep_for	36	SENT_357	[p21l1958t995r2089b1030],
51	.	.	O	.	_	0	SENT_357	[p21l1958t995r2089b1030],

1	Dr	NNP	O	Dr	nn	2	SENT_358	[p21l2107t997r2152b1030],
2	Hochholzer	NNP	PERSON	Hochholzer	nsubj	3	SENT_358	[p21l1134t1047r1378b1082],
3	reported	VBD	O	report	_	0	SENT_358	[p21l1402t1047r1582b1093],
4	serving	VBG	O	serve	xcomp	3	SENT_358	[p21l1608t1050r1762b1093],
5	on	IN	O	on	prep	4	SENT_358	[p21l1785t1058r1833b1082],
6	a	DT	O	a	det	7	SENT_358	[p21l1859t1058r1880b1082],
7	consultant	NN	O	consultant	dep	5	SENT_358	[p21l1903t1047r2150b1083],
8	/	:	O	/	punct	7	SENT_358	[p21l1903t1047r2150b1083],

1	advisory	JJ	O	advisory	amod	2	SENT_359	[p21l1132t1175r1297b1220],
2	board	NN	O	board	_	0	SENT_359	[p21l1319t1175r1429b1210],
3	for	IN	O	for	_	0	SENT_359	[p21l1450t1174r1507b1210],
4	sanofi-aventis	NN	O	sanofi-aventi	prep_for	2	SENT_359	[p21l1526t1174r1814b1210],
5	.	.	O	.	_	0	SENT_359	[p21l1526t1174r1814b1210],

1	Dr	NNP	O	Dr	nn	2	SENT_360	[p21l1839t1177r1885b1210],
2	Frelinger	NNP	PERSON	Frelinger	nsubj	3	SENT_360	[p21l1905t1175r2078b1220],
3	reported	VBD	O	report	_	0	SENT_360	[p21l2098t1186r2148b1210, p21l1134t1227r1257b1273],
4	receiving	VBG	O	receive	xcomp	3	SENT_360	[p21l1279t1230r1451b1273],
5	research	NN	O	research	nn	6	SENT_360	[p21l1470t1227r1626b1262],
6	grants	NNS	O	grant	dobj	4	SENT_360	[p21l1647t1230r1766b1273],
7	from	IN	O	from	_	0	SENT_360	[p21l1783t1227r1874b1262],
8	Bristol-Myers	NNP	O	Bristol-Myers	nn	9	SENT_360	[p21l1896t1227r2150b1273],
9	Squibb/sanofi-aventis	NNP	O	Squibb/sanofi-aventis	prep_from	4	SENT_360	[p21l1133t1279r1552b1326],
10	,	,	O	,	_	0	SENT_360	[p21l1133t1279r1552b1326],
11	Eli	NNP	ORGANIZATION	Eli	nn	12	SENT_360	[p21l1567t1279r1603b1314],
12	Lilly	NNP	ORGANIZATION	Lilly	appos	9	SENT_360	[p21l1617t1279r1696b1325],
13	,	,	O	,	_	0	SENT_360	[p21l1617t1279r1696b1325],
14	Daiichi	NNP	ORGANIZATION	Daiichi	nn	15	SENT_360	[p21l1711t1279r1832b1315],
15	Sankyo	NNP	ORGANIZATION	Sankyo	appos	9	SENT_360	[p21l1845t1279r1990b1325],
16	,	,	O	,	_	0	SENT_360	[p21l1845t1279r1990b1325],
17	GL	NNP	O	GL	nn	18	SENT_360	[p21l2004t1282r2056b1315],
18	Synthesis	NN	O	synthesis	appos	9	SENT_360	[p21l2067t1282r2149b1325, p21l1132t1407r1257b1449],
19	,	,	O	,	_	0	SENT_360	[p21l2067t1282r2149b1325, p21l1132t1407r1257b1449],

1	and	CC	O	and	_	0	SENT_361	[p21l1281t1407r1352b1443],
2	Takeda	NNP	PERSON	Takeda	dep	1	SENT_361	[p21l1374t1407r1523b1443],
3	and	CC	O	and	_	0	SENT_361	[p21l1543t1407r1614b1443],
4	serving	VBG	O	serve	conj_and	1	SENT_361	[p21l1638t1410r1783b1453],
5	on	IN	O	on	prep	4	SENT_361	[p21l1804t1418r1851b1442],
6	a	DT	O	a	det	7	SENT_361	[p21l1874t1418r1896b1443],
7	consultant	NN	O	consultant	dep	5	SENT_361	[p21l1916t1407r2149b1443],
8	/	:	O	/	punct	7	SENT_361	[p21l1916t1407r2149b1443],
9	advisory	JJ	O	advisory	amod	10	SENT_361	[p21l1133t1459r1292b1505],
10	board	NN	O	board	dep	7	SENT_361	[p21l1309t1459r1417b1495],
11	for	IN	O	for	dep	10	SENT_361	[p21l1434t1459r1489b1495],
12	Eli	NNP	ORGANIZATION	Eli	nn	13	SENT_361	[p21l1505t1459r1542b1494],
13	Lilly	NNP	ORGANIZATION	Lilly	pobj	11	SENT_361	[p21l1561t1459r1642b1505],
14	.	.	O	.	_	0	SENT_361	[p21l1561t1459r1642b1505],

1	Dr	NNP	O	Dr	nn	2	SENT_362	[p21l1663t1462r1708b1494],
2	Angiolillo	NNP	O	Angiolillo	nsubj	3	SENT_362	[p21l1720t1459r1901b1505],
3	reported	VBD	O	report	_	0	SENT_362	[p21l1918t1459r2080b1506],
4	receiving	VBG	O	receive	ccomp	3	SENT_362	[p21l2099t1470r2149b1495, p21l1133t1514r1268b1557],
5	research	NN	O	research	nn	6	SENT_362	[p21l1284t1512r1440b1547],
6	grants	NNS	O	grant	dobj	4	SENT_362	[p21l1457t1515r1576b1557],
7	from	IN	O	from	_	0	SENT_362	[p21l1590t1511r1680b1547],
8	Eli	NNP	ORGANIZATION	Eli	nn	9	SENT_362	[p21l1699t1512r1736b1547],
9	Lilly	NNP	ORGANIZATION	Lilly	prep_from	4	SENT_362	[p21l1755t1512r1837b1557],
10	,	,	O	,	_	0	SENT_362	[p21l1755t1512r1837b1557],
11	Daiichi	NNP	ORGANIZATION	Daiichi	nn	12	SENT_362	[p21l1855t1512r1981b1547],
12	Sankyo	NNP	ORGANIZATION	Sankyo	prep_from	4	SENT_362	[p21l1998t1512r2148b1557],
13	,	,	O	,	_	0	SENT_362	[p21l1998t1512r2148b1557],
14	The	DT	ORGANIZATION	the	det	16	SENT_362	[p21l1131t1563r1202b1599],
15	Medicines	NNP	ORGANIZATION	Medicines	nn	16	SENT_362	[p21l1214t1563r1404b1599],
16	Company	NNP	ORGANIZATION	Company	prep_from	4	SENT_362	[p21l1416t1566r1610b1610],
17	,	,	O	,	_	0	SENT_362	[p21l1416t1566r1610b1610],
18	Portola	NNP	LOCATION	Portola	prep_from	4	SENT_362	[p21l1626t1563r1767b1605],
19	,	,	O	,	_	0	SENT_362	[p21l1626t1563r1767b1605],
20	Accumetrics	NNP	O	Accumetrics	conj_and	18	SENT_362	[p21l1779t1566r2018b1605],
21	,	,	O	,	_	0	SENT_362	[p21l1779t1566r2018b1605],
22	Schering-Plough	NNP	ORGANIZATION	Schering-Plough	conj_and	18	SENT_362	[p21l2032t1563r2149b1599, p21l1134t1616r1357b1661],
23	,	,	O	,	_	0	SENT_362	[p21l2032t1563r2149b1599, p21l1134t1616r1357b1661],
24	AstraZeneca	NNP	ORGANIZATION	AstraZeneca	conj_and	18	SENT_362	[p21l1375t1618r1626b1657],
25	,	,	O	,	_	0	SENT_362	[p21l1375t1618r1626b1657],
26	Eisai	NNP	ORGANIZATION	Eisai	conj_and	18	SENT_362	[p21l1648t1618r1738b1657],
27	,	,	O	,	_	0	SENT_362	[p21l1648t1618r1738b1657],
28	Johnson	NNP	ORGANIZATION	Johnson	conj_and	18	SENT_362	[p21l1755t1616r1913b1651],
29	&	CC	ORGANIZATION	&	_	0	SENT_362	[p21l1934t1618r1963b1651],
30	Johnson	NNP	ORGANIZATION	Johnson	conj_and	18	SENT_362	[p21l1979t1616r2148b1657],
31	,	,	O	,	_	0	SENT_362	[p21l1979t1616r2148b1657],
32	Bristol-Myers	NNP	O	Bristol-Myers	nn	33	SENT_362	[p21l1134t1668r1381b1714],
33	Squibb/sanofi-aventis	NNP	O	Squibb/sanofi-aventis	conj_and	9	SENT_362	[p21l1393t1668r1815b1714],
34	,	,	O	,	_	0	SENT_362	[p21l1393t1668r1815b1714],
35	GlaxoSmithKline	NNP	ORGANIZATION	GlaxoSmithKline	conj_and	9	SENT_362	[p21l1828t1668r2149b1709],
36	,	,	O	,	_	0	SENT_362	[p21l1828t1668r2149b1709],
37	and	CC	O	and	_	0	SENT_362	[p21l1133t1720r1201b1756],
38	Otsuka	NNP	PERSON	Otsuka	conj_and	9	SENT_362	[p21l1216t1720r1364b1762],
39	;	:	O	;	_	0	SENT_362	[p21l1216t1720r1364b1762],
40	other	JJ	O	other	amod	42	SENT_362	[p21l1378t1720r1481b1756],
41	research	NN	O	research	nn	42	SENT_362	[p21l1493t1720r1648b1756],
42	support	NN	O	support	conj_and	9	SENT_362	[p21l1662t1723r1809b1767],
43	from	IN	O	from	_	0	SENT_362	[p21l1819t1720r1908b1756],
44	alames	NNS	O	alame	prep_from	42	SENT_362	[p21l1922t1723r2068b1756],
45	and	CC	O	and	_	0	SENT_362	[p21l2080t1720r2148b1756],
46	Esther	NNP	ORGANIZATION	Esther	nn	50	SENT_362	[p21l1134t1773r1252b1808],
47	King	NNP	ORGANIZATION	King	nn	50	SENT_362	[p21l1271t1775r1357b1818],
48	Biomedical	NNP	ORGANIZATION	Biomedical	nn	50	SENT_362	[p21l1378t1773r1584b1808],
49	Research	NNP	ORGANIZATION	Research	nn	50	SENT_362	[p21l1607t1773r1778b1808],
50	Grant	NNP	ORGANIZATION	Grant	prep_from	42	SENT_362	[p21l1799t1775r1920b1814],
51	;	:	O	;	_	0	SENT_362	[p21l1799t1775r1920b1814],
52	and	CC	O	and	_	0	SENT_362	[p21l1941t1773r2011b1808],
53	honoraria	NN	O	honorarium	conj_and	9	SENT_362	[p21l2033t1773r2148b1808, p21l1134t1828r1217b1860],
54	for	IN	O	for	mark	55	SENT_362	[p21l1233t1825r1289b1860],
55	lectures	VBZ	O	lecture	advcl	4	SENT_362	[p21l1307t1825r1452b1860],
56	from	IN	O	from	_	0	SENT_362	[p21l1470t1824r1560b1860],
57	Bristol-Myers	NNP	O	Bristol-Myers	nn	58	SENT_362	[p21l1583t1825r1837b1870],
58	Squibb	NNP	O	Squibb	prep_from	55	SENT_362	[p21l1856t1825r1998b1871],
59	,	,	O	,	_	0	SENT_362	[p21l1856t1825r1998b1871],
60	sanofiaventis	NN	O	sanofiaventi	prep_from	55	SENT_362	[p21l2018t1825r2148b1860, p21l1132t1880r1278b1919],
61	,	,	O	,	_	0	SENT_362	[p21l2018t1825r2148b1860, p21l1132t1880r1278b1919],
62	Eli	NNP	PERSON	Eli	nn	63	SENT_362	[p21l1300t1877r1337b1912],
63	Lilly	NNP	PERSON	Lilly	prep_from	55	SENT_362	[p21l1359t1877r1441b1923],
64	,	,	O	,	_	0	SENT_362	[p21l1359t1877r1441b1923],
65	and	CC	O	and	_	0	SENT_362	[p21l1462t1877r1531b1913],
66	Daiichi	NNP	ORGANIZATION	Daiichi	nn	67	SENT_362	[p21l1553t1877r1679b1913],
67	Sankyo	NNP	ORGANIZATION	Sankyo	prep_from	55	SENT_362	[p21l1699t1877r1838b1923],
68	and	CC	O	and	_	0	SENT_362	[p21l1857t1877r1926b1913],
69	serving	VBG	O	serve	conj_and	4	SENT_362	[p21l1947t1880r2085b1923],
70	on	IN	O	on	_	0	SENT_362	[p21l2102t1888r2148b1913],
71	consultant/advisory	NN	O	consultant/advisory	nn	72	SENT_362	[p21l1133t1929r1516b1975],
72	boards	NNS	O	board	prep_on	69	SENT_362	[p21l1533t1929r1661b1965],
73	for	IN	O	for	_	0	SENT_362	[p21l1675t1929r1731b1965],
74	The	DT	ORGANIZATION	the	det	76	SENT_362	[p21l1743t1929r1815b1965],
75	Medicines	NNP	ORGANIZATION	Medicines	nn	76	SENT_362	[p21l1831t1929r2026b1965],
76	Company	NNP	ORGANIZATION	Company	prep_for	72	SENT_362	[p21l2042t1931r2148b1965, p21l1134t1993r1235b2028],
77	,	,	O	,	_	0	SENT_362	[p21l2042t1931r2148b1965, p21l1134t1993r1235b2028],
78	Portola	NNP	LOCATION	Portola	nn	94	SENT_362	[p21l1250t1982r1392b2023],
79	,	,	O	,	_	0	SENT_362	[p21l1250t1982r1392b2023],
80	Novartis	NNP	ORGANIZATION	Novartis	appos	94	SENT_362	[p21l1407t1984r1571b2023],
81	,	,	O	,	_	0	SENT_362	[p21l1407t1984r1571b2023],
82	Medicure	NNP	O	Medicure	appos	94	SENT_362	[p21l1585t1982r1774b2023],
83	,	,	O	,	_	0	SENT_362	[p21l1585t1982r1774b2023],
84	Accumetrics	NNP	O	Accumetrics	appos	94	SENT_362	[p21l1786t1984r2025b2023],
85	,	,	O	,	_	0	SENT_362	[p21l1786t1984r2025b2023],
86	Arena	NNP	ORGANIZATION	Arena	appos	94	SENT_362	[p21l2037t1984r2152b2017],
87	Pharmaceuticals	NNP	ORGANIZATION	Pharmaceuticals	nn	94	SENT_362	[p21l1134t2034r1447b2075],
88	,	,	O	,	_	0	SENT_362	[p21l1134t2034r1447b2075],
89	Merck	NNP	PERSON	Merck	appos	94	SENT_362	[p21l1461t2034r1590b2076],
90	,	,	O	,	_	0	SENT_362	[p21l1461t2034r1590b2076],
91	Evolva	NNP	O	Evolva	appos	94	SENT_362	[p21l1605t2034r1735b2075],
92	,	,	O	,	_	0	SENT_362	[p21l1605t2034r1735b2075],
93	Bristol-Myers	NNP	O	Bristol-Myers	appos	94	SENT_362	[p21l1751t2034r1998b2080],
94	Squibb	NNP	O	Squibb	appos	76	SENT_362	[p21l2010t2034r2149b2080],
95	,	,	O	,	_	0	SENT_362	[p21l2010t2034r2149b2080],

1	loss-of-function	JJ	O	loss-of-function	amod	2	SENT_363	[p21l187t2084r440b2113],
2	CYP2Cl	NN	O	cyp2cl	_	0	SENT_363	[p21l449t2086r574b2113],
3	9	CD	NUMBER	9	num	4	SENT_363	[p21l580t2086r598b2113],
4	allele	NN	O	allele	dep	2	SENT_363	[p21l606t2084r688b2113],
5	but	CC	O	but	_	0	SENT_363	[p21l695t2084r750b2113],
6	not	RB	O	not	_	0	SENT_363	[p21l757t2091r811b2113],
7	2	CD	NUMBER	2	dep	2	SENT_363	[p21l188t2128r241b2159],
8	.	.	O	.	_	0	SENT_363	[p21l188t2128r241b2159],

1	”	NN	O	”	nn	3	SENT_364	[p21l188t2128r241b2159],
2	Such	JJ	O	such	amod	3	SENT_364	[p21l251t2130r331b2159],
3	patients	NNS	O	patient	nsubjpass	7	SENT_364	[p21l339t2133r468b2168],
4	may	MD	O	may	aux	7	SENT_364	[p21l478t2140r547b2168],
5	be	VB	O	be	auxpass	7	SENT_364	[p21l554t2130r592b2159],
6	better	RBR	O	better	advmod	7	SENT_364	[p21l600t2130r696b2159],
7	served	VBN	O	serve	_	0	SENT_364	[p21l705t2130r810b2159],
8	by	IN	O	by	_	0	SENT_364	[p21l186t2176r226b2214],
9	treatment	NN	O	treatment	agent	7	SENT_364	[p21l235t2183r393b2205],
10	with	IN	O	with	_	0	SENT_364	[p21l401t2176r475b2205],
11	prasugrel	NN	O	prasugrel	prep_with	9	SENT_364	[p21l483t2176r636b2214],
12	or	CC	O	or	_	0	SENT_364	[p21l646t2186r679b2205],
13	ticagrelor	NN	O	ticagrelor	prep_with	9	SENT_364	[p21l689t2179r809b2214, p21l187t2222r243b2256],
14	,	,	O	,	_	0	SENT_364	[p21l689t2179r809b2214, p21l187t2222r243b2256],
15	or	CC	O	or	_	0	SENT_364	[p21l261t2232r296b2251],
16	perhaps	RB	O	perhaps	advmod	18	SENT_364	[p21l311t2222r444b2260],
17	the	DT	O	the	det	18	SENT_364	[p21l462t2222r513b2251],
18	addition	NN	O	addition	nsubj	39	SENT_364	[p21l529t2222r671b2251],
19	of	IN	O	of	_	0	SENT_364	[p21l687t2221r721b2251],
20	cilostazol	NN	O	cilostazol	prep_of	18	SENT_364	[p21l735t2222r809b2251, p21l187t2268r290b2302],
21	,	,	O	,	_	0	SENT_364	[p21l735t2222r809b2251, p21l187t2268r290b2302],
22	all	DT	O	all	dep	23	SENT_364	[p21l301t2268r339b2297],
23	of	IN	O	of	nsubj	27	SENT_364	[p21l349t2267r383b2297],
24	which	WDT	O	which	pobj	23	SENT_364	[p21l388t2268r490b2297],
25	do	VBP	O	do	aux	27	SENT_364	[p21l500t2268r539b2297],
26	not	RB	O	not	neg	27	SENT_364	[p21l549t2275r604b2297],
27	appear	VB	O	appear	rcmod	18	SENT_364	[p21l613t2278r722b2306],
28	to	TO	O	to	aux	31	SENT_364	[p21l732t2275r762b2297],
29	be	VB	O	be	cop	31	SENT_364	[p21l772t2268r809b2297],
30	300	CD	NUMBER	300	num	31	SENT_364	[p21l859t2086r919b2113],
31	mg	NN	O	mg	xcomp	27	SENT_364	[p21l931t2094r981b2122],
32	of	IN	O	of	_	0	SENT_364	[p21l993t2084r1026b2113],
33	clopidogrel	NN	O	clopidogrel	prep_of	31	SENT_364	[p21l1035t2084r1220b2122],
34	daily	RB	SET	daily	advmod	27	SENT_364	[p21l1231t2084r1319b2122],
35	,	,	O	,	_	0	SENT_364	[p21l1231t2084r1319b2122],
36	however	RB	O	however	advmod	27	SENT_364	[p21l1331t2084r1480b2119],
37	,	,	O	,	_	0	SENT_364	[p21l1331t2084r1480b2119],
38	is	VBZ	O	be	cop	39	SENT_364	[p21l859t2133r884b2159],
39	unlikely	JJ	O	unlikely	conj_or	7	SENT_364	[p21l893t2130r1029b2168],
40	to	TO	O	to	aux	41	SENT_364	[p21l1039t2137r1069b2159],
41	result	VB	O	result	xcomp	39	SENT_364	[p21l1079t2130r1173b2159],
42	in	IN	O	in	_	0	SENT_364	[p21l1182t2133r1214b2158],
43	optimal	JJ	O	optimal	amod	44	SENT_364	[p21l1224t2130r1349b2168],
44	degrees	NNS	O	degree	prep_in	41	SENT_364	[p21l1359t2130r1481b2168],
45	of	IN	O	of	_	0	SENT_364	[p21l860t2175r892b2205],
46	platelet	NN	O	platelet	nn	47	SENT_364	[p21l897t2176r1015b2214],
47	inhibition	NN	O	inhibition	prep_of	44	SENT_364	[p21l1023t2176r1182b2205],
48	in	IN	O	in	_	0	SENT_364	[p21l1190t2179r1222b2204],
49	CYP2C19	NN	O	cyp2c19	nn	50	SENT_364	[p21l1231t2174r1418b2205],
50	*	NN	O	*	prep_in	41	SENT_364	[p21l1231t2174r1418b2205],
51	2	CD	NUMBER	2	num	52	SENT_364	[p21l1231t2174r1418b2205],
52	homozygotes	NNS	O	homozygote	dep	50	SENT_364	[p21l1428t2176r1481b2205, p21l859t2229r1038b2260],
53	.	.	O	.	_	0	SENT_364	[p21l1428t2176r1481b2205, p21l859t2229r1038b2260],

1	These	DT	O	these	det	2	SENT_365	[p21l1049t2222r1143b2251],
2	data	NNS	O	datum	nsubj	3	SENT_365	[p21l1152t2222r1218b2251],
3	help	VBP	O	help	_	0	SENT_365	[p21l1227t2222r1296b2260],
4	define	VB	O	define	dep	3	SENT_365	[p21l1306t2221r1404b2251],
5	how	WRB	O	how	advmod	6	SENT_365	[p21l1412t2222r1482b2251],
6	patients	NNS	O	patient	dep	4	SENT_365	[p21l859t2271r988b2306],
7	with	IN	O	with	_	0	SENT_365	[p21l996t2268r1070b2297],
8	different	JJ	O	different	amod	10	SENT_365	[p21l1080t2267r1219b2297],
9	CYP2C19	NN	O	cyp2c19	nn	10	SENT_365	[p21l1229t2269r1381b2297],
10	genosanofi-aventis	NN	O	genosanofi-aventi	prep_with	6	SENT_365	[p21l1390t2278r1481b2306, p21l1531t2083r1702b2108],
11	,	,	O	,	_	0	SENT_365	[p21l1390t2278r1481b2306, p21l1531t2083r1702b2108],
12	Eli	NNP	PERSON	Eli	nn	13	SENT_365	[p21l1715t2083r1738b2104],
13	Lilly	NNP	PERSON	Lilly	conj_and	10	SENT_365	[p21l1751t2083r1801b2111],
14	,	,	O	,	_	0	SENT_365	[p21l1751t2083r1801b2111],
15	Daiichi	NNP	ORGANIZATION	Daiichi	nn	16	SENT_365	[p21l1815t2083r1892b2105],
16	Sankyo	NNP	ORGANIZATION	Sankyo	prep_with	6	SENT_365	[p21l1904t2083r1995b2111],
17	,	,	O	,	_	0	SENT_365	[p21l1904t2083r1995b2111],
18	Abbott	NNP	PERSON	Abbott	nn	19	SENT_365	[p21l2007t2083r2091b2105],
19	Vascular	NNP	PERSON	Vascular	prep_with	6	SENT_365	[p21l2100t2084r2152b2105, p21l1531t2115r1593b2140],
20	,	,	O	,	_	0	SENT_365	[p21l2100t2084r2152b2105, p21l1531t2115r1593b2140],
21	and	CC	O	and	_	0	SENT_365	[p21l1604t2115r1646b2137],
22	Astrazeneca	NNP	ORGANIZATION	Astrazeneca	conj_and	10	SENT_365	[p21l1656t2117r1809b2137],
23	.	.	O	.	_	0	SENT_365	[p21l1656t2117r1809b2137],

1	Dr	NNP	O	Dr	nn	2	SENT_366	[p21l1821t2117r1849b2136],
2	Ruff	NNP	PERSON	Ruff	nsubj	3	SENT_366	[p21l1858t2115r1907b2137],
3	reported	VBD	O	report	_	0	SENT_366	[p21l1917t2115r2016b2143],
4	receiving	VBG	O	receive	ccomp	3	SENT_366	[p21l2027t2117r2132b2143],
5	a	DT	O	a	det	7	SENT_366	[p21l2141t2122r2154b2137],
6	research	NN	O	research	nn	7	SENT_366	[p21l1532t2147r1632b2169],
7	grant	NN	O	grant	dobj	4	SENT_366	[p21l1646t2149r1711b2175],
8	from	IN	O	from	_	0	SENT_366	[p21l1722t2147r1779b2169],
9	Bristol-Myers	NNP	O	Bristol-Myers	nn	10	SENT_366	[p21l1794t2147r1957b2175],
10	Squibb/sanofiaventis	NNP	O	Squibb/sanofiaventis	prep_from	4	SENT_366	[p21l1970t2147r2152b2175, p21l1531t2180r1622b2201],
11	and	CC	O	and	_	0	SENT_366	[p21l1636t2179r1681b2200],
12	Merck	NNP	PERSON	Merck	conj_and	10	SENT_366	[p21l1697t2179r1777b2201],
13	and	CC	O	and	_	0	SENT_366	[p21l1791t2179r1836b2201],
14	serving	VBG	O	serve	conj_and	4	SENT_366	[p21l1852t2180r1945b2207],
15	on	IN	O	on	_	0	SENT_366	[p21l1959t2186r1988b2201],
16	consultantl	NN	O	consultantl	nn	18	SENT_366	[p21l2004t2179r2153b2201],
17	advisory	JJ	O	advisory	amod	18	SENT_366	[p21l1531t2211r1628b2239],
18	boards	NNS	O	board	prep_on	14	SENT_366	[p21l1636t2211r1714b2233],
19	for	IN	O	for	_	0	SENT_366	[p21l1720t2211r1754b2232],
20	Daiichi	NNP	ORGANIZATION	Daiichi	nn	21	SENT_366	[p21l1762t2211r1838b2233],
21	Sankyo	NNP	ORGANIZATION	Sankyo	prep_for	18	SENT_366	[p21l1847t2211r1938b2239],
22	,	,	O	,	_	0	SENT_366	[p21l1847t2211r1938b2239],
23	Beckman	NNP	PERSON	Beckman	nn	24	SENT_366	[p21l1947t2211r2051b2233],
24	Coulter	NNP	PERSON	Coulter	prep_for	18	SENT_366	[p21l2060t2211r2152b2236],
25	,	,	O	,	_	0	SENT_366	[p21l2060t2211r2152b2236],
26	and	CC	O	and	_	0	SENT_366	[p21l1531t2243r1572b2264],
27	Alere	NNP	LOCATION	Alere	prep_for	18	SENT_366	[p21l1580t2243r1645b2264],
28	.	.	O	.	_	0	SENT_366	[p21l1580t2243r1645b2264],

1	Dr	NNP	O	Dr	nn	2	SENT_367	[p21l1655t2244r1682b2264],
2	Scirica	NNP	PERSON	Scirica	nsubj	3	SENT_367	[p21l1688t2244r1759b2264],
3	reported	VBD	O	report	_	0	SENT_367	[p21l1767t2243r1863b2271],
4	receiving	VBG	O	receive	xcomp	3	SENT_367	[p21l1872t2244r1974b2271],
5	research	NN	O	research	nn	6	SENT_367	[p21l1981t2243r2074b2264],
6	grants	NNS	O	grant	dobj	4	SENT_367	[p21l2082t2245r2153b2271],
7	from	IN	O	from	_	0	SENT_367	[p21l1530t2274r1585b2296],
8	Astrazeneca	NNP	ORGANIZATION	Astrazeneca	prep_from	4	SENT_367	[p21l1592t2276r1741b2300],
9	,	,	O	,	_	0	SENT_367	[p21l1592t2276r1741b2300],
10	Bristol-Myers	NNP	O	Bristol-Myers	nn	16	SENT_367	[p21l1751t2275r1902b2303],
11	Squibb	NNP	O	Squibb	nn	16	SENT_367	[p21l1910t2275r1995b2303],
12	,	,	O	,	_	0	SENT_367	[p21l1910t2275r1995b2303],
13	Merck	NNP	ORGANIZATION	Merck	appos	16	SENT_367	[p21l2003t2275r2082b2300],
14	,	,	O	,	_	0	SENT_367	[p21l2003t2275r2082b2300],
15	John	NNP	PERSON	John	appos	16	SENT_367	[p21l2089t2275r2153b2296, p21l188t2345r262b2367],
16	©	NNP	O	©	appos	8	SENT_367	[p21l2089t2275r2153b2296, p21l188t2345r262b2367],
17	201	CD	NUMBER	201	number	18	SENT_367	[p21l2089t2275r2153b2296, p21l188t2345r262b2367],
18	1	CD	NUMBER	1	dep	16	SENT_367	[p21l268t2345r280b2366],
19	American	NNP	ORGANIZATION	American	nn	21	SENT_367	[p21l291t2345r426b2366],
20	Medical	NNP	ORGANIZATION	Medical	nn	21	SENT_367	[p21l434t2343r545b2366],
21	Association	NNP	ORGANIZATION	Association	dep	18	SENT_367	[p21l553t2345r724b2366],
22	.	.	O	.	_	0	SENT_367	[p21l553t2345r724b2366],

1	All	DT	O	all	det	2	SENT_368	[p21l734t2343r774b2366],
2	rights	NNS	O	rights	nsubj	3	SENT_368	[p21l783t2343r864b2374],
3	reserved	VBN	O	reserve	_	0	SENT_368	[p21l873t2343r997b2366],
4	.	.	O	.	_	0	SENT_368	[p21l873t2343r997b2366],

1	JAMA	NNP	O	JAMA	_	0	SENT_369	[p21l1455t2346r1534b2370],
2	,	,	O	,	_	0	SENT_369	[p21l1455t2346r1534b2370],
3	November	NNP	DATE	November	appos	1	SENT_369	[p21l1545t2345r1670b2366],
4	23/30	CD	DATE	23/30	num	3	SENT_369	[p21l1680t2346r1755b2370],
5	,	,	O	,	_	0	SENT_369	[p21l1680t2346r1755b2370],
6	20ll	CD	NUMBER	20ll	num	3	SENT_369	[p21l1766t2345r1898b2366],
7	.	.	O	.	_	0	SENT_369	[p21l1766t2345r1898b2366],

1	—	NN	O	—	_	0	SENT_370	[p21l1766t2345r1898b2366],
2	.	.	O	.	_	0	SENT_370	[p21l1766t2345r1898b2366],

1	Vol	NN	O	vol	_	0	SENT_371	[p21l1766t2345r1898b2366],
2	306	CD	NUMBER	306	dep	1	SENT_371	[p21l1908t2346r1960b2371],
3	,	,	O	,	_	0	SENT_371	[p21l1908t2346r1960b2371],
4	No.	NN	O	no.	appos	2	SENT_371	[p21l1971t2346r2012b2366],
5	20	CD	NUMBER	20	number	6	SENT_371	[p21l2024t2346r2053b2366],
6	2227	CD	DATE	2227	dep	4	SENT_371	[p21l2083t2346r2153b2366],

1	Downloaded	NNP	O	Downloaded	_	0	SENT_372	[p21l6t2450r183b2474],
2	From	IN	O	from	dep	1	SENT_372	[p21l192t2450r280b2473],
3	:	:	O	:	_	0	SENT_372	[p21l192t2450r280b2473],
4	http://jama.jaInanetwork.com/	NN	O	http://jama.jainanetwork.com/	pobj	2	SENT_372	[p21l291t2449r729b2480],
5	by	IN	O	by	_	0	SENT_372	[p21l737t2450r771b2480],
6	a	DT	O	a	det	7	SENT_372	[p21l780t2457r796b2473],
7	University	NNP	ORGANIZATION	University	prep_by	4	SENT_372	[p21l805t2449r953b2480],
8	of	IN	ORGANIZATION	of	_	0	SENT_372	[p21l962t2449r991b2473],
9	Wisconsin	NNP	ORGANIZATION	Wisconsin	prep_of	7	SENT_372	[p21l998t2449r1144b2474],
10	-	:	O	-	_	0	SENT_372	[p21l1153t2449r1287b2473],
11	Madison	NNP	O	Madison	nn	12	SENT_372	[p21l1153t2449r1287b2473],
12	User	NN	O	user	dep	4	SENT_372	[p21l1296t2450r1362b2474],
13	on	IN	O	on	_	0	SENT_372	[p21l1380t2457r1414b2473],
14	01/05/2014	CD	DATE	01/05/2014	prep_on	12	SENT_372	[p21l1423t2449r1574b2474],

1	CLOPIDOGREL	NN	O	clopidogrel	_	0	SENT_373	[p21l59t2580r311b2606],
2	DOSES	NNS	O	dose	dep	1	SENT_373	[p21l322t2580r432b2606],
3	AND	CC	O	and	_	0	SENT_373	[p21l443t2580r519b2605],
4	CYP2Cl9	NN	O	cyp2cl9	nn	5	SENT_373	[p21l532t2580r675b2606],
5	GENOTYPE	NN	O	genotype	dep	1	SENT_373	[p21l688t2580r877b2606],

1	son	NN	O	son	_	0	SENT_374	[p21l9t2864r137b2913],
2	&	CC	O	&	_	0	SENT_374	[p21l169t2848r226b2913],
3	Johnson	NNP	PERSON	Johnson	conj_and	1	SENT_374	[p21l248t2842r588b2925],
4	,	,	O	,	_	0	SENT_374	[p21l248t2842r588b2925],
5	Bayer	NNP	ORGANIZATION	Bayer	nn	8	SENT_374	[p21l623t2848r835b2933],
6	Healthcare	NNP	ORGANIZATION	Healthcare	nn	8	SENT_374	[p21l860t2842r1295b2925],
7	,	,	O	,	_	0	SENT_374	[p21l860t2842r1295b2925],
8	Gilead	NNP	ORGANIZATION	Gilead	appos	1	SENT_374	[p21l1326t2842r1589b2925],
9	,	,	O	,	_	0	SENT_374	[p21l1326t2842r1589b2925],
10	and	CC	O	and	_	0	SENT_374	[p21l1619t2842r1757b2913],
11	Daiichi	NNP	ORGANIZATION	Daiichi	nn	12	SENT_374	[p21l1790t2842r2042b2913],
12	Sankyo	NNP	ORGANIZATION	Sankyo	appos	1	SENT_374	[p21l9t2945r283b3037],
13	and	CC	O	and	_	0	SENT_374	[p21l308t2945r445b3016],
14	serving	VBG	O	serve	appos	1	SENT_374	[p21l472t2950r744b3036],
15	on	IN	O	on	_	0	SENT_374	[p21l766t2967r856b3016],
16	consultant/advisory	NN	O	consultant/advisory	nn	17	SENT_374	[p21l884t2945r1640b3037],
17	boards	NNS	O	board	prep_on	14	SENT_374	[p21l1666t2945r1918b3016],
18	for	IN	O	for	_	0	SENT_374	[p21l1940t2944r2050b3016],
19	Gilead	NNP	ORGANIZATION	Gilead	prep_for	17	SENT_374	[p21l9t3049r248b3120],
20	and	CC	O	and	_	0	SENT_374	[p21l289t3049r428b3120],
21	AstraZeneca	NNP	ORGANIZATION	AstraZeneca	prep_for	17	SENT_374	[p21l467t3055r966b3120],
22	.	.	O	.	_	0	SENT_374	[p21l467t3055r966b3120],

1	Dr	NNP	O	Dr	nn	2	SENT_375	[p21l1013t3055r1104b3119],
2	Michelson	NNP	PERSON	Michelson	nsubj	3	SENT_375	[p21l1139t3049r1530b3120],
3	reported	VBD	O	report	_	0	SENT_375	[p21l1575t3049r1898b3142],
4	receiving	VBG	O	receive	ccomp	3	SENT_375	[p21l1943t3071r2041b3120, p21l9t3158r282b3245],
5	research	NN	O	research	nn	6	SENT_375	[p21l322t3153r637b3224],
6	grants	NNS	O	grant	dobj	4	SENT_375	[p21l680t3160r920b3244],
7	from	IN	O	from	_	0	SENT_375	[p21l957t3152r1139b3224],
8	Bristol-Myers	NNP	O	Bristol-Myers	nn	9	SENT_375	[p21l1185t3153r1699b3245],
9	Squibb	NNP	O	Squibb	prep_from	4	SENT_375	[p21l1738t3153r2044b3245],
10	/	:	O	/	punct	11	SENT_375	[p21l1738t3153r2044b3245],
11	sanofi-aventis	NN	O	sanofi-aventi	dep	9	SENT_375	[p21l9t3258r569b3341],
12	,	,	O	,	_	0	SENT_375	[p21l9t3258r569b3341],
13	Eli	NNP	ORGANIZATION	Eli	nn	14	SENT_375	[p21l605t3258r678b3327],
14	Lilly	NNP	ORGANIZATION	Lilly	dep	9	SENT_375	[p21l714t3258r878b3349],
15	,	,	O	,	_	0	SENT_375	[p21l714t3258r878b3349],
16	Daiichi	NNP	ORGANIZATION	Daiichi	nn	17	SENT_375	[p21l914t3258r1166b3329],
17	Sankyo	NNP	ORGANIZATION	Sankyo	dep	9	SENT_375	[p21l1198t3258r1498b3349],
18	,	,	O	,	_	0	SENT_375	[p21l1198t3258r1498b3349],
19	GL	NNP	O	GL	nn	20	SENT_375	[p21l1531t3263r1636b3329],
20	Synthesis	NN	O	synthesis	dep	9	SENT_375	[p21l1665t3258r2041b3349],
21	,	,	O	,	_	0	SENT_375	[p21l1665t3258r2041b3349],
22	and	CC	O	and	_	0	SENT_375	[p21l9t3362r143b3432],
23	Takeda	NNP	PERSON	Takeda	dep	9	SENT_375	[p21l166t3362r440b3433],
24	and	CC	O	and	_	0	SENT_375	[p21l459t3362r593b3432],
25	serving	VBG	O	serve	ccomp	3	SENT_375	[p21l617t3367r881b3452],
26	on	IN	O	on	_	0	SENT_375	[p21l901t3384r991b3432],
27	a	DT	O	a	det	28	SENT_375	[p21l1016t3384r1059b3432],
28	consultant	NN	O	consultant	prep_on	25	SENT_375	[p21l1077t3362r1499b3433],
29	/	:	O	/	punct	31	SENT_375	[p21l1077t3362r1499b3433],
30	advisory	JJ	O	advisory	amod	31	SENT_375	[p21l1504t3362r1811b3453],
31	board	NN	O	board	dep	28	SENT_375	[p21l1834t3362r2043b3432],
32	for	IN	O	for	_	0	SENT_375	[p21l7t3465r118b3536],
33	Eli	NNP	ORGANIZATION	Eli	nn	34	SENT_375	[p21l157t3465r230b3535],
34	Lilly	NNP	ORGANIZATION	Lilly	prep_for	31	SENT_375	[p21l275t3465r437b3557],
35	.	.	O	.	_	0	SENT_375	[p21l275t3465r437b3557],

1	Dr	NNP	O	Dr	nn	2	SENT_376	[p21l484t3471r574b3535],
2	Sabatine	NNP	PERSON	Sabatine	nsubj	3	SENT_376	[p21l609t3465r938b3536],
3	reported	VBD	O	report	_	0	SENT_376	[p21l978t3465r1301b3558],
4	receiving	VBG	O	receive	xcomp	3	SENT_376	[p21l1346t3471r1690b3557],
5	research	NN	O	research	nn	6	SENT_376	[p21l1729t3465r2041b3536],
6	grants	NNS	O	grant	dobj	4	SENT_376	[p21l9t3576r240b3661],
7	from	IN	O	from	_	0	SENT_376	[p21l261t3568r437b3640],
8	AstraZeneca	NNP	ORGANIZATION	AstraZeneca	nn	11	SENT_376	[p21l460t3574r947b3652],
9	,	,	O	,	_	0	SENT_376	[p21l460t3574r947b3652],
10	Bristol-Myers	NNP	O	Bristol-Myers	appos	11	SENT_376	[p21l977t3569r1468b3661],
11	Squibb/sanofi	NNP	O	Squibb/sanofi	prep_from	4	SENT_376	[p21l1491t3568r2043b3661],
12	—	CD	NUMBER	—	num	11	SENT_376	[p21l1491t3568r2043b3661],
13	aventis	NN	O	aventi	nn	15	SENT_376	[p21l9t3680r277b3745],
14	joint	JJ	O	joint	amod	15	SENT_376	[p21l302t3680r478b3765],
15	venture	NN	O	venture	dep	11	SENT_376	[p21l505t3680r822b3757],
16	,	,	O	,	_	0	SENT_376	[p21l505t3680r822b3757],
17	Daiichi	NNP	ORGANIZATION	Daiichi	nn	18	SENT_376	[p21l860t3674r1112b3745],
18	Sankyo	NNP	ORGANIZATION	Sankyo	appos	11	SENT_376	[p21l1147t3674r1446b3765],
19	,	,	O	,	_	0	SENT_376	[p21l1147t3674r1446b3765],
20	sanofi-aventis	NN	O	sanofi-aventi	appos	11	SENT_376	[p21l1482t3674r2041b3757],
21	,	,	O	,	_	0	SENT_376	[p21l1482t3674r2041b3757],

1	and	CC	O	and	_	0	SENT_377	[p22l9t13r145b84],
2	Schering-Plough	NNP	ORGANIZATION	Schering-Plough	_	0	SENT_377	[p22l173t13r799b104],
3	and	CC	O	and	_	0	SENT_377	[p22l827t13r963b84],
4	other	JJ	O	other	amod	6	SENT_377	[p22l991t13r1194b84],
5	research	NN	O	research	nn	6	SENT_377	[p22l1218t13r1526b84],
6	support	NN	O	support	conj_and	2	SENT_377	[p22l1553t19r1846b106],
7	from	IN	O	from	_	0	SENT_377	[p22l1866t13r2044b84],
8	Nanosphere	NNP	LOCATION	Nanosphere	prep_from	6	SENT_377	[p22l12t117r459b210],
9	and	CC	O	and	_	0	SENT_377	[p22l481t117r615b188],
10	sewing	VBG	O	sew	conj_and	2	SENT_377	[p22l640t123r906b209],
11	on	IN	O	on	_	0	SENT_377	[p22l925t139r1015b188],
12	consultant/advisory	NN	O	consultant/advisory	nn	13	SENT_377	[p22l1041t117r1776b209],
13	boards	NNS	O	board	prep_on	10	SENT_377	[p22l1800t117r2047b188],
14	for	IN	O	for	_	0	SENT_377	[p22l7t221r129b292],
15	AstraZeneca	NNP	ORGANIZATION	AstraZeneca	prep_for	10	SENT_377	[p22l171t226r729b303],
16	,	,	O	,	_	0	SENT_377	[p22l171t226r729b303],
17	Bristol-Myers	NNP	O	Bristol-Myers	nn	18	SENT_377	[p22l785t221r1355b312],
18	Squibb/sanofiaventis	NNP	O	Squibb/sanofiaventis	prep_for	10	SENT_377	[p22l1403t221r2041b314, p22l9t332r299b409],
19	,	,	O	,	_	0	SENT_377	[p22l1403t221r2041b314, p22l9t332r299b409],
20	Daiichi	NNP	ORGANIZATION	Daiichi	nn	22	SENT_377	[p22l343t326r594b397],
21	Sankyo/Eli	NNP	ORGANIZATION	Sankyo/Eli	nn	22	SENT_377	[p22l633t326r1035b417],
22	Lilly	NNP	ORGANIZATION	Lilly	prep_for	10	SENT_377	[p22l1078t326r1243b417],
23	,	,	O	,	_	0	SENT_377	[p22l1078t326r1243b417],
24	Eli	NNP	PERSON	Eli	nn	25	SENT_377	[p22l1285t326r1359b395],
25	Lilly	NNP	PERSON	Lilly	conj_and	15	SENT_377	[p22l1402t326r1566b417],
26	,	,	O	,	_	0	SENT_377	[p22l1402t326r1566b417],
27	and	CC	O	and	_	0	SENT_377	[p22l1605t326r1742b397],
28	sanofiaventis	NN	O	sanofiaventi	conj_and	15	SENT_377	[p22l1781t326r2042b397, p22l9t434r297b500],
29	.	.	O	.	_	0	SENT_377	[p22l1781t326r2042b397, p22l9t434r297b500],

1	No	DT	O	no	det	3	SENT_378	[p22l339t434r445b500],
2	other	JJ	O	other	amod	3	SENT_378	[p22l477t429r684b500],
3	disclosures	NNS	O	disclosure	nsubjpass	5	SENT_378	[p22l711t429r1122b500],
4	were	VBD	O	be	auxpass	5	SENT_378	[p22l1153t451r1341b500],
5	reported	VBN	O	report	_	0	SENT_378	[p22l1376t429r1723b522],
6	.	.	O	.	_	0	SENT_378	[p22l1376t429r1723b522],

1	Funding/Support	NNP	O	Funding/Support	_	0	SENT_379	[p22l12t534r719b625],
2	:	:	O	:	_	0	SENT_379	[p22l12t534r719b625],
3	The	DT	O	the	det	6	SENT_379	[p22l760t534r906b605],
4	ELEVATE-TIMI	NN	O	elevate-timus	nn	6	SENT_379	[p22l950t539r1527b605],
5	56	CD	NUMBER	56	num	6	SENT_379	[p22l1573t540r1671b605],
6	trial	NN	O	trial	nsubjpass	8	SENT_379	[p22l1708t534r1852b605],
7	was	VBD	O	be	auxpass	8	SENT_379	[p22l1894t556r2044b605],
8	funded	VBN	O	fund	dep	1	SENT_379	[p22l7t638r277b709],
9	by	IN	O	by	_	0	SENT_379	[p22l308t638r395b729],
10	an	DT	O	a	det	12	SENT_379	[p22l418t660r505b709],
11	investigator-initiated	JJ	O	investigator-initiated	amod	12	SENT_379	[p22l536t638r1323b729],
12	grant	NN	O	grant	agent	8	SENT_379	[p22l1350t644r1554b729],
13	from	IN	O	from	_	0	SENT_379	[p22l1573t638r1753b709],
14	BristolREFERENCES	NN	O	bristolreference	prep_from	12	SENT_379	[p22l1784t638r2042b709, p22l12t905r516b971],

1	1	LS	NUMBER	1	_	0	SENT_380	[p22l9t1051r75b1114],
2	.	.	O	.	_	0	SENT_380	[p22l9t1051r75b1114],

1	Yusuf	NNP	PERSON	Yusuf	nn	2	SENT_381	[p22l126t1043r346b1115],
2	S	NNP	PERSON	S	_	0	SENT_381	[p22l366t1048r426b1127],
3	,	,	O	,	_	0	SENT_381	[p22l366t1048r426b1127],
4	Zhao	NNP	PERSON	Zhao	nn	5	SENT_381	[p22l453t1044r643b1115],
5	F	NN	PERSON	f	appos	2	SENT_381	[p22l670t1049r727b1127],
6	,	,	O	,	_	0	SENT_381	[p22l670t1049r727b1127],
7	Mehta	NNP	ORGANIZATION	Mehta	nn	8	SENT_381	[p22l755t1044r1007b1115],
8	SR	NN	ORGANIZATION	sr	appos	2	SENT_381	[p22l1029t1048r1144b1127],
9	,	,	O	,	_	0	SENT_381	[p22l1029t1048r1144b1127],
10	Chrolavicius	NNP	O	Chrolavicius	nn	11	SENT_381	[p22l1172t1044r1628b1115],
11	S	NNP	O	S	appos	2	SENT_381	[p22l1652t1048r1712b1127],
12	,	,	O	,	_	0	SENT_381	[p22l1652t1048r1712b1127],
13	Tognoni	NNP	PERSON	Tognoni	nn	14	SENT_381	[p22l1737t1049r2050b1136],
14	G	NNP	PERSON	G	appos	2	SENT_381	[p22l9t1154r91b1233],
15	,	,	O	,	_	0	SENT_381	[p22l9t1154r91b1233],
16	Fox	NNP	ORGANIZATION	Fox	nn	17	SENT_381	[p22l138t1155r270b1220],
17	KK	NNP	ORGANIZATION	KK	appos	2	SENT_381	[p22l313t1154r437b1233],
18	;	:	O	;	_	0	SENT_381	[p22l313t1154r437b1233],
19	Clopidogrel	NNP	O	Clopidogrel	dep	2	SENT_381	[p22l481t1149r928b1242],
20	in	IN	O	in	_	0	SENT_381	[p22l972t1155r1032b1219],
21	Unstable	NNP	O	Unstable	nn	22	SENT_381	[p22l1079t1149r1416b1220],
22	Angina	NNP	O	Angina	prep_in	19	SENT_381	[p22l1454t1155r1734b1241],
23	to	TO	O	to	aux	24	SENT_381	[p22l1770t1155r1846b1220],
24	Prevent	VB	O	prevent	infmod	19	SENT_381	[p22l1889t1155r2039b1220, p22l7t1262r179b1326],
25	Recurrent	JJ	O	recurrent	amod	26	SENT_381	[p22l218t1260r595b1326],
26	Events	NNS	O	event	nsubj	28	SENT_381	[p22l634t1260r878b1326],
27	Trial	NNP	O	Trial	nn	28	SENT_381	[p22l914t1255r1076b1326],
28	Investigators	NNS	O	investigator	xcomp	24	SENT_381	[p22l1122t1260r1632b1346],
29	.	.	O	.	_	0	SENT_381	[p22l1122t1260r1632b1346],

1	Effects	NNS	O	effect	_	0	SENT_382	[p22l1680t1254r1930b1326],
2	of	IN	O	of	_	0	SENT_382	[p22l1968t1254r2047b1326],
3	clopidogrel	NN	O	clopidogrel	prep_of	1	SENT_382	[p22l9t1361r426b1454],
4	in	IN	O	in	_	0	SENT_382	[p22l455t1367r513b1431],
5	addition	NN	O	addition	_	0	SENT_382	[p22l541t1361r847b1432],
6	to	TO	O	to	_	0	SENT_382	[p22l873t1367r949b1432],
7	aspirin	NN	O	aspirin	prep_in_addition_to	1	SENT_382	[p22l973t1367r1213b1454],
8	in	IN	O	in	_	0	SENT_382	[p22l1244t1367r1302b1431],
9	patients	NNS	O	patient	prep_in	1	SENT_382	[p22l1332t1367r1629b1454],
10	with	IN	O	with	_	0	SENT_382	[p22l1652t1361r1814b1432],
11	acute	JJ	O	acute	amod	13	SENT_382	[p22l1842t1367r2046b1432],
12	coronary	JJ	O	coronary	amod	13	SENT_382	[p22l9t1489r349b1558],
13	syndromes	NNS	O	syndrome	prep_with	9	SENT_382	[p22l384t1467r801b1558],
14	without	IN	O	without	_	0	SENT_382	[p22l835t1467r1139b1538],
15	ST-segment	NN	O	st-segment	nn	16	SENT_382	[p22l1172t1471r1636b1558],
16	elevation	NN	O	elevation	prep_without	13	SENT_382	[p22l1669t1467r2039b1538],
17	.	.	O	.	_	0	SENT_382	[p22l1669t1467r2039b1538],

1	N	NN	O	n	_	0	SENT_383	[p22l7t1577r71b1644],
2	Engl	NNP	O	Engl	nn	4	SENT_383	[p22l99t1574r264b1664],
3	J	NNP	O	J	nn	4	SENT_383	[p22l288t1578r324b1644],
4	Med	NNP	O	Med	dep	1	SENT_383	[p22l352t1574r552b1644],
5	.	.	O	.	_	0	SENT_383	[p22l352t1574r552b1644],

1	2001	CD	DATE	2001	_	0	SENT_384	[p22l588t1579r772b1644],
2	;	:	O	;	_	0	SENT_384	[p22l798t1575r1463b1656],
3	345	CD	NUMBER	345	num	4	SENT_384	[p22l798t1575r1463b1656],
4	(	NN	O	(	dep	1	SENT_384	[p22l798t1575r1463b1656],
5	7	CD	NUMBER	7	num	6	SENT_384	[p22l798t1575r1463b1656],
6	)	NN	O	)	dep	4	SENT_384	[p22l798t1575r1463b1656],
7	:494	CD	NUMBER	:494	num	8	SENT_384	[p22l798t1575r1463b1656],
8	-502	CD	NUMBER	-502	dep	4	SENT_384	[p22l798t1575r1463b1656],
9	.	.	O	.	_	0	SENT_384	[p22l798t1575r1463b1656],

1	2	LS	NUMBER	2	_	0	SENT_385	[p22l6t1683r79b1748],
2	.	.	O	.	_	0	SENT_385	[p22l6t1683r79b1748],

1	Sabatine	NNP	PERSON	Sabatine	nn	2	SENT_386	[p22l140t1678r489b1749],
2	MS	NN	O	m	_	0	SENT_386	[p22l535t1682r687b1760],
3	,	,	O	,	_	0	SENT_386	[p22l535t1682r687b1760],
4	Cannon	NNP	ORGANIZATION	Cannon	nn	5	SENT_386	[p22l736t1682r1050b1749],
5	CP	NNP	ORGANIZATION	CP	appos	2	SENT_386	[p22l1098t1682r1231b1760],
6	,	,	O	,	_	0	SENT_386	[p22l1098t1682r1231b1760],
7	Gibson	NNP	PERSON	Gibson	nn	8	SENT_386	[p22l1279t1678r1558b1749],
8	CM	NN	O	cm	appos	2	SENT_386	[p22l1606t1682r1775b1760],
9	,	,	O	,	_	0	SENT_386	[p22l1606t1682r1775b1760],
10	et	FW	O	et	nn	11	SENT_386	[p22l1822t1684r1898b1749],
11	al	FW	O	al	appos	2	SENT_386	[p22l1938t1678r2027b1760],
12	;	:	O	;	_	0	SENT_386	[p22l1938t1678r2027b1760],
13	CLARITY-TIMI	NN	O	clarity-timus	dep	2	SENT_386	[p22l9t1789r577b1855],
14	28	CD	NUMBER	28	num	15	SENT_386	[p22l607t1790r703b1855],
15	Investigators	NNS	O	investigator	dep	13	SENT_386	[p22l735t1790r1243b1876],
16	.	.	O	.	_	0	SENT_386	[p22l735t1790r1243b1876],

1	Addition	NN	O	addition	_	0	SENT_387	[p22l1271t1784r1600b1855],
2	of	IN	O	of	_	0	SENT_387	[p22l1630t1784r1708b1855],
3	clopidogrel	NN	O	clopidogrel	prep_of	1	SENT_387	[p22l1731t1784r2042b1877, p22l9t1889r148b1980],
4	to	TO	O	to	_	0	SENT_387	[p22l177t1896r254b1960],
5	aspirin	NN	O	aspirin	prep_to	3	SENT_387	[p22l283t1894r528b1982],
6	and	CC	O	and	_	0	SENT_387	[p22l561t1889r698b1960],
7	fibrinolytic	JJ	O	fibrinolytic	amod	8	SENT_387	[p22l730t1888r1139b1980],
8	therapy	NN	O	therapy	prep_of	1	SENT_387	[p22l1164t1889r1461b1982],
9	for	IN	O	for	_	0	SENT_387	[p22l1487t1889r1599b1960],
10	myocardial	JJ	O	myocardial	amod	11	SENT_387	[p22l1627t1889r2042b1980],
11	infarction	NN	O	infarction	prep_for	8	SENT_387	[p22l11t1993r371b2064],
12	with	IN	O	with	_	0	SENT_387	[p22l404t1994r568b2064],
13	ST-segment	NN	O	st-segment	nn	14	SENT_387	[p22l602t1998r1067b2084],
14	elevation	NN	O	elevation	prep_with	1	SENT_387	[p22l1095t1993r1465b2064],
15	.	.	O	.	_	0	SENT_387	[p22l1095t1993r1465b2064],

1	N	NN	O	n	_	0	SENT_388	[p22l1499t1998r1562b2064],
2	Engl	NNP	O	Engl	nn	4	SENT_388	[p22l1589t1994r1754b2084],
3	J	NNP	O	J	nn	4	SENT_388	[p22l1777t1999r1812b2064],
4	Med	NNP	O	Med	dep	1	SENT_388	[p22l1839t1994r2039b2064],
5	.	.	O	.	_	0	SENT_388	[p22l1839t1994r2039b2064],

1	2005	CD	DATE	2005	_	0	SENT_389	[p22l8t2101r606b2181],
2	;	:	O	;	_	0	SENT_389	[p22l8t2101r606b2181],
3	352	CD	NUMBER	352	number	4	SENT_389	[p22l8t2101r606b2181],
4	(	CD	NUMBER	(	num	6	SENT_389	[p22l8t2101r606b2181],
5	’	NN	O	’	nn	6	SENT_389	[p22l8t2101r606b2181],
6	l2	NN	O	l2	dep	1	SENT_389	[p22l8t2101r606b2181],
7	)	CD	NUMBER	)	dep	6	SENT_389	[p22l8t2101r606b2181],
8	:	:	O	:	_	0	SENT_389	[p22l8t2101r606b2181],
9	’	CD	NUMBER	’	num	10	SENT_389	[p22l8t2101r606b2181],
10	l	NN	O	l	dep	1	SENT_389	[p22l8t2101r606b2181],
11	179-1	CD	NUMBER	179-1	number	12	SENT_389	[p22l630t2104r845b2170],
12	189	CD	NUMBER	189	dep	10	SENT_389	[p22l870t2104r1032b2170],
13	.	.	O	.	_	0	SENT_389	[p22l870t2104r1032b2170],

1	3	LS	NUMBER	3	_	0	SENT_390	[p22l8t2210r77b2275],
2	.	.	O	.	_	0	SENT_390	[p22l8t2210r77b2275],

1	Chen	NNP	ORGANIZATION	Chen	nn	2	SENT_391	[p22l136t2205r338b2275],
2	ZM	NNP	ORGANIZATION	ZM	_	0	SENT_391	[p22l382t2210r540b2287],
3	,	,	O	,	_	0	SENT_391	[p22l382t2210r540b2287],
4	Jiang	NNP	PERSON	Jiang	nn	5	SENT_391	[p22l580t2210r784b2295],
5	LX	NNP	O	LX	appos	2	SENT_391	[p22l827t2208r943b2287],
6	,	,	O	,	_	0	SENT_391	[p22l827t2208r943b2287],
7	Chen	NNP	PERSON	Chen	nn	8	SENT_391	[p22l988t2205r1191b2275],
8	YP	NNP	O	YP	appos	2	SENT_391	[p22l1233t2208r1361b2287],
9	,	,	O	,	_	0	SENT_391	[p22l1233t2208r1361b2287],
10	et	FW	O	et	nn	11	SENT_391	[p22l1405t2210r1481b2275],
11	al	FW	O	al	appos	2	SENT_391	[p22l1518t2205r1603b2287],
12	;	:	O	;	_	0	SENT_391	[p22l1518t2205r1603b2287],
13	COMMIT	NNP	O	COMMIT	dep	2	SENT_391	[p22l1649t2208r2036b2275],
14	(	CD	NUMBER	(	num	13	SENT_391	[p22l11t2311r513b2404],
15	ClOpidogre	NNP	O	ClOpidogre	nn	16	SENT_391	[p22l11t2311r513b2404],
16	|	NN	O	|	dep	13	SENT_391	[p22l11t2311r513b2404],
17	and	CC	O	and	_	0	SENT_391	[p22l555t2311r694b2382],
18	Metoprolol	NN	O	metoprolol	conj_and	16	SENT_391	[p22l736t2311r1169b2404],
19	in	IN	O	in	_	0	SENT_391	[p22l1213t2316r1271b2381],
20	Myocardial	JJ	O	myocardial	amod	22	SENT_391	[p22l1315t2311r1747b2402],
21	Infarction	NN	O	infarction	nn	22	SENT_391	[p22l1793t2311r2041b2382, p22l7t2422r152b2487],
22	Trial	NN	O	trial	prep_in	16	SENT_391	[p22l192t2416r384b2498],
23	)	CD	NUMBER	)	num	25	SENT_391	[p22l192t2416r384b2498],
24	collaborative	JJ	O	collaborative	amod	25	SENT_391	[p22l424t2416r917b2487],
25	group	NN	O	group	dep	16	SENT_391	[p22l956t2438r1205b2509],
26	.	.	O	.	_	0	SENT_391	[p22l956t2438r1205b2509],

1	Addition	NN	O	addition	nsubj	14	SENT_392	[p22l1246t2416r1575b2487],
2	of	IN	O	of	_	0	SENT_392	[p22l1617t2416r1695b2487],
3	clopidogrel	NN	O	clopidogrel	prep_of	1	SENT_392	[p22l1731t2416r2042b2509, p22l9t2523r148b2614],
4	to	TO	O	to	dep	5	SENT_392	[p22l178t2529r255b2594],
5	aspirin	NN	O	aspirin	dep	14	SENT_392	[p22l284t2528r529b2616],
6	in	IN	O	in	_	0	SENT_392	[p22l564t2529r623b2593],
7	45,852	CD	NUMBER	45,852	num	8	SENT_392	[p22l653t2529r925b2606],
8	patients	NNS	O	patient	prep_in	5	SENT_392	[p22l962t2529r1263b2616],
9	with	IN	O	with	_	0	SENT_392	[p22l1292t2523r1455b2594],
10	acute	JJ	O	acute	amod	12	SENT_392	[p22l1488t2529r1696b2594],
11	myocardial	JJ	O	myocardial	amod	12	SENT_392	[p22l1729t2545r2042b2615, p22l9t2629r138b2699],
12	infarction	NN	O	infarction	prep_with	8	SENT_392	[p22l182t2628r568b2699],
13	:	:	O	:	_	0	SENT_392	[p22l182t2628r568b2699],
14	randomised	VBN	O	randomise	_	0	SENT_392	[p22l615t2628r1063b2699],
15	placebo-controlled	JJ	O	placebo-controlled	amod	16	SENT_392	[p22l1108t2628r1833b2721],
16	trial	NN	O	trial	dobj	14	SENT_392	[p22l1874t2628r2039b2699],
17	.	.	O	.	_	0	SENT_392	[p22l1874t2628r2039b2699],

1	Lancet	NNP	O	Lancet	_	0	SENT_393	[p22l7t2741r283b2806],
2	.	.	O	.	_	0	SENT_393	[p22l7t2741r283b2806],

1	2005	CD	DATE	2005	_	0	SENT_394	[p22l319t2738r1022b2818],
2	;	:	O	;	_	0	SENT_394	[p22l319t2738r1022b2818],
3	366	CD	NUMBER	366	number	4	SENT_394	[p22l319t2738r1022b2818],
4	(	CD	NUMBER	(	dep	1	SENT_394	[p22l319t2738r1022b2818],
5	9497	CD	NUMBER	9497	num	6	SENT_394	[p22l319t2738r1022b2818],
6	)	CD	NUMBER	)	dep	4	SENT_394	[p22l319t2738r1022b2818],
7	:	:	O	:	_	0	SENT_394	[p22l319t2738r1022b2818],
8	’	CD	NUMBER	’	num	9	SENT_394	[p22l319t2738r1022b2818],
9	l	NN	O	l	dep	1	SENT_394	[p22l319t2738r1022b2818],
10	607-1	CD	NUMBER	607-1	number	11	SENT_394	[p22l1043t2741r1262b2805],
11	621	CD	NUMBER	621	dep	9	SENT_394	[p22l1282t2741r1414b2805],
12	.	.	O	.	_	0	SENT_394	[p22l1439t2794r1449b2804],

1	4	LS	NUMBER	4	_	0	SENT_395	[p22l6t2846r75b2909],
2	.	.	O	.	_	0	SENT_395	[p22l6t2846r75b2909],

1	Steinhubl	NNP	O	Steinhubl	_	0	SENT_396	[p22l130t2840r483b2910],
2	SR	JJ	O	sr	amod	5	SENT_396	[p22l511t2843r626b2922],
3	,	,	O	,	_	0	SENT_396	[p22l511t2843r626b2922],
4	Berger	NNP	PERSON	Berger	dep	5	SENT_396	[p22l659t2845r905b2930],
5	PB	NN	O	pb	dep	1	SENT_396	[p22l929t2845r1042b2922],
6	,	,	O	,	_	0	SENT_396	[p22l929t2845r1042b2922],
7	Mann	NNP	PERSON	Mann	nn	9	SENT_396	[p22l1070t2845r1292b2910],
8	JT	NNP	O	JT	nn	9	SENT_396	[p22l1317t2845r1397b2910],
9	III	NNP	O	III	appos	5	SENT_396	[p22l1435t2845r1520b2922],
10	,	,	O	,	_	0	SENT_396	[p22l1435t2845r1520b2922],
11	et	FW	O	et	nn	12	SENT_396	[p22l1548t2846r1621b2910],
12	al	FW	O	al	appos	5	SENT_396	[p22l1642t2840r1723b2922],
13	;	:	O	;	_	0	SENT_396	[p22l1642t2840r1723b2922],
14	CREDO	NNP	O	CREDO	nn	15	SENT_396	[p22l1752t2843r2047b2911],
15	Investigators	NNS	O	investigator	dep	5	SENT_396	[p22l14t2952r517b3038],
16	.	.	O	.	_	0	SENT_396	[p22l14t2952r517b3038],

1	Clopidogrel	NNP	O	Clopidogrel	_	0	SENT_397	[p22l547t2946r987b3039],
2	for	IN	O	for	_	0	SENT_397	[p22l1013t2946r1123b3017],
3	the	DT	O	the	det	4	SENT_397	[p22l1142t2946r1263b3017],
4	Reduction	NN	O	reduction	prep_for	7	SENT_397	[p22l1293t2946r1673b3017],
5	of	IN	O	of	_	0	SENT_397	[p22l1701t2946r1780b3017],
6	Events	NNS	O	event	prep_of	4	SENT_397	[p22l1804t2952r2047b3017],
7	During	IN	O	during	dep	1	SENT_397	[p22l12t3057r272b3143],
8	Observation	NN	O	observation	pobj	7	SENT_397	[p22l296t3052r788b3122],
9	.	.	O	.	_	0	SENT_397	[p22l296t3052r788b3122],

1	Early	RB	O	early	advmod	3	SENT_398	[p22l823t3052r999b3143],
2	and	CC	O	and	cc	1	SENT_398	[p22l1024t3052r1161b3122],
3	sustained	VBD	O	sustain	_	0	SENT_398	[p22l1188t3052r1542b3122],
4	dual	JJ	O	dual	amod	7	SENT_398	[p22l1570t3052r1728b3122],
5	oral	JJ	O	oral	amod	7	SENT_398	[p22l1756t3052r1893b3122],
6	antiplatelet	JJ	O	antiplatelet	amod	7	SENT_398	[p22l1921t3074r2043b3122, p22l7t3157r340b3250],
7	therapy	NN	O	therapy	dep	3	SENT_398	[p22l358t3157r650b3250],
8	following	VBG	O	follow	_	0	SENT_398	[p22l672t3157r1029b3248],
9	percutaneous	JJ	O	percutaneous	amod	11	SENT_398	[p22l1054t3163r1566b3250],
10	coronary	JJ	O	coronary	amod	11	SENT_398	[p22l1589t3179r1924b3249],
11	intervention	NN	O	intervention	prep_following	7	SENT_398	[p22l1949t3163r2043b3227, p22l7t3268r412b3334],
12	:	:	O	:	_	0	SENT_398	[p22l1949t3163r2043b3227, p22l7t3268r412b3334],
13	a	DT	O	a	nsubj	14	SENT_398	[p22l440t3285r483b3334],
14	randomized	VBN	O	randomize	parataxis	3	SENT_398	[p22l505t3263r944b3334],
15	controlled	JJ	O	controlled	amod	16	SENT_398	[p22l970t3263r1341b3334],
16	trial	NN	O	trial	dobj	14	SENT_398	[p22l1365t3263r1522b3334],
17	.	.	O	.	_	0	SENT_398	[p22l1365t3263r1522b3334],

1	JAMA	NN	O	jama	_	0	SENT_399	[p22l1544t3268r1803b3334],
2	.	.	O	.	_	0	SENT_399	[p22l1544t3268r1803b3334],

1	2002	CD	DATE	2002	num	3	SENT_400	[p22l1830t3268r2045b3345],
2	;	:	O	;	_	0	SENT_400	[p22l1830t3268r2045b3345],
3	288	CD	NUMBER	288	_	0	SENT_400	[p22l7t3372r479b3449],
4	(	CD	NUMBER	(	number	5	SENT_400	[p22l7t3372r479b3449],
5	’	CD	NUMBER	’	dep	3	SENT_400	[p22l7t3372r479b3449],
6	l9	NN	O	l9	dep	5	SENT_400	[p22l7t3372r479b3449],
7	)	CD	NUMBER	)	number	8	SENT_400	[p22l7t3372r479b3449],
8	:24	CD	NUMBER	:24	num	9	SENT_400	[p22l7t3372r479b3449],
9	’	NN	O	’	dep	3	SENT_400	[p22l7t3372r479b3449],
10	l	NN	O	l	tmod	9	SENT_400	[p22l7t3372r479b3449],
11	’	CD	NUMBER	’	num	12	SENT_400	[p22l503t3375r530b3438],
12	l	NN	O	l	dep	3	SENT_400	[p22l503t3375r530b3438],
13	-2420	CD	NUMBER	-2420	dep	12	SENT_400	[p22l553t3375r804b3440],
14	.	.	O	.	_	0	SENT_400	[p22l553t3375r804b3440],

1	5	CD	NUMBER	5	_	0	SENT_401	[p23l9t25r75b89],
2	.	.	O	.	_	0	SENT_401	[p23l9t25r75b89],

1	Bonello	NNP	PERSON	Bonello	nn	2	SENT_402	[p23l135t19r415b89],
2	L	NNP	PERSON	L	_	0	SENT_402	[p23l453t24r511b101],
3	,	,	O	,	_	0	SENT_402	[p23l453t24r511b101],
4	Tantry	NNP	ORGANIZATION	Tantry	nn	5	SENT_402	[p23l546t24r796b110],
5	US	NNP	ORGANIZATION	US	appos	2	SENT_402	[p23l834t22r958b101],
6	,	,	O	,	_	0	SENT_402	[p23l834t22r958b101],
7	Marcucci	NNP	PERSON	Marcucci	nn	8	SENT_402	[p23l996t24r1342b89],
8	R	NNP	PERSON	R	appos	2	SENT_402	[p23l1383t24r1449b101],
9	,	,	O	,	_	0	SENT_402	[p23l1383t24r1449b101],
10	et	FW	O	et	nn	11	SENT_402	[p23l1487t25r1561b89],
11	al	FW	O	al	appos	2	SENT_402	[p23l1591t19r1673b101],
12	;	:	O	;	_	0	SENT_402	[p23l1591t19r1673b101],
13	Working	NNP	ORGANIZATION	Working	nn	14	SENT_402	[p23l1707t19r2047b109],
14	Group	NNP	ORGANIZATION	Group	dep	2	SENT_402	[p23l9t129r245b217],
15	on	IN	O	on	_	0	SENT_402	[p23l269t146r359b195],
16	High	NNP	O	High	nn	19	SENT_402	[p23l388t124r559b216],
17	On-Treatment	NNP	O	On-Treatment	nn	19	SENT_402	[p23l586t129r1136b195],
18	Platelet	NN	O	platelet	nn	19	SENT_402	[p23l1158t124r1432b195],
19	Reactivity	NN	O	reactivity	prep_on	14	SENT_402	[p23l1455t130r1831b216],
20	.	.	O	.	_	0	SENT_402	[p23l1455t130r1831b216],

1	Consensus	NN	O	consensus	nn	4	SENT_403	[p23l1860t129r2043b195, p23l9t252r258b301],
2	and	CC	O	and	_	0	SENT_403	[p23l285t230r423b301],
3	future	JJ	DATE	future	nn	4	SENT_403	[p23l451t229r686b301],
4	directions	NNS	O	direction	_	0	SENT_403	[p23l714t230r1084b301],
5	on	IN	O	on	_	0	SENT_403	[p23l1112t252r1204b301],
6	the	DT	O	the	det	7	SENT_403	[p23l1233t230r1355b300],
7	definition	NN	O	definition	prep_on	4	SENT_403	[p23l1383t229r1745b300],
8	of	IN	O	of	_	0	SENT_403	[p23l1776t229r1854b301],
9	high	JJ	O	high	amod	12	SENT_403	[p23l1882t230r2041b322],
10	on-treatment	JJ	O	on-treatment	amod	12	SENT_403	[p23l9t342r596b407],
11	platelet	NN	O	platelet	nn	12	SENT_403	[p23l646t336r972b429],
12	reactivity	NN	O	reactivity	prep_of	4	SENT_403	[p23l1022t342r1424b428],
13	to	TO	O	to	_	0	SENT_403	[p23l1471t342r1554b407],
14	adenosine	NN	O	adenosine	nn	15	SENT_403	[p23l1605t336r2044b407],
15	diphosphate	NN	O	diphosphate	prep_to	12	SENT_403	[p23l9t442r511b535],
16	.	.	O	.	_	0	SENT_403	[p23l9t442r511b535],

1	J	NNP	O	J	nn	4	SENT_404	[p23l549t447r584b513],
2	Am	NNP	O	Am	nn	4	SENT_404	[p23l620t447r752b513],
3	Coll	NNP	PERSON	Coll	nn	4	SENT_404	[p23l796t442r953b513],
4	Cardiol	NNP	PERSON	Cardiol	_	0	SENT_404	[p23l992t442r1297b513],
5	.	.	O	.	_	0	SENT_404	[p23l992t442r1297b513],

1	2010	CD	DATE	2010	_	0	SENT_405	[p23l1340t445r2041b524, p23l7t554r176b619],
2	;	:	O	;	_	0	SENT_405	[p23l1340t445r2041b524, p23l7t554r176b619],
3	56	CD	NUMBER	56	number	4	SENT_405	[p23l1340t445r2041b524, p23l7t554r176b619],
4	(	CD	NUMBER	(	dep	1	SENT_405	[p23l1340t445r2041b524, p23l7t554r176b619],
5	12	CD	NUMBER	12	num	6	SENT_405	[p23l1340t445r2041b524, p23l7t554r176b619],
6	)	NN	O	)	dep	4	SENT_405	[p23l1340t445r2041b524, p23l7t554r176b619],
7	:919933	CD	NUMBER	:919933	dep	4	SENT_405	[p23l1340t445r2041b524, p23l7t554r176b619],
8	.	.	O	.	_	0	SENT_405	[p23l1340t445r2041b524, p23l7t554r176b619],

1	6	CD	NUMBER	6	_	0	SENT_406	[p23l9t659r74b725],
2	.	.	O	.	_	0	SENT_406	[p23l9t659r74b725],

1	Umemura	NNP	PERSON	Umemura	nn	2	SENT_407	[p23l132t659r508b725],
2	K	NNP	PERSON	K	_	0	SENT_407	[p23l533t658r599b736],
3	,	,	O	,	_	0	SENT_407	[p23l533t658r599b736],
4	Furuta	NNP	PERSON	Furuta	nn	5	SENT_407	[p23l629t659r870b725],
5	T	NN	O	t	appos	2	SENT_407	[p23l888t659r955b736],
6	,	,	O	,	_	0	SENT_407	[p23l888t659r955b736],
7	Kondo	NNP	PERSON	Kondo	nn	9	SENT_407	[p23l986t654r1230b725],
8	K.	NNP	O	K.	nn	9	SENT_407	[p23l1257t658r1322b724],
9	The	NNP	O	The	appos	2	SENT_407	[p23l1348t654r1489b725],
10	common	JJ	O	common	amod	12	SENT_407	[p23l1512t676r1842b725],
11	gene	NN	O	gene	nn	12	SENT_407	[p23l1869t676r2052b745],
12	variants	NNS	O	variant	dep	9	SENT_407	[p23l7t765r294b830],
13	of	IN	O	of	_	0	SENT_407	[p23l315t759r392b830],
14	C	NN	O	c	nn	15	SENT_407	[p23l412t764r467b830],
15	YP2C	NN	O	yp2c	prep_of	12	SENT_407	[p23l474t764r677b830],
16	7	CD	NUMBER	7	number	17	SENT_407	[p23l683t765r716b829],
17	9	CD	NUMBER	9	num	19	SENT_407	[p23l725t765r771b830],
18	affect	NN	O	affect	nn	19	SENT_407	[p23l794t759r1004b830],
19	pharmacokinetics	NNS	O	pharmacokinetic	dep	2	SENT_407	[p23l1026t759r1668b852],
20	and	CC	O	and	_	0	SENT_407	[p23l1688t759r1822b830],
21	pharmacodynamics	NNS	O	pharmacodynamic	conj_and	19	SENT_407	[p23l1850t759r2044b852, p23l12t864r582b955],
22	in	IN	O	in	_	0	SENT_407	[p23l614t869r673b934],
23	an	DT	O	a	det	25	SENT_407	[p23l705t886r791b935],
24	active	JJ	O	active	amod	25	SENT_407	[p23l824t869r1046b935],
25	metabolite	NN	O	metabolite	prep_in	19	SENT_407	[p23l1078t864r1485b935],
26	of	IN	O	of	_	0	SENT_407	[p23l1515t863r1594b935],
27	clopidogrel	NN	O	clopidogrel	prep_of	25	SENT_407	[p23l1619t864r2042b957],
28	in	IN	O	in	_	0	SENT_407	[p23l11t975r74b1039],
29	healthy	JJ	O	healthy	amod	30	SENT_407	[p23l125t970r426b1060],
30	subjects	NNS	O	subject	prep_in	27	SENT_407	[p23l470t970r821b1060],
31	.	.	O	.	_	0	SENT_407	[p23l470t970r821b1060],

1	J	NNP	O	J	nn	3	SENT_408	[p23l865t975r900b1040],
2	Thromb	NNP	O	Thromb	nn	3	SENT_408	[p23l948t970r1263b1040],
3	Haemost	NNP	O	Haemost	_	0	SENT_408	[p23l1309t975r1698b1040],
4	.	.	O	.	_	0	SENT_408	[p23l1309t975r1698b1040],

1	2008	CD	DATE	2008	_	0	SENT_409	[p23l1746t975r2039b1052],
2	;	:	O	;	_	0	SENT_409	[p23l1746t975r2039b1052],
3	6	CD	NUMBER	6	num	4	SENT_409	[p23l1746t975r2039b1052],
4	(	NN	O	(	dep	1	SENT_409	[p23l11t1079r176b1156],
5	8	CD	NUMBER	8	num	6	SENT_409	[p23l11t1079r176b1156],
6	)	NN	O	)	dep	4	SENT_409	[p23l11t1079r176b1156],
7	:	:	O	:	_	0	SENT_409	[p23l11t1079r176b1156],
8	’	CD	NUMBER	’	num	9	SENT_409	[p23l11t1079r176b1156],
9	l	NN	O	l	dep	1	SENT_409	[p23l11t1079r176b1156],
10	439-1441	CD	NUMBER	439-1441	dep	9	SENT_409	[p23l195t1081r604b1145],
11	.	.	O	.	_	0	SENT_409	[p23l195t1081r604b1145],

1	7	CD	NUMBER	7	_	0	SENT_410	[p23l8t1187r75b1250],
2	.	.	O	.	_	0	SENT_410	[p23l8t1187r75b1250],

1	BrandtJT	NNP	O	BrandtJT	_	0	SENT_411	[p23l133t1181r502b1263],
2	,	,	O	,	_	0	SENT_411	[p23l133t1181r502b1263],
3	Close	NNP	O	Close	nn	4	SENT_411	[p23l531t1181r736b1250],
4	SL	NNP	O	SL	appos	1	SENT_411	[p23l761t1184r867b1263],
5	,	,	O	,	_	0	SENT_411	[p23l761t1184r867b1263],
6	lturria	NN	O	lturrium	nn	7	SENT_411	[p23l900t1186r1125b1250],
7	SJ	NN	O	sj	appos	1	SENT_411	[p23l1147t1184r1237b1263],
8	,	,	O	,	_	0	SENT_411	[p23l1147t1184r1237b1263],
9	et	FW	O	et	nn	10	SENT_411	[p23l1265t1187r1339b1250],
10	al.	FW	O	al.	appos	1	SENT_411	[p23l1359t1181r1439b1250],
11	.	.	O	.	_	0	SENT_411	[p23l1359t1181r1439b1250],

1	Common	JJ	O	common	amod	2	SENT_412	[p23l1469t1184r1824b1250],
2	polymorphisms	NNS	O	polymorphism	nsubj	7	SENT_412	[p23l1855t1181r2044b1272, p23l12t1286r426b1379],
3	of	IN	O	of	_	0	SENT_412	[p23l450t1286r529b1357],
4	CYP2C79	NN	O	cyp2c79	prep_of	2	SENT_412	[p23l552t1291r921b1357],
5	and	CC	O	and	_	0	SENT_412	[p23l947t1286r1083b1357],
6	CYPZC9	NN	O	cypzc9	conj_and	4	SENT_412	[p23l1112t1291r1432b1357],
7	affect	VBP	O	affect	_	0	SENT_412	[p23l1457t1286r1675b1357],
8	the	DT	O	the	det	12	SENT_412	[p23l1695t1286r1816b1357],
9	pharmacokinetic	JJ	O	pharmacokinetic	amod	12	SENT_412	[p23l1844t1286r2043b1379, p23l12t1392r466b1463],
10	and	CC	O	and	_	0	SENT_412	[p23l487t1392r623b1461],
11	pharmacodynamic	JJ	O	pharmacodynamic	amod	12	SENT_412	[p23l654t1392r1359b1483],
12	response	NN	O	response	dobj	7	SENT_412	[p23l1384t1413r1715b1483],
13	to	TO	O	to	_	0	SENT_412	[p23l1737t1398r1814b1461],
14	clopidogrel	NN	O	clopidogrel	prep_to	12	SENT_412	[p23l1838t1392r2043b1483, p23l9t1497r249b1588],
15	but	CC	O	but	_	0	SENT_412	[p23l289t1497r415b1568],
16	not	RB	O	not	_	0	SENT_412	[p23l448t1503r574b1568],
17	prasugrel	NN	O	prasugrel	dobj	7	SENT_412	[p23l607t1497r980b1590],
18	.	.	O	.	_	0	SENT_412	[p23l607t1497r980b1590],

1	J	NNP	O	J	nn	3	SENT_413	[p23l1013t1503r1048b1568],
2	Thromb	NNP	O	Thromb	nn	3	SENT_413	[p23l1085t1498r1383b1568],
3	Haemost	NNP	O	Haemost	_	0	SENT_413	[p23l1417t1503r1784b1568],
4	.	.	O	.	_	0	SENT_413	[p23l1417t1503r1784b1568],

1	2007	CD	DATE	2007	_	0	SENT_414	[p23l1820t1503r2041b1580],
2	;	:	O	;	_	0	SENT_414	[p23l1820t1503r2041b1580],
3	5	CD	NUMBER	5	number	4	SENT_414	[p23l9t1605r702b1684],
4	(	CD	NUMBER	(	dep	1	SENT_414	[p23l9t1605r702b1684],
5	12	CD	NUMBER	12	num	6	SENT_414	[p23l9t1605r702b1684],
6	)	NN	O	)	dep	4	SENT_414	[p23l9t1605r702b1684],
7	:2429	CD	DURATION	:2429	num	8	SENT_414	[p23l9t1605r702b1684],
8	-2436	CD	DURATION	-2436	dep	4	SENT_414	[p23l9t1605r702b1684],
9	.	.	O	.	_	0	SENT_414	[p23l9t1605r702b1684],

1	8	CD	NUMBER	8	_	0	SENT_415	[p23l9t1715r75b1780],
2	.	.	O	.	_	0	SENT_415	[p23l9t1715r75b1780],

1	Trenk	NN	PERSON	trenk	nn	2	SENT_416	[p23l129t1709r349b1780],
2	D	NN	O	d	_	0	SENT_416	[p23l385t1715r463b1792],
3	,	,	O	,	_	0	SENT_416	[p23l385t1715r463b1792],
4	Hochholzer	NNP	PERSON	Hochholzer	nn	5	SENT_416	[p23l503t1709r944b1780],
5	W	NNP	PERSON	W	appos	2	SENT_416	[p23l971t1714r1081b1792],
6	,	,	O	,	_	0	SENT_416	[p23l971t1714r1081b1792],
7	Fromm	NNP	PERSON	Fromm	nn	8	SENT_416	[p23l1120t1715r1387b1780],
8	MF	NN	O	mf	appos	2	SENT_416	[p23l1424t1715r1570b1792],
9	,	,	O	,	_	0	SENT_416	[p23l1424t1715r1570b1792],
10	et	FW	O	et	nn	11	SENT_416	[p23l1606t1715r1680b1780],
11	al.	FW	O	al.	appos	2	SENT_416	[p23l1709t1709r1789b1780],
12	.	.	O	.	_	0	SENT_416	[p23l1709t1709r1789b1780],

1	Cytochrome	NN	O	cytochrome	nn	3	SENT_417	[p23l1828t1713r2041b1800, p23l9t1814r296b1884],
2	P450	NN	O	p450	nn	3	SENT_417	[p23l324t1819r518b1883],
3	2C	NN	O	2c	nsubj	16	SENT_417	[p23l540t1817r747b1884],
4	’	CD	NUMBER	’	num	5	SENT_417	[p23l540t1817r747b1884],
5	l9	NN	O	l9	dep	3	SENT_417	[p23l540t1817r747b1884],
6	681	CD	NUMBER	681	num	7	SENT_417	[p23l769t1819r900b1883],
7	G	NN	O	g	npadvmod	8	SENT_417	[p23l922t1817r1119b1884],
8	>	JJR	O	>	amod	10	SENT_417	[p23l922t1817r1119b1884],
9	A	DT	O	a	det	10	SENT_417	[p23l922t1817r1119b1884],
10	polymorphism	NN	O	polymorphism	dep	3	SENT_417	[p23l1144t1814r1688b1905],
11	and	CC	O	and	_	0	SENT_417	[p23l1715t1814r1852b1884],
12	high	JJ	O	high	amod	15	SENT_417	[p23l1883t1814r2042b1904],
13	on-clopidogrel	JJ	O	on-clopidogrel	amod	15	SENT_417	[p23l9t1919r602b2012],
14	platelet	NN	O	platelet	nn	15	SENT_417	[p23l651t1919r952b2012],
15	reactivity	NN	O	reactivity	conj_and	10	SENT_417	[p23l996t1925r1366b2011],
16	associated	VBN	O	associate	_	0	SENT_417	[p23l1408t1919r1822b1990],
17	with	IN	O	with	_	0	SENT_417	[p23l1868t1919r2039b1990],
18	adverse	JJ	O	adverse	amod	21	SENT_417	[p23l9t2025r302b2096],
19	1-year	JJ	DURATION	1-year	amod	21	SENT_417	[p23l342t2032r590b2117],
20	clinical	JJ	O	clinical	amod	21	SENT_417	[p23l621t2025r872b2096],
21	outcome	NN	O	outcome	prep_with	16	SENT_417	[p23l911t2032r1249b2096],
22	of	IN	O	of	_	0	SENT_417	[p23l1285t2024r1364b2096],
23	elective	JJ	O	elective	amod	26	SENT_417	[p23l1396t2025r1685b2096],
24	percutaneous	JJ	O	percutaneous	amod	26	SENT_417	[p23l1723t2032r2041b2117, p23l12t2153r231b2202],
25	coronary	JJ	O	coronary	amod	26	SENT_417	[p23l253t2153r584b2222],
26	intervention	NN	O	intervention	prep_of	21	SENT_417	[p23l608t2137r1053b2202],
27	with	IN	O	with	_	0	SENT_417	[p23l1078t2131r1238b2202],
28	d	NN	O	d	nn	29	SENT_417	[p23l1263t2131r1305b2202],
29	rug-eluting	NN	O	rug-eluting	prep_with	16	SENT_417	[p23l1317t2131r1732b2222],
30	or	CC	O	or	_	0	SENT_417	[p23l1753t2153r1830b2202],
31	baremetal	JJ	O	baremetal	amod	32	SENT_417	[p23l1852t2131r2042b2202, p23l12t2236r219b2307],
32	stents	NNS	O	stent	prep_with	16	SENT_417	[p23l254t2242r497b2307],
33	.	.	O	.	_	0	SENT_417	[p23l254t2242r497b2307],

1	J	NNP	O	J	nn	4	SENT_418	[p23l530t2241r565b2307],
2	Am	NNP	O	Am	nn	4	SENT_418	[p23l594t2241r725b2306],
3	Coll	NNP	PERSON	Coll	nn	4	SENT_418	[p23l763t2236r920b2307],
4	Cardiol	NNP	PERSON	Cardiol	_	0	SENT_418	[p23l952t2236r1254b2307],
5	.	.	O	.	_	0	SENT_418	[p23l952t2236r1254b2307],

1	2008	CD	DATE	2008	num	3	SENT_419	[p23l1291t2238r2041b2318],
2	;	:	O	;	_	0	SENT_419	[p23l1291t2238r2041b2318],
3	51	CD	NUMBER	51	_	0	SENT_419	[p23l1291t2238r2041b2318],
4	(	CD	NUMBER	(	number	5	SENT_419	[p23l1291t2238r2041b2318],
5	20	CD	NUMBER	20	num	6	SENT_419	[p23l1291t2238r2041b2318],
6	)	NN	O	)	dep	3	SENT_419	[p23l1291t2238r2041b2318],
7	:1925	CD	NUMBER	:1925	num	8	SENT_419	[p23l1291t2238r2041b2318],
8	—	NN	O	—	dep	6	SENT_419	[p23l1291t2238r2041b2318],

1	9	CD	NUMBER	9	_	0	SENT_420	[p23l8t2453r75b2519],
2	.	.	O	.	_	0	SENT_420	[p23l8t2453r75b2519],

1	Shuldiner	NNP	PERSON	Shuldiner	nn	2	SENT_421	[p23l132t2448r495b2519],
2	AR	NNS	O	ar	_	0	SENT_421	[p23l524t2453r659b2530],
3	,	,	O	,	_	0	SENT_421	[p23l524t2453r659b2530],
4	O'Connell	NNP	PERSON	O'Connell	nn	5	SENT_421	[p23l697t2448r1089b2519],
5	JR	NNP	O	JR	appos	2	SENT_421	[p23l1123t2453r1229b2530],
6	,	,	O	,	_	0	SENT_421	[p23l1123t2453r1229b2530],
7	Bliden	NNP	PERSON	Bliden	nn	8	SENT_421	[p23l1271t2448r1496b2519],
8	KP	NNP	O	KP	appos	2	SENT_421	[p23l1538t2452r1657b2530],
9	,	,	O	,	_	0	SENT_421	[p23l1538t2452r1657b2530],
10	et	FW	O	et	nn	11	SENT_421	[p23l1694t2454r1768b2519],
11	al.	FW	O	al.	appos	2	SENT_421	[p23l1800t2448r1879b2519],
12	.	.	O	.	_	0	SENT_421	[p23l1800t2448r1879b2519],

1	Association	NNP	O	Association	_	0	SENT_422	[p23l1916t2453r2041b2519, p23l9t2560r345b2625],
2	of	IN	O	of	_	0	SENT_422	[p23l387t2554r465b2625],
3	cytochrome	NN	O	cytochrome	nn	8	SENT_422	[p23l500t2554r956b2646],
4	P450	NN	O	p450	nn	8	SENT_422	[p23l999t2560r1193b2625],
5	2C	NN	O	2c	nn	8	SENT_422	[p23l1229t2559r1437b2625],
6	’	CD	NUMBER	’	num	8	SENT_422	[p23l1229t2559r1437b2625],
7	l9	NN	O	l9	nn	8	SENT_422	[p23l1229t2559r1437b2625],
8	genotype	NN	O	genotype	prep_of	1	SENT_422	[p23l1475t2560r1840b2647],
9	with	IN	O	with	_	0	SENT_422	[p23l1877t2554r2041b2625],
10	the	DT	O	the	det	12	SENT_422	[p23l7t2660r129b2730],
11	antiplatelet	JJ	O	antiplatelet	amod	12	SENT_422	[p23l157t2660r591b2752],
12	effect	NN	O	effect	prep_with	8	SENT_422	[p23l615t2659r836b2731],
13	and	CC	O	and	_	0	SENT_422	[p23l859t2660r997b2730],
14	clinical	JJ	O	clinical	amod	15	SENT_422	[p23l1027t2660r1278b2731],
15	efficacy	NN	O	efficacy	conj_and	12	SENT_422	[p23l1307t2659r1603b2752],
16	of	IN	O	of	_	0	SENT_422	[p23l1628t2659r1707b2731],
17	clopidogrel	NN	O	clopidogrel	nn	18	SENT_422	[p23l1731t2660r2042b2752, p23l9t2766r148b2858],
18	therapy	NN	O	therapy	prep_of	1	SENT_422	[p23l180t2766r496b2859],
19	.	.	O	.	_	0	SENT_422	[p23l180t2766r496b2859],

1	JA/VIA	NN	O	ja/via	_	0	SENT_423	[p23l527t2772r791b2837],
2	.	.	O	.	_	0	SENT_423	[p23l527t2772r791b2837],

1	2009	CD	DATE	2009	_	0	SENT_424	[p23l827t2769r1703b2850],
2	;	:	O	;	_	0	SENT_424	[p23l827t2769r1703b2850],
3	302	CD	NUMBER	302	number	4	SENT_424	[p23l827t2769r1703b2850],
4	(	CD	NUMBER	(	dep	1	SENT_424	[p23l827t2769r1703b2850],
5	8	CD	NUMBER	8	num	6	SENT_424	[p23l827t2769r1703b2850],
6	)	NN	O	)	dep	4	SENT_424	[p23l827t2769r1703b2850],
7	:849	CD	NUMBER	:849	num	8	SENT_424	[p23l827t2769r1703b2850],
8	-857	CD	NUMBER	-857	dep	4	SENT_424	[p23l827t2769r1703b2850],
9	.	.	O	.	_	0	SENT_424	[p23l827t2769r1703b2850],

1	10	CD	NUMBER	10	_	0	SENT_425	[p23l9t2877r130b2943],
2	.	.	O	.	_	0	SENT_425	[p23l9t2877r130b2943],

1	Mega	JJ	ORGANIZATION	mega	amod	2	SENT_426	[p23l188t2877r418b2963],
2	JL	NN	ORGANIZATION	jl	_	0	SENT_426	[p23l453t2877r552b2954],
3	,	,	O	,	_	0	SENT_426	[p23l453t2877r552b2954],
4	Simon	NNP	PERSON	Simon	nn	5	SENT_426	[p23l597t2876r837b2943],
5	T	NN	PERSON	t	appos	2	SENT_426	[p23l879t2877r950b2954],
6	,	,	O	,	_	0	SENT_426	[p23l879t2877r950b2954],
7	Collet	NNP	ORGANIZATION	Collet	nn	8	SENT_426	[p23l996t2872r1228b2943],
8	JP	NNP	ORGANIZATION	JP	appos	2	SENT_426	[p23l1263t2877r1366b2954],
9	,	,	O	,	_	0	SENT_426	[p23l1263t2877r1366b2954],
10	et	FW	O	et	nn	11	SENT_426	[p23l1411t2878r1485b2943],
11	al.	FW	O	al.	appos	2	SENT_426	[p23l1523t2872r1606b2943],
12	.	.	O	.	_	0	SENT_426	[p23l1523t2872r1606b2943],

1	Reducedfunction	NN	O	reducedfunction	nn	3	SENT_427	[p23l1657t2872r2031b2943, p23l7t2977r322b3048],
2	CYPZC79	NN	O	cypzc79	nn	3	SENT_427	[p23l352t2982r722b3048],
3	genotype	NN	O	genotype	nsubj	12	SENT_427	[p23l749t2983r1111b3070],
4	and	CC	O	and	_	0	SENT_427	[p23l1136t2977r1273b3048],
5	risk	NN	O	risk	conj_and	3	SENT_427	[p23l1304t2977r1426b3048],
6	of	IN	O	of	_	0	SENT_427	[p23l1450t2977r1528b3048],
7	adverse	JJ	O	adverse	amod	9	SENT_427	[p23l1550t2977r1841b3048],
8	clinical	JJ	O	clinical	amod	9	SENT_427	[p23l1866t2977r2043b3048, p23l9t3083r107b3154],
9	outcomes	NNS	O	outcome	prep_of	5	SENT_427	[p23l148t3089r524b3154],
10	among	IN	O	among	_	0	SENT_427	[p23l562t3105r834b3174],
11	patients	NNS	O	patient	prep_among	9	SENT_427	[p23l873t3088r1174b3176],
12	treated	VBN	O	treat	_	0	SENT_427	[p23l1210t3083r1482b3154],
13	with	IN	O	with	_	0	SENT_427	[p23l1523t3083r1688b3154],
14	clopidogrel	NN	O	clopidogrel	prep_with	12	SENT_427	[p23l1730t3083r2041b3176, p23l9t3189r148b3280],
15	predominantly	RB	O	predominantly	advmod	12	SENT_427	[p23l188t3188r750b3281],
16	for	IN	O	for	_	0	SENT_427	[p23l783t3188r894b3259],
17	PCI	NNP	O	PCI	prep_for	12	SENT_427	[p23l930t3193r1078b3259],
18	:	:	O	:	_	0	SENT_427	[p23l930t3193r1078b3259],
19	a	DT	O	a	det	20	SENT_427	[p23l1118t3210r1160b3259],
20	meta-analysis	NN	O	meta-analysis	dep	17	SENT_427	[p23l1195t3189r1742b3280],
21	.	.	O	.	_	0	SENT_427	[p23l1195t3189r1742b3280],

1	JA/VIA	NN	O	ja/via	_	0	SENT_428	[p23l1776t3194r2039b3259],
2	.	.	O	.	_	0	SENT_428	[p23l1776t3194r2039b3259],

1	20	CD	NUMBER	20	number	2	SENT_429	[p23l8t3296r759b3376],
2	’	CD	NUMBER	’	_	0	SENT_429	[p23l8t3296r759b3376],
3	|	NN	O	|	nn	4	SENT_429	[p23l8t3296r759b3376],
4	O	NN	O	o	dep	2	SENT_429	[p23l8t3296r759b3376],
5	;	:	O	;	_	0	SENT_429	[p23l8t3296r759b3376],
6	304	CD	NUMBER	304	number	7	SENT_429	[p23l8t3296r759b3376],
7	(	CD	NUMBER	(	dep	2	SENT_429	[p23l8t3296r759b3376],
8	16	CD	NUMBER	16	num	9	SENT_429	[p23l8t3296r759b3376],
9	)	NN	O	)	dep	7	SENT_429	[p23l8t3296r759b3376],
10	:	:	O	:	_	0	SENT_429	[p23l8t3296r759b3376],
11	’	CD	NUMBER	’	num	12	SENT_429	[p23l8t3296r759b3376],
12	I82	NN	O	i82	dep	2	SENT_429	[p23l8t3296r759b3376],
13	’	CD	NUMBER	’	num	14	SENT_429	[p23l8t3296r759b3376],
14	|	NN	O	|	dep	12	SENT_429	[p23l8t3296r759b3376],
15	-1830	CD	NUMBER	-1830	dep	12	SENT_429	[p23l782t3299r1032b3365],
16	.	.	O	.	_	0	SENT_429	[p23l782t3299r1032b3365],

1	11	CD	NUMBER	11	_	0	SENT_430	[p23l9t3406r124b3469],
2	.	.	O	.	_	0	SENT_430	[p23l9t3406r124b3469],

1	Michelson	NNP	PERSON	Michelson	nn	2	SENT_431	[p23l179t3400r563b3470],
2	AD	NN	O	ad	_	0	SENT_431	[p23l588t3405r732b3482],
3	,	,	O	,	_	0	SENT_431	[p23l588t3405r732b3482],
4	FrelingerAL	NNP	O	FrelingerAL	nn	5	SENT_431	[p23l762t3400r1208b3490],
5	Ill	NNP	O	Ill	appos	2	SENT_431	[p23l1248t3405r1333b3482],
6	,	,	O	,	_	0	SENT_431	[p23l1248t3405r1333b3482],
7	Braunwald	NNP	PERSON	Braunwald	nn	8	SENT_431	[p23l1364t3400r1759b3470],
8	E	NNP	O	E	appos	2	SENT_431	[p23l1790t3405r1847b3482],
9	,	,	O	,	_	0	SENT_431	[p23l1790t3405r1847b3482],
10	et	FW	O	et	nn	11	SENT_431	[p23l1874t3405r1947b3470],
11	al	FW	O	al	appos	2	SENT_431	[p23l1967t3400r2047b3482],
12	;	:	O	;	_	0	SENT_431	[p23l1967t3400r2047b3482],
13	TR	NN	O	tr	dep	2	SENT_431	[p23l6t3510r538b3577],
14	|	CD	NUMBER	|	num	15	SENT_431	[p23l6t3510r538b3577],
15	TON	NN	O	ton	dep	13	SENT_431	[p23l6t3510r538b3577],
16	.	.	O	.	_	0	SENT_431	[p23l6t3510r538b3577],

1	—	NN	O	—	_	0	SENT_432	[p23l6t3510r538b3577],
2	.	.	O	.	_	0	SENT_432	[p23l6t3510r538b3577],

1	T	NN	O	t	nn	4	SENT_433	[p23l6t3510r538b3577],
2	|	CD	NUMBER	|	num	4	SENT_433	[p23l6t3510r538b3577],
3	M	NN	O	m	nn	4	SENT_433	[p23l6t3510r538b3577],
4	|	NN	O	|	_	0	SENT_433	[p23l6t3510r538b3577],
5	38	CD	NUMBER	38	num	6	SENT_433	[p23l566t3511r660b3576],
6	Investigators	NNS	O	investigator	dep	4	SENT_433	[p23l689t3511r1185b3597],
7	.	.	O	.	_	0	SENT_433	[p23l689t3511r1185b3597],

1	Pharmacodynamic	JJ	O	pharmacodynamic	amod	2	SENT_434	[p23l1217t3506r1918b3597],
2	asMyers	NNS	O	asmyer	_	0	SENT_434	[p23l1940t3528r2045b3577, p24l35t68r153b110],

1	Sq	NN	O	sq	_	0	SENT_435	[p24l165t67r208b111],
2	uibb/sanofi-aventis	NN	O	uibb/sanofi-aventi	dep	1	SENT_435	[p24l215t65r596b100],
3	.	.	O	.	_	0	SENT_435	[p24l215t65r596b100],

1	Research	NNP	O	Research	nn	2	SENT_436	[p24l613t65r780b100],
2	supplies	NNS	O	supplies	nsubjpass	4	SENT_436	[p24l794t65r945b111],
3	were	VBD	O	be	auxpass	4	SENT_436	[p24l957t76r1050b100],
4	provided	VBN	O	provide	_	0	SENT_436	[p24l36t116r202b161],
5	by	IN	O	by	_	0	SENT_436	[p24l222t116r266b161],
6	Accumetrics	NNPS	O	Accumetrics	agent	4	SENT_436	[p24l280t118r514b151],
7	and	CC	O	and	_	0	SENT_436	[p24l530t116r599b151],
8	Nanosphere	NNP	O	Nanosphere	agent	4	SENT_436	[p24l618t116r860b161],
9	.	.	O	.	_	0	SENT_436	[p24l618t116r860b161],

1	Dr	NN	O	dr	nsubjpass	4	SENT_437	[p24l880t118r925b150],
2	Mega	JJ	O	mega	amod	1	SENT_437	[p24l940t118r1052b161],
3	is	VBZ	O	be	auxpass	4	SENT_437	[p24l36t168r59b200],
4	supported	VBN	O	support	_	0	SENT_437	[p24l70t165r259b211],
5	in	IN	O	in	_	0	SENT_437	[p24l273t168r302b199],
6	part	NN	O	part	prep_in	4	SENT_437	[p24l316t168r390b211],
7	by	IN	O	by	_	0	SENT_437	[p24l402t165r445b210],
8	grant	NN	O	grant	nn	9	SENT_437	[p24l456t168r556b210],
9	K99	NN	O	k99	agent	4	SENT_437	[p24l568t167r660b200],
10	/	:	O	/	punct	12	SENT_437	[p24l568t167r660b200],
11	Roo	NNP	O	Roo	nn	12	SENT_437	[p24l665t168r738b200],
12	HL098461	NNP	O	HL098461	dep	9	SENT_437	[p24l751t168r943b200],
13	from	IN	O	from	_	0	SENT_437	[p24l961t165r1049b200],
14	the	DT	O	the	det	16	SENT_437	[p24l34t216r93b251],
15	National	NNP	ORGANIZATION	National	nn	16	SENT_437	[p24l107t216r262b251],
16	Institutes	NNPS	ORGANIZATION	Institutes	prep_from	12	SENT_437	[p24l277t218r444b251],
17	of	IN	ORGANIZATION	of	_	0	SENT_437	[p24l455t215r494b251],
18	Health	NNP	ORGANIZATION	Health	prep_of	9	SENT_437	[p24l506t216r637b251],
19	.	.	O	.	_	0	SENT_437	[p24l506t216r637b251],

1	Dr	NNP	O	Dr	nn	2	SENT_438	[p24l653t218r697b250],
2	Hochholzer	NNP	O	Hochholzer	nsubjpass	4	SENT_438	[p24l709t216r924b251],
3	is	VBZ	O	be	auxpass	4	SENT_438	[p24l935t218r958b251],
4	supported	VBN	O	support	_	0	SENT_438	[p24l969t226r1049b261, p24l36t265r159b311],
5	in	IN	O	in	_	0	SENT_438	[p24l178t268r207b300],
6	part	NN	O	part	prep_in	4	SENT_438	[p24l226t268r302b311],
7	by	IN	O	by	_	0	SENT_438	[p24l318t265r362b310],
8	the	DT	O	the	det	11	SENT_438	[p24l377t265r438b300],
9	German	JJ	O	german	amod	11	SENT_438	[p24l454t267r606b300],
10	Heart	NNP	ORGANIZATION	Heart	nn	11	SENT_438	[p24l626t268r731b300],
11	Foundation	NNP	ORGANIZATION	Foundation	agent	4	SENT_438	[p24l747t265r976b300],
12	.	.	O	.	_	0	SENT_438	[p24l747t265r976b300],

1	Role	NN	O	role	_	0	SENT_439	[p24l36t316r123b351],
2	of	IN	O	of	_	0	SENT_439	[p24l143t315r182b351],
3	the	DT	O	the	det	4	SENT_439	[p24l200t316r263b351],
4	Sponsor	NNP	O	Sponsor	prep_of	1	SENT_439	[p24l283t318r456b361],
5	:	:	O	:	_	0	SENT_439	[p24l283t318r456b361],
6	The	DT	O	the	det	7	SENT_439	[p24l477t316r549b351],
7	funding	NN	O	funding	dep	1	SENT_439	[p24l569t315r724b361],
8	sources	NNS	O	source	nsubj	9	SENT_439	[p24l744t326r889b351],
9	had	VBD	O	have	rcmod	7	SENT_439	[p24l911t316r980b351],
10	no	DT	O	no	det	11	SENT_439	[p24l1003t326r1050b351],
11	role	NN	O	role	dobj	9	SENT_439	[p24l36t366r105b402],
12	in	IN	O	in	_	0	SENT_439	[p24l126t369r155b401],
13	the	DT	O	the	det	14	SENT_439	[p24l176t366r237b402],
14	design	NN	O	design	prep_in	11	SENT_439	[p24l256t366r379b412],
15	and	CC	O	and	_	0	SENT_439	[p24l400t366r469b402],
16	conduct	NN	O	conduct	conj_and	14	SENT_439	[p24l490t366r647b402],
17	of	IN	O	of	_	0	SENT_439	[p24l665t366r704b402],
18	the	DT	O	the	det	19	SENT_439	[p24l721t366r782b402],
19	study	NN	O	study	prep_of	14	SENT_439	[p24l801t366r916b412],
20	;	:	O	;	_	0	SENT_439	[p24l801t366r916b412],
21	in	IN	O	in	_	0	SENT_439	[p24l939t369r968b401],
22	the	DT	O	the	det	23	SENT_439	[p24l988t366r1050b402],
23	collection	NN	O	collection	prep_in	19	SENT_439	[p24l34t417r228b458],
24	,	,	O	,	_	0	SENT_439	[p24l34t417r228b458],
25	analysis	NN	O	analysis	conj_and	23	SENT_439	[p24l243t417r401b462],
26	,	,	O	,	_	0	SENT_439	[p24l243t417r401b462],
27	and	CC	O	and	_	0	SENT_439	[p24l416t417r485b452],
28	interpretation	NN	O	interpretation	conj_and	23	SENT_439	[p24l502t419r762b462],
29	of	IN	O	of	_	0	SENT_439	[p24l778t416r817b452],
30	the	DT	O	the	det	31	SENT_439	[p24l828t417r889b452],
31	data	NNS	O	datum	prep_of	23	SENT_439	[p24l903t417r997b458],
32	;	:	O	;	_	0	SENT_439	[p24l903t417r997b458],
33	or	CC	O	or	_	0	SENT_439	[p24l1013t427r1052b452],
34	in	IN	O	in	_	0	SENT_439	[p24l36t469r65b501],
35	the	DT	O	the	det	36	SENT_439	[p24l81t466r142b501],
36	preparation	NN	O	preparation	conj_or	14	SENT_439	[p24l159t469r391b512],
37	,	,	O	,	_	0	SENT_439	[p24l159t469r391b512],
38	review	NN	O	review	conj_or	14	SENT_439	[p24l409t469r545b507],
39	,	,	O	,	_	0	SENT_439	[p24l409t469r545b507],
40	or	CC	O	or	_	0	SENT_439	[p24l562t477r601b501],
41	approval	NN	O	approval	conj_or	14	SENT_439	[p24l614t466r780b512],
42	of	IN	O	of	_	0	SENT_439	[p24l796t466r835b501],
43	the	DT	O	the	det	44	SENT_439	[p24l848t466r909b501],
44	manuscript	NN	O	manuscript	prep_of	36	SENT_439	[p24l925t477r1049b501, p24l34t519r146b563],
45	.	.	O	.	_	0	SENT_439	[p24l925t477r1049b501, p24l34t519r146b563],

1	ELEVATE-TIMI	NN	O	elevate-timus	dep	99	SENT_440	[p24l36t570r320b604],
2	56	CD	NUMBER	56	dep	99	SENT_440	[p24l340t571r388b604],
3	Investigators	NNS	O	investigator	dep	99	SENT_440	[p24l409t571r672b614],
4	:	:	O	:	_	0	SENT_440	[p24l409t571r672b614],
5	A.	NN	PERSON	a.	dep	99	SENT_440	[p24l691t571r730b604],
6	Albirini	NNP	PERSON	Albirini	dep	99	SENT_440	[p24l751t568r897b610],
7	,	,	O	,	_	0	SENT_440	[p24l751t568r897b610],
8	D.	NNP	PERSON	D.	dep	99	SENT_440	[p24l920t571r958b603],
9	Angiolillo	NNP	PERSON	Angiolillo	dep	99	SENT_440	[p24l978t571r1049b604, p24l35t619r165b665],
10	,	,	O	,	_	0	SENT_440	[p24l978t571r1049b604, p24l35t619r165b665],
11	G.	NNP	PERSON	G.	dep	99	SENT_440	[p24l179t621r218b655],
12	Aycock	NNP	PERSON	Aycock	dep	99	SENT_440	[p24l231t619r379b665],
13	,	,	O	,	_	0	SENT_440	[p24l231t619r379b665],
14	B.	NNP	PERSON	B.	dep	99	SENT_440	[p24l394t621r424b654],
15	Bertolet	NNP	PERSON	Bertolet	dep	99	SENT_440	[p24l440t619r594b661],
16	,	,	O	,	_	0	SENT_440	[p24l440t619r594b661],
17	R.	NNP	PERSON	R.	dep	99	SENT_440	[p24l610t622r642b655],
18	Bhagwat	NNP	PERSON	Bhagwat	dep	99	SENT_440	[p24l658t619r833b665],
19	,	,	O	,	_	0	SENT_440	[p24l658t619r833b665],
20	R.	NNP	PERSON	R.	dep	99	SENT_440	[p24l849t622r881b655],
21	Blonder	NNP	PERSON	Blonder	dep	99	SENT_440	[p24l897t619r1049b661],
22	,	,	O	,	_	0	SENT_440	[p24l897t619r1049b661],
23	H.	NNP	PERSON	H.	dep	99	SENT_440	[p24l36t672r74b704],
24	Chandna	NNP	PERSON	Chandna	dep	99	SENT_440	[p24l94t669r279b710],
25	,	,	O	,	_	0	SENT_440	[p24l94t669r279b710],
26	J.	NNP	PERSON	J.	dep	99	SENT_440	[p24l296t672r320b704],
27	Cole	NNP	PERSON	Cole	dep	99	SENT_440	[p24l339t669r435b710],
28	,	,	O	,	_	0	SENT_440	[p24l339t669r435b710],
29	S.	NNP	PERSON	S.	dep	99	SENT_440	[p24l454t671r483b704],
30	Denning	NNP	PERSON	Denning	dep	99	SENT_440	[p24l504t672r678b714],
31	,	,	O	,	_	0	SENT_440	[p24l504t672r678b714],
32	D.	NNP	PERSON	D.	dep	99	SENT_440	[p24l698t672r736b704],
33	Doty	NNP	PERSON	Doty	dep	99	SENT_440	[p24l757t672r859b714],
34	,	,	O	,	_	0	SENT_440	[p24l757t672r859b714],
35	C.	NNP	PERSON	C.	dep	99	SENT_440	[p24l878t671r915b704],
36	Fastabend	NNP	PERSON	Fastabend	dep	99	SENT_440	[p24l936t672r1048b704, p24l36t719r141b760],
37	,	,	O	,	_	0	SENT_440	[p24l936t672r1048b704, p24l36t719r141b760],
38	L.	NNP	PERSON	L.	dep	99	SENT_440	[p24l161t721r189b753],
39	Ferrier	NNP	PERSON	Ferrier	dep	99	SENT_440	[p24l210t721r340b760],
40	,	,	O	,	_	0	SENT_440	[p24l210t721r340b760],
41	W.	NNP	PERSON	W.	dep	99	SENT_440	[p24l357t721r411b753],
42	Ginete	NNP	PERSON	Ginete	dep	99	SENT_440	[p24l430t721r567b760],
43	,	,	O	,	_	0	SENT_440	[p24l430t721r567b760],
44	S.	NNP	PERSON	S.	dep	99	SENT_440	[p24l585t721r615b754],
45	Gips	NNP	PERSON	Gips	dep	99	SENT_440	[p24l634t721r727b765],
46	,	,	O	,	_	0	SENT_440	[p24l634t721r727b765],
47	R.	NNP	PERSON	R.	dep	99	SENT_440	[p24l747t721r780b754],
48	Goldberg	NNP	PERSON	Goldberg	dep	99	SENT_440	[p24l799t719r990b764],
49	,	,	O	,	_	0	SENT_440	[p24l799t719r990b764],
50	G.	NNP	PERSON	G.	dep	99	SENT_440	[p24l1008t721r1048b754],
51	Hamroff	NNP	PERSON	Hamroff	dep	99	SENT_440	[p24l36t769r207b810],
52	,	,	O	,	_	0	SENT_440	[p24l36t769r207b810],
53	E.	NNP	PERSON	E.	dep	99	SENT_440	[p24l228t772r256b804],
54	Haskel	NNP	PERSON	Haskel	dep	99	SENT_440	[p24l277t769r412b810],
55	,	,	O	,	_	0	SENT_440	[p24l277t769r412b810],
56	S.	NNP	PERSON	S.	dep	99	SENT_440	[p24l431t771r460b804],
57	Isserman	NNP	PERSON	Isserman	dep	99	SENT_440	[p24l482t772r660b810],
58	,	,	O	,	_	0	SENT_440	[p24l482t772r660b810],
59	B.	NNP	O	B.	dep	99	SENT_440	[p24l681t772r711b804],
60	lteld	NNP	O	lteld	dep	99	SENT_440	[p24l733t769r825b810],
61	,	,	O	,	_	0	SENT_440	[p24l733t769r825b810],
62	S.	NNP	PERSON	S.	dep	99	SENT_440	[p24l844t771r873b804],
63	Jones	NNP	PERSON	Jones	dep	99	SENT_440	[p24l891t772r1007b810],
64	,	,	O	,	_	0	SENT_440	[p24l891t772r1007b810],
65	J.	NNP	PERSON	J.	dep	99	SENT_440	[p24l1024t772r1048b804],
66	Katopodis	NNP	PERSON	Katopodis	dep	99	SENT_440	[p24l36t819r240b865],
67	,	,	O	,	_	0	SENT_440	[p24l36t819r240b865],
68	D.	NNP	PERSON	D.	dep	99	SENT_440	[p24l263t821r301b853],
69	Kereiakes	NNP	PERSON	Kereiakes	dep	99	SENT_440	[p24l325t819r518b860],
70	,	,	O	,	_	0	SENT_440	[p24l325t819r518b860],
71	N.	NNP	PERSON	N.	dep	99	SENT_440	[p24l542t821r580b854],
72	Kleiman	NNP	PERSON	Kleiman	dep	99	SENT_440	[p24l604t819r769b860],
73	,	,	O	,	_	0	SENT_440	[p24l604t819r769b860],
74	E.	NNP	PERSON	E.	dep	99	SENT_440	[p24l792t821r820b853],
75	Korban	NNP	PERSON	Korban	dep	99	SENT_440	[p24l844t819r993b860],
76	,	,	O	,	_	0	SENT_440	[p24l844t819r993b860],
77	B.	NNP	PERSON	B.	dep	99	SENT_440	[p24l1017t821r1047b853],
78	Peart	NNP	PERSON	Peart	dep	99	SENT_440	[p24l1133t68r1244b106],
79	,	,	O	,	_	0	SENT_440	[p24l1133t68r1244b106],
80	J.	NNP	PERSON	J.	dep	99	SENT_440	[p24l1265t68r1289b100],
81	Peterson	NNP	PERSON	Peterson	dep	99	SENT_440	[p24l1314t68r1496b106],
82	,	,	O	,	_	0	SENT_440	[p24l1314t68r1496b106],
83	B.	NNP	PERSON	B.	dep	99	SENT_440	[p24l1521t68r1552b100],
84	Reddy	NNP	PERSON	Reddy	dep	99	SENT_440	[p24l1577t65r1711b110],
85	,	,	O	,	_	0	SENT_440	[p24l1577t65r1711b110],
86	W.	NNP	PERSON	W.	dep	99	SENT_440	[p24l1732t67r1786b100],
87	Rogers	NNP	PERSON	Rogers	dep	99	SENT_440	[p24l1811t68r1956b110],
88	,	,	O	,	_	0	SENT_440	[p24l1811t68r1956b110],
89	C.	NNP	PERSON	C.	dep	99	SENT_440	[p24l1979t67r2017b100],
90	SotoIongo	NNP	PERSON	SotoIongo	dep	99	SENT_440	[p24l2040t67r2145b100, p24l1132t116r1251b161],
91	,	,	O	,	_	0	SENT_440	[p24l2040t67r2145b100, p24l1132t116r1251b161],
92	C.	NNP	PERSON	C.	dep	99	SENT_440	[p24l1269t118r1306b151],
93	Staniloae	NNP	PERSON	Staniloae	dep	99	SENT_440	[p24l1324t116r1510b157],
94	,	,	O	,	_	0	SENT_440	[p24l1324t116r1510b157],
95	R.	NNP	PERSON	R.	dep	99	SENT_440	[p24l1529t118r1562b151],
96	Vicari	NNP	PERSON	Vicari	dep	99	SENT_440	[p24l1580t118r1698b157],
97	,	,	O	,	_	0	SENT_440	[p24l1580t118r1698b157],
98	F.	NNP	PERSON	F.	dep	99	SENT_440	[p24l1717t118r1745b150],
99	Wefald	NNP	PERSON	Wefald	_	0	SENT_440	[p24l1762t115r1913b151],
100	.	.	O	.	_	0	SENT_440	[p24l1762t115r1913b151],

1	Online-Only	NNP	O	Online-Only	nn	2	SENT_441	[p24l1131t165r1374b210],
2	Material	NNP	O	Material	_	0	SENT_441	[p24l1385t165r1553b200],
3	:	:	O	:	_	0	SENT_441	[p24l1385t165r1553b200],
4	eFigures	NNS	O	efigure	dep	2	SENT_441	[p24l1565t168r1719b210],
5	1	CD	NUMBER	1	num	4	SENT_441	[p24l1732t168r1745b199],
6	and	CC	O	and	_	0	SENT_441	[p24l1763t165r1830b200],
7	2	CD	NUMBER	2	dep	2	SENT_441	[p24l1842t168r1863b199],
8	and	CC	O	and	_	0	SENT_441	[p24l1876t165r1943b200],
9	the	DT	O	the	det	11	SENT_441	[p24l1955t165r2014b200],
10	eTab	NNP	O	eTab	nn	11	SENT_441	[p24l2025t165r2147b200],
11	|	NN	O	|	conj_and	4	SENT_441	[p24l2025t165r2147b200],
12	e	SYM	O	e	dep	14	SENT_441	[p24l2025t165r2147b200],
13	are	VBP	O	be	cop	14	SENT_441	[p24l1131t226r1189b251],
14	available	JJ	O	available	dep	11	SENT_441	[p24l1205t216r1372b251],
15	at	IN	O	at	_	0	SENT_441	[p24l1388t219r1424b251],
16	http://www.jama.com	NNP	O	http://www.jama.com	prep_at	14	SENT_441	[p24l1440t216r1890b261],
17	.	.	O	.	_	0	SENT_441	[p24l1440t216r1890b261],

1	Additional	JJ	O	additional	amod	2	SENT_442	[p24l1130t265r1334b300],
2	Contributions	NNS	O	contribution	_	0	SENT_442	[p24l1356t265r1637b300],
3	:	:	O	:	_	0	SENT_442	[p24l1356t265r1637b300],
4	The	DT	O	the	det	6	SENT_442	[p24l1656t265r1728b300],
5	following	VBG	O	follow	amod	6	SENT_442	[p24l1745t265r1927b310],
6	individuals	NNS	O	individual	nsubj	7	SENT_442	[p24l1946t265r2147b300],
7	contributed	VBD	O	contribute	dep	2	SENT_442	[p24l1131t316r1346b351],
8	to	TO	O	to	_	0	SENT_442	[p24l1359t319r1396b351],
9	the	DT	O	the	det	10	SENT_442	[p24l1407t316r1467b351],
10	study	NN	O	study	prep_to	7	SENT_442	[p24l1478t316r1589b361],
11	:	:	O	:	_	0	SENT_442	[p24l1478t316r1589b361],
12	Laura	NNP	PERSON	Laura	nn	13	SENT_442	[p24l1605t318r1708b351],
13	Grip	NNP	PERSON	Grip	dep	10	SENT_442	[p24l1719t318r1808b361],
14	,	,	O	,	_	0	SENT_442	[p24l1719t318r1808b361],
15	BA	NN	ORGANIZATION	ba	appos	13	SENT_442	[p24l1823t318r1883b356],
16	;	:	O	;	_	0	SENT_442	[p24l1823t318r1883b356],
17	Robert	NNP	PERSON	Robert	nn	18	SENT_442	[p24l1899t316r2024b351],
18	Mesa	NNP	PERSON	Mesa	dep	10	SENT_442	[p24l2034t318r2146b357],
19	,	,	O	,	_	0	SENT_442	[p24l2034t318r2146b357],
20	BS	NNP	O	BS	appos	18	SENT_442	[p24l1133t368r1186b408],
21	;	:	O	;	_	0	SENT_442	[p24l1133t368r1186b408],
22	John	NNP	PERSON	John	nn	23	SENT_442	[p24l1197t366r1283b402],
23	Mattimore	NNP	PERSON	Mattimore	conj_and	13	SENT_442	[p24l1296t369r1505b408],
24	,	,	O	,	_	0	SENT_442	[p24l1296t369r1505b408],
25	BA	NN	ORGANIZATION	ba	appos	23	SENT_442	[p24l1520t369r1580b408],
26	;	:	O	;	_	0	SENT_442	[p24l1520t369r1580b408],
27	John	NNP	PERSON	John	nn	28	SENT_442	[p24l1592t366r1677b402],
28	Cyr	NNP	PERSON	Cyr	conj_and	13	SENT_442	[p24l1691t368r1765b412],
29	,	,	O	,	_	0	SENT_442	[p24l1691t368r1765b412],
30	PA	NN	ORGANIZATION	pa	appos	28	SENT_442	[p24l1780t369r1840b408],
31	;	:	O	;	_	0	SENT_442	[p24l1780t369r1840b408],
32	and	CC	O	and	_	0	SENT_442	[p24l1853t366r1920b402],
33	David	NNP	PERSON	David	nn	34	SENT_442	[p24l1935t366r2039b402],
34	Berg	NNP	PERSON	Berg	conj_and	13	SENT_442	[p24l2054t369r2146b412],
35	,	,	O	,	_	0	SENT_442	[p24l2054t369r2146b412],
36	MD	NNP	O	MD	nn	41	SENT_442	[p24l1131t419r1204b451],
37	(	NNP	O	(	nn	41	SENT_442	[p24l1225t418r1328b456],
38	TIMI	NNP	ORGANIZATION	TIMI	nn	41	SENT_442	[p24l1225t418r1328b456],
39	Study	NNP	ORGANIZATION	Study	nn	41	SENT_442	[p24l1350t417r1460b462],
40	Group	NNP	ORGANIZATION	Group	nn	41	SENT_442	[p24l1479t418r1626b462],
41	)	NN	O	)	appos	34	SENT_442	[p24l1479t418r1626b462],
42	.	.	O	.	_	0	SENT_442	[p24l1479t418r1626b462],

1	Additional	JJ	O	additional	amod	3	SENT_443	[p24l1647t417r1846b452],
2	statistical	JJ	O	statistical	amod	3	SENT_443	[p24l1867t417r2042b452],
3	support	NN	O	support	nsubjpass	5	SENT_443	[p24l2063t427r2145b462, p24l1133t469r1211b512],
4	was	VBD	O	be	auxpass	5	SENT_443	[p24l1228t477r1302b501],
5	provided	VBN	O	provide	_	0	SENT_443	[p24l1322t466r1489b512],
6	by	IN	O	by	_	0	SENT_443	[p24l1512t466r1556b511],
7	Satish	NNP	PERSON	Satish	nn	8	SENT_443	[p24l1575t466r1684b501],
8	Mohanavelu	NNP	PERSON	Mohanavelu	agent	5	SENT_443	[p24l1706t466r1960b507],
9	,	,	O	,	_	0	SENT_443	[p24l1706t466r1960b507],
10	MS	NN	O	m	agent	5	SENT_443	[p24l1981t468r2055b507],
11	,	,	O	,	_	0	SENT_443	[p24l1981t468r2055b507],
12	and	CC	O	and	_	0	SENT_443	[p24l2076t466r2145b501],
13	Kevin	NNP	PERSON	Kevin	nn	14	SENT_443	[p24l1133t519r1235b552],
14	Crowley	NNP	PERSON	Crowley	agent	5	SENT_443	[p24l1255t517r1425b563],
15	,	,	O	,	_	0	SENT_443	[p24l1255t517r1425b563],
16	MS	NN	O	m	agent	5	SENT_443	[p24l1445t519r1507b552],
17	(	CD	NUMBER	(	num	21	SENT_443	[p24l1526t518r1629b557],
18	TIMI	NNP	ORGANIZATION	TIMI	nn	21	SENT_443	[p24l1526t518r1629b557],
19	Study	NNP	ORGANIZATION	Study	nn	21	SENT_443	[p24l1649t517r1758b563],
20	Group	NNP	ORGANIZATION	Group	nn	21	SENT_443	[p24l1776t518r1923b563],
21	)	NN	O	)	dep	16	SENT_443	[p24l1776t518r1923b563],
22	,	,	O	,	_	0	SENT_443	[p24l1776t518r1923b563],
23	and	CC	O	and	_	0	SENT_443	[p24l1942t517r2011b552],
24	Lanyu	NNP	ORGANIZATION	Lanyu	nn	27	SENT_443	[p24l2033t519r2145b563],
25	Lei	NNP	ORGANIZATION	Lei	nn	27	SENT_443	[p24l1133t571r1183b604],
26	(	NNP	O	(	nn	27	SENT_443	[p24l1203t568r1369b609],
27	Harvard	NNP	ORGANIZATION	Harvard	conj_and	8	SENT_443	[p24l1203t568r1369b609],
28	Clinical	JJ	ORGANIZATION	clinical	amod	31	SENT_443	[p24l1389t568r1524b604],
29	Research	NNP	ORGANIZATION	Research	nn	31	SENT_443	[p24l1545t568r1713b604],
30	Institute	NNP	ORGANIZATION	Institute	nn	31	SENT_443	[p24l1735t570r1903b609],
31	)	NN	O	)	dep	27	SENT_443	[p24l1735t570r1903b609],
32	and	CC	O	and	_	0	SENT_443	[p24l1922t568r1991b604],
33	Gheorghe	NNP	PERSON	Gheorghe	conj_and	31	SENT_443	[p24l2011t568r2145b604, p24l1131t619r1202b665],

1	Doros	NNP	PERSON	Doros	_	0	SENT_444	[p24l1223t621r1347b661],
2	,	,	O	,	_	0	SENT_444	[p24l1223t621r1347b661],
3	PhD	NNP	O	PhD	nn	7	SENT_444	[p24l1369t619r1448b654],
4	(	NNP	O	(	nn	7	SENT_444	[p24l1469t620r1614b659],
5	Boston	NNP	ORGANIZATION	Boston	nn	7	SENT_444	[p24l1469t620r1614b659],
6	University	NNP	ORGANIZATION	University	nn	7	SENT_444	[p24l1637t620r1854b665],
7	)	NN	O	)	appos	1	SENT_444	[p24l1637t620r1854b665],
8	.	.	O	.	_	0	SENT_444	[p24l1637t620r1854b665],

1	Dr	NNP	O	Dr	nn	2	SENT_445	[p24l1877t621r1923b654],
2	Doros	NNP	PERSON	Doros	nsubjpass	4	SENT_445	[p24l1942t622r2054b655],
3	was	VBD	O	be	auxpass	4	SENT_445	[p24l2073t630r2147b655],
4	compensated	VBN	O	compensate	_	0	SENT_445	[p24l1131t669r1388b715],
5	for	IN	O	for	_	0	SENT_445	[p24l1403t669r1458b704],
6	his	PRP$	O	he	poss	7	SENT_445	[p24l1472t669r1520b704],
7	contribution	NN	O	contribution	prep_for	4	SENT_445	[p24l1534t669r1768b704],
8	by	IN	O	by	_	0	SENT_445	[p24l1785t669r1829b714],
9	Harvard	NNP	ORGANIZATION	Harvard	agent	4	SENT_445	[p24l1844t669r1995b704],
10	Clinical	JJ	ORGANIZATION	clinical	amod	12	SENT_445	[p24l2011t669r2146b704],
11	Research	NNP	ORGANIZATION	Research	nn	12	SENT_445	[p24l1133t719r1306b754],
12	Institute	NNP	ORGANIZATION	Institute	dep	9	SENT_445	[p24l1330t721r1500b754],
13	.	.	O	.	_	0	SENT_445	[p24l1330t721r1500b754],

1	The	DT	O	the	det	3	SENT_446	[p24l1521t719r1594b754],
2	other	JJ	O	other	amod	3	SENT_446	[p24l1614t719r1720b754],
3	individuals	NNS	O	individual	nsubjpass	6	SENT_446	[p24l1739t719r1947b754],
4	were	VBD	O	be	auxpass	6	SENT_446	[p24l1966t730r2062b754],
5	not	RB	O	not	neg	6	SENT_446	[p24l2084t722r2148b754],
6	compensated	VBN	O	compensate	_	0	SENT_446	[p24l1131t769r1397b815],
7	for	IN	O	for	_	0	SENT_446	[p24l1419t769r1476b804],
8	their	PRP$	O	they	poss	9	SENT_446	[p24l1495t769r1587b804],
9	contributions	NNS	O	contribution	prep_for	6	SENT_446	[p24l1606t769r1871b804],
10	besides	IN	O	besides	_	0	SENT_446	[p24l1893t769r2036b804],
11	their	PRP$	O	they	poss	12	SENT_446	[p24l2056t769r2148b804],
12	salaries	NNS	O	salary	prep_besides	9	SENT_446	[p24l1131t819r1278b854],
13	.	.	O	.	_	0	SENT_446	[p24l1131t819r1278b854],

1	sessment	NN	O	sessment	_	0	SENT_447	[p24l34t1022r211b1054],
2	of	IN	O	of	_	0	SENT_447	[p24l226t1019r265b1054],
3	platelet	NN	O	platelet	nn	4	SENT_447	[p24l281t1019r423b1065],
4	inhibition	NN	O	inhibition	prep_of	1	SENT_447	[p24l439t1019r616b1054],
5	by	IN	O	by	_	0	SENT_447	[p24l636t1019r680b1064],
6	prasugrel	NN	O	prasugrel	prep_by	1	SENT_447	[p24l698t1019r872b1065],
7	vs	CC	O	vs	_	0	SENT_447	[p24l889t1030r928b1054],
8	clopidogrel	NN	O	clopidogrel	conj_vs	6	SENT_447	[p24l944t1019r1049b1065, p24l34t1070r153b1116],
9	in	IN	O	in	_	0	SENT_447	[p24l167t1073r196b1105],
10	the	DT	O	the	det	13	SENT_447	[p24l209t1070r270b1106],
11	TRITON-TIMI	NN	O	triton-timus	nn	13	SENT_447	[p24l281t1072r547b1106],
12	38	CD	NUMBER	38	num	13	SENT_447	[p24l561t1073r609b1106],
13	trial	NN	O	trial	prep_in	1	SENT_447	[p24l620t1070r700b1106],
14	.	.	O	.	_	0	SENT_447	[p24l620t1070r700b1106],

1	Eur	NNP	O	Eur	nn	3	SENT_448	[p24l714t1073r777b1106],
2	Heart	NNP	O	Heart	nn	3	SENT_448	[p24l786t1073r893b1106],
3	J.	NNP	O	J.	_	0	SENT_448	[p24l900t1073r927b1106],
4	2009	CD	DATE	2009	num	3	SENT_448	[p24l941t1073r1050b1112],
5	;	:	O	;	_	0	SENT_448	[p24l941t1073r1050b1112],
6	30	CD	NUMBER	30	number	7	SENT_448	[p24l34t1123r406b1162],
7	(	CD	NUMBER	(	dep	3	SENT_448	[p24l34t1123r406b1162],
8	14	CD	NUMBER	14	num	9	SENT_448	[p24l34t1123r406b1162],
9	)	NN	O	)	dep	7	SENT_448	[p24l34t1123r406b1162],
10	:1753	CD	DURATION	:1753	num	11	SENT_448	[p24l34t1123r406b1162],
11	-1763	CD	DURATION	-1763	dep	7	SENT_448	[p24l34t1123r406b1162],
12	.	.	O	.	_	0	SENT_448	[p24l34t1123r406b1162],

1	12	CD	NUMBER	12	_	0	SENT_449	[p24l35t1176r93b1208],
2	.	.	O	.	_	0	SENT_449	[p24l35t1176r93b1208],

1	Brar	NNP	O	Brar	nn	2	SENT_450	[p24l123t1176r198b1208],
2	SS	NNP	O	SS	_	0	SENT_450	[p24l213t1175r266b1214],
3	,	,	O	,	_	0	SENT_450	[p24l213t1175r266b1214],
4	Ten	CD	PERSON	ten	num	6	SENT_450	[p24l282t1176r352b1208],
5	Berg	NN	PERSON	berg	nn	6	SENT_450	[p24l372t1176r457b1218],
6	J	NN	PERSON	j	appos	2	SENT_450	[p24l470t1176r494b1214],
7	,	,	O	,	_	0	SENT_450	[p24l470t1176r494b1214],
8	Marcucci	NNP	PERSON	Marcucci	nn	9	SENT_450	[p24l513t1176r685b1208],
9	R	NNP	O	R	appos	2	SENT_450	[p24l704t1176r738b1214],
10	,	,	O	,	_	0	SENT_450	[p24l704t1176r738b1214],
11	et	FW	O	et	nn	12	SENT_450	[p24l756t1176r792b1208],
12	al.	FW	O	al.	appos	2	SENT_450	[p24l807t1173r847b1208],
13	.	.	O	.	_	0	SENT_450	[p24l807t1173r847b1208],

1	Impact	NN	O	impact	_	0	SENT_451	[p24l868t1176r998b1219],
2	of	IN	O	of	_	0	SENT_451	[p24l1013t1173r1052b1208],
3	platelet	NN	O	platelet	nn	4	SENT_451	[p24l36t1224r178b1270],
4	reactivity	NN	O	reactivity	prep_of	1	SENT_451	[p24l192t1226r366b1269],
5	on	IN	O	on	_	0	SENT_451	[p24l380t1235r426b1259],
6	clinical	JJ	O	clinical	amod	7	SENT_451	[p24l442t1224r567b1259],
7	outcomes	NNS	O	outcome	prep_on	4	SENT_451	[p24l583t1227r771b1259],
8	after	IN	O	after	_	0	SENT_451	[p24l785t1224r876b1259],
9	percutaneous	JJ	O	percutaneous	amod	11	SENT_451	[p24l890t1227r1049b1270, p24l36t1286r149b1310],
10	coronary	JJ	O	coronary	amod	11	SENT_451	[p24l169t1286r340b1321],
11	intervention	NN	O	intervention	prep_after	7	SENT_451	[p24l361t1278r606b1310],
12	:	:	O	:	_	0	SENT_451	[p24l361t1278r606b1310],
13	a	DT	O	a	det	15	SENT_451	[p24l628t1286r649b1310],
14	collaborative	JJ	O	collaborative	amod	15	SENT_451	[p24l667t1275r916b1310],
15	metaanalysis	NN	O	metaanalysis	dep	1	SENT_451	[p24l937t1278r1049b1310, p24l34t1327r189b1372],
16	of	IN	O	of	_	0	SENT_451	[p24l210t1326r250b1362],
17	individual	JJ	O	individual	amod	19	SENT_451	[p24l271t1327r463b1362],
18	participant	NN	O	participant	nn	19	SENT_451	[p24l487t1329r703b1373],
19	data	NNS	O	datum	prep_of	15	SENT_451	[p24l722t1327r820b1362],
20	.	.	O	.	_	0	SENT_451	[p24l722t1327r820b1362],

1	J	NNP	O	J	nn	4	SENT_452	[p24l841t1329r858b1362],
2	Am	NNP	O	Am	nn	4	SENT_452	[p24l878t1329r944b1362],
3	Coll	NNP	PERSON	Coll	nn	4	SENT_452	[p24l968t1327r1049b1362],
4	Cardiol	NNP	PERSON	Cardiol	_	0	SENT_452	[p24l35t1378r186b1413],
5	.	.	O	.	_	0	SENT_452	[p24l35t1378r186b1413],

1	2011	CD	DATE	2011	_	0	SENT_453	[p24l204t1380r296b1413],
2	;	:	O	;	_	0	SENT_453	[p24l309t1379r690b1419],
3	58	CD	NUMBER	58	number	4	SENT_453	[p24l309t1379r690b1419],
4	(	CD	NUMBER	(	dep	1	SENT_453	[p24l309t1379r690b1419],
5	19	CD	NUMBER	19	num	6	SENT_453	[p24l309t1379r690b1419],
6	)	NN	O	)	dep	4	SENT_453	[p24l309t1379r690b1419],
7	:1945	CD	DURATION	:1945	num	8	SENT_453	[p24l309t1379r690b1419],
8	-1954	CD	DURATION	-1954	dep	4	SENT_453	[p24l309t1379r690b1419],
9	.	.	O	.	_	0	SENT_453	[p24l309t1379r690b1419],

1	13	CD	NUMBER	13	_	0	SENT_454	[p24l35t1433r93b1466],
2	.	.	O	.	_	0	SENT_454	[p24l35t1433r93b1466],

1	Price	NNP	O	Price	nn	2	SENT_455	[p24l123t1433r209b1466],
2	MJ	NNP	O	MJ	_	0	SENT_455	[p24l224t1433r289b1472],
3	,	,	O	,	_	0	SENT_455	[p24l224t1433r289b1472],
4	Angiolillo	NNP	O	Angiolillo	nn	5	SENT_455	[p24l304t1430r479b1476],
5	DJ	NNP	O	DJ	appos	2	SENT_455	[p24l496t1433r549b1472],
6	,	,	O	,	_	0	SENT_455	[p24l496t1433r549b1472],
7	Teirstein	NNP	PERSON	Teirstein	nn	8	SENT_455	[p24l564t1433r720b1466],
8	PS	NNP	O	PS	appos	2	SENT_455	[p24l739t1432r791b1472],
9	,	,	O	,	_	0	SENT_455	[p24l739t1432r791b1472],
10	et	FW	O	et	nn	11	SENT_455	[p24l808t1433r844b1466],
11	al.	FW	O	al.	appos	2	SENT_455	[p24l857t1430r896b1466],
12	.	.	O	.	_	0	SENT_455	[p24l857t1430r896b1466],

1	Platelet	NN	O	platelet	nn	2	SENT_456	[p24l915t1430r1052b1466],
2	reactivity	NN	O	reactivity	_	0	SENT_456	[p24l36t1484r218b1526],
3	and	CC	O	and	_	0	SENT_456	[p24l239t1481r310b1516],
4	cardiovascular	JJ	O	cardiovascular	amod	5	SENT_456	[p24l332t1481r621b1516],
5	outcomes	NNS	O	outcome	conj_and	2	SENT_456	[p24l640t1484r835b1516],
6	after	IN	O	after	_	0	SENT_456	[p24l856t1481r950b1516],
7	percutaneous	JJ	O	percutaneous	amod	9	SENT_456	[p24l970t1492r1048b1527, p24l34t1535r231b1567],
8	coronary	JJ	O	coronary	amod	9	SENT_456	[p24l250t1543r419b1577],
9	intervention	NN	O	intervention	prep_after	5	SENT_456	[p24l439t1535r679b1567],
10	:	:	O	:	_	0	SENT_456	[p24l439t1535r679b1567],
11	a	DT	O	a	det	13	SENT_456	[p24l701t1543r722b1567],
12	time-dependent	JJ	O	time-dependent	amod	13	SENT_456	[p24l738t1532r1051b1578],
13	analysis	NN	O	analysis	dep	2	SENT_456	[p24l34t1584r178b1629],
14	of	IN	O	of	_	0	SENT_456	[p24l196t1583r235b1619],
15	the	DT	O	the	det	17	SENT_456	[p24l250t1584r311b1619],
16	Gauging	NNP	O	Gauging	nn	17	SENT_456	[p24l329t1586r492b1629],
17	Responsiveness	NN	O	responsiveness	prep_of	13	SENT_456	[p24l511t1586r802b1629],
18	with	IN	O	with	_	0	SENT_456	[p24l820t1584r900b1619],
19	a	DT	O	a	det	22	SENT_456	[p24l920t1594r941b1619],
20	VerifyNow	NNP	O	VerifyNow	nn	22	SENT_456	[p24l957t1586r1048b1619, p24l34t1634r161b1679],
21	P2Y12	NN	O	p2y12	nn	22	SENT_456	[p24l174t1636r294b1669],
22	assay	NN	O	assay	prep_with	17	SENT_456	[p24l307t1645r415b1679],
23	:	:	O	:	_	0	SENT_456	[p24l307t1645r415b1679],
24	Impact	NN	O	impact	dep	2	SENT_456	[p24l431t1637r559b1680],
25	on	IN	O	on	_	0	SENT_456	[p24l568t1645r614b1669],
26	Thrombosis	NN	O	thrombosis	prep_on	24	SENT_456	[p24l626t1634r844b1669],
27	and	CC	O	and	_	0	SENT_456	[p24l855t1634r923b1669],
28	Safety	NN	O	safety	nn	30	SENT_456	[p24l936t1634r1051b1679],
29	(	CD	NUMBER	(	num	30	SENT_456	[p24l36t1687r275b1726],
30	GRAVITAS	NN	O	gravitas	conj_and	24	SENT_456	[p24l36t1687r275b1726],
31	)	CD	NUMBER	)	num	32	SENT_456	[p24l36t1687r275b1726],
32	trial	NN	O	trial	dep	30	SENT_456	[p24l295t1686r377b1721],
33	.	.	O	.	_	0	SENT_456	[p24l295t1686r377b1721],

1	Circulation	NN	O	circulation	_	0	SENT_457	[p24l400t1686r626b1721],
2	.	.	O	.	_	0	SENT_457	[p24l400t1686r626b1721],

1	2011	CD	DATE	2011	_	0	SENT_458	[p24l648t1687r1046b1727, p24l35t1793r91b1824],
2	;	:	O	;	_	0	SENT_458	[p24l648t1687r1046b1727, p24l35t1793r91b1824],
3	124	CD	NUMBER	124	number	4	SENT_458	[p24l648t1687r1046b1727, p24l35t1793r91b1824],
4	(	CD	NUMBER	(	dep	1	SENT_458	[p24l648t1687r1046b1727, p24l35t1793r91b1824],
5	10	CD	NUMBER	10	num	6	SENT_458	[p24l648t1687r1046b1727, p24l35t1793r91b1824],
6	)	NN	O	)	dep	4	SENT_458	[p24l648t1687r1046b1727, p24l35t1793r91b1824],
7	:113214	CD	NUMBER	:113214	dep	4	SENT_458	[p24l648t1687r1046b1727, p24l35t1793r91b1824],
8	.	.	O	.	_	0	SENT_458	[p24l648t1687r1046b1727, p24l35t1793r91b1824],

1	Guidance	NN	O	guidance	_	0	SENT_459	[p24l116t1790r294b1825],
2	for	IN	O	for	_	0	SENT_459	[p24l304t1789r359b1825],
3	industry	NN	O	industry	prep_for	1	SENT_459	[p24l370t1790r528b1835],
4	:	:	O	:	_	0	SENT_459	[p24l370t1790r528b1835],
5	statistical	JJ	O	statistical	amod	6	SENT_459	[p24l542t1790r709b1825],
6	approaches	NNS	O	approach	dep	1	SENT_459	[p24l722t1790r937b1835],
7	to	TO	O	to	_	0	SENT_459	[p24l948t1793r985b1825],
8	establishing	VBG	O	establish	prepc_to	6	SENT_459	[p24l997t1800r1049b1825, p24l34t1840r219b1885],
9	bioequivalence	NN	O	bioequivalence	dobj	8	SENT_459	[p24l232t1840r528b1886],
10	.	.	O	.	_	0	SENT_459	[p24l232t1840r528b1886],

1	US	NNP	ORGANIZATION	US	_	0	SENT_460	[p24l545t1842r595b1875],
2	Food	NNP	ORGANIZATION	Food	nn	6	SENT_460	[p24l610t1840r702b1875],
3	and	CC	ORGANIZATION	and	_	0	SENT_460	[p24l716t1840r785b1875],
4	Drug	NNP	ORGANIZATION	Drug	nn	6	SENT_460	[p24l801t1843r896b1885],
5	Administration	NNP	ORGANIZATION	Administration	nn	6	SENT_460	[p24l906t1840r1049b1875, p24l36t1894r185b1927],
6	site	NN	O	site	dep	1	SENT_460	[p24l199t1894r271b1927],
7	.	.	O	.	_	0	SENT_460	[p24l199t1894r271b1927],

1	http://www.fda.gov/down	JJ	O	http://www.fda.gov/down	amod	3	SENT_461	[p24l288t1891r935b1937],
2	|	NN	O	|	nn	3	SENT_461	[p24l288t1891r935b1937],
3	oads	NNS	O	oad	_	0	SENT_461	[p24l288t1891r935b1937],
4	/	:	O	/	punct	5	SENT_461	[p24l288t1891r935b1937],
5	Drugs	NNS	O	drug	dep	3	SENT_461	[p24l940t1894r1051b1937],
6	/	:	O	/	punct	5	SENT_461	[p24l35t1942r1048b1988],
7	GuidanceComp	NNP	O	GuidanceComp	dep	10	SENT_461	[p24l35t1942r1048b1988],
8	|	CD	NUMBER	|	dep	7	SENT_461	[p24l35t1942r1048b1988],
9	ianceRegu	NNP	O	ianceRegu	dep	10	SENT_461	[p24l35t1942r1048b1988],
10	|	CD	NUMBER	|	dep	13	SENT_461	[p24l35t1942r1048b1988],
11	atoryInformation	NN	O	atoryinformation	dep	10	SENT_461	[p24l35t1942r1048b1988],
12	/	:	O	/	punct	13	SENT_461	[p24l34t1993r600b2039],
13	Guidances/ucm070244	NN	O	guidances/ucm070244	dep	5	SENT_461	[p24l34t1993r600b2039],
14	.	.	O	.	_	0	SENT_461	[p24l34t1993r600b2039],

1	pdf	NN	O	pdf	_	0	SENT_462	[p24l34t1993r600b2039],
2	.	.	O	.	_	0	SENT_462	[p24l34t1993r600b2039],

1	Accessed	VBN	O	access	_	0	SENT_463	[p24l619t1994r793b2029],
2	October	NNP	DATE	October	tmod	1	SENT_463	[p24l813t1994r974b2029],
3	28	CD	DATE	28	num	2	SENT_463	[p24l989t1996r1049b2035],
4	,	,	DATE	,	_	0	SENT_463	[p24l989t1996r1049b2035],
5	2011	CD	DATE	2011	num	2	SENT_463	[p24l34t2047r143b2079],
6	.	.	O	.	_	0	SENT_463	[p24l34t2047r143b2079],

1	15	CD	NUMBER	15	_	0	SENT_464	[p24l35t2098r93b2130],
2	.	.	O	.	_	0	SENT_464	[p24l35t2098r93b2130],

1	Aleil	NN	O	aleil	nn	2	SENT_465	[p24l120t2095r200b2130],
2	B	NN	O	b	_	0	SENT_465	[p24l217t2097r249b2136],
3	,	,	O	,	_	0	SENT_465	[p24l217t2097r249b2136],
4	Jacquemin	NNP	PERSON	Jacquemin	nn	5	SENT_465	[p24l263t2097r465b2141],
5	L	NNP	O	L	appos	2	SENT_465	[p24l483t2097r511b2136],
6	,	,	O	,	_	0	SENT_465	[p24l483t2097r511b2136],
7	De	NNP	O	De	nn	9	SENT_465	[p24l529t2097r580b2130],
8	Poli	NNP	O	Poli	nn	9	SENT_465	[p24l596t2095r660b2130],
9	F	NN	O	f	appos	2	SENT_465	[p24l678t2097r706b2136],
10	,	,	O	,	_	0	SENT_465	[p24l678t2097r706b2136],
11	et	FW	O	et	nn	12	SENT_465	[p24l722t2098r759b2130],
12	al.	FW	O	al.	appos	2	SENT_465	[p24l771t2095r811b2130],
13	.	.	O	.	_	0	SENT_465	[p24l771t2095r811b2130],

1	Clopidogrel	NN	O	clopidogrel	nn	3	SENT_466	[p24l828t2095r1049b2141],
2	150	CD	NUMBER	150	num	3	SENT_466	[p24l36t2149r108b2181],
3	mg/day	NN	O	mg/day	_	0	SENT_466	[p24l125t2146r276b2191],
4	to	TO	O	to	aux	5	SENT_466	[p24l291t2149r329b2181],
5	overcome	VB	O	overcome	infmod	3	SENT_466	[p24l346t2157r535b2181],
6	low	JJ	O	low	amod	7	SENT_466	[p24l553t2146r620b2181],
7	responsiveness	NN	O	responsiveness	dobj	5	SENT_466	[p24l638t2149r923b2192],
8	in	IN	O	in	_	0	SENT_466	[p24l940t2149r969b2181],
9	patients	NNS	O	patient	prep_in	5	SENT_466	[p24l989t2157r1049b2192, p24l34t2199r138b2232],
10	undergoing	VBG	O	undergo	partmod	9	SENT_466	[p24l153t2197r375b2242],
11	elective	JJ	O	elective	amod	14	SENT_466	[p24l387t2197r531b2232],
12	percutaneous	JJ	O	percutaneous	amod	14	SENT_466	[p24l545t2200r805b2243],
13	coronary	JJ	O	coronary	amod	14	SENT_466	[p24l818t2208r988b2242],
14	intervention	NN	O	intervention	dobj	10	SENT_466	[p24l1001t2199r1049b2231, p24l34t2252r245b2285],
15	:	:	O	:	_	0	SENT_466	[p24l1001t2199r1049b2231, p24l34t2252r245b2285],
16	results	NNS	O	result	dep	14	SENT_466	[p24l268t2249r390b2285],
17	from	IN	O	from	dep	19	SENT_466	[p24l408t2249r499b2285],
18	the	DT	O	the	det	19	SENT_466	[p24l519t2249r581b2285],
19	VASP-02	NN	O	vasp-02	dep	21	SENT_466	[p24l600t2251r775b2285],
20	(	CD	NUMBER	(	num	21	SENT_466	[p24l797t2249r1049b2290, p24l35t2300r242b2335],
21	Vasodi	NNP	O	Vasodi	dep	3	SENT_466	[p24l797t2249r1049b2290, p24l35t2300r242b2335],
22	|	CD	NUMBER	|	num	21	SENT_466	[p24l797t2249r1049b2290, p24l35t2300r242b2335],
23	atorStimulated	VBN	O	atorstimulate	partmod	21	SENT_466	[p24l797t2249r1049b2290, p24l35t2300r242b2335],

1	Phosphoprotein-02	NN	O	phosphoprotein-02	nsubj	3	SENT_467	[p24l265t2300r659b2346],
2	)	CD	NUMBER	)	num	1	SENT_467	[p24l265t2300r659b2346],
3	randomized	VBN	O	randomize	_	0	SENT_467	[p24l682t2300r910b2335],
4	study	NN	O	study	dobj	3	SENT_467	[p24l932t2300r1048b2345],
5	.	.	O	.	_	0	SENT_467	[p24l932t2300r1048b2345],

1	JACC	NNP	O	JACC	nn	3	SENT_468	[p24l32t2353r142b2386],
2	Cardiovasc	NNP	O	Cardiovasc	nn	3	SENT_468	[p24l157t2352r371b2386],
3	Interv	NNP	O	Interv	_	0	SENT_468	[p24l385t2354r506b2386],
4	.	.	O	.	_	0	SENT_468	[p24l385t2354r506b2386],

1	2008	CD	DATE	2008	_	0	SENT_469	[p24l524t2353r910b2392],
2	;	:	O	;	_	0	SENT_469	[p24l524t2353r910b2392],
3	1	CD	NUMBER	1	number	4	SENT_469	[p24l524t2353r910b2392],
4	(	CD	NUMBER	(	dep	1	SENT_469	[p24l524t2353r910b2392],
5	6	CD	NUMBER	6	num	6	SENT_469	[p24l524t2353r910b2392],
6	)	NN	O	)	dep	4	SENT_469	[p24l524t2353r910b2392],
7	:631	CD	NUMBER	:631	num	8	SENT_469	[p24l524t2353r910b2392],
8	-638	CD	NUMBER	-638	dep	4	SENT_469	[p24l524t2353r910b2392],
9	.	.	O	.	_	0	SENT_469	[p24l524t2353r910b2392],

1	16	CD	NUMBER	16	_	0	SENT_470	[p24l35t2406r93b2439],
2	.	.	O	.	_	0	SENT_470	[p24l35t2406r93b2439],

1	Simon	NNP	PERSON	Simon	nn	2	SENT_471	[p24l121t2405r238b2439],
2	T	NN	PERSON	t	_	0	SENT_471	[p24l253t2405r288b2445],
3	,	,	O	,	_	0	SENT_471	[p24l253t2405r288b2445],
4	Bhatt	NNP	ORGANIZATION	Bhatt	nn	5	SENT_471	[p24l306t2403r406b2439],
5	DL	NNP	ORGANIZATION	DL	appos	2	SENT_471	[p24l421t2406r483b2445],
6	,	,	O	,	_	0	SENT_471	[p24l421t2406r483b2445],
7	Bergougnan	NNP	PERSON	Bergougnan	nn	8	SENT_471	[p24l502t2406r733b2449],
8	L	NNP	PERSON	L	appos	2	SENT_471	[p24l752t2405r780b2445],
9	,	,	O	,	_	0	SENT_471	[p24l752t2405r780b2445],
10	et	FW	O	et	nn	11	SENT_471	[p24l797t2406r833b2439],
11	al.	FW	O	al.	appos	2	SENT_471	[p24l846t2403r886b2439],
12	.	.	O	.	_	0	SENT_471	[p24l846t2403r886b2439],

1	Genetic	JJ	O	genetic	amod	2	SENT_472	[p24l904t2405r1051b2439],
2	polymorphisms	NNS	O	polymorphism	_	0	SENT_472	[p24l36t2454r329b2500],
3	and	CC	O	and	_	0	SENT_472	[p24l347t2454r416b2489],
4	the	DT	O	the	det	5	SENT_472	[p24l434t2454r495b2489],
5	impact	NN	O	impact	conj_and	2	SENT_472	[p24l515t2457r644b2500],
6	of	IN	O	of	_	0	SENT_472	[p24l661t2454r700b2489],
7	a	DT	O	a	det	11	SENT_472	[p24l716t2465r737b2489],
8	higher	JJR	O	higher	amod	11	SENT_472	[p24l756t2454r877b2499],
9	clopidogrel	NN	O	clopidogrel	nn	11	SENT_472	[p24l893t2454r1049b2500, p24l34t2505r103b2550],
10	dose	NN	O	dose	nn	11	SENT_472	[p24l118t2505r206b2540],
11	regimen	NN	O	regimen	prep_of	2	SENT_472	[p24l221t2508r374b2550],
12	on	IN	O	on	_	0	SENT_472	[p24l389t2516r435b2540],
13	active	JJ	O	active	amod	15	SENT_472	[p24l450t2508r561b2540],
14	metabolite	NN	O	metabolite	nn	15	SENT_472	[p24l575t2505r779b2540],
15	exposure	NN	O	exposure	prep_on	2	SENT_472	[p24l792t2516r967b2551],
16	and	CC	O	and	_	0	SENT_472	[p24l980t2505r1048b2540],
17	antiplatelet	JJ	O	antiplatelet	amod	18	SENT_472	[p24l34t2557r251b2603],
18	response	NN	O	response	conj_and	15	SENT_472	[p24l270t2568r438b2603],
19	in	IN	O	in	_	0	SENT_472	[p24l457t2559r487b2592],
20	healthy	JJ	O	healthy	amod	21	SENT_472	[p24l509t2557r649b2603],
21	subjects	NNS	O	subject	prep_in	2	SENT_472	[p24l667t2557r829b2602],
22	.	.	O	.	_	0	SENT_472	[p24l667t2557r829b2602],

1	C/in	NNP	O	C/in	nn	3	SENT_473	[p24l851t2557r927b2592],
2	Pharmacol	NNP	O	Pharmacol	nn	3	SENT_473	[p24l946t2557r1048b2592, p24l33t2608r152b2643],
3	Ther	NNP	O	Ther	_	0	SENT_473	[p24l169t2608r262b2643],
4	.	.	O	.	_	0	SENT_473	[p24l169t2608r262b2643],

1	2011	CD	DATE	2011	_	0	SENT_474	[p24l280t2611r372b2643],
2	;	:	O	;	_	0	SENT_474	[p24l385t2609r692b2649],
3	90	CD	NUMBER	90	num	4	SENT_474	[p24l385t2609r692b2649],
4	(	NN	O	(	dep	1	SENT_474	[p24l385t2609r692b2649],
5	2	CD	NUMBER	2	number	6	SENT_474	[p24l385t2609r692b2649],
6	)	CD	NUMBER	)	dep	4	SENT_474	[p24l385t2609r692b2649],
7	:287	CD	NUMBER	:287	num	8	SENT_474	[p24l385t2609r692b2649],
8	-295	CD	NUMBER	-295	dep	6	SENT_474	[p24l385t2609r692b2649],
9	.	.	O	.	_	0	SENT_474	[p24l385t2609r692b2649],

1	17	CD	NUMBER	17	_	0	SENT_475	[p24l35t2663r93b2695],
2	.	.	O	.	_	0	SENT_475	[p24l35t2663r93b2695],

1	Pena	NNP	PERSON	Pena	nn	2	SENT_476	[p24l123t2662r216b2695],
2	A	NNP	O	A	_	0	SENT_476	[p24l230t2662r270b2701],
3	,	,	O	,	_	0	SENT_476	[p24l230t2662r270b2701],
4	Collet	NNP	ORGANIZATION	Collet	nn	5	SENT_476	[p24l289t2660r401b2695],
5	JP	NNP	ORGANIZATION	JP	appos	2	SENT_476	[p24l415t2662r465b2701],
6	,	,	O	,	_	0	SENT_476	[p24l415t2662r465b2701],
7	Hulot	NNP	PERSON	Hulot	nn	8	SENT_476	[p24l486t2660r592b2695],
8	JS	NNP	O	JS	appos	2	SENT_476	[p24l606t2662r653b2701],
9	,	,	O	,	_	0	SENT_476	[p24l606t2662r653b2701],
10	et	FW	O	et	nn	11	SENT_476	[p24l672t2663r709b2695],
11	al.	FW	O	al.	appos	2	SENT_476	[p24l724t2660r764b2695],
12	.	.	O	.	_	0	SENT_476	[p24l724t2660r764b2695],

1	Can	MD	O	can	aux	3	SENT_477	[p24l784t2662r858b2695],
2	we	PRP	O	we	nsubj	3	SENT_477	[p24l876t2671r932b2695],
3	override	VB	O	override	_	0	SENT_477	[p24l949t2671r1048b2695, p24l36t2711r107b2746],

1	clopidogrel	NN	O	clopidogrel	nn	2	SENT_478	[p24l127t2711r344b2757],
2	resistance	NN	O	resistance	_	0	SENT_478	[p24l367t2713r581b2746],
3	?	.	O	?	_	0	SENT_478	[p24l367t2713r581b2746],

1	Circulation	NN	O	circulation	_	0	SENT_479	[p24l603t2711r834b2746],
2	.	.	O	.	_	0	SENT_479	[p24l603t2711r834b2746],

1	2009	CD	DATE	2009	_	0	SENT_480	[p24l856t2714r1048b2752],
2	;	:	O	;	_	0	SENT_480	[p24l856t2714r1048b2752],
3	119	CD	NUMBER	119	number	4	SENT_480	[p24l856t2714r1048b2752],
4	(	CD	NUMBER	(	dep	1	SENT_480	[p24l36t2764r355b2803],
5	21	CD	NUMBER	21	num	6	SENT_480	[p24l36t2764r355b2803],
6	)	NN	O	)	dep	4	SENT_480	[p24l36t2764r355b2803],
7	:2854	CD	DURATION	:2854	num	8	SENT_480	[p24l36t2764r355b2803],
8	-2857	CD	DURATION	-2857	dep	4	SENT_480	[p24l36t2764r355b2803],
9	.	.	O	.	_	0	SENT_480	[p24l36t2764r355b2803],

1	18	CD	NUMBER	18	_	0	SENT_481	[p24l35t2818r93b2851],
2	.	.	O	.	_	0	SENT_481	[p24l35t2818r93b2851],

1	Barker	NNP	PERSON	Barker	nn	2	SENT_482	[p24l122t2815r242b2851],
2	CM	NN	O	cm	_	0	SENT_482	[p24l253t2817r333b2857],
3	,	,	O	,	_	0	SENT_482	[p24l253t2817r333b2857],
4	Murray	NNP	PERSON	Murray	nn	5	SENT_482	[p24l348t2818r489b2861],
5	SS	NNP	O	SS	appos	2	SENT_482	[p24l501t2817r553b2857],
6	,	,	O	,	_	0	SENT_482	[p24l501t2817r553b2857],
7	Teirstein	NNP	ORGANIZATION	Teirstein	nn	8	SENT_482	[p24l566t2818r726b2851],
8	PS	NNP	ORGANIZATION	PS	appos	5	SENT_482	[p24l742t2817r796b2857],
9	,	,	O	,	_	0	SENT_482	[p24l742t2817r796b2857],
10	Kandzari	NNP	ORGANIZATION	Kandzari	nn	11	SENT_482	[p24l812t2815r974b2851],
11	DE	NN	ORGANIZATION	de	appos	5	SENT_482	[p24l989t2818r1051b2857],
12	,	,	O	,	_	0	SENT_482	[p24l989t2818r1051b2857],
13	Topol	NNP	ORGANIZATION	Topol	nn	14	SENT_482	[p24l33t2867r142b2912],
14	EJ	NNP	ORGANIZATION	EJ	appos	5	SENT_482	[p24l162t2869r205b2908],
15	,	,	O	,	_	0	SENT_482	[p24l162t2869r205b2908],
16	Price	NNP	O	Price	nn	17	SENT_482	[p24l226t2869r314b2902],
17	MJ	NNP	O	MJ	appos	5	SENT_482	[p24l331t2869r396b2902],
18	.	.	O	.	_	0	SENT_482	[p24l331t2869r396b2902],

1	Pilot	NN	O	pilot	nn	2	SENT_483	[p24l417t2867r500b2902],
2	study	NN	O	study	_	0	SENT_483	[p24l515t2867r619b2912],
3	of	IN	O	of	_	0	SENT_483	[p24l635t2866r674b2902],
4	the	DT	O	the	det	6	SENT_483	[p24l688t2867r749b2902],
5	antiplatelet	JJ	O	antiplatelet	amod	6	SENT_483	[p24l766t2867r983b2912],
6	effect	NN	O	effect	prep_of	2	SENT_483	[p24l997t2866r1049b2902, p24l34t2917r106b2953],
7	of	IN	O	of	_	0	SENT_483	[p24l117t2917r156b2953],
8	increased	VBN	O	increase	amod	11	SENT_483	[p24l168t2918r344b2953],
9	clopidogrel	NN	O	clopidogrel	nn	11	SENT_483	[p24l358t2918r569b2964],
10	maintenance	NN	O	maintenance	nn	11	SENT_483	[p24l584t2920r830b2953],
11	dosing	NN	O	dosing	prep_of	6	SENT_483	[p24l842t2918r970b2963],
12	and	CC	O	and	_	0	SENT_483	[p24l981t2918r1049b2953],
13	its	PRP$	O	its	poss	14	SENT_483	[p24l36t2971r74b3003],
14	relationship	NN	O	relationship	prep_of	6	SENT_483	[p24l88t2968r307b3014],
15	to	TO	O	to	_	0	SENT_483	[p24l319t2971r357b3003],
16	C	NN	O	c	nn	18	SENT_483	[p24l370t2970r398b3003],
17	YP2C19	NN	O	yp2c19	nn	18	SENT_483	[p24l402t2970r555b3003],
18	genotype	NN	O	genotype	prep_to	14	SENT_483	[p24l568t2971r748b3014],
19	in	IN	O	in	_	0	SENT_483	[p24l762t2971r791b3003],
20	patients	NNS	O	patient	prep_in	18	SENT_483	[p24l807t2971r956b3014],
21	with	IN	O	with	_	0	SENT_483	[p24l968t2968r1049b3003],
22	high	JJ	O	high	amod	24	SENT_483	[p24l36t3020r115b3066],
23	on-treatment	JJ	O	on-treatment	amod	24	SENT_483	[p24l129t3023r385b3056],
24	reactivity	NN	O	reactivity	prep_with	20	SENT_483	[p24l397t3023r576b3066],
25	.	.	O	.	_	0	SENT_483	[p24l397t3023r576b3066],

1	JACC	NNP	O	JACC	nn	3	SENT_484	[p24l588t3022r697b3056],
2	Cardiovasc	NNP	O	Cardiovasc	nn	3	SENT_484	[p24l709t3020r919b3056],
3	Interv	NNP	O	Interv	_	0	SENT_484	[p24l929t3022r1048b3056],
4	.	.	O	.	_	0	SENT_484	[p24l929t3022r1048b3056],

1	2010	CD	DATE	2010	_	0	SENT_485	[p24l34t3073r493b3113],
2	;	:	O	;	_	0	SENT_485	[p24l34t3073r493b3113],
3	3	CD	NUMBER	3	num	4	SENT_485	[p24l34t3073r493b3113],
4	(	NN	O	(	dep	1	SENT_485	[p24l34t3073r493b3113],
5	10	CD	NUMBER	10	number	6	SENT_485	[p24l34t3073r493b3113],
6	)	CD	NUMBER	)	dep	4	SENT_485	[p24l34t3073r493b3113],
7	:1001	CD	DURATION	:1001	num	8	SENT_485	[p24l34t3073r493b3113],
8	-1007	CD	DURATION	-1007	dep	6	SENT_485	[p24l34t3073r493b3113],
9	.	.	O	.	_	0	SENT_485	[p24l34t3073r493b3113],

1	19	CD	NUMBER	19	_	0	SENT_486	[p24l35t3126r93b3158],
2	.	.	O	.	_	0	SENT_486	[p24l35t3126r93b3158],

1	Jeong	NNP	PERSON	Jeong	nn	4	SENT_487	[p24l119t3126r233b3168],
2	YH	NNP	O	YH	nn	4	SENT_487	[p24l248t3125r318b3164],
3	,	,	O	,	_	0	SENT_487	[p24l248t3125r318b3164],
4	Kim	NNP	PERSON	Kim	nsubj	8	SENT_487	[p24l339t3125r409b3158],
5	IS	VBZ	O	be	cop	8	SENT_487	[p24l430t3125r471b3164],
6	,	,	O	,	_	0	SENT_487	[p24l430t3125r471b3164],
7	Park	NNP	O	Park	nn	8	SENT_487	[p24l492t3123r573b3158],
8	Y	NN	O	y	_	0	SENT_487	[p24l590t3125r627b3164],
9	,	,	O	,	_	0	SENT_487	[p24l590t3125r627b3164],
10	et	FW	O	et	nn	11	SENT_487	[p24l646t3126r682b3158],
11	al.	FW	O	al.	appos	8	SENT_487	[p24l698t3123r738b3158],
12	.	.	O	.	_	0	SENT_487	[p24l698t3123r738b3158],

1	Carriage	NN	O	carriage	nsubjpass	7	SENT_488	[p24l758t3125r920b3168],
2	of	IN	O	of	_	0	SENT_488	[p24l937t3123r976b3158],
3	cytochrome	NN	O	cytochrome	nn	5	SENT_488	[p24l992t3134r1048b3168, p24l34t3175r219b3210],
4	2C19	NN	O	2c19	nn	5	SENT_488	[p24l233t3177r336b3210],
5	polymorphism	NN	O	polymorphism	prep_of	1	SENT_488	[p24l352t3175r625b3221],
6	is	VBZ	O	be	auxpass	7	SENT_488	[p24l642t3177r665b3210],
7	associated	VBN	O	associate	_	0	SENT_488	[p24l679t3175r875b3210],
8	with	IN	O	with	_	0	SENT_488	[p24l890t3175r972b3210],
9	risk	NN	O	risk	prep_with	7	SENT_488	[p24l989t3175r1050b3210],
10	of	IN	O	of	_	0	SENT_488	[p24l34t3226r73b3261],
11	high	JJ	O	high	amod	14	SENT_488	[p24l84t3226r161b3271],
12	post-treatment	JJ	O	post-treatment	amod	14	SENT_488	[p24l176t3229r457b3272],
13	platelet	NN	O	platelet	nn	14	SENT_488	[p24l468t3226r604b3272],
14	reactivity	NN	O	reactivity	prep_of	9	SENT_488	[p24l615t3229r782b3271],
15	on	IN	O	on	_	0	SENT_488	[p24l792t3237r837b3261],
16	high	JJ	O	high	amod	18	SENT_488	[p24l852t3226r930b3271],
17	maintenance-dose	JJ	O	maintenance-dose	amod	18	SENT_488	[p24l944t3229r1049b3261, p24l34t3278r295b3313],
18	clopidogrel	NN	O	clopidogrel	prep_on	14	SENT_488	[p24l313t3278r525b3323],
19	of	IN	O	of	_	0	SENT_488	[p24l544t3277r584b3313],
20	150	CD	NUMBER	150	num	21	SENT_488	[p24l602t3280r673b3312],
21	mg/day	NN	O	mg/day	prep_of	18	SENT_488	[p24l692t3278r853b3323],
22	:	:	O	:	_	0	SENT_488	[p24l692t3278r853b3323],
23	results	NNS	O	result	dep	18	SENT_488	[p24l875t3278r995b3313],
24	of	IN	O	of	_	0	SENT_488	[p24l1013t3277r1052b3313],
25	the	DT	O	the	det	30	SENT_488	[p24l34t3328r95b3363],
26	ACCEL-DOUBLE	NN	O	accel-double	nn	30	SENT_488	[p24l110t3330r437b3363],
27	(	CD	NUMBER	(	num	30	SENT_488	[p24l455t3328r693b3368],
28	Accelerated	NNP	O	Accelerated	nn	30	SENT_488	[p24l455t3328r693b3368],
29	Platelet	NN	O	platelet	nn	30	SENT_488	[p24l712t3328r854b3363],
30	Inhibition	NN	O	inhibition	prep_of	23	SENT_488	[p24l870t3328r1048b3363],
31	by	IN	O	by	_	0	SENT_488	[p24l36t3380r80b3425],
32	a	DT	O	a	det	34	SENT_488	[p24l95t3390r116b3415],
33	Double	JJ	O	double	amod	34	SENT_488	[p24l132t3380r269b3415],
34	Dose	NN	O	dose	prep_by	30	SENT_488	[p24l286t3382r380b3415],
35	of	IN	O	of	_	0	SENT_488	[p24l395t3379r434b3415],
36	Clopidogrel	NNP	O	Clopidogrel	prep_of	34	SENT_488	[p24l449t3380r670b3425],
37	According	VBG	O	accord	_	0	SENT_488	[p24l685t3380r882b3425],
38	to	TO	O	to	prepc_according_to	7	SENT_488	[p24l896t3383r934b3415],
39	Gene	NNP	O	Gene	pobj	7	SENT_488	[p24l950t3382r1050b3415],
40	Polymorphism	NN	O	polymorphism	nn	42	SENT_488	[p24l36t3430r323b3476],
41	)	NN	O	)	nn	42	SENT_488	[p24l36t3430r323b3476],
42	study	NN	O	study	dep	39	SENT_488	[p24l336t3430r449b3475],
43	.	.	O	.	_	0	SENT_488	[p24l336t3430r449b3475],

1	JACC	NNP	O	JACC	nn	3	SENT_489	[p24l461t3432r571b3465],
2	Cardiovasc	NNP	O	Cardiovasc	nn	3	SENT_489	[p24l583t3430r795b3465],
3	Interv	NNP	O	Interv	_	0	SENT_489	[p24l805t3433r926b3465],
4	.	.	O	.	_	0	SENT_489	[p24l805t3433r926b3465],

1	2010	CD	DATE	2010	_	0	SENT_490	[p24l940t3433r1049b3471],
2	;	:	O	;	_	0	SENT_490	[p24l940t3433r1049b3471],
3	3	CD	NUMBER	3	num	4	SENT_490	[p24l34t3482r306b3521],
4	(	NN	O	(	dep	1	SENT_490	[p24l34t3482r306b3521],
5	7	CD	NUMBER	7	num	6	SENT_490	[p24l34t3482r306b3521],
6	)	NN	O	)	dep	4	SENT_490	[p24l34t3482r306b3521],
7	:731	CD	NUMBER	:731	num	8	SENT_490	[p24l34t3482r306b3521],
8	-741	CD	NUMBER	-741	dep	4	SENT_490	[p24l34t3482r306b3521],
9	.	.	O	.	_	0	SENT_490	[p24l34t3482r306b3521],

1	20	CD	NUMBER	20	_	0	SENT_491	[p24l33t3535r91b3567],
2	.	.	O	.	_	0	SENT_491	[p24l33t3535r91b3567],

1	Alexopoulos	NNP	PERSON	Alexopoulos	nn	2	SENT_492	[p24l115t3532r344b3578],
2	D	NNP	O	D	_	0	SENT_492	[p24l357t3535r394b3573],
3	,	,	O	,	_	0	SENT_492	[p24l357t3535r394b3573],
4	Dimitropoulos	NNP	PERSON	Dimitropoulos	nn	5	SENT_492	[p24l409t3532r668b3578],
5	G	NNP	PERSON	G	appos	2	SENT_492	[p24l679t3534r718b3573],
6	,	,	O	,	_	0	SENT_492	[p24l679t3534r718b3573],
7	Davlouros	NNP	PERSON	Davlouros	nn	8	SENT_492	[p24l732t3532r917b3567],
8	P	NN	PERSON	p	appos	2	SENT_492	[p24l929t3535r960b3573],
9	,	,	O	,	_	0	SENT_492	[p24l929t3535r960b3573],
10	et	FW	O	et	nn	11	SENT_492	[p24l972t3535r1007b3567],
11	al.	FW	O	al.	appos	2	SENT_492	[p24l1016t3532r1054b3567],
12	.	.	O	.	_	0	SENT_492	[p24l1016t3532r1054b3567],

1	Prasugrel	NNP	O	Prasugrel	nsubj	2	SENT_493	[p24l36t3584r210b3630],
2	overcomes	VBZ	O	overcome	_	0	SENT_493	[p24l226t3595r434b3619],
3	high	JJ	O	high	amod	6	SENT_493	[p24l450t3584r530b3630],
4	on-clopidogrel	JJ	O	on-clopidogrel	amod	6	SENT_493	[p24l546t3584r826b3630],
5	platelet	NN	O	platelet	nn	6	SENT_493	[p24l843t3584r985b3630],
6	reactivity	NN	O	reactivity	dobj	2	SENT_493	[p24l999t3595r1049b3619, p24l34t3638r178b3680],
7	post-stenting	VBG	O	post-stent	partmod	6	SENT_493	[p24l200t3638r467b3681],
8	more	RBR	O	more	advmod	9	SENT_493	[p24l487t3646r587b3670],
9	effectively	RB	O	effectively	advmod	7	SENT_493	[p24l608t3635r815b3680],
10	than	IN	O	than	_	0	SENT_493	[p24l835t3635r922b3670],
11	highdose	JJ	O	highdose	amod	15	SENT_493	[p24l947t3635r1048b3680, p24l34t3687r130b3722],
12	(	NN	O	(	nn	15	SENT_493	[p24l155t3688r355b3732],
13	150-mg	JJ	O	150-mg	amod	15	SENT_493	[p24l155t3688r355b3732],
14	)	NN	O	)	nn	15	SENT_493	[p24l155t3688r355b3732],
15	clopidogrel	NN	O	clopidogrel	prep_than	7	SENT_493	[p24l380t3686r630b3732],
16	:	:	O	:	_	0	SENT_493	[p24l380t3686r630b3732],
17	the	DT	O	the	det	18	SENT_493	[p24l656t3686r722b3722],
18	importance	NN	O	importance	dep	6	SENT_493	[p24l747t3689r986b3732],
19	of	IN	O	of	_	0	SENT_493	[p24l1010t3686r1051b3722],
20	CYP2C79	NN	O	cyp2c79	nn	21	SENT_493	[p24l35t3738r274b3772],
21	*	NN	O	*	prep_of	18	SENT_493	[p24l35t3738r274b3772],
22	2	CD	NUMBER	2	num	23	SENT_493	[p24l35t3738r274b3772],
23	genotyping	NN	O	genotyping	dep	18	SENT_493	[p24l295t3740r532b3783],
24	.	.	O	.	_	0	SENT_493	[p24l295t3740r532b3783],

1	JACC	NNP	O	JACC	nn	3	SENT_494	[p24l552t3739r664b3772],
2	Cardiovasc	NNP	O	Cardiovasc	nn	3	SENT_494	[p24l684t3738r903b3772],
3	Interv	NNP	O	Interv	_	0	SENT_494	[p24l921t3740r1046b3772],
4	.	.	O	.	_	0	SENT_494	[p24l921t3740r1046b3772],

1	tions	NNS	O	tion	_	0	SENT_495	[p24l1130t1021r1222b1054],
2	and	CC	O	and	_	0	SENT_495	[p24l1240t1019r1308b1054],
3	practical	JJ	O	practical	amod	4	SENT_495	[p24l1329t1019r1486b1065],
4	considerations	NNS	O	consideration	conj_and	1	SENT_495	[p24l1504t1019r1791b1054],
5	.	.	O	.	_	0	SENT_495	[p24l1504t1019r1791b1054],

1	JACC	NNP	O	JACC	nn	3	SENT_496	[p24l1808t1021r1918b1054],
2	Cardiovasc	NNP	O	Cardiovasc	nn	3	SENT_496	[p24l1935t1019r2149b1054],
3	Interv	NNP	O	Interv	_	0	SENT_496	[p24l1131t1073r1252b1106],
4	.	.	O	.	_	0	SENT_496	[p24l1131t1073r1252b1106],

1	2011	CD	DATE	2011	_	0	SENT_497	[p24l1270t1073r1362b1106],
2	;	:	O	;	_	0	SENT_497	[p24l1375t1071r1656b1112],
3	4	CD	NUMBER	4	number	4	SENT_497	[p24l1375t1071r1656b1112],
4	(	CD	NUMBER	(	dep	1	SENT_497	[p24l1375t1071r1656b1112],
5	4	CD	NUMBER	4	num	6	SENT_497	[p24l1375t1071r1656b1112],
6	)	NN	O	)	dep	4	SENT_497	[p24l1375t1071r1656b1112],
7	:411	CD	NUMBER	:411	num	8	SENT_497	[p24l1375t1071r1656b1112],
8	-414	CD	NUMBER	-414	dep	4	SENT_497	[p24l1375t1071r1656b1112],
9	.	.	O	.	_	0	SENT_497	[p24l1375t1071r1656b1112],

1	22	CD	NUMBER	22	_	0	SENT_498	[p24l1130t1124r1190b1157],
2	.	.	O	.	_	0	SENT_498	[p24l1130t1124r1190b1157],

1	Collet	NNP	ORGANIZATION	Collet	nn	2	SENT_499	[p24l1218t1122r1330b1157],
2	JP	NNP	ORGANIZATION	JP	_	0	SENT_499	[p24l1346t1124r1396b1163],
3	,	,	O	,	_	0	SENT_499	[p24l1346t1124r1396b1163],
4	Hulot	NNP	PERSON	Hulot	nn	5	SENT_499	[p24l1419t1122r1524b1157],
5	JS	NNP	O	JS	appos	2	SENT_499	[p24l1540t1124r1588b1163],
6	,	,	O	,	_	0	SENT_499	[p24l1540t1124r1588b1163],
7	Anzaha	NNP	O	Anzaha	nn	8	SENT_499	[p24l1607t1122r1754b1157],
8	G	NNP	O	G	appos	2	SENT_499	[p24l1772t1124r1813b1163],
9	,	,	O	,	_	0	SENT_499	[p24l1772t1124r1813b1163],
10	et	FW	O	et	nn	11	SENT_499	[p24l1833t1125r1870b1157],
11	al	FW	O	al	appos	2	SENT_499	[p24l1887t1122r1928b1163],
12	;	:	O	;	_	0	SENT_499	[p24l1887t1122r1928b1163],
13	CLOVIS-2	NN	O	clovis-2	dep	2	SENT_499	[p24l1949t1124r2144b1157],

1	Investigators	NNS	O	investigator	_	0	SENT_500	[p24l1134t1176r1387b1218],
2	.	.	O	.	_	0	SENT_500	[p24l1134t1176r1387b1218],

1	High	JJ	O	high	amod	2	SENT_501	[p24l1405t1173r1492b1218],
2	doses	NNS	O	dose	nsubj	6	SENT_501	[p24l1508t1173r1614b1208],
3	of	IN	O	of	_	0	SENT_501	[p24l1628t1173r1667b1208],
4	clopidogrel	NN	O	clopidogrel	prep_of	2	SENT_501	[p24l1679t1173r1891b1219],
5	to	TO	O	to	aux	6	SENT_501	[p24l1905t1176r1943b1208],
6	overcome	VB	O	overcome	_	0	SENT_501	[p24l1957t1184r2147b1208],
7	genetic	JJ	O	genetic	amod	8	SENT_501	[p24l1131t1226r1265b1269],
8	resistance	NN	O	resistance	dobj	6	SENT_501	[p24l1277t1226r1463b1259],
9	:	:	O	:	_	0	SENT_501	[p24l1277t1226r1463b1259],
10	the	DT	O	the	nsubj	11	SENT_501	[p24l1475t1224r1534b1259],
11	randomized	VBN	O	randomize	parataxis	6	SENT_501	[p24l1547t1224r1762b1259],
12	crossover	NN	O	crossover	dobj	11	SENT_501	[p24l1775t1235r1949b1259],
13	CLOVIS-2	NN	O	clovis-2	nn	15	SENT_501	[p24l1958t1226r2146b1259],
14	(	CD	NUMBER	(	num	15	SENT_501	[p24l1132t1275r1369b1321],
15	Clopidogrel	NNP	O	Clopidogrel	dep	12	SENT_501	[p24l1132t1275r1369b1321],
16	and	CC	O	and	_	0	SENT_501	[p24l1390t1275r1459b1310],
17	Response	NNP	O	Response	nn	20	SENT_501	[p24l1482t1278r1663b1321],
18	Variability	NNP	O	Variability	nn	20	SENT_501	[p24l1682t1275r1877b1320],
19	Investigation	NNP	O	Investigation	nn	20	SENT_501	[p24l1898t1278r2144b1320],
20	Study	NNP	O	Study	conj_and	12	SENT_501	[p24l1132t1327r1242b1372],
21	2	CD	NUMBER	2	number	22	SENT_501	[p24l1261t1328r1310b1367],
22	)	CD	NUMBER	)	dep	20	SENT_501	[p24l1261t1328r1310b1367],
23	.	.	O	.	_	0	SENT_501	[p24l1261t1328r1310b1367],

1	JACC	NNP	O	JACC	nn	3	SENT_502	[p24l1329t1329r1441b1362],
2	Cardiovasc	NNP	O	Cardiovasc	nn	3	SENT_502	[p24l1460t1327r1678b1362],
3	Interv	NNP	O	Interv	_	0	SENT_502	[p24l1695t1329r1819b1362],
4	.	.	O	.	_	0	SENT_502	[p24l1695t1329r1819b1362],

1	2011	CD	DATE	2011	_	0	SENT_503	[p24l1841t1328r2144b1368, p24l1130t1380r1214b1413],
2	;	:	O	;	_	0	SENT_503	[p24l1841t1328r2144b1368, p24l1130t1380r1214b1413],
3	4	CD	NUMBER	4	number	4	SENT_503	[p24l1841t1328r2144b1368, p24l1130t1380r1214b1413],
4	(	CD	NUMBER	(	dep	1	SENT_503	[p24l1841t1328r2144b1368, p24l1130t1380r1214b1413],
5	4	CD	NUMBER	4	num	6	SENT_503	[p24l1841t1328r2144b1368, p24l1130t1380r1214b1413],
6	)	NN	O	)	dep	4	SENT_503	[p24l1841t1328r2144b1368, p24l1130t1380r1214b1413],
7	:392402	CD	NUMBER	:392402	dep	4	SENT_503	[p24l1841t1328r2144b1368, p24l1130t1380r1214b1413],
8	.	.	O	.	_	0	SENT_503	[p24l1841t1328r2144b1368, p24l1130t1380r1214b1413],

1	23	CD	NUMBER	23	_	0	SENT_504	[p24l1130t1433r1188b1466],
2	.	.	O	.	_	0	SENT_504	[p24l1130t1433r1188b1466],

1	Wiviott	NNP	PERSON	Wiviott	nn	2	SENT_505	[p24l1212t1432r1350b1466],
2	SD	NN	O	sd	_	0	SENT_505	[p24l1359t1432r1421b1472],
3	,	,	O	,	_	0	SENT_505	[p24l1359t1432r1421b1472],
4	Trenk	NN	PERSON	trenk	nn	5	SENT_505	[p24l1432t1430r1537b1466],
5	D	NN	O	d	appos	2	SENT_505	[p24l1550t1432r1588b1472],
6	,	,	O	,	_	0	SENT_505	[p24l1550t1432r1588b1472],
7	Frelinger	NNP	ORGANIZATION	Frelinger	nn	8	SENT_505	[p24l1602t1430r1760b1476],
8	AL	NNP	ORGANIZATION	AL	appos	2	SENT_505	[p24l1768t1432r1828b1472],
9	,	,	O	,	_	0	SENT_505	[p24l1768t1432r1828b1472],
10	et	FW	O	et	nn	11	SENT_505	[p24l1840t1433r1876b1466],
11	al	FW	O	al	appos	2	SENT_505	[p24l1885t1430r1923b1472],
12	;	:	O	;	_	0	SENT_505	[p24l1885t1430r1923b1472],
13	PRINCIPLETIMI	NNP	O	PRINCIPLETIMI	dep	2	SENT_505	[p24l1938t1432r2152b1466, p24l1130t1484r1219b1516],
14	44	CD	NUMBER	44	num	15	SENT_505	[p24l1235t1484r1284b1516],
15	Investigators	NNS	O	investigator	dep	13	SENT_505	[p24l1300t1484r1553b1526],
16	.	.	O	.	_	0	SENT_505	[p24l1300t1484r1553b1526],

1	Prasugrel	NNP	O	Prasugrel	_	0	SENT_506	[p24l1571t1481r1745b1526],
2	compared	VBN	O	compare	_	0	SENT_506	[p24l1761t1481r1951b1527],
3	with	IN	O	with	prepc_compared_with	1	SENT_506	[p24l1966t1481r2048b1516],
4	high	JJ	O	high	amod	5	SENT_506	[p24l2065t1481r2145b1526],
5	loading	NN	O	loading	pobj	1	SENT_506	[p24l1132t1532r1293b1577],
6	-	:	O	-	_	0	SENT_506	[p24l1132t1532r1293b1577],
7	and	CC	O	and	_	0	SENT_506	[p24l1314t1532r1384b1567],
8	maintenance-dose	JJ	O	maintenance-dose	amod	9	SENT_506	[p24l1408t1532r1771b1567],
9	clopidogrel	NN	O	clopidogrel	conj_and	1	SENT_506	[p24l1792t1532r2008b1578],
10	in	IN	O	in	_	0	SENT_506	[p24l2031t1534r2061b1566],
11	patients	NNS	O	patient	prep_in	9	SENT_506	[p24l2084t1543r2145b1578, p24l1130t1586r1235b1618],
12	with	IN	O	with	_	0	SENT_506	[p24l1248t1583r1330b1618],
13	planned	VBN	O	plan	amod	16	SENT_506	[p24l1347t1583r1498b1629],
14	percutaneous	JJ	O	percutaneous	amod	16	SENT_506	[p24l1515t1586r1775b1629],
15	coronary	JJ	O	coronary	amod	16	SENT_506	[p24l1789t1594r1959b1629],
16	intervention	NN	O	intervention	prep_with	11	SENT_506	[p24l1974t1586r2145b1618, p24l1130t1637r1214b1669],
17	:	:	O	:	_	0	SENT_506	[p24l1974t1586r2145b1618, p24l1130t1637r1214b1669],
18	the	DT	O	the	det	19	SENT_506	[p24l1232t1634r1293b1669],
19	Prasugrel	NNP	O	Prasugrel	dep	1	SENT_506	[p24l1312t1634r1486b1679],
20	in	IN	O	in	_	0	SENT_506	[p24l1504t1637r1534b1669],
21	Comparison	NN	O	comparison	prep_in	19	SENT_506	[p24l1552t1636r1783b1680],
22	to	TO	O	to	_	0	SENT_506	[p24l1800t1637r1839b1669],
23	Clopidogrel	NNP	O	Clopidogrel	prep_to	21	SENT_506	[p24l1856t1634r2077b1680],
24	for	IN	O	for	_	0	SENT_506	[p24l2093t1634r2149b1669],
25	Inhibition	NN	O	inhibition	prep_for	23	SENT_506	[p24l1134t1685r1317b1721],
26	of	IN	O	of	_	0	SENT_506	[p24l1339t1685r1379b1721],
27	Platelet	NN	O	platelet	nn	28	SENT_506	[p24l1399t1685r1545b1721],
28	Activation	NN	O	activation	prep_of	25	SENT_506	[p24l1562t1688r1762b1721],
29	and	CC	O	and	_	0	SENT_506	[p24l1784t1685r1854b1721],
30	AggregationThrombolysis	NN	O	aggregationthrombolysis	prep_of	25	SENT_506	[p24l1875t1688r2148b1731, p24l1130t1738r1411b1784],
31	in	IN	O	in	_	0	SENT_506	[p24l1436t1741r1468b1773],
32	Myocardial	JJ	O	myocardial	amod	35	SENT_506	[p24l1493t1738r1727b1784],
33	Infarction	NN	O	infarction	nn	35	SENT_506	[p24l1754t1738r1954b1774],
34	44	CD	NUMBER	44	num	35	SENT_506	[p24l1978t1741r2030b1773],
35	trial	NN	O	trial	prep_in	19	SENT_506	[p24l2052t1738r2144b1774],
36	.	.	O	.	_	0	SENT_506	[p24l2052t1738r2144b1774],

1	Circulation	NN	O	circulation	_	0	SENT_507	[p24l1132t1790r1357b1824],
2	.	.	O	.	_	0	SENT_507	[p24l1132t1790r1357b1824],

1	2007	CD	DATE	2007	_	0	SENT_508	[p24l1374t1791r1888b1830],
2	;	:	O	;	_	0	SENT_508	[p24l1374t1791r1888b1830],
3	116	CD	NUMBER	116	number	4	SENT_508	[p24l1374t1791r1888b1830],
4	(	CD	NUMBER	(	dep	1	SENT_508	[p24l1374t1791r1888b1830],
5	25	CD	NUMBER	25	num	6	SENT_508	[p24l1374t1791r1888b1830],
6	)	NN	O	)	dep	4	SENT_508	[p24l1374t1791r1888b1830],
7	:2923	CD	DURATION	:2923	num	8	SENT_508	[p24l1374t1791r1888b1830],
8	-2932	CD	DURATION	-2932	dep	4	SENT_508	[p24l1374t1791r1888b1830],
9	.	.	O	.	_	0	SENT_508	[p24l1374t1791r1888b1830],

1	24	CD	NUMBER	24	_	0	SENT_509	[p24l1130t1843r1190b1875],
2	.	.	O	.	_	0	SENT_509	[p24l1130t1843r1190b1875],

1	Bliden	NNP	PERSON	Bliden	nn	2	SENT_510	[p24l1219t1840r1332b1875],
2	KP	NNP	O	KP	_	0	SENT_510	[p24l1349t1842r1409b1881],
3	,	,	O	,	_	0	SENT_510	[p24l1349t1842r1409b1881],
4	Tantry	NNP	LOCATION	Tantry	nn	5	SENT_510	[p24l1423t1843r1548b1885],
5	US	NNP	LOCATION	US	appos	2	SENT_510	[p24l1564t1842r1625b1881],
6	,	,	O	,	_	0	SENT_510	[p24l1564t1842r1625b1881],
7	Storey	NNP	ORGANIZATION	Storey	nn	8	SENT_510	[p24l1641t1842r1762b1885],
8	RF	NNP	O	RF	appos	2	SENT_510	[p24l1777t1843r1834b1881],
9	,	,	O	,	_	0	SENT_510	[p24l1777t1843r1834b1881],
10	et	FW	O	et	nn	11	SENT_510	[p24l1849t1843r1886b1875],
11	al.	FW	O	al.	appos	2	SENT_510	[p24l1898t1840r1938b1875],
12	.	.	O	.	_	0	SENT_510	[p24l1898t1840r1938b1875],

1	The	DT	O	the	det	2	SENT_511	[p24l1953t1840r2024b1875],
2	effect	NN	O	effect	_	0	SENT_511	[p24l2038t1840r2148b1875],
3	of	IN	O	of	_	0	SENT_511	[p24l1131t1891r1170b1927],
4	ticagrelor	NN	O	ticagrelor	prep_of	2	SENT_511	[p24l1181t1892r1363b1937],
5	versus	CC	O	versus	prep	4	SENT_511	[p24l1374t1902r1493b1927],
6	clopidogrel	NN	O	clopidogrel	dep	5	SENT_511	[p24l1506t1892r1717b1937],
7	on	IN	O	on	_	0	SENT_511	[p24l1732t1902r1778b1927],
8	high	JJ	O	high	amod	11	SENT_511	[p24l1794t1892r1874b1937],
9	on-treatment	JJ	O	on-treatment	amod	11	SENT_511	[p24l1889t1895r2149b1927],
10	platelet	NN	O	platelet	nn	11	SENT_511	[p24l1133t1942r1274b1988],
11	reactivity	NN	O	reactivity	prep_on	6	SENT_511	[p24l1290t1945r1473b1987],
12	:	:	O	:	_	0	SENT_511	[p24l1290t1945r1473b1987],
13	combined	JJ	O	combined	amod	14	SENT_511	[p24l1491t1942r1679b1977],
14	analysis	NN	O	analysis	dep	2	SENT_511	[p24l1696t1942r1843b1987],
15	of	IN	O	of	_	0	SENT_511	[p24l1859t1942r1898b1977],
16	the	DT	O	the	det	17	SENT_511	[p24l1911t1942r1972b1977],
17	ONSET	NNP	O	ONSET	prep_of	14	SENT_511	[p24l1988t1944r2147b1977],
18	/	:	O	/	punct	2	SENT_511	[p24l1988t1944r2147b1977],
19	OFFSET	NNP	O	OFFSET	dep	2	SENT_511	[p24l1132t1996r1285b2029],
20	and	CC	O	and	_	0	SENT_511	[p24l1303t1994r1372b2029],
21	RESPOND	NNP	O	RESPOND	nn	22	SENT_511	[p24l1395t1996r1593b2029],
22	studies	NNS	O	study	conj_and	19	SENT_511	[p24l1613t1994r1756b2029],
23	.	.	O	.	_	0	SENT_511	[p24l1613t1994r1756b2029],

1	Am	VBP	O	be	_	0	SENT_512	[p24l1776t1996r1841b2028],
2	Heart	NNP	O	Heart	nsubj	3	SENT_512	[p24l1862t1996r1971b2029],
3	J.	NNP	O	J.	xcomp	1	SENT_512	[p24l1985t1996r2013b2029],
4	2011	CD	DATE	2011	dep	3	SENT_512	[p24l2034t1996r2145b2035],
5	;	:	O	;	_	0	SENT_512	[p24l2034t1996r2145b2035],

1	25	CD	NUMBER	25	_	0	SENT_513	[p24l1130t2097r1191b2130],
2	.	.	O	.	_	0	SENT_513	[p24l1130t2097r1191b2130],

1	Wiviott	NNP	PERSON	Wiviott	nn	2	SENT_514	[p24l1219t2097r1369b2130],
2	SD	NN	O	sd	_	0	SENT_514	[p24l1388t2097r1453b2136],
3	,	,	O	,	_	0	SENT_514	[p24l1388t2097r1453b2136],
4	Braunwald	NNP	PERSON	Braunwald	nn	5	SENT_514	[p24l1477t2095r1685b2130],
5	E	NNP	O	E	appos	2	SENT_514	[p24l1709t2097r1738b2136],
6	,	,	O	,	_	0	SENT_514	[p24l1709t2097r1738b2136],
7	McCabe	NNP	PERSON	McCabe	nn	8	SENT_514	[p24l1761t2095r1926b2130],
8	CH	NN	O	ch	appos	2	SENT_514	[p24l1948t2097r2020b2136],
9	,	,	O	,	_	0	SENT_514	[p24l1948t2097r2020b2136],
10	et	FW	O	et	nn	11	SENT_514	[p24l2042t2098r2079b2130],
11	al	FW	O	al	appos	2	SENT_514	[p24l2098t2095r2141b2136],
12	;	:	O	;	_	0	SENT_514	[p24l2098t2095r2141b2136],

1	TRITON-TIMI	NN	O	triton-timus	_	0	SENT_515	[p24l1130t2148r1395b2181],
2	38	CD	NUMBER	38	num	3	SENT_515	[p24l1409t2149r1456b2181],
3	Investigators	NNS	O	investigator	dep	1	SENT_515	[p24l1470t2149r1718b2191],
4	.	.	O	.	_	0	SENT_515	[p24l1470t2149r1718b2191],

1	Prasugrel	NNP	O	Prasugrel	_	0	SENT_516	[p24l1734t2146r1904b2191],
2	versus	CC	O	versus	prep	1	SENT_516	[p24l1916t2157r2033b2181],
3	clopidogrel	NN	O	clopidogrel	dep	2	SENT_516	[p24l2045t2146r2147b2192, p24l1131t2197r1253b2242],
4	in	IN	O	in	_	0	SENT_516	[p24l1276t2199r1305b2231],
5	patients	NNS	O	patient	prep_in	1	SENT_516	[p24l1328t2199r1482b2243],
6	with	IN	O	with	_	0	SENT_516	[p24l1501t2197r1584b2232],
7	acute	JJ	O	acute	amod	9	SENT_516	[p24l1606t2200r1711b2232],
8	coronary	JJ	O	coronary	amod	9	SENT_516	[p24l1730t2208r1903b2242],
9	syndromes	NNS	O	syndrome	prep_with	5	SENT_516	[p24l1923t2197r2144b2242],
10	.	.	O	.	_	0	SENT_516	[p24l1923t2197r2144b2242],

1	N	NN	O	n	_	0	SENT_517	[p24l1131t2251r1162b2285],
2	Engl	NNP	O	Engl	nn	4	SENT_517	[p24l1176t2250r1259b2295],
3	J	NNP	O	J	nn	4	SENT_517	[p24l1271t2252r1288b2285],
4	Med	NNP	O	Med	dep	1	SENT_517	[p24l1302t2250r1402b2285],
5	.	.	O	.	_	0	SENT_517	[p24l1302t2250r1402b2285],

1	2007	CD	DATE	2007	_	0	SENT_518	[p24l1420t2250r1933b2291],
2	;	:	O	;	_	0	SENT_518	[p24l1420t2250r1933b2291],
3	357	CD	NUMBER	357	number	4	SENT_518	[p24l1420t2250r1933b2291],
4	(	CD	NUMBER	(	dep	1	SENT_518	[p24l1420t2250r1933b2291],
5	20	CD	NUMBER	20	num	6	SENT_518	[p24l1420t2250r1933b2291],
6	)	NN	O	)	dep	4	SENT_518	[p24l1420t2250r1933b2291],
7	:2001	CD	DURATION	:2001	num	8	SENT_518	[p24l1420t2250r1933b2291],
8	-2015	CD	DURATION	-2015	dep	4	SENT_518	[p24l1420t2250r1933b2291],
9	.	.	O	.	_	0	SENT_518	[p24l1420t2250r1933b2291],

1	26	CD	NUMBER	26	_	0	SENT_519	[p24l1130t2303r1190b2335],
2	.	.	O	.	_	0	SENT_519	[p24l1130t2303r1190b2335],

1	Wallentin	NNP	PERSON	Wallentin	nn	2	SENT_520	[p24l1216t2300r1401b2335],
2	L	NNP	PERSON	L	_	0	SENT_520	[p24l1424t2302r1453b2341],
3	,	,	O	,	_	0	SENT_520	[p24l1424t2302r1453b2341],
4	Becker	NNP	PERSON	Becker	nn	5	SENT_520	[p24l1475t2300r1602b2335],
5	RC	NNP	O	RC	appos	2	SENT_520	[p24l1621t2302r1685b2341],
6	,	,	O	,	_	0	SENT_520	[p24l1621t2302r1685b2341],
7	Budaj	NNP	PERSON	Budaj	nn	8	SENT_520	[p24l1708t2300r1811b2345],
8	A	NNP	O	A	appos	2	SENT_520	[p24l1830t2302r1870b2341],
9	,	,	O	,	_	0	SENT_520	[p24l1830t2302r1870b2341],
10	et	FW	O	et	nn	11	SENT_520	[p24l1890t2303r1927b2335],
11	al	FW	O	al	appos	2	SENT_520	[p24l1945t2300r1986b2341],
12	;	:	O	;	_	0	SENT_520	[p24l1945t2300r1986b2341],
13	PLATO	NNP	O	PLATO	dep	2	SENT_520	[p24l2008t2302r2145b2335],
14	Investigators	NNS	O	investigator	dep	13	SENT_520	[p24l1134t2354r1399b2396],
15	.	.	O	.	_	0	SENT_520	[p24l1134t2354r1399b2396],

1	Ticagrelor	NNP	O	Ticagrelor	_	0	SENT_521	[p24l1421t2351r1622b2396],
2	versus	CC	O	versus	prep	1	SENT_521	[p24l1640t2362r1764b2386],
3	clopidogrel	NN	O	clopidogrel	dep	2	SENT_521	[p24l1784t2351r2005b2397],
4	in	IN	O	in	_	0	SENT_521	[p24l2028t2354r2058b2386],
5	patients	NNS	O	patient	prep_in	1	SENT_521	[p24l2082t2362r2144b2397, p24l1130t2405r1235b2439],
6	with	IN	O	with	_	0	SENT_521	[p24l1248t2403r1330b2439],
7	acute	JJ	O	acute	amod	9	SENT_521	[p24l1345t2406r1448b2439],
8	coronary	JJ	O	coronary	amod	9	SENT_521	[p24l1462t2414r1632b2449],
9	syndromes	NNS	O	syndrome	prep_with	5	SENT_521	[p24l1646t2403r1863b2449],
10	.	.	O	.	_	0	SENT_521	[p24l1646t2403r1863b2449],

1	N	NN	O	n	_	0	SENT_522	[p24l1879t2405r1910b2438],
2	Engl	NNP	O	Engl	nn	4	SENT_522	[p24l1923t2403r2005b2449],
3	J	NNP	O	J	nn	4	SENT_522	[p24l2015t2405r2032b2439],
4	Med	NNP	O	Med	dep	1	SENT_522	[p24l2044t2403r2144b2439],
5	.	.	O	.	_	0	SENT_522	[p24l2044t2403r2144b2439],

1	2009	CD	DATE	2009	_	0	SENT_523	[p24l1131t2455r1640b2495],
2	;	:	O	;	_	0	SENT_523	[p24l1131t2455r1640b2495],
3	361	CD	NUMBER	361	number	4	SENT_523	[p24l1131t2455r1640b2495],
4	(	CD	NUMBER	(	dep	1	SENT_523	[p24l1131t2455r1640b2495],
5	11	CD	NUMBER	11	num	6	SENT_523	[p24l1131t2455r1640b2495],
6	)	NN	O	)	dep	4	SENT_523	[p24l1131t2455r1640b2495],
7	:1045	CD	DURATION	:1045	num	8	SENT_523	[p24l1131t2455r1640b2495],
8	-1057	CD	DURATION	-1057	dep	4	SENT_523	[p24l1131t2455r1640b2495],
9	.	.	O	.	_	0	SENT_523	[p24l1131t2455r1640b2495],

1	27	CD	NUMBER	27	_	0	SENT_524	[p24l1130t2508r1192b2540],
2	.	.	O	.	_	0	SENT_524	[p24l1130t2508r1192b2540],

1	Mega	JJ	O	mega	amod	2	SENT_525	[p24l1223t2507r1339b2550],
2	JL	NN	O	jl	_	0	SENT_525	[p24l1357t2507r1407b2546],
3	,	,	O	,	_	0	SENT_525	[p24l1357t2507r1407b2546],
4	Close	NNP	O	Close	nn	5	SENT_525	[p24l1431t2505r1539b2540],
5	SL	NNP	O	SL	appos	2	SENT_525	[p24l1561t2507r1617b2546],
6	,	,	O	,	_	0	SENT_525	[p24l1561t2507r1617b2546],
7	Wiviott	NNP	PERSON	Wiviott	nn	8	SENT_525	[p24l1639t2507r1791b2540],
8	SD	NN	O	sd	appos	2	SENT_525	[p24l1811t2507r1877b2546],
9	,	,	O	,	_	0	SENT_525	[p24l1811t2507r1877b2546],
10	et	FW	O	et	nn	11	SENT_525	[p24l1900t2508r1938b2540],
11	al.	FW	O	al.	appos	2	SENT_525	[p24l1958t2505r2001b2540],
12	.	.	O	.	_	0	SENT_525	[p24l1958t2505r2001b2540],

1	Cytochrome	NN	O	cytochrome	nn	2	SENT_526	[p24l2025t2507r2137b2550, p24l1131t2557r1280b2592],
2	P450	NN	O	p450	_	0	SENT_526	[p24l1303t2559r1403b2592],
3	genetic	JJ	O	genetic	amod	4	SENT_526	[p24l1423t2559r1569b2602],
4	polymorphisms	NNS	O	polymorphism	dep	2	SENT_526	[p24l1590t2557r1894b2603],
5	and	CC	O	and	_	0	SENT_526	[p24l1915t2557r1986b2592],
6	the	DT	O	the	det	7	SENT_526	[p24l2007t2557r2071b2592],
7	response	NN	O	response	conj_and	2	SENT_526	[p24l2093t2568r2145b2592, p24l1131t2619r1263b2654],
8	to	TO	O	to	_	0	SENT_526	[p24l1275t2611r1313b2643],
9	prasugrel	NN	O	prasugrel	prep_to	7	SENT_526	[p24l1328t2608r1513b2654],
10	:	:	O	:	_	0	SENT_526	[p24l1328t2608r1513b2654],
11	relationship	NN	O	relationship	dep	2	SENT_526	[p24l1530t2608r1752b2654],
12	to	TO	O	to	_	0	SENT_526	[p24l1764t2611r1802b2643],
13	pharmacokinetic	JJ	O	pharmacokinetic	prep_to	11	SENT_526	[p24l1816t2608r2145b2654],
14	,	,	O	,	_	0	SENT_526	[p24l1816t2608r2145b2654],
15	pharmacodynamic	JJ	O	pharmacodynamic	prep_to	11	SENT_526	[p24l1133t2660r1491b2706],
16	,	,	O	,	_	0	SENT_526	[p24l1133t2660r1491b2706],
17	and	CC	O	and	_	0	SENT_526	[p24l1505t2660r1572b2695],
18	clinical	JJ	O	clinical	amod	19	SENT_526	[p24l1585t2660r1706b2695],
19	outcomes	NNS	O	outcome	conj_and	13	SENT_526	[p24l1719t2663r1913b2695],
20	.	.	O	.	_	0	SENT_526	[p24l1719t2663r1913b2695],

1	Circulation	NN	O	circulation	_	0	SENT_527	[p24l1927t2660r2146b2695],
2	.	.	O	.	_	0	SENT_527	[p24l1927t2660r2146b2695],

1	2009	CD	DATE	2009	_	0	SENT_528	[p24l1131t2712r1642b2752],
2	;	:	O	;	_	0	SENT_528	[p24l1131t2712r1642b2752],
3	119	CD	NUMBER	119	number	4	SENT_528	[p24l1131t2712r1642b2752],
4	(	CD	NUMBER	(	dep	1	SENT_528	[p24l1131t2712r1642b2752],
5	19	CD	NUMBER	19	num	6	SENT_528	[p24l1131t2712r1642b2752],
6	)	NN	O	)	dep	4	SENT_528	[p24l1131t2712r1642b2752],
7	:2553	CD	DURATION	:2553	num	8	SENT_528	[p24l1131t2712r1642b2752],
8	-2560	CD	DURATION	-2560	dep	4	SENT_528	[p24l1131t2712r1642b2752],
9	.	.	O	.	_	0	SENT_528	[p24l1131t2712r1642b2752],

1	28	CD	NUMBER	28	_	0	SENT_529	[p24l1130t2765r1190b2798],
2	.	.	O	.	_	0	SENT_529	[p24l1130t2765r1190b2798],

1	Wallentin	NNP	PERSON	Wallentin	nn	2	SENT_530	[p24l1217t2763r1404b2798],
2	L	NNP	PERSON	L	_	0	SENT_530	[p24l1427t2765r1456b2804],
3	,	,	O	,	_	0	SENT_530	[p24l1427t2765r1456b2804],
4	James	NNP	PERSON	James	nn	5	SENT_530	[p24l1476t2765r1592b2798],
5	S	NNP	PERSON	S	appos	2	SENT_530	[p24l1612t2765r1643b2804],
6	,	,	O	,	_	0	SENT_530	[p24l1612t2765r1643b2804],
7	Storey	NNP	PERSON	Storey	nn	8	SENT_530	[p24l1664t2765r1787b2808],
8	RF	NNP	PERSON	RF	appos	2	SENT_530	[p24l1808t2765r1865b2804],
9	,	,	O	,	_	0	SENT_530	[p24l1808t2765r1865b2804],
10	et	FW	O	et	nn	11	SENT_530	[p24l1887t2766r1924b2798],
11	al	FW	O	al	appos	2	SENT_530	[p24l1941t2763r1983b2804],
12	;	:	O	;	_	0	SENT_530	[p24l1941t2763r1983b2804],
13	PLATO	NNP	ORGANIZATION	PLATO	dep	2	SENT_530	[p24l2006t2765r2144b2798],
14	investigators	NNS	O	investigator	dep	13	SENT_530	[p24l1132t2818r1384b2861],
15	.	.	O	.	_	0	SENT_530	[p24l1132t2818r1384b2861],

1	Effect	NN	O	effect	_	0	SENT_531	[p24l1407t2815r1515b2851],
2	of	IN	O	of	_	0	SENT_531	[p24l1532t2815r1571b2851],
3	CYP2C19	NN	O	cyp2c19	nn	8	SENT_531	[p24l1588t2817r1774b2851],
4	and	CC	O	and	_	0	SENT_531	[p24l1792t2815r1861b2851],
5	ABCB1	NN	O	abcb1	nn	8	SENT_531	[p24l1880t2817r2016b2851],
6	single	JJ	O	single	amod	8	SENT_531	[p24l2038t2815r2147b2861],
7	nucleotide	NN	O	nucleotide	nn	8	SENT_531	[p24l1133t2866r1341b2901],
8	polymorphisms	NNS	O	polymorphism	prep_of	1	SENT_531	[p24l1363t2866r1669b2912],
9	on	IN	O	on	_	0	SENT_531	[p24l1690t2877r1737b2901],
10	outcomes	NNS	O	outcome	prep_on	1	SENT_531	[p24l1759t2869r1954b2901],
11	of	IN	O	of	_	0	SENT_531	[p24l1975t2866r2016b2901],
12	treatment	NN	O	treatment	prep_of	10	SENT_531	[p24l2034t2869r2145b2901, p24l1133t2921r1230b2953],
13	with	IN	O	with	_	0	SENT_531	[p24l1240t2918r1320b2953],
14	ticagrelor	NN	O	ticagrelor	prep_with	12	SENT_531	[p24l1333t2918r1512b2963],
15	versus	CC	O	versus	prep	14	SENT_531	[p24l1521t2929r1639b2953],
16	clopidogrel	NN	O	clopidogrel	dep	15	SENT_531	[p24l1650t2918r1858b2964],
17	for	IN	O	for	_	0	SENT_531	[p24l1870t2918r1925b2953],
18	acute	JJ	O	acute	amod	20	SENT_531	[p24l1934t2921r2036b2953],
19	coronary	JJ	O	coronary	amod	20	SENT_531	[p24l2048t2929r2146b2953, p24l1133t2979r1213b3014],
20	syndromes	NNS	O	syndrome	prep_for	16	SENT_531	[p24l1223t2969r1434b3014],
21	:	:	O	:	_	0	SENT_531	[p24l1223t2969r1434b3014],
22	a	DT	O	a	det	24	SENT_531	[p24l1448t2979r1469b3004],
23	genetic	JJ	O	genetic	amod	24	SENT_531	[p24l1479t2971r1615b3014],
24	substudy	NN	O	substudy	dep	1	SENT_531	[p24l1625t2969r1792b3014],
25	of	IN	O	of	_	0	SENT_531	[p24l1803t2968r1841b3004],
26	the	DT	O	the	det	28	SENT_531	[p24l1850t2969r1909b3004],
27	PLATO	NNP	O	PLATO	nn	28	SENT_531	[p24l1923t2971r2056b3004],
28	trial	NN	O	trial	prep_of	24	SENT_531	[p24l2067t2969r2145b3004],
29	.	.	O	.	_	0	SENT_531	[p24l2067t2969r2145b3004],

1	Lancet	NNP	O	Lancet	_	0	SENT_532	[p24l1131t3023r1268b3056],
2	.	.	O	.	_	0	SENT_532	[p24l1131t3023r1268b3056],

1	2010	CD	DATE	2010	_	0	SENT_533	[p24l1286t3021r1849b3062],
2	;	:	O	;	_	0	SENT_533	[p24l1286t3021r1849b3062],
3	376	CD	NUMBER	376	number	4	SENT_533	[p24l1286t3021r1849b3062],
4	(	CD	NUMBER	(	num	6	SENT_533	[p24l1286t3021r1849b3062],
5	9749	CD	NUMBER	9749	number	6	SENT_533	[p24l1286t3021r1849b3062],
6	)	CD	NUMBER	)	dep	1	SENT_533	[p24l1286t3021r1849b3062],
7	:1320	CD	DURATION	:1320	num	8	SENT_533	[p24l1286t3021r1849b3062],
8	-1328	CD	DURATION	-1328	dep	6	SENT_533	[p24l1286t3021r1849b3062],
9	.	.	O	.	_	0	SENT_533	[p24l1286t3021r1849b3062],

1	29	CD	NUMBER	29	_	0	SENT_534	[p24l1130t3074r1191b3107],
2	.	.	O	.	_	0	SENT_534	[p24l1130t3074r1191b3107],

1	Bonello	NNP	PERSON	Bonello	nn	2	SENT_535	[p24l1221t3072r1364b3107],
2	L	NNP	PERSON	L	_	0	SENT_535	[p24l1386t3074r1415b3113],
3	,	,	O	,	_	0	SENT_535	[p24l1386t3074r1415b3113],
4	Camoin-Jau	NNP	O	Camoin-Jau	nn	5	SENT_535	[p24l1437t3074r1670b3107],
5	L	NNP	O	L	appos	2	SENT_535	[p24l1693t3074r1722b3113],
6	,	,	O	,	_	0	SENT_535	[p24l1693t3074r1722b3113],
7	Arques	NNP	O	Arques	nn	8	SENT_535	[p24l1743t3074r1880b3118],
8	S	NNP	O	S	appos	2	SENT_535	[p24l1901t3074r1932b3113],
9	,	,	O	,	_	0	SENT_535	[p24l1901t3074r1932b3113],
10	et	FW	O	et	nn	11	SENT_535	[p24l1953t3075r1990b3107],
11	al.	FW	O	al.	appos	2	SENT_535	[p24l2008t3072r2049b3107],
12	.	.	O	.	_	0	SENT_535	[p24l2008t3072r2049b3107],

1	Adjusted	VBN	O	adjust	dep	25	SENT_536	[p24l2071t3072r2142b3107, p24l1128t3123r1243b3168],
2	clopidogrel	NN	O	clopidogrel	dobj	1	SENT_536	[p24l1264t3123r1475b3169],
3	loading	VBG	O	load	partmod	2	SENT_536	[p24l1496t3123r1638b3168],
4	doses	NNS	O	dose	dobj	3	SENT_536	[p24l1656t3123r1762b3158],
5	according	VBG	O	accord	_	0	SENT_536	[p24l1781t3123r1969b3168],
6	to	TO	O	to	prepc_according_to	3	SENT_536	[p24l1986t3126r2024b3158],
7	vasodilator-stimulated	JJ	O	vasodilator-stimulated	amod	12	SENT_536	[p24l2043t3134r2146b3158, p24l1131t3175r1460b3210],
8	phosphoprotein	NN	O	phosphoprotein	nn	12	SENT_536	[p24l1475t3175r1770b3221],
9	phosphorylation	NN	O	phosphorylation	nn	12	SENT_536	[p24l1784t3175r2086b3221],
10	index	NN	O	index	nn	12	SENT_536	[p24l2100t3177r2146b3210, p24l1131t3226r1200b3261],
11	decrease	NN	O	decrease	nn	12	SENT_536	[p24l1220t3226r1391b3261],
12	rate	NN	O	rate	pobj	3	SENT_536	[p24l1413t3229r1486b3261],
13	of	IN	O	of	_	0	SENT_536	[p24l1506t3226r1546b3261],
14	major	JJ	O	major	amod	17	SENT_536	[p24l1566t3229r1677b3271],
15	adverse	JJ	O	adverse	amod	17	SENT_536	[p24l1695t3226r1845b3261],
16	cardiovascular	JJ	O	cardiovascular	amod	17	SENT_536	[p24l1865t3226r2148b3261],
17	events	NNS	O	event	prep_of	12	SENT_536	[p24l1131t3281r1255b3313],
18	in	IN	O	in	_	0	SENT_536	[p24l1271t3280r1300b3312],
19	patients	NNS	O	patient	prep_in	17	SENT_536	[p24l1319t3280r1469b3323],
20	with	IN	O	with	_	0	SENT_536	[p24l1483t3278r1565b3313],
21	clopidogrel	NN	O	clopidogrel	nn	22	SENT_536	[p24l1582t3278r1793b3323],
22	resistance	NN	O	resistance	prep_with	19	SENT_536	[p24l1811t3280r2007b3313],
23	:	:	O	:	_	0	SENT_536	[p24l1811t3280r2007b3313],
24	a	DT	O	a	det	25	SENT_536	[p24l2024t3288r2045b3313],
25	multicenter	JJ	O	multicenter	_	0	SENT_536	[p24l2060t3278r2145b3313, p24l1130t3331r1282b3363],
26	randomized	VBN	O	randomize	partmod	25	SENT_536	[p24l1302t3328r1533b3363],
27	prospective	JJ	O	prospective	amod	28	SENT_536	[p24l1557t3331r1783b3374],
28	study	NN	O	study	dobj	26	SENT_536	[p24l1804t3328r1921b3373],
29	.	.	O	.	_	0	SENT_536	[p24l1804t3328r1921b3373],

1	J	NNP	O	J	nn	4	SENT_537	[p24l1941t3331r1959b3363],
2	Am	NNP	O	Am	nn	4	SENT_537	[p24l1978t3331r2044b3363],
3	Coll	NNP	PERSON	Coll	nn	4	SENT_537	[p24l2067t3329r2147b3363],
4	Cardiol	NNP	PERSON	Cardiol	_	0	SENT_537	[p24l1132t3380r1283b3415],
5	.	.	O	.	_	0	SENT_537	[p24l1132t3380r1283b3415],

1	2008	CD	DATE	2008	_	0	SENT_538	[p24l1301t3381r1787b3421],
2	;	:	O	;	_	0	SENT_538	[p24l1301t3381r1787b3421],
3	51	CD	NUMBER	51	number	4	SENT_538	[p24l1301t3381r1787b3421],
4	(	CD	NUMBER	(	dep	1	SENT_538	[p24l1301t3381r1787b3421],
5	14	CD	NUMBER	14	num	6	SENT_538	[p24l1301t3381r1787b3421],
6	)	NN	O	)	dep	4	SENT_538	[p24l1301t3381r1787b3421],
7	:1404	CD	DURATION	:1404	num	8	SENT_538	[p24l1301t3381r1787b3421],
8	-1411	CD	DURATION	-1411	dep	4	SENT_538	[p24l1301t3381r1787b3421],
9	.	.	O	.	_	0	SENT_538	[p24l1301t3381r1787b3421],

1	30	CD	NUMBER	30	_	0	SENT_539	[p24l1131t3433r1189b3465],
2	.	.	O	.	_	0	SENT_539	[p24l1131t3433r1189b3465],

1	Price	NNP	O	Price	nn	2	SENT_540	[p24l1218t3433r1305b3465],
2	MJ	NNP	O	MJ	_	0	SENT_540	[p24l1318t3433r1383b3471],
3	,	,	O	,	_	0	SENT_540	[p24l1318t3433r1383b3471],
4	Berger	NNP	PERSON	Berger	nn	5	SENT_540	[p24l1398t3433r1520b3475],
5	PB	NN	O	pb	appos	2	SENT_540	[p24l1532t3433r1588b3471],
6	,	,	O	,	_	0	SENT_540	[p24l1532t3433r1588b3471],
7	Teirstein	NNP	PERSON	Teirstein	nn	8	SENT_540	[p24l1601t3433r1759b3465],
8	PS	NNP	O	PS	appos	2	SENT_540	[p24l1774t3432r1828b3471],
9	,	,	O	,	_	0	SENT_540	[p24l1774t3432r1828b3471],
10	et	FW	O	et	nn	11	SENT_540	[p24l1842t3433r1878b3465],
11	al	FW	O	al	appos	2	SENT_540	[p24l1888t3430r1928b3471],
12	;	:	O	;	_	0	SENT_540	[p24l1888t3430r1928b3471],
13	GRAVITAS	NNP	O	GRAVITAS	dep	2	SENT_540	[p24l1942t3432r2149b3465],
14	Investigators	NNS	O	investigator	dep	13	SENT_540	[p24l1134t3483r1376b3526],
15	.	.	O	.	_	0	SENT_540	[p24l1134t3483r1376b3526],

1	Standard	NNP	O	Standard	_	0	SENT_541	[p24l1389t3481r1570b3516],
2	-	:	O	-	_	0	SENT_541	[p24l1389t3481r1570b3516],
3	vs	CC	O	vs	cc	4	SENT_541	[p24l1582t3492r1619b3516],
4	high-dose	JJ	O	high-dose	nsubj	1	SENT_541	[p24l1632t3481r1815b3526],
5	clopidogrel	NN	O	clopidogrel	dep	4	SENT_541	[p24l1826t3481r2029b3527],
6	based	VBN	O	base	_	0	SENT_541	[p24l2043t3481r2147b3516],
7	on	IN	O	on	_	0	SENT_541	[p24l1131t3543r1177b3567],
8	platelet	NN	O	platelet	nn	10	SENT_541	[p24l1195t3532r1337b3578],
9	function	NN	O	function	nn	10	SENT_541	[p24l1349t3532r1507b3567],
10	testing	NN	O	testing	prep_based_on	1	SENT_541	[p24l1523t3535r1654b3577],
11	after	IN	O	after	_	0	SENT_541	[p24l1667t3532r1757b3567],
12	percutaneous	JJ	O	percutaneous	amod	14	SENT_541	[p24l1772t3535r2031b3578],
13	coronary	JJ	O	coronary	amod	14	SENT_541	[p24l2046t3543r2145b3567, p24l1133t3595r1216b3630],
14	intervention	NN	O	intervention	prep_after	1	SENT_541	[p24l1236t3586r1480b3620],
15	:	:	O	:	_	0	SENT_541	[p24l1236t3586r1480b3620],
16	the	DT	O	the	det	17	SENT_541	[p24l1501t3584r1563b3620],
17	GRAVITAS	NNP	O	GRAVITAS	nsubj	18	SENT_541	[p24l1583t3586r1793b3620],
18	randomized	VBD	O	randomize	parataxis	1	SENT_541	[p24l1815t3584r2041b3620],
19	trial	NN	O	trial	dobj	18	SENT_541	[p24l2061t3584r2144b3620],
20	.	.	O	.	_	0	SENT_541	[p24l2061t3584r2144b3620],

1	JAMA	NN	O	jama	_	0	SENT_542	[p24l1128t3638r1260b3670],
2	.	.	O	.	_	0	SENT_542	[p24l1128t3638r1260b3670],

1	201	CD	NUMBER	201	num	2	SENT_543	[p24l1278t3636r1787b3676],
2	’	NN	O	’	_	0	SENT_543	[p24l1278t3636r1787b3676],
3	l	NN	O	l	tmod	2	SENT_543	[p24l1278t3636r1787b3676],
4	;	:	O	;	_	0	SENT_543	[p24l1278t3636r1787b3676],
5	305	CD	NUMBER	305	number	6	SENT_543	[p24l1278t3636r1787b3676],
6	(	CD	NUMBER	(	dep	2	SENT_543	[p24l1278t3636r1787b3676],
7	11	CD	NUMBER	11	num	8	SENT_543	[p24l1278t3636r1787b3676],
8	)	NN	O	)	dep	6	SENT_543	[p24l1278t3636r1787b3676],
9	:1097	CD	DURATION	:1097	num	10	SENT_543	[p24l1278t3636r1787b3676],
10	-1105	CD	DURATION	-1105	dep	6	SENT_543	[p24l1278t3636r1787b3676],
11	.	.	O	.	_	0	SENT_543	[p24l1278t3636r1787b3676],

1	31	CD	NUMBER	31	_	0	SENT_544	[p24l1131t3689r1190b3722],
2	.	.	O	.	_	0	SENT_544	[p24l1131t3689r1190b3722],

1	Parodi	NNP	PERSON	Parodi	nn	2	SENT_545	[p24l1219t3687r1337b3722],
2	G	NNP	PERSON	G	_	0	SENT_545	[p24l1357t3689r1397b3728],
3	,	,	O	,	_	0	SENT_545	[p24l1357t3689r1397b3728],
4	Marcucci	NNP	PERSON	Marcucci	nn	5	SENT_545	[p24l1417t3689r1590b3722],
5	R	NNP	PERSON	R	appos	2	SENT_545	[p24l1612t3689r1645b3728],
6	,	,	O	,	_	0	SENT_545	[p24l1612t3689r1645b3728],
7	Valenti	NNP	PERSON	Valenti	nn	8	SENT_545	[p24l1664t3687r1797b3722],
8	R	NNP	O	R	appos	2	SENT_545	[p24l1819t3689r1852b3728],
9	,	,	O	,	_	0	SENT_545	[p24l1819t3689r1852b3728],
10	et	FW	O	et	nn	11	SENT_545	[p24l1872t3690r1909b3722],
11	al.	FW	O	al.	appos	2	SENT_545	[p24l1925t3687r1965b3722],
12	.	.	O	.	_	0	SENT_545	[p24l1925t3687r1965b3722],

1	High	JJ	O	high	amod	3	SENT_546	[p24l1987t3687r2074b3732],
2	residual	JJ	O	residual	amod	3	SENT_546	[p24l2096t3698r2145b3722, p24l1131t3737r1238b3772],
3	platelet	NN	O	platelet	_	0	SENT_546	[p24l1254t3737r1396b3783],
4	reactivity	NN	O	reactivity	dep	3	SENT_546	[p24l1409t3740r1582b3782],
5	after	IN	O	after	_	0	SENT_546	[p24l1595t3737r1685b3772],
6	clopidogrel	NN	O	clopidogrel	nn	7	SENT_546	[p24l1696t3737r1907b3783],
7	loading	NN	O	loading	prep_after	4	SENT_546	[p24l1923t3737r2065b3782],
8	and	CC	O	and	advmod	7	SENT_546	[p24l2077t3737r2145b3772],

1	201	CD	NUMBER	201	number	2	SENT_547	[p25l34t12r101b44],
2	’	CD	NUMBER	’	num	3	SENT_547	[p25l113t12r126b43],
3	|	NN	O	|	_	0	SENT_547	[p25l113t12r126b43],
4	;	:	O	;	_	0	SENT_547	[p25l138t10r420b50],
5	4	CD	NUMBER	4	number	6	SENT_547	[p25l138t10r420b50],
6	(	CD	NUMBER	(	dep	3	SENT_547	[p25l138t10r420b50],
7	4	CD	NUMBER	4	num	8	SENT_547	[p25l138t10r420b50],
8	)	NN	O	)	dep	6	SENT_547	[p25l138t10r420b50],
9	:403	CD	NUMBER	:403	num	10	SENT_547	[p25l138t10r420b50],
10	-410	CD	NUMBER	-410	dep	6	SENT_547	[p25l138t10r420b50],
11	.	.	O	.	_	0	SENT_547	[p25l138t10r420b50],

1	long-term	JJ	O	long-term	amod	3	SENT_548	[p25l1132t9r1321b54],
2	cardiovascular	JJ	O	cardiovascular	amod	3	SENT_548	[p25l1335t9r1609b44],
3	events	NNS	O	event	_	0	SENT_548	[p25l1620t12r1743b44],
4	among	IN	O	among	_	0	SENT_548	[p25l1755t20r1890b54],
5	patients	NNS	O	patient	prep_among	3	SENT_548	[p25l1903t11r2052b55],
6	with	IN	O	with	_	0	SENT_548	[p25l2064t9r2146b44],
7	21	CD	NUMBER	21	prep_with	3	SENT_548	[p25l33t63r93b95],
8	.	.	O	.	_	0	SENT_548	[p25l33t63r93b95],

1	Angiolillo	JJ	O	angiolillo	amod	8	SENT_549	[p25l120t60r300b105],
2	DJ	NNP	O	DJ	tmod	1	SENT_549	[p25l318t63r372b101],
3	,	,	O	,	_	0	SENT_549	[p25l318t63r372b101],
4	Ueno	NNP	PERSON	Ueno	nn	6	SENT_549	[p25l392t63r493b95],
5	M.	NNP	PERSON	M.	nn	6	SENT_549	[p25l509t63r559b95],
6	Optimizing	NNP	PERSON	Optimizing	appos	2	SENT_549	[p25l577t62r793b106],
7	platelet	NN	O	platelet	nn	8	SENT_549	[p25l809t60r951b106],
8	inhi	NN	O	inhus	_	0	SENT_549	[p25l966t60r1049b95],
9	-	:	O	-	_	0	SENT_549	[p25l966t60r1049b95],
10	acute	JJ	O	acute	amod	12	SENT_549	[p25l1131t63r1235b95],
11	coronary	JJ	O	coronary	amod	12	SENT_549	[p25l1254t71r1425b106],
12	syndromes	NNS	O	syndrome	dep	8	SENT_549	[p25l1444t60r1653b106],
13	undergoing	VBG	O	undergo	partmod	12	SENT_549	[p25l1674t60r1898b105],
14	PCI	NN	O	pcus	dobj	13	SENT_549	[p25l1918t62r1992b95],
15	.	.	O	.	_	0	SENT_549	[p25l1918t62r1992b95],

1	JA	NN	O	ja	_	0	SENT_550	[p25l2011t63r2144b95],
2	/	:	O	/	punct	1	SENT_550	[p25l2011t63r2144b95],
3	\	CD	NUMBER	\	nsubj	21	SENT_550	[p25l2011t63r2144b95],
4	/	:	O	/	punct	20	SENT_550	[p25l2011t63r2144b95],
5	lA.	NN	O	la.	nn	6	SENT_550	[p25l2011t63r2144b95],
6	bition	NN	O	bition	dep	20	SENT_550	[p25l36t111r138b146],
7	in	IN	O	in	prep	6	SENT_550	[p25l152t113r180b145],
8	clopidogrel	NN	O	clopidogrel	nn	10	SENT_550	[p25l193t111r397b157],
9	poor	JJ	O	poor	amod	10	SENT_550	[p25l411t122r498b157],
10	metabolizersz	NN	O	metabolizersz	dep	7	SENT_550	[p25l509t111r752b146],
11	therapeutic	JJ	O	therapeutic	amod	12	SENT_550	[p25l764t111r976b157],
12	op	NN	O	op	dep	10	SENT_550	[p25l987t122r1049b157],
13	-	:	O	-	_	0	SENT_550	[p25l987t122r1049b157],
14	2011	CD	DATE	2011	dep	10	SENT_550	[p25l1131t112r1640b152],
15	;	:	O	;	_	0	SENT_550	[p25l1131t112r1640b152],
16	306	CD	NUMBER	306	num	17	SENT_550	[p25l1131t112r1640b152],
17	(	NN	O	(	dep	14	SENT_550	[p25l1131t112r1640b152],
18	1	CD	NUMBER	1	number	19	SENT_550	[p25l1131t112r1640b152],
19	’	CD	NUMBER	’	dep	17	SENT_550	[p25l1131t112r1640b152],
20	I	PRP	O	I	dep	3	SENT_550	[p25l1131t112r1640b152],
21	)	VBP	O	)	dep	1	SENT_550	[p25l1131t112r1640b152],
22	:1215	CD	DURATION	:1215	num	23	SENT_550	[p25l1131t112r1640b152],
23	-1223	CD	DURATION	-1223	dobj	21	SENT_550	[p25l1131t112r1640b152],
24	.	.	O	.	_	0	SENT_550	[p25l1131t112r1640b152],

1	2228	CD	DATE	2228	_	0	SENT_551	[p25l195t235r268b256],
2	JAMA	NNP	O	JAMA	nn	4	SENT_551	[p25l298t235r380b260],
3	,	,	O	,	_	0	SENT_551	[p25l298t235r380b260],
4	November	NNP	DATE	November	dep	1	SENT_551	[p25l392t233r522b256],
5	23/30	CD	DATE	23/30	num	4	SENT_551	[p25l532t235r610b260],
6	,	,	DATE	,	_	0	SENT_551	[p25l532t235r610b260],
7	2011	CD	DATE	2011	num	4	SENT_551	[p25l622t233r759b256],
8	.	.	O	.	_	0	SENT_551	[p25l622t233r759b256],

1	—	NN	O	—	_	0	SENT_552	[p25l622t233r759b256],
2	.	.	O	.	_	0	SENT_552	[p25l622t233r759b256],

1	Vo1	NN	O	vo1	_	0	SENT_553	[p25l622t233r759b256],
2	306	CD	NUMBER	306	num	1	SENT_553	[p25l769t235r823b260],
3	,	,	O	,	_	0	SENT_553	[p25l769t235r823b260],
4	No.	NN	O	no.	nn	10	SENT_553	[p25l834t235r877b256],
5	20	CD	NUMBER	20	num	10	SENT_553	[p25l889t235r919b256],
6	©	CD	NUMBER	©	num	10	SENT_553	[p25l1396t234r1492b256],
7	2011	CD	DATE	2011	num	10	SENT_553	[p25l1396t234r1492b256],
8	American	NNP	ORGANIZATION	American	nn	10	SENT_553	[p25l1503t234r1643b256],
9	Medical	NNP	ORGANIZATION	Medical	nn	10	SENT_553	[p25l1652t232r1768b256],
10	Association	NNP	ORGANIZATION	Association	appos	1	SENT_553	[p25l1776t234r1954b256],
11	.	.	O	.	_	0	SENT_553	[p25l1776t234r1954b256],

1	All	DT	O	all	det	2	SENT_554	[p25l1964t232r2006b256],
2	rights	NNS	O	rights	nsubj	3	SENT_554	[p25l2015t232r2099b264],
3	reserved	VBN	O	reserve	_	0	SENT_554	[p25l6t273r135b298],
4	.	.	O	.	_	0	SENT_554	[p25l6t273r135b298],

1	Downloaded	NNP	O	Downloaded	_	0	SENT_555	[p25l145t274r322b298],
2	From	IN	O	from	dep	1	SENT_555	[p25l331t274r419b297],
3	:	:	O	:	_	0	SENT_555	[p25l331t274r419b297],
4	http://jama.jaInanetwork.com/	NN	O	http://jama.jainanetwork.com/	pobj	2	SENT_555	[p25l430t273r868b304],
5	by	IN	O	by	_	0	SENT_555	[p25l876t274r910b304],
6	a	DT	O	a	det	7	SENT_555	[p25l920t281r935b297],
7	University	NNP	ORGANIZATION	University	prep_by	4	SENT_555	[p25l944t273r1092b304],
8	of	IN	ORGANIZATION	of	_	0	SENT_555	[p25l1101t273r1130b297],
9	Wisconsin	NNP	ORGANIZATION	Wisconsin	prep_of	7	SENT_555	[p25l1137t273r1283b297],
10	-	:	O	-	_	0	SENT_555	[p25l1292t273r1426b297],
11	Madison	NNP	O	Madison	nn	12	SENT_555	[p25l1292t273r1426b297],
12	User	NN	O	user	dep	4	SENT_555	[p25l1435t274r1501b298],
13	on	IN	O	on	_	0	SENT_555	[p25l1519t281r1553b297],
14	01/05/2014	CD	DATE	01/05/2014	prep_on	12	SENT_555	[p25l1562t273r1713b298],

